PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Smart, N; Risebro, CA; Melville, AAD; Moses, K; Schwartz, RJ; Chien, KR; Riley, PR				Smart, Nicola; Risebro, Catherine A.; Melville, Athalie A. D.; Moses, Kelvin; Schwartz, Robert J.; Chien, Kenneth R.; Riley, Paul R.			Thymosin beta 4 induces adult epicardial progenitor mobilization and neovascularization	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; ASPARTYL-LYSYL-PROLINE; HEART; MORPHOGENESIS; GROWTH; CELLS; ANGIOGENESIS; INVOLVEMENT; REPAIR	Cardiac failure has a principal underlying aetiology of ischaemic damage arising from vascular insufficiency. Molecules that regulate collateral growth in the ischaemic heart also regulate coronary vasculature formation during embryogenesis. Here we identify thymosin beta 4 (T beta 4) as essential for all aspects of coronary vessel development in mice, and demonstrate that T beta 4 stimulates significant outgrowth from quiescent adult epicardial explants, restoring pluripotency and triggering differentiation of fibroblasts, smooth muscle cells and endothelial cells. T beta 4 knockdown in the heart is accompanied by significant reduction in the pro-angiogenic cleavage product N-acetyl-seryl-aspartyl-lysyl-proline ( AcSDKP). Although injection of AcSDKP was unable to rescue T beta 4 mutant hearts, it significantly enhanced endothelial cell differentiation from adult epicardially derived precursor cells. This study identifies T beta 4 and AcSDKP as potent stimulators of coronary vasculogenesis and angiogenesis, and reveals T beta 4-induced adult epicardial cells as a viable source of vascular progenitors for continued renewal of regressed vessels at low basal level or sustained neovascularization following cardiac injury.	UCL Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA; Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA	University of London; University College London; Baylor College of Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Riley, PR (corresponding author), UCL Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.	P.Riley@ich.ucl.ac.uk	Smart, Nicola/AAD-3874-2020; Smart, Nicola/AAN-4011-2020	Smart, Nicola/0000-0002-3501-7254; 	MRC [G0200073] Funding Source: UKRI; Medical Research Council [G0200073] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen J, 1998, J BIOL CHEM, V273, P1252, DOI 10.1074/jbc.273.2.1252; Chen THP, 2002, DEV BIOL, V250, P198, DOI 10.1006/dbio.2002.0796; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; GRILLON C, 1990, FEBS LETT, V274, P30, DOI 10.1016/0014-5793(90)81322-F; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Luttun A, 2003, CARDIOVASC RES, V58, P378, DOI 10.1016/S0008-6363(03)00258-X; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Peng HM, 2005, CIRCULATION, V112, P2436, DOI 10.1161/CIRCULATIONAHA.104.528695; Poelmann RE, 2002, TEX HEART I J, V29, P255; Pokharel S, 2004, CIRCULATION, V110, P3129, DOI 10.1161/01.CIR.0000147180.87553.79; Rasoul S, 2004, J HYPERTENS, V22, P593, DOI 10.1097/00004872-200403000-00023; RIEGER KJ, 1993, BIOCHEM J, V296, P373, DOI 10.1042/bj2960373; Saiura A, 2001, NAT MED, V7, P382, DOI 10.1038/86394; Smart N, 2002, MECH DEVELOP, V119, pS65, DOI 10.1016/S0925-4773(03)00093-5; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tomanek RJ, 2004, MOL CELL BIOCHEM, V264, P3, DOI 10.1023/B:MCBI.0000044369.88528.a3; von Kodpolitsch Y, 2004, Z KARDIOL, V93, P929, DOI 10.1007/s00392-004-0152-7; Wang DH, 2004, AM J PHYSIOL-HEART C, V287, pH2099, DOI 10.1152/ajpheart.00592.2004; Ward NL, 2002, SEMIN CELL DEV BIOL, V13, P19, DOI 10.1006/scdb.2001.0288; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zeisberg EM, 2005, J CLIN INVEST, V115, P1522, DOI 10.1172/JCI23769	27	499	525	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					177	182		10.1038/nature05383	http://dx.doi.org/10.1038/nature05383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17108969				2022-12-01	WOS:000243384300044
J	Cho, US; Xu, WQ				Cho, Uhn Soo; Xu, Wenqing			Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme	NATURE			English	Article							REGULATORY B SUBUNITS; MIDDLE TUMOR-ANTIGEN; CATALYTIC SUBUNIT; CARBOXYL METHYLATION; B56 SUBUNIT; CORE ENZYME; A-SUBUNIT; PP2A; ALPHA; IDENTIFICATION	Protein phosphatase 2A (PP2A) is a principal Ser/Thr phosphatase, the deregulation of which is associated with multiple human cancers, Alzheimer's disease and increased susceptibility to pathogen infections. How PP2A is structurally organized and functionally regulated remains unclear. Here we report the crystal structure of an AB'C heterotrimeric PP2A holoenzyme. The structure reveals that the HEAT repeats of the scaffold A subunit form a horseshoe-shaped fold, holding the catalytic C and regulatory B' subunits together on the same side. The regulatory B' subunit forms pseudo-HEAT repeats and interacts with the C subunit near the active site, thereby defining substrate specificity. The methylated carboxy-terminal tail of the C subunit interacts with a highly negatively charged region at the interface between A and B' subunits, suggesting that the C-terminal carboxyl methylation of the C subunit promotes B' subunit recruitment by neutralizing charge repulsion. Together, our structural results establish a crucial foundation for understanding PP2A assembly, substrate recruitment and regulation.	Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Xu, WQ (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	wxu@u.washington.edu		Xu, Wenqing/0000-0002-2884-3101; cho, uhn-soo/0000-0002-6992-2455				CAI LW, 1995, BIOCHEM BIOPH RES CO, V208, P274, DOI 10.1006/bbrc.1995.1334; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Ikehara T, 2006, PROTEIN EXPRES PURIF, V45, P150, DOI 10.1016/j.pep.2005.06.002; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrotti D, 2006, BRIT J CANCER, V95, P775, DOI 10.1038/sj.bjc.6603317; PHILIPS MR, 2004, SCI STKE, pPE13; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Ruediger R, 1999, J VIROL, V73, P839, DOI 10.1128/JVI.73.1.839-842.1999; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Smith GD, 1998, ACTA CRYSTALLOGR D, V54, P799, DOI 10.1107/S0907444997018805; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185	40	326	344	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					53	57		10.1038/nature05351	http://dx.doi.org/10.1038/nature05351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17086192				2022-12-01	WOS:000243225100033
J	Moroz, LL; Edwards, JR; Puthanveettil, SV; Kohn, AB; Hla, T; Heyland, A; Knudsen, L; Sahni, A; Yu, FH; Liu, L; Jezzini, S; Lovell, P; Iannucculli, W; Chen, MC; Nguyen, T; Sheng, HT; Shaw, R; Kalachikov, S; Panchin, YV; Farmerie, W; Russo, JJ; Ju, JY; Kandel, ER				Moroz, Leonid L.; Edwards, John R.; Puthanveettil, Sathyanarayanan V.; Kohn, Andrea B.; Hla, Thomas; Heyland, Andreas; Knudsen, Ljame; Sahni, Anuj; Yu, Fahong; Liu, Li; Jezzini, Sami; Lovell, Peter; Iannucculli, William; Chen, Minchen; Nguyen, Tuan; Sheng, Huitao; Shaw, Regina; Kalachikov, Sergey; Panchin, Yuri V.; Farmerie, William; Russo, James J.; Ju, Jingyue; Kandel, Eric R.			Neuronal transcriptome of Aplysia: neuronal compartments and circuitry	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; OPISTHOBRANCHIA MOLLUSCA; PHYLOGENETIC ANALYSIS; ABDOMINAL GANGLION; METACEREBRAL CELLS; ANIMAL PHYLOGENY; GENE-SEQUENCES; CDNA LIBRARY; CALIFORNICA; EVOLUTION	Molecular analyses of Aplysia, a well-established model organism for cellular and systems neural science, have been seriously handicapped by a lack of adequate genomic information. By sequencing cDNA libraries from the central nervous system (CNS), we have identified over 175,000 expressed sequence tags (ESTs), of which 19,814 are unique neuronal gene products and represent 50%-70% of the total Aplysia neuronal transcriptome. We have characterized the transcriptome at three levels: (1) the central nervous system, (2) the elementary components of a simple behavior: the gill-withdrawal reflex-by analyzing sensory, motor, and serotonergic modulatory neurons, and (3) processes of individual neurons. In addition to increasing the amount of available gene sequences of Aplysia by two orders of magnitude, this collection represents the largest database available for any member of the Lophotrochozoa and therefore provides additional insights into evolutionary strategies used by this highly successful diversified lineage, one of the three proposed super-clacles of bilateral animals.	Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32611 USA; Columbia Univ, Columbia Genome Ctr, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, New York State Psychiat Inst, New York, NY 10032 USA; Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32611 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; State University System of Florida; University of Florida; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Moroz, LL (corresponding author), Univ Florida, Whitney Lab Marine Biosci, 9505 Ocean Shore Blvd, St Augustine, FL 32080 USA.	moroz@whitney.ufl.edu; erk5@columbia.edu		Heyland, Andreas/0000-0002-7592-4473; Panchin, Yuri/0000-0002-8006-2839; Moroz, Leonid/0000-0002-1333-3176	NHGRI NIH HHS [P50 HG002806] Funding Source: Medline; NIMH NIH HHS [R01 MH075026] Funding Source: Medline; NINDS NIH HHS [NS39103, R01 NS039103] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039103] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Brannvall K, 2003, BIOCHEM BIOPH RES CO, V308, P369, DOI 10.1016/S0006-291X(03)01386-X; Brusca R. C., 2003, INVERTEBRATES; CASH D, 1989, J NEUROBIOL, V20, P25, DOI 10.1002/neu.480200104; Cheney-Choker S, 2004, POETRY WALES, V40, P55; CLEARY LJ, 1993, J NEUROPHYSIOL, V70, P1767, DOI 10.1152/jn.1993.70.5.1767; Cravchik A, 2001, ARCH NEUROL-CHICAGO, V58, P1772, DOI 10.1001/archneur.58.11.1772; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; Diaz-Rios M, 1999, J COMP NEUROL, V413, P255, DOI 10.1002/(SICI)1096-9861(19991018)413:2<255::AID-CNE7>3.0.CO;2-E; Fantappie MR, 2001, EXP PARASITOL, V98, P162, DOI 10.1006/expr.2001.4630; Fitzgerald KK, 1997, LEARN MEMORY, V3, P366, DOI 10.1101/lm.3.5.366; FU GK, 2002, Patent No. 6387624; Fujisawa Y, 1999, J NEUROSCI, V19, P9618; GILLER E, 1971, J NEUROPHYSIOL, V34, P93, DOI 10.1152/jn.1971.34.1.93; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Grande C, 2004, MOL PHYLOGENET EVOL, V33, P378, DOI 10.1016/j.ympev.2004.06.008; Grande C, 2004, MOL BIOL EVOL, V21, P303, DOI 10.1093/molbev/msh016; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haag ES, 1999, DEV BIOL, V211, P77, DOI 10.1006/dbio.1999.9283; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Haszprunar G, 2000, AM MALACOL BULL, V15, P115; HENING WA, 1979, BRAIN RES, V179, P231, DOI 10.1016/0006-8993(79)90441-4; Heyland A, 2006, J EXP ZOOL PART B, V306B, P551, DOI 10.1002/jez.b.21113; Holland ND, 2003, NAT REV NEUROSCI, V4, P617, DOI 10.1038/nrn1175; JAHANPARWAR B, 1979, BEHAV NEURAL BIOL, V27, P39, DOI 10.1016/S0163-1047(79)92744-4; Jezzini SH, 2005, J NEUROSCI METH, V149, P15, DOI 10.1016/j.jneumeth.2005.05.007; Jezzini SH, 2004, MOL BRAIN RES, V127, P27, DOI 10.1016/j.molbrainres.2004.05.007; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KANDEL E.R., 1979, BEHAV BIOL APLYSIA; KANDEL ER, 1966, J PHYSIOL-LONDON, V183, P287, DOI 10.1113/jphysiol.1966.sp007867; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kandel ER, 1976, CELLULAR BASIS BEHAV; Knudsen B, 2006, MOL PHYLOGENET EVOL, V38, P459, DOI 10.1016/j.ympev.2005.08.017; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; KUPFERMANN I, 1974, BEHAV BIOL, V10, P1, DOI 10.1016/S0091-6773(74)91644-7; KUPFERMANN I, 1982, BRAIN RES, V241, P334, DOI 10.1016/0006-8993(82)91072-1; KUPFERMANN I, 1969, SCIENCE, V164, P847, DOI 10.1126/science.164.3881.847; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lehesjoki AE, 2003, EMBO J, V22, P3473, DOI 10.1093/emboj/cdg338; Lovell P, 2006, INTEGR COMP BIOL, V46, P847, DOI 10.1093/icb/icl042; Lydeard C, 2000, MOL PHYLOGENET EVOL, V15, P83, DOI 10.1006/mpev.1999.0719; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; Moccia R, 2003, J NEUROSCI, V23, P9409; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Nielsen C, 2005, EVOL DEV, V7, P483, DOI 10.1111/j.1525-142X.2005.05051.x; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Passamaneck Y, 2006, MOL PHYLOGENET EVOL, V40, P20, DOI 10.1016/j.ympev.2006.02.001; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Pojeta J. Jr, 1987, P270; RAE PMM, 1979, NUCLEIC ACIDS RES, V6, P2987, DOI 10.1093/nar/6.9.2987; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; ROSEN SC, 1989, J NEUROSCI, V9, P1562; Sakharov D A, 1974, J Neural Transm, VSuppl 11, P43; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Valentine J.W., 2004, ORIGIN PHYLA; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; WEISS KR, 1976, BRAIN RES, V117, P33, DOI 10.1016/0006-8993(76)90554-0; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404; YANG ZB, 1994, J MOL EVOL, V39, P105; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	70	246	251	3	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1453	1467		10.1016/j.cell.2006.09.052	http://dx.doi.org/10.1016/j.cell.2006.09.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190607	Green Accepted, Bronze			2022-12-01	WOS:000243690000023
J	Ye, QZ; Krug, RM; Tao, YZJ				Ye, Qiaozhen; Krug, Robert M.; Tao, Yizhi Jane			The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA	NATURE			English	Article							NUCLEAR-LOCALIZATION; CRYSTAL-STRUCTURE; POLYMERASE; IDENTIFICATION; IMPORT; NP	Influenza A viruses pose a serious threat to world public health, particularly the currently circulating avian H5N1 viruses. The influenza viral nucleoprotein forms the protein scaffold of the helical genomic ribonucleoprotein complexes, and has a critical role in viral RNA replication(1). Here we report a 3.2 angstrom crystal structure of this nucleoprotein, the overall shape of which resembles a crescent with a head and a body domain, with a protein fold different compared with that of the rhabdovirus nucleoprotein(2,3). Oligomerization of the influenza virus nucleoprotein is mediated by a flexible tail loop that is inserted inside a neighbouring molecule. This flexibility in the tail loop enables the nucleoprotein to form loose polymers as well as rigid helices, both of which are important for nucleoprotein functions. Single residue mutations in the tail loop result in the complete loss of nucleoprotein oligomerization. An RNA-binding groove, which is found between the head and body domains at the exterior of the nucleoprotein oligomer, is lined with highly conserved basic residues widely distributed in the primary sequence. The nucleoprotein structure shows that only one of two proposed nuclear localization signals are accessible, and suggests that the body domain of nucleoprotein contains the binding site for the viral polymerase. Our results identify the tail loop binding pocket as a potential target for antiviral development.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Rice University; University of Texas System; University of Texas Austin	Tao, YZJ (corresponding author), Rice Univ, Dept Biochem & Cell Biol, 6100 Main St,MS140, Houston, TX 77005 USA.	ytao@rice.edu		Ye, Qiaozhen/0000-0002-3942-4121				Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; ALBO C, 1995, J VIROL, V69, P3799, DOI 10.1128/JVI.69.6.3799-3806.1995; Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Cros JF, 2005, TRAFFIC, V6, P205, DOI 10.1111/j.1600-0854.2005.00263.x; Digard P, 1999, J VIROL, V73, P2222, DOI 10.1128/JVI.73.3.2222-2231.1999; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; HONDA A, 1988, J BIOCHEM-TOKYO, V104, P1021, DOI 10.1093/oxfordjournals.jbchem.a122569; Iseni F, 1998, J GEN VIROL, V79, P2909, DOI 10.1099/0022-1317-79-12-2909; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOBAYASHI M, 1994, J VIROL, V68, P8433, DOI 10.1128/JVI.68.12.8433-8436.1994; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Medcalf L, 1999, J VIROL, V73, P7349, DOI 10.1128/JVI.73.9.7349-7356.1999; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Rudolph MG, 2003, STRUCTURE, V11, P1219, DOI 10.1016/j.str.2003.08.011; SHAPIRO GI, 1988, J VIROL, V62, P2285, DOI 10.1128/JVI.62.7.2285-2290.1988; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang P, 1997, J VIROL, V71, P1850, DOI 10.1128/JVI.71.3.1850-1856.1997; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329	30	327	353	5	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1078	1082		10.1038/nature05379	http://dx.doi.org/10.1038/nature05379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17151603				2022-12-01	WOS:000242971100058
J	Lange, LA; Carlson, CS; Hindorff, LA; Lange, EM; Walston, J; Durda, JP; Cushman, M; Bis, JC; Zeng, DL; Lin, D; Kuller, LH; Nickerson, DA; Psaty, BM; Tracy, RP; Reiner, AP				Lange, Leslie A.; Carlson, Christopher S.; Hindorff, Lucia A.; Lange, Ethan M.; Walston, Jeremy; Durda, J. Peter; Cushman, Mary; Bis, Joshua C.; Zeng, Donglin; Lin, Danyu; Kuller, Lewis H.; Nickerson, Deborah A.; Psaty, Bruce M.; Tracy, Russell P.; Reiner, Alexander P.			Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; INTIMA-MEDIA THICKNESS; MENDELIAN RANDOMIZATION; INFLAMMATORY RESPONSE; RISK-FACTORS; HEALTH; ATHEROSCLEROSIS; PROMOTER; LINKAGE	Context C-reactive protein (CRP) is an inflammation protein that may play a role in the pathogenesis of cardiovascular disease (CVD). Objective To assess whether polymorphisms in the CRP gene are associated with plasma CRP, carotid intima-media thickness (CIMT), and CVD events. Design, Setting, and Participants In the prospective, population-based Cardiovascular Health Study, 4 tag single-nucleotide polymorphisms ( SNPs) (1919A/ T, 2667G/C, 3872G/A, 5237A/G) were genotyped in 3941 white ( European American) participants and 5 tag SNPs ( addition of 790A/T) were genotyped in 700 black ( African American) participants, aged 65 years or older, all of whom were without myocardial infarction (MI) or stroke before study entry. Median follow-up was 13 years (1989-2003). Main Outcome Measures Baseline CIMT; occurrence of MI, stroke, and CVD mortality during follow-up. Results In white participants, 461 incident MIs, 491 incident strokes, and 490 CVD-related deaths occurred; in black participants, 67 incident MIs, 78 incident strokes, and 75 CVD-related deaths occurred. The 1919T and 790T alleles were associated with higher CRP levels in white and black participants, respectively. The 3872A allele was associated with lower CRP levels in both populations, and the 2667C allele was associated with lower CRP levels in white participants only. There was no association between CIMT and any CRP gene polymorphism in either population. In white participants, the 1919T allele was associated with increased risk of stroke for TT vs AA ( hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.06- 1.87) and for CVD mortality ( HR, 1.40; 95% CI, 1.10-1.90). In black participants, homozygosity for the 790T allele was associated with a 4-fold increased risk of MI compared with homozygosity for the 790A allele ( 95% CI, 1.58-10.53). The minor alleles of the 2 SNPs associated with lower plasma CRP concentration in white participants ( 2667C and 3872A) were associated with decreased risk of CVD mortality. Conclusions Genetic variation in the CRP gene is associated with plasma CRP levels and CVD risk in older adults.	Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Ctr Aging & Hlth, Baltimore, MD USA; Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Vermont; University of Vermont; University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lange, LA (corresponding author), Univ N Carolina, Dept Genet, Campus Box 7264,103 Mason Farm Rd, Chapel Hill, NC 27599 USA.	leslie_lange@med.unc.edu			NHLBI NIH HHS [N01-HC-85079, N01-HC-85084, N01-HC-85081, N01-HC-85085, N01-HC-85086, R01 HL-071862-03, N01-HC-85082, N01-HC-85083, N01 HC-15103, N01-HC-35129, N01-HC-85080] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC085079, N01HC085086, N01HC085081, N01HC085082, N01HC085083, N01HC085080, N01HC085085, N01HC035129, N01HC085084] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071862] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Danenberg HD, 2003, CIRCULATION, V108, P512, DOI 10.1161/01.CIR.0000085568.13915.1E; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danik JS, 2006, ANN HUM GENET, V70, P705, DOI 10.1111/j.1469-1809.2006.00272.x; de Maat MPM, 2004, ARTERIOSCL THROM VAS, V24, P2168, DOI 10.1161/01.ATV.0000143856.01669.e7; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gill R, 2004, J CEREBR BLOOD F MET, V24, P1214, DOI 10.1097/01.WCB.0000136517.61642.99; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jialal I, 2004, HYPERTENSION, V44, P6, DOI 10.1161/01.HYP.0000130484.20501.df; Juonala M, 2006, ARTERIOSCL THROM VAS, V26, P1883, DOI 10.1161/01.ATV.0000228818.11968.7a; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kobayashi S, 2003, ARTERIOSCL THROM VAS, V23, P1398, DOI 10.1161/01.ATV.0000081637.36475.BC; KULLER L, 1994, AM J EPIDEMIOL, V139, P1164, DOI 10.1093/oxfordjournals.aje.a116963; Ledue TB, 2003, CLIN CHEM, V49, P1258, DOI 10.1373/49.8.1258; LEWONTIN RC, 1964, GENETICS, V49, P49; Lin DY, 2004, GENET EPIDEMIOL, V26, P255, DOI 10.1002/gepi.10317; Macy EM, 1997, CLIN CHEM, V43, P52; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sano T, 2003, CIRCULATION, V108, P282, DOI 10.1161/01.CIR.0000079173.84669.4F; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Smith GD, 2004, QJM-INT J MED, V97, P163, DOI 10.1093/qjmed/hch025; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167; Vickers MA, 2002, CARDIOVASC RES, V53, P1029, DOI 10.1016/S0008-6363(01)00534-X; Williams TN, 2004, ARTERIOSCL THROM VAS, V24, P61, DOI 10.1161/01.ATV.0000104014.24367.16; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	45	209	222	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2703	2711		10.1001/jama.296.22.2703	http://dx.doi.org/10.1001/jama.296.22.2703			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164456	Bronze			2022-12-01	WOS:000242765700025
J	Urakawa, I; Yamazaki, Y; Shimada, T; Iijima, K; Hasegawa, H; Okawa, K; Fujita, T; Fukumoto, S; Yamashita, T				Urakawa, Itaru; Yamazaki, Yuji; Shimada, Takashi; Iijima, Kousuke; Hasegawa, Hisashi; Okawa, Katsuya; Fujita, Toshiro; Fukumoto, Seiji; Yamashita, Takeyoshi			Klotho converts canonical FGF receptor into a specific receptor for FGF23	NATURE			English	Article							FIBROBLAST GROWTH FACTOR-23; VITAMIN-D METABOLISM; PHOSPHATE REABSORPTION; PROTEIN; GENE; HYPOPHOSPHATEMIA; REGULATOR; MICE; OSTEOMALACIA; SUPPRESSION	FGF23 is a unique member of the fibroblast growth factor (FGF) family because it acts as a hormone that derives from bone and regulates kidney functions, whereas most other family members are thought to regulate various cell functions at a local level(1-5). The renotropic activity of circulating FGF23 indicates the possible presence of an FGF23-specific receptor in the kidney(6). Here we show that a previously undescribed receptor conversion by Klotho, a senescence-related molecule(7), generates the FGF23 receptor. Using a renal homogenate, we found that Klotho binds to FGF23. Forced expression of Klotho enabled the high-affinity binding of FGF23 to the cell surface and restored the ability of a renal cell line to respond to FGF23 treatment. Moreover, FGF23 incompetence was induced by injecting wild-type mice with an anti-Klotho monoclonal antibody. Thus, Klotho is essential for endogenous FGF23 function. Because Klotho alone seemed to be incapable of intracellular signalling, we searched for other components of the FGF23 receptor and found FGFR1(IIIc), which was directly converted by Klotho into the FGF23 receptor. Thus, the concerted action of Klotho and FGFR1( IIIc) reconstitutes the FGF23 receptor. These findings provide insights into the diversity and specificity of interactions between FGF and FGF receptors.	Kirin Brewery Co Ltd, Pharmaceut Res Labs, Gunma 3701295, Japan; Tokyo Univ Hosp, Dept Internal Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan	Kirin Brewery Company Limited; University of Tokyo	Urakawa, I (corresponding author), Kirin Brewery Co Ltd, Pharmaceut Res Labs, 3 Miyahara, Gunma 3701295, Japan.	iurakawa@kirin.co.jp	Fukumoto, Seiji/B-7853-2015	Fukumoto, Seiji/0000-0003-3610-3469; Fujita, Toshiro/0000-0001-9141-7060				CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Liu LX, 2000, BLOOD, V96, P1772, DOI 10.1182/blood.V96.5.1772.h8001772_1772_1781; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; Nabeshima Y, 2002, AGEING RES REV, V1, P627, DOI 10.1016/S1568-1637(02)00027-2; Ornitz D.M., 2001, GENOME BIOL, V2; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; VAINIKKA S, 1994, J BIOL CHEM, V269, P18320; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wikvall K, 2001, INT J MOL MED, V7, P201; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	30	1303	1422	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					770	774		10.1038/nature05315	http://dx.doi.org/10.1038/nature05315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17086194				2022-12-01	WOS:000242581100063
J	Pfingsten, JS; Costantino, DA; Kieft, JS				Pfingsten, Jennifer S.; Costantino, David A.; Kieft, Jeffrey S.			Structural basis for ribosome recruitment and manipulation by a viral IRES RNA	SCIENCE			English	Article							METHIONINE-INDEPENDENT INITIATION; ENTRY SITE; TRANSLATION; PROTEIN; VISUALIZATION; ELONGATION; SUBUNIT; BINDING	Canonical cap - dependent translation initiation requires a large number of protein factors that act in a stepwise assembly process. In contrast, internal ribosomal entry sites (IRESs) are cis-acting RNAs that in some cases completely supplant these factors by recruiting and activating the ribosome using a single structured RNA. Here we present the crystal structure of the ribosome-binding domain from a Dicistroviridae intergenic region IRES at 3.1 angstrom resolution, providing a view of the prefolded architecture of an all-RNA translation initiation apparatus. Docking of the structure into cryo - electron microscopy reconstructions of an IRES-ribosome complex suggests a model for ribosome manipulation by a dynamic IRES RNA.	Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Kieft, JS (corresponding author), Univ Colorado Denver, Dept Biochem & Mol Genet, Mail Stop 8101,POB 6511, Aurora, CO 80045 USA.	Jeffrey.Kieft@uchsc.edu			NIGMS NIH HHS [R01 GM072560-01, R01 GM072560-05, R01 GM072560-04, R01 GM072560, R01 GM072560-03, R01 GM072560-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072560] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Bonnal S, 2003, NUCLEIC ACIDS RES, V31, P427, DOI 10.1093/nar/gkg003; Costantino D, 2005, RNA, V11, P332, DOI 10.1261/rna.7184705; Fukushi S, 2001, J BIOL CHEM, V276, P20824, DOI 10.1074/jbc.C100206200; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hilbers CW, 1998, BIOPOLYMERS, V48, P137, DOI 10.1002/(SICI)1097-0282(1998)48:2<137::AID-BIP4>3.0.CO;2-H; Jan E, 2001, COLD SPRING HARB SYM, V66, P285, DOI 10.1101/sqb.2001.66.285; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; JUCKER FM, 1995, RNA, V1, P219; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	25	126	130	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1450	1454		10.1126/science.1133281	http://dx.doi.org/10.1126/science.1133281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17124290	Green Accepted			2022-12-01	WOS:000242406100041
J	McDearmon, EL; Patel, KN; Ko, CH; Walisser, JA; Schook, AC; Chong, JL; Wilsbacher, LD; Song, EJ; Hong, HK; Bradfield, CA; Takahashi, JS				McDearmon, Erin L.; Patel, Kush N.; Ko, Caroline H.; Walisser, Jacqueline A.; Schook, Andrew C.; Chong, Jason L.; Wilsbacher, Lisa D.; Song, Eun J.; Hong, Hee-Kyung; Bradfield, Christopher A.; Takahashi, Joseph S.			Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice	SCIENCE			English	Article							GENE-EXPRESSION; CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION; COMPONENT; MOUSE; LIVER; MOP3	The basic helix-loop-helix ( bHLH) - Per-Arnt-Sim ( PAS) domain transcription factor BMAL1 is an essential component of the mammalian circadian pacemaker. Bmal1(-/-) mice lose circadian rhythmicity but also display tendon calcification and decreased activity, body weight, and longevity. To investigate whether these diverse functions of BMAL1 are tissue-specific, we produced transgenic mice that constitutively express Bmal1 in brain or muscle and examined the effects of rescued gene expression in Bmal1(-/-) mice. Circadian rhythms of wheel-running activity were restored in brain-rescued Bmal1(-/-) mice in a conditional manner; however, activity levels and body weight were lower than those of wild-type mice. In contrast, muscle-rescued Bmal1(-/-) mice exhibited normal activity levels and body weight yet remained behaviorally arrhythmic. Thus, Bmal1 has distinct tissue-specific functions that regulate integrative physiology.	Northwestern Univ, Dept Neurobiol & Physiol, Howard Hughes Med Inst, Evanston, IL 60208 USA; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	Howard Hughes Medical Institute; Northwestern University; University of Toronto; University of Wisconsin System; University of Wisconsin Madison	Takahashi, JS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Howard Hughes Med Inst, 2153 Sheridan Rd, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Ko, Caroline/E-6877-2010	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIEHS NIH HHS [R01 ES005703] Funding Source: Medline; NIMH NIH HHS [P50 MH074924] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HONG H, 2006, BIENN M SOC RES BIOL; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kornmann B, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e51; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; SUN Y, 2006, J BIOMED SCI; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906	23	235	240	3	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1304	1308		10.1126/science.1132430	http://dx.doi.org/10.1126/science.1132430			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124323	Green Accepted			2022-12-01	WOS:000242215800045
J	Uauy, C; Distelfeld, A; Fahima, T; Blechl, A; Dubcovsky, J				Uauy, Cristobal; Distelfeld, Assaf; Fahima, Tzion; Blechl, Ann; Dubcovsky, Jorge			A NAC gene regulating senescence improves grain protein, zinc, and iron content in wheat	SCIENCE			English	Article							L. VAR. DICOCCOIDES; DURUM-WHEAT; GPC-B1	Enhancing the nutritional value of food crops is a means of improving human nutrition and health. We report here the positional cloning of Gpc-B1, a wheat quantitative trait locus associated with increased grain protein, zinc, and iron content. The ancestral wild wheat allele encodes a NAC transcription factor (NAM-B1) that accelerates senescence and increases nutrient remobilization from leaves to developing grains, whereas modern wheat varieties carry a nonfunctional NAM-B1 allele. Reduction in RNA levels of the multiple NAM homologs by RNA interference delayed senescence by more than 3 weeks and reduced wheat grain protein, zinc, and iron content by more than 30%.	Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; Univ Haifa, Inst Evolut, IL-31905 Haifa, Israel; ARS, USDA, Western Reg Res Ctr, Albany, CA 94710 USA	University of California System; University of California Davis; University of Haifa; United States Department of Agriculture (USDA)	Dubcovsky, J (corresponding author), Univ Calif Davis, Dept Plant Sci, 1 Shields Ave, Davis, CA 95616 USA.	jdubcovsky@ucdavis.edu	Uauy, Cristobal/B-3879-2011; Dubcovsky, Jorge/T-5214-2019; Distelfeld, Assaf/D-4951-2014; Dubcovsky, Jorge/A-4969-2008; Uauy, Cristobal/T-4382-2019; Uauy, Cristobal/B-7912-2014	Distelfeld, Assaf/0000-0003-1777-3053; Dubcovsky, Jorge/0000-0002-7571-4345; Uauy, Cristobal/0000-0002-9814-1770; Uauy, Cristobal/0000-0002-9814-1770; Fahima, Tzion/0000-0001-5555-0040	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AVIVI L, 1978, HIGH PROTEIN CONTENT; Cakmak I, 2004, SOIL SCI PLANT NUTR, V50, P1047, DOI 10.1080/00380768.2004.10408573; Chee PW, 2001, CROP SCI, V41, P295, DOI 10.2135/cropsci2001.412295x; Distelfeld A, 2006, NEW PHYTOL, V169, P753, DOI 10.1111/j.1469-8137.2005.01627.x; DISTELFELD A, IN PRESS PHYSL PLANT; Distelfeld Assaf, 2004, Functional & Integrative Genomics, V4, P59, DOI 10.1007/s10142-003-0097-3; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Joppa LR, 1997, CROP SCI, V37, P1586, DOI 10.2135/cropsci1997.0011183X003700050030x; Maccaferri M, 2003, THEOR APPL GENET, V107, P783, DOI 10.1007/s00122-003-1319-8; Mesfin A, 1999, CROP SCI, V39, P508, DOI 10.2135/cropsci1999.0011183X003900020035x; Olmos S, 2003, THEOR APPL GENET, V107, P1243, DOI 10.1007/s00122-003-1377-y; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; *UN FOOD AGR ORG, 2005, FOOD OUTL; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; *WHO, 2001, M INT PART NUTR	18	985	1128	13	329	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1298	1301		10.1126/science.1133649	http://dx.doi.org/10.1126/science.1133649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124321	Green Accepted			2022-12-01	WOS:000242215800043
J	Okada, A; Charron, F; Morin, S; Shin, DS; Wong, K; Fabre, PJ; Tessier-Lavigne, M; McConnell, SK				Okada, Ami; Charron, Frederic; Morin, Steves; Shin, David S.; Wong, Karen; Fabre, Pierre J.; Tessier-Lavigne, Marc; McConnell, Susan K.			Boc is a receptor for sonic hedgehog in the guidance of commissural axons	NATURE			English	Article							IG SUPERFAMILY MEMBER; CDO; PROTEINS; PATHWAY; GENE; EXPRESSION; COMPONENTS; NETRIN-1; ENCODES; FAMILY	In the spinal cord, sonic hedgehog ( Shh) is secreted by the floor plate to control the generation of distinct classes of ventral neurons along the dorsoventral axis (1). Genetic and in vitro studies have shown that Shh also later acts as a midline- derived chemoattractant for commissural axons(2). However, the receptor( s) responsible for Shh attraction remain unknown. Here we show that two Robo-related proteins, Boc and Cdon, bind specifically to Shh and are therefore candidate receptors for the action of Shh as an axon guidance ligand. Boc is expressed by commissural neurons, and targeted disruption of Boc in mouse results in the misguidance of commissural axons towards the floor plate. RNA- interference-mediated knockdown of Boc impairs the ability of rat commissural axons to turn towards an ectopic source of Shh in vitro. Taken together, these data suggest that Boc is essential as a receptor for Shh in commissural axon guidance.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Genentech Inc, San Francisco, CA 94080 USA	Stanford University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Roche Holding; Genentech	Okada, A (corresponding author), Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA.	amio@stanford.edu	Charron, Frederic/D-2140-2009; Charron, Frederic/O-8017-2019; Fabre, Pierre J/A-6800-2017; Fabre, Pierre/O-5763-2019	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Fabre, Pierre J/0000-0002-5936-8120; 				Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Cheng HJ, 2000, METH MOL B, V124, P313; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Connor RM, 2005, J COMP NEUROL, V485, P32, DOI 10.1002/cne.20503; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ericson J, 1995, INT J DEV BIOL, V39, P809; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Ming JE, 1998, CLIN GENET, V53, P155; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Mulieri PJ, 2000, DEV DYNAM, V219, P40, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1032>3.0.CO;2-M; Mulieri PJ, 2002, DEV DYNAM, V223, P379, DOI 10.1002/dvdy.10063; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	30	217	225	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					369	373		10.1038/nature05246	http://dx.doi.org/10.1038/nature05246			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17086203				2022-12-01	WOS:000242018300049
J	Pichlmair, A; Schulz, O; Tan, CP; Naslund, TI; Liljestrom, P; Weber, F; Sousa, CRE				Pichlmair, Andreas; Schulz, Oliver; Tan, Choon Ping; Naslund, Tanja I.; Liljestrom, Peter; Weber, Friedemann; Sousa, Caetano Reis E.			RIG-I-mediated antiviral responses to single-stranded RNA bearing 5 '-phosphates	SCIENCE			English	Article							NS1 PROTEIN; VIRAL-INFECTION; INNATE; INTERFERON; DNA; RECOGNITION; INDUCTION; IMMUNITY; VIRUSES; REPLICATION	Double-stranded RNA ( dsRNA) produced during viral replication is believed to be the critical trigger for activation of antiviral immunity mediated by the RNA helicase enzymes retinoic acid inducible gene I (RIG-I) and melanoma differentiation - associated gene 5 (MDA5). We showed that influenza A virus infection does not generate dsRNA and that RIG-I is activated by viral genomic single-stranded RNA (ssRNA) bearing 5'-phosphates. This is blocked by the influenza protein nonstructured protein 1 (NS1), which is found in a complex with RIG-I in infected cells. These results identify RIG-I as a ssRNA sensor and potential target of viral immune evasion and suggest that its ability to sense 5'-phosphorylated RNA evolved in the innate immune system as a means of discriminating between self and nonself.	London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England; Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; Univ Freiburg, Dept Virol, D-79104 Freiburg, Germany	Cancer Research UK; Karolinska Institutet; University of Freiburg	Sousa, CRE (corresponding author), London Res Inst, Canc Res UK, Immunobiol Lab, London WC2A 3PX, England.	caetano@cancer.org.uk	Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021; Weber, Friedemann/AAB-3425-2019	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Liljestrom, Peter/0000-0002-2132-0981; Weber, Friedemann/0000-0001-9737-337X; Schulz, Oliver/0000-0002-1493-3341				Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Roizman B., 2001, FIELDS VIROLOGY, V4th ed.; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	23	1671	1772	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					997	1001		10.1126/science.1132998	http://dx.doi.org/10.1126/science.1132998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17038589				2022-12-01	WOS:000241896000055
J	Ledford, H				Ledford, Heidi			A breed apart	NATURE			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					137	137		10.1038/444137a	http://dx.doi.org/10.1038/444137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093424	Bronze			2022-12-01	WOS:000241867200010
J	Gandhi, NR; Moll, A; Sturm, AW; Pawinski, R; Govender, T; Lalloo, U; Zeller, K; Andrews, J; Friedland, G				Gandhi, Neel R.; Moll, Anthony; Sturm, A. Willem; Pawinski, Robert; Govender, Thiloshini; Lalloo, Umesh; Zeller, Kimberly; Andrews, Jason; Friedland, Gerald			Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; ACTIVE ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-TUBERCULOSIS; COUNTRIES; OUTBREAK; EMERGENCE; RATES; ERA	Background The epidemics of HIV-1 and tuberculosis in South Africa are closely related. High mortality rates in co-infected patients have improved with antiretroviral. therapy, but drug-resistant tuberculosis has emerged as a major cause of death. We assessed the prevalence and consequences of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in a rural area in KwaZulu Natal, South Africa. Methods We undertook enhanced surveillance for drug-resistant tuberculosis with sputum culture and drug susceptibility testing in patients with known or suspected tuberculosis. Genotyping was done for isolates resistant to first-line and second-line drugs. Results From January, 2005, to March, 2006, sputum was obtained from 1539 patients. We detected MDR tuberculosis in 221 patients, of whom 53 had XDR tuberculosis. Prevalence among 475 patients with culture-confirmed tuberculosis was 39% (185 patients) for MDR and 6% (30) for XDR tuberculosis. Only 55% (26 of 47) of patients with XDR tuberculosis had never been previously treated for tuberculosis; 67% (28 of 42) had a recent hospital admission. All 44 patients with XDR tuberculosis who were tested for HIV were co-infected. 52 of 53 patients with XDR tuberculosis died, with median survival of 16 days from time of diagnosis (IQR 6-37) among the 42 patients with confirmed dates of death. Genotyping of isolates showed that 39 of 46 (85%, 95% Cl 74-95) patients with XDR tuberculosis had similar strains. Conclusions MDR tuberculosis is more prevalent than previously realised in this setting. XDR tuberculosis has been transmitted to HIV co-infected patients and is associated with high mortality. These observations warrant urgent intervention and threaten the success of treatment programmes for tuberculosis and HIV.	Yale Univ, Sch Med, AIDS Program, Infect Dis Sect,Dept Internal Med, New Haven, CT 06520 USA; Church Scotland Hosp & Philanjalo, Tugela Ferry, South Africa; Nelson R Mandela Sch Med, Dept Med Microbiol, Durban, South Africa; Nelson R Mandela Sch Med, Dept Med, Durban, South Africa; Kwazulu Natal Dept Hlth, Kwa Zulu, South Africa; Brown Univ, Sch Med, Providence, RI 02912 USA; Albert Einstein Coll Med, Dept Med, Div Gen Internal Med, Bronx, NY 10467 USA	Yale University; University of Kwazulu Natal; University of Kwazulu Natal; Brown University; Yeshiva University; Albert Einstein College of Medicine	Gandhi, NR (corresponding author), Yale Univ, Sch Med, AIDS Program, Infect Dis Sect,Dept Internal Med, New Haven, CT 06520 USA.	negandhi@montefiore.org		Andrews, Jason/0000-0002-5967-251X				Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; BARNES L, 2006, WITNESS         0821; Campos PE, 2003, EMERG INFECT DIS, V9, P1571, DOI 10.3201/eid0912.020731; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Davies GR, 1999, INT J TUBERC LUNG D, V3, P799; De Cock KM, 2005, AM J RESP CRIT CARE, V172, P3, DOI 10.1164/rccm.2504003; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; DECOCK KM, 1992, JAMA-J AM MED ASSOC, V268, P1581, DOI 10.1001/jama.1992.03490120095035; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; Farmer P, 1999, INT J TUBERC LUNG D, V3, P643; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; Friedland G, 2004, CLIN INFECT DIS, V38, pS421, DOI 10.1086/421407; GANDHI N, 2006, TOR 16 INT AIDS C; Hannan MM, 2001, J HOSP INFECT, V47, P91, DOI 10.1053/jhin.2000.0884; Harries AD, 1997, T ROY SOC TROP MED H, V91, P15, DOI 10.1016/S0035-9203(97)90376-X; Jack C, 2004, JAIDS-J ACQ IMM DEF, V36, P929, DOI 10.1097/00126334-200408010-00006; Joseph P, 2006, AIDS, V20, P415, DOI 10.1097/01.aids.0000206505.09159.9a; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Lalloo UG, 2006, CURR OPIN PULM MED, V12, P179, DOI 10.1097/01.mcp.0000219266.27439.52; LAWN S, 2006, TOR 16 INT AIDS C; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Nunes EA, 2005, INT J TUBERC LUNG D, V9, P494; O'Brien RJ, 2005, CLIN CHEST MED, V26, P327, DOI 10.1016/j.ccm.2005.02.013; Punnotok J, 2000, INT J TUBERC LUNG D, V4, P537; RAVIGLIONE MC, 1997, AIDS, V11, P115; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; Rullan JV, 1996, EMERG INFECT DIS, V2, P125, DOI 10.3201/eid0202.960208; *S AFR TUB CONTR P, 2000, S AFR TUB CONTR PROG; Sacks LV, 1999, CLIN INFECT DIS, V29, P96, DOI 10.1086/520189; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; STURM AW, 2006, UKZN OUTBREAK EXPERT; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; WEYER K, 2003, SURVEY TUBERCULOSIS; *WHO, 2006, GEN M GLOB XDR TB TA; *WHO, 2003, 7 WHO; *WHO IUATLD GLOB P, 2004, 3 WHOIUATLD GLOB PRO; Wilkinson D, 1997, S AFR MED J, V87, P447; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2006, WHOHTM2006361; World Health Organization, 1994, WHOTB94179; World Health Organization, 2006, WHOHTMTB2006362; 1991, MMWR MORB MORTAL WKL, V40, P585; 2006, MMWR MORB MORTAL WKL, V55, P301	45	1182	1238	1	86	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1575	1580		10.1016/S0140-6736(06)69573-1	http://dx.doi.org/10.1016/S0140-6736(06)69573-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084757				2022-12-01	WOS:000242180900026
J	Axtell, MJ; Jan, C; Rajagopalan, R; Bartel, DP				Axtell, Michael J.; Jan, Calvin; Rajagopalan, Ramya; Bartel, David P.			A two-hit trigger for siRNA biogenesis in plants	CELL			English	Article							TRANS-ACTING SIRNAS; INTERFERING RNA; ARABIDOPSIS; MICRORNAS; EXPRESSION; TARGETS; DICER; ACCUMULATION; DCL4	In Arabidopsis, microRNA-directed cleavage can define one end of RNAs that then generate phased siRNAs. However, most miRNA-targeted RNAs do not spawn siRNAs, suggesting the existence of additional determinants within those that do. We find that in moss, phased siRNAs arise from regions flanked by dual miR390 cleavage sites. AtTAS3, an siRNA locus important for development and conserved among higher plants, also has dual miR390 complementary sites. Both sites bind miR390 in vitro and are functionally required in Arabidopsis, but cleavage is undetectable at the 5' site-demonstrating that noncleavable sites can be functional in plants. Phased siRNAs also emanate from the bounded regions of every Arabidopsis gene with two known microRNA/siRNA complementary sites, but only rarely from genes with single sites. Therefore, two "hits,"-often, but not always, two cleavage events-constitute a conserved trigger for siRNA biogenesis, a finding with implications for recognition and silencing of aberrant RNA.	MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Bartel, DP (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dbartel@wi.mit.edu						Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Elmayan T, 1996, PLANT J, V9, P787, DOI 10.1046/j.1365-313X.1996.9060787.x; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Garcia D, 2006, CURR BIOL, V16, P933, DOI 10.1016/j.cub.2006.03.064; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hunter C, 2006, DEVELOPMENT, V133, P2973, DOI 10.1242/dev.02491; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; SMITH HA, 1994, PLANT CELL, V6, P1441, DOI 10.1105/tpc.6.10.1441; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	33	460	522	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					565	577		10.1016/j.cell.2006.09.032	http://dx.doi.org/10.1016/j.cell.2006.09.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081978	Bronze			2022-12-01	WOS:000241937000020
J	Muller, H; Fogeron, ML; Lehmann, V; Lehrach, H; Lange, BMH				Mueller, Hannah; Fogeron, Marie-Laure; Lehmann, Verena; Lehrach, Hans; Lange, Bodo M. H.			A centrosome-independent role for gamma-TuRC proteins in the spindle assembly checkpoint	SCIENCE			English	Article							TUBULIN COMPLEXES; VERTEBRATES	The spindle assembly checkpoint guards the fidelity of chromosome segregation. It requires the close cooperation of cell cycle regulatory proteins and cytoskeletal elements to sense spindle integrity. The role of the centrosome, the organizing center of the microtubule cytoskeleton, in the spindle checkpoint is unclear. We found that the molecular requirements for a functional spindle checkpoint included components of the large gamma-tubulin ring complex (gamma-TuRC). However, their localization at the centrosome and centrosome integrity were not essential for this function. Thus, the spindle checkpoint can be activated at the level of microtubule nucleation.	Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany	Max Planck Society	Lange, BMH (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 73, D-14195 Berlin, Germany.	lange_b@molgen.mpg.de						Barbosa V, 2003, J CELL SCI, V116, P929, DOI 10.1242/jcs.00295; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Colornbie N, 2006, MOL BIOL CELL, V17, P272, DOI 10.1091/mbc.e05-08-0722; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Job D, 2003, CURR OPIN CELL BIOL, V15, P111, DOI 10.1016/S0955-0674(02)00003-0; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Lange BMH, 2002, CURR OPIN CELL BIOL, V14, P35, DOI 10.1016/S0955-0674(01)00291-5; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Oakley BR, 2000, CURR TOP DEV BIOL, V49, P27; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Prigozhina NL, 2004, MOL BIOL CELL, V15, P1374, DOI 10.1091/mbc.E03-06-0405; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Sluder G, 2005, NAT REV MOL CELL BIO, V6, P743, DOI 10.1038/nrm1712; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Vardy L, 2000, EMBO J, V19, P6098, DOI 10.1093/emboj/19.22.6098; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	29	32	34	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					654	657		10.1126/science.1132834	http://dx.doi.org/10.1126/science.1132834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068266	Green Submitted			2022-12-01	WOS:000241557800050
J	Eichacker, PQ; Natanson, C; Danner, RL				Eichacker, Peter Q.; Natanson, Charles; Danner, Robert L.			Surviving sepsis - Practice guidelines, marketing campaign, and Eli Lilly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Eichacker, PQ (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.				CLINICAL CENTER [ZIACL008060, Z01CL008060] Funding Source: NIH RePORTER	CLINICAL CENTER		Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Levy M, 2004, CRIT CARE MED, V32, P2002, DOI 10.1097/01.CCM.0000142729.07050.C9; LILLY E, SURVIVING SEPSIS CAS; *NIH, ONL ANN BIBL SURV SE; REGALADO R, 2003, WALL STREET J   0918, pA1	6	148	154	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1640	1642		10.1056/NEJMp068197	http://dx.doi.org/10.1056/NEJMp068197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050887				2022-12-01	WOS:000241357300004
J	Russell, AG; Charette, JM; Spencer, DF; Gray, MW				Russell, Anthony G.; Charette, J. Michael; Spencer, David F.; Gray, Michael W.			An early evolutionary origin for the minor spliceosome	NATURE			English	Article							MESSENGER-RNA INTRONS; AT-AC INTRON; U12-DEPENDENT INTRONS; U12 SNRNA; U12-TYPE SPLICEOSOME; IN-VIVO; IDENTIFICATION; CONSERVATION; GENOME; VERTEBRATES	The minor spliceosome is a ribonucleoprotein complex that catalyses the removal of an atypical class of spliceosomal introns (U12-type) from eukaryotic messenger RNAs1,2. It was first identified and characterized in animals, where it was found to contain several unique RNA constituents that share structural similarity with and seem to be functionally analogous to the small nuclear RNAs (snRNAs) contained in the major spliceosome(3-8). Subsequently, minor spliceosomal components and U12-type introns have been found in plants(9-12) but not in fungi. Unlike that of the major spliceosome, which arose early in the eukaryotic lineage(13,14), the evolutionary history of the minor spliceosome is unclear because there is evidence of it in so few organisms. Here we report the identification of homologues of minor-spliceosome-specific proteins and snRNAs, and U12-type introns, in distantly related eukaryotic microbes (protists) and in a fungus ( Rhizopus oryzae). Cumulatively, our results indicate that the minor spliceosome had an early origin: several of its characteristic constituents are present in representative organisms from all eukaryotic supergroups for which there is any substantial genome sequence information. In addition, our results reveal marked evolutionary conservation of functionally important sequence elements contained within U12-type introns and snRNAs.	Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Dalhousie University	Gray, MW (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, 5850 Coll St, Halifax, NS B3H 1X5, Canada.	m.w.gray@dal.ca		Gray, Michael/0000-0001-7125-2625				Anderson IJ, 2005, PROTIST, V156, P203, DOI 10.1016/j.protis.2005.04.001; Benecke H, 2005, EMBO J, V24, P3057, DOI 10.1038/sj.emboj.7600765; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Dietrich RC, 2005, RNA, V11, P1430, DOI 10.1261/rna.7206305; Dietrich RC, 2001, MOL CELL BIOL, V21, P1942, DOI 10.1128/MCB.21.6.1942-1952.2001; Dietrich RC, 1997, MOL CELL, V1, P151, DOI 10.1016/S1097-2765(00)80016-7; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kolossova I, 1997, RNA, V3, P227; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Lorkovic ZJ, 2005, RNA, V11, P1095, DOI 10.1261/rna.2440305; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Rodriguez-Trelles F, 2006, ANNU REV GENET, V40, P47, DOI 10.1146/annurev.genet.40.110405.090625; Russell AG, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-45; Russell AG, 2006, J MOL BIOL, V357, P1548, DOI 10.1016/j.jmb.2006.01.063; Schneider C, 2004, P NATL ACAD SCI USA, V101, P9584, DOI 10.1073/pnas.0403400101; Shukla GC, 1999, RNA, V5, P525, DOI 10.1017/S1355838299982213; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; TARN WY, 1995, RNA, V1, P644; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Will CL, 1999, SCIENCE, V284, P2003, DOI 10.1126/science.284.5422.2003; Yu YT, 1997, P NATL ACAD SCI USA, V94, P6030, DOI 10.1073/pnas.94.12.6030; Zhu W, 2003, NUCLEIC ACIDS RES, V31, P4561, DOI 10.1093/nar/gkg492	30	84	85	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					863	866		10.1038/nature05228	http://dx.doi.org/10.1038/nature05228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051219				2022-12-01	WOS:000241362700053
J	Rubino, A; Roskell, N; Tennis, P; Mines, D; Weich, S; Andrews, E				Rubino, Annalisa; Roskell, Neil; Tennis, Pat; Mines, Daniel; Weich, Scott; Andrews, Elizabeth			Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; ANTIDEPRESSANTS; PLACEBO; DEPRESSION; TRIALS; SSRIS	Objective To compare the risk of suicide in adults using the antidepressant venlafaxine with the risk of suicide in adult using citalopram, fluoxetine, and dothiepin. Design Retrospective cohort study. Setting UK General Practice Research Database. Participants 219088 patients, aged 18-89 years, who were prescribed venlafaxine, citalopram, fluoxetine, or dothiepin from 1995 to 2005. Main outcome measures Completed suicide and attempted suicide. Results Venlafaxine users had a higher burden of risk factors for suicide, including previous suicide attempts and proxies for severe depression or depression that was difficult to treat. In the analysis for completed suicides, unadjusted and adjusted hazard ratios for venlafaxine compared with citalopram were 2.44 (95% confidence interval 1.12 to 5.31) and 1.70 (0.76 to 3.80), for venlafaxine compared with fluoxetine were 2.85 (1.37 to 5.94) and 1.63 (0.74 to 3.59), and for venlafaxine compared with dothiepin were 2.54 (1.07 to 6.02) and 1.31 (0.53 to 3.25). Compared with other study drugs, venlafaxine was also associated with an increased risk of attempted suicide, but adjustment for measured confounders substantially reduced the hazard ratios. Conclusions Venlafaxine use was consistently associated with higher risk of suicide compared with citalopram, fluoxetine, and dothiepin. Venlafaxine users had a higher burden of suicide risk factors, however, and adjustment for measured confounders substantially reduced the excess risks. Since the secondary data used in this analysis allowed only indirect and partial measurements of potential confounders, it is possible that residual confounding explains much, if not all, of the observed excess risk.	RTI Hlth Solut, Manchester M15 6SE, Lancs, England; RTI Hlth Solut, Pharmacoepidemiol & Risk Management, Res Triangle Pk, NC USA; Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	Research Triangle Institute; Research Triangle Institute; University of Warwick	Rubino, A (corresponding author), RTI Hlth Solut, Manchester Sci Pk, Manchester M15 6SE, Lancs, England.	arubino@rti.org		Andrews, Elizabeth B./0000-0003-1131-5983; Mines, Daniel/0000-0002-9134-2836				Collins MH, 2001, PEDIATR TRANSPLANT, V5, P250, DOI 10.1034/j.1399-3046.2001.005004250.x; De Hert M, 2001, SCHIZOPHR RES, V47, P127, DOI 10.1016/S0920-9964(00)00003-7; Didham RC, 2005, BRIT J CLIN PHARMACO, V60, P519, DOI 10.1111/j.1365-2125.2005.02480.x; Egberts ACG, 1997, J CLIN PSYCHOPHARM, V17, P149, DOI 10.1097/00004714-199706000-00002; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; JICK H, 1992, PHARMACOTHERAPY, V12, P451; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; Juurlink DN, 2006, AM J PSYCHIAT, V163, P813, DOI 10.1176/appi.ajp.163.5.813; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Mines D, 2005, PHARMACOEPIDEM DR S, V14, P367, DOI 10.1002/pds.1095; Plunkett A, 2001, AMBUL PEDIATR, V1, P262, DOI 10.1367/1539-4409(2001)001<0262:SRFCSA>2.0.CO;2; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rothman KJ, 2003, EPIDEMIOLOGY, V14, P55, DOI 10.1097/00001648-200301000-00014; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; SAVITZ DA, 1989, AM J EPIDEMIOL, V129, P1062, DOI 10.1093/oxfordjournals.aje.a115210; Simon TR, 2002, SUICIDE LIFE-THREAT, V32, P42, DOI 10.1521/suli.32.1.42.22181; Stahl SM, 2005, CNS SPECTRUMS, V10, P732, DOI 10.1017/S1092852900019726; Storosum JG, 2001, AM J PSYCHIAT, V158, P1271, DOI 10.1176/appi.ajp.158.8.1271; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	23	78	85	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2007	334	7587					242	245		10.1136/bmj.39041.445104.BE	http://dx.doi.org/10.1136/bmj.39041.445104.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135SD	17164297	Green Published, Bronze			2022-12-01	WOS:000244172400029
J	Ives, A; Saunders, C; Bulsara, M; Semmens, J				Ives, Angela; Saunders, Christobel; Bulsara, Max; Semmens, James			Pregnancy after breast cancer: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WESTERN-AUSTRALIA; CARCINOMA; PROGNOSIS; SURVIVAL; OUTCOMES; WOMEN	Objectives To identify women who survived breast cancer and subsequently conceived and to determine the rate of pregnancy (proportion), management, outcome of the cancer, and outcome of the first subsequent pregnancy. Design Population based descriptive study with cases identified from the Western Australian data linkage system and validated by review of medical charts. Supplementary data obtained from hospital and clinician records. Setting Western Australia, 1982-2003. Participants Women aged <45 with a diagnosis of breast cancer who subsequently conceived. Main outcome measures Pregnancy outcome and rate, survival, time from diagnosis to pregnancy. Results Sixty two (54%) women with a diagnosis of breast cancer who subsequently conceived did so less than two years after their diagnosis: 29 of them had an abortion, 27 had a live birth, and six miscarried. Within a proportional hazards regression model subsequent pregnancy was associated with improved overall survival (hazard ratio 0.59, 95% confidence interval 0.37 to 0.95). When the model was stratified by time from diagnosis subsequent pregnancy was associated with improved overall survival in women who waited at least 24 months to conceive (0.48, 0.27 to 0.83) and a non-significant protective effect was seen for women who waited at least six months to become pregnant. Conclusions Our study does not support the current medical advice given to premenopausal women with a diagnosis of breast cancer to wait two years before attempting to conceive. This recommendation may be valid for women who are receiving treatment or have systemic disease at diagnosis, but for women with localised disease early conception, six months after completing treatment, is unlikely to reduce survival.	Univ Western Australia, Sch Surg & Pathol, Crawley, WA, Australia; Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; Curtin Univ Technol, Sch Publ Hlth, Bentley, WA 6845, Australia	University of Western Australia; University of Western Australia; Curtin University	Ives, A (corresponding author), Univ Western Australia, Sch Surg & Pathol, M507, Crawley, WA, Australia.	angela.ives@uwa.edu.au	Saunders, Christobel M/H-5779-2014; Bulsara, Max/A-5966-2008; Ives, Angela D/H-5113-2014	Saunders, Christobel M/0000-0003-2281-9829; Bulsara, Max/0000-0002-8033-6123; Ives, Angela Denise/0000-0001-5734-0821				Blakely LJ, 2004, CANCER-AM CANCER SOC, V100, P465, DOI 10.1002/cncr.11929; Clark R M, 1989, Clin Oncol (R Coll Radiol), V1, P11, DOI 10.1016/S0936-6555(89)80004-4; CLARK RM, 1978, INT J RADIAT ONCOL, V4, P693, DOI 10.1016/0360-3016(78)90196-7; GUINEE VF, 1994, LANCET, V343, P1587; Gwyn K, 2001, ONCOLOGY-NY, V15, P39; HARVEY JC, 1981, SURG GYNECOL OBSTET, V153, P723; HOLLEB AI, 1962, SURG GYNECOL OBSTET, V115, P65; Ives Angela, 2002, Aust Fam Physician, V31, P929; Kroman N, 1997, LANCET, V350, P319, DOI 10.1016/S0140-6736(97)03052-3; McEvoy SP, 2004, MED J AUSTRALIA, V181, P305, DOI 10.5694/j.1326-5377.2004.tb06294.x; *NAT CTR CLASS, 2000, INT STAT CLASS DIS R; National Coding Centre, 1995, AUSTR VERS INT CLASS; NUGENT P, 1985, ARCH SURG-CHICAGO, V120, P1221; Peters MV, 1968, PROGNOSTIC FACTORS B, P65; PETREK JA, 1994, CANCER-AM CANCER SOC, V74, P528, DOI 10.1002/cncr.2820741342; Reichman B S, 1994, J Natl Cancer Inst Monogr, P125; RIBEIRO G, 1986, BRIT J SURG, V73, P607, DOI 10.1002/bjs.1800730805; RIBEIRO GG, 1977, BRIT MED J, V2, P1524, DOI 10.1136/bmj.2.6101.1524; SANKILA R, 1994, AM J OBSTET GYNECOL, V170, P818, DOI 10.1016/S0002-9378(94)70290-X; Semmens JB, 1998, AUST NZ J SURG, V68, P397, DOI 10.1111/j.1445-2197.1998.tb04786.x; Singh KL, 2005, HUM REPROD UPDATE, V11, P69, DOI 10.1093/humupd/dmh052; SUTTON R, 1990, CANCER, V65, P847, DOI 10.1002/1097-0142(19900215)65:4<847::AID-CNCR2820650402>3.0.CO;2-A; Velentgas P, 1999, CANCER, V85, P2424, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2424::AID-CNCR17>3.0.CO;2-4	23	164	174	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2007	334	7586					194	196B		10.1136/bmj.39035.667176.55	http://dx.doi.org/10.1136/bmj.39035.667176.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17158581	Green Published			2022-12-01	WOS:000244027600035
J	Dahn, RD; Davis, MC; Pappano, WN; Shubin, NH				Dahn, Randall D.; Davis, Marcus C.; Pappano, William N.; Shubin, Neil H.			Sonic hedgehog function in chondrichthyan fins and the evolution of appendage patterning	NATURE			English	Article							RETINOIC ACID; PECTORAL FIN; POLARIZING ACTIVITY; POLYODON-SPATHULA; LIMB; EXPRESSION; ZEBRAFISH; RANGE; SHH; ENHANCER	The genetic mechanisms regulating tetrapod limb development are well characterized, but how they were assembled during evolution and their function in basal vertebrates is poorly understood. Initial studies report that chondrichthyans, the most primitive extant vertebrates with paired appendages, differ from ray-finned fish and tetrapods in having Sonic hedgehog (Shh)-independent patterning of the appendage skeleton(1). Here we demonstrate that chondrichthyans share patterns of appendage Shh expression, Shh appendage-specific regulatory DNA, and Shh function with ray-finned fish and tetrapods(2-10). These studies demonstrate that some aspects of Shh function are deeply conserved in vertebrate phylogeny, but also highlight how the evolution of Shh regulation may underlie major morphological changes during appendage evolution.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Field Museum Nat Hist, Chicago, IL 60605 USA	University of Chicago; Howard Hughes Medical Institute; Johns Hopkins University; Field Museum of Natural History (Chicago)	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu		Pappano, William/0000-0003-2848-2219; Davis, Marcus/0000-0002-2462-0138				AKIMENKO MA, 1995, DEV BIOL, V170, P243, DOI 10.1006/dbio.1995.1211; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; BEMIS WE, 1992, J MORPHOL, V213, P47, DOI 10.1002/jmor.1052130106; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Davis MC, 2004, J MORPHOL, V262, P608, DOI 10.1002/jmor.10264; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Hoffman L, 2002, INT J DEV BIOL, V46, P949; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Maas SA, 2005, DEV DYNAM, V232, P345, DOI 10.1002/dvdy.20254; Pearse RV, 2001, DEV BIOL, V239, P15, DOI 10.1006/dbio.2001.0430; Prince VE, 1998, DEVELOPMENT, V125, P407; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Tanaka M, 2002, NATURE, V416, P527, DOI 10.1038/416527a; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; Vandersea MW, 1998, DEV GENES EVOL, V208, P61, DOI 10.1007/s004270050155	21	100	105	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2007	445	7125					311	314		10.1038/nature05436	http://dx.doi.org/10.1038/nature05436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17187056				2022-12-01	WOS:000243504700044
J	Saeij, JPJ; Coller, S; Boyle, JP; Jerome, ME; White, MW; Boothroyd, JC				Saeij, J. P. J.; Coller, S.; Boyle, J. P.; Jerome, M. E.; White, M. W.; Boothroyd, J. C.			Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue	NATURE			English	Article							GONDII STRAINS; PARASITOPHOROUS VACUOLE; PARASITE GENOTYPE; MACROPHAGES; MICROARRAYS; MEMBRANE; LINEAGES; INVASION; REVEALS; IL-12	Toxoplasma gondii, an obligate intracellular parasite of the phylum Apicomplexa, can cause severe disease in humans with an immature or suppressed immune system. The outcome of Toxoplasma infection is highly dependent on the strain type, as are many of its in vitro growth properties(1). Here we use genetic crosses between type II and III lines to show that strain-specific differences in the modulation of host cell transcription are mediated by a putative protein kinase, ROP16. Upon invasion by the parasite, this polymorphic protein is released from the apical organelles known as rhoptries and injected into the host cell, where it ultimately affects the activation of signal transducer and activator of transcription ( STAT) signalling pathways and consequent downstream effects on a key host cytokine, interleukin (IL)-12. Our findings provide a new mechanism for how an intracellular eukaryotic pathogen can interact with its host and reveal important differences in how different Toxoplasma lineages have evolved to exploit this interaction.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Montana State Univ, Coll Agr, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Stanford University; Montana State University System; Montana State University Bozeman	Boothroyd, JC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Fairchild Bldg D305,300 Pasteur Dr, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu	White, Michael/A-4978-2012	Saeij, Jeroen/0000-0003-0289-7109; Boothroyd, John C./0000-0001-9719-745X	NIAID NIH HHS [R01 AI021423, R01 AI021423-20] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021423] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BURG JL, 1988, J IMMUNOL, V141, P3584; Butcher BA, 2005, J IMMUNOL, V174, P3148, DOI 10.4049/jimmunol.174.6.3148; Carme B, 2002, J CLIN MICROBIOL, V40, P4037, DOI 10.1128/JCM.40.11.4037-4044.2002; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Darde ML, 1998, J CLIN MICROBIOL, V36, P324; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; GILBERT LA, 2006, EUKARYOT CELL   1103, DOI DOI 10.1128/EC/00309-06; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Limnander A, 2004, MOL CELL, V15, P329, DOI 10.1016/j.molcel.2004.06.041; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	24	406	439	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					324	327		10.1038/nature05395	http://dx.doi.org/10.1038/nature05395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17183270	Green Accepted			2022-12-01	WOS:000243504700047
J	Ricci-Vitiani, L; Lombardi, DG; Pilozzi, E; Biffoni, M; Todaro, M; Peschle, C; De Maria, R				Ricci-Vitiani, Lucia; Lombardi, Dario G.; Pilozzi, Emanuela; Biffoni, Mauro; Todaro, Matilde; Peschle, Cesare; De Maria, Ruggero			Identification and expansion of human colon-cancer-initiating cells	NATURE			English	Article							STEM-CELLS; CARCINOEMBRYONIC ANTIGEN; EXPRESSION; MUTATIONS; LEUKEMIA; TUMORS	Colon carcinoma is the second most common cause of death from cancer(1). The isolation and characterization of tumorigenic colon cancer cells may help to devise novel diagnostic and therapeutic procedures. Although there is increasing evidence that a rare population of undifferentiated cells is responsible for tumour formation and maintenance(2-4), this has not been explored for colorectal cancer. Here, we show that tumorigenic cells in colon cancer are included in the high-density CD133(+) population, which accounts for about 2.5% of the tumour cells. Subcutaneous injection of colon cancer CD133(+) cells readily reproduced the original tumour in immunodeficient mice, whereas CD133(-) cells did not form tumours. Such tumours were serially transplanted for several generations, in each of which we observed progressively faster tumour growth without significant phenotypic alterations. Unlike CD133(-) cells, CD133(+) colon cancer cells grew exponentially for more than one year in vitro as undifferentiated tumour spheres in serum-free medium, maintaining the ability to engraft and reproduce the same morphological and antigenic pattern of the original tumour. We conclude that colorectal cancer is created and propagated by a small number of undifferentiated tumorigenic CD133(+) cells, which should therefore be the target of future therapies.	Ist Super Sanita, Dept Hematol & Oncol, I-00161 Rome, Italy; Mediterranean Inst Oncol, I-95029 Catania, Italy; Univ Roma La Sapienza, Sant Andrea Hosp, Dept Lab Med & Pathol, I-00189 Rome, Italy; Univ Palermo, Dept Surg & Oncol Sci, I-90127 Palermo, Italy	Istituto Superiore di Sanita (ISS); Mediterranean Institute of Oncology; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Palermo	De Maria, R (corresponding author), Ist Super Sanita, Dept Hematol & Oncol, Viale Regina Elena 299, I-00161 Rome, Italy.	rdemaria@tin.it	Ricci Vitiani, Lucia/J-8320-2016; Biffoni, Mauro/J-8318-2016; De Maria, Ruggero/S-6385-2019; todaro, matilde/AAC-1003-2022; PILOZZI, Emanuela/AAC-1854-2022	Ricci Vitiani, Lucia/0000-0001-7336-5615; Biffoni, Mauro/0000-0002-1304-9060; De Maria, Ruggero/0000-0003-2255-0583; todaro, matilde/0000-0001-8686-8043; PILOZZI, Emanuela/0000-0002-7110-9172				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chu PG, 2000, MODERN PATHOL, V13, P962, DOI 10.1038/modpathol.3880175; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; Davidson B, 2002, AM J CLIN PATHOL, V118, P85; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; EE HC, 1995, AM J PATHOL, V147, P586; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; JESSUP JM, 1988, CANCER RES, V48, P1689; Moll R, 1998, Subcell Biochem, V31, P205; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; SHEAHAN K, 1990, AM J CLIN PATHOL, V94, P157, DOI 10.1093/ajcp/94.2.157; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Witek ME, 2005, CLIN CANCER RES, V11, P8549, DOI 10.1158/1078-0432.CCR-05-1624; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012	22	3140	3398	6	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					111	115		10.1038/nature05384	http://dx.doi.org/10.1038/nature05384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17122771				2022-12-01	WOS:000243225100046
J	Szutorisz, H; Georgiou, A; Tora, L; Dillon, N				Szutorisz, Henrietta; Georgiou, Andrew; Tora, Laszlo; Dillon, Niall			The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells	CELL			English	Article							RNA-POLYMERASE-II; PROTEIN-DEGRADATION; REGULATORY PARTICLE; 20S PROTEASOME; CHROMATIN; COMPLEX; COACTIVATOR; RECRUITMENT; TURNOVER; DOMAIN	The ability of stem cells to activate different gene expression programs requires the choreographed assembly of trans-acting factors at enhancers and promoters during cell differentiation. In this study, we show that the proteasome acts on specific regulatory regions in embryonic stem (ES) cells to prevent incorrect transcriptional initiation. Chemical or siRNA-mediated inhibition of proteasome activity results in increased transcription factor and RNA polymerase II binding and leads to activation of cryptic promoters. Analysis of the binding profiles of different proteasome subunits in normal ES cells and following RNAi knockdown of individual subunits provides evidence for a targeted assembly of the 26S proteasome at specific regulatory elements. Our results suggest that the proteasome promotes a dynamic turnover of transcription factor and Pol II binding at tissue-specific gene domains in ES cells, thereby restricting permissive transcriptional activity and keeping the genes in a potentiated state, ready for activation at later stages.	Univ London Imperial Coll Sci & Technol, Gene Regulat & Chromatin Grp, MRC Clin Sci Ctr, Fac Med, London W12 0NN, England; ULP, INSERM, IGBMC, CNRS,UMR 7104, F-67404 Illkirch Graffenstaden, France	Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Szutorisz, H (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	henrietta.szutorisz@csc.mrc.ac.uk; niall.dillon@csc.mrc.ac.uk	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250	Medical Research Council [MC_U120036884] Funding Source: Medline; MRC [MC_U120036884] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; AUID KL, 2006, CELL, V21, P861; Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 2005, J BIOL CHEM, V280, P21689, DOI 10.1074/jbc.R500004200; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Liu XH, 2003, J BIOL CHEM, V278, P20405, DOI 10.1074/jbc.M211795200; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Minaee S, 2005, MOL IMMUNOL, V42, P1283, DOI 10.1016/j.molimm.2005.01.003; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perry P, 2004, CELL CYCLE, V3, P1645; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Rasti M, 2006, EMBO J, V25, P2710, DOI 10.1038/sj.emboj.7601169; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Routledge SJE, 2002, J MOL BIOL, V323, P601, DOI 10.1016/S0022-2836(02)01011-2; Sabbattini P, 2005, SEMIN IMMUNOL, V17, P121, DOI 10.1016/j.smim.2005.01.004; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Vieira KF, 2004, J BIOL CHEM, V279, P50350, DOI 10.1074/jbc.M408883200; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603	42	96	99	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1375	1388		10.1016/j.cell.2006.10.045	http://dx.doi.org/10.1016/j.cell.2006.10.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190601	Bronze			2022-12-01	WOS:000243690000017
J	Sethi, D; Racioppi, F; Baumgarten, I; Bertollini, R				Sethi, Dinesh; Racioppi, Francesca; Baumgarten, Inge; Bertollini, Roberto			Reducing inequalities from injuries in Europe	LANCET			English	Article							ALCOHOL-CONSUMPTION; SOCIOECONOMIC INEQUALITIES; EASTERN-EUROPE; PUBLIC-HEALTH; GLOBAL BURDEN; POLICY-MAKING; CHILD INJURY; SOCIAL-CLASS; MORTALITY; RUSSIA	Injuries cause 9% of deaths and 14% of ill health in the WHO European Region. This problem is neglected; injuries are often seen as part of everyday life. However, although western Europe has good safety levels, death and disability from injury are rising in eastern Europe. People in low-to-middle-income countries in the Region are 3.6 times more likely to die from injuries than those in high-income countries. Economic and political change have led to unemployment, income inequalities, increased traffic, reduced restrictions on alcohol, and loss of social support. Risks such as movement of vulnerable populations and transfer of lifestyles and products between countries also need attention. In many countries, the public-health response has been inadequate, yet the cost is devastating to individuals and health-service budgets. More than half a million lives could be saved annually in the Region if recent knowledge could be used to prevent injuries and thus redress social injustice in this area.	WHO European Ctr Environm & Hlth, Special Programme Hlth & Environm, WHO Reg Off Europe, Accid Transport & Hlth, I-00187 Rome, Italy; WHO Reg Off Europe, Special Programme Hlth & Environm, Copenhagen, Denmark; WHO Reg Off Europe, Violence Prevent, Copenhagen, Denmark	World Health Organization; World Health Organization	Sethi, D (corresponding author), WHO European Ctr Environm & Hlth, Special Programme Hlth & Environm, WHO Reg Off Europe, Accid Transport & Hlth, I-00187 Rome, Italy.	din@ecr.euro.who.int		Racioppi, Francesca/0000-0002-7287-9603				*AD HOC COMM, 1996, AD HOC COMM HLTH RES; Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; Bauer Robert, 2005, Int J Inj Contr Saf Promot, V12, P57, DOI 10.1080/15660970412331289715; Bobak M, 1999, ANN EPIDEMIOL, V9, P335; Boland M, 2005, INJURY PREV, V11, P38, DOI 10.1136/ip.2004.005371; Breen J, 2004, BRIT MED J, V328, P888, DOI 10.1136/bmj.328.7444.888; Chenet L, 2001, INT J EPIDEMIOL, V30, P743, DOI 10.1093/ije/30.4.743; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Choi BCK, 2005, J EPIDEMIOL COMMUN H, V59, P632, DOI 10.1136/jech.2004.031765; Coker RJ, 2004, LANCET, V363, P1389, DOI 10.1016/S0140-6736(04)16053-4; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; *DEP TRANSP, 2004, BACKGR PARTN DEM PRO; Department of Health, 1999, RED HLTH IN ACT REP; DIMITROV P, 2004, OVERVIEW ENV HLTH EF; *EUR C MIN TRANSP, 2006, ROAD SAF PERF NAT PE; *EUR COMM, 2001, CONS MEMB STAT EL PR; European Commission, 2001, WHIT PAP EUR TRANSP; FOXCROFT DR, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003024; *FRENCH NAT OBS RO, FRANC REC DEV ROAD S; Fustukian S., 2002, HLTH POLICY GLOBALIS, P208; *GOV RUSS FED, FED TARG PROGR ENH R; GUSTAFSSON LH, 1979, PAEDIATRICIAN, V8, P181; HIBBEL B, 2004, 2003 ESPAD REPORT AL; Holder Y, 2001, INJURY SURVEILLANCE; HOWSON CP, 1998, ADLV, V351, P586; Hyder AA, 2003, LANCET, V362, P2034, DOI 10.1016/S0140-6736(03)15145-8; JENKINS R, 2005, BMJ-BRIT MED J, V34, P1203; KOUPILOVA I, 2002, 29 EUR ENV AG, P130; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; LAFLAMME L, 1998, SOCIAL INEQUALITY IN; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Macintyre S, 2003, BRIT MED J, V326, P5, DOI 10.1136/bmj.326.7379.5; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; MCALLISTER JFO, 2005, TIME            1219; McKee M, 2000, LANCET, V356, P665, DOI 10.1016/S0140-6736(00)02616-7; McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263; McKee M, 1999, ALCOHOL ALCOHOLISM, V34, P824, DOI 10.1093/alcalc/34.6.824; McKee M, 2004, BRIT MED J, V329, P1428, DOI 10.1136/bmj.329.7480.1428; Mckee M, 2005, ADDICTION, V100, P1205, DOI 10.1111/j.1360-0443.2005.01162.x; McKee M, 2004, BRIT MED J, V328, P1025, DOI 10.1136/bmj.328.7447.1025; MCKEE M, 2005, INT J EPIDEMIOL, V1093, P1; Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964; Miller TR, 2000, MED CARE, V38, P562, DOI 10.1097/00005650-200006000-00003; *MIN HLTH, 2003, MORT POP RUSS FED 20; Mock C, 2005, B WORLD HEALTH ORGAN, V83, P294; MULRHAD N, 2004, GAMBIT C P GDANSK; *NAT CTR INJ PREV, 2000, WORK PREV CONTR INJ; Nemtsov A, 2003, DRUG ALCOHOL DEPEN, V71, P161, DOI 10.1016/S0376-8716(03)00094-2; Nemtsov AV, 1998, ADDICTION, V93, P1501, DOI 10.1046/j.1360-0443.1998.931015016.x; Peden M, 2002, INJURY LEADING CAUSE; Peden M., 2004, WORLD REPORT ROAD TR; Pomerleau J, 2005, ADDICTION, V100, P1647, DOI 10.1111/j.1360-0443.2005.01233.x; Powles JW, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-116; Pridemore WA, 2002, AM J PUBLIC HEALTH, V92, P1921, DOI 10.2105/AJPH.92.12.1921; Racioppi F., 2004, PREVENTING ROAD TRAF; Rehm J, 2004, COMP QUANTIFICATION, P959; Roberts I, 1996, BRIT MED J, V313, P784; Roberts I, 1997, J EPIDEMIOL COMMUN H, V51, P334, DOI 10.1136/jech.51.3.334; Roberts I, 2004, INJURY PREV, V10, P65, DOI 10.1136/ip.2004.005140; Room R, 2005, ADDICTION, V100, P579, DOI 10.1111/rp10.1017-S1367943003213238; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Ross L, 2001, J VIROL METHODS, V96, P1, DOI 10.1016/S0166-0934(00)00275-5; SETHI D, 1999, HLTH MORTALITY ISSUE, P412; SETHI D, IN PRESS INJURIES VI; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; *SURESTART, ACC INJ; *TEACH VIP, 2005, US MAN; Towner Elizabeth, 2005, Int J Inj Contr Saf Promot, V12, P79, DOI 10.1080/15660970500073682; *UN, 2004, 58289 UN; Walberg P, 1998, BRIT MED J, V317, P312, DOI 10.1136/bmj.317.7154.312; Walby S., 2004, COST DOMESTIC VIOLEN; Watt K, 2004, ADDICTION, V99, P1262, DOI 10.1111/j.1360-0443.2004.00823.x; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; *WHO, 2005, MORT 67 CAUS DEATH A; *WHO, 2003, WHA5624 WHO; WHO, 2004, WHA5710 WHO; *WHO, 2005, STAT INF SYST WHOSIS; *WHO, GBD EST; WHO, 2000, EUR ALC ACT PLAN 200, piii; *WHO EUR MIN C MEN, MENT HLTH ACT PLAN E; *WHO REG COMM, 2005, EURRC5510 WHO REG CO; *WHO REG COMM EUR, 2005, EURRC55R9 WHO REG CO; Wilkinson RG, 2003, SOCIAL DETERMINANTS; *WORLD BANK, 2002, TRANS 1 10 YEARS AN; World Bank, 2005, DYING TOO YOUNG ADDR; *WORLD BANK, 2002, COUNTR CLASS CLASS E; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 1996, WHA4925 WHO; ZWI A, 2002, POVERTY INEQUALITY H, P263	90	49	52	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2243	2250		10.1016/S0140-6736(06)68895-8	http://dx.doi.org/10.1016/S0140-6736(06)68895-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	120HY	17189036				2022-12-01	WOS:000243076800032
J	Gibbs, SJ; Bown, PR; Sessa, JA; Bralower, TJ; Wilson, PA				Gibbs, Samantha J.; Bown, Paul R.; Sessa, Jocelyn A.; Bralower, Timothy J.; Wilson, Paul A.			Nannoplankton extinction and origination across the Paleocene-Eocene Thermal Maximum	SCIENCE			English	Article							OCEAN; CARBON; SEA; ACIDIFICATION; METHANE; RISE; END	The Paleocene-Eocene Thermal Maximum (PETM, similar to 55 million years ago) was an interval of global warming and ocean acidification attributed to rapid release and oxidation of buried carbon. We show that the onset of the PETM coincided with a prominent increase in the origination and extinction of calcareous phytoplankton. Yet major perturbation of the surface-water saturation state across the PETM was not detrimental to the survival of most calcareous nannoplankton taxa and did not impart a calcification or ecological bias to the pattern of evolutionary turnover. Instead, the rate of environmental change appears to have driven turnover, preferentially affecting rare taxa living close to their viable limits.	Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; UCL, Dept Earth Sci, London WC1E 6BT, England; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	NERC National Oceanography Centre; University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gibbs, SJ (corresponding author), Natl Oceanog Ctr, Sch Ocean & Earth Sci, European Way, Southampton SO14 3ZH, Hants, England.	sxg@noc.soton.ac.uk	Bown, Paul/C-5235-2011	Bown, Paul/0000-0001-6777-4463; Sessa, Jocelyn A./0000-0003-1509-5519; Wilson, Paul/0000-0001-6425-8906	Natural Environment Research Council [NE/C002407/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Bralower TJ, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000662; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; COLOSIMO AB, 2006, P OC DRILL PROGR SCI, V0198; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Farley KA, 2003, EARTH PLANET SC LETT, V208, P135, DOI 10.1016/S0012-821X(03)00017-7; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gibbs SJ, 2006, GEOLOGY, V34, P233, DOI 10.1130/G22381.1; Gingerich P. D., 2003, SPECIAL PAPERS GEOLO, P463; Houghton J. T., 2001, CLIMATE CHANGE 2001; Katz ME, 1999, SCIENCE, V286, P1531, DOI 10.1126/science.286.5444.1531; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; NORRIS RD, 2000, DEEP TIME PALEOBIOLO, P236; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas E, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P214; Wilson E. O., 1994, DIVERSITY LIFE; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110	24	141	148	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1770	1773		10.1126/science.1133902	http://dx.doi.org/10.1126/science.1133902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170303				2022-12-01	WOS:000242833600057
J	Bershtein, S; Segal, M; Bekerman, R; Tokuriki, N; Tawfik, DS				Bershtein, Shimon; Segal, Michal; Bekerman, Roy; Tokuriki, Nobuhiko; Tawfik, Dan S.			Robustness-epistasis link shapes the fitness landscape of a randomly drifting protein	NATURE			English	Article							SEXUAL REPRODUCTION; TOLERANCE; EVOLUTION; SUBSTITUTIONS; MUTATIONS; STABILITY; VIEW	The distribution of fitness effects of protein mutations is still unknown(1,2). Of particular interest is whether accumulating deleterious mutations interact, and how the resulting epistatic effects shape the protein's fitness landscape. Here we apply a model system in which bacterial fitness correlates with the enzymatic activity of TEM-1 beta-lactamase ( antibiotic degradation). Subjecting TEM-1 to random mutational drift and purifying selection ( to purge deleterious mutations) produced changes in its fitness landscape indicative of negative epistasis; that is, the combined deleterious effects of mutations were, on average, larger than expected from the multiplication of their individual effects. As observed in computational systems(3-5), negative epistasis was tightly associated with higher tolerance to mutations ( robustness). Thus, under a low selection pressure, a large fraction of mutations was initially tolerated ( high robustness), but as mutations accumulated, their fitness toll increased, resulting in the observed negative epistasis. These findings, supported by FoldX stability computations of the mutational effects(6), prompt a new model in which the mutational robustness ( or neutrality) observed in proteins, and other biological systems, is due primarily to a stability margin, or threshold, that buffers the deleterious physico-chemical effects of mutations on fitness. Threshold robustness is inherently epistatic - once the stability threshold is exhausted, the deleterious effects of mutations become fully pronounced, thereby making proteins far less robust than generally assumed.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	TOKURIKI, NOBUHIKO/A-2968-2010	Bershtein, Shimon/0000-0003-4322-1025				Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; HOROVITZ A, 1996, FOLDING DESIGN, V1, P121, DOI DOI 10.1016/S1359-0278(96)00056-9; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; SAUER UH, 1992, J BIOL CHEM, V267, P2393; Shafikhani S, 1997, BIOTECHNIQUES, V23, P304, DOI 10.2144/97232rr01; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wagner GP, 1998, GENETICA, V102-3, P569, DOI 10.1023/A:1017088321094; Wilke CO, 2001, P ROY SOC B-BIOL SCI, V268, P1469, DOI 10.1098/rspb.2001.1690; Wolf J. B., 2000, EPISTASIS EVOLUTIONA	22	293	298	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					929	932		10.1038/nature05385	http://dx.doi.org/10.1038/nature05385			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17122770				2022-12-01	WOS:000242805400056
J	Poole, AJ; Li, Y; Kim, Y; Lin, SCJ; Lee, WH; Lee, EYHP				Poole, Aleksandra Jovanovic; Li, Ying; Kim, Yoon; Lin, Suh-Chin J.; Lee, Wen-Hwa; Lee, Eva Y. -H. P.			Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist	SCIENCE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SUSCEPTIBILITY GENE BRCA1; BREAST-CANCER; GLAND DEVELOPMENT; EPITHELIAL-CELLS; EXPRESSION; PROLIFERATION; MORPHOGENESIS; MUTATION; LACKING	Women with mutations in the breast cancer susceptibility gene BRCA1 are predisposed to breast and ovarian cancers. Why the BRCA1 protein suppresses tumor development specifically in ovarian hormone - sensitive tissues remains unclear. We demonstrate that mammary glands of nulliparous Brca1/p53-deficient mice accumulate lateral branches and undergo extensive alveologenesis, a phenotype that occurs only during pregnancy in wild-type mice. Progesterone receptors, but not estrogen receptors, are overexpressed in the mutant mammary epithelial cells because of a defect in their degradation by the proteasome pathway. Treatment of Brca1/p53-deficient mice with the progesterone antagonist mifepristone (RU 486) prevented mammary tumorigenesis. These findings reveal a tissue-specific function for the BRCA1 protein and raise the possibility that antiprogesterone treatment may be useful for breast cancer prevention in individuals with BRCA1 mutations.	Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Lee, EYHP (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	elee@uci.edu	Lee, Wen-Hwa/C-2519-2014		NATIONAL CANCER INSTITUTE [R37CA049649, R01CA049649, R29CA049649] Funding Source: NIH RePORTER; NCI NIH HHS [CA049649] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aupperlee MD, 2005, ENDOCRINOLOGY, V146, P3577, DOI 10.1210/en.2005-0346; Beral V, 2002, LANCET, V360, P942, DOI 10.1016/S0140-6736(02)11032-4; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; BRESCIANI F, 1964, SCIENCE, V146, P653, DOI 10.1126/science.146.3644.653; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Jones LP, 2005, ONCOGENE, V24, P3554, DOI 10.1038/sj.onc.1208426; King TA, 2004, CANCER RES, V64, P5051, DOI 10.1158/0008-5472.CAN-04-1283; KORACH KS, 1994, SCIENCE, V266, P1524, DOI 10.1126/science.7985022; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Lee S, 2006, INT J CANCER, V118, P1285, DOI 10.1002/ijc.21481; Li XT, 2004, MECH AGEING DEV, V125, P669, DOI 10.1016/j.mad.2004.04.007; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Ma YX, 2006, MOL ENDOCRINOL, V20, P14, DOI 10.1210/me.2004-0488; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; NANDI S, 1958, J NATL CANCER I, V21, P1039; Razandi M, 2004, MOL CELL BIOL, V24, P5900, DOI 10.1128/MCB.24.13.5900-5913.2004; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shyamala G, 1998, P NATL ACAD SCI USA, V95, P696, DOI 10.1073/pnas.95.2.696; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Ting NSY, 2004, DNA REPAIR, V3, P935, DOI 10.1016/j.dnarep.2004.03.026; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	32	239	249	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1467	1470		10.1126/science.1130471	http://dx.doi.org/10.1126/science.1130471			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138902				2022-12-01	WOS:000242406100046
J	Rowland, BD; Bernards, R				Rowland, Benjamin D.; Bernards, Rene			Re-evaluating cell-cycle regulation by E2Fs	CELL			English	Editorial Material							S-PHASE; FAMILY; GROWTH; EXPRESSION; PROLIFERATION; SUPPRESSION; REPRESSION; APOPTOSIS; ARREST; E2F/DP		Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423				Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bargou RC, 1996, J EXP MED, V183, P1205, DOI 10.1084/jem.183.3.1205; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Humbert PO, 2000, GENE DEV, V14, P690; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Wu CL, 1996, MOL CELL BIOL, V16, P3698; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Zhang L, 1999, NEW DIAM FRONT C TEC, V9, P53	20	67	69	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					871	874		10.1016/j.cell.2006.11.019	http://dx.doi.org/10.1016/j.cell.2006.11.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129771	Green Published, Bronze			2022-12-01	WOS:000242613800002
J	Summerfield, C; Egner, T; Greene, M; Koechlin, E; Mangels, J; Hirsch, J				Summerfield, Christopher; Egner, Tobias; Greene, Matthew; Koechlin, Etienne; Mangels, Jennifer; Hirsch, Joy			Predictive codes for forthcoming perception in the frontal cortex	SCIENCE			English	Article							FACE PERCEPTION; BRAIN; DECISION; OBJECTS; MEMORY	Incoming sensory information is often ambiguous, and the brain has to make decisions during perception. "Predictive coding" proposes that the brain resolves perceptual ambiguity by anticipating the forthcoming sensory environment, generating a template against which to match observed sensory evidence. We observed a neural representation of predicted perception in the medial frontal cortex, while human subjects decided whether visual objects were faces or not. Moreover, perceptual decisions about faces were associated with an increase in top-down connectivity from the frontal cortex to face-sensitive visual areas, consistent with the matching of predicted and observed evidence for the presence of faces.	Columbia Univ, Dept Psychol, New York, NY 10027 USA; Ecole Normale Super, INSERM, U742, Dept Etud Cognit, F-75005 Paris, France; Columbia Univ, Neurol Inst, Funct MRI Res Ctr, New York, NY 10032 USA; Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; Columbia Univ, Neurol Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Columbia University; Northwestern University; Feinberg School of Medicine; Columbia University	Summerfield, C (corresponding author), Columbia Univ, Dept Psychol, 1190 Amsterdam Ave, New York, NY 10027 USA.	summerfd@paradox.columbia.edu	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021; Egner, Tobias/AAD-5864-2022; Egner, Tobias/A-5237-2009	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Egner, Tobias/0000-0001-7956-3241; Egner, Tobias/0000-0001-7956-3241; Hirsch, Joy/0000-0002-1418-6489	PHS HHS [R21066129] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Barbas H, 2000, ADV NEUROL, V84, P87; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Sharma J, 2003, SCIENCE, V300, P1758, DOI 10.1126/science.1081721; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Summerfield C, 2006, CEREB CORTEX, V16, P500, DOI 10.1093/cercor/bhi129; Swets J. A., 1964, SIGNAL DETECT RECOG, P164; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; TODOROV A, 2006, NEUROPSYCHOLOGIA; WALD A, 1949, P NATL ACAD SCI USA, V35, P99, DOI 10.1073/pnas.35.2.99	28	368	371	7	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1311	1314		10.1126/science.1132028	http://dx.doi.org/10.1126/science.1132028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124325				2022-12-01	WOS:000242215800047
J	Canals, M; Puig, P; de Madron, XD; Heussner, S; Palanques, A; Fabres, J				Canals, Miquel; Puig, Pere; de Madron, Xavier Durrieu; Heussner, Serge; Palanques, Albert; Fabres, Joan			Flushing submarine canyons	NATURE			English	Article							DENSE WATER; CONTINENTAL-SHELF; GRAVITY FLOW; CASCADES; DYNAMICS	The continental slope is a steep, narrow fringe separating the coastal zone from the deep ocean. During low sea- level stands, slides and dense, sediment- laden flows erode the outer continental shelf and the continental slope, leading to the formation of submarine canyons that funnel large volumes of sediment and organic matter from shallow regions to the deep ocean (1). During high sea-level stands, such as at present, these canyons still experience occasional sediment gravity flows(2 - 5), which are usually thought to be triggered by sediment failure or river flooding. Here we present observations from a submarine canyon on the Gulf of Lions margin, in the northwest Mediterranean Sea, that demonstrate that these flows can also be triggered by dense shelf water cascading ( DSWC) - a type of current that is driven solely by seawater density contrast. Our results show that DSWC can transport large amounts of water and sediment, reshape submarine canyon floors and rapidly affect the deep- sea environment. This cascading is seasonal, resulting from the formation of dense water by cooling and/ or evaporation, and occurs on both high- and low- latitude continental margins(6 - 8). DSWC may therefore transport large amounts of sediment and organic matter to the deep ocean. Furthermore, changes in the frequency and intensity of DSWC driven by future climate change may have a significant impact on the supply of organic matter to deep- sea ecosystems and on the amount of carbon stored on continental margins and in ocean basins.	Univ Barcelona, Dept Stratig Paleontol & Marine Geosci, CRG Marine Geosci, E-08028 Barcelona, Spain; CSIC, Inst Marine Sci, E-08003 Barcelona, Spain; Univ Perpignan, CEFREM, CNRS, UMR 5110, F-66860 Perpignan, France	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia	Canals, M (corresponding author), Univ Barcelona, Dept Stratig Paleontol & Marine Geosci, CRG Marine Geosci, E-08028 Barcelona, Spain.	miquelcanals@ub.edu	Canals, Miquel/F-4922-2013; Palanques, Albert/C-2661-2013; Puig, Pere/E-5422-2013	Canals, Miquel/0000-0001-5267-7601; Puig, Pere/0000-0001-6189-5504; Palanques, Albert/0000-0003-2544-2342				Avril B, 2002, DEEP-SEA RES PT II, V49, P2163, DOI 10.1016/S0967-0645(02)00033-4; Bethoux JP, 2002, J MARINE SYST, V33, P117, DOI 10.1016/S0924-7963(02)00055-6; CAUWET G, 1994, MAR CHEM, V47, P55, DOI 10.1016/0304-4203(94)90013-2; Dasgupta P, 2003, EARTH-SCI REV, V62, P265, DOI 10.1016/S0012-8252(02)00160-5; de Madron XD, 2005, PROG OCEANOGR, V64, P83, DOI 10.1016/j.pocean.2004.08.004; *EARTH RES INF SYS, 1996, GLOB 30 ARC SEC EL D; FLOOD RD, 1983, GEOL SOC AM BULL, V94, P630, DOI 10.1130/0016-7606(1983)94<630:COSFAA>2.0.CO;2; FLOOD RD, 1994, PALEOCEANOGRAPHY, V9, P1049, DOI 10.1029/94PA01801; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Hill AE, 1998, J MAR RES, V56, P87, DOI 10.1357/002224098321836127; HONJO S, 1988, DEEP-SEA RES, V35, P1223, DOI 10.1016/0198-0149(88)90078-7; Houghton J. T., 2001, CLIMATE CHANGE 2001; Ivanov VV, 2004, PROG OCEANOGR, V60, P47, DOI 10.1016/j.pocean.2003.12.002; Khripounoff A, 2003, MAR GEOL, V194, P151, DOI 10.1016/S0025-3227(02)00677-1; LACOMBE H, 1985, PROG OCEANOGR, V14, P319, DOI 10.1016/0079-6611(85)90015-1; Lopez-Jurado JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024430; MASSON DG, 1996, OCEANOGRAPHY ILLUSTR, P146; Mulder T, 2001, GEO-MAR LETT, V21, P149, DOI 10.1007/s003670100077; Paull CK, 2003, GEO-MAR LETT, V22, P227, DOI 10.1007/s00367-003-0117-2; Posamentier H.W., 1988, SPECIAL PUBLICATION, V42, P110; Puig P, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001918; Shapiro GI, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001610; Shapiro GI, 1997, J PHYS OCEANOGR, V27, P2381, DOI 10.1175/1520-0485(1997)027<2381:DODWCA>2.0.CO;2; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Tsunogai S, 1999, TELLUS B, V51, P701, DOI 10.1034/j.1600-0889.1999.t01-2-00010.x; WHITEHEAD JA, 1987, NATURE, V327, P656, DOI 10.1038/327656a0; YODER JA, 1989, CONT SHELF RES, V9, P547, DOI 10.1016/0278-4343(89)90020-4	27	585	594	5	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					354	357		10.1038/nature05271	http://dx.doi.org/10.1038/nature05271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108962				2022-12-01	WOS:000242018300045
J	Sodergren, E; Weinstock, GM; Davidson, EH; Cameron, RA; Gibbs, RA; Weinstock, GM; Angerer, RC; Angerer, LM; Arnone, MI; Burgess, DR; Burke, RD; Cameron, RA; Coffman, JA; Davidson, EH; Dean, M; Elphick, MR; Ettensohn, CA; Foltz, KR; Hamdoun, A; Hynes, RO; Klein, WH; Marzluff, W; McClay, DR; Morris, RL; Mushegian, A; Rast, JP; Sodergren, E; Smith, LC; Thorndyke, MC; Vacquier, VD; Weinstock, GM; Wessel, GM; Wray, G; Zhang, L; Sodergren, E; Weinstock, GM; Angerer, RC; Angerer, LM; Cameron, RA; Davidson, EH; Elsik, CG; Ermolaeva, O; Hlavina, W; Hofmann, G; Kitts, P; Landrum, MJ; Mackey, AJ; Maglott, D; Panopoulou, G; Poustka, AJ; Pruitt, K; Sapojnikov, V; Song, XZ; Souvorov, A; Solovyev, V; Wei, Z; Whittaker, CA; Worley, K; Zhang, L; Sodergren, E; Weinstock, GM; Durbin, KJ; Gibbs, RA; Shen, YF; Song, XZ; Worley, K; Zhang, L; Wray, G; Fedrigo, O; Garfield, D; Haygood, R; Primus, A; Satija, R; Severson, T; Zhang, L; Sodergren, E; Weinstock, GM; Gonzalez-Garay, ML; Jackson, AR; Milosavljevic, A; Song, XZ; Tong, M; Worley, K; Ettensohn, CA; Cameron, RA; Killian, CE; Landrum, MJ; Livingston, BT; Wilt, FH; Coffman, JA; Marzluff, W; Mushegian, A; Adams, N; Belle, R; Carbonneau, S; Cheung, R; Cormier, P; Cosson, B; Croce, J; Fernandez-Guerra, A; Geneviere, AM; Goel, M; Kelkar, H; Morales, J; Mulner-Lorillon, O; Robertson, AJ; Hamdoun, A; Goldstone, JV; Adams, N; Cole, B; Dean, M; Epel, D; Gold, B; Hahn, ME; Howard-Ashby, M; Scally, M; Stegeman, JJ; Morris, RL; Allgood, EL; Cool, J; Judkins, KM; McCafferty, SS; Musante, AM; Obar, RA; Rawson, AP; Rossetti, BJ; Burgess, DR; Allgood, EL; Cool, J; Gibbons, IR; Hoffman, MP; Judkins, KM; Leone, A; McCafferty, SS; Morris, RL; Musante, AM; Obar, RA; Rawson, AP; Rossetti, BJ; Wessel, GM; Davidson, EH; Cameron, RA; Istrail, S; Materna, SC; Samanta, MP; Stolc, V; Tongprasit, W; Tu, Q; Angerer, RC; Angerer, LM; Wei, Z; Hynes, RO; Bergeron, KF; Brandhorst, BP; Burke, RD; Whittaker, CA; Whittle, J; Cameron, RA; Berney, K; Bottjer, DJ; Calestani, C; Davidson, EH; Peterson, K; Chow, E; Yuan, QA; Elhaik, E; Elsik, CG; Graur, D; Reese, JT; Bosdet, I; Heesun, S; Marra, MA; Schein, J; Dean, M; Hamdoun, A; Rast, JP; Smith, LC; Anderson, MK; Berney, K; Brockton, V; Buckley, KM; Cameron, RA; Cohen, AH; Fugmann, SD; Hibino, T; Loza-Coll, M; Majeske, AJ; Messier, C; Nair, SV; Pancer, Z; Terwilliger, DP; Burke, RD; Elphick, MR; Klein, WH; Thorndyke, MC; Agca, C; Angerer, LM; Arboleda, E; Arnone, MI; Brandhorst, BP; Chen, NS; Churcher, AM; Hallbook, F; Humphrey, GW; Hynes, RO; Idris, MM; Kiyama, T; Liang, SG; Mellott, D; Mu, XQ; Murray, G; Olinski, RP; Raible, F; Rowe, M; Taylor, JS; Tessmar-Raible, K; Wang, D; Wilson, KH; Yaguchi, S; Foltz, KR; Vacquier, VD; Wessel, GM; Gaasterland, T; Galindo, BE; Gunaratne, HJ; Howard-Ashby, M; Humphrey, GW; Juliano, C; Kinukawa, M; Moy, GW; Neill, AT; Nomura, M; Raisch, M; Reade, A; Roux, MM; Song, JL; Su, YH; Townley, IK; Voronina, E; Wong, JL; Arnone, MI; Thorndyke, MC; Amore, G; Angerer, LM; Arboleda, E; Branno, M; Brown, ER; Cavalieri, V; Duboc, V; Duloquin, L; Elphick, MR; Flytzanis, C; Gache, C; Geneviere, AM; Idris, MM; Lapraz, F; Lepage, T; Locascio, A; Martinez, P; Matassi, G; Matranga, V; McClay, DR; Morales, J; Poustka, AJ; Raible, F; Range, R; Rizzo, F; Rottinger, E; Rowe, M; Tessmar-Raible, K; Sodergren, E; Weinstock, GM; Wilson, K; McClay, DR; Angerer, LM; Arnone, MI; Beane, W; Bradham, C; Byrum, C; Croce, J; Duboc, V; Duloquin, L; Gache, C; Geneviere, AM; Glenn, T; Hibino, T; Hussain, S; Lapraz, F; Lepage, T; Livingston, BT; Loza, M; Manning, G; Miranda, E; Range, R; Rizzo, F; Rottinger, E; Thomason, R; Walton, K; Wei, Z; Wessel, GM; Wikramanayke, A; Wilson, KH; Whittaker, C; Wu, SY; Xu, RH; Davidson, EH; Arnone, MI; Branno, M; Brown, CT; Cameron, RA; Chen, LL; Gray, RF; Howard-Ashby, M; Istrail, S; Lee, PY; Locascio, A; Martinez, P; Materna, SC; Nam, J; Oliveri, P; Rizzo, F; Smith, J; Muzny, D; Sodergren, E; Gibbs, RA; Weinstock, GM; Bell, S; Chacko, J; Cree, A; Curry, S; Davis, C; Dinh, H; Dugan-Rocha, S; Fowler, J; Gill, R; Hamilton, C; Hernandez, J; Hines, S; Hume, J; Jackson, L; Jolivet, A; Kovar, C; Lee, S; Lewis, L; Miner, G; Morgan, M; Nazareth, LV; Okwuonu, G; Parker, D; Pu, LL; Shen, YF; Thom, R; Wright, R				Sodergren, Erica; Weinstock, George M.; Davidson, Eric H.; Cameron, R. Andrew; Gibbs, Richard A.; Weinstock, George M.; Angerer, Robert C.; Angerer, Lynne M.; Arnone, Maria Ina; Burgess, David R.; Burke, Robert D.; Cameron, R. Andrew; Coffman, James A.; Davidson, Eric H.; Dean, Michael; Elphick, Maurice R.; Ettensohn, Charles A.; Foltz, Kathy R.; Hamdoun, Amro; Hynes, Richard O.; Klein, William H.; Marzluff, William; McClay, David R.; Morris, Robert L.; Mushegian, Arcady; Rast, Jonathan P.; Sodergren, Erica; Smith, L. Courtney; Thorndyke, Michael C.; Vacquier, Victor D.; Weinstock, George M.; Wessel, Gary M.; Wray, Greg; Zhang, Lan; Sodergren, Erica; Weinstock, George M.; Angerer, Robert C.; Angerer, Lynne M.; Cameron, R. Andrew; Davidson, Eric H.; Elsik, Christine G.; Ermolaeva, Olga; Hlavina, Wratko; Hofmann, Gretchen; Kitts, Paul; Landrum, Melissa J.; Mackey, Aaron J.; Maglott, Donna; Panopoulou, Georgia; Poustka, Albert J.; Pruitt, Kim; Sapojnikov, Victor; Song, Xingzhi; Souvorov, Alexandre; Solovyev, Victor; Wei, Zheng; Whittaker, Charles A.; Worley, Kim; Zhang, Lan; Sodergren, Erica; Weinstock, George M.; Durbin, K. James; Gibbs, Richard A.; Shen, Yufeng; Song, Xingzhi; Worley, Kim; Zhang, Lan; Wray, Greg; Fedrigo, Olivier; Garfield, David; Haygood, Ralph; Primus, Alexander; Satija, Rahul; Severson, Tonya; Zhang, Lan; Sodergren, Erica; Weinstock, George M.; Gonzalez-Garay, Manuel L.; Jackson, Andrew R.; Milosavljevic, Aleksandar; Song, Xingzhi; Tong, Mark; Worley, Kim; Ettensohn, Charles A.; Cameron, R. Andrew; Killian, Christopher E.; Landrum, Melissa J.; Livingston, Brian T.; Wilt, Fred H.; Coffman, James A.; Marzluff, William; Mushegian, Arcady; Adams, Nikki; Belle, Robert; Carbonneau, Seth; Cheung, Rocky; Cormier, Patrick; Cosson, Bertrand; Croce, Jenifer; Fernandez-Guerra, Antonio; Geneviere, Anne-Marie; Goel, Manisha; Kelkar, Hemant; Morales, Julia; Mulner-Lorillon, Odile; Robertson, Anthony J.; Hamdoun, Amro; Goldstone, Jared V.; Adams, Nikki; Cole, Bryan; Dean, Michael; Epel, David; Gold, Bert; Hahn, Mark E.; Howard-Ashby, Meredith; Scally, Mark; Stegeman, John J.; Morris, Robert L.; Allgood, Erin L.; Cool, Jonah; Judkins, Kyle M.; McCafferty, Shawn S.; Musante, Ashlan M.; Obar, Robert A.; Rawson, Amanda P.; Rossetti, Blair J.; Burgess, David R.; Allgood, Erin L.; Cool, Jonah; Gibbons, Ian R.; Hoffman, Matthew P.; Judkins, Kyle M.; Leone, Andrew; McCafferty, Shawn S.; Morris, Robert L.; Musante, Ashlan M.; Obar, Robert A.; Rawson, Amanda P.; Rossetti, Blair J.; Wessel, Gary M.; Davidson, Eric H.; Cameron, R. Andrew; Istrail, Sorin; Materna, Stefan C.; Samanta, Manoj P.; Stolc, Viktor; Tongprasit, Waraporn; Tu, Qiang; Angerer, Robert C.; Angerer, Lynne M.; Wei, Zheng; Hynes, Richard O.; Bergeron, Karl-Frederik; Brandhorst, Bruce P.; Burke, Robert D.; Whittaker, Charles A.; Whittle, James; Cameron, R. Andrew; Berney, Kevin; Bottjer, David J.; Calestani, Cristina; Davidson, Eric H.; Peterson, Kevin; Chow, Elly; Yuan, Qiu Autumn; Elhaik, Eran; Elsik, Christine G.; Graur, Dan; Reese, Justin T.; Bosdet, Ian; Heesun, Shin; Marra, Marco A.; Schein, Jacqueline; Dean, Michael; Hamdoun, Amro; Rast, Jonathan P.; Smith, L. Courtney; Anderson, Michele K.; Berney, Kevin; Brockton, Virginia; Buckley, Katherine M.; Cameron, R. Andrew; Cohen, Avis H.; Fugmann, Sebastian D.; Hibino, Taku; Loza-Coll, Mariano; Majeske, Audrey J.; Messier, Cynthia; Nair, Sham V.; Pancer, Zeev; Terwilliger, David P.; Burke, Robert D.; Elphick, Maurice R.; Klein, William H.; Thorndyke, Michael C.; Agca, Cavit; Angerer, Lynne M.; Arboleda, Enrique; Arnone, Maria Ina; Brandhorst, Bruce P.; Chen, Nansheng; Churcher, Allison M.; Hallboeoek, F.; Humphrey, Glen W.; Hynes, Richard O.; Idris, Mohammed M.; Kiyama, Takae; Liang, Shuguang; Mellott, Dan; Mu, Xiuqian; Murray, Greg; Olinski, Robert P.; Raible, Florian; Rowe, Matthew; Taylor, John S.; Tessmar-Raible, Kristin; Wang, D.; Wilson, Karen H.; Yaguchi, Shunsuke; Foltz, Kathy R.; Vacquier, Victor D.; Wessel, Gary M.; Gaasterland, Terry; Galindo, Blanca E.; Gunaratne, Herath J.; Howard-Ashby, Meredith; Humphrey, Glen W.; Juliano, Celina; Kinukawa, Masashi; Moy, Gary W.; Neill, Anna T.; Nomura, Mamoru; Raisch, Michael; Reade, Anna; Roux, Michelle M.; Song, Jia L.; Su, Yi-Hsien; Townley, Ian K.; Voronina, Ekaterina; Wong, Julian L.; Arnone, Maria Ina; Thorndyke, Michael C.; Amore, Gabriele; Angerer, Lynne M.; Arboleda, Enrique; Branno, Margherita; Brown, Euan R.; Cavalieri, Vincenzo; Duboc, Veronique; Duloquin, Louise; Elphick, Maurice R.; Flytzanis, Constantin; Gache, Christian; Geneviere, Anne-Marie; Idris, Mohammed M.; Lapraz, Francois; Lepage, Thierry; Locascio, Annamaria; Martinez, Pedro; Matassi, Giorgio; Matranga, Valeria; McClay, David R.; Morales, Julia; Poustka, Albert J.; Raible, Florian; Range, Ryan; Rizzo, Francesca; Roettinger, Eric; Rowe, Matthew; Tessmar-Raible, Kristin; Sodergren, Erica; Weinstock, George M.; Wilson, Karen; McClay, David R.; Angerer, Lynne M.; Arnone, Maria Ina; Beane, Wendy; Bradham, Cynthia; Byrum, Christine; Croce, Jenifer; Duboc, Veronique; Duloquin, Louise; Gache, Christian; Geneviere, Anne-Marie; Glenn, Tom; Hibino, Taku; Hussain, Sofia; Lapraz, Francois; Lepage, Thierry; Livingston, Brian T.; Loza, Mariano; Manning, Gerard; Miranda, Esther; Range, Ryan; Rizzo, Francesca; Roettinger, Eric; Thomason, Rebecca; Walton, Katherine; Wei, Zheng; Wessel, Gary M.; Wikramanayke, Athula; Wilson, Karen H.; Whittaker, Charles; Wu, Shu-Yu; Xu, Ronghui; Davidson, Eric H.; Arnone, Maria Ina; Branno, Margherita; Brown, C. Titus; Cameron, R. Andrew; Chen, Lili; Gray, Rachel F.; Howard-Ashby, Meredith; Istrail, Sorin; Lee, Pei Yun; Locascio, Annamaria; Martinez, Pedro; Materna, Stefan C.; Nam, Jongmin; Oliveri, Paola; Rizzo, Francesca; Smith, Joel; Muzny, Donna; Sodergren, Erica; Gibbs, Richard A.; Weinstock, George M.; Bell, Stephanie; Chacko, Joseph; Cree, Andrew; Curry, Stacey; Davis, Clay; Dinh, Huyen; Dugan-Rocha, Shannon; Fowler, Jerry; Gill, Rachel; Hamilton, Cerrissa; Hernandez, Judith; Hines, Sandra; Hume, Jennifer; Jackson, LaRonda; Jolivet, Angela; Kovar, Christie; Lee, Sandra; Lewis, Lora; Miner, George; Morgan, Margaret; Nazareth, Lynne V.; Okwuonu, Geoffrey; Parker, David; Pu, Ling-Ling; Shen, Yufeng; Thom, Rachel; Wright, Rita		Sea Urchin Genome Sequencing Consortium	Research article - The genome of the sea urchin Strongylocentrotus purpuratus	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; IMMUNE-SYSTEM; EVOLUTION; VERTEBRATE; COMPLEMENT; INSIGHTS; DUPLICATION; CELOMOCYTES; SEQUENCE; CHORDATE		Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Stn Zool A Dohrn, I-70121 Bari, Italy; Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3N5, Canada; Mt Desert Isl Biol Lab, Salsbury Cove, ME 04672 USA; NCI, Human Genet Sect, Lab Genom Divers, Frederick, MD 21702 USA; Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; MIT, Howard Hughes Med Inst, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ N Carolina, Dept Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA; Wheaton Coll, Dept Biol, Norton, MA 02766 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Microbiol, Kansas City, KS 66160 USA; Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Immunol, Toronto, ON M4N 3M5, Canada; George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; Royal Swedish Acad Sci, Kristineberg Marine Res Stn, S-45034 Fiskebackskil, Sweden; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Brown Univ, Dept Mol & Cellular Biol & Biochem, Providence, RI 02912 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; Natl Ctr Biotechnol Informat, Natl Lib Med, NIH, Bethesda, MD 20894 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA; Univ Penn, Penn Genom Inst, Philadelphia, PA 19104 USA; Max Planck Inst Mol Genet, Evolut & Dev Grp, D-14195 Berlin, Germany; Royal Holloway Univ London, Egham TW20 0EX, Surrey, England; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ S Florida, Dept Biol, Tampa, FL 33618 USA; Univ Paris 06, UMR 7150, Equipe Cycle Cellulaire & Dev, Stn Biol Roscoff, F-29682 Roscoff, France; CNRS, UMR 7150, Stn Biol Roscoff, F-29682 Roscoff, France; Univ Paris 06, UMR7628, F-66650 Banyuls sur Mer, France; Univ N Carolina, Ctr Bioinformat, Chapel Hill, NC 27599 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Tethys Res LLC, Bangor, ME 04401 USA; Univ Calif Berkeley, Dept Mol Cellular & Dev Biol, Berkeley, CA 94720 USA; Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; NASA, Ames Res Ctr, Genome Res Facil, Moffett Field, CA 94035 USA; Systemix Inst, Cupertino, CA 95014 USA; Simon Fraser Univ, Dept Biochem & Mol Biol, Burnaby, BC V5A 1S6, Canada; MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; CALTECH, Beckman Inst, Ctr Computat Regulatory Genom, Pasadena, CA 91125 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, Syst Res Inst, College Pk, MD 20742 USA; NIA, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA; Macquarie Univ, Sch Biol Sci, Sydney, NSW 2109, Australia; UMBI, Ctr Marine Biotechnol, Baltimore, MD 21202 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA; Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; Uppsala Univ, Dept Neurosci, Uppsala, Sweden; NICHD, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA; European Mol Biol Lab, Dev Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Computat Unit, D-69117 Heidelberg, Germany; Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca 62250, Morelos, Mexico; Univ Palermo, Dept Cellular & Dev Biol Alberto Monroy, I-90146 Palermo, Italy; CNRS, UMR 7009, Dev Biol Lab, F-06230 Villefranche Sur Mer, France; Univ Paris 06, Observ Oceanol, F-06230 Villefranche Sur Mer, France; Univ Patras, Dept Biol, Patras, Greece; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Barcelona, Dept Genet, E-08028 Barcelona, Spain; Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; Inst Jacques Monod, CNR, UMR 7592, F-75005 Paris, France; CNR, Ist Biomed & Immunol Mol Alberto Monroy, I-90146 Palermo, Italy; Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, San Diego, CA 92186 USA; Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA	Baylor College of Medicine; Baylor College of Medicine; California Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Boston College; University of Victoria; Mount Desert Island Biological Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of London; Queen Mary University London; Carnegie Mellon University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Stanford University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; George Washington University; Royal Swedish Academy of Sciences; University of California System; University of California San Diego; Scripps Institution of Oceanography; Brown University; Duke University; Duke University; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of California System; University of California Santa Barbara; National Institutes of Health (NIH) - USA; University of Pennsylvania; Max Planck Society; University of London; Royal Holloway University London; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; State University System of Florida; University of South Florida; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of North Carolina; University of North Carolina Chapel Hill; Woods Hole Oceanographic Institution; University of California System; University of California Berkeley; Brown University; Brown University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Simon Fraser University; Massachusetts Institute of Technology (MIT); University of Southern California; State University System of Florida; University of Central Florida; Dartmouth College; California Institute of Technology; University of Houston System; University of Houston; British Columbia Cancer Agency; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Macquarie University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Victoria; Uppsala University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Universidad Nacional Autonoma de Mexico; University of Palermo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Patras; Baylor College of Medicine; University of Barcelona; ICREA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Salk Institute; University of Hawaii System; University of Hawaii Manoa	Weinstock, GM (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	gwstock@bcm.tmc.edu	Schein, Jacquie E/G-3674-2015; Fernandez-Guerra, Antonio/B-2851-2009; Su, Yi-Hsien/F-2910-2014; Matassi, Giorgio/G-6301-2014; Hahn, Mark/AAV-7516-2020; Croce, Jenifer C/P-1159-2016; Hamdoun, Amro/AAE-1905-2021; Churcher, Allison M/M-6169-2013; Dean, Michael/R-7501-2019; Lepage, Thierry/AAF-8925-2019; Brown, Euan R/A-5558-2008; Satija, Rahul/AAF-9564-2019; Raible, Florian/G-6019-2011; Peterson, Kevin J/A-2188-2009; 拓, 日比野/D-8115-2013; Elhaik, Eran/H-6838-2019; Chen, Nansheng/E-6450-2012; Marra, Marco A/B-5987-2008; Mu, Xiuqian/I-9146-2014; Rizzo, Francesca/AAE-7664-2020; Solovyev, Victor/C-4614-2013; Brandhorst, Bruce Peter/A-3157-2008; Bradham, Cynthia/GXV-9373-2022; Mushegian, Arcady/ABF-5387-2021; Yaguchi, Shunsuke/H-7270-2019; Weinstock, George M/C-6314-2013; Röttinger, Eric/AAX-6277-2021; Agca, Cavit/AAY-9574-2020; Elsik, Christine G/C-4120-2017; Garfield, David/AAG-1524-2020; Rizzo, Francesca/K-3057-2016; Lapraz, Francois/W-4948-2017; Buckley, Katherine Michele/AAY-8151-2021; Geneviere, Anne-Marie/A-3942-2013; Martinez, Pedro/O-5025-2014; Brown, Euan Robert/I-2389-2019; Tu, Qiang/AAJ-1582-2020; Croce, Jenifer/AGE-1719-2022; Lepage, Thierry/V-4208-2019; Locascio, Annamaria/E-8714-2015; Tessmar-Raible, Kristin/F-9642-2011; Dean, Michael C/G-8172-2012; Manning, Gerard/C-8308-2009	Matassi, Giorgio/0000-0003-4923-226X; Hahn, Mark/0000-0003-4358-2082; Croce, Jenifer C/0000-0001-7092-0257; Churcher, Allison M/0000-0003-1902-3002; Brown, Euan R/0000-0002-5995-834X; 拓, 日比野/0000-0002-4789-7375; Elhaik, Eran/0000-0003-4795-1084; Marra, Marco A/0000-0001-7146-7175; Mu, Xiuqian/0000-0002-8003-7529; Rizzo, Francesca/0000-0003-1783-5015; Solovyev, Victor/0000-0001-8885-493X; Mushegian, Arcady/0000-0002-6809-9225; Yaguchi, Shunsuke/0000-0002-8326-5762; Weinstock, George M/0000-0002-2997-4592; Agca, Cavit/0000-0001-8472-7052; Elsik, Christine G/0000-0002-4248-7713; Rizzo, Francesca/0000-0003-1783-5015; Lapraz, Francois/0000-0001-9209-2018; Buckley, Katherine Michele/0000-0002-6585-8943; Martinez, Pedro/0000-0003-3956-7541; Brown, Euan Robert/0000-0002-5995-834X; Tu, Qiang/0000-0002-7579-8315; Lepage, Thierry/0000-0003-2889-5064; Locascio, Annamaria/0000-0001-6956-2157; Tessmar-Raible, Kristin/0000-0002-8038-1741; Dean, Michael C/0000-0003-2234-0631; Smith, Joel/0000-0003-0311-7055; ARNONE, Maria Immacolata/0000-0002-9012-7624; MATRANGA, VALERIA/0000-0001-9843-3426; Hallbook, Finn/0000-0001-7552-187X; Rottinger, Eric/0000-0002-2938-6774; Anderson, Michele/0000-0002-8820-5910; Oliveri, Paola/0000-0002-3477-8529; Manning, Gerard/0000-0002-5087-9151; Duboc, veronique/0000-0002-2376-5159; Stegeman, John/0000-0001-8204-5357; Brown, C. Titus/0000-0001-6001-2677; Cheung, Rocky/0000-0001-6736-9687; Pruitt, Kim/0000-0001-7950-1374; Elphick, Maurice/0000-0002-9169-0048; Beane, Wendy/0000-0002-3762-1025; Fernandez-Guerra, Antonio/0000-0002-8679-490X; Rossetti, Blair/0000-0003-2405-4209; Ashby, Meredith/0000-0002-4385-9486; Burke, Robert/0000-0001-5527-4410; Cosson, Bertrand/0000-0003-3401-7137; Goldstone, Jared/0000-0002-9618-4961; Bergeron, Karl-F./0000-0002-7215-9104; Arboleda, Enrique/0000-0001-9800-1674; Morales, Julia/0000-0003-1632-5419; Walton, Katherine/0000-0001-9108-5617; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Loza Coll, Mariano/0000-0002-3123-1229; Raisch, Michael/0000-0002-7473-0378; Calestani, Cristina/0000-0001-8122-9349; Cameron, R. Andrew/0000-0003-3947-6041; Worley, Kim/0000-0002-0282-1000; Whittaker, Charles/0000-0002-2400-0094; Materna, Stefan/0000-0003-1737-2479; Leone, Andrew/0000-0003-4749-9809; Voronina, Ekaterina/0000-0002-0194-4260; Latimer, Rebecca Thomason/0000-0002-0254-6803; CAVALIERI, Vincenzo/0000-0003-0906-9963	Biotechnology and Biological Sciences Research Council [S19916] Funding Source: Medline; NCI NIH HHS [R43 CA093106, P30 CA014051, R44 CA093106, P30-CA14051] Funding Source: Medline; NCRR NIH HHS [P40 RR015044, RR-15044] Funding Source: Medline; NEI NIH HHS [R01 EY011930, EY11930] Funding Source: Medline; NHGRI NIH HHS [5 U54 HG003273, U54 HG003273] Funding Source: Medline; NICHD NIH HHS [P01 HD039948, F32 HD047136-03, F32 HD047136, R37-HD12896, P01 HD037105, R01 HD066219, R01 HD014483, HD14483, HD039948, F32-HD47136, F32 HD047136-02, HD-37105, HD66219, R01 HD028152] Funding Source: Medline; NIEHS NIH HHS [F32 ES012794, R01ES006272, R01 ES006272, R01 ES006272-13, P42 ES007381] Funding Source: Medline; NIGMS NIH HHS [R01 GM070840, GM61464, R01 GM058231, T32 GM007601, GM070840, R01 GM061464, R01 GM061005, GM61005, GM058231] Funding Source: Medline; NIH HHS [P40 OD010959] Funding Source: Medline; PHS HHS [2P42 ESO7381, F32 ESO12794] Funding Source: Medline; ICREA Funding Source: Custom; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028152, P01HD037105, R01HD066219, R01HD014483] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039948, F32HD047136] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014051, R44CA093106, R43CA093106] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR015044] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011930] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES012794, R01ES006272, P42ES007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058231, T32GM007601, R01GM061464, R01GM070840, R01GM061005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000388] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010959] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); ICREA(ICREA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BEANE W, IN PRESS DEV BIOL; BRADHAM C, IN PRESS DEV BIOL; BRITTEN RJ, 1978, CELL, V15, P1175, DOI 10.1016/0092-8674(78)90044-2; BURKE RD, IN PRESS DEV BIOL; BYRUM C, IN PRESS DEV BIOL; Cai WW, 2001, GENOME RES, V11, P1619, DOI 10.1101/gr.198101; Cobb J. L., 1987, NERVOUS SYSTEMS INVE, P483; COBB JLS, 1977, TISSUE CELL, V9, P125, DOI 10.1016/0040-8166(77)90054-4; CROCE J, IN PRESS DEV BIOL; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DAVIDSON EH, 2006, GENE REGULATORY NETW; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; ELSIK CG, IN PRESS GENOME BIOL; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GOLDSTONE J, IN PRESS DEV BIOL; Grobben K, 1909, VERH ZOOL BOT GES WI, V58, P491; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; HIBINO T, IN PRESS DEV BIOL; HINEGARDNER RT, 1971, ANAL BIOCHEM, V39, P197, DOI 10.1016/0003-2697(71)90476-3; HOWARDASHBY M, IN PRESS DEV BIOL; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kawasaki K, 2004, P NATL ACAD SCI USA, V101, P11356, DOI 10.1073/pnas.0404279101; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; LIVINGSTON BT, IN PRESS DEV BIOL; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MATERNA SC, IN PRESS DEV BIOL; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; MORRIS RL, IN PRESS DEV BIOL; Pancer Z, 2000, P NATL ACAD SCI USA, V97, P13156, DOI 10.1073/pnas.230096397; Pancer Z, 1999, IMMUNOGENETICS, V49, P773, DOI 10.1007/s002510050551; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; RAIBLE F, IN PRESS DEV BIOL; Rast JP, 2006, SCIENCE, V314, P952, DOI 10.1126/science.1134301; Samanta MP, 2006, SCIENCE, V314, P960, DOI 10.1126/science.1131898; Smith LC, 1999, IMMUNOPHARMACOLOGY, V42, P107, DOI 10.1016/S0162-3109(99)00009-0; Smith LC, 2001, IMMUNOL REV, V180, P16, DOI 10.1034/j.1600-065X.2001.1800102.x; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; WEI Z, IN PRESS DEV BIOL; WHITTAKER CA, IN PRESS DEV BIOL; Xie W, 2001, J BIOL CHEM, V276, P37739, DOI 10.1074/jbc.R100033200	50	839	870	3	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					941	952		10.1126/science.1133609	http://dx.doi.org/10.1126/science.1133609			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095691	Green Accepted, Green Published			2022-12-01	WOS:000241896000039
J	Sponheimer, M; Passey, BH; de Ruiter, DJ; Guatelli-Steinberg, D; Cerling, TE; Lee-Thorp, JA				Sponheimer, Matt; Passey, Benjamin H.; de Ruiter, Darryl J.; Guatelli-Steinberg, Debbie; Cerling, Thure E.; Lee-Thorp, Julia A.			Isotopic evidence for dietary variability in the early hominin Paranthropus robustus	SCIENCE			English	Article							HOMO; STERKFONTEIN; CHIMPANZEES; MICROWEAR; TIME; WEST	Traditional methods of dietary reconstruction do not allow the investigation of dietary variability within the lifetimes of individual hominins. However, laser ablation stable isotope analysis reveals that the delta C-13 values of Paranthropus robustus individuals often changed seasonally and interannually. These data suggest that Paranthropus was not a dietary specialist and that by about 1.8 million years ago, savanna-based foods such as grasses or sedges or animals eating these foods made up an important but highly variable part of its diet.	Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Bradford, Dept Archeol Sci, Bradford BD1 7DP, W Yorkshire, England	University of Colorado System; University of Colorado Boulder; Utah System of Higher Education; University of Utah; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah; University of Bradford	Sponheimer, M (corresponding author), Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.		Sponheimer, Matt/A-6075-2013; Passey, Benjamin/F-9644-2010	Sponheimer, Matt/0000-0002-8743-1123; Cerling, Thure/0000-0002-3590-294X; Passey, Benjamin/0000-0002-3483-4148; de Ruiter, Darryl/0000-0003-1183-0352				Ambrose SH, 1993, PREHISTORIC HUMAN BO; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; FOLEY R, 1987, ANOTHER UNIQUE SPECI, P210; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; HILL A, 1992, NATURE, V355, P719, DOI 10.1038/355719a0; Jolly CJ, 2001, YEARB PHYS ANTHROPOL, V44, P177, DOI 10.1002/ajpa.10021; LACRUZ RJ, 2006, J HUM EVOL, DOI DOI 10.1016/J.HJEVOL.2006.05.007; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; MCGREW WC, 1981, J HUM EVOL, V10, P227, DOI 10.1016/S0047-2484(81)80061-9; O'Connell JF, 1999, J HUM EVOL, V36, P461, DOI 10.1006/jhev.1998.0285; Passey BH, 2006, CHEM GEOL, V235, P238, DOI 10.1016/j.chemgeo.2006.07.002; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; ROBINSON JT, 1954, EVOLUTION, V8, P324, DOI 10.2307/2405779; Schoeninger MJ, 1999, AM J PRIMATOL, V49, P297, DOI 10.1002/(SICI)1098-2345(199912)49:4<297::AID-AJP2>3.0.CO;2-N; SCHRENK F, 1993, NATURE, V365, P833, DOI 10.1038/365833a0; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Sponheimer M, 2005, J HUM EVOL, V48, P301, DOI 10.1016/j.jhevol.2004.11.008; Sponheimer M, 2003, J MAMMAL, V84, P471, DOI 10.1644/1545-1542(2003)084&lt;0471:DOSABS&gt;2.0.CO;2; van der Merwe NJ, 2003, J HUM EVOL, V44, P581, DOI 10.1016/S0047-2484(03)00050-2; VOGEL JC, 1978, S AFR J SCI, V74, P209; Vrba E.S., 1988, P405; WALKER A, 1986, NATURE, V322, P517, DOI 10.1038/322517a0; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004	30	154	163	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					980	982		10.1126/science.1133827	http://dx.doi.org/10.1126/science.1133827			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095699				2022-12-01	WOS:000241896000049
J	Briscoe, WH; Titmuss, S; Tiberg, F; Thomas, RK; McGillivray, DJ; Klein, J				Briscoe, Wuge H.; Titmuss, Simon; Tiberg, Fredrik; Thomas, Robert K.; McGillivray, Duncan J.; Klein, Jacob			Boundary lubrication under water	NATURE			English	Article							CATIONIC SURFACTANTS; MONOLAYERS; ADHESION; FRICTION; LAYERS; FORCE; SURFACES; SOLIDS	Boundary lubrication, in which the rubbing surfaces are coated with molecular monolayers, has been studied extensively for over half a century(1-7). Such monolayers generally consist of amphiphilic surfactants anchored by their polar headgroups; sliding occurs at the interface between the layers, greatly reducing friction and especially wear of the underlying substrates. This process, widespread in engineering applications, is also predicted to occur in biological lubrication via phospholipid films(8,9), though few systematic studies on friction between surfactant layers in aqueous environments have been carried out(5,10). Here we show that the frictional stress between two sliding surfaces bearing surfactant monolayers may decrease, when immersed in water, to as little as one per cent or less of its value in air ( or oil). We attribute this to the shift of the slip plane from between the surfactant layers, to the surfactant/ substrate interface. The low friction would then be due to the fluid hydration layers surrounding the polar head groups attached to the substrate. These results may have implications for future technological and biomedical applications.	Univ Oxford, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; Weizmann Inst Sci, IL-76100 Rehovot, Israel	University of Oxford; Weizmann Institute of Science	Klein, J (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, S Parks Rd, Oxford OX1 3QZ, England.	jacob.klein@chem.ox.ac.uk	McGillivray, Duncan/B-9819-2009; Briscoe, Wuge H/H-5435-2018	McGillivray, Duncan/0000-0003-2127-8792; Briscoe, Wuge H/0000-0001-8025-960X	Engineering and Physical Sciences Research Council [EP/C535421/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bowden F. P., 1964, FRICTION LUBRICATION, V2; Bowden FP, 1950, FRICTION LUBRICATION, V1; BRISCOE BJ, 1982, P ROY SOC LOND A MAT, V380, P389, DOI 10.1098/rspa.1982.0048; CHEN YL, 1992, J PHYS CHEM-US, V96, P7752, DOI 10.1021/j100198a048; CHEN YLE, 1989, J PHYS CHEM-US, V93, P7057, DOI 10.1021/j100357a008; Christenson HK, 2001, ADV COLLOID INTERFAC, V91, P391, DOI 10.1016/S0001-8686(00)00036-1; DERJAGUIN BV, 1987, SURFACE FORCES, pCH4; Drummond C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066110; Grant LM, 2002, BIOPHYS J, V82, P1373, DOI 10.1016/S0006-3495(02)75492-1; HAMNERIUS Y, 1978, CHEM PHYS LIPIDS, V22, P135, DOI 10.1016/0009-3084(78)90039-7; Hills BA, 2000, P I MECH ENG H, V214, P83, DOI 10.1243/0954411001535264; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Klein J, 1998, J CHEM PHYS, V108, P6996, DOI 10.1063/1.476114; Langmuir I, 1938, SCIENCE, V87, P493, DOI 10.1126/science.87.2266.493; McGillivray DJ, 2003, LANGMUIR, V19, P7719, DOI 10.1021/la026745v; Raviv U, 2003, NATURE, V425, P163, DOI 10.1038/nature01970; Raviv U, 2002, SCIENCE, V297, P1540, DOI 10.1126/science.1074481; Sarma AV, 2001, J ORTHOP RES, V19, P671, DOI 10.1016/S0736-0266(00)00064-4; Stern HA, 2003, J CHEM PHYS, V118, P3401, DOI 10.1063/1.1537244; Suda H, 2001, LANGMUIR, V17, P6045, DOI 10.1021/la0106384; Teschke O, 2001, PHYS CHEM CHEM PHYS, V3, P3761, DOI 10.1039/b009744f; Vecchio P, 1999, RHEUMATOLOGY, V38, P1020, DOI 10.1093/rheumatology/38.10.1020; Wennerstrom H., 1975, AM CHEM SOC        S, V9, P253; Williams-Daryn S, 2002, J COLLOID INTERF SCI, V256, P314, DOI 10.1006/jcis.2002.8685; Yamada S, 1998, J PHYS CHEM B, V102, P234, DOI 10.1021/jp972875e; YOSHIZAWA H, 1993, J PHYS CHEM-US, V97, P4128, DOI 10.1021/j100118a033; Zhang LZ, 2002, LANGMUIR, V18, P5448, DOI 10.1021/la011718a; Zilberman S, 2001, J CHEM PHYS, V115, P11268, DOI 10.1063/1.1421105	28	257	264	8	291	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					191	194		10.1038/nature05196	http://dx.doi.org/10.1038/nature05196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093447				2022-12-01	WOS:000241867200037
J	Dong, CJ; Beis, K; Nesper, J; Brunkan-LaMontagne, AL; Clarke, BR; Whitfield, C; Naismith, JH				Dong, Changjiang; Beis, Konstantinos; Nesper, Jutta; Brunkan-LaMontagne, Anne L.; Clarke, Bradley R.; Whitfield, Chris; Naismith, James H.			Wza the translocon for E-coli capsular polysaccharides defines a new class of membrane protein	NATURE			English	Article							COLANIC ACID BIOSYNTHESIS; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; TYROSINE AUTOKINASE; FUNCTIONAL-ANALYSIS; GROUP-1 CAPSULES; COMPLEX; LIPOPOLYSACCHARIDE; PHOSPHORYLATION; LIPOPROTEIN	Many types of bacteria produce extracellular polysaccharides (EPSs). Some are secreted polymers and show only limited association with the cell surface, whereas others are firmly attached to the cell surface and form a discrete structural layer, the capsule, which envelopes the cell and allows the bacteria to evade or counteract the host immune system(1). EPSs have critical roles in bacterial colonization of surfaces(2), such as epithelia and medical implants; in addition some EPSs have important industrial and biomedical applications in their own right(3). Here we describe the 2.26 angstrom resolution structure of the 340 kDa octamer of Wza, an integral outer membrane lipoprotein, which is essential for group 1 capsule export in Escherichia coli. The transmembrane region is a novel alpha-helical barrel. The bulk of the Wza structure is located in the periplasm and comprises three novel domains forming a large central cavity. Wza is open to the extracellular environment but closed to the periplasm. We propose a route and mechanism for translocation of the capsular polysaccharide. This work may provide insight into the export of other large polar molecules such as DNA and proteins.	Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9RH, Fife, Scotland; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of St Andrews; University of Guelph	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9RH, Fife, Scotland.	naismith@st-and.ac.uk	Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Beis, Konstantinos/0000-0001-5727-4721	Wellcome Trust [081862, 067305] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Beis K, 2004, J BIOL CHEM, V279, P28227, DOI 10.1074/jbc.M402913200; Beis K, 2004, ACTA CRYSTALLOGR D, V60, P558, DOI 10.1107/S0907444903029494; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Collins RF, 2006, J BIOL CHEM, V281, P2144, DOI 10.1074/jbc.M508078200; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Drummelsmith J, 1999, MOL MICROBIOL, V31, P1321, DOI 10.1046/j.1365-2958.1999.01277.x; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635; Moothoo DN, 1998, GLYCOBIOLOGY, V8, P173, DOI 10.1093/glycob/8.2.173; Nesper J, 2003, J BIOL CHEM, V278, P49763, DOI 10.1074/jbc.M308775200; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Rahn A, 1999, J BACTERIOL, V181, P2307, DOI 10.1128/JB.181.7.2307-2313.1999; Reid AN, 2005, J BACTERIOL, V187, P5470, DOI 10.1128/JB.187.15.5470-5481.2005; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Sutherland IW, 1998, TRENDS BIOTECHNOL, V16, P41, DOI 10.1016/S0167-7799(97)01139-6; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	30	265	277	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					226	229		10.1038/nature05267	http://dx.doi.org/10.1038/nature05267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17086202	Green Accepted			2022-12-01	WOS:000241867200045
J	Costello, A; Azad, K; Barnett, S				Costello, Anthony; Azad, Kishwar; Barnett, Sarah			An alternative strategy to reduce maternal mortality	LANCET			English	Editorial Material							RANDOMIZED-TRIAL		UCL, Inst Child Hlth, UCL Ctr Int Hlth & Dev, London WC1 1EH, England; BIRDEM Hosp, Perinatal Care Project, Dhaka, Bangladesh	University of London; University College London	Costello, A (corresponding author), UCL, Inst Child Hlth, UCL Ctr Int Hlth & Dev, London WC1 1EH, England.	a.costello@ich.ucl.ac.uk						Afessa B, 2001, CHEST, V120, P1271, DOI 10.1378/chest.120.4.1271; *COMM IMPR BIRTH O, 2003, IMPR BIRTH OUTC M CH; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lema V M, 2005, East Afr Med J, V82, P3; MANANDHAR D, EFFECT PARTICIPATORY; *NAT I POP RES TRA, 2003, BANGL MAT HLTH SERV; *NAT STAT OFF ORC, 2004, MAL DEM HLTH SURV 20; Rosato M, 2006, LANCET, V368, P1180, DOI 10.1016/S0140-6736(06)69475-0; Tew M., 1990, SAFER CHILDBIRTH CRI; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; World Health Organization (WHO), 2005, WORLD HLTH REP 2005	13	70	71	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 28	2006	368	9546					1477	1479		10.1016/S0140-6736(06)69388-4	http://dx.doi.org/10.1016/S0140-6736(06)69388-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	099GZ	17071268				2022-12-01	WOS:000241582700008
J	Hambidge, SJ; Glanz, JM; France, EK; McClure, D; Xu, S; Yamasaki, K; Jackson, L; Mullooly, JP; Zangwill, KM; Marcy, SM; Black, SB; Lewis, EM; Shinefield, HR; Belongia, E; Nordin, J; Chen, RT; Shay, DK; Davis, RL; DeStefano, F				Hambidge, Simon J.; Glanz, Jason M.; France, Eric K.; McClure, David; Xu, Stanley; Yamasaki, Kristi; Jackson, Lisa; Mullooly, John P.; Zangwill, Kenneth M.; Marcy, S. Michael; Black, Steven B.; Lewis, Edwin M.; Shinefield, Henry R.; Belongia, Edward; Nordin, James; Chen, Robert T.; Shay, David K.; Davis, Robert L.; DeStefano, Frank		Vaccine Safety Datalink Team	Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY-DISEASE; CLINICAL REACTIONS; CONTROLLED-TRIAL; ADVERSE EVENTS; YOUNG-CHILDREN; CASE SERIES; INFANTS; MEASLES; MUMPS; RISK	Context Beginning with the winter season of 2004-2005, influenza vaccination has been recommended for all children 6 to 23 months old in the United States. However, its safety in young children has not been adequately studied in large populations. Objective To screen for medically attended events in the clinic, emergency department, or hospital after administration of trivalent inactivated influenza vaccine in children 6 to 23 months old. Design, Setting, and Participants Retrospective cohort using self-control analysis, with chart review of significant medically attended events at 8 managed care organizations in the United States that comprise the Vaccine Safety Datalink. Participants were all children in the Vaccine Safety Datalink cohort 6 to 23 months old who received trivalent inactivated influenza vaccine between January 1, 1991, and May 31, 2003 ( 45 356 children with 69 359 vaccinations). Main Outcome Measure Any medically attended event significantly associated with trivalent inactivated influenza vaccine in risk windows 0 to 3 days, 1 to 14 days ( primary analysis), 1 to 42 days, or 15 to 42 days after vaccination, compared with 2 control periods, one before vaccination and the second after the risk window. All individual ICD-9 codes as well as predefined aggregate codes were examined. Results Before chart review, only 1 diagnosis, gastritis/duodenitis, was more likely to occur in the 14 days after trivalent inactivated influenza vaccine ( matched odds ratio [ OR], 5.50; 95% confidence interval [CI], 1.22-24.81 for control period 1, and matched OR, 4.33; 95% CI, 1.23-15.21 for control period 2). Thirteen medically attended events were less likely to occur after trivalent inactivated influenza vaccine, including acute upper respiratory tract infection, asthma, bronchiolitis, and otitis media. After chart review, gastritis/duodenitis was not significantly associated with trivalent inactivated influenza vaccine ( matched OR, 4.00; 95% CI, 0.85-18.84 for control period 1; matched OR, 3.34; 95% CI, 0.92-12.11 for control period 2). Conclusions In the largest population-based study to date of the safety of trivalent inactivated influenza vaccine in young children, there were very few medically attended events, none of which were serious, significantly associated with the vaccine. This study provides additional evidence supporting the safety of universally immunizing all children 6 to 23 months old with influenza vaccine.	Kaiser Permanente Colorado, Clin Res Unit, Denver, CO 80237 USA; Denver Hlth, Community Hlth Serv, Denver, CO USA; Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; Univ Colorado, Sch Med, Dept Prevent Med & Biostat, Denver, CO USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; NW Kaiser Permanente, Ctr Hlth Res, Portland, OR USA; Univ Calif Los Angeles, Ctr Vaccine Res, Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Los Angeles, CA 90024 USA; So Calif Kaiser Permanente, Panorama City, CA USA; No Calif Kaiser Permanente, Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Marshfield Clin Res Fdn, Marshfield, WI USA; Hlth Partners Res Fdn, Minneapolis, MN USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Kaiser Permanente; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Group Health Cooperative; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Kaiser Permanente; Kaiser Permanente; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA	Hambidge, SJ (corresponding author), Kaiser Permanente Colorado, Clin Res Unit, POB 378066, Denver, CO 80237 USA.	simon.hambidge@dhha.org	Chen, Robert T/AIA-8164-2022	Chen, Robert T/0000-0002-3094-8367; Shay, David/0000-0001-9619-4820; Nordin, James/0000-0002-3359-5843; Belongia, Edward/0000-0001-7478-0415	PHS HHS [200-2002-00732] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Bergen R, 2004, PEDIATR INFECT DIS J, V23, P138, DOI 10.1097/01.inf.0000109392.96411.4f; BERNSTEIN DI, 1982, PEDIATRICS, V69, P404; Castro M, 2001, NEW ENGL J MED, V345, P1529, DOI 10.1056/NEJMoa011961; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Euler G. L., 2005, Morbidity and Mortality Weekly Report, V54, P304; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Fine PEM, 2004, BMJ-BRIT MED J, V329, P1297, DOI 10.1136/bmj.329.7478.1297; Finkelstein Jonathan A., 2001, Pediatrics, V108, P1, DOI 10.1542/peds.108.1.1; France EK, 2004, ARCH PEDIAT ADOL MED, V158, P1031, DOI 10.1001/archpedi.158.11.1031; Glanz JM, 2006, J CLIN EPIDEMIOL, V59, P808, DOI 10.1016/j.jclinepi.2005.11.012; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Goodman MJ, 2006, PEDIATRICS, V117, pE821, DOI 10.1542/peds.2005-2234; Grijalva CG, 2006, EMERG INFECT DIS, V12, P103; GROOTHUIS JR, 1991, PEDIATRICS, V87, P823; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Kramarz P, 2001, J PEDIATR-US, V138, P306, DOI 10.1067/mpd.2001.112168; LIANG KY, 1987, BIOMETRICS, V43, P289, DOI 10.2307/2531813; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; McMahon AW, 2005, PEDIATRICS, V115, P453, DOI 10.1542/peds.2004-1519; Mullooly JP, 2006, VACCINE, V24, P2256, DOI 10.1016/j.vaccine.2005.11.038; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Orr P, 2002, Can Commun Dis Rep, V28, P1; PELTOLA H, 1986, LANCET, V1, P939; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; PIEDRA PA, 1993, VACCINE, V11, P718, DOI 10.1016/0264-410X(93)90255-V; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Rennels MB, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e80; Ropper AH, 1998, NEW ENGL J MED, V339, P1845, DOI 10.1056/NEJM199812173392509; Scheifele DW, 2003, CLIN INFECT DIS, V36, P850, DOI 10.1086/368189; Skowronski DM, 2006, PEDIATRICS, V117, P1963, DOI 10.1542/peds.2005-2607; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1; Tata LJ, 2003, THORAX, V58, P835, DOI 10.1136/thorax.58.10.835; Virtanen M, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.5.e62; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; WRIGHT PF, 1976, J PEDIATR-US, V88, P31, DOI 10.1016/S0022-3476(76)80722-6; Zangwill KM, 2004, PEDIATR INFECT DIS J, V23, P189, DOI 10.1097/01.inf.0000116292.46143.d6	40	101	110	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					1990	1997		10.1001/jama.296.16.1990	http://dx.doi.org/10.1001/jama.296.16.1990			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098BL	17062862	Bronze			2022-12-01	WOS:000241495300021
J	James, TY; Kauff, F; Schoch, CL; Matheny, PB; Hofstetter, V; Cox, CJ; Celio, G; Gueidan, C; Fraker, E; Miadlikowska, J; Lumbsch, HT; Rauhut, A; Reeb, V; Arnold, AE; Amtoft, A; Stajich, JE; Hosaka, K; Sung, GH; Johnson, D; O'Rourke, B; Crockett, M; Binder, M; Curtis, JM; Slot, JC; Wang, Z; Wilson, AW; Schussler, A; Longcore, JE; O'Donnell, K; Mozley-Standridge, S; Porter, D; Letcher, PM; Powell, MJ; Taylor, JW; White, MM; Griffith, GW; Davies, DR; Humber, RA; Morton, JB; Sugiyama, J; Rossman, AY; Rogers, JD; Pfister, DH; Hewitt, D; Hansen, K; Hambleton, S; Shoemaker, RA; Kohlmeyer, J; Volkmann-Kohlmeyer, B; Spotts, RA; Serdani, M; Crous, PW; Hughes, KW; Matsuura, K; Langer, E; Langer, G; Untereiner, WA; Lucking, R; Budel, B; Geiser, DM; Aptroot, A; Diederich, P; Schmitt, I; Schultz, M; Yahr, R; Hibbett, DS; Lutzoni, F; McLaughlin, DJ; Spatafora, JW; Vilgalys, R				James, Timothy Y.; Kauff, Frank; Schoch, Conrad L.; Matheny, P. Brandon; Hofstetter, Valerie; Cox, Cymon J.; Celio, Gail; Gueidan, Cecile; Fraker, Emily; Miadlikowska, Jolanta; Lumbsch, H. Thorsten; Rauhut, Alexandra; Reeb, Valerie; Arnold, A. Elizabeth; Amtoft, Anja; Stajich, Jason E.; Hosaka, Kentaro; Sung, Gi-Ho; Johnson, Desiree; O'Rourke, Ben; Crockett, Michael; Binder, Manfred; Curtis, Judd M.; Slot, Jason C.; Wang, Zheng; Wilson, Andrew W.; Schuessler, Arthur; Longcore, Joyce E.; O'Donnell, Kerry; Mozley-Standridge, Sharon; Porter, David; Letcher, Peter M.; Powell, Martha J.; Taylor, John W.; White, Merlin M.; Griffith, Gareth W.; Davies, David R.; Humber, Richard A.; Morton, Joseph B.; Sugiyama, Junta; Rossman, Amy Y.; Rogers, Jack D.; Pfister, Don H.; Hewitt, David; Hansen, Karen; Hambleton, Sarah; Shoemaker, Robert A.; Kohlmeyer, Jan; Volkmann-Kohlmeyer, Brigitte; Spotts, Robert A.; Serdani, Maryna; Crous, Pedro W.; Hughes, Karen W.; Matsuura, Kenji; Langer, Ewald; Langer, Gitta; Untereiner, Wendy A.; Lucking, Robert; Buedel, Burkhard; Geiser, David M.; Aptroot, Andre; Diederich, Paul; Schmitt, Imke; Schultz, Matthias; Yahr, Rebecca; Hibbett, David S.; Lutzoni, Francois; McLaughlin, David J.; Spatafora, Joseph W.; Vilgalys, Rytas			Reconstructing the early evolution of Fungi using a six-gene phylogeny	NATURE			English	Article							MOLECULAR PHYLOGENY; TREE; GLOMEROMYCOTA; MICROSPORIDIA; SEQUENCES; RELATIVES; ANIMALS; TUBULIN; ROZELLA; UTILITY	The ancestors of fungi are believed to be simple aquatic forms with flagellated spores, similar to members of the extant phylum Chytridiomycota (chytrids). Current classifications assume that chytrids form an early-diverging clade within the kingdom Fungi and imply a single loss of the spore flagellum, leading to the diversification of terrestrial fungi. Here we develop phylogenetic hypotheses for Fungi using data from six gene regions and nearly 200 species. Our results indicate that there may have been at least four independent losses of the flagellum in the kingdom Fungi. These losses of swimming spores coincided with the evolution of new mechanisms of spore dispersal, such as aerial dispersal in mycelial groups and polar tube eversion in the microsporidia ( unicellular forms that lack mitochondria). The enigmatic microsporidia seem to be derived from an endoparasitic chytrid ancestor similar to Rozella allomycis, on the earliest diverging branch of the fungal phylogenetic tree.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; Clark Univ, Dept Biol, Worcester, MA 01610 USA; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; Field Museum Nat Hist, Chicago, IL 60605 USA; Fachbereich Biol, Abt Pflanzenokol & Systemat, D-67653 Kaiserslautern, Germany; New York Bot Garden, Inst Systemat Bot, Bronx, NY 10458 USA; Duke Univ, Univ Program Genet & Genom, Durham, NC 27708 USA; Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA; USDA ARS, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA; Univ Georgia, Dept Plant Biol, Athens, GA 30605 USA; Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales; Inst Grassland & Environm Res, Aberystwyth SY23 3EB, Dyfed, Wales; ARS, US Plant Soil & Nutr Lab, USDA, Plant Protect Res Unit, Ithaca, NY 14853 USA; W Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; TechnoSuruga, Chiyoda Ku, Tokyo 1010052, Japan; ARS, Systemat Bot & Mycol Lab, USDA, Beltsville, MD 20705 USA; Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; Harvard Univ Hebaria, Cambridge, MA 02138 USA; Agr & Agri Food Canada, Biodivers Mycol & Bot, Ottawa, ON K1A 0C6, Canada; Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; Oregon State Univ, Mid Columbia Agr Res & Extens Ctr, Hood River, OR 97031 USA; Cent Bur Schimmelcultures, Fungal Biodivers Ctr, NL-3508 AD Utrecht, Netherlands; Univ Tennessee, Dept Bot, Knoxville, TN 37996 USA; Okayama Univ, Fac Agr, Okayama 7008530, Japan; Univ Kassel, Inst Biol, D-34132 Kassel, Germany; Brandon Univ, Dept Bot, Brandon, MB R7A 6A9, Canada; Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; Adviesbur Bryol Lichenol, NL-3762 XK Soest, Netherlands; Museum Natl Hist Nat, L-2160 Luxembourg, Luxembourg; Univ Hamburg, Biozentrum Klein Flottbek & Bot Garten, D-22609 Hamburg, Germany	Duke University; Oregon State University; Clark University; University of Minnesota System; University of Minnesota Twin Cities; Field Museum of Natural History (Chicago); New York Botanical Garden; Duke University; Technical University of Darmstadt; University of Maine System; University of Maine Orono; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Tuscaloosa; University of California System; University of California Berkeley; University of Kansas; Aberystwyth University; Aberystwyth University; United States Department of Agriculture (USDA); West Virginia University; United States Department of Agriculture (USDA); Washington State University; Harvard University; Agriculture & Agri Food Canada; University of North Carolina; University of North Carolina Chapel Hill; Oregon State University; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Tennessee System; University of Tennessee Knoxville; Okayama University; Universitat Kassel; Brandon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Hamburg	James, TY (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	tyj2@duke.edu; fungi@duke.edu	Lumbsch, Thorsten/K-3573-2012; Schoch, Conrad L./J-4825-2012; Slot, Jason/E-4802-2011; Wang, Zheng/A-2318-2011; Slot, Jason/L-5500-2018; Stajich, Jason Eric/C-7297-2008; Griffith, Gareth W./A-1970-2009; Crous, Pedro W/H-1489-2012; Geiser, David/J-9950-2013; Gueidan, Cecile/C-8803-2014; Wynns, Anja/E-5434-2012; Schoch, Conrad/HCH-2412-2022; Schüßler, Arthur/F-1681-2011; Matsuura, Kenji/H-8364-2019; Hewitt, David/AAA-9160-2021; Langer, Ewald JG/D-8479-2012; Cox, Cymon/D-1303-2012; Binder, Manfred/C-8571-2013	Lumbsch, Thorsten/0000-0003-1512-835X; Schoch, Conrad L./0000-0003-1839-5322; Wang, Zheng/0000-0002-8849-8549; Stajich, Jason Eric/0000-0002-7591-0020; Griffith, Gareth W./0000-0001-6914-3745; Crous, Pedro W/0000-0001-9085-8825; Gueidan, Cecile/0000-0001-9295-9996; Schoch, Conrad/0000-0003-1839-5322; Matsuura, Kenji/0000-0002-9099-6694; Hewitt, David/0000-0003-3789-9534; Cox, Cymon/0000-0002-4927-979X; Amtoft Wynns, Anja/0000-0002-6013-9456; Aptroot, Andre/0000-0001-7949-2594; Lucking, Robert/0000-0002-3431-4636; Vilgalys, Rytas/0000-0001-8299-3605; Yahr, Rebecca/0000-0003-1518-9451				BARR DJS, 1992, MYCOLOGIA, V84, P1, DOI 10.2307/3760397; Berbee ML, 2001, MYCOTA, V7, P229; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; BLACKWELL M, 1989, MYCOLOGIA, V81, P735, DOI 10.2307/3759878; Cavalier-Smith T, 2001, MYCOTA, V7, P3; CAVALIERSMITH T, 1995, P ROY SOC B-BIOL SCI, V261, P1, DOI 10.1098/rspb.1995.0108; Corradi N, 2004, FUNGAL GENET BIOL, V41, P1037, DOI 10.1016/j.fgb.2004.08.005; Gill EE, 2006, GENE, V375, P103, DOI 10.1016/j.gene.2006.02.023; Groth-Malonek M, 2005, MOL BIOL EVOL, V22, P117, DOI 10.1093/molbev/msh259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; HELD AA, 1981, BOT REV, V47, P451, DOI 10.1007/BF02860539; Hibbett DS, 2000, NATURE, V407, P506, DOI 10.1038/35035065; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; James Timothy Y., 2000, Canadian Journal of Botany, V78, P336; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2003, FUNGAL GENET BIOL, V38, P298, DOI 10.1016/S1087-1845(02)00537-6; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; KEELING PJ, 2005, INSECT FUNGAL ASS EC, P97; KIRK PM, 2001, AINSWORTH BISBYS DIC, V60; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Maddison DR, 2002, MACCLADE VERSION 4 0; Maddison W.P., 2003, MESQUITE MODULAR SYS; MCKERRACHER LJ, 1985, MYCOLOGIA, V77, P412, DOI 10.2307/3793197; Medina M, 2003, INT J ASTROBIOL, V2, P203, DOI [DOI 10.1017/S1473550403001551), 10.1017/S1473550403001551, DOI 10.1017/S1473550403001551]; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; NAGAHAMA T, 1995, MYCOLOGIA, V87, P203, DOI 10.2307/3760906; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; POWELL MJ, 1984, MYCOLOGIA, V76, P1039, DOI 10.2307/3793019; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A, 2002, PLANT SOIL, V244, P75, DOI 10.1023/A:1020238728910; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Tehler A, 2003, MYCOL RES, V107, P901, DOI 10.1017/S0953756203008128; Ustinova I, 2000, PROTIST, V151, P253, DOI 10.1078/1434-4610-00023; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA	41	1247	1333	7	392	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					818	822		10.1038/nature05110	http://dx.doi.org/10.1038/nature05110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051209				2022-12-01	WOS:000241362700042
J	Shen, YQ; Joachimiak, A; Rosner, MR; Tang, WJ				Shen, Yuequan; Joachimiak, Andrzej; Rosner, Marsha Rich; Tang, Wei-Jen			Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism	NATURE			English	Article							AMYLOID BETA-PROTEIN; MITOCHONDRIAL PROCESSING PEPTIDASE; BUD-SITE SELECTION; ALZHEIMERS-DISEASE; IN-VIVO; DEGRADATION; DOMAIN; INSULYSIN; GLUCAGON; AMYLIN	Insulin-degrading enzyme (IDE), a Zn2+-metalloprotease, is involved in the clearance of insulin and amyloid-beta (refs 1 - 3). Loss-of-function mutations of IDE in rodents cause glucose intolerance and cerebral accumulation of amyloid-beta, whereas enhanced IDE activity effectively reduces brain amyloid-beta ( refs 4 - 7). Here we report structures of human IDE in complex with four substrates ( insulin B chain, amyloid-beta peptide ( 1 - 40), amylin and glucagon). The amino- and carboxy-terminal domains of IDE (IDE-N and IDE-C, respectively) form an enclosed cage just large enough to encapsulate insulin. Extensive contacts between IDE-N and IDE-C keep the degradation chamber of IDE inaccessible to substrates. Repositioning of the IDE domains enables substrate access to the catalytic cavity. IDE uses size and charge distribution of the substrate-binding cavity selectively to entrap structurally diverse polypeptides. The enclosed substrate undergoes conformational changes to form beta-sheets with two discrete regions of IDE for its degradation. Consistent with this model, mutations disrupting the contacts between IDE-N and IDE-C increase IDE catalytic activity 40-fold. The molecular basis for substrate recognition and allosteric regulation of IDE could aid in designing IDE-based therapies to control cerebral amyloid-beta and blood sugar concentrations(1,8,9).	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Tang, WJ (corresponding author), Univ Chicago, Ben May Inst Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995	NIGMS NIH HHS [U54 GM074942, U54 GM074942-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMES N, 1995, SCIENCE, V270, P464, DOI 10.1126/science.270.5235.464; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; BRAUN W, 1983, J MOL BIOL, V169, P921, DOI 10.1016/S0022-2836(83)80143-0; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2003, J BIOL CHEM, V278, P37314, DOI 10.1074/jbc.M305627200; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Luciano P, 1996, EXPERIENTIA, V52, P1077, DOI 10.1007/BF01952105; Mascioni A, 2003, BIOPOLYMERS, V69, P29, DOI 10.1002/bip.10305; MASKOS K, 2004, HDB METALLOPROTEINS, P190; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; PERLMAN RK, 1994, J BIOL CHEM, V269, P33140; SASAKI K, 1975, NATURE, V257, P751, DOI 10.1038/257751a0; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9	30	275	291	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					870	874		10.1038/nature05143	http://dx.doi.org/10.1038/nature05143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051221	Green Accepted			2022-12-01	WOS:000241362700055
J	Acquisti, C; Kleffe, J; Collins, S				Acquisti, Claudia; Kleffe, Juergen; Collins, Sinead			Oxygen content of transmembrane proteins over macroevolutionary time scales	NATURE			English	Article							AMINO-ACID-COMPOSITION; MEMBRANE-PROTEINS; EVOLUTION; GENOMES; ORGANISMS; EUKARYOTES; PROTEOMES; TOPOLOGY; MODEL; LIFE	We observe that the time of appearance of cellular compartmentalization correlates with atmospheric oxygen concentration. To explore this correlation, we predict and characterize the topology of all transmembrane proteins in 19 taxa and correlate differences in topology with historical atmospheric oxygen concentrations. Here we show that transmembrane proteins, individually and as a group, were probably selectively excluding oxygen in ancient ancestral taxa, and that this constraint decreased over time when atmospheric oxygen levels rose. As this constraint decreased, the size and number of communication-related transmembrane proteins increased. We suggest the hypothesis that atmospheric oxygen concentrations affected the timing of the evolution of cellular compartmentalization by constraining the size of domains necessary for communication across membranes.	Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; Inst Mol Biol & Biochem, D-14195 Berlin, Germany	Max Planck Society	Acquisti, C (corresponding author), Arizona State Univ, Ctr Evolutionary Funct Genom, Biodesign Inst, Tempe, AZ 85287 USA.	Claudia.Acquisti.1@asu.edu	Collins, Sinead/F-3788-2010	Collins, Sinead/0000-0003-3856-4285				AITCHISON J, 1986, STAT ANAL COMPOSITIO, P154; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; ANDERSON JS, IN PRESS MAJOR TRANS; Baudouin-Cornu P, 2004, J BIOL CHEM, V279, P5421, DOI 10.1074/jbc.M306415200; Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052; Berner RA, 1999, P NATL ACAD SCI USA, V96, P10955, DOI 10.1073/pnas.96.20.10955; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Elser JJ, 2006, MOL BIOL EVOL, V23, P1946, DOI 10.1093/molbev/msl068; Elser JJ, 2006, ECOL LETT, V9, P292, DOI 10.1111/j.1461-0248.2005.00873.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; Hasenfuss I, 2002, J ZOOL SYST EVOL RES, V40, P65, DOI 10.1046/j.1439-0469.2002.00180.x; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Kay AD, 2005, OIKOS, V109, P6, DOI 10.1111/j.0030-1299.2005.14048.x; KNOLL AH, 1994, P NATL ACAD SCI USA, V91, P6743, DOI 10.1073/pnas.91.15.6743; Knoll AH, 2003, LIFE YOUNG PLANET 1; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lio P, 2003, GENE, V317, P29, DOI 10.1016/S0378-1119(03)00666-8; Liu JF, 2001, PROTEIN SCI, V10, P1970, DOI 10.1110/ps.10101; Martin W, 2003, IUBMB LIFE, V55, P193, DOI 10.1080/1521654031000141231; MAZEL D, 1989, NATURE, V341, P245, DOI 10.1038/341245a0; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; Schopf J. W., 1992, PROTEROZOIC BIOSPHER; Sheridan PP, 2003, GEOMICROBIOL J, V20, P1, DOI 10.1080/01490450303891; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Tamames J, 1996, FEBS LETT, V389, P96, DOI 10.1016/0014-5793(96)00527-3; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420	34	52	55	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					47	52		10.1038/nature05450	http://dx.doi.org/10.1038/nature05450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17183269	Green Published			2022-12-01	WOS:000243225100032
J	Gilsdorf, JR				Gilsdorf, Janet R.			A long time ago	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												gilsdorf@umich.edu							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2777	2778		10.1001/jama.296.23.2777	http://dx.doi.org/10.1001/jama.296.23.2777			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179446				2022-12-01	WOS:000242826400001
J	Olivieri, A; Achilli, A; Pala, M; Battaglia, V; Fornarino, S; Al-Zahery, N; Scozzari, R; Cruciani, F; Behar, DM; Dugoujon, JM; Coudray, C; Santachiara-Benerecetti, AS; Semino, O; Bandelt, HJ; Torroni, A				Olivieri, Anna; Achilli, Alessandro; Pala, Maria; Battaglia, Vincenza; Fornarino, Simona; Al-Zahery, Nadia; Scozzari, Rosaria; Cruciani, Fulvio; Behar, Doron M.; Dugoujon, Jean-Michel; Coudray, Clotilde; Santachiara-Benerecetti, A. Silvana; Semino, Ornella; Bandelt, Hans-Juergen; Torroni, Antonio			The mtDNA legacy of the Levantine early Upper Palaeolithic in Africa	SCIENCE			English	Article							SUB-SAHARAN AFRICA; NEAR-EASTERN; GENE FLOW; MITOCHONDRIAL; ASIA; HUMANS; NORTH	Sequencing of 81 entire human mitochondrial DNAs (mtDNAs) belonging to haplogroups M1 and U6 reveals that these predominantly North African clades arose in southwestern Asia and moved together to Africa about 40,000 to 45,000 years ago. Their arrival temporally overlaps with the event(s) that led to the peopling of Europe by modern humans and was most likely the result of the same change in climate conditions that allowed humans to enter the Levant, opening the way to the colonization of both Europe and North Africa. Thus, the early Upper Palaeolithic population( s) carrying M1 and U6 did not return to Africa along the southern coastal route of the "out of Africa" exit, but from the Mediterranean area; and the North African Dabban and European Aurignacian industries derived from a common Levantine source.	Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; Univ Baghdad, Coll Sci, Dept Biotechnol, Baghdad, Iraq; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Mol Med Lab, IL-31096 Haifa, Israel; Univ Toulouse 3, Ctr Anthropol, FRE 2960, CNRS, F-31073 Toulouse, France; Univ Hamburg, Dept Math, D-20146 Hamburg, Germany	University of Pavia; University of Baghdad; Sapienza University Rome; Rambam Health Care Campus; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hamburg	Torroni, A (corresponding author), Univ Pavia, Dept Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	Battaglia, Vincenza/F-6950-2017; OLIVIERI, ANNA/I-9235-2012; Al-Zahery, Nadia/AAV-5878-2020; Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; Cruciani, Fulvio/G-6105-2012	OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; Cruciani, Fulvio/0000-0002-6900-024X; SEMINO, Ornella/0000-0002-9675-9403; Pala, Maria/0000-0001-9202-8331				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Burroughs W. J., 2005, CLIMATE CHANGE PREHI; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Richards M, 2006, NUCL ACID M, V18, P225; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Shackleton NJ, 2004, QUATERNARY SCI REV, V23, P1513, DOI 10.1016/j.quascirev.2004.03.006; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Van Peer P., 1990, EMERGENCE MODERN HUM, P139; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5	29	190	191	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1767	1770		10.1126/science.1135566	http://dx.doi.org/10.1126/science.1135566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170302				2022-12-01	WOS:000242833600056
J	Ruby, JG; Jan, C; Player, C; Axtell, MJ; Lee, W; Nusbaum, C; Ge, H; Bartel, DP				Ruby, J. Graham; Jan, Calvin; Player, Christopher; Axtell, Michael J.; Lee, William; Nusbaum, Chad; Ge, Hui; Bartel, David P.			Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C-elegans	CELL			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; GERM-LINE; INTERFERENCE; POLYMERASE; GENES; IDENTIFICATION; MECHANISMS; PROTEIN; DSRNA	We sequenced 400,000 small RNAs from Caenorhabditis elegans. Another 18 microRNA (miRNA) genes were identified, thereby extending to 112 our tally of confidently identified miRNA genes in C. elegans. Also observed were thousands of endogenous siRNAs generated by RNA-directed RNA polymerases acting preferentially on transcripts associated with spermatogenesis and transposons. In addition, a third class of nematode small RNAs, called 21 U-RNAs, was discovered. 21 U-RNAs are precisely 21 nucleotides long, begin with a uridine 5'-monophosphate but are diverse in their remaining 20 nucleotides, and appear modified at their 3'-terminal ribose. 21 U-RNAs originate from more than 5700 genomic loci dispersed in two broad regions of chromosome IV-primarily between protein-coding genes or within their introns. These loci share a large upstream motif that enables accurate prediction of additional 21 U-RNAs. The motif is conserved in other nematodes, presumably because of its importance for producing these diverse, autonomously expressed, small RNAs (dasRNAs).	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duchaine TF, 2006, CELL, V124, P343, DOI 10.1016/j.cel.2005.11.036; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KEMPER B, 1976, NATURE, V262, P321, DOI 10.1038/262321a0; Kent WJ, 2000, NUCLEIC ACIDS RES, V28, P91, DOI 10.1093/nar/28.1.91; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARTIN CT, 1989, BIOCHEMISTRY-US, V28, P2760, DOI 10.1021/bi00433a002; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; PAK J, 2006, IN PRESS SCIENCE; Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; WILLIAMS KP, 1995, NUCLEIC ACIDS RES, V23, P4220, DOI 10.1093/nar/23.20.4220; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	58	703	869	2	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1193	1207		10.1016/j.cell.2006.10.040	http://dx.doi.org/10.1016/j.cell.2006.10.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174894	Bronze, Green Submitted			2022-12-01	WOS:000242991000017
J	Fathalla, MF; Sinding, SW; Rosenfield, A; Fathalla, MMF				Fathalla, Mahmoud F.; Sinding, Steven W.; Rosenfield, Allan; Fathalla, Mohammed M. F.			Sexual and reproductive health 6 - Sexual and reproductive health for all: a call for action	LANCET			English	Article							GOALS	At the United Nations International Conference on Population and Development in Cairo in 1994, the international community agreed to make reproductive health care universally available no later than 2015. After a 5-year review of progress towards implementation of the Cairo programme of action, that commitment was extended to include sexual, as well as reproductive, health and rights. Although progress has been made towards this commitment, it has fallen a long way short of the original goal. We argue that sexual and reproductive health for all is an achievable goal-if cost-effective interventions are properly scaled up; political commitment is revitalised; and financial resources are mobilised, rationally allocated, and more effectively used. National action will need to be backed up by international action. Sustained effort is needed by governments in developing countries and in the donor community, by inter-governmental organisations, non-governmental. organisations, civil society groups, the women's health movement, philanthropic foundations, the private for-profit sector, the health profession, and the research community.	Assiut Univ, Dept Obstet & Gynaecol, Assiut, Egypt; Int Planned Parenthood Federat, London, England; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Egyptian Knowledge Bank (EKB); Assiut University; Columbia University	Fathalla, MF (corresponding author), Assiut Univ, Dept Obstet & Gynaecol, POB 30, Assiut, Egypt.	mfathall@intouch.com		Fathalla, Mahmoud/0000-0001-6955-1933				Bernstein S., 2006, PUBLIC CHOICES PRIVA; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cleland J, 2005, LANCET, V366, P1899, DOI 10.1016/S0140-6736(05)67603-9; CLELAND J, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69480-4; Fathalla MF., 2002, AGENDA PEOPLE UNFPA, P24; GLASIER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69478-6; Grimes DA, 2004, OBSTET GYNECOL, V104, P220, DOI 10.1097/01.AOG.0000135804.89369.59; GRIMES DA, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69481-6; Gwatkin DR, 2005, LANCET, V365, P813, DOI 10.1016/S0140-6736(05)17992-6; LANGER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69486-5; LOW N, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69482-8; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Rosenfield A, 2005, NEW ENGL J MED, V352, P647, DOI 10.1056/NEJMp048281; Simmons R., 2006, SCALING HLTH SERVICE; Singh S, 2003, ADDING BENEFITS INVE; *UN, 1994, INT C POP DEV 1994 S; *UN COMM POP DEV, 2006, INT C POP DEV NEW YO; *UN FUND POP ACT, 2004, SEC SUPPL PEOPL REL; UN Millennium Project, 2005, INV DEV PRACT PLAN A; *UN POP DIV DEP EC, 2004, STESASERA215 UN POP; VLASSOFF M, RESOURCE REQUIREMENT; WELLINGS K, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69479-8; *WHO DEP REPR HLTH, 2004, WHORHR048; *WHO DEP REPR HLTH, 2006, WHORHR063; *WHO UNFPA UNAIDS, 2005, SEX REPR HLTH HIV AI; [No title captured]	26	55	55	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2095	2100		10.1016/S0140-6736(06)69483-X	http://dx.doi.org/10.1016/S0140-6736(06)69483-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114JY	17161731				2022-12-01	WOS:000242663700024
J	Richmond, C				Richmond, Caroline			Shark cartilage in the water - Ignorance based cancer treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Letter												c@roline.demon.co.uk						Waxman J, 2006, BRIT MED J, V333, P1129, DOI 10.1136/bmj.39037.692743.59	1	1	1	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2006	333	7580					1222	1222		10.1136/bmj.39051.727350.3A	http://dx.doi.org/10.1136/bmj.39051.727350.3A			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	119JW	17158402	Green Published			2022-12-01	WOS:000243009600032
J	Shin, D; Lee, J; Huang, H; Groisman, EA				Shin, Dongwoo; Lee, Eun-Jin; Huang, Henry; Groisman, Eduardo A.			A positive feedback loop promotes transcription surge that jump-starts Salmonella virulence circuit	SCIENCE			English	Article							2-COMPONENT REGULATORY SYSTEM; ANTIMICROBIAL PEPTIDE RESISTANCE; SIGNAL-TRANSDUCTION SYSTEM; ESCHERICHIA-COLI; PHOP-PHOQ; STREPTOCOCCUS-PNEUMONIAE; TYPHIMURIUM VIRULENCE; ENTERICA; EXPRESSION; GENE	The PhoP/ PhoQ two-component system is a master regulator of Salmonella pathogenicity. Here we report that induction of the PhoP/ PhoQ system results in an initial surge of PhoP phosphorylation; the occupancy of target promoters by the PhoP protein; and the transcription of PhoP-activated genes, which then subsides to reach new steady-state levels. This surge in PhoP activity is due to PhoP positively activating its own transcription, because a strain constitutively expressing the PhoP protein attained steady-state levels of activation asymptotically, without the surge. The strain constitutively expressing the PhoP protein was attenuated for virulence in mice, demonstrating that the surge conferred by PhoP's positive feedback loop is necessary to jump-start Salmonella's virulence program.	Washington Univ, Sch Med, Dept Mol Microbiol, Howard Hughes Med Inst, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Howard Hughes Med Inst, Campus Box 8230,660 S Euclid Ave, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49561] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Guiral S, 2006, MICROBIOL-SGM, V152, P323, DOI 10.1099/mic.0.28425-0; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Hutchings MI, 2006, MOL MICROBIOL, V59, P923, DOI 10.1111/j.1365-2958.2005.04953.x; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Montagne M, 2001, J BACTERIOL, V183, P1787, DOI 10.1128/JB.183.5.1787-1791.2001; Mouslim C, 2004, MOL MICROBIOL, V54, P386, DOI 10.1111/j.1365-2958.2004.04293.x; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Shin D, 2005, J BIOL CHEM, V280, P4089, DOI 10.1074/jbc.M412741200; Soncini FC, 1996, J BACTERIOL, V178, P6796, DOI 10.1128/jb.178.23.6796-6801.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Valdivia RH, 2000, INFECT IMMUN, V68, P7126, DOI 10.1128/IAI.68.12.7126-7131.2000; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	29	105	107	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1607	1609		10.1126/science.1134930	http://dx.doi.org/10.1126/science.1134930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158330				2022-12-01	WOS:000242624600045
J	Piccirillo, SGM; Reynolds, BA; Zanetti, N; Lamorte, G; Binda, E; Broggi, G; Brem, H; Olivi, A; Dimeco, F; Vescovi, AL				Piccirillo, S. G. M.; Reynolds, B. A.; Zanetti, N.; Lamorte, G.; Binda, E.; Broggi, G.; Brem, H.; Olivi, A.; Dimeco, F.; Vescovi, A. L.			Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells	NATURE			English	Article							NEURAL STEM-CELLS; TGF-BETA; CNS; CANCER; DIFFERENTIATION; IDENTIFICATION; PRECURSORS; APOPTOSIS; SMAD; BMPS	Transformed, oncogenic precursors, possessing both defining neural-stem-cell properties and the ability to initiate intracerebral tumours, have been identified in human brain cancers(1). Here we report that bone morphogenetic proteins (BMPs), amongst which BMP4 elicits the strongest effect, trigger a significant reduction in the stem-like, tumour-initiating precursors of human glioblastomas (GBMs). Transient in vitro exposure to BMP4 abolishes the capacity of transplanted GBM cells to establish intracerebral GBMs. Most importantly, in vivo delivery of BMP4 effectively blocks the tumour growth and associated mortality that occur in 100% of mice after intracerebral grafting of human GBM cells. We demonstrate that BMPs activate their cognate receptors (BMPRs) and trigger the Smad signalling cascade in cells isolated from human glioblastomas ( GBMs). This is followed by a reduction in proliferation, and increased expression of markers of neural differentiation, with no effect on cell viability. The concomitant reduction in clonogenic ability, in the size of the CD133(+) population and in the growth kinetics of GBM cells indicates that BMP4 reduces the tumour-initiating cell pool of GBMs. These findings show that the BMP - BMPR signalling system - which controls the activity of normal brain stem cells(2,3) - may also act as a key inhibitory regulator of tumour-initiating, stem-like cells from GBMs and the results also identify BMP4 as a novel, non-cytotoxic therapeutic effector, which may be used to prevent growth and recurrence of GBMs in humans.	Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; Univ Milano Bicocca, StemGen Spa, Unit Canc Stem Cell Biol, I-20126 Milan, Italy; Univ Queensland, Queensland Brain Inst, Lab Neural Stem Cell Biol, Brisbane, Qld, Australia; Hosp San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Natl Neurol Inst C Besta, I-20133 Milan, Italy; Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21287 USA	University of Milano-Bicocca; University of Milano-Bicocca; University of Queensland; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Istituto Neurologico Besta; Johns Hopkins University	Vescovi, AL (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy.	vescovi@tin.it	Olivi, Alessandro/K-6531-2016; Binda, Elena/B-2650-2017; Vescovi, Angelo Luigi/A-4919-2015; DiMeco, Francesco/Z-5431-2019; Zanetti, Nadia/AAK-4682-2021; DiMeco, Francesco/Q-3785-2016	Olivi, Alessandro/0000-0002-4489-7564; Binda, Elena/0000-0002-8750-2905; Vescovi, Angelo Luigi/0000-0002-1742-4112; Zanetti, Nadia/0000-0003-1485-8983; Lamorte, Giuseppe/0000-0001-9377-7537; Piccirillo, Sara Grazia Maria/0000-0003-4109-1992; DiMeco, Francesco/0000-0001-6213-5793				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Barker FG, 1998, NEUROSURGERY, V42, P709, DOI 10.1097/00006123-199804000-00013; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Golestaneh N, 2005, ONCOGENE, V24, P5722, DOI 10.1038/sj.onc.1208925; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Iantosca MR, 1999, J NEUROSCI RES, V56, P248; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kjellman C, 2000, INT J CANCER, V89, P251, DOI 10.1002/1097-0215(20000520)89:3<251::AID-IJC7>3.0.CO;2-5; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li WW, 1998, J NEUROSCI, V18, P8853; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weiss S, 1996, J NEUROSCI, V16, P7599	30	906	953	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					761	765		10.1038/nature05349	http://dx.doi.org/10.1038/nature05349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151667				2022-12-01	WOS:000242581100061
J	Brouwer, JLP; Veeger, NJGM; Kluin-Nelemans, HC; van der Meer, J				Brouwer, Jan-Leendert P.; Veeger, Nic J. G. M.; Kluin-Nelemans, Hanneke C.; van der Meer, Jan			The pathogenesis of venous thromboembolism: Evidence for multiple interrelated causes	ANNALS OF INTERNAL MEDICINE			English	Article							PROTEIN-S DEFICIENCY; DEEP-VEIN THROMBOSIS; FACTOR-V-LEIDEN; PROSPECTIVE COHORT; RISK-FACTOR; INHERITED THROMBOPHILIA; ANTITHROMBIN-III; FAMILIES; PROTHROMBIN; RESISTANCE	Background: Venous thromboembolism (VTE) is thought to result from interactions between multiple genetic and environmental risk factors. Objective: To assess the contribution of multiple thrombophilic defects and exogenous risk factors to the absolute risk for VTE. Design: Retrospective family cohort study. Setting: Single university hospital. Participants: 468 relatives of 91 probands with a symptomatic hereditary deficiency of protein S, protein C, or antithrombin. Measurements: All relatives were tested for 10 thrombophilic deficiencies and defects in addition to the index deficiency and were assessed for exogenous risk factors (surgery, trauma, immobilization, use of oral contraceptives, and pregnancy). The authors compared annual incidences and relative risks for VTE in deficient and nondeficient relatives. Results: Annual incidences of VTE in relatives with 0, 1, and 2 or more additional thrombophilic deficiencies or defects were 1.16 (95% Cl, 0.60 to 2.03), 1.75 (Cl, 1.17 to 2.53), and 2.64 (Cl, 1.67 to 3.96) per 100 person-years, respectively, compared with 0.06 (CI, 0.002 to 0.33) per 100 person-years in nondeficient relatives without additional deficiencies or defects. Adjusted relative risks were 16.3 (CI, 2.0 to 131.0), 50.3 (6.5 to 389.7), and 102.8 (12.5 to 843.4). Of deficient relatives, 38% with no additional defect, 57% with 1 additional defect, and 81 % with 2 or more additional defects had VTE at age 65 years compared with 5% of nondeficient relatives (P < 0.001). In deficient relatives with additional deficiencies or defects, exogenous risk factors increased the risk for VTE from 1.20% to 2.51% per year (relative risk, 2.1 [CI, 1.1 to 4.2]). Limitations: This was a retrospective study without the ability to distinguish interactions between specific thrombophilic deficiencies and defects. Conclusion: Additional thrombophilic defects and exogenous risk factors increase the risk for VTE in persons with hereditary deficiencies of protein S, protein C, or antithrombin and provide evidence that multiple genetic and environmental risk factors contribute to VTE.	Univ Groningen, Med Ctr, Dept Hematol, Div Hameostasis Thrombosis & Rheol, NL-9713 GZ Groningen, Netherlands	University of Groningen	van der Meer, J (corresponding author), Univ Groningen, Med Ctr, Dept Hematol, Div Hameostasis Thrombosis & Rheol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	j.van.der.meer@int.umcg.nl	Veeger, Nic JGM/F-2966-2013; Kluin-Nelemans, Johanna C/F-8658-2018	Veeger, Nic JGM/0000-0002-1492-7937; Kluin-Nelemans, Johanna C/0000-0003-2617-9427				ALLAART CF, 1995, BRIT MED J, V311, P910; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Brouwer JLP, 2005, BRIT J HAEMATOL, V128, P703, DOI 10.1111/j.1365-2141.2005.05371.x; Caprini JA, 2004, CIRCULATION, V109, pI4, DOI 10.1161/01.CIR.0000122869.59485.36; Castaman G, 2000, BLOOD COAGUL FIBRIN, V11, P321, DOI 10.1097/00001721-200006000-00002; Danneberg J, 1998, CLIN CHEM, V44, P349; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056/NEJM199603213341203; DESTEFANO V, 1994, THROMB HAEMOSTASIS, V72, P352; EXNER T, 1991, THROMB HAEMOSTASIS, V65, P320; Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257; KOELEMAN BPC, 1994, BLOOD, V84, P1031; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; PABINGER I, 1994, THROMB HAEMOSTASIS, V71, P441; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; ROSENDAAL FR, 1991, LANCET, V337, P260, DOI 10.1016/0140-6736(91)90867-O; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P247; Sanson BJ, 1999, BLOOD, V94, P3702; Simioni P, 1999, THROMB HAEMOSTASIS, V81, P198, DOI 10.1055/s-0037-1614442; Tirado I, 2001, HAEMATOLOGICA, V86, P1200; vanBoven HH, 1996, THROMB HAEMOSTASIS, V75, P417; vandenBelt AGM, 1996, CLIN APPL THROMB-HEM, V2, P227, DOI 10.1177/107602969600200402; Vossen CY, 2005, J THROMB HAEMOST, V3, P459, DOI 10.1111/j.1538-7836.2005.01197.x; ZOLLER B, 1995, BLOOD, V85, P3518, DOI 10.1182/blood.V85.12.3518.bloodjournal85123518	27	61	63	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					807	815		10.7326/0003-4819-145-11-200612050-00005	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114PE	17146065				2022-12-01	WOS:000242677300002
J	Heo, WD; Inoue, T; Park, WS; Kim, ML; Park, BO; Wandless, TJ; Meyer, T				Heo, Won Do; Inoue, Takanari; Park, Wei Sun; Kim, Man Lyang; Park, Byung Ouk; Wandless, Thomas J.; Meyer, Tobias			PI(3,4,5)P-3 and PI(4,5)P-2 lipids target proteins with polybasic clusters to the plasma membrane	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; RAS PROTEINS; LOCALIZATION; CELLS; BINDING; TRANSLOCATION; ORGANIZATION; EXPRESSION; PATHWAY; GTPASES	Many signaling, cytoskeletal, and transport proteins have to be localized to the plasma membrane ( PM) in order to carry out their function. We surveyed PM-targeting mechanisms by imaging the subcellular localization of 125 fluorescent protein - conjugated Ras, Rab, Arf, and Rho proteins. Out of 48 proteins that were PM-localized, 37 contained clusters of positively charged amino acids. To test whether these polybasic clusters bind negatively charged phosphatidylinositol 4,5-bisphosphate [PI(4,5) P-2] lipids, we developed a chemical phosphatase activation method to deplete PM PI(4,5) P-2. Unexpectedly, proteins with polybasic clusters dissociated from the PM only when both PI(4,5) P-2 and phosphatidylinositol 3,4,5-trisphosphate [PI( 3,4,5) P-3] were depleted, arguing that both lipid second messengers jointly regulate PM targeting.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA; Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju 660701, South Korea; Gyeongsang Natl Univ, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea	Stanford University; Gyeongsang National University; Gyeongsang National University	Meyer, T (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, 318 Campus Dr,Clark Bldg, Stanford, CA 94305 USA.	tobias1@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	NIGMS NIH HHS [R01 GM030179-25, R01 GM030179, R01 GM030179-24A1, R01 GM063702] Funding Source: Medline; NIMH NIH HHS [R01 MH064801] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R01GM063702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064801] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; CHAPLINE C, 1993, J BIOL CHEM, V268, P6858; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Fivaz M, 2003, NEURON, V40, P319, DOI 10.1016/S0896-6273(03)00634-2; GHOMASHCHI F, 1995, BIOCHEMISTRY-US, V34, P11910, DOI 10.1021/bi00037a032; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Heo WD, 2003, CELL, V113, P315; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; KOH A, UNPUB; Lee CHJ, 1996, J NEUROSCI, V16, P6784; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Poh TW, 2005, CANCER RES, V65, P6264, DOI 10.1158/0008-5472.CAN-05-0152; Poser S, 2000, EMBO J, V19, P4955, DOI 10.1093/emboj/19.18.4955; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; SCHURMANN A, 1994, J BIOL CHEM, V269, P15683; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200	24	579	588	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1458	1461		10.1126/science.1134389	http://dx.doi.org/10.1126/science.1134389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17095657	Green Accepted			2022-12-01	WOS:000242406100043
J	de Graaf, BHJ; Rudd, JJ; Wheeler, MJ; Perry, RM; Bell, EM; Osman, K; Franklin, FCH; Franklin-Tong, VE				de Graaf, Barend H. J.; Rudd, Jason J.; Wheeler, Michael J.; Perry, Ruth M.; Bell, Elizabeth M.; Osman, Kim; Franklin, F. Christopher H.; Franklin-Tong, Vernonica E.			Self-incompatibility in Papaver targets soluble inorganic pyrophosphatases in pollen	NATURE			English	Article							PROGRAMMED CELL-DEATH; STREPTOCOCCUS-AGALACTIAE; MOLECULAR-CLONING; ESCHERICHIA-COLI; STARCH SYNTHESIS; PROTEIN-KINASE; RHOEAS; POTATO; ACTIN; DEPOLYMERIZATION	In higher plants, sexual reproduction involves interactions between pollen and pistil. A key mechanism to prevent inbreeding is self-incompatibility through rejection of incompatible ('self') pollen(1). In Papaver rhoeas, S proteins encoded by the stigma interact with incompatible pollen, triggering a Ca2+-dependent signalling network(2-5) resulting in pollen tube inhibition and programmed cell death(6). The cytosolic phosphoprotein p26.1, which has been identified in incompatible pollen, shows rapid, self-incompatibility-induced Ca2+-dependent hyperphosphorylation in vivo(3). Here we show that p26.1 comprises two proteins, Pr-p26.1a and Pr-p26.1b, which are soluble inorganic pyrophosphatases (sPPases). These proteins have classic Mg2+-dependent sPPase activity, which is inhibited by Ca2+, and unexpectedly can be phosphorylated in vitro. We show that phosphorylation inhibits sPPase activity, establishing a previously unknown mechanism for regulating eukaryotic sPPases. Reduced sPPase activity is predicted to result in the inhibition of many biosynthetic pathways, suggesting that there may be additional mechanisms of self-incompatibility-mediated pollen tube inhibition. We provide evidence that sPPases are required for growth and that self-incompatibility results in an increase in inorganic pyrophosphate, implying a functional role for Pr-p26.1.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Franklin-Tong, VE (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	v.e.franklin-tong@bham.ac.uk	De Graaf, Barend HJ/A-5880-2010; Franklin-Tong, Vernonica E/D-1287-2012	Franklin-Tong, Noni/0000-0003-1782-8413; de Graaf, Barend H J/0000-0003-0542-5510; Rudd, Jason/0000-0002-4743-1401; Franklin, F. Chris H./0000-0003-3507-722X				CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; COOPERMAN BS, 1992, TRENDS BIOCHEM SCI, V17, P262, DOI 10.1016/0968-0004(92)90406-Y; DUJARDIN P, 1995, PLANT PHYSIOL, V109, P853, DOI 10.1104/pp.109.3.853; ESTRUCH JJ, 1994, P NATL ACAD SCI USA, V91, P8837, DOI 10.1073/pnas.91.19.8837; Franklin-Tong VE, 1997, PLANT J, V12, P1375, DOI 10.1046/j.1365-313x.1997.12061375.x; FRANKLINTONG VE, 1993, PLANT J, V4, P163, DOI 10.1046/j.1365-313X.1993.04010163.x; Geigenberger P, 1998, PLANTA, V205, P428, DOI 10.1007/s004250050340; Geitmann A, 2000, PLANT CELL, V12, P1239, DOI 10.1105/tpc.12.7.1239; GROSS P, 1986, PLANTA, V167, P140, DOI 10.1007/BF00446381; JACOB JL, 1989, PLANT PHYSIOL BIOCH, V27, P355; KORNBERG A, 1962, METABOLIC SIGNIFICAN; McClure BA, 2006, PLANTA, V224, P233, DOI 10.1007/s00425-006-0284-2; Moutinho A, 2001, SEX PLANT REPROD, V14, P101, DOI 10.1007/s004970100086; Perez-Castineira JR, 2002, P NATL ACAD SCI USA, V99, P15914, DOI 10.1073/pnas.242625399; PLAXTON WC, 2004, PLANT RESPONSE STRES; Rajagopal L, 2005, MOL MICROBIOL, V56, P1329, DOI 10.1111/j.1365-2958.2005.04620.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rojas-Beltran JA, 1999, PLANT MOL BIOL, V39, P449, DOI 10.1023/A:1006136624210; Rudd JJ, 1996, PLANT CELL, V8, P713, DOI 10.1105/tpc.8.4.713; Sivula T, 1999, FEBS LETT, V454, P75, DOI 10.1016/S0014-5793(99)00779-6; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; SONNEWALD U, 1992, PLANT J, V2, P571; Thomas SG, 2004, NATURE, V429, P305, DOI 10.1038/nature02540; Thomas SG, 2006, J CELL BIOL, V174, P221, DOI 10.1083/jcb.200604011; VENER AV, 1990, FEBS LETT, V264, P40, DOI 10.1016/0014-5793(90)80759-C; Visser K, 1998, PLANT MOL BIOL, V37, P131, DOI 10.1023/A:1005931003483	26	63	66	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					490	493		10.1038/nature05311	http://dx.doi.org/10.1038/nature05311			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17086195				2022-12-01	WOS:000242215700047
J	Hallan, SI; Dahl, K; Oien, CM; Grootendorst, DC; Aasberg, A; Holmen, J; Dekker, FW				Hallan, Stein I.; Dahl, Ketil; Oien, Cecilia M.; Grootendorst, Diana C.; Aasberg, Arne; Holmen, Jostein; Dekker, Friedo W.			Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To find an effective screening strategy for detecting patients with chronic kidney disease and to describe the natural course of the disease. Design Eight year follow-up of a cross sectional health survey (the HUNT II study). Setting Nord-Trondelag County, Norway Participants 65 604 people (70.6% of 0 adults aged >= 20 in the county). Main outcome measures Incident end stage renal disease (ESRD) and cardiovascular mortality monitored by individual linkage to central registries. Results 3069/65 604 (4.7%) people had chronic kidney disease (estimated glomerular filtration rate < 60 ml/min/1.73 m(2)), so we would need to screen 20.6 people (95% confidence interval 20.0 to 21.2) to identify one case. Restriction of screening to those with hypertension, diabetes, or age > 55 would identify 93.2% (92.4% to 94.0%) of patients with chronic kidney disease, with a number needed to screen of 8.7 (8.5 to 9.0). Restriction of screening according to guidelines of the United States kidney disease outcomes quality initiative (US KDOQI) gave similar results, but restriction according to the United Kingdom's chronic kidney disease guidelines detected only 51.6% (49.6% to 53.4%) of cases. Screening only people with previously known diabetes or hypertension detected 44.2% (42.7% to 45.7%) of all cases, with a number needed to screen of six. During the eight year follow-up only 38 of the 3069 people with chronic kidney disease progressed to end stage renal disease, and the risk was especially low in people without diabetes or hypertension, women, and those aged >= 70 or with a glomerular filtration rate 45-59 ml/min/1.73 m(2) at screeiting. In contrast, there was a high cardiovascular mortality: 3.5, 7.4, and 10.1 deaths per 100 person years among people with a glomerular filtration rate 45-59, 30-44, and < 30 ml/min/1.73 m(2), respectively. Conclusion Screening people with hypertension, diabetes mellitus, or age > 55 was the most effective strategy to detect patients with chronic kidney disease, but the risk of end stage renal disease among those detected was low.	Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Biol, N-7006 Trondheim, Norway; St Olavs Univ Hosp, Dept Med, Div Nephrol, N-7006 Trondheim, Norway; Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 Leiden, Netherlands; St Olaf Univ Hosp, Dept Clin Biochem, N-7006 Trondheim, Norway; Norwegian Univ Sci & Technol, Fac Med, HUNT Res Ctr, N-7650 Verdal, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Norwegian University of Science & Technology (NTNU)	Hallan, SI (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Biol, N-7006 Trondheim, Norway.	stein.hallan@ntnu.no	Dekker, Friedo W/B-6452-2011	Dekker, Friedo W/0000-0002-2433-2494				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; [Anonymous], 2005, ISN NEWS, V13, P3; BOULWARE LE, 2003, JAMA-J AM MED ASSOC, V17, P3101; Brown WW, 2003, AM J KIDNEY DIS, V42, P22, DOI 10.1016/S0272-6386(03)00405-0; de Jong PE, 2004, KIDNEY INT, V66, P2109, DOI 10.1111/j.1523-1755.2004.66001.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Holmen JMK., 2003, NORSK EPIDEMIOL, V13, P19, DOI [10.5324/nje.v13i1.305, DOI 10.5324/NJE.V13I1.305]; McClellan WM, 2003, J AM SOC NEPHROL, V14, pS81, DOI 10.1097/01.ASN.0000070144.86024.04; Nahas ME, 2005, KIDNEY INT, V68, P2918, DOI 10.1111/j.1523-1755.2005.00774.x; Remuzzi G, 2005, LANCET, V365, P556; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634	11	224	237	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 18	2006	333	7577					1047	1050		10.1136/bmj.39001.657755.BE	http://dx.doi.org/10.1136/bmj.39001.657755.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	108HB	17062598	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000242229800016
J	Revyakin, A; Liu, CY; Ebright, RH; Strick, TR				Revyakin, Andrey; Liu, Chenyu; Ebright, Richard H.; Strick, Terence R.			Abortive initiation and productive initiation by RNA polymerase involve DNA scrunching	SCIENCE			English	Article							LAC UV5 PROMOTER; TRANSCRIPTION INITIATION; BUBBLE COLLAPSE; COMPLEX; ELONGATION; CLEARANCE; NANOMANIPULATION; RELEASE; ESCAPE	Using single-molecule DNA nanomanipulation, we show that abortive initiation involves DNA "scrunching" - in which RNA polymerase (RNAP) remains stationary and unwinds and pulls downstream DNA into itself - and that scrunching requires RNA synthesis and depends on RNA length. We show further that promoter escape involves scrunching, and that scrunching occurs in most or all instances of promoter escape. Our results support the existence of an obligatory stressed intermediate, with approximately one turn of additional DNA unwinding, in escape and are consistent with the proposal that stress in this intermediate provides the driving force to break RNAP-promoter and RNAP-initiation-factor interactions in escape.	Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Inst Jacques Monod, CNRS, UMR 7592, F-75251 Paris 05, France; Univ Paris 06, F-75251 Paris 05, France; Univ Paris 07, F-75251 Paris 05, France	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Cold Spring Harbor Laboratory; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Revyakin, A (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Piscataway, NJ 08854 USA.	ebright@waksman.rutgers.edu; strick@ijm.jussieu.fr	Strick, Terence R/J-1886-2012; Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140; Strick, Terence/0000-0003-1744-3679	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041376, R01GM041376] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM041376, R01 GM041376-16, R01 GM041376-18, R01 GM041376, R01 GM041376-17, R01 GM041376-15, GM41376] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, BIOPHYS J, V89, pL61, DOI 10.1529/biophysj.105.074195; Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Esposito EA, 2004, J BIOL CHEM, V279, P44270, DOI 10.1074/jbc.M407688200; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; GRACHEV MA, 1980, FEBS LETT, V115, P23, DOI 10.1016/0014-5793(80)80718-6; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Liu CH, 2002, J BIOL CHEM, V277, P2725, DOI 10.1074/jbc.M108856200; Margeat E, 2006, BIOPHYS J, V90, P1419, DOI 10.1529/biophysj.105.069252; MUNSON LM, 1981, BIOCHEMISTRY-US, V20, P2081, DOI 10.1021/bi00511a003; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; RECORD MT, 1996, ESCHERICHIA COLI SAL, V1, P792; Revyakin A, 2005, NAT METHODS, V2, P127, DOI 10.1038/nmeth0205-127; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2003, METHOD ENZYMOL, V370, P577; SPASSKY A, 1986, J MOL BIOL, V188, P99, DOI 10.1016/0022-2836(86)90484-5; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3	30	263	272	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1139	1143		10.1126/science.1131398	http://dx.doi.org/10.1126/science.1131398			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110577	Green Accepted			2022-12-01	WOS:000242045800043
J	Woodside, MT; Anthony, PC; Behnke-Parks, WM; Larizadeh, K; Herschlag, D; Block, SM				Woodside, Michael T.; Anthony, Peter C.; Behnke-Parks, William M.; Larizadeh, Kevan; Herschlag, Daniel; Block, Steven M.			Direct measurement of the full, sequence-dependent folding landscape of a nucleic acid	SCIENCE			English	Article							STRUCTURE PREDICTION; SMALL PROTEINS; FORCE; RNA; MOLECULES	Nucleic acid hairpins provide a powerful model system for understanding macromolecular folding, with free-energy landscapes that can be readily manipulated by changing the hairpin sequence. The full shapes of energy landscapes for the reversible folding of DNA hairpins under controlled loads exerted by an optical force clamp were obtained by deconvolution from high-resolution, single-molecule trajectories. The locations and heights of the energy barriers for hairpin folding could be tuned by adjusting the number and location of G: C base pairs, and the presence and position of folding intermediates were controlled by introducing single-nucleotide mismatches.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada; Stanford Univ, Biophys Program, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; National Research Council Canada; Stanford University; Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	sblock@stanford.edu			NIGMS NIH HHS [R01 GM057035-12, P01-GM066275, R01 GM057035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035, P01GM066275] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Buchner J, 2005, PROTEIN FOLDING HANDBOOK, P1, DOI 10.1002/9783527619498; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fernandez JM, 2001, SCIENCE, V292, P653, DOI 10.1126/science.1060884; FRESHT A, 1999, STRUCTURE MECH PROTE; Greenleaf WJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208102; Hyeon CB, 2003, P NATL ACAD SCI USA, V100, P10249, DOI 10.1073/pnas.1833310100; Jansson P., 1997, DECONVOLUTION IMAGES; Jeney S, 2004, CHEMPHYSCHEM, V5, P1150, DOI 10.1002/cphc.200301027; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.bi.59.070190.003215; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Li PTX, 2006, BIOPHYS J, V90, P250, DOI 10.1529/biophysj.105.068049; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; McCann LI, 1999, NATURE, V402, P785, DOI 10.1038/45492; Onoa B, 2003, SCIENCE, V299, P1892, DOI 10.1126/science.1081338; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Walther KA, 2006, BIOPHYS J, V90, P3806, DOI 10.1529/biophysj.105.076224; Woodside MT, 2006, P NATL ACAD SCI USA, V103, P6190, DOI 10.1073/pnas.0511048103	21	291	317	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					1001	1004		10.1126/science.1133601	http://dx.doi.org/10.1126/science.1133601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095702	Green Accepted			2022-12-01	WOS:000241896000056
J	Yang, ZL; Camp, NJ; Sun, H; Tong, ZZ; Gibbs, D; Cameron, DJ; Chen, HY; Zhao, Y; Pearson, E; Li, X; Chien, J; DeWan, A; Harmon, J; Bernstein, PS; Shridhar, V; Zabriskie, NA; Hoh, J; Howes, K; Zhang, K				Yang, Zhenglin; Camp, Nicola J.; Sun, Hui; Tong, Zongzhong; Gibbs, Daniel; Cameron, D. Joshua; Chen, Haoyu; Zhao, Yu; Pearson, Erik; Li, Xi; Chien, Jeremy; DeWan, Andrew; Harmon, Jennifer; Bernstein, Paul S.; Shridhar, Viji; Zabriskie, Norman A.; Hoh, Josephine; Howes, Kimberly; Zhang, Kang			A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration	SCIENCE			English	Article							COMPLEMENT FACTOR-H; CIGARETTE-SMOKING; RISK; POLYMORPHISM; CFH; ASSOCIATION; MACULOPATHY; LOC387715; DISEASE	Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world and has a strong genetic predisposition. A locus at human chromosome 10q26 affects the risk of AMD, but the precise gene(s) have not been identified. We genotyped 581 AMD cases and 309 normal controls in a Caucasian cohort in Utah. We demonstrate that a single-nucleotide polymorphism, rs11200638, in the promoter region of HTRA1 is the most likely causal variant for AMD at 10q26 and is estimated to confer a population attributable risk of 49.3%. The HTRA1 gene encodes a secreted serine protease. Preliminary analysis of lymphocytes and retinal pigment epithelium from four AMD patients revealed that the risk allele was associated with elevated expression levels of HTRA1 mRNA and protein. We also found that drusen in the eyes of AMD patients were strongly immunolabeled with HTRA1 antibody. Together, these findings support a key role for HTRA1 in AMD susceptibility and identify a potential new pathway for AMD pathogenesis.	Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Eccles Inst Human Genet, Program Human Mol Biol & Genet, Salt Lake City, UT 84132 USA; Sichuan Prov Peoples Hosp, Chengdu 610071, Sichuan, Peoples R China; Univ Utah, Sch Med, Dept Biomed Informat, Div Genet Epidemiol, Salt Lake City, UT 84108 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Mayo Clin, Coll Med, Dept Lab Med & Expt Pathol, Rochester, MN 55905 USA; Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Sichuan Provincial People's Hospital; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Mayo Clinic; Yale University	Zhang, K (corresponding author), Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.	kzhang@hmbg.utah.edu	Zhang, Kang/Y-2740-2019; Chu, Kai On/E-2325-2016; Chien, Jeremy/AID-8939-2022; Chen, Haoyu/A-7432-2013; Seal, Sudipta/A-7698-2012	Zhang, Kang/0000-0002-4549-1697; Chen, Haoyu/0000-0003-0676-4610; DeWan, Andrew/0000-0002-7679-8704; Chien, Jeremy/0000-0003-4744-8374	NATIONAL CANCER INSTITUTE [K07CA098364] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015771, P30EY014800, R01EY014448, R01EY014428] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141	18	609	654	8	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					992	993		10.1126/science.1133811	http://dx.doi.org/10.1126/science.1133811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17053109				2022-12-01	WOS:000241896000053
J	Shuchman, M				Shuchman, Miriam			Trading restenosis for thrombosis? New questions about drug electing stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Buffalo, Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shuchman, M (corresponding author), Univ Buffalo, Sch Med & Biomed Sci, Dept Psychiat, Buffalo, NY 14260 USA.							Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; ANTMAN EM, 2005, J AM COLL CARDIOL, V45, P1376; CAMENZIND E, 2006, WORLD C CARD 2006 BA; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; PFISTERER ME, IN PRESS J AM COLL C; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138	6	107	118	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1949	1952		10.1056/NEJMp068234	http://dx.doi.org/10.1056/NEJMp068234			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093244				2022-12-01	WOS:000241833000001
J	Go, AS; Lee, WY; Yang, JR; Lo, JC; Gurwitz, JH				Go, Alan S.; Lee, Wendy Y.; Yang, Jingrong; Lo, Joan C.; Gurwitz, Jerry H.			Statin therapy and risks for death and hospitalization in chronic heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; SERUM CREATININE; ATORVASTATIN; SURVIVAL; INFLAMMATION; METAANALYSIS; CHOLESTEROL; MORTALITY; OUTCOMES	Context Whether statin therapy has beneficial effects on clinical outcomes in patients with heart failure is unclear. Objective To evaluate the association between initiation of statin therapy and risks for death and hospitalization among adults with chronic heart failure. Design, Setting, and Patients Propensity-adjusted cohort study of adults diagnosed with heart failure who were eligible for lipid-lowering therapy but had no previous known statin use, within an integrated health care delivery system in northern California between January 1, 1996, and December 31, 2004. Statin use was estimated from filled outpatient prescriptions in pharmacy databases. Main Outcome Measures All-cause death and hospitalization for heart failure during a median of 2.4 years of follow-up. We examined the independent relationships between statin therapy and risks for adverse events overall and stratified by the presence or absence of coronary heart disease after multivariable adjustment for potential confounders. Results Among 24 598 adults diagnosed with heart failure who had no prior statin use, those initiating statin therapy (n = 12 648; 51.4%) were more likely to be younger, male, and have known cardiovascular disease, diabetes, and hypertension. There were 8235 patients who died. Using an intent-to-treat approach, incident statin use was associated with lower risks of death (age- and sex-adjusted rate of 14.5 per 100 person-years with statin therapy vs 25.3 per 100 person-years without statin therapy; adjusted hazard ratio, 0.76 [95% confidence interval, 0.72-0.80]) and hospitalization for heart failure (age- and sex-adjusted rate of 21.9 per 100 person-years with statin therapy vs 31.1 per 100 person-years without statin therapy; adjusted hazard ratio, 0.79 [95% confidence interval, 0.74-0.85]) even after adjustment for the propensity to take statins, cholesterol level, use of other cardiovascular medications, and other potential confounders. Incident statin use was associated with lower adjusted risks of adverse outcomes in patients with or without known coronary heart disease. Conclusion Among adults diagnosed with heart failure who had no prior statin use, incident statin use was independently associated with lower risks of death and hospitalization among patients with or without coronary heart disease.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Tufts Sch Med, Dept Med, Boston, MA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Endocrinol, San Francisco, CA USA; Univ Massachusetts, Sch Med, Fallon Clin Fdn, Meyers Primary Care Inst, Worcester, MA USA; Fallon Community Hlth Plan, Worcester, MA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway St,3rd Floor, Oakland, CA 94612 USA.	Alan.S.Go@kp.org	Go, Alan S./AAE-7745-2019					American Heart Association, 2005, HEART DIS STROKE STA; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Bleske BE, 2006, J AM COLL CARDIOL, V47, P338, DOI 10.1016/j.jacc.2005.06.087; Bohm M, 2005, Z KARDIOL, V94, P223, DOI 10.1007/s00392-005-0210-9; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Henke PK, 2004, J VASC SURG, V39, P357, DOI 10.1016/j.jvs.2003.08.030; Horwich TB, 2004, J AM COLL CARDIOL, V43, P642, DOI 10.1016/j.jacc.2003.07.049; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519a; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Kjekshus J, 2005, EUR J HEART FAIL, V7, P1059, DOI 10.1016/j.ejheart.2005.09.005; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lee WY, 2004, AM J CARDIOL, V94, P1147, DOI 10.1016/j.amjcard.2004.07.081; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; Mozaffarian D, 2005, AM J CARDIOL, V96, P1699, DOI 10.1016/j.amjcard.2005.07.092; Mozaffarian D, 2004, AM J CARDIOL, V93, P1124, DOI 10.1016/j.amjcard.2004.01.039; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Rauchhaus M, 2000, LANCET, V356, P930, DOI 10.1016/S0140-6736(00)02690-8; Rauchhaus M, 2003, J AM COLL CARDIOL, V42, P1933, DOI 10.1016/j.jacc.2003.07.016; Ray JG, 2005, ARCH INTERN MED, V165, P62, DOI 10.1001/archinte.165.1.62; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rundek T, 2004, ARCH NEUROL-CHICAGO, V61, P889, DOI 10.1001/archneur.61.6.889; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Strey CH, 2005, ATHEROSCLEROSIS, V179, P201, DOI 10.1016/j.atherosclerosis.2004.10.009; Tavazzi L, 2004, EUR J HEART FAIL, V6, P635, DOI 10.1016/j.ejheart.2004.03.001; TM Therneau., 2000, MODELING SURVIVAL DA, DOI DOI 10.1007/978; Tousoulis D, 2005, ATHEROSCLEROSIS, V178, P359, DOI 10.1016/j.atherosclerosis.2004.08.037; Urbich C, 2005, KIDNEY INT, V67, P1672, DOI 10.1111/j.1523-1755.2005.00261.x; van der Harst P, 2006, PLOS MED, V3, P1403, DOI 10.1371/journal.pmed.0030333; Vrtovec B, 2005, J CARD FAIL, V11, P684, DOI 10.1016/j.cardfail.2005.06.439; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427	44	210	223	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2006	296	17					2105	2111		10.1001/jama.296.17.2105	http://dx.doi.org/10.1001/jama.296.17.2105			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100KM	17077375	Bronze			2022-12-01	WOS:000241668000022
J	Paterson, DS; Trachtenberg, FL; Thompson, EG; Belliveau, RA; Beggs, AH; Darnall, R; Chadwick, AE; Krous, HF; Kinney, HC				Paterson, David S.; Trachtenberg, Felicia L.; Thompson, Eric G.; Belliveau, Richard A.; Beggs, Alan H.; Darnall, Ryan; Chadwick, Amy E.; Krous, Henry F.; Kinney, Hannah C.			Multiple serotonergic brainstem abnormalities in sudden infant death syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							5-HT1A RECEPTOR-BINDING; TRANSPORTER GENE; IN-VITRO; NEURONS; MEDULLA; NUCLEUS; RHYTHM; RISK; AGE; POLYMORPHISM	Context The serotonergic (5-hydroxytryptamine [5-HT]) neurons in the medulla oblongata project extensively to autonomic and respiratory nuclei in the brainstem and spinal cord and help regulate homeostatic function. Previously, abnormalities in 5-HT receptor binding in the medullae of infants dying from sudden infant death syndrome (SIDS) were identified, suggesting that medullary 5-HT dysfunction may be responsible for a subset of SIDS cases. Objective To investigate cellular defects associated with altered 5-HT receptor binding in the 5-HT pathways of the medulla in SIDS cases. Design, Setting, and Participants Frozen medullae from infants dying from SIDS (cases) or from causes other than SIDS (controls) were obtained from the San Diego Medical Examiner's office between 1997 and 2005. Markers of 5-HT function were compared between SIDS cases and controls, adjusted for postconceptional age and postmortem interval. The number of samples available for each analysis ranged from 16 to 31 for SIDS cases and 6 to 10 for controls. An exploratory analysis of the correlation between markers and 6 recognized risk factors for SIDS was performed. Main Outcome Measures 5-HT neuron count and density, 5-HT1A receptor binding density, and 5-HT transporter (5-HTT) binding density in the medullary 5-HT system; correlation between these markers and 6 recognized risk factors for SIDS. Results Compared with controls, SIDS cases had a significantly higher 5-HT neuron count (mean [SD], 148.04 [51.96] vs 72.56 [52.36] cells, respectively; P < .001) and 5-HT neuron density (P < .001), as well as a significantly lower density of 5-HT1A receptor binding sites (P <. 01 for all 9 nuclei) in regions of the medulla involved in homeostatic function. The ratio of 5-HTT binding density to 5-HT neuron count in the medulla was significantly lower in SIDS cases compared with controls (mean [SD], 0.70 [0.33] vs 1.93 [1.25] fmol/mg, respectively; P =. 001). Male SIDS cases had significantly lower 5-HT1A binding density in the raphe obscurus compared with female cases (mean [SD], 16.2 [2.0] vs 29.6 [16.5] fmol/mg, respectively; P =. 04) or with male and female controls combined (mean [SD], 53.9 [19.8] fmol/mg; P =. 005). No association was found between 5-HT neuron count or density, 5-HT1A receptor binding density, or 5-HTT receptor binding density and other risk factors. Conclusions Medullary 5-HT pathology in SIDS is more extensive than previously delineated, potentially including abnormal 5-HT neuron firing, synthesis, release, and clearance. This study also provides preliminary neurochemical evidence that may help explain the increased vulnerability of boys to SIDS.	Childrens Hosp Boston, Dept Pathol, Boston, MA USA; Childrens Hosp Boston, Dept Pediat, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; New England Res Inst, Watertown, MA 02172 USA; Rady Childrens Hosp & Hlth Ctr, San Diego, CA USA; Univ Calif San Diego, San Diego Sch Med, San Diego, CA 92103 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; HealthCore, Inc; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Paterson, DS (corresponding author), 300 Longwood Ave,Enders Bldg Room 1109, Boston, MA 02115 USA.	david.paterson@childrens.harvard.edu	Paterson, David/C-1517-2009	Beggs, Alan/0000-0001-8818-0568	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, P01HD036379] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020991] Funding Source: NIH RePORTER; NICHD NIH HHS [P01-HD36379, P30-HD18655, R37-HD20991] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARANGO V, 1995, BRAIN RES, V688, P121, DOI 10.1016/0006-8993(95)00523-S; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; BARTLETT D, 1990, PROG CLIN BIOL RES, V345, P99; Berner NJ, 1999, BRAIN RES, V831, P155, DOI 10.1016/S0006-8993(99)01426-2; Blair PS, 2006, BRIT MED J, V332, P178, DOI 10.1136/bmj.332.7534.178-a; Blakely RD, 2005, PHYSIOLOGY, V20, P225, DOI 10.1152/physiol.00013.2005; Bou-Flores C, 2000, J NEUROSCI, V20, P4646, DOI 10.1523/JNEUROSCI.20-12-04646.2000; Darnall RA, 2005, J NEUROSCI, V25, P8322, DOI 10.1523/JNEUROSCI.1770-05.2005; DILLON KA, 1991, BRAIN RES, V554, P56, DOI 10.1016/0006-8993(91)90171-Q; EATON MJ, 1995, DEV BIOL, V170, P169, DOI 10.1006/dbio.1995.1205; EMERIT MB, 1992, BIOL NEONATE, V62, P193; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; GILLIS RA, 1989, J PHARMACOL EXP THER, V248, P851; Heils A, 1997, J NEURAL TRANSM, V104, P1005, DOI 10.1007/BF01273314; Henderson LA, 2000, NEUROSCIENCE, V98, P779, DOI 10.1016/S0306-4522(00)00117-2; Johns JM, 2002, DEV NEUROSCI-BASEL, V24, P522, DOI 10.1159/000069363; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; KING KA, 1991, EUR J PHARMACOL, V200, P357, DOI 10.1016/0014-2999(91)90596-I; Kinney HC, 2005, J NEUROPATH EXP NEUR, V64, P689, DOI 10.1097/01.jnen.0000174334.27708.43; Kinney HC, 2003, J NEUROPATH EXP NEUR, V62, P1178, DOI 10.1093/jnen/62.11.1178; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; KINNEY HC, 2004, PATHOLOGY GENETICS D; KRAMMER EB, 1979, BRAIN RES, V170, P533, DOI 10.1016/0006-8993(79)90970-3; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; LALLEY PM, 1994, BRAIN RES, V648, P87, DOI 10.1016/0006-8993(94)91909-7; LALLEY PM, 1994, J PHYSIOL-LONDON, V476, P117; Messier ML, 2004, J APPL PHYSIOL, V96, P1909, DOI 10.1152/japplphysiol.00805.2003; Narita N, 2001, PEDIATRICS, V107, P690, DOI 10.1542/peds.107.4.690; Olszewski J, 1954, CYTOARCHITECTURE HUM; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Parsey RV, 2002, BRAIN RES, V954, P173, DOI 10.1016/S0006-8993(02)03243-2; Paterson DS, 2006, AUTON NEUROSCI-BASIC, V124, P112, DOI 10.1016/j.autneu.2005.12.009; Paterson DS, 2004, J COMP NEUROL, V472, P221, DOI 10.1002/cne.20105; Pena F, 2002, J NEUROSCI, V22, P11055; Penatti EM, 2006, J APPL PHYSIOL, V101, P1177, DOI 10.1152/japplphysiol.00376.2006; Raydo LJL, 2005, NEONATAL NETW, V24, P9; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Tappin D, 2004, LANCET, V363, P994, DOI 10.1016/S0140-6736(04)15806-6; Tryba AK, 2006, J NEUROSCI, V26, P2623, DOI 10.1523/JNEUROSCI.4186-05.2006; Weese-Mayer DE, 2003, AM J MED GENET A, V122A, P238, DOI 10.1002/ajmg.a.20427; Weese-Mayer DE, 2003, AM J MED GENET A, V117A, P268, DOI 10.1002/ajmg.a.20005; WILLINGER M, 1991, Pediatric Pathology, V11, P677; 2006, CHILD HLTH ALERT, V24, P3	43	352	368	0	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2006	296	17					2124	2132		10.1001/jama.296.17.2124	http://dx.doi.org/10.1001/jama.296.17.2124			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100KM	17077377	Bronze			2022-12-01	WOS:000241668000024
J	Tirichine, L; Sandal, N; Madsen, LH; Radutoiu, S; Albrektsen, AS; Sato, S; Asamizu, E; Tabata, S; Stougaard, J				Tirichine, Leila; Sandal, Niels; Madsen, Lene H.; Radutoiu, Simona; Albrektsen, Anita S.; Sato, Shusei; Asamizu, Erika; Tabata, Satoshi; Stougaard, Jens			A gain-of-function mutation in a cytokinin receptor triggers spontaneous root nodule organogenesis	SCIENCE			English	Article							LEGUME LOTUS-JAPONICUS; SIGNAL-TRANSDUCTION; CHASE DOMAIN; ARABIDOPSIS; NODULATION; KINASE; GENE; PERCEPTION; MUTANTS; EXPRESSION	Legume root nodules originate from differentiated cortical cells that reenter the cell cycle and form organ primordia. We show that perception of the phytohormone cytokinin is a key element in this switch. Mutation of a Lotus japonicus cytokinin receptor gene leads to spontaneous development of root nodules in the absence of rhizobia or rhizobial signal molecules. The mutant histidine kinase receptor has cytokinin-independent activity and activates an Escherichia coli two-component phosphorelay system in vivo. Mutant analysis shows that cytokinin signaling is required for cell divisions that initiate nodule development and defines an autoregulated process where cytokinin induction of nodule stem cells is controlled by shoots.	Aarhus Univ, Dept Mol Biol, Gene Express Lab, DK-8000 Aarhus C, Denmark; Kazusa DNA Res Inst, Chiba 2920818, Japan	Aarhus University; Kazusa DNA Research Institute	Stougaard, J (corresponding author), Aarhus Univ, Dept Mol Biol, Gene Express Lab, Gustav Wieds Vej 10, DK-8000 Aarhus C, Denmark.	stougaard@mb.au.dk	Sato, Shusei/A-3616-2015	Sato, Shusei/0000-0002-0293-5366; Stougaard, Jens/0000-0002-9312-2685				Anantharaman V, 2001, TRENDS BIOCHEM SCI, V26, P579, DOI 10.1016/S0968-0004(01)01968-5; COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; DEHIO C, 1992, PLANT J, V2, P117; Fang YW, 1998, PLANT PHYSIOL, V116, P53, DOI 10.1104/pp.116.1.53; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; HANSEN J, 1989, PLANT CELL REP, V8, P12, DOI 10.1007/BF00735768; Hutchison CE, 2002, PLANT CELL, V14, pS47, DOI 10.1105/tpc.010444; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kakimoto T, 2001, PLANT CELL PHYSIOL, V42, P677, DOI 10.1093/pcp/pce112; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Lohar DP, 2004, PLANT J, V38, P203, DOI 10.1111/j.1365-313X.2004.02038.x; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mathesius U, 1998, PLANT J, V14, P23, DOI 10.1046/j.1365-313X.1998.00090.x; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Nishimura N, 2004, PLANT CELL PHYSIOL, V45, P1485, DOI 10.1093/pcp/pch171; Niwa S, 2001, MOL PLANT MICROBE IN, V14, P848, DOI 10.1094/MPMI.2001.14.7.848; Pas J, 2004, FEBS LETT, V576, P287, DOI 10.1016/j.febslet.2004.09.020; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Rashotte AM, 2003, PLANT PHYSIOL, V132, P1998, DOI 10.1104/pp.103.021436; STOUGAARD J, 1987, MOL GEN GENET, V207, P251, DOI 10.1007/BF00331586; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Tirichine L, 2006, MOL PLANT MICROBE IN, V19, P373, DOI 10.1094/MPMI-19-0373; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862	26	368	387	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					104	107		10.1126/science.1132397	http://dx.doi.org/10.1126/science.1132397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17110537				2022-12-01	WOS:000243259100047
J	Pasrija, S; Sharma, N				Pasrija, Shikha; Sharma, Nayantara			Images in clinical medicine: Benign diffuse breast hyperplasia during pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tagore Garden, New Delhi 110027, India		Pasrija, S (corresponding author), Tagore Garden, New Delhi 110027, India.	shikhapasrija@hotmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2006	355	26					2771	2771		10.1056/NEJMicm040539	http://dx.doi.org/10.1056/NEJMicm040539			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120UA	17192543				2022-12-01	WOS:000243110500010
J	Yang, YX; Lewis, JD; Epstein, S; Metz, DC				Yang, Yu-Xiao; Lewis, James D.; Epstein, Solomon; Metz, David C.			Long-term proton pump inhibitor therapy and risk of hip fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							L-LACTIC ACID; ORAL CORTICOSTEROIDS; CALCIUM-ABSORPTION; BONE-RESORPTION; K+-ATPASE; OMEPRAZOLE; OSTEOPOROSIS; POPULATION; H+; CARBONATE	Context Proton pump inhibitors (PPIs) may interfere with calcium absorption through induction of hypochlorhydria but they also may reduce bone resorption through inhibition of osteoclastic vacuolar proton pumps. Objective To determine the association between PPI therapy and risk of hip fracture. Design, Setting, and Patients A nested case-control study was conducted using the General Practice Research Database (1987-2003), which contains information on patients in the United Kingdom. The study cohort consisted of users of PPI therapy and nonusers of acid suppression drugs who were older than 50 years. Cases included all patients with an incident hip fracture. Controls were selected using incidence density sampling, matched for sex, index date, year of birth, and both calendar period and duration of up-to-standard follow-up before the index date. For comparison purposes, a similar nested case-control analysis for histamine 2 receptor antagonists was performed. Main Outcome Measure The risk of hip fractures associated with PPI use. Results There were 13 556 hip fracture cases and 135 386 controls. The adjusted odds ratio (AOR) for hip fracture associated with more than 1 year of PPI therapy was 1.44 (95% confidence interval [CI], 1.30-1.59). The risk of hip fracture was significantly increased among patients prescribed long-term high-dose PPIs ( AOR, 2.65; 95% CI, 1.80-3.90; P <. 001). The strength of the association increased with increasing duration of PPI therapy ( AOR for 1 year, 1.22 [ 95% CI, 1.15-1.30]; 2 years, 1.41 [ 95% CI, 1.28-1.56]; 3 years, 1.54 [ 95% CI, 1.37-1.73]; and 4 years, 1.59 [ 95% CI, 1.39-1.80]; P <. 001 for all comparisons). Conclusion Long-term PPI therapy, particularly at high doses, is associated with an increased risk of hip fracture.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Endocrinol, Philadelphia, PA 19104 USA; Doylestown Hosp Res Ctr, Dept Med, Doylestown, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Yang, YX (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 722 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	yangy@mail.med.upenn.edu	yang, yx/GZM-0464-2022		NIDDK NIH HHS [K08 DK062978] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK062978] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOLINN GW, 1984, J CLIN INVEST, V73, P640, DOI 10.1172/JCI111254; CHISHOLM J, 1990, BRIT MED J, V300, P1092, DOI 10.1136/bmj.300.6732.1092; Chonan O, 1998, J NUTR SCI VITAMINOL, V44, P473, DOI 10.3177/jnsv.44.473; Chonan O, 1998, J NUTR SCI VITAMINOL, V44, P869, DOI 10.3177/jnsv.44.869; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; Cumming RG, 1997, EPIDEMIOL REV, V19, P244, DOI 10.1093/oxfordjournals.epirev.a017956; Dawson-Hughes B, 2002, OSTEOPOROSIS INT, V13, P657, DOI 10.1007/s001980200089; DONALDSON LJ, 1990, J EPIDEMIOL COMMUN H, V44, P241, DOI 10.1136/jech.44.3.241; Farina C, 2002, CURR PHARM DESIGN, V8, P2033, DOI 10.2174/1381612023393369; GOERSS JB, 1992, J BONE MINER RES, V7, P573; Hollowell J, 1997, Popul Trends, P36; IVANOVIC.P, 1967, ANN INTERN MED, V66, P917, DOI 10.7326/0003-4819-66-5-917; Jacobson BC, 2003, AM J GASTROENTEROL, V98, P51, DOI 10.1111/j.1572-0241.2003.07186.x; Johansson S, 2003, ALIMENT PHARM THER, V18, P973, DOI 10.1046/j.1365-2036.2003.01798.x; LANDAHL S, 1992, CLIN PHARMACOKINET, V23, P469, DOI 10.2165/00003088-199223060-00006; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; MARSHALL BJ, 1994, AM J GASTROENTEROL, V89, pS116; MIZUNASHI K, 1993, CALCIFIED TISSUE INT, V53, P21, DOI 10.1007/BF01352010; NILAS L, 1985, GUT, V26, P252, DOI 10.1136/gut.26.3.252; Nordin BEC, 1997, NUTRITION, V13, P664, DOI 10.1016/S0899-9007(97)00136-6; O'Connell MB, 2005, AM J MED, V118, P778, DOI 10.1016/j.amjmed.2005.02.007; *OFF NAT STAT, 1996, STUD MED POP SUBJ, V60; Perry J, 1978, OXMIS PROBLEM CODES; RECKER RR, 1985, NEW ENGL J MED, V313, P70, DOI 10.1056/NEJM198507113130202; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Schoofs MWCJ, 2003, ANN INTERN MED, V139, P476, DOI 10.7326/0003-4819-139-6-200309160-00010; SERFATYLACROSNIERE C, 1995, J AM COLL NUTR, V14, P364; SHEIKH MS, 1987, NEW ENGL J MED, V317, P532, DOI 10.1056/NEJM198708273170903; Shin JM, 2004, J AM CHEM SOC, V126, P7800, DOI 10.1021/ja049607w; TUUKKANEN J, 1986, CALCIFIED TISSUE INT, V38, P123, DOI 10.1007/BF02556841; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; van Staa TP, 2001, JAMA-J AM MED ASSOC, V285, P1850, DOI 10.1001/jama.285.14.1850; Vestergaard P, 2006, CALCIFIED TISSUE INT, V79, P76, DOI 10.1007/s00223-006-0021-7; ZAIDI M, 1990, BIOSCIENCE REP, V10, P547, DOI 10.1007/BF01116615	37	832	885	1	37	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2006	296	24					2947	2953		10.1001/jama.296.24.2947	http://dx.doi.org/10.1001/jama.296.24.2947			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120FD	17190895	Bronze			2022-12-01	WOS:000243069000026
J	Catania, KC				Catania, Kenneth C.			Olfaction - Underwater 'sniffing' by semi-aquatic mammals	NATURE			English	Article							EVOLUTION		Vanderbilt Univ, Dept Biol Sci, VU Stn B, Nashville, TN 37235 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	ken.catania@vanderbilt.edu						Catania KC, 2000, BRAIN BEHAV EVOLUT, V56, P146, DOI 10.1159/000047201; ESTES JA, 1989, CARNIVORE BEHAV ECOL, V1, P242; Howell A. B., 1930, AQUATIC MAMMALS THEI; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; REPENNING CA, 1976, SYST ZOOL, V25, P375, DOI 10.2307/2412512; Sanchez-Villagra MR, 2002, MAMMALIA, V66, P93, DOI 10.1515/mamm.2002.66.1.93; STEPHAN H, 1984, Z ZOOL SYST EVOL, V22, P328; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4	9	44	45	5	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1024	1025		10.1038/4441024a	http://dx.doi.org/10.1038/4441024a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183311				2022-12-01	WOS:000242971100044
J	Pennington, DJ; Silva-Santos, B; Silberzahn, T; Escorcio-Correia, M; Woodward, MJ; Roberts, SJ; Smith, AL; Dyson, PJ; Hayday, AC				Pennington, Daniel J.; Silva-Santos, Bruno; Silberzahn, Tobias; Escorcio-Correia, Monica; Woodward, Martin J.; Roberts, Scott J.; Smith, Adrian L.; Dyson, P. Julian; Hayday, Adrian C.			Early events in the thymus affect the balance of effector and regulatory T cells	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; ALPHA-BETA; ANTIGEN 4; TOLERANCE; LINEAGE; GENE; INFLAMMATION; PROGENITORS; ENRICHMENT; SELECTION	In cellular immunology the critical balance between effector and regulatory mechanisms is highlighted by serious immunopathologies attributable to mutations in Foxp3, a transcription factor required for a major subset of regulatory T (T(R)) cells(1-3). Thus, many studies have focused on the developmental origin of T(R) cells, with the prevailing view that they emerge in the thymus from late-stage T-cell progenitors whose T-cell receptors (TCRs) engage high affinity (agonist) ligands(4-6). This study questions the completeness of that interpretation. Here we show that without any obvious effect on TCR-mediated selection, the normal differentiation of mouse gamma delta T cells into potent cytolytic and interferon-gamma-secreting effector cells is switched towards an aggregate regulatory phenotype by limiting the capacity of CD4(+) CD8(+) T-cell progenitors to influence in trans early gamma delta cell progenitors. Unexpectedly, we found that the propensity of early TCR-alpha beta(+) progenitors to differentiate into Foxp3 1 T(R) cells is also regulated in trans by CD4(+) CD8(+) T-cell progenitor cells, before agonist selection.	Guys Hosp, Kings Coll London Sch Med, Peter Gorer Dept Immunobiol, London SE1 9RT, England; Queen Mary Coll, London & Barts Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England; Fac Med Lisbon, Inst Mol Med, P-1649028 Lisbon, Portugal; Inst Child Hlth, Mol Haematol & Canc Biol Unit, Camelia Botnar Labs, London WC1N 1EH, England; Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; Inst Anim Hlth, Compton Lab, Newbury RG20 7NN, Berks, England; Hammersmith Hosp, Imperial Coll, Div Med, London W12 0HS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; Queen Mary University London; Universidade de Lisboa; University of London; University College London; Yale University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Imperial College London	Pennington, DJ (corresponding author), Guys Hosp, Kings Coll London Sch Med, Peter Gorer Dept Immunobiol, London SE1 9RT, England.	d.pennington@qmul.ac.uk; adrian.hayday@kcl.ac.uk	England, Philip C/A-1920-2010	England, Philip C/0000-0002-9024-8901; Escorcio Correia Wang, Monica/0000-0002-9205-1993; Smith, Adrian/0000-0002-7657-6191; Pennington, Daniel/0000-0001-7889-9923; HAYDAY, ADRIAN/0000-0002-9495-5793; Silva-Santos, Bruno/0000-0003-4141-9302	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001048, BBS/E/I/00001160] Funding Source: Medline; Wellcome Trust [071534] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Bosco N, 2006, J IMMUNOL, V177, P5014, DOI 10.4049/jimmunol.177.8.5014; Buer J, 1997, J EXP MED, V185, P1541, DOI 10.1084/jem.185.9.1541; Carter JD, 2005, J IMMUNOL, V174, P6627, DOI 10.4049/jimmunol.174.11.6627; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gibbons D, 2001, J EXP MED, V194, P695, DOI 10.1084/jem.194.5.695; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lerman MA, 2004, J IMMUNOL, V173, P236, DOI 10.4049/jimmunol.173.1.236; Livak F, 1997, EUR J IMMUNOL, V27, P2948, DOI 10.1002/eji.1830271130; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; WISE E, UNPUB J IMMUNOL; Zelenika D, 2002, J IMMUNOL, V168, P1069, DOI 10.4049/jimmunol.168.3.1069	30	84	86	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1073	1077		10.1038/nature06051	http://dx.doi.org/10.1038/nature06051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17190001				2022-12-01	WOS:000242971100057
J	Schapira, A				Schapira, Allan			DDT: a polluted debate in malaria control	LANCET			English	Editorial Material												a.schapira@bluewin.ch	Schapira, Allan/AAZ-8116-2020					Etang J, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-46; *GLOB MAL PROGR, 2006, IND RES SPRAY US IND; Lengeler C., 2004, COCHRANE DB SYST REV, V2; *PEST ACT NETW N A, 2006, GLOB COAL HLTH TOX E; Schapira A, 2004, NATURE, V432, P439, DOI 10.1038/432439b; STOSSEL J, 2006, HOORAY DDTS LIFE SAV; *WHO, 2006, WHO GIV IND US DDT C	7	14	14	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2111	2113		10.1016/S0140-6736(06)69812-7	http://dx.doi.org/10.1016/S0140-6736(06)69812-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174693				2022-12-01	WOS:000242856900006
J	Alper, H; Moxley, J; Nevoigt, E; Fink, GR; Stephanopoulos, G				Alper, Hal; Moxley, Joel; Nevoigt, Elke; Fink, Gerald R.; Stephanopoulos, Gregory			Engineering yeast transcription machinery for improved ethanol tolerance and production	SCIENCE			English	Article							TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; POLYMERASE-II; STRESS; MECHANISM; GROWTH; SAGA; DNA	Global transcription machinery engineering (gTME) is an approach for reprogramming gene transcription to elicit cellular phenotypes important for technological applications. Here we show the application of gTME to Saccharomyces cerevisiae for improved glucose/ethanol tolerance, a key trait for many biofuels programs. Mutagenesis of the transcription factor Spt15p and selection led to dominant mutations that conferred increased tolerance and more efficient glucose conversion to ethanol. The desired phenotype results from the combined effect of three separate mutations in the SPT15 gene [ serine substituted for phenylalanine ( Phe(177)Ser) and, similarly, Tyr(195)His, and Lys(218)Arg]. Thus, gTME can provide a route to complex phenotypes that are not readily accessible by traditional methods.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Berlin Univ Technol, Dept Microbiol & Genet, D-13353 Berlin, Germany; MIT, Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Technical University of Berlin; Massachusetts Institute of Technology (MIT); Whitehead Institute	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Room 56-469, Cambridge, MA 02139 USA.	gregstep@mit.edu	Nevoigt, Elke/F-5887-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035010, R01GM035010] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM035010] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALPER HHS, 2006, THESIS MIT; Bai FW, 2004, J BIOTECHNOL, V110, P287, DOI 10.1016/j.jbiotec.2004.01.017; Cakar ZP, 2005, FEMS YEAST RES, V5, P569, DOI 10.1016/j.femsyr.2004.10.010; Cang Y, 1999, EMBO J, V18, P6662, DOI 10.1093/emboj/18.23.6662; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; Furukawa K, 2004, J BIOSCI BIOENG, V98, P107, DOI [10.1016/S1389-1723(04)70250-9, 10.1263/jbb.98.107]; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Klejman MP, 2005, NUCLEIC ACIDS RES, V33, P5426, DOI 10.1093/nar/gki850; Kou HP, 2003, MOL CELL BIOL, V23, P3186, DOI 10.1128/MCB.23.9.3186-3201.2003; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Nozawa M, 2002, J BIOSCI BIOENG, V93, P288, DOI 10.1263/jbb.93.288; OCONNOR GM, 1992, BIOTECHNOL BIOENG, V39, P293, DOI 10.1002/bit.260390307; Ogawa Y, 2000, J BIOSCI BIOENG, V90, P313, DOI 10.1016/S1389-1723(00)80087-0; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; STININGER B, 2005, APPL MICROBIAL BIOTE, DOI DOI 10.1007/S00253-006-0435-1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takagi H, 2005, APPL ENVIRON MICROB, V71, P8656, DOI 10.1128/AEM.71.12.8656-8662.2005; THATIPAMALA R, 1992, BIOTECHNOL BIOENG, V40, P289, DOI 10.1002/bit.260400213; van Voorst F, 2006, YEAST, V23, P351, DOI 10.1002/yea.1359	27	562	680	7	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1565	1568		10.1126/science.1131969	http://dx.doi.org/10.1126/science.1131969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158319				2022-12-01	WOS:000242624600032
J	Randerson, JT; Liu, H; Flanner, MG; Chambers, SD; Jin, Y; Hess, PG; Pfister, G; Mack, MC; Treseder, KK; Welp, LR; Chapin, FS; Harden, JW; Goulden, ML; Lyons, E; Neff, JC; Schuur, EAG; Zender, CS				Randerson, J. T.; Liu, H.; Flanner, M. G.; Chambers, S. D.; Jin, Y.; Hess, P. G.; Pfister, G.; Mack, M. C.; Treseder, K. K.; Welp, L. R.; Chapin, F. S.; Harden, J. W.; Goulden, M. L.; Lyons, E.; Neff, J. C.; Schuur, E. A. G.; Zender, C. S.			The impact of boreal forest fire on climate warming	SCIENCE			English	Article							ALBEDO; SNOW; ATMOSPHERE; VEGETATION; AEROSOLS; GASES	We report measurements and analysis of a boreal forest fire, integrating the effects of greenhouse gases, aerosols, black carbon deposition on snow and sea ice, and postfire changes in surface albedo. The net effect of all agents was to increase radiative forcing during the first year ( 34 +/- 31 Watts per square meter of burned area), but to decrease radiative forcing when averaged over an 80-year fire cycle (- 2.3 +/- 2.2 Watts per square meter) because multidecadal increases in surface albedo had a larger impact than fire-emitted greenhouse gases. This result implies that future increases in boreal fire may not accelerate climate warming.	Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; Jackson State Univ, Dept Phys Atmospher Sci & Gen Sci, Jackson, MS 39217 USA; Australian Nucl Sci & Technol Org, Environm Div, Menai, NSW 2234, Australia; Natl Ctr Atmospher Res, Div Atmospher Chem, Boulder, CO 80301 USA; Univ Florida, Dept Bot, Gainesville, FL 32611 USA; CALTECH, Pasadena, CA 91125 USA; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Univ Colorado, Boulder, CO 80309 USA	University of California System; University of California Irvine; Jackson State University; Australian Nuclear Science & Technology Organisation; National Center Atmospheric Research (NCAR) - USA; State University System of Florida; University of Florida; California Institute of Technology; University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Colorado System; University of Colorado Boulder	Randerson, JT (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	jranders@uci.edu	Goulden, Michael L/B-9934-2008; Hess, Peter/M-3145-2015; Neff, Jason/A-1211-2012; Zender, Charles S/D-4485-2012; Randerson, James/Y-2550-2019; , Scott/AAI-6917-2020; Flanner, Mark/C-6139-2011; Treseder, Kathleen K/E-5148-2011; Chapin, F Stuart/AAZ-3931-2020; Pfister, Gabriele/A-9349-2008	Hess, Peter/0000-0003-2439-3796; Zender, Charles S/0000-0003-0129-8024; Randerson, James/0000-0001-6559-7387; Flanner, Mark/0000-0003-4012-174X; Treseder, Kathleen K/0000-0003-2847-6935; Chapin, F Stuart/0000-0002-2558-9910; Welp, Lisa/0000-0001-7125-0478; Harden, Jennifer W/0000-0002-6570-8259; Goulden, Michael/0000-0002-9379-3948; Lyons, Evan/0000-0003-0863-1619; NEFF, JASON/0000-0002-8290-1472; Chambers, Scott/0000-0002-2521-959X				ACIA, 2005, ARCTIC CLIMATE IMPAC; Amiro BD, 2001, CAN J FOREST RES, V31, P512, DOI 10.1139/cjfr-31-3-512; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; BRIEGLEB BP, 1992, J GEOPHYS RES-ATMOS, V97, P7603, DOI 10.1029/92JD00291; Brovkin V, 2004, GLOBAL CHANGE BIOL, V10, P1253, DOI 10.1111/j.1365-2486.2004.00812.x; Chambers SD, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000530; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; ENTING IG, 2001, 31 COMM SCI IND RES; Flanner MG, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006834; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.1890/1051-0761(2002)012[0891:FCSITN]2.0.CO;2; Hansen J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005776; Hansen J, 2004, P NATL ACAD SCI USA, V101, P423, DOI 10.1073/pnas.2237157100; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Johnson EA, 1992, CAMBRIDGE STUDIES EC; Kasischke ES, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002300; KASISCHKE ES, 2000, ECOLOGICAL STUDIES; Kuang ZM, 2000, GEOPHYS RES LETT, V27, P1299, DOI 10.1029/1999GL011116; Kurz W.A., 1995, BIOTIC FEEDBACKS GLO, P119; Liu HP, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005158; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; Neff JC, 2005, CAN J FOREST RES, V35, P2178, DOI 10.1139/X05-154; Pfister G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022995; Pielke RA, 2002, PHILOS T ROY SOC A, V360, P1705, DOI 10.1098/rsta.2002.1027; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Ramaswamy V., 2001, CLIMATE CHANGE 2001, P350; Rasch PJ, 2001, J GEOPHYS RES-ATMOS, V106, P7337, DOI 10.1029/2000JD900508; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Snyder PK, 2004, CLIM DYNAM, V23, P279, DOI 10.1007/s00382-004-0430-0; WARREN SG, 1980, J ATMOS SCI, V37, P2734, DOI 10.1175/1520-0469(1980)037<2734:AMFTSA>2.0.CO;2	33	573	581	5	300	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1130	1132		10.1126/science.1132075	http://dx.doi.org/10.1126/science.1132075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110574	Green Submitted			2022-12-01	WOS:000242045800040
J	Halton, TL; Willett, WC; Liu, SM; Manson, JE; Albert, CM; Rexrode, K; Hu, FB				Halton, Thomas L.; Willett, Walter C.; Liu, Simin; Manson, JoAnn E.; Albert, Christine M.; Rexrode, Kathryn; Hu, Frank B.			Low-carbohydrate-diet score and the risk of coronary heart disease in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-PROTEIN; WEIGHT-LOSS; FAT; COHORT; MEN	BACKGROUND: Low-carbohydrate diets have been advocated for weight loss and to prevent obesity, but the long-term safety of these diets has not been determined. METHODS: We evaluated data on 82,802 women in the Nurses' Health Study who had completed a validated food-frequency questionnaire. Data from the questionnaire were used to calculate a low-carbohydrate-diet score, which was based on the percentage of energy as carbohydrate, fat, and protein (a higher score reflects a higher intake of fat and protein and a lower intake of carbohydrate). The association between the low-carbohydrate-diet score and the risk of coronary heart disease was examined. RESULTS: During 20 years of follow-up, we documented 1994 new cases of coronary heart disease. After multivariate adjustment, the relative risk of coronary heart disease comparing highest and lowest deciles of the low-carbohydrate-diet score was 0.94 (95% confidence interval [CI], 0.76 to 1.18; P for trend=0.19). The relative risk comparing highest and lowest deciles of a low-carbohydrate-diet score on the basis of the percentage of energy from carbohydrate, animal protein, and animal fat was 0.94 (95% CI, 0.74 to 1.19; P for trend=0.52), whereas the relative risk on the basis of the percentage of energy from intake of carbohydrates, vegetable protein, and vegetable fat was 0.70 (95% CI, 0.56 to 0.88; P for trend=0.002). A higher glycemic load was strongly associated with an increased risk of coronary heart disease (relative risk comparing highest and lowest deciles, 1.90; 95% CI, 1.15 to 3.15; P for trend=0.003). CONCLUSIONS: Our findings suggest that diets lower in carbohydrate and higher in protein and fat are not associated with increased risk of coronary heart disease in women. When vegetable sources of fat and protein are chosen, these diets may moderately reduce the risk of coronary heart disease.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Hu, Frank/C-1919-2013; Rexrode, Kathryn M/I-1177-2018; Liu, Simin/GSN-4159-2022; Liu, Simin/I-3689-2014	Liu, Simin/0000-0003-2098-3844; Albert, Christine/0000-0002-2081-1121; Rexrode, Kathryn/0000-0003-3387-8429	NCI NIH HHS [CA87969] Funding Source: Medline; NHLBI NIH HHS [HL34594, HL60712] Funding Source: Medline; NIDDK NIH HHS [DK58845, P30 DK040561-11, P30 DK040561] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712, R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, P30DK040561] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AHA, 2006, AHA REC; *AM HEART ASS, 2002, AM HEART ASS STAT HI; [Anonymous], 1997, J AM DIET ASSOC, V97, P71; Ascherio A, 1996, BMJ-BRIT MED J, V313, P84, DOI 10.1136/bmj.313.7049.84; ATKINS RC, 1998, ATKINS NEWDIET REVOL; Cox DR., 1984, ANAL SURVIVAL DATA; *DEP AGR, 1993, COMP FOODS RAW PROC; EADES MR, 1999, PROTEIN POWER; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; HELLER RF, 1993, CARBOHYDRATE ADDICTS; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, AM J CLIN NUTR, V70, P221; Jeor STS, 2001, CIRCULATION, V104, P1869, DOI 10.1161/hc4001.096152; Knight EL, 2003, ANN INTERN MED, V138, P460, DOI 10.7326/0003-4819-138-6-200303180-00009; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; KUSHI LH, 1985, NEW ENGL J MED, V312, P811, DOI 10.1056/NEJM198503283121302; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; MCGEE DL, 1984, AM J EPIDEMIOL, V119, P667, DOI 10.1093/oxfordjournals.aje.a113788; Nordmann, 2006, ARCH INTERN MED, V166, P932; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Oomen CM, 2001, LANCET, V357, P746, DOI 10.1016/S0140-6736(00)04166-0; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rose GA., 1982, WHO MONOGRAPH SERIES, V58; SEARS B, 1995, ZONE DIET ROAD MAP L; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stein K, 2000, J AM DIET ASSOC, V100, P760, DOI 10.1016/S0002-8223(00)00219-4; STEWARD HL, 1995, SUGAR BUSTERS; Thomas PR, 1995, WEIGHING OPTIONS CRI; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; 1998, OBES RES, V6, P464	37	329	336	3	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1991	2002		10.1056/NEJMoa055317	http://dx.doi.org/10.1056/NEJMoa055317			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102SG	17093250				2022-12-01	WOS:000241833000007
J	Prabhakar, S; Noonan, JP; Paabo, S; Rubin, EM				Prabhakar, Shyam; Noonan, James P.; Paeaebo, Svante; Rubin, Edward M.			Accelerated evolution of conserved noncoding sequences in humans	SCIENCE			English	Article									US DOE, Joint Genome Inst, Walnut Breek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	United States Department of Energy (DOE); Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Max Planck Society	Rubin, EM (corresponding author), US DOE, Joint Genome Inst, Walnut Breek, CA 94598 USA.	emrubin@lbl.gov	Noonan, James/ABF-1320-2021		NHLBI NIH HHS [HL066681] Funding Source: Medline; NIGMS NIH HHS [1-F32-GM074367] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074367] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488	2	285	293	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					786	786		10.1126/science.1130738	http://dx.doi.org/10.1126/science.1130738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082449				2022-12-01	WOS:000241729800036
J	Mahata, B; Mukherjee, S; Mishra, S; Bandyopadhyay, A; Adhya, S				Mahata, Bidesh; Mukherjee, Saikat; Mishra, Sumita; Bandyopadhyay, Arun; Adhya, Samit			Functional delivery of a cytosolic tRNA into mutant mitochondria of human cells	SCIENCE			English	Article							LEISHMANIA-MITOCHONDRIA; ALZHEIMER-DISEASE; MERRF-SYNDROME; DNA; MUTATION; IMPORT; ENDOCYTOSIS; TRNA(LYS); DELETIONS; MEMBRANE	Many maternally inherited and incurable neuromyopathies are caused by mutations in mitochondrial (mt) transfer RNA ( tRNA) genes. Kinetoplastid protozoa, including Leishmania, have evolved specialized systems for importing nucleus-encoded tRNAs into mitochondria. We found that the Leishmania RNA import complex (RIC) could enter human cells by a caveolin-1-dependent pathway, where it induced import of endogenous cytosolic tRNAs, including tRNALys, and restored mitochondrial function in a cybrid harboring a mutant mt tRNALys (MT-TK) gene. The use of protein complexes to modulate mitochondrial function may help in the management of such genetic disorders.	Indian Inst Chem Biol, Kolkata 700032, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adhya, S (corresponding author), Indian Inst Chem Biol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.	sadhya@iicb.res.in	MUKHERJEE, SAIKAT/ABF-1050-2021	Mahata, Bidesh/0000-0002-4506-0184; Mishra, Sumita/0000-0002-6455-4075				Bhattacharyya SN, 2003, MOL CELL BIOL, V23, P5217, DOI 10.1128/MCB.23.15.5217-5224.2003; Bhattacharyya Suvendra Nath, 2004, RNA Biol, V1, P84, DOI 10.4161/rna.1.2.1180; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4; Goswami S, 2003, NUCLEIC ACIDS RES, V31, P5552, DOI 10.1093/nar/gkg773; Goswami S, 2006, P NATL ACAD SCI USA, V103, P8354, DOI 10.1073/pnas.0510869103; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; GOTO Y, 1995, MUSCLE NERVE, pS107; HAUSER R, 1995, EMBO J, V14, P4212, DOI 10.1002/j.1460-2075.1995.tb00095.x; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Mahata B, 2005, J BIOL CHEM, V280, P5141, DOI 10.1074/jbc.C400572200; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794	23	77	80	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					471	474		10.1126/science.1129754	http://dx.doi.org/10.1126/science.1129754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053148				2022-12-01	WOS:000241382500044
J	Schaeffer, AJ				Schaeffer, Anthony J.			Chronic prostatitis and the chronic pelvic pain syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC BACTERIAL PROSTATITIS; PLACEBO-CONTROLLED MULTICENTER; CHRONIC ABACTERIAL PROSTATITIS; DOUBLE-BLIND TRIAL; QUALITY-OF-LIFE; NATIONAL-INSTITUTES; FOLLOW-UP; INTRAVENOUS UROGRAPHY; SYMPTOM INDEX; MEN		Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Schaeffer, AJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, 303 E Chicago Ave,Tarry 16-703, Chicago, IL 60611 USA.	ajschaeffer@northwestern.edu			NIDDK NIH HHS [U01 DK65277-04] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK065277] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander RB, 2004, ANN INTERN MED, V141, P581, DOI 10.7326/0003-4819-141-8-200410190-00005; Anderson RU, 2005, J UROLOGY, V174, P155, DOI 10.1097/01.ju.0000161609.31185.d5; Andrews SJ, 2002, BRIT MED J, V324, P454, DOI 10.1136/bmj.324.7335.454; Barbalias GA, 1998, J UROLOGY, V159, P883, DOI 10.1016/S0022-5347(01)63761-3; Bates S, 2000, SEX TRANSM INFECT, V76, P398, DOI 10.1136/sti.76.5.398; Bundrick W, 2003, UROLOGY, V62, P537, DOI 10.1016/S0090-4295(03)00565-X; Calhoun EA, 2004, ARCH INTERN MED, V164, P1231; Cheah PY, 2003, J UROLOGY, V169, P592, DOI 10.1016/S0022-5347(05)63960-2; Cheah PY, 2003, UROLOGY, V61, P60, DOI 10.1016/S0090-4295(02)02081-2; Chen R, 2003, UROLOGY, V61, P1156, DOI 10.1016/S0090-4295(03)00141-9; Collins MM, 2000, ANN INTERN MED, V133, P367, DOI 10.7326/0003-4819-133-5-200009050-00013; Collins MM, 2000, UROLOGY, V55, P403, DOI 10.1016/S0090-4295(99)00536-1; Collins MM, 2001, J UROLOGY, V166, P1800, DOI 10.1016/S0022-5347(05)65678-9; Collins MM, 2001, J GEN INTERN MED, V16, P656; Collins MM, 1998, J UROLOGY, V159, P1224, DOI 10.1016/S0022-5347(01)63564-X; De Rose AF, 2004, UROLOGY, V63, P13, DOI 10.1016/j.urology.2003.08.006; DELAROSETTE JJMCH, 1993, UROLOGY, V41, P301, DOI 10.1016/0090-4295(93)90584-W; DOBLE A, 1991, UROLOGY, V38, P247, DOI 10.1016/S0090-4295(91)80355-B; Engeler DS, 2003, EUR UROL, V44, P546, DOI 10.1016/S0302-2838(03)00370-1; Evliyaoglu Yalcin, 2002, International Urology and Nephrology, V34, P351, DOI 10.1023/A:1024487604631; FELICIANO AE, 1999, TXB PROSTATITIS, P311; GOLZ R, 1991, MYCOSES, V34, P381, DOI 10.1111/j.1439-0507.1991.tb00799.x; HANUS PM, 1984, CLIN PHARMACY, V3, P49; Hu WL, 2002, ASIAN J ANDROL, V4, P163; Kaplan SA, 1996, UROLOGY, V47, P836, DOI 10.1016/S0090-4295(96)00038-6; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 2002, J UROLOGY, V167, P2574, DOI 10.1016/S0022-5347(05)65041-0; Little MA, 2000, NEPHROL DIAL TRANSPL, V15, P200, DOI 10.1093/ndt/15.2.200; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; MEARES EM, 1968, INVEST UROL, V5, P492; Mehik A, 2003, UROLOGY, V62, P425, DOI 10.1016/S0090-4295(03)00466-7; Motrich RD, 2005, HUM REPROD, V20, P2567, DOI 10.1093/humrep/dei073; Naber KG, 2002, INT J ANTIMICROB AG, V20, P18, DOI 10.1016/S0924-8579(02)00067-5; Naber KG, 2000, INT J ANTIMICROB AG, V14, P143, DOI 10.1016/S0924-8579(99)00142-9; Nadler RB, 2006, UROLOGY, V67, P337, DOI 10.1016/j.urology.2005.08.031; Nadler RB, 2002, UROLOGY, V60, P42, DOI 10.1016/S0090-4295(02)02390-7; Nadler RB, 2001, J UROLOGY, V166, P2293, DOI 10.1016/S0022-5347(05)65554-1; Nickel J C, 1997, Tech Urol, V3, P38; Nickel JC, 2005, J UROLOGY, V173, P1252, DOI 10.1097/01.ju.0000159198.83103.01; Nickel JC, 2004, BJU INT, V93, P991, DOI 10.1111/j.1464-410X.2003.04766.x; Nickel JC, 2004, J UROLOGY, V171, P1594, DOI 10.1097/01.ju.0000117811.40279.19; Nickel JC, 2003, UROLOGY, V62, P614, DOI 10.1016/S0090-4295(03)00583-1; Nickel JC, 2003, J UROLOGY, V170, P818, DOI 10.1097/01.ju.0000082252.49374.e9; Pontari MA, 2003, DRUG AGING, V20, P1111, DOI 10.2165/00002512-200320150-00004; Propert KJ, 2006, J UROLOGY, V175, P619, DOI 10.1016/S0022-5347(05)00233-8; SCHAEFFER AJ, 1990, J UROLOGY, V144, P690, DOI 10.1016/S0022-5347(17)39556-3; Schneider H, 2004, UROLOGY, V63, P1027, DOI 10.1016/j.urology.2004.02.002; Shoskes DA, 2002, UROLOGY, V60, P35, DOI 10.1016/S0090-4295(02)02383-X; WEIDNER W, 1991, INFECTION, V19, pS119, DOI 10.1007/BF01643680; WEIDNER W, 1991, J UROLOGY, V146, P350, DOI 10.1016/S0022-5347(17)37791-1; WEIDNER W, 1994, PROSTATITIS ETIOPATH, P158	51	144	159	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1690	1698		10.1056/NEJMcp060423	http://dx.doi.org/10.1056/NEJMcp060423			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050893				2022-12-01	WOS:000241357300010
J	Baier, DB; Gatesy, SM; Jenkins, FA				Baier, David B.; Gatesy, Stephen M.; Jenkins, Farish A., Jr.			A critical ligamentous mechanism in the evolution of avian flight	NATURE			English	Article							PIGEONS COLUMBA-LIVIA; FLAPPING FLIGHT; SPEEDS; RANGE; CHINA; BIRD; KINEMATICS; SHOULDER; ANATOMY; HUMERUS	Despite recent advances in aerodynamic(1,2), neuromuscular(3-5) and kinematic(6,7) aspects of avian flight and dozens of relevant fossil discoveries(8), the origin of aerial locomotion and the transition from limbs to wings continue to be debated(9,10). Interpreting this transition depends on understanding the mechanical interplay of forces in living birds, particularly at the shoulder where most wing motion takes place. Shoulder function depends on a balance of forces from muscles, ligaments and articular cartilages, as well as inertial, gravitational and aerodynamic loads on the wing(11). Here we show that the force balance system of the shoulder evolved from a primarily muscular mechanism to one in which the acrocoracohumeral ligament has a critical role. Features of the shoulder of Mesozoic birds and closely related theropod dinosaurs indicate that the evolution of flight preceded the acquisition of the ligament-based force balance system and that some basal birds are intermediate in shoulder morphology.	Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Brown University; Harvard University; Harvard University	Baier, DB (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	David_Baier@brown.edu						Bannasch R., 1986, Gegenbaurs Morphologisches Jahrbuch, V132, P757; BIEWENER AA, 1995, J MORPHOL, V225, P61, DOI 10.1002/jmor.1052250106; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe LM., 2002, MESOZOIC BIRDS; de Beer G., 1954, CRAFTSMANS HDB; DIAL KP, 1993, J EXP BIOL, V176, P31; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Gatesy SM, 2005, PALEOBIOLOGY, V31, P382, DOI 10.1666/0094-8373(2005)031[0382:TOOTAF]2.0.CO;2; Gatesy S, 2004, J VERTEBR PALEONTOL, V24, p63A; Goslow GE, 2000, BRAIN BEHAV EVOLUT, V55, P85; Gray S.J., 1968, ANIMAL LOCOMOTION; Hedrick TL, 2004, J EXP BIOL, V207, P1689, DOI 10.1242/jeb.00933; JENKINS FA, 1988, SCIENCE, V241, P1495, DOI 10.1126/science.241.4872.1495; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; JENKINS FA, 1983, J MORPHOL, V175, P195, DOI 10.1002/jmor.1051750207; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; Paul G. S., 2002, DINOSAURS OF THE AIR; PENNYCUICK CJ, 1967, J EXP BIOL, V46, P219; Poore SO, 1997, J EXP BIOL, V200, P2987; Poore SO, 1997, NATURE, V387, P799, DOI 10.1038/42930; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Sy M., 1936, Journal fuer Ornithologie Berlin, V84, P199, DOI 10.1007/BF01906709; Tobalske BW, 1999, J EXP BIOL, V202, P1725; TOBALSKE BW, 1995, J EXP BIOL, V198, P1259; Usherwood JR, 2005, J EXP BIOL, V208, P355, DOI 10.1242/jeb.01359; Woolley JD, 2000, J EXP BIOL, V203, P1767; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930	30	52	54	4	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					307	310		10.1038/nature05435	http://dx.doi.org/10.1038/nature05435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17173029				2022-12-01	WOS:000243504700043
J	Shima, K; Isoda, M; Mushiake, H; Tanji, J				Shima, Keisetsu; Isoda, Masaki; Mushiake, Hajime; Tanji, Jun			Categorization of behavioural sequences in the prefrontal cortex	NATURE			English	Article							SUPPLEMENTARY MOTOR AREA; TEMPORAL ORGANIZATION; NEURONAL-ACTIVITY; MULTIPLE MOVEMENTS; MONKEY; REPRESENTATION; DAMAGE; CELLS	Although it has long been thought that the prefrontal cortex of primates is involved in the integrative regulation of behaviours(1-4), the neural architecture underlying specific aspects of cognitive behavioural planning has yet to be clarified(5-8). If subjects are required to remember a large number of complex motor sequences and plan to execute each of them individually, categorization of the sequences according to the specific temporal structure inherent in each subset of sequences serves to facilitate higher-order planning based on memory. Here we show, using these requirements, that cells in the lateral prefrontal cortex selectively exhibit activity for a specific category of behavioural sequences, and that categories of behaviours, embodied by different types of movement sequences, are represented in prefrontal cells during the process of planning. This cellular activity implies the generation of neural representations capable of storing structured event complexes at an abstract level, exemplifying the development of macro-structured action knowledge in the lateral prefrontal cortex(9).	Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan; Tamagawa Univ Res Inst, Brain Sci Res Ctr, Tokyo 1948610, Japan	Tohoku University	Tanji, J (corresponding author), Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan.	tanji@lab.tamagawa.ac.jp		Mushiake, Hajime/0000-0002-5130-4720				Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Averbeck BB, 2003, EXP BRAIN RES, V150, P127, DOI 10.1007/s00221-003-1416-6; BARONE P, 1989, EXP BRAIN RES, V78, P447; Dominey PF, 1998, J COGNITIVE NEUROSCI, V10, P734, DOI 10.1162/089892998563130; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Fuster J, 1989, PREFRONTAL CORTEX; Goldman-Rakic P. S., 1987, HDB PHYSL, V5, P373, DOI DOI 10.1002/CPHY.CP010509; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; GREEN DM, 1966, SIGNAL DETECTION THE; Isoda M, 2003, J NEUROPHYSIOL, V90, P3054, DOI 10.1152/jn.00367.2003; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; MUSHIAKE H, 1990, EXP BRAIN RES, V82, P208; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; PASSINGHAM PE, 1993, FRONTAL LOBES VOLUNT; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; Shallice T, 1996, PHILOS T R SOC B, V351, P1405, DOI 10.1098/rstb.1996.0124; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; SIRIGU A, 1995, CORTEX, V31, P301, DOI 10.1016/S0010-9452(13)80364-4; Sirigu A, 1995, ANN NY ACAD SCI, V769, P277, DOI 10.1111/j.1749-6632.1995.tb38145.x; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Zalla T, 2003, NEUROPSYCHOLOGIA, V41, P1619, DOI 10.1016/S0028-3932(03)00098-8	30	147	149	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2007	445	7125					315	318		10.1038/nature05470	http://dx.doi.org/10.1038/nature05470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17183266				2022-12-01	WOS:000243504700045
J	Palike, H; Norris, RD; Herrle, JO; Wilson, PA; Coxall, HK; Lear, CH; Shackleton, NJ; Tripati, AK; Wade, BS				Paelike, Heiko; Norris, Richard D.; Herrle, Jens O.; Wilson, Paul A.; Coxall, Helen K.; Lear, Caroline H.; Shackleton, Nicholas J.; Tripati, Aradhna K.; Wade, Bridget S.			The heartbeat of the oligocene climate system	SCIENCE			English	Article							SEDIMENTS ODP SITE-1218; INSOLATION QUANTITIES; ANTARCTIC GLACIATION; CALCITE COMPENSATION; MIOCENE BOUNDARY; ATMOSPHERIC CO2; CARBON-DIOXIDE; CALIBRATION; MYR; CONSTRAINTS	A 13-million-year continuous record of Oligocene climate from the equatorial Pacific reveals a pronounced "heartbeat" in the global carbon cycle and periodicity of glaciations. This heartbeat consists of 405,000-, 127,000-, and 96,000- year eccentricity cycles and 1.2-million-year obliquity cycles in periodically recurring glacial and carbon cycle events. That climate system response to intricate orbital variations suggests a fundamental interaction of the carbon cycle, solar forcing, and glacial events. Box modeling shows that the interaction of the carbon cycle and solar forcing modulates deep ocean acidity as well as the production and burial of global biomass. The pronounced 405,000- year eccentricity cycle is amplified by the long residence time of carbon in the oceans.	Southampton Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3AT, S Glam, Wales; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	NERC National Oceanography Centre; University of Southampton; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Alberta; Cardiff University; University of Cambridge; Rutgers State University New Brunswick	Palike, H (corresponding author), Southampton Sch Ocean & Earth Sci, Natl Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.	H.Palike@soton.ac.uk	Palike, Heiko/A-6560-2008; Wade, Bridget S/F-4987-2014; Lear, Caroline/D-2582-2009; Tripati, Aradhna/C-9419-2011; Herrle, Jens O/B-9088-2008	Palike, Heiko/0000-0003-3386-0923; Wade, Bridget S/0000-0002-7245-8614; Tripati, Aradhna/0000-0002-1695-1754; Wilson, Paul/0000-0001-6425-8906; Lear, Caroline/0000-0002-7533-4430; Coxall, Helen/0000-0002-2843-2898	NERC [NE/D000343/1] Funding Source: UKRI; Natural Environment Research Council [NE/D000343/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Billups K, 2004, EARTH PLANET SC LETT, V224, P33, DOI 10.1016/j.epsl.2004.05.004; Broecker W., 1982, TRACERS SEA; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; GHIL M, 2002, REV GEOPHYS, V40; Imbrie J., 1984, MILANKOVITCH CLIMA 1, P269; KENNETT JP, 1976, NATURE, V260, P513, DOI 10.1038/260513a0; Lanci L, 2005, EARTH PLANET SC LETT, V237, P617, DOI 10.1016/j.epsl.2005.07.004; Lanci L, 2004, EARTH PLANET SC LETT, V226, P207, DOI 10.1016/j.epsl.2004.07.025; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; Lear CH, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001039; Loutre MF, 2004, EARTH PLANET SC LETT, V221, P1, DOI 10.1016/S0012-821X(04)00108-6; LYLE M, 2002, INIT REP P OCEAN DRI, V199; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; OPDYKE BN, 1992, GEOLOGY, V20, P733, DOI 10.1130/0091-7613(1992)020<0733:ROTCRH>2.3.CO;2; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI DOI 10.1029/96E000259; Palike H, 2004, GEOLOGY, V32, P929, DOI 10.1130/G20750.1; Palike H, 2000, EARTH PLANET SC LETT, V182, P1, DOI 10.1016/S0012-821X(00)00229-6; PALIKE H, 2005, SCI RES P OCEAN DRIL, V199; PALIKE H, IN PRESS QUAT SCI RE; Paul HA, 2000, PALEOCEANOGRAPHY, V15, P471, DOI 10.1029/1999PA000443; Pekar SF, 2002, GEOLOGY, V30, P903, DOI 10.1130/0091-7613(2002)030<0903:CBEEFB>2.0.CO;2; Raffi I, 1999, PHILOS T R SOC A, V357, P1975, DOI 10.1098/rsta.1999.0410; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Shackleton NJ, 2000, GEOLOGY, V28, P447, DOI 10.1130/0091-7613(2000)028<0447:ACAFTO>2.3.CO;2; TRIPATI A, 2006, SCI RES P OCEAN DRIL, V199; Van Simaeys S, 2005, GEOLOGY, V33, P709, DOI 10.1130/G21634.1; VANANDEL TH, 1975, EARTH PLANET SC LETT, V26, P187, DOI 10.1016/0012-821X(75)90086-2; Wade BS, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001042; WALKER JCG, 1992, GLOBAL PLANET CHANGE, V97, P151, DOI 10.1016/0921-8181(92)90009-Y; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001; Zachos JC, 2001, SCIENCE, V292, P274, DOI 10.1126/science.1058288; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571	36	438	474	11	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1894	1898		10.1126/science.1133822	http://dx.doi.org/10.1126/science.1133822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185595	Green Accepted			2022-12-01	WOS:000242996800039
J	Munger, KL; Levin, LI; Hollis, BW; Howard, NS; Ascherio, A				Munger, Kassandra L.; Levin, Lynn I.; Hollis, Bruce W.; Howard, Noel S.; Ascherio, Alberto			Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VITAMIN-D DEFICIENCY; AUTOIMMUNE; EXPOSURE; ENCEPHALOMYELITIS; PREVALENCE; PREVENTION; MECHANISMS; SYMPTOMS; SUNLIGHT; DISEASE	Context Epidemiological and experimental evidence suggests that high levels of vitamin D, a potent immunomodulator, may decrease the risk of multiple sclerosis. There are no prospective studies addressing this hypothesis. Objective To examine whether levels of 25-hydroxyvitamin D are associated with risk of multiple sclerosis. Design, Setting, and Participants Prospective, nested case-control study among more than 7 million US military personnel who have serum samples stored in the Department of Defense Serum Repository. Multiple sclerosis cases were identified through Army and Navy physical disability databases for 1992 through 2004, and diagnoses were confirmed by medical record review. Each case (n= 257) was matched to 2 controls by age, sex, race/ethnicity, and dates of blood collection. Vitamin D status was estimated by averaging 25-hydroxyvitamin D levels of 2 or more serum samples collected before the date of initial multiple sclerosis symptoms. Main Outcome Measures Odds ratios of multiple sclerosis associated with continuous or categorical levels (quantiles or a priori - defined categories) of serum 25-hydroxyvitamin D within each racial/ethnic group. Results Among whites ( 148 cases, 296 controls), the risk of multiple sclerosis significantly decreased with increasing levels of 25-hydroxyvitamin D ( odds ratio [ OR] for a 50-nmol/L increase in 25-hydroxyvitamin D, 0.59; 95% confidence interval, 0.36-0.97). In categorical analyses using the lowest quintile ( < 63.3 nmol/L) as the reference, the ORs for each subsequent quintile were 0.57, 0.57, 0.74, and 0.38 (P=. 02 for trend across quintiles). Only the OR for the highest quintile, corresponding to 25-hydroxyvitamin D levels higher than 99.1 nmol/L, was significantly different from 1.00 ( OR, 0.38; 95% confidence interval, 0.19-0.75; P=. 006). The inverse relation with multiple sclerosis risk was particularly strong for 25-hydroxyvitamin D levels measured before age 20 years. Among blacks and Hispanics ( 109 cases, 218 controls), who had lower 25-hydroxyvitamin D levels than whites, no significant associations between vitamin D and multiple sclerosis risk were found. Conclusion The results of our study suggest that high circulating levels of vitamin D are associated with a lower risk of multiple sclerosis.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Walter Reed Army Inst Res, Div Prevent Med, Silver Spring, MD USA; Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Mol Biol, Charleston, SC 29425 USA; Dept Navy, Navy Council Review Boards, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Ascherio, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave,3rd Floor, Boston, MA 02115 USA.	aascheri@hsph.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042194, R01NS046635] Funding Source: NIH RePORTER; NINDS NIH HHS [NS46635, NS042194] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; ANDERSON DW, 1992, ANN NEUROL, V31, P333, DOI 10.1002/ana.410310317; Aubin F, 2003, EUR J DERMATOL, V13, P515; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; BLISS CI, 1958, CONN AGRIC EXPT ST B, P615; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Compston Alastair, 2002, Curr Neurol Neurosci Rep, V2, P259, DOI 10.1007/s11910-002-0085-3; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Freedman DM, 2000, OCCUP ENVIRON MED, V57, P418, DOI 10.1136/oem.57.6.418; Gale CR, 1995, PROG NEUROBIOL, V47, P425, DOI 10.1016/0301-0082(95)00033-X; Giulietti A, 2004, DIABETOLOGIA, V47, P451, DOI 10.1007/s00125-004-1329-3; GOLDBERG P, 1974, INT J ENVIRON STUD, V6, P19, DOI 10.1080/00207237408709630; HAUSER SL, 1984, J IMMUNOL, V132, P1276; Hayes CE, 2003, CELL MOL BIOL, V49, P277; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2004, AM J CLIN NUTR, V79, P362; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; LEIBOWITZ U, 1967, BRAIN, V90, P871, DOI 10.1093/brain/90.4.871; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Lucas RM, 2006, PROG BIOPHYS MOL BIO, V92, P140, DOI 10.1016/j.pbiomolbio.2006.02.019; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Nashold FE, 2001, J NEUROIMMUNOL, V119, P16, DOI 10.1016/S0165-5728(01)00360-5; *NAT WEATH SERV CL, 2006, UV IND ANN TIM SER; Ozgocmen S, 2005, J BONE MINER METAB, V23, P309, DOI 10.1007/s00774-005-0604-9; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSER CM, 1995, J NEUROL NEUROSUR PS, V58, P253, DOI 10.1136/jnnp.58.2.253-a; RAHMANIYAN M, 2005, VITAMIN D, V1, P769; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine, 1997, DIET REF INT CALC PH; SUTHERLAND JM, 1962, BRAIN, V85, P149, DOI 10.1093/brain/85.1.149; Van Den SK, 2004, NEUROEPIDEMIOLOGY PR, P188; van der Mei IAF, 2003, BRIT MED J, V327, P316, DOI 10.1136/bmj.327.7410.316; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Weiner HL, 2004, ARCH NEUROL-CHICAGO, V61, P1613, DOI 10.1001/archneur.61.10.1613; Zadshir A., 2005, ETHN DIS S5, V15, DOI DOI 10.1136/JMG.2004.024083	47	1264	1295	2	100	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2832	2838		10.1001/jama.296.23.2832	http://dx.doi.org/10.1001/jama.296.23.2832			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179460	Bronze			2022-12-01	WOS:000242826400025
J	Sibert, J; Hampton, J; Kleiber, P; Maunder, M				Sibert, John; Hampton, John; Kleiber, Pierre; Maunder, Mark			Biomass, size, and trophic status of top predators in the Pacific Ocean	SCIENCE			English	Article								Fisheries have removed at least 50 million tons of tuna and other top-level predators from the Pacific Ocean pelagic ecosystem since 1950, leading to concerns about a catastrophic reduction in population biomass and the collapse of oceanic food chains. We analyzed all available data from Pacific tuna fisheries for 1950-2004 to provide comprehensive estimates of fishery impacts on population biomass and size structure. Current biomass ranges among species from 36 to 91% of the biomass predicted in the absence of fishing, a level consistent with or higher than standard fisheries management targets. Fish larger than 175 centimeters fork length have decreased from 5% to approximately 1% of the total population. The trophic level of the catch has decreased slightly, but there is no detectable decrease in the trophic level of the population. These results indicate substantial, though not catastrophic, impacts of fisheries on these top-level predators and minor impacts on the ecosystem in the Pacific Ocean.	Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; Secretariat Pacific Community, Ocean Fisheries Programme, Noumea 98848, New Caledonia; NOAA, Pacific Isl Fisheries Sci Ctr, Natl Marine Fisheries Serv, Honolulu, HI 96822 USA; Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA	University of Hawaii System; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Sibert, J (corresponding author), Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	sibert@hawaii.edu						Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005	1	174	179	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1773	1776		10.1126/science.1135347	http://dx.doi.org/10.1126/science.1135347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170304				2022-12-01	WOS:000242833600058
J	Xu, YH; Xing, YN; Chen, Y; Chao, Y; Lin, Z; Fan, E; Yu, JW; Strack, S; Jeffrey, PD; Shi, YG				Xu, Yanhui; Xing, Yongna; Chen, Yu; Chao, Yang; Lin, Zheng; Fan, Eugene; Yu, Jong W.; Strack, Stefan; Jeffrey, Philip D.; Shi, Yigong			Structure of the protein phosphatase 2A holoenzyme	CELL			English	Article							B56-GAMMA REGULATORY SUBUNIT; PP2A CATALYTIC SUBUNIT; A-ALPHA SUBUNIT; MOLECULAR-CLONING; TRUNCATED ISOFORM; B-SUBUNITS; CARBOXYL METHYLATION; REDUCED EXPRESSION; TUMOR-ANTIGENS; BETA	Protein Phosphatase 2A (PP2A) plays an essential role in many aspects of cellular physiology. The PP2A holoenzyme consists of a heterodimeric core enzyme, which comprises a scaffolding subunit and a catalytic subunit, and a variable regulatory subunit. Here we report the crystal structure of the heterotrimeric PP2A holoenzyme involving the regulatory subunit B'/B56/PR61. Surprisingly, the B'/PR61 subunit has a HEAT-like (huntingtin-elongation-A subunit-TOR-like) repeat structure, similar to that of the scaffolding subunit. The regulatory B'/B56/ PR61 subunit simultaneously interacts with the catalytic subunit as well as the conserved ridge of the scaffolding subunit. The carboxyterminus of the catalytic subunit recognizes a surface groove at the interface between the B'/B56/ PR61 subunit and the scaffolding subunit. Compared to the scaffolding subunit in the PP2A core enzyme, formation of the holoenzyme forces the scaffolding subunit to undergo pronounced conformational rearrangements. This structure reveals significant ramifications for understanding the function and regulation of PP2A.	Princeton Univ, Lewis Thomas Lab, Dept Biol Mol, Princeton, NJ 08544 USA; Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	Princeton University; University of Iowa	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Biol Mol, Princeton, NJ 08544 USA.	ygshi@princeton.edu	Xu, Yanhui/D-5119-2019	Strack, Stefan/0000-0002-6175-7280; Jeffrey, Philip/0000-0002-4351-5341; Shi, Yigong/0000-0003-2030-168X				ARINO J, 1988, P NATL ACAD SCI USA, V85, P4252, DOI 10.1073/pnas.85.12.4252; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; CHO US, 2006, NATURE; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; GREEN DD, 1987, P NATL ACAD SCI USA, V84, P4880, DOI 10.1073/pnas.84.14.4880; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ito A, 2003, AM J PATHOL, V162, P81, DOI 10.1016/S0002-9440(10)63800-X; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2003, J BIOL CHEM, V278, P10697, DOI 10.1074/jbc.M211717200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMIBAYASHI C, 1994, J BIOL CHEM, V269, P20139; KAMIBAYASHI C, 1992, J BIOL CHEM, V267, P21864; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Koma YI, 2004, HISTOL HISTOPATHOL, V19, P391, DOI 10.14670/HH-19.391; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Li XH, 2002, EUR J BIOCHEM, V269, P546, DOI 10.1046/j.0014-2956.2001.02680.x; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Suzuki K, 2003, INT J ONCOL, V23, P1263; TAKATA K, 2000, BREED RES, V2, P11; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; WALTER G, 1989, P NATL ACAD SCI USA, V86, P8669, DOI 10.1073/pnas.86.22.8669; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185	50	329	352	1	59	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1239	1251		10.1016/j.cell.2006.11.033	http://dx.doi.org/10.1016/j.cell.2006.11.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174897	Bronze			2022-12-01	WOS:000242991000020
J	King, JC,; Stoddard, JJ; Gaglani, MJ; Moore, KA; Magder, L; McClure, E; Rubin, JD; Englund, JA; Neuzil, K				King, James C., Jr.; Stoddard, Jeffrey J.; Gaglani, Manjusha J.; Moore, Kristine A.; Magder, Laurence; McClure, Elizabeth; Rubin, Judith D.; Englund, Janet A.; Neuzil, Kathleen			Effectiveness of school-based influenza vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS INFECTIONS; CAIV-T; CHILDREN; SCHOOLCHILDREN; SURVEILLANCE; COMMUNITY; TRIVALENT; ILLNESS	BACKGROUND: Vaccination of children in school is one strategy to reduce the spread of influenza in households and communities. METHODS: We identified 11 demographically similar clusters of elementary schools in four states, consisting of one school we assigned to participate in a vaccination program (intervention school) and one or two schools that did not participate (control schools). During a predicted week of peak influenza activity in each state, all households with children in intervention and control schools were surveyed regarding demographic characteristics, influenza vaccination, and outcomes of influenza-like illness during the previous 7 days. RESULTS: In all, 47% of students in intervention schools received live attenuated influenza vaccine. As compared with control-school households, intervention-school households had significantly fewer influenza-like symptoms and outcomes during the recall week. Paradoxically, intervention-school households (both children and adults) had higher rates of hospitalization per 100 persons than did control-school households. However, there was no difference in the overall hospitalization rates for children or adults in households with vaccinated children, as compared with those with unvaccinated children, regardless of study-group assignment. Rates of school absenteeism for any cause (based on school records) were not significantly different between intervention and control schools. CONCLUSIONS: Most outcomes related to influenza-like illness were significantly lower in intervention-school households than in control-school households.	Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; Medimmune Inc, Gaithersburg, MD 20878 USA; Texas A&M Univ, Scott & White Clin, Temple, TX USA; Univ Minnesota, Minneapolis, MN USA; Univ Washington, Seattle, WA 98195 USA	University System of Maryland; University of Maryland Baltimore; AstraZeneca; Medimmune; Scott & White Medical Center; Texas A&M University System; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle	King, JC, (corresponding author), Univ Maryland, Sch Med, Dept Pediat, 737 W Lombard St, Baltimore, MD 21201 USA.	jking@peds.umaryland.edu	Gaglani, Manjusha/AFQ-6802-2022	Gaglani, Manjusha/0000-0002-3952-9230				CLOVER RD, 1986, AM J DIS CHILD, V140, P706, DOI 10.1001/archpedi.1986.02140210104036; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; FOY HM, 1988, J INFECT DIS, V157, P180, DOI 10.1093/infdis/157.1.180; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Halloran ME, 2003, AM J EPIDEMIOL, V158, P305, DOI 10.1093/aje/kwg163; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; King JC, 2005, PEDIATRICS, V116, pE868, DOI 10.1542/peds.2005-1301; Long CE, 1997, ARCH FAM MED, V6, P459, DOI 10.1001/archfami.6.5.459; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; *MEDIMMUNE VACC, 2004, FLUMIST INFL VIR VAC; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 2005, MMWR MORB MORTAL WKL, V54, P328	18	231	238	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2523	2532		10.1056/NEJMoa055414	http://dx.doi.org/10.1056/NEJMoa055414			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116BZ	17167135				2022-12-01	WOS:000242778800004
J	Bowles, S				Bowles, Samuel			Group competition, reproductive leveling, and the evolution of human altruism	SCIENCE			English	Article							GROUP SELECTION; CHIMPANZEES; BEHAVIORS; EVOLVE	Humans behave altruistically in natural settings and experiments. A possible explanation-that groups with more altruists survive when groups compete-has long been judged untenable on empirical grounds for most species. But there have been no empirical tests of this explanation for humans. My empirical estimates show that genetic differences between early human groups are likely to have been great enough so that lethal intergroup competition could account for the evolution of altruism. Crucial to this process were distinctive human practices such as sharing food beyond the immediate family, monogamy, and other forms of reproductive leveling. These culturally transmitted practices presuppose advanced cognitive and linguistic capacities, possibly accounting for the distinctive forms of altruism found in our species.	Santa Fe Inst, Santa Fe, NM 87501 USA; Univ Siena, I-53100 Siena, Italy	The Santa Fe Institute; University of Siena	Bowles, S (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.	bowles@santafe.edu						Alexander RD, 1987, BIOL MORAL SYSTEMS; AOKI K, 1983, EVOL INT J ORG EVOL, V36, P832; BOEHM C, 1982, J SOC BIOL STRUCT, V5, P413, DOI 10.1016/S0140-1750(82)92069-3; BOEHM C, 2000, HIERARCHY FOREST; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Bowles S, 2003, J THEOR BIOL, V223, P135, DOI 10.1016/S0022-5193(03)00060-2; BOYD R, 1990, J THEOR BIOL, V145, P331, DOI 10.1016/S0022-5193(05)80113-4; BOYD R, 2003, P NATL ACAD SCI USA, V20, P123; COHEN MN, 1980, BIOSOCIAL MECHANISMS, P275; Darwin Charles., 1998, DESCENT MAN; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; EIBLEIBESFELDT I, 1982, Z TIERPSYCHOL, V60, P177; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Giles BE, 1997, AM NAT, V149, P507, DOI 10.1086/286002; Goldberg TL, 1997, MOL BIOL EVOL, V14, P976, DOI 10.1093/oxfordjournals.molbev.a025841; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; Hassan Fekri A., 1980, BIOSOCIAL MECH POPUL; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Kaplan H., 2005, MORAL SENTIMENTS MAT; Kerr B, 2004, TRENDS ECOL EVOL, V19, P135, DOI 10.1016/j.tree.2003.10.004; MANSON JH, 1991, CURR ANTHROPOL, V32, P369, DOI 10.1086/203974; NOE R, 1995, INT J PRIMATOL, V16, P77, DOI 10.1007/BF02700154; Pandit SA, 2003, BEHAV ECOL SOCIOBIOL, V55, P161, DOI 10.1007/s00265-003-0692-2; PRICE GR, 1972, ANN HUM GENET, V35, P485, DOI 10.1111/j.1469-1809.1957.tb01874.x; RIDLEY M, 1981, ANIM BEHAV, V29, P954, DOI 10.1016/S0003-3472(81)80034-6; ROGERS AR, 1987, ANN HUM GENET, V51, P169, DOI 10.1111/j.1469-1809.1987.tb01059.x; SOLTIS J, 1995, CURR ANTHROPOL, V36, P473, DOI 10.1086/204381; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Watts DP, 2006, AM J PRIMATOL, V68, P161, DOI 10.1002/ajp.20214; Williams G. C., 1966, P307; Wilson DS, 1997, AM NAT, V149, P336, DOI 10.1086/285993; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; WILSON DS, 1997, AM NAT S, V150; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; WRIGHT S, 1950, J CELL COMPAR PHYSL, V35, P187, DOI 10.1002/jcp.1030350414; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	37	334	342	4	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1569	1572		10.1126/science.1134829	http://dx.doi.org/10.1126/science.1134829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158320				2022-12-01	WOS:000242624600033
J	Ottesen, EA; Hong, JW; Quake, SR; Leadbetter, JR				Ottesen, Elizabeth A.; Hong, Jong Wook; Quake, Stephen R.; Leadbetter, Jared R.			Microfluidic digital PCR enables multigene analysis of individual environmental bacteria	SCIENCE			English	Article							TERMITE RETICULITERMES-FLAVIPES; IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENES; H-2 PLUS CO2; PHYLOGENETIC DIVERSITY; MICROBIAL COMMUNITIES; ACETATE SYNTHESIS; METABOLISM; HINDGUT; METAGENOMICS	Gene inventory and metagenomic techniques have allowed rapid exploration of bacterial diversity and the potential physiologies present within microbial communities. However, it remains nontrivial to discover the identities of environmental bacteria carrying two or more genes of interest. We have used microfluidic digital polymerase chain reaction (PCR) to amplify and analyze multiple, different genes obtained from single bacterial cells harvested from nature. A gene encoding a key enzyme involved in the mutualistic symbiosis occurring between termites and their gut microbiota was used as an experimental hook to discover the previously unknown ribosomal RNA - based species identity of several symbionts. The ability to systematically identify bacteria carrying a particular gene and to link any two or more genes of interest to single species residing in complex ecosystems opens up new opportunities for research on the environment.	CALTECH, Environm Sci & Engn Program, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Auburn Univ, Samuel Ginn Coll Engn, Mat Res & Educ Ctr, Auburn, AL 36849 USA; Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	California Institute of Technology; California Institute of Technology; Auburn University System; Auburn University; Stanford University; Howard Hughes Medical Institute; Stanford University	Leadbetter, JR (corresponding author), CALTECH, Environm Sci & Engn Program, Pasadena, CA 91125 USA.	jleadbetter@caltech.edu	Baird, Cheryl L/F-6569-2011	Leadbetter, Jared/0000-0002-7033-0844	NHGRI NIH HHS [1R01 HG002644-01A1] Funding Source: Medline; NIGMS NIH HHS [5 T32 GM07616] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; BRAUMAN A, 1992, SCIENCE, V257, P1384, DOI 10.1126/science.257.5075.1384; BREZNAK JA, 1986, APPL ENVIRON MICROB, V52, P623, DOI 10.1128/AEM.52.4.623-630.1986; BREZNAK JA, 1977, APPL ENVIRON MICROB, V33, P406, DOI 10.1128/AEM.33.2.406-426.1977; Gray ND, 2001, ENVIRON MICROBIOL, V3, P481, DOI 10.1046/j.1462-2920.2001.00214.x; Hong JW, 2003, NAT BIOTECHNOL, V21, P1179, DOI 10.1038/nbt871; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Leadbetter JR, 1996, APPL ENVIRON MICROB, V62, P3620, DOI 10.1128/AEM.62.10.3620-3631.1996; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Lilburn TG, 1999, ENVIRON MICROBIOL, V1, P331; LJUNGDAHL LG, 1986, ANNU REV MICROBIOL, V40, P415, DOI 10.1146/annurev.mi.40.100186.002215; MANEFIELD M, 2002, APPL ENVIRON MICROB, V68, P2002; Nielsen JL, 2003, ENVIRON MICROBIOL, V5, P202, DOI 10.1046/j.1462-2920.2003.00402.x; ODELSON DA, 1983, APPL ENVIRON MICROB, V45, P1602, DOI 10.1128/AEM.45.5.1602-1613.1983; Ohkuma M, 1996, APPL ENVIRON MICROB, V62, P461, DOI 10.1128/AEM.62.2.461-468.1996; PANG HL, 1993, J BACTERIOL, V175, P3893, DOI 10.1128/JB.175.12.3893-3896.1993; Rainey FA, 1996, MICROBIOL-UK, V142, P2087, DOI 10.1099/13500872-142-8-2087; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Salmassi TM, 2003, MICROBIOL-SGM, V149, P2529, DOI 10.1099/mic.0.26351-0; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sogin S J, 1971, J Mol Evol, V1, P173; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tholen A, 2000, ENVIRON MICROBIOL, V2, P436, DOI 10.1046/j.1462-2920.2000.00127.x; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4; Zwirglmaier K, 2004, MOL MICROBIOL, V51, P89, DOI 10.1046/j.1365-2958.2003.03834.x	35	545	618	15	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1464	1467		10.1126/science.1131370	http://dx.doi.org/10.1126/science.1131370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138901	Green Submitted			2022-12-01	WOS:000242406100045
J	Zeeman, B				Zeeman, Beth			HIV-AIDS in Tanzania - Realities on the ground	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Med Ctr, Ctr Infect Dis, Boston, MA USA; Metrowest Med Ctr, Natick, MA USA; Metrowest Med Ctr, Framingham, MA USA	Boston Medical Center	Zeeman, B (corresponding author), Boston Med Ctr, Ctr Infect Dis, Boston, MA USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2276	2277		10.1056/NEJMp068243	http://dx.doi.org/10.1056/NEJMp068243			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	110CG	17135581				2022-12-01	WOS:000242355300002
J	Singh, S				Singh, Susheela			Hospital admissions resulting from unsafe abortion: estimates from 13 developing countries	LANCET			English	Article							SOUTH-AFRICA; EPIDEMIOLOGY; PHILIPPINES; PREGNANCY; HEALTH; LEVEL; AGE	Background Complications from unsafe abortion are believed to account for the largest proportion of hospital admissions for gynaecological services in developing countries. The WHO estimates that one in eight pregnancy-related deaths result from unsafe abortions. The social stigma and legal restrictions associated with abortion in many countries means that data on the magnitude of this problem are scarce; this article estimates the rate and numbers of hospital admissions resulting from unsafe abortions in developing countries to help quantify the problem. Methods National estimates of abortion-related hospital admissions in women aged 15-44 years were compiled for 13 developing countries: Africa (Egypt, Nigeria, and Uganda), Asia (Bangladesh, Pakistan, and the Philippines), and Latin America and the Caribbean (Brazil, Chile, Colombia, Dominican Republic, Guatemala, Mexico, and Peru). These data were combined with supplementary data from five countries in sub-Saharan Africa (Burkina Faso, Ghana, Kenya, Nigeria, and South Africa) to give estimates for the three world regions. Findings The annual hospitalisation rate varies from a low of about 3 per 1000 women in Bangladesh to a high of about 15 per 1000 in Egypt and Uganda. Nigeria, Pakistan, and the Philippines have rates of 4-7 per 1000, and two countries in Latin America with recent data have rates of almost 9 per 1000. In the developing world as a whole, an estimated five million women are admitted to hospital for treatment of complications from induced abortions each year. This equates to an average rate of 5.7 per 1000 women per year in all developing regions, excluding China. By comparison, in developed countries complications from abortion procedures or hospitalisation are rare. Interpretation These results help quantify the magnitude of the adverse health effects of unsafe abortion in developing countries and highlight the need for improved access to post-abortion care. The provision of abortion services is changing to include the drug misoprostol and this could reduce the severity of abortion complications and the number of women who are hospitalised. Researchers will need to monitor these changes to provide countries with up-to-date information on illness and death from unsafe abortion. Improved contraceptive services are necessary to prevent unintended pregnancy. However, increasing access to safe abortion services is the most effective way of preventing the burden of unsafe abortion, and remains a high priority for developing countries.	Alan Guttmacher Inst, New York, NY 10005 USA		Singh, S (corresponding author), Alan Guttmacher Inst, 120 Wall St, New York, NY 10005 USA.	ssingh@guttmacher.org						*A GUTTM I, 1999, SHAR RESP WOM SOC AB; AAHMAN E, 2004, UNSAFE ABORTION GLOB; AbouZahr C, 2000, B WORLD HEALTH ORGAN, V78, P655; Ahiadeke C, 2001, INT FAM PLAN PERSPEC, V27, P96, DOI 10.2307/2673822; [Anonymous], 2003, ADDING IT BENEFITS I; Blanchard K, 2000, J Am Med Womens Assoc (1972), V55, P189; BONGAARTS J, 1983, FERTILITY BIOL BEHAV, P39; *BRAZ MIN HLTH, SIST INF HOSP SUS SI; Carbonell J L, 1997, Eur J Contracept Reprod Health Care, V2, P181; Duggal R, 2002, ABORTION SERVICES IN; FERRANDO D, 2001, UNPUB PREVALENCIA AB; Gebreselassie H, 2005, BJOG-INT J OBSTET GY, V112, P1229, DOI 10.1111/j.1471-0528.2004.00503.x; Harlap S, 1980, HUMAN EMBRYONIC FETA, p[148, 157]; Henshaw SK, 1998, INT FAM PLAN PERSPEC, V24, P156, DOI 10.2307/2991973; HENSHAW SK, 2005, INT UN SCI STUD POP; Huntington D, 1998, INT FAM PLAN PERSPEC, V24, P25, DOI 10.2307/2991916; Jewkes R, 2005, BJOG-INT J OBSTET GY, V112, P355, DOI 10.1111/j.1471-0528.2004.00422.x; Juarez F, 2005, INT FAM PLAN PERSPEC, V31, P140, DOI 10.1363/3114005; Koopersmith TB, 1996, CONTRACEPTION, V53, P237, DOI 10.1016/0010-7824(96)00043-1; Rees H, 1997, S AFR MED J, V87, P432; Rossier C, 2006, SOC SCI MED, V62, P254, DOI 10.1016/j.socscimed.2005.05.024; Rossier C, 2003, STUD FAMILY PLANN, V34, P87, DOI 10.1111/j.1728-4465.2003.00087.x; SATHAR Z, POP ASS AM ANN M MAR; Shah L, 2004, REPROD HEALTH MATTER, V12, P9, DOI 10.1016/S0968-8080(04)24002-2; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P100, DOI 10.2307/2950765; Singh S, 1997, INT FAM PLAN PERSPEC, V23, P59, DOI 10.2307/2950825; Singh S, 1994, INT FAM PLAN PERSPEC, V20, P4, DOI [10.2307/2133331, DOI 10.2307/2133331]; Singh S, 2006, INT FAM PLAN PERSPEC, V32, P136, DOI 10.1363/3213606; *WHO, 2002, EST DALYS SEX CAUS W; *WHO, 1993, INT CLASS DIS REL HL, P131; World Health Organization, 1992, PREV MAN UNS AB REP	32	189	196	4	33	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1887	1892		10.1016/S0140-6736(06)69778-X	http://dx.doi.org/10.1016/S0140-6736(06)69778-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126721				2022-12-01	WOS:000242345900030
J	Brideau, NJ; Flores, HA; Wang, J; Maheshwari, S; Wang, X; Barbash, DA				Brideau, Nicholas J.; Flores, Heather A.; Wang, Jun; Maheshwari, Shamoni; Wang, Xu; Barbash, Daniel A.			Two Dobzhansky-Muller genes interact to cause hybrid lethality in Drosophila	SCIENCE			English	Article							MALE-STERILITY; RESCUE GENE; SIMULANS; MELANOGASTER; INVIABILITY; HP1; LOCALIZATION; CHROMOSOME; MAURITIANA; EVOLUTION	The Dobzhansky-Muller model proposes that hybrid incompatibilities are caused by the interaction between genes that have functionally diverged in the respective hybridizing species. Here, we show that Lethal hybrid rescue (Lhr) has functionally diverged in Drosophila simulans and interacts with Hybrid male rescue (Hmr), which has functionally diverged in D. melanogaster, to cause lethality in F1 hybrid males. LHR localizes to heterochromatic regions of the genome and has diverged extensively in sequence between these species in a manner consistent with positive selection. Rapidly evolving heterochromatic DNA sequences may be driving the evolution of this incompatibility gene.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Barbash, DA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	dab87@cornell.edu	Wang, Xu/B-4587-2008; TATSUTA, HARUKI/F-2997-2010; Flores, Heather/A-7403-2019	Wang, Xu/0000-0002-7594-5004; Flores, Heather/0000-0001-5003-7547	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074737] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074737-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbash DA, 2000, GENETICS, V154, P1747; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Barbash DA, 2004, PLOS BIOL, V2, P839, DOI 10.1371/journal.pbio.0020142; Bhaskar V, 2002, GENE, V299, P173, DOI 10.1016/S0378-1119(02)01058-2; CABOT EL, 1994, GENETICS, V137, P175; Carvajal AR, 1996, GENETICA, V98, P1, DOI 10.1007/BF00120214; CHRISTIE P, 1984, J HERED, V75, P510, DOI 10.1093/oxfordjournals.jhered.a110004; Coyne J.A., 2004, SPECIATION; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Fanti L, 2003, GENETICA, V117, P135, DOI 10.1023/A:1022971407290; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hutchinson JB, 1932, J GENET, V25, P281, DOI 10.1007/BF02984592; Kazianis S, 1998, GENE CHROMOSOME CANC, V22, P210, DOI 10.1002/(SICI)1098-2264(199807)22:3<210::AID-GCC6>3.3.CO;2-E; Mallet J, 2006, TRENDS ECOL EVOL, V21, P386, DOI 10.1016/j.tree.2006.05.004; Maside XR, 1998, GENETICS, V150, P745; Orr HA, 2000, GENETICS, V155, P225; ORR HA, COMMUNICATION; Pontecorvo G, 1943, J GENET, V45, P51, DOI 10.1007/BF02982774; POWERS JA, 1993, J CELL BIOL, V120, P291, DOI 10.1083/jcb.120.2.291; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Sweigart AL, 2006, GENETICS, V172, P2465, DOI 10.1534/genetics.105.053686; Tao Y, 2003, GENETICS, V164, P1399; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; WATANABE TK, 1979, JPN J GENET, V54, P325, DOI 10.1266/jjg.54.325; Yamamoto MT, 1997, GENES GENET SYST, V72, P297, DOI 10.1266/ggs.72.297	27	294	298	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1292	1295		10.1126/science.1133953	http://dx.doi.org/10.1126/science.1133953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124320				2022-12-01	WOS:000242215800041
J	Oner, AF; Bay, A; Arslan, S; Akdeniz, H; Sahin, HA; Cesur, Y; Epcacan, S; Yilmaz, N; Deger, I; Kizilyildiz, B; Karsen, H; Ceyhan, M				Oner, Ahmet Faik; Bay, Ali; Arslan, Sukru; Akdeniz, Hayrettin; Sahin, Huseyin Avni; Cesur, Yasar; Epcacan, Serdar; Yilmaz, Neziha; Deger, Ibrahim; Kizilyildiz, Baran; Karsen, Hasan; Ceyhan, Mehmet			Avian influenza A (H5N1) infection in eastern Turkey in 2006	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS-INFECTION; HUMAN-DISEASE; DIAGNOSIS	Background: An outbreak of highly pathogenic avian influenza A (H5N1) that had previously been detected throughout Asia, with major economic and health repercussions, extended to eastern Turkey in late December 2005 and early January 2006. Methods: We documented the epidemiologic, clinical, and radiologic features of all cases of confirmed H5N1 virus infection in patients who were admitted to Yuzuncu Yil University Hospital in Van, Turkey, between December 31, 2005, and January 10, 2006. Results: H5N1 virus infection was diagnosed in eight patients. The patients were 5 to 15 years of age, and all eight had a history of close contact with diseased or dead chickens. The mean (+/- SD) time between exposure and the onset of illness was 5.0 +/- 1.3 days. All the patients had fever, and seven had clinical and radiologic evidence of pneumonia at presentation; four patients died. Results of enzyme-linked immunosorbent assay and rapid influenza tests were negative in all patients, and the diagnosis was made by means of a polymerase-chain-reaction assay. Conclusions: H5N1, which causes a spectrum of illnesses in humans, including severe and fatal respiratory disease, can be difficult to diagnose.	Saydam Hyg Inst, Ankara, Turkey; Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey; Yuzuncu Yil Univ, Fac Med, Van, Turkey	Refik Saydam Hifzissihha Merkezi Baskanligi; Hacettepe University; Yuzuncu Yil University	Oner, AF (corresponding author), Arastirma Hst Cocuk Hst Srv, Van, Turkey.	afo59@yahoo.com	yılmaz, neziha/AAH-3524-2020; Arslan, Şükrü/ABC-4250-2021	Arslan, Şükrü/0000-0001-5632-8273				Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Hien TT, 2004, NEW ENGL J MED, V351, P2363, DOI 10.1056/NEJMp048267; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Schultsz C, 2005, EMERG INFECT DIS, V11, P1158; Spackman E, 2005, J VET DIAGN INVEST, V17, P76, DOI 10.1177/104063870501700117; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; WHO, 2005, REC LAB TESTS ID AV; *WHO, 2005, WHO INT COUNS INFL A; *WHO, 2006, CUM NUMB CONF HUM CA; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	14	146	162	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2179	2185		10.1056/NEJMoa060601	http://dx.doi.org/10.1056/NEJMoa060601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124015				2022-12-01	WOS:000242170900004
J	Qin, Y; Polacek, N; Vesper, O; Staub, E; Einfeldt, E; Wilson, DN; Nierhaus, KH				Qin, Yan; Polacek, Norbert; Vesper, Oliver; Staub, Eike; Einfeldt, Edda; Wilson, Daniel N.; Nierhaus, Knud H.			The highly conserved LepA is a ribosomal elongation factor that back-translocates the ribosorne	CELL			English	Article							TRANSFER-RNA; ESCHERICHIA-COLI; SIGNAL PEPTIDASE; FACTOR-TU; P-SITES; A-SITES; BINDING; PROTEIN; GENE; SUBUNIT	The ribosomal elongation cycle describes a series of reactions prolonging the nascent poly-pepticle chain by one amino acid and driven by two universal elongation factors termed EF-Tu and EF-G in bacteria. Here we demonstrate that the extremely conserved LepA protein, present in all bacteria and mitochondria, is a third elongation factor required for accurate and efficient protein synthesis. LepA has the unique function of back-translocating post-translocational ribosomes, and the results suggest that it recognizes ribosomes after a defective translocation reaction and induces a back-translocation, thus giving EF-G a second chance to translocate the tRNAs correctly. We suggest renaming LepA as elongation factor 4 (EF4).	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Innsbruck Med Univ, Div Genom & RNomics, Bioctr, A-6020 Innsbruck, Austria	Max Planck Society; Medical University of Innsbruck	Nierhaus, KH (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	nierhaus@molgen.mpg.de	Polacek, Norbert/AAV-7346-2020; Staub, Eike/B-9801-2009; Wilson, Daniel/AAE-8504-2019	Wilson, Daniel/0000-0003-3816-3828; Polacek, Norbert/0000-0001-5317-3990; Staub, Eike/0000-0002-5039-3098				Bayfield MA, 2001, P NATL ACAD SCI USA, V98, P10096, DOI 10.1073/pnas.171319598; Blaha G, 2000, METHOD ENZYMOL, V317, P292; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Colca JR, 2003, J BIOL CHEM, V278, P21972, DOI 10.1074/jbc.M302109200; Connell SR, 2003, EMBO J, V22, P945, DOI 10.1093/emboj/cdg093; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; DIBB NJ, 1986, J BACTERIOL, V166, P83, DOI 10.1128/jb.166.1.83-87.1986; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; Frank J, 2001, COLD SPRING HARB SYM, V66, P67, DOI 10.1101/sqb.2001.66.67; HAPKE B, 1976, J MOL BIOL, V105, P97, DOI 10.1016/0022-2836(76)90196-0; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; HARTZ D, 1991, J MOL BIOL, V218, P99, DOI 10.1016/0022-2836(91)90876-8; HARTZ D, 1990, RIBOSOME, P275; ISKAKOVA MB, 2006, IN PRESS NUCL ACIDS; KISER GL, 1995, YEAST, V11, P1311, DOI 10.1002/yea.320111312; Knight J, 2004, NATURE, V429, P236, DOI 10.1038/429236a; MARCH PE, 1985, J BIOL CHEM, V260, P7206; MARCH PE, 1985, P NATL ACAD SCI USA, V82, P7500, DOI 10.1073/pnas.82.22.7500; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Martemyanov KA, 1999, FEBS LETT, V452, P155, DOI 10.1016/S0014-5793(99)00635-3; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; Nierhaus K. H., 2004, PROTEIN SYNTHESIS RI; Nierhaus KH, 1996, NATURE, V379, P491, DOI 10.1038/379491a0; Nierhaus KH, 1996, ANGEW CHEM INT EDIT, V35, P2198, DOI 10.1002/anie.199621981; Nissen P, 2000, EMBO J, V19, P489, DOI 10.1093/emboj/19.4.489; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; PETIT PX, 1990, EUR J BIOCHEM, V194, P389, DOI 10.1111/j.1432-1033.1990.tb15632.x; Polacek N, 1998, RNA, V4, P1282, DOI 10.1017/S1355838298980347; Polacek N, 2000, MOL CELL, V6, P159, DOI 10.1016/S1097-2765(00)00017-4; RHEINBERGER HJ, 1981, P NATL ACAD SCI-BIOL, V78, P5310, DOI 10.1073/pnas.78.9.5310; Schafer MA, 2002, J BIOL CHEM, V277, P19095, DOI 10.1074/jbc.M108902200; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P20473, DOI 10.1074/jbc.270.35.20473; Wolf YI, 1999, GENOME RES, V9, P689; ZIMMERMANN RA, 1971, P NATL ACAD SCI USA, V68, P2263, DOI 10.1073/pnas.68.9.2263; ZWIZINSKI C, 1980, J BIOL CHEM, V255, P7973	38	160	171	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					721	733		10.1016/j.cell.2006.09.037	http://dx.doi.org/10.1016/j.cell.2006.09.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110332	Bronze			2022-12-01	WOS:000242330600019
J	Shirane, M; Nakayama, KI				Shirane, Michiko; Nakayama, Keiichi I.			Protrudin induces neurite formation by directional membrane trafficking	SCIENCE			English	Article							GDP-DISSOCIATION INHIBITOR; RECYCLING ENDOSOMES; SECRETORY PATHWAYS; RAB11; PROTEINS; MECHANISMS; TRANSPORT; OUTGROWTH; NEURONS; FUSION	Guanosine triphosphatases of the Rab family are key regulators of membrane trafficking, with Rab11 playing a specific role in membrane recycling. We identified a mammalian protein, protrudin, that promoted neurite formation through interaction with the guanosine diphosphate (GDP) - bound form of Rab11. Phosphorylation of protrudin by extracellular signal - regulated kinase (ERK) in response to nerve growth factor promoted protrudin association with Rab11-GDP. Down-regulation of protrudin by RNA interference induced membrane extension in all directions and inhibited neurite formation. Thus, protrudin regulates Rab11-dependent membrane recycling to promote the directional membrane trafficking required for neurite formation.	Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp		Shirane, Michiko/0000-0002-8297-9245				An Y, 2003, STRUCTURE, V11, P347, DOI 10.1016/S0969-2126(03)00034-0; Anderson E, 2005, J CELL BIOL, V170, P595, DOI 10.1083/jcb.200506051; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Junutula JR, 2004, J BIOL CHEM, V279, P33430, DOI 10.1074/jbc.M404633200; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	27	154	162	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					818	821		10.1126/science.1134027	http://dx.doi.org/10.1126/science.1134027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082457				2022-12-01	WOS:000241729800047
J	Rigaud, S; Fondaneche, MC; Lambert, N; Pasquier, B; Mateo, V; Soulas, P; Galicier, L; Le Deist, F; Rieux-Laucat, F; Revy, P; Fischer, A; Basile, GD; Latour, S				Rigaud, Stephaine; Fondaneche, Marie-Claude; Lambert, Nathalie; Pasquier, Benoit; Mateo, Veronique; Soulas, Pauline; Galicier, Lionel; Le Deist, Francoise; Rieux-Laucat, Frederic; Revy, Patrick; Fischer, Alain; de Saint Basile, Genevieve; Latour, Sylvain			XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome	NATURE			English	Article							NKT CELL-DEVELOPMENT; ENCODING GENE; T-CELLS; DISEASE; SAP; MUTATIONS; PRODUCT; MICE	The homeostasis of the immune response requires tight regulation of the proliferation and apoptosis of activated lymphocytes(1,2). In humans, defects in immune homeostasis result in lymphoproliferation disorders including autoimmunity, haemophagocytic lymphohystiocytosis and lymphomas. The X-linked lymphoproliferative syndrome (XLP) is a rare, inherited immunodeficiency that is characterized by lymphohystiocytosis, hypogammaglobulinaemia and lymphomas, and that usually develops in response to infection with Epstein - Barr virus (EBV)(3-5). Mutations in the signalling lymphocyte activation molecule ( SLAM)- associated protein SAP, a signalling adaptor molecule, underlie 60% of cases of familial XLP6-8. Here, we identify mutations in the gene that encodes the X-linked inhibitor-of-apoptosis XIAP ( also termed BIRC4) in patients with XLP from three families without mutations in SAP. These mutations lead to defective expression of XIAP. We show that apoptosis of lymphocytes from XIAP-deficient patients is enhanced in response to various stimuli including the T-cell antigen receptor (TCR) - CD3 complex, the death receptor CD95 ( also termed Fas or Apo-1) and the TNF-associated apoptosis-inducing ligand receptor (TRAIL-R). We also found that XIAP-deficient patients, like SAP-deficient patients, have low numbers of natural killer T-lymphocytes (NKT cells)(9,10), indicating that XIAP is required for the survival and/or differentiation of NKT cells. The observation that XIAP-deficiency and SAP-deficiency are both associated with a defect in NKT cells strengthens the hypothesis that NKT cells have a key role in the immune response to EBV. Furthermore, by identifying an XLP immunodeficiency that is caused by mutations in XIAP, we show that XIAP is a potent regulator of lymphocyte homeostasis in vivo.	Univ Paris 05, INSERM, U768, Lab Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France; Hop Necker Enfants Malad, APHP, Ctr Etud Deficits Immunitaires, F-75015 Paris, France; Hop St Louis, APHP, Serv Immunohematol, F-75010 Paris, France; Hop Necker Enfants Malad, APHP, Unite Immunol Hematol Pediat, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Latour, S (corresponding author), Univ Paris 05, INSERM, U768, Lab Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France.	latour@necker.fr	Rieux-Laucat, Frédéric/A-7916-2017; Mateo, Véronique/AAD-1379-2019; Mateo, Véronique/O-9738-2017; Revy, Patrick/H-8137-2017; de Saint Basile, Genevieve/G-9731-2017; Latour, Sylvain/H-3652-2017	Rieux-Laucat, Frédéric/0000-0001-7858-7866; Mateo, Véronique/0000-0002-9327-1277; Mateo, Véronique/0000-0002-9327-1277; de Saint Basile, Genevieve/0000-0002-1913-5269; Latour, Sylvain/0000-0001-8238-4391; Soulas-Sprauel, Pauline/0000-0002-2058-4811; Revy, Patrick/0000-0003-0758-8022				BASILE GD, 2003, CURR OPIN RHEUMATOL, V15, P436; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Gaspar HB, 2002, BRIT J HAEMATOL, V119, P585, DOI 10.1046/j.1365-2141.2002.03851.x; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; PURTILO D T, 1975, Lancet, V1, P935; RATHMELL JC, 2002, CELL S, V109, P97; Rieux-Laucat F, 2003, CURR OPIN IMMUNOL, V15, P325, DOI 10.1016/S0952-7915(03)00042-6; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Strauss G, 2003, J IMMUNOL, V171, P1172, DOI 10.4049/jimmunol.171.3.1172; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wasem C, 2003, J CLIN INVEST, V111, P1191, DOI 10.1172/JCI200316344; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4	21	511	534	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					110	114		10.1038/nature05257	http://dx.doi.org/10.1038/nature05257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080092				2022-12-01	WOS:000241701500056
J	Cooper, TA				Cooper, Thomas A.			A reversal of misfortune for myotonic dystrophy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Cooper, TA (corresponding author), Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.							Harper PS, 2001, MYOTONIC DYSTROPHY; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014	4	16	18	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1825	1827		10.1056/NEJMcibr064708	http://dx.doi.org/10.1056/NEJMcibr064708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065646				2022-12-01	WOS:000241512500016
J	Tomita, K; Ishitani, R; Fukai, S; Nureki, O				Tomita, Kozo; Ishitani, Ryuichiro; Fukai, Shuya; Nureki, Osamu			Complete crystallographic analysis of the dynamics of CCA sequence addition	NATURE			English	Article							ADDING ENZYME; TRANSFER-RNA; STRUCTURAL BASIS; MECHANISM; NUCLEOTIDYLTRANSFERASE; POLYMERIZATION	CCA-adding polymerase matures the essential 39-CCA terminus of transfer RNA without any nucleic-acid template. However, it remains unclear how the correct nucleotide triphosphate is selected in each reaction step and how the polymerization is driven by the protein and RNA dynamics. Here we present complete sequential snapshots of six complex structures of CCA-adding enzyme and four distinct RNA substrates with and without CTP ( cytosine triphosphate) or ATP ( adenosine triphosphate). The CCA-lacking RNA stem extends by one base pair to force the discriminator nucleoside into the active-site pocket, and then tracks back after incorporation of the first cytosine monophosphate (CMP). Accommodation of the second CTP clamps the catalytic cleft, inducing a reorientation of the beta-turn, which flips C74 to allow CMP to be accepted. In contrast, after the second CMP is added, the polymerase and RNA primer are locked in the closed state, which directs the subsequent A addition. Between the CTP- and ATP-binding stages, the side-chain conformation of Arg 224 changes markedly; this is controlled by the global motion of the enzyme and position of the primer terminus, and is likely to achieve the CTP/ATP discrimination, depending on the polymerization stage. Throughout the CCA-adding reaction, the enzyme tail domain firmly anchors the TYC-loop of the tRNA, which ensures accurate polymerization and termination.	Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058565, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Kanagawa 2258501, Japan; JST, SORST, Kawaguchi, Saitama 3320012, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Tomita, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, 1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	kozo-tomita@aist.go.jp; nureki@bio.titech.ac.jp	Tomita, Kozo/J-5746-2013; Tomita, Kozo/E-9390-2017; Fukai, Shuya/X-4838-2018; NUREKI, OSAMU/G-4960-2014	Tomita, Kozo/0000-0002-7374-3898; Fukai, Shuya/0000-0002-1241-1443; 				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deutscher M. P., 1983, ENZYMES NUCLEIC ACID, V2, P159; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Matsumoto A, 1999, EUR BIOPHYS J BIOPHY, V28, P369, DOI 10.1007/s002490050221; NAKAMURA S, 1994, NUCLEIC ACIDS RES, V22, P514, DOI 10.1093/nar/22.3.514; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712; Weiner AM, 2004, CURR BIOL, V14, pR883, DOI 10.1016/j.cub.2004.09.069; Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yue DX, 1996, RNA, V2, P895	23	60	61	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					956	960		10.1038/nature05204	http://dx.doi.org/10.1038/nature05204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17051158				2022-12-01	WOS:000241523400046
J	Kundig, P				Kuendig, Peter			Chemistry: The future of organic synthesis	SCIENCE			English	Editorial Material							CATALYSIS		Univ Geneva, Dept Organ Chem, CH-1211 Geneva, Switzerland	University of Geneva	Kundig, P (corresponding author), Univ Geneva, Dept Organ Chem, CH-1211 Geneva, Switzerland.	peter.kundig@chiorg.unige.ch						Anastas PT, 2002, ACCOUNTS CHEM RES, V35, P686, DOI 10.1021/ar010065m; Arp FO, 2005, J AM CHEM SOC, V127, P10482, DOI 10.1021/ja053751f; Baxendale IR, 2006, CHEM COMMUN, P2566, DOI 10.1039/b600382f; Baxendale IR, 2006, SYNLETT, P427, DOI 10.1055/S-2006-926244; Belder D, 2006, ANGEW CHEM INT EDIT, V45, P2463, DOI 10.1002/anie.200504205; de Bruin B, 2006, ANGEW CHEM INT EDIT, V45, P2660, DOI 10.1002/anie.200504480; Dijk EW, 2004, TETRAHEDRON, V60, P9687, DOI 10.1016/j.tet.2004.06.148; Doi T, 2006, CHEM-ASIAN J, V1, P370, DOI 10.1002/asia.200600156; GUENARD D, 1993, ACCOUNTS CHEM RES, V26, P160, DOI 10.1021/ar00028a005; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; Marko IE, 2001, SCIENCE, V294, P1842, DOI 10.1126/science.1067545; Martin-Matute B, 2006, CHEM-EUR J, V12, P6053, DOI 10.1002/chem.200600257; Noyori R, 2005, PHILOS T ROY SOC A, V363, P901, DOI 10.1098/rsta.2004.1536; Shibasaki M, 2006, CHEM SOC REV, V35, P269, DOI 10.1039/b506346a; Solinas M, 2005, ANGEW CHEM INT EDIT, V44, P2291, DOI 10.1002/anie.200461768; Webb PB, 2004, CHEM COMMUN, P612, DOI 10.1039/b316311c; Zard SZ, 2006, ANGEW CHEM INT EDIT, V45, P2496, DOI 10.1002/anie.200600811; 2006, 1 EUR CHEM C 27 31 A	18	22	22	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					430	431		10.1126/science.1134084	http://dx.doi.org/10.1126/science.1134084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053137				2022-12-01	WOS:000241382500029
J	Lin, LH; Wang, PL; Rumble, D; Lippmann-Pipke, J; Boice, E; Pratt, LM; Lollar, BS; Brodie, EL; Hazen, TC; Andersen, GL; DeSantis, TZ; Moser, DP; Kershaw, D; Onstott, TC				Lin, Li-Hung; Wang, Pei-Ling; Rumble, Douglas; Lippmann-Pipke, Johanna; Boice, Erik; Pratt, Lisa M.; Sherwood Lollar, Barbara; Brodie, Eoin L.; Hazen, Terry C.; Andersen, Gary L.; DeSantis, Todd Z.; Moser, Duane P.; Kershaw, Dave; Onstott, T. C.			Long-term sustainability of a high-energy, low-diversity crustal biome	SCIENCE			English	Article							WITWATERSRAND BASIN; DEEP; SULFATE; SUBSURFACE; FLUIDS; GEOCHEMISTRY; WATERS; SEA	Geochemical, microbiological, and molecular analyses of alkaline saline groundwater at 2.8 kilometers depth in Archaean metabasalt revealed a microbial biome dominated by a single phylotype affiliated with thermophilic sulfate reducers belonging to Firmicutes. These sulfate reducers were sustained by geologically produced sulfate and hydrogen at concentrations sufficient to maintain activities for millions of years with no apparent reliance on photosynthetically derived substrates.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Natl Taiwan Univ, Dept Geosci, Taipei 10764, Taiwan; Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; Univ Toronto, Dept Geol, Toronto, ON, Canada; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Ecol, Berkeley, CA 94720 USA; Desert Res Inst, Div Earth & Ecosyst Sci, Las Vegas, NV USA; Anglo Gold, Mponeng Mine, Johannesburg, South Africa	Princeton University; National Taiwan University; National Taiwan University; Carnegie Institution for Science; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Indiana University System; Indiana University Bloomington; University of Toronto; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Lin, LH (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	lhlin@ntu.edu.tw	Rumble, Douglas/AAU-3930-2020; Hazen, Terry C/C-1076-2012; Andersen, Gary/G-2792-2015; Lippmann-Pipke, Johanna/D-7987-2011; Brodie, Eoin L/A-7853-2008; Lin, Li-Hung/K-8091-2012	Rumble, Douglas/0000-0002-7440-9189; Hazen, Terry C/0000-0002-2536-9993; Andersen, Gary/0000-0002-1618-9827; Lippmann-Pipke, Johanna/0000-0002-9765-3803; Brodie, Eoin L/0000-0002-8453-8435; Lin, Li-Hung/0000-0002-0985-1464; WANG, PEI-LING/0000-0002-4392-3935; Onstott, Tullis/0000-0002-2898-3374				BADZIONG W, 1978, ARCH MICROBIOL, V117, P209, DOI 10.1007/BF00402310; Campbell L. L., 1986, BERGEYS MANUAL SYSTE, V2, P1200; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Cowen JP, 2003, SCIENCE, V299, P120, DOI 10.1126/science.1075653; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; Drennan GR, 1999, MINER PETROL, V66, P83, DOI 10.1007/BF01161723; Frimmel HE, 1999, MINER PETROL, V66, P55, DOI 10.1007/BF01161722; JONES MQW, 1988, J GEOPHYS RES-SOLID, V93, P3243, DOI 10.1029/JB093iB04p03243; Karl DM, 1995, MICR EXTREM UNUSUAL, P35; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; Lin LH, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000907; Lippmann J, 2003, GEOCHIM COSMOCHIM AC, V67, P4597, DOI 10.1016/S0016-7037(03)00414-9; Liu YT, 1997, INT J SYST BACTERIOL, V47, P615, DOI 10.1099/00207713-47-3-615; Lollar BS, 2006, CHEM GEOL, V226, P328, DOI 10.1016/j.chemgeo.2005.09.027; Moser DP, 2003, GEOMICROBIOL J, V20, P517, DOI 10.1080/713851170; MURPHY EM, 1992, WATER RESOUR RES, V28, P723, DOI 10.1029/91WR02678; Nakagawa T, 2002, FEMS MICROBIOL ECOL, V41, P199, DOI 10.1111/j.1574-6941.2002.tb00981.x; NAZINA T N, 1988, Mikrobiologiya, V57, P823; Omar GI, 2003, GEOFLUIDS, V3, P69, DOI 10.1046/j.1468-8123.2003.00050.x; Onstott TC, 1999, ENIGMATIC MICROORGAN, P489; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Sass H, 2004, SYST APPL MICROBIOL, V27, P541, DOI 10.1078/0723202041748181; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Tardy-Jacquenod C, 1998, INT J SYST BACTERIOL, V48, P333, DOI 10.1099/00207713-48-2-333; ZHAO B, 2004, GEOSCIENCE AFRICA, V2, P732	29	252	273	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					479	482		10.1126/science.1127376	http://dx.doi.org/10.1126/science.1127376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053150	Green Published, Green Submitted			2022-12-01	WOS:000241382500046
J	Tfelt-Hansen, P; Olesen, J				Tfelt-Hansen, Peer; Olesen, Jes			Increasing the effect of triptans in migraine	LANCET			English	Editorial Material							EFFERVESCENT ASPIRIN; DOUBLE-BLIND; TRIMEBUTINE; METOCLOPRAMIDE; ABSORPTION; PLACEBO; ATTACKS		Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, DK-2600 Glostrup, Denmark	University of Copenhagen	Tfelt-Hansen, P (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, DK-2600 Glostrup, Denmark.	tfelt@inet.uni2.dk		Olesen, Jes/0000-0002-6712-2702				Delvaux M, 1997, J INT MED RES, V25, P225, DOI 10.1177/030006059702500501; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; Kaufman J., 1936, RADIOLOGY, V27, P301; Krymchantowski AV, 2006, CEPHALALGIA, V26, P871, DOI 10.1111/j.1468-2982.2006.01136.x; Saivin S, 2000, ARZNEIMITTEL-FORSCH, V50, P717; Tfelt-Hansen P, 2006, HEADACHES, P505; TFELTHANSEN P, 1995, LANCET, V346, P923, DOI 10.1016/S0140-6736(95)91554-0; TFELTHANSEN P, 1984, CEPHALALGIA, V4, P107, DOI 10.1046/j.1468-2982.1984.0402107.x; Thomsen LL, 1996, CEPHALALGIA, V16, P270, DOI 10.1046/j.1468-2982.1996.1604270.x; VOLANS GN, 1974, BRIT MED J, V4, P265, DOI 10.1136/bmj.4.5939.265; VOLANS GN, 1975, BRIT J CLIN PHARMACO, V2, P57, DOI 10.1111/j.1365-2125.1975.tb00472.x; Wang HY, 2002, J CHROMATOGR B, V779, P173, DOI 10.1016/S1570-0232(02)00369-0; WILKINSON M, 1976, HEADACHE, V15, P291, DOI 10.1111/j.1526-4610.1976.hed1504291.x	13	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2006	368	9544					1313	1314		10.1016/S0140-6736(06)69536-6	http://dx.doi.org/10.1016/S0140-6736(06)69536-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046449				2022-12-01	WOS:000241388100010
J	Sudarsan, N; Hammond, MC; Block, KF; Welz, R; Barrick, JE; Roth, A; Breaker, RR				Sudarsan, Narasimhan; Hammond, Ming C.; Block, Kirsten F.; Welz, Ruediger; Barrick, Jeffrey E.; Roth, Adam; Breaker, Ronald R.			Tandem riboswitch architectures exhibit complex gene control functions	SCIENCE			English	Article							INTRINSIC TRANSCRIPTION TERMINATION; GRAM-POSITIVE BACTERIA; S-ADENOSYLMETHIONINE; MESSENGER-RNA; METHIONINE SYNTHASE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; LIGAND-BINDING; METE GENE; EXPRESSION	Riboswitches are structured RNAs typically located in the 5' untranslated regions of bacterial mRNAs that bind metabolites and control gene expression. Most riboswitches sense one metabolite and function as simple genetic switches. However, we found that the 5' region of the Bacillus clausii metE messenger RNA includes two riboswitches that respond to S-adenosylmethionine and coenzyme B-12. This tandem arrangement yields a composite gene control system that functions as a two-input Boolean NOR logic gate. These findings and the discovery of additional tandem riboswitch architectures reveal how simple RNA elements can be assembled to make sophisticated genetic decisions without involving protein factors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Block, Kirsten/F-1600-2010; Breaker, Ronald/E-9679-2010; Barrick, Jeffrey/A-3046-2012	Block, Kirsten/0000-0003-4401-3754; Barrick, Jeffrey/0000-0003-0888-7358; Breaker, Ronald/0000-0002-2165-536X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068819] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM068819, GM 068819, GM 07223-31] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P11101, DOI 10.1021/bi00502a013; Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; Gophna U, 2005, GENE, V355, P48, DOI 10.1016/j.gene.2005.05.028; GREGG JR, 1998, UNDERSTANDING SCI TE, P77; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Gutierrez-Preciado A, 2005, TRENDS GENET, V21, P432, DOI 10.1016/j.tig.2005.06.001; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; McCarthy TJ, 2005, CHEM BIOL, V12, P1221, DOI 10.1016/j.chembiol.2005.09.006; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Pejchal R, 2005, PLOS BIOL, V3, P254, DOI 10.1371/journal.pbio.0030031; Ptashne M., 2002, GENES SIGNALS; Rodionov DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r90; Rodionov DA, 2004, NUCLEIC ACIDS RES, V32, P3340, DOI 10.1093/nar/gkh659; Roth A, 2006, RNA, V12, P607, DOI 10.1261/rna.2266506; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Soukup JK, 2004, CURR OPIN STRUC BIOL, V14, P344, DOI 10.1016/j.sbi.2004.04.007; Weinberg Z, 2006, BIOINFORMATICS, V22, P35, DOI 10.1093/bioinformatics/bti743; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; WU WF, 1992, J BACTERIOL, V174, P4833, DOI 10.1128/JB.174.14.4833-4837.1992; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yocum RR, 1996, J BACTERIOL, V178, P4604, DOI 10.1128/jb.178.15.4604-4610.1996	36	183	205	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					300	304		10.1126/science.1130716	http://dx.doi.org/10.1126/science.1130716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038623				2022-12-01	WOS:000241194100042
J	Peppiatt, CM; Howarth, C; Mobbs, P; Attwell, D				Peppiatt, Claire M.; Howarth, Clare; Mobbs, Peter; Attwell, David			Bidirectional control of CNS capillary diameter by pericytes	NATURE			English	Article							RAT RETINA; CONTAINING MICROVASCULATURE; BLOOD-FLOW; IN-VIVO; BRAIN; CALCIUM; MUSCLE; CORTEX; CELLS	Neural activity increases local blood flow in the central nervous system (CNS), which is the basis of BOLD (blood oxygen level dependent) and PET (positron emission tomography) functional imaging techniques(1-3). Blood flow is assumed to be regulated by precapillary arterioles, because capillaries lack smooth muscle. However, most (65%) noradrenergic innervation of CNS blood vessels terminates near capillaries rather than arterioles(4), and in muscle and brain a dilatory signal propagates from vessels near metabolically active cells to precapillary arterioles(5,6), suggesting that blood flow control is initiated in capillaries. Pericytes, which are apposed to CNS capillaries and contain contractile proteins(7), could initiate such signalling. Here we show that pericytes can control capillary diameter in whole retina and cerebellar slices. Electrical stimulation of retinal pericytes evoked a localized capillary constriction, which propagated at similar to 2 mu m s(-1) to constrict distant pericytes. Superfused ATP in retina or noradrenaline in cerebellum resulted in constriction of capillaries by pericytes, and glutamate reversed the constriction produced by noradrenaline. Electrical stimulation or puffing GABA (gamma-amino butyric acid) receptor blockers in the inner retina also evoked pericyte constriction. In simulated ischaemia, some pericytes constricted capillaries. Pericytes are probably modulators of blood flow in response to changes in neural activity, which may contribute to functional imaging signals and to CNS vascular disease.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Attwell, D (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	D.Attwell@ucl.ac.uk	Attwell, David/ABE-6750-2020	Peppiatt-Wildman, Claire/0000-0002-4406-8571; Howarth, Clare/0000-0002-6660-9770	Wellcome Trust [017948, 075232] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Berg BR, 1997, AM J PHYSIOL-HEART C, V272, pH2693, DOI 10.1152/ajpheart.1997.272.6.H2693; BUTRYN RK, 1995, MICROVASC RES, V50, P80, DOI 10.1006/mvre.1995.1040; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; DUFFY S, 1995, J NEUROSCI, V15, P5535; HAEFLIGER IO, 1994, INVEST OPHTH VIS SCI, V35, P991; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hauck EF, 2004, J CEREBR BLOOD F MET, V24, P383, DOI 10.1097/00004647-200404000-00003; HERMAN IM, 1985, J CELL BIOL, V101, P43, DOI 10.1083/jcb.101.1.43; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Iadecola C, 1997, J NEUROPHYSIOL, V78, P651, DOI 10.1152/jn.1997.78.2.651; Kawamura H, 2004, J PHYSIOL-LONDON, V561, P671, DOI 10.1113/jphysiol.2004.073098; Kawamura H, 2003, J PHYSIOL-LONDON, V551, P787, DOI 10.1113/jphsiol.2003.047977; LEFFLER CW, 1989, AM J PHYSIOL, V257, pH266, DOI 10.1152/ajpheart.1989.257.1.H266; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Roy C S, 1890, J Physiol, V11, P85; Rucker HK, 2000, BRAIN RES BULL, V51, P363, DOI 10.1016/S0361-9230(99)00260-9; Sakagami K, 2001, MICROVASC RES, V62, P196, DOI 10.1006/mvre.2001.2343; Schonfelder U, 1998, MICROVASC RES, V56, P22, DOI 10.1006/mvre.1998.2086; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Simard M, 2003, J NEUROSCI, V23, P9254; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Wu DM, 2003, AM J PHYSIOL-HEART C, V284, pH2083, DOI 10.1152/ajpheart.01007.2002; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	30	743	772	6	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					700	704		10.1038/nature05193	http://dx.doi.org/10.1038/nature05193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036005	Green Accepted			2022-12-01	WOS:000241160500048
J	Allen, CDC; Okada, T; Tang, HL; Cyster, JG				Allen, Christopher D. C.; Okada, Takaharu; Tang, H. Lucy; Cyster, Jason G.			Imaging of germinal center selection events during affinity maturation	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; PROLIFERATION; OPINION; MEMORY; ZONE	The germinal center ( GC) is an important site for the generation and selection of B cells bearing high-affinity antibodies, yet GC cell migration and interaction dynamics have not been directly observed. Using two-photon microscopy of mouse lymph nodes, we revealed that GC B cells are highly motile and extend long cell processes. They transited between GC dark and light zones and divided in both regions, although these B cells resided for only several hours in the light zone where antigen is displayed. GC B cells formed few stable contacts with GC T cells despite frequent encounters, and T cells were seen to carry dead B cell blebs. On the basis of these observations, we propose a model in which competition for T cell help plays a more dominant role in the selection of GC B cells than previously appreciated.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Okada, T (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Takaharu.Okada@ucsf.edu; Jason.Cyster@ucsf.edu	Okada, Takaharu/N-7931-2015	Allen, Christopher/0000-0002-1879-9047				Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; KEPLER TB, 1993, IMMUNOL TODAY, V14, P412, DOI 10.1016/0167-5699(93)90145-B; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Manser T, 2004, J IMMUNOL, V172, P3369, DOI 10.4049/jimmunol.172.6.3369; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; Meyer-Hermann ME, 2006, MATH MED BIOL, V23, P255, DOI 10.1093/imammb/dql012; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Ryser JE, 1999, NUCL MED BIOL, V26, P673, DOI 10.1016/S0969-8051(99)00042-6; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012	17	566	576	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					528	531		10.1126/science.1136736	http://dx.doi.org/10.1126/science.1136736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17185562				2022-12-01	WOS:000243726600051
J	Zegerman, P; Diffley, JFX				Zegerman, Philip; Diffley, John F. X.			Phosphorylation of Sld2 and Sld3 by cyclin-dependent kinases promotes DNA replication in budding yeast	NATURE			English	Article							B-TYPE CYCLINS; SACCHAROMYCES-CEREVISIAE; S-PHASE; CHROMOSOMAL DNA; POLYMERASE-ALPHA; CELL-CYCLE; PROTEIN; COMPLEX; G1; ORIGINS	Cyclin-dependent kinases (CDKs) drive major cell cycle events including the initiation of chromosomal DNA replication. We identified two S phase CDK (S-CDK) phosphorylation sites in the budding yeast Sld3 protein that, together, are essential for DNA replication. Here we show that, when phosphorylated, these sites bind to the amino-terminal BRCT repeats of Dpb11. An Sld3 - Dpb11 fusion construct bypasses the requirement for both Sld3 phosphorylation and the N-terminal BRCT repeats of Dpb11. Co-expression of this fusion with a phospho-mimicking mutant in a second essential CDK substrate, Sld2, promotes DNA replication in the absence of S-CDK. Therefore, Sld2 and Sld3 are the minimal set of S-CDK targets required for DNA replication. DNA replication in cells lacking G1 phase CDK (G1-CDK) required expression of the Cdc7 kinase regulatory subunit, Dbf4, as well as Sld2 and Sld3 bypass. Our results help to explain how G1- and S-CDKs promote DNA replication in yeast.	Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	John.Diffley@cancer.org.uk		Zegerman, Philip/0000-0002-5707-1083; Diffley, John/0000-0001-5184-7680				Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; Desdouets C, 1998, EMBO J, V17, P4139, DOI 10.1093/emboj/17.14.4139; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; HARLOW E, 1998, USING ANTIBODIES LAB; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; KUHNE C, 1993, EMBO J, V12, P3437, DOI 10.1002/j.1460-2075.1993.tb06018.x; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Noguchi E, 2002, CURR BIOL, V12, P599, DOI 10.1016/S0960-9822(02)00739-X; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Wilmes GM, 2004, GENE DEV, V18, P981, DOI 10.1101/gad.1202304; Yamamoto RR, 2000, GENETICS, V156, P711; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	40	356	359	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					281	285		10.1038/nature05432	http://dx.doi.org/10.1038/nature05432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17167417				2022-12-01	WOS:000243504700037
J	Sari, ABA; Sheldon, TA; Cracknell, A; Turnbull, A				Sari, Ali Baba-Akbari; Sheldon, Trevor A.; Cracknell, Alison; Turnbull, Alastair			Sensitivity of routine system for reporting patient safety incidents in an NHS hospital: retrospective patient case note review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ADVERSE EVENTS; BARRIERS; ERROR	Objective To evaluate the performance of a routine incident reporting system in identifying patient safety incidents. Design Two stage retrospective review of patients' case notes and analysis of data submitted to the routine incident reporting system on the same patients. Setting A large NHS hospital in England. Population 1006 hospital admissions between January and May 2004: surgery (n=311), general medicine (n=251), elderly care (n=184), orthopaedics (n=131), urology (n=61), and three other specialties (n=68). Main outcome measures Proportion of admissions with at least one patient safety incident; proportion and type of patient safety incidents missed by routine incident reporting and case note review methods. Results 324 patient safety incidents were identified in 230/1006 admissions (22.9%; 95% confidence interval 20.3% to 25.5%). 270 (83%) patient safety incidents were identified by case note review only, 21 (7%) by the routine reporting system only, and 33 (100%) by both methods. 110 admissions (10.9%; 9.0% to 12.8%) had at least one patient safety incident resulting in patient harm, all of which were detected by the case note review and six (5%) by the reporting system. Conclusion The routine incident reporting system may be poor at identifying patient safety incidents, particularly those resulting in harm. Structured case note review may have a useful role in surveillance of routine incident reporting and associated quality improvement programmes.	Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; York Hosp, York YO31 8HE, N Yorkshire, England	University of York - UK; Leeds General Infirmary	Sheldon, TA (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	tas5@york.ac.uk	Sheldon, Trevor/AAK-7088-2021	Sheldon, Trevor/0000-0002-7479-5913				Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Campbell M.J., 1999, MED STAT SUMMARY APP, V3rd; Davis Peter, 2002, N Z Med J, V115, pU271; Evans SM, 2006, QUAL SAF HEALTH CARE, V15, P39, DOI 10.1136/qshc.2004.012559; Firth-Cozens J, 2002, QUAL SAF HEALTH CARE, V11, P7, DOI 10.1136/qhc.11.1.7; Kilbridge PM, 2006, QUAL SAF HEALTH CARE, V15, P148, DOI 10.1136/qshc.2006.018218; Kingston MJ, 2004, MED J AUSTRALIA, V181, P36, DOI 10.5694/j.1326-5377.2004.tb06158.x; National Patient Safety Agency, 2005, BUILD MEM PREV HARM; Thomas EJ, 2003, J GEN INTERN MED, V18, P61, DOI 10.1046/j.1525-1497.2003.20147.x; Uribe CL, 2002, J HEALTHC MANAG, V47, P263, DOI 10.1097/00115514-200207000-00009; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; VINCENT C, 2001, CLIN RISK MANAGEMENT; Vincent C, 2006, PATIENT SAFETY; Walsh T, 2002, PHYSIOL MEAS, V23, pR111, DOI 10.1088/0967-3334/23/3/201; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	16	252	255	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	2007	334	7584					79	81		10.1136/bmj.39031.507153.AE	http://dx.doi.org/10.1136/bmj.39031.507153.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	127DZ	17175566	Bronze, Green Published			2022-12-01	WOS:000243566800030
J	O'Brien, CA; Pollett, A; Gallinger, S; Dick, JE				O'Brien, Catherine A.; Pollett, Aaron; Gallinger, Steven; Dick, John E.			A human colon cancer cell capable of initiating tumour growth in immunodeficient mice	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; SELF-RENEWAL; COLORECTAL-CANCER; XENOGRAFT MODELS; EPITHELIAL-CELLS; IDENTIFICATION; EXPRESSION	Colon cancer is one of the best-understood neoplasms from a genetic perspective(1-3), yet it remains the second most common cause of cancer-related death, indicating that some of its cancer cells are not eradicated by current therapies(4,5). What has yet to be established is whether every colon cancer cell possesses the potential to initiate and sustain tumour growth, or whether the tumour is hierarchically organized so that only a subset of cells - cancer stem cells - possess such potential(6,7). Here we use renal capsule transplantation in immunodeficient NOD/SCID mice to identify a human colon cancer-initiating cell (CC-IC). Purification experiments established that all CC-ICs were CD133(+); the CD133(-) cells that comprised the majority of the tumour were unable to initiate tumour growth. We calculated by limiting dilution analysis that there was one CC-IC in 5.7 x 10(4) unfractionated tumour cells, whereas there was one CC-IC in 262 CD133(+) cells, representing >200-fold enrichment. CC-ICs within the CD133(+) population were able to maintain themselves as well as differentiate and reestablish tumour heterogeneity upon serial transplantation. The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem cells.	Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Dick, JE (corresponding author), Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	Pollett, Aaron/J-2308-2016; Gallinger, Steven/E-4575-2013; Pollett, Aaron/AAQ-2540-2021	Pollett, Aaron/0000-0001-5121-8788; Pollett, Aaron/0000-0001-5121-8788; Dick, John/0000-0002-9527-8317; O'Brien, Catherine/0000-0003-0682-3879				Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Dick JE, 2003, P NATL ACAD SCI USA, V100, P3547, DOI 10.1073/pnas.0830967100; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEARON ER, 1992, FASEB J, V6, P2783, DOI 10.1096/fasebj.6.10.1321771; Golas JM, 2005, CANCER RES, V65, P5358, DOI 10.1158/0008-5472.CAN-04-2484; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ishida H, 2004, CANCER LETT, V207, P109, DOI 10.1016/j.canlet.2003.10.032; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liang JT, 2004, BRIT J SURG, V91, P355, DOI 10.1002/bjs.4447; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Nelson H, 2001, JNCI-J NATL CANCER I, V93, P583, DOI 10.1093/jnci/93.8.583; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Pocard M, 1996, IN VIVO, V10, P463; Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379; PORTER EH, 1963, BRIT J CANCER, V17, P583, DOI 10.1038/bjc.1963.78; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Ravi R, 2004, CANCER RES, V64, P9105, DOI 10.1158/0008-5472.CAN-04-2488; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sack MJ, 1997, DIAGN CYTOPATHOL, V16, P132, DOI 10.1002/(SICI)1097-0339(199702)16:2<132::AID-DC7>3.0.CO;2-J; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004	26	3162	3376	16	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					106	110		10.1038/nature05372	http://dx.doi.org/10.1038/nature05372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17122772				2022-12-01	WOS:000243225100045
J	Allemann, Y; Hutter, D; Lipp, E; Sartori, C; Duplain, H; Egli, M; Cook, S; Scherrer, U; Seiler, C				Allemann, Yves; Hutter, Damian; Lipp, Ernst; Sartori, Claudio; Duplain, Herve; Egli, Marc; Cook, Stephane; Scherrer, Urs; Seiler, Christian			Patent Foramen ovale and high-altitude pulmonary edema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DECOMPRESSION ILLNESS; HYPOXEMIA; CLOSURE; PREVENTION; PREVALENCE; PRESSURE	Context Individuals susceptible to high-altitude pulmonary edema ( HAPE) are characterized by exaggerated pulmonary hypertension and arterial hypoxemia at high altitude, but the underlying mechanism is incompletely understood. Anecdotal evidence suggests that shunting across a patent foramen ovale (PFO) may exacerbate hypoxemia in HAPE. Objective We hypothesized that PFO is more frequent in HAPE-susceptible individuals and may contribute to more severe arterial hypoxemia at high altitude. Design, Setting, and Participants Case-control study of 16 HAPE-susceptible participants and 19 mountaineers resistant to this condition ( repeated climbing to peaks above 4000 m and no symptoms of HAPE). Main Outcome Measures Presence of PFO determined by transesophageal echocardiography, estimated pulmonary artery pressure by Doppler echocardiography, and arterial oxygen saturation measured by pulse oximetry in HAPE-susceptible and HAPE-resistant participants at low ( 550 m) and high altitude ( 4559 m). Results The frequency of PFO was more than 4 times higher in HAPE-susceptible than in HAPE-resistant participants, both at low altitude (56% vs 11%, P=.004; odds ratio [ OR], 10.9 [95% confidence interval {CI}, 1.9-64.0]) and high altitude (69% vs 16%, P=. 001; OR, 11.7 [ 95% CI, 2.3-59.5]). At high altitude, mean (SD) arterial oxygen saturation prior to the onset of pulmonary edema was significantly lower in HAPE-susceptible participants than in the control group (73% [10%] vs 83% [7%], P=. 001). Moreover, in the HAPE-susceptible group, participants with a large PFO had more severe arterial hypoxemia (65% [6%] vs 77% [8%], P=. 02) than those with smaller or no PFO. Conclusions Patent foramen ovale was roughly 4 times more frequent in HAPE-susceptible mountaineers than in participants resistant to this condition. At high altitude, HAPE-susceptible participants with a large PFO had more severe hypoxemia. We speculate that at high altitude, a large PFO may contribute to exaggerated arterial hypoxemia and facilitate HAPE.	Univ Hosp Bern, Inselspital, Swiss Cardiovasc Ctr Bern, Dept Cardiol, CH-3010 Bern, Switzerland; CHU Vaudois, Dept Internal Med, Lausanne, Switzerland; CHU Vaudois, Botnar Ctr Extreme Med, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Allemann, Y (corresponding author), Univ Hosp Bern, Inselspital, Swiss Cardiovasc Ctr Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	yves.allemann@insel.ch						Allemann Y, 2000, AM J PHYSIOL-HEART C, V279, pH2013, DOI 10.1152/ajpheart.2000.279.4.H2013; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; Das BB, 2004, ARCH PEDIAT ADOL MED, V158, P1170, DOI 10.1001/archpedi.158.12.1170; Godart F, 2000, EUR HEART J, V21, P483, DOI 10.1053/euhj.1999.1944; HACKETT PH, 1988, J APPL PHYSIOL, V64, P1268, DOI 10.1152/jappl.1988.64.3.1268; HACKETT PH, 1992, INT J SPORTS MED, V13, pS68, DOI 10.1055/s-2007-1024599; Hegland DD, 2005, NEW ENGL J MED, V353, P2385, DOI 10.1056/NEJMcps050473; Kerut EK, 2001, J AM COLL CARDIOL, V38, P613, DOI 10.1016/S0735-1097(01)01427-9; Landzberg MJ, 2004, HEART, V90, P219, DOI 10.1136/hrt.2003.019315; LEVINE BD, 1991, ANN INTERN MED, V114, P569, DOI 10.7326/0003-4819-114-7-569; Maggiorini M, 2001, CIRCULATION, V103, P2078; Sartori C, 2004, EUR RESPIR J, V23, P916, DOI 10.1183/09031936.04.00115304; Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183; Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003; Seiler C, 2004, HEART, V90, P1245, DOI 10.1136/hrt.2003.031500; Shanoudy H, 1998, CHEST, V113, P91, DOI 10.1378/chest.113.1.91; Soliman A, 1999, J AM SOC ECHOCARDIOG, V12, P99, DOI 10.1016/S0894-7317(99)70121-5; Torti SR, 2004, EUR HEART J, V25, P1014, DOI 10.1016/j.ehj.2004.04.028; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; Wilmshurst PT, 2000, LANCET, V356, P1648, DOI 10.1016/S0140-6736(00)03160-3	20	105	105	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2006	296	24					2954	2958		10.1001/jama.296.24.2954	http://dx.doi.org/10.1001/jama.296.24.2954			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120FD	17190896	Bronze			2022-12-01	WOS:000243069000027
J	Eisenstein, M				Eisenstein, Michael			Protein arrays - Growing pains	NATURE			English	Article																			0	33	37	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					959	964		10.1038/444959a	http://dx.doi.org/10.1038/444959a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167490	Green Published, Bronze			2022-12-01	WOS:000242805400063
J	Chen, IA				Chen, Irene A.			The emergence of cells during the origin of life	SCIENCE			English	Editorial Material							FATTY-ACID VESICLES; GROWTH; RNA		Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA 02115 USA; MIT, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Chen, IA (corresponding author), Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA 02115 USA.	ichen@post.harvard.edu		Chen, Irene/0000-0001-6040-7927				ALLEN WILLIAM V., 1967, CURR MOD BIOL, V1, P24; Chen IA, 2005, J AM CHEM SOC, V127, P13213, DOI 10.1021/ja051784p; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen IA, 2004, SCIENCE, V305, P1474, DOI 10.1126/science.1100757; Chen IA, 2004, P NATL ACAD SCI USA, V101, P7965, DOI 10.1073/pnas.0308045101; Chen IA, 2006, COLD SPRING HARB MON, V43, P57; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Knoll AH, 2003, LIFE YOUNG PLANET 1; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; Rushdi AI, 2001, ORIGINS LIFE EVOL B, V31, P103, DOI 10.1023/A:1006702503954; Steitz TA, 2003, TRENDS BIOCHEM SCI, V28, P411, DOI 10.1016/S0968-0004(03)00169-5; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; YUEN GU, 1973, NATURE, V246, P301, DOI 10.1038/246303a0	16	31	32	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1558	1559		10.1126/science.1137541	http://dx.doi.org/10.1126/science.1137541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158315				2022-12-01	WOS:000242624600029
J	Dequeant, ML; Glynn, E; Gaudenz, K; Wahl, M; Chen, J; Mushegian, A; Pourquie, O				Dequeant, Mary-Lee; Glynn, Earl; Gaudenz, Karin; Wahl, Matthias; Chen, Jie; Mushegian, Arcady; Pourquie, Olivier			A complex oscillating network of signaling genes underlies the mouse segmentation clock	SCIENCE			English	Article							BETA-CATENIN; C-MYC; EXPRESSION; ACTIVATION; MESODERM; PATHWAY; SOMITOGENESIS; TRANSCRIPTION; TARGETS; DKK1	The segmental pattern of the spine is established early in development, when the vertebral precursors, the somites, are rhythmically produced from the presomitic mesoderm. Microarray studies of the mouse presomitic mesoderm transcriptome reveal that the oscillator associated with this process, the segmentation clock, drives the periodic expression of a large network of cyclic genes involved in cell signaling. Mutually exclusive activation of the notch-fibroblast growth factor and Wnt pathways during each cycle suggests that coordinated regulation of these three pathways underlies the clock oscillator.	Howard Hughes Med Inst, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Missouri, Dept Math & Stat, Kansas City, MO 64110 USA	Howard Hughes Medical Institute; University of Kansas; University of Kansas Medical Center; Stowers Institute for Medical Research; University of Missouri System; University of Missouri Kansas City	Pourquie, O (corresponding author), Howard Hughes Med Inst, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Pourquié, Olivier/CAJ-5443-2022; Mushegian, Arcady/ABF-5387-2021; Chen, Jie/S-1161-2019	Pourquié, Olivier/0000-0001-5189-1227; Mushegian, Arcady/0000-0002-6809-9225; Chen, Jie/0000-0003-2151-5276				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Buttitta L, 2003, DEV BIOL, V258, P91, DOI 10.1016/S0012-1606(03)00116-7; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; EBIAGHIE MC, 2003, CURR BIOL, V13, P1009; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ishikawa A, 2004, MECH DEVELOP, V121, P1443, DOI 10.1016/j.mod.2004.08.003; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Minowada G, 1999, DEVELOPMENT, V126, P4465; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Park CG, 1996, IMMUNITY, V4, P583, DOI 10.1016/S1074-7613(00)80484-7; Pirot P, 2004, BIOCHEM BIOPH RES CO, V322, P526, DOI 10.1016/j.bbrc.2004.07.157; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041	21	324	343	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1595	1598		10.1126/science.1133141	http://dx.doi.org/10.1126/science.1133141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17095659				2022-12-01	WOS:000242624600041
J	Kopec, C; Malinow, R				Kopec, Charles; Malinow, Roberto			Matters of size	SCIENCE			English	Editorial Material							LONG-TERM POTENTIATION; DENDRITIC SPINES; AMPA RECEPTORS; ACTIN; PLASTICITY; HIPPOCAMPUS; LTP; SYNAPSES		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Kopec, C (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org						Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Kim CH, 1999, J NEUROSCI, V19, P4314; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lin B, 2005, J NEUROSCI, V25, P2062, DOI 10.1523/JNEUROSCI.4283-04.2005; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; ZADOR A, 1990, P NATL ACAD SCI USA, V87, P6718, DOI 10.1073/pnas.87.17.6718	19	19	19	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1554	1555		10.1126/science.1137595	http://dx.doi.org/10.1126/science.1137595			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113UX	17158312				2022-12-01	WOS:000242624600026
J	Walker, J; Cliff, RA; Latham, AG				Walker, Joanne; Cliff, Robert A.; Latham, Alfred G.			U-Pb isotopic age of the StW 573 hominid from Sterkfontein, South Africa	SCIENCE			English	Article							COSMOGENIC AL-26; FOOT BONES; REAPPRAISAL; INFORMATION; BE-10; DECAY; RIVER	Sterkfontein cave, South Africa, has yielded an australopith skeleton, StW 573, whose completeness has excited great interest in paleoanthropology. StW 573, or "Little Foot," was found 25 meters below the surface in the Silberberg Grotto. U-238-Pb-206 measurements on speleothems immediately above and below the fossil remains, corrected for initial U-234 disequilibrium, yield ages of 2.17 +/- 0.17 million years ago (Ma) and 2.24(-0.07)(+0.09) Ma, respectively, indicating an age for StW 573 of close to 2.2 Ma. This age is in contrast to an age of similar to 3.3 Ma suggested by magnetochronology and ages of similar to 4 Ma based on Be-10 and Al-26, but it is compatible with a faunal age range of 4 to 2 Ma.	Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; Univ Liverpool, Sch Archaeol Class & Egyptol, Liverpool L69 3GS, Merseyside, England	University of Leeds; University of Liverpool	Cliff, RA (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	bob@earth.leeds.ac.uk						Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; BRAIN CK, 1958, TRANSVAAL MUS MEM, V111; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; CLARKE RJ, 1995, SCIENCE, V269, P521, DOI 10.1126/science.7624772; Clarke RJ, 2002, S AFR J SCI, V98, P523; Clarke RJ, 2002, S AFR J SCI, V98, P415; Clarke RJ, 1998, S AFR J SCI, V94, P460; de Lumley MA, 1982, P 1 INT C HUM PAL, P707; Delson E., 1988, P317; Gibbons A, 2003, SCIENCE, V300, P562, DOI 10.1126/science.300.5619.562; Granger DE, 1997, GEOLOGY, V25, P107, DOI 10.1130/0091-7613(1997)025<0107:QDROTN>2.3.CO;2; Granger DE, 2001, GEOL SOC AM BULL, V113, P825, DOI 10.1130/0016-7606(2001)113<0825:PPIOTG>2.0.CO;2; KENDALL AC, 1978, J SEDIMENT PETROL, V48, P519; KRONFELD J, 1994, EARTH PLANET SC LETT, V123, P81, DOI 10.1016/0012-821X(94)90259-3; Lanphere MA, 2002, GEOL SOC AM BULL, V114, P559, DOI 10.1130/0016-7606(2002)114<0559:RAFTOT>2.0.CO;2; Latham AG, 1993, APPL PALEOMAGNETISM, P150; LUDWIG KR, 1977, J RES US GEOL SURV, V5, P663; MCDOUGALL I, 1992, GEOPHYS RES LETT, V19, P2349, DOI 10.1029/92GL02714; McKee JK, 1996, SCIENCE, V272, P339; Muzikar P, 2006, EARTH PLANET SC LETT, V243, P400, DOI 10.1016/j.epsl.2005.12.020; Partridge T. C., 2005, Transactions of the Royal Society of South Africa, V60, P107; PARTRIDGE TC, 1978, NATURE, V275, P282, DOI 10.1038/275282a0; Partridge TC, 2003, SCIENCE, V300, P607, DOI 10.1126/science.1081651; Partridge TC, 1999, J QUATERNARY SCI, V14, P293, DOI 10.1002/(SICI)1099-1417(199907)14:4<293::AID-JQS471>3.0.CO;2-X; Richards DA, 1998, GEOCHIM COSMOCHIM AC, V62, P3683, DOI 10.1016/S0016-7037(98)00256-7; SCHWARCZ HP, 1994, J HUM EVOL, V26, P175, DOI 10.1006/jhev.1994.1010; Turner A., 1997, Palaeontologia Africana, V34, P115; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385	28	73	83	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1592	1594		10.1126/science.1132916	http://dx.doi.org/10.1126/science.1132916			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158326				2022-12-01	WOS:000242624600040
J	Gomendio, M; Malo, AF; Soler, AJ; Fernandez-Santos, MR; Esteso, MC; Garcia, AJ; Roldan, ERS; Garde, J				Gomendio, Montserrat; Malo, Aurelio F.; Soler, Ana J.; Fernandez-Santos, Maria R.; Esteso, Milagros C.; Garcia, Andres J.; Roldan, Eduardo R. S.; Garde, Julian			Male fertility and sex ratio at birth in red deer	SCIENCE			English	Article							SPERM; QUALITY; CHROMOSOME; DAUGHTERS; BEARING; SUCCESS; MOUSE; SONS	Efforts to test sex ratio theory have focused mostly on females. However, when males possess traits that could enhance the reproductive success of sons, males would also benefit from the manipulation of the offspring sex ratio. We tested the prediction that more-fertile red deer males produce more sons. Our findings reveal that male fertility is positively related to the proportion of male offspring. We also show that there is a positive correlation between the percentage of morphologically normal spermatozoa ( a main determinant of male fertility) and the proportion of male offspring. Thus, males may contribute significantly to biases in sex ratio at birth among mammals, creating the potential for conflicts of interest between males and females.	CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Grp, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain; Univ Castilla La Mancha, CSIC, Inst Invest Recursos Cineget, Junta Communidades Castilla La Mancha, Albacete 02071, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Gomendio, M (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Grp, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	montseg@mncn.csic.es; roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Malo, Aurelio F/D-3973-2011; Esteso, Milagros C/K-7895-2014; Soler, Ana Josefa/M-8209-2013; López-Brea, José Julián Garde/AAE-5894-2019; Soler, Ana Josefa/AAB-1024-2020; Malo, Aurelio F/X-8865-2019; Fernández-Santos, Maria Rocío/H-1522-2018; Garde, Julian J/O-5607-2015; Garcia Diaz, Andres Jose/A-9162-2012	Roldan, Eduardo R.S./0000-0002-7545-4248; Malo, Aurelio F/0000-0002-0846-2096; Esteso, Milagros C/0000-0002-8963-5736; Soler, Ana Josefa/0000-0002-6429-5157; López-Brea, José Julián Garde/0000-0002-3667-6518; Soler, Ana Josefa/0000-0002-6429-5157; Malo, Aurelio F/0000-0002-0846-2096; Fernández-Santos, Maria Rocío/0000-0002-3359-1623; Garde, Julian J/0000-0002-3667-6518; Garcia Diaz, Andres Jose/0000-0002-4662-2185				Carranza J, 1996, ETHOLOGY, V102, P793; Chandler JE, 2002, THERIOGENOLOGY, V57, P1327, DOI 10.1016/S0093-691X(01)00721-X; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; GOMENDIO M, 1990, NATURE, V343, P261, DOI 10.1038/343261a0; Gomendio M., 1998, SPERM COMPETITION SE; Henter HJ, 2004, J EVOLUTION BIOL, V17, P886, DOI 10.1111/j.1420-9101.2004.00746.x; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; LaMunyon CW, 1997, P NATL ACAD SCI USA, V94, P185, DOI 10.1073/pnas.94.1.185; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Smital J, 2005, ANIM REPROD SCI, V86, P119, DOI 10.1016/j.anireprosci.2004.05.023; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Ward MA, 2006, BIOL REPROD, V74, P652, DOI 10.1095/biolreprod.105.048090	17	74	75	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1445	1447		10.1126/science.1133064	http://dx.doi.org/10.1126/science.1133064			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138900	Green Submitted			2022-12-01	WOS:000242406100039
J	Darieva, Z; Bulmer, R; Pic-Taylor, A; Doris, KS; Geymonat, M; Sedgwick, SG; Morgan, BA; Sharrocks, AD				Darieva, Zoulfia; Bulmer, Richard; Pic-Taylor, Aline; Doris, Kathryn S.; Geymonat, Marco; Sedgwick, Steven G.; Morgan, Brian A.; Sharrocks, Andrew D.			Polo kinase controls cell-cycle-dependent transcription by targeting a coactivator protein	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-TRANSCRIPTION; MITOTIC PROGRAM; FHA DOMAIN; YEAST; FKH2P; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; EXECUTION	Polo kinases have crucial conserved functions in controlling the eukaryotic cell cycle through orchestrating several events during mitosis(1,2). An essential element of cell cycle control is exerted by altering the expression of key regulators(3). Here we show an important function for the polo kinase Cdc5p in controlling cell-cycle-dependent gene expression that is crucial for the execution of mitosis in the model eukaryote Saccharomyces cerevisiae. In particular, we find that Cdc5p is temporally recruited to promoters of the cell-cycle-regulated CLB2 gene cluster, where it targets the Mcm1p-Fkh2p-Ndd1p transcription factor complex, through direct phosphorylation of the coactivator protein Ndd1p. This phosphorylation event is required for the normal temporal expression of cell-cycle-regulated genes such as CLB2 and SWI5 in G2/M phases. Furthermore, severe defects in cell division occur in the absence of Cdc5p-mediated phosphorylation of Ndd1p. Thus, polo kinase is required for the production of key mitotic regulators, in addition to previously defined roles in controlling other mitotic events.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Newcastle Univ, Fac Med Sci, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Natl Inst Med Res, Div Yeast Genet, London NW7 1AA, England	University of Manchester; Newcastle University - UK; MRC National Institute for Medical Research	Morgan, BA (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	b.a.morgan@ncl.ac.uk; a.d.sharrocks@man.ac.uk	Pic-Taylor, Aline/AGY-4728-2022	Pic-Taylor, Aline/0000-0002-5121-8814	MRC [MC_U117531949] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02509] Funding Source: Medline; Medical Research Council [MC_U117531949] Funding Source: Medline; Wellcome Trust [078085] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; ALTHOEFER H, 1995, MOL CELL BIOL, V15, P5917; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Breeden LL, 2000, CURR BIOL, V10, pR586, DOI 10.1016/S0960-9822(00)00634-5; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Futcher B, 2002, CURR OPIN CELL BIOL, V14, P676, DOI 10.1016/S0955-0674(02)00391-5; Geymonat M, 2003, J BIOL CHEM, V278, P14591, DOI 10.1074/jbc.C300059200; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581; Zilahi E, 2000, FEBS LETT, V481, P105, DOI 10.1016/S0014-5793(00)01990-6	30	51	53	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					494	498		10.1038/nature05339	http://dx.doi.org/10.1038/nature05339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122856	Green Accepted			2022-12-01	WOS:000242215700048
J	Margolis, SS; Perry, JA; Forester, CM; Nutt, LK; Guo, YX; Jardim, MJ; Thomenius, MJ; Freel, CD; Darbandi, R; Ahn, JH; Arroyo, JD; Wang, XF; Shenolikar, S; Nairn, AC; Dunphy, WG; Hahn, WC; Virshup, DM; Kornbluth, S				Margolis, Seth S.; Perry, Jennifer A.; Forester, Craig M.; Nutt, Leta K.; Guo, Yanxiang; Jardim, Melanie J.; Thomenius, Michael J.; Freel, Christopher D.; Darbandi, Rashid; Ahn, Jung-Hyuck; Arroyo, Jason D.; Wang, Xiao-Fan; Shenolikar, Shirish; Nairn, Angus C.; Dunphy, William G.; Hahn, William C.; Virshup, David M.; Kornbluth, Sally			Role for the PP2A/B56 delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis	CELL			English	Article							CHECKPOINT CONTROL; IN-VITRO; PHOSPHORYLATION; KINASE; 2A; SUBUNIT; BINDING; PROGRESSION; ACTIVATION; KERATINS	DNA-responsive checkpoints prevent cell-cycle progression following DNA damage or replication inhibition. The mitotic activator Cdc25 is suppressed by checkpoints through inhibitory phosphorylation at Ser287 (Xenopus numbering) and docking of 14-3-3. Ser287 phosphorylation is a major locus of G2/M checkpoint control, although several checkpoint-independent kinases can phosphorylate this site. We reported previously that mitotic entry requires 14-3-3 removal and Ser287 dephosphorylation. We show here that DNA-responsive checkpoints also activate PP2A/B56 delta phosphatase complexes to dephosphorylate Cdc25 at a site distinct from Ser287 (T138), the phosphorylation of which is required for 14-3-3 release. However, phosphorylation of T138 is not sufficient for 14-3-3 release from Cdc25. Our data suggest that creation of a 14-3-3 "sink," consisting of phosphorylated 14-3-3 binding intermediate filament proteins, including keratins, coupled with reduced Cdc25-14-3-3 affinity, contribute to Cdc25 activation. These observations identify PP2A/B56 delta as a central checkpoint effector and suggest a mechanism for controlling 14-3-3 interactions to promote mitosis.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; MIT, Boston, MA 02115 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Duke University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Pfizer; Yale University; California Institute of Technology; Massachusetts Institute of Technology (MIT); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kornb001@mc.duke.edu	Virshup, David M/C-1449-2009; Forester, Craig/HCI-4174-2022	Virshup, David M/0000-0001-6976-850X; Nairn, Angus/0000-0002-7075-0195; Darbandi, Rashid/0000-0002-1239-6191; Arroyo, Jason/0000-0002-5674-6739; Ahn, Jung-Hyuck/0000-0001-9589-3881	NATIONAL CANCER INSTITUTE [P01CA050661, P01CA073992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067225, R01GM070891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA050661-190009, P01 CA050661, P01 CA073992, P01 CA50661] Funding Source: Medline; NIDA NIH HHS [P01 DA010044] Funding Source: Medline; NIGMS NIH HHS [R01 GM 070891, R01 GM 067225, R01 GM067225, R01 GM067225-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CLARK DB, 1993, BIOTROPICA, V25, P397, DOI 10.2307/2388863; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Inoue R, 1999, J BIOCHEM-TOKYO, V126, P1127, DOI 10.1093/oxfordjournals.jbchem.a022558; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Kumagai A, 1998, MOL BIOL CELL, V9, P345, DOI 10.1091/mbc.9.2.345; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Lin XH, 1998, P NATL ACAD SCI USA, V95, P14693, DOI 10.1073/pnas.95.25.14693; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; RUEDIGER R, 1991, MOL CELL BIOL, V11, P4282, DOI 10.1128/MCB.11.8.4282; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Stanford JS, 2005, MOL BIOL CELL, V16, P5749, DOI 10.1091/mbc.E05-06-0541; Tanabe O, 1996, FEBS LETT, V379, P107, DOI 10.1016/0014-5793(95)01500-0; Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Wang YC, 1997, MOL CELL BIOL, V17, P620, DOI 10.1128/MCB.17.2.620; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	37	158	163	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					759	773		10.1016/j.cell.2006.10.035	http://dx.doi.org/10.1016/j.cell.2006.10.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110335	Bronze, Green Accepted			2022-12-01	WOS:000242330600022
J	Curiel, TJ				Curiel, Tyler J.			Murder or mercy? Hurricane Katrina and the need for disaster training.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									San Antonio Canc Inst, San Antonio, TX USA; Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Curiel, TJ (corresponding author), San Antonio Canc Inst, San Antonio, TX USA.								0	16	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2067	2069		10.1056/NEJMp068196	http://dx.doi.org/10.1056/NEJMp068196			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104YU	17108341	Bronze			2022-12-01	WOS:000241997300003
J	Yoshida, S; Handa, Y; Suzuki, T; Ogawa, M; Suzuki, M; Tamai, A; Abe, A; Katayama, E; Sasakawa, C				Yoshida, Sei; Handa, Yutaka; Suzuki, Toshihiko; Ogawa, Michinaga; Suzuki, Masato; Tamai, Asuka; Abe, Akio; Katayama, Eisaku; Sasakawa, Chihiro			Microtubule-severing activity of Shigella is pivotal for intercellular spreading	SCIENCE			English	Article							ACTIN-BASED MOTILITY; LISTERIA-MONOCYTOGENES; VIRULENCE GENE; BURKHOLDERIA-PSEUDOMALLEI; RICKETTSIA-CONORII; ARP2/3 COMPLEX; LARGE PLASMID; N-WASP; FLEXNERI; PROTEIN	Some pathogenic bacteria actually invade the cytoplasm of their target host cells. Invasive bacteria acquire the propulsive force to move by recruiting actin and inducing its polymerization. Here we show that Shigella movement within the cytoplasm was severely hindered by microtubules and that the bacteria destroyed surrounding microtubules by secreting VirA by means of the type III secretion system. Degradation of microtubules by VirA was dependent on its alpha- tubulin - specific cysteine protease - like activity. virA mutants did not move within the host cytoplasm and failed to move into adjacent cells.	Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Basic Med Sci,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Control,Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Kitasato Univ, Kitasato Inst Life Sci, Lab Bacterial Infect, Minato Ku, Tokyo 1088641, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kitasato University	Sasakawa, C (corresponding author), Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Microbiol & Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Suzuki, Masato/B-7568-2013; Abe, Akio/AAQ-2464-2020	Suzuki, Masato/0000-0001-8975-2193; Yoshida, Sei/0000-0002-4771-3900				Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Breitbach K, 2003, CELL MICROBIOL, V5, P385, DOI 10.1046/j.1462-5822.2003.00277.x; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Demers B, 1998, EMBO J, V17, P2894, DOI 10.1093/emboj/17.10.2894; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Giardini PA, 2001, BIOPHYS J, V81, P3193, DOI 10.1016/S0006-3495(01)75955-3; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; OGAWA H, 1968, JPN J MED SCI BIOL, V21, P259, DOI 10.7883/yoken1952.21.259; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pfeuffer T, 2000, CELL MICROBIOL, V2, P101, DOI 10.1046/j.1462-5822.2000.00034.x; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Suzuki T, 2000, J EXP MED, V191, P1905, DOI 10.1084/jem.191.11.1905; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; UCHIYA KI, 1995, MOL MICROBIOL, V17, P241, DOI 10.1111/j.1365-2958.1995.mmi_17020241.x; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Yoshida S, 2002, EMBO J, V21, P2923, DOI 10.1093/emboj/cdf319	28	80	85	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					985	989		10.1126/science.1133174	http://dx.doi.org/10.1126/science.1133174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095701				2022-12-01	WOS:000241896000051
J	Siemens, J; Zhou, S; Piskorowski, R; Nikai, T; Lumpkin, EA; Basbaum, AI; King, D; Julius, D				Siemens, Jan; Zhou, Sharleen; Piskorowski, Rebecca; Nikai, Tetsuro; Lumpkin, Ellen A.; Basbaum, Allan I.; King, David; Julius, David			Spider toxins activate the capsaicin receptor to produce inflammatory pain	NATURE			English	Article							DEPENDENT K+ CHANNELS; ION-CHANNEL; TRP CHANNELS; POTASSIUM CHANNELS; TARANTULA TOXINS; GATING MODIFIER; PEPTIDES; SENSITIVITY; INHIBITION; PEPPERS	Bites and stings from venomous creatures can produce pain and inflammation as part of their defensive strategy to ward off predators or competitors(1,2). Molecules accounting for lethal effects of venoms have been extensively characterized, but less is known about the mechanisms by which they produce pain. Venoms from spiders, snakes, cone snails or scorpions contain a pharmacopoeia of peptide toxins that block receptor or channel activation as a means of producing shock, paralysis or death(3-5). We examined whether these venoms also contain toxins that activate ( rather than inhibit) excitatory channels on somatosensory neurons to produce a noxious sensation in mammals. Here we show that venom from a tarantula that is native to the West Indies contains three inhibitor cysteine knot (ICK) peptides that target the capsaicin receptor (TRPV1), an excitatory channel expressed by sensory neurons of the pain pathway(6). In contrast with the predominant role of ICK toxins as channel inhibitors(5,7), these previously unknown 'vanillotoxins' function as TRPV1 agonists, providing new tools for understanding mechanisms of TRP channel gating. Some vanillotoxins also inhibit voltage-gated potassium channels, supporting potential similarities between TRP and voltage-gated channel structures. TRP channels can now be included among the targets of peptide toxins, showing that animals, like plants ( for example, chilli peppers), avert predators by activating TRP channels on sensory nerve fibres to elicit pain and inflammation.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Mass Spectrometry Lab, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu	Piskorowski, Rebecca Ann/G-6610-2017	Piskorowski, Rebecca Ann/0000-0003-0120-2360; Siemens, Jan/0000-0001-9051-9217; Lumpkin, Ellen/0000-0002-1166-3374	NIAMS NIH HHS [R01 AR051219-03, R01 AR051219] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051219] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAHL LA, 1975, PAIN, V1, P3, DOI 10.1016/0304-3959(75)90003-2; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung J, 1999, J NEUROSCI, V19, P529; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Martinez-Caro L, 2000, NEUROREPORT, V11, P1213, DOI 10.1097/00001756-200004270-00014; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Salinas M, 2006, J PHYSIOL-LONDON, V570, P339, DOI 10.1113/jphysiol.2005.095810; SCHMIDT JO, 1982, ANNU REV ENTOMOL, V27, P339, DOI 10.1146/annurev.en.27.010182.002011; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Zhang PF, 2003, TOXICON, V42, P15, DOI 10.1016/S0041-0101(03)00095-3; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje	30	248	260	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					208	212		10.1038/nature05285	http://dx.doi.org/10.1038/nature05285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093448				2022-12-01	WOS:000241867200041
J	Kamper, J; Kahmann, R; Bolker, M; Ma, LJ; Brefort, T; Saville, BJ; Banuett, F; Kronstad, JW; Gold, SE; Muller, O; Perlin, MH; Wosten, HAB; de Vries, R; Ruiz-Herrera, J; Reynaga-Pena, CG; Snetselaar, K; McCann, M; Perez-Martin, J; Feldbrugge, M; Basse, CW; Steinberg, G; Ibeas, JI; Holloman, W; Guzman, P; Farman, M; Stajich, JE; Sentandreu, R; Gonzalez-Prieto, JM; Kennell, JC; Molina, L; Schirawski, J; Mendoza-Mendoza, A; Greilinger, D; Munch, K; Rossel, N; Scherer, M; Vranes, M; Ladendorf, O; Vincon, V; Fuchs, U; Sandrock, B; Meng, S; Ho, ECH; Cahill, MJ; Boyce, KJ; Klose, J; Klosterman, SJ; Deelstra, HJ; Ortiz-Castellanos, L; Li, WX; Sanchez-Alonso, P; Schreier, PH; Hauser-Hahn, I; Vaupel, M; Koopmann, E; Friedrich, G; Voss, H; Schluter, T; Margolis, J; Platt, D; Swimmer, C; Gnirke, A; Chen, F; Vysotskaia, V; Mannhaupt, G; Guldener, U; Munsterkotter, M; Haase, D; Oesterheld, M; Mewes, HW; Mauceli, EW; DeCaprio, D; Wade, CM; Butler, J; Young, S; Jaffe, DB; Calvo, S; Nusbaum, C; Galagan, J; Birren, BW				Kaemper, Joerg; Kahmann, Regine; Boelker, Michael; Ma, Li-Jun; Brefort, Thomas; Saville, Barry J.; Banuett, Flora; Kronstad, James W.; Gold, Scott E.; Mueller, Olaf; Perlin, Michael H.; Woesten, Han A. B.; de Vries, Ronald; Ruiz-Herrera, Jose; Reynaga-Pena, Cristina G.; Snetselaar, Karen; McCann, Michael; Perez-Martin, Jose; Feldbruegge, Michael; Basse, Christoph W.; Steinberg, Gero; Ibeas, Jose I.; Holloman, William; Guzman, Plinio; Farman, Mark; Stajich, Jason E.; Sentandreu, Rafael; Gonzalez-Prieto, Juan M.; Kennell, John C.; Molina, Lazaro; Schirawski, Jan; Mendoza-Mendoza, Artemio; Greilinger, Doris; Muench, Karin; Roessel, Nicole; Scherer, Mario; Vranes, Miroslav; Ladendorf, Oliver; Vincon, Volker; Fuchs, Uta; Sandrock, Bjoern; Meng, Shaowu; Ho, Eric C. H.; Cahill, Matt J.; Boyce, Kylie J.; Klose, Jana; Klosterman, Steven J.; Deelstra, Heine J.; Ortiz-Castellanos, Lucila; Li, Weixi; Sanchez-Alonso, Patricia; Schreier, Peter H.; Haeuser-Hahn, Isolde; Vaupel, Martin; Koopmann, Edda; Friedrich, Gabi; Voss, Hartmut; Schlueter, Thomas; Margolis, Jonathan; Platt, Darren; Swimmer, Candace; Gnirke, Andreas; Chen, Feng; Vysotskaia, Valentina; Mannhaupt, Gertrud; Gueldener, Ulrich; Muensterkoetter, Martin; Haase, Dirk; Oesterheld, Matthias; Mewes, Hans-Werner; Mauceli, Evan W.; DeCaprio, David; Wade, Claire M.; Butler, Jonathan; Young, Sarah; Jaffe, David B.; Calvo, Sarah; Nusbaum, Chad; Galagan, James; Birren, Bruce W.			Insights from the genome of the biotrophic fungal plant pathogen Ustilago maydis	NATURE			English	Article							PROTEINS; SEQUENCE; CELLS; DNA; CENTROMERES; HAUSTORIA; SYSTEM; GENES; YEAST; MAP	Ustilago maydis is a ubiquitous pathogen of maize and a well-established model organism for the study of plant - microbe interactions(1). This basidiomycete fungus does not use aggressive virulence strategies to kill its host. U. maydis belongs to the group of biotrophic parasites ( the smuts) that depend on living tissue for proliferation and development(2). Here we report the genome sequence for a member of this economically important group of biotrophic fungi. The 20.5-million-base U. maydis genome assembly contains 6,902 predicted protein-encoding genes and lacks pathogenicity signatures found in the genomes of aggressive pathogenic fungi, for example a battery of cell-wall-degrading enzymes. However, we detected unexpected genomic features responsible for the pathogenicity of this organism. Specifically, we found 12 clusters of genes encoding small secreted proteins with unknown function. A significant fraction of these genes exists in small gene families. Expression analysis showed that most of the genes contained in these clusters are regulated together and induced in infected tissue. Deletion of individual clusters altered the virulence of U. maydis in five cases, ranging from a complete lack of symptoms to hypervirulence. Despite years of research into the mechanism of pathogenicity in U. maydis, no 'true' virulence factors(3) had been previously identified. Thus, the discovery of the secreted protein gene clusters and the functional demonstration of their decisive role in the infection process illuminate previously unknown mechanisms of pathogenicity operating in biotrophic fungi. Genomic analysis is, similarly, likely to open up new avenues for the discovery of virulence determinants in other pathogens.	Max Planck Inst Terr Microbiol, Dept Organism Interact, D-35043 Marburg, Germany; Univ Marburg, Dept Biol, D-35032 Marburg, Germany; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; Univ Louisville, Dept Biol, Program Dis Evolut, Louisville, KY 40292 USA; Univ Utrecht, Inst Biomembranes, Dept Microbiol, NL-3705 SN Utrecht, Netherlands; IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Unidad Biotecnol & Ingn Genet Plantas, Irapuato 36500, Gto, Mexico; St Josephs Univ, Dept Biol, Philadelphia, PA 19131 USA; CSIC, Ctr Nacl Biotecnol, Dept Microbiol Biotechnol, E-28049 Madrid, Spain; Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; CINVESTAV, Dept Plant Genet Engn, Guanajuato 36821, Mexico; Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Univ Valencia, Fac Farm, Dept Microbiol & Ecol, Valencia 46100, Spain; IPN, Ctr Biotecnol Genom, Dept Biotecnol Vegetal 2, Tamaulipas 88710, Mexico; St Louis Univ, Dept Biol, St Louis, MO 63103 USA; Univ Kentucky, Dept Biol, Lexington, KY 40546 USA; Bayer CropSci AG, D-40789 Monheim, Germany; LION Biosci AG, D-69123 Heidelberg, Germany; Exelixis Inc, San Francisco, CA 94080 USA; GSF NAtl Res Ctr Environm & Hlth, Inst Bioinformat MIPS, D-85764 Neuherberg, Germany; Tech Univ Munich, D-85354 Freising Weihenstephan, Germany	Max Planck Society; Philipps University Marburg; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Toronto; University Toronto Mississauga; California State University System; California State University Long Beach; University of British Columbia; University System of Georgia; University of Georgia; University of Louisville; Utrecht University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Saint Joseph's University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Cornell University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Kentucky; Duke University; University of Valencia; Instituto Politecnico Nacional - Mexico; Saint Louis University; University of Kentucky; Bayer AG; Bayer CropScience; Exelixis, Inc.; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Kahmann, R (corresponding author), Max Planck Inst Terr Microbiol, Dept Organism Interact, Karl von Frisch Str, D-35043 Marburg, Germany.	kaemper@mpi-marburg.mpg.de; kahmann@mpi-marburg.mpg.de; boelker@staff.uni-marburg.de	Mendoza, Artemio Mendoza/F-3519-2013; Mendoza, Artemio Mendoza/P-7540-2019; de Vries, Ronald P./F-8125-2011; Guzman, Plinio/A-3073-2012; Stajich, Jason Eric/C-7297-2008; Molina, Lazaro/K-9645-2014; Li, WeiXi/AAM-5381-2021; Corcelles, Jose Ignacio Ibeas/B-7615-2015; Perez-Martin, Jose/K-5117-2014; Feldbrügge, Michael/AAS-3939-2021; Ma, Li-Jun/AAG-2359-2020; Schirawski, Jan/Q-9393-2019; Wösten, Han AB/K-2769-2016; Münsterkötter, Martin/C-5288-2017; Münsterkötter, Martin/L-3436-2019; Kahmann, Regine/AAS-1230-2021; Güldener, Ulrich/G-5227-2012; Reynaga Peña, Cristina/D-4803-2016; Reynaga-Peña, Cristina G./GMX-3386-2022; Mewes, Hans-Werner/A-8204-2019	Mendoza, Artemio Mendoza/0000-0002-1532-3406; Mendoza, Artemio Mendoza/0000-0002-1532-3406; de Vries, Ronald P./0000-0002-4363-1123; Stajich, Jason Eric/0000-0002-7591-0020; Molina, Lazaro/0000-0002-8483-9203; Corcelles, Jose Ignacio Ibeas/0000-0002-2394-7075; Perez-Martin, Jose/0000-0001-9849-7382; Feldbrügge, Michael/0000-0003-0046-983X; Schirawski, Jan/0000-0003-1615-1201; Wösten, Han AB/0000-0002-0399-3648; Münsterkötter, Martin/0000-0002-0044-2381; Münsterkötter, Martin/0000-0002-0044-2381; Güldener, Ulrich/0000-0001-5052-8610; Reynaga-Peña, Cristina G./0000-0003-3039-551X; Ma, Li-Jun/0000-0002-2733-3708; DeCaprio, Dave/0000-0001-8931-9461; Boyce, Kylie J./0000-0002-7167-5414; Schlueter, Thomas/0000-0001-5829-9381; Mewes, Hans-Werner/0000-0002-9713-6398; Wade, Claire/0000-0003-3413-4771; Galagan, James/0000-0003-0542-3291				Banuett F, 1995, ANNU REV GENET, V29, P179, DOI 10.1146/annurev.ge.29.120195.001143; BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Brachmann A, 2003, EMBO J, V22, P2199, DOI 10.1093/emboj/cdg198; Cambareri EB, 1998, MOL CELL BIOL, V18, P5465, DOI 10.1128/MCB.18.9.5465; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Holliday R, 2004, DNA REPAIR, V3, P671, DOI 10.1016/j.dnarep.2004.02.002; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Houben A, 2003, CURR OPIN PLANT BIOL, V6, P554, DOI 10.1016/j.pbi.2003.09.007; Kamper J, 2004, MOL GENET GENOMICS, V271, P103, DOI 10.1007/s00438-003-0962-8; Kemen E, 2005, MOL PLANT MICROBE IN, V18, P1130, DOI 10.1094/MPMI-18-1130; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Martinez-Espinoza AD, 2002, FUNGAL GENET BIOL, V35, P1, DOI 10.1006/fgbi.2001.1301; Meksem K, 2005, GENOME, V48, P207, DOI [10.1139/G04-099, 10.1139/g04-099]; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Vernis L, 2001, J MOL BIOL, V305, P203, DOI 10.1006/jmbi.2000.4300; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; Zarnack K, 2006, FUNGAL GENET BIOL, V43, P727, DOI 10.1016/j.fgb.2006.05.006	29	827	1224	7	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					97	101		10.1038/nature05248	http://dx.doi.org/10.1038/nature05248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080091	hybrid			2022-12-01	WOS:000241701500053
J	Deng, M; Hochstrasser, M				Deng, Min; Hochstrasser, Mark			Spatially regulated ubiquitin ligation by an ER/nuclear membrane ligase	NATURE			English	Article							NUCLEAR-PORE COMPLEX; MAT-ALPHA-2 REPRESSOR; TRANSCRIPTION FACTOR; PROTEIN-DEGRADATION; YEAST; RETICULUM; TRANSPORT; ARCHITECTURE; SYSTEM; ACTIN	The ubiquitin system targets many cellular proteins. Doa10 ( also known as Ssm4), a yeast transmembrane ubiquitin ligase (E3), resides in the endoplasmic reticulum ( ER), but it attaches ubiquitin to soluble proteins that concentrate in the nucleus. A central question is how nuclear substrates gain access to an enzyme in the ER. Here we show that Doa10 reaches the inner nuclear membrane. A subcomplex of nuclear pore subunits is important for this transport. Notably, another ER transmembrane E3, Hrd1 ( also known as Der3), cannot localize efficiently to the inner nuclear membrane. Tethering Doa10 at the cell periphery inhibits degradation of soluble nuclear substrates but not cytoplasmic ones. If Doa10 is released from these peripheral sites, localization of Doa10 to the nuclear envelope and degradation of its nuclear substrates are restored in parallel. Thus, localization of Doa10 to the inner nuclear membrane is necessary for nuclear substrate degradation. These data indicate that different membrane ubiquitin ligases are spatially sorted within the ER - nuclear envelope membrane system and that this differential localization contributes to their specificity.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,POB 208114, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Hochstrasser, Mark/0000-0002-1131-5484				Andrulis ED, 1998, NATURE, V395, P525, DOI 10.1038/26795; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Damelin M, 2002, BIOPHYS J, V83, P3626, DOI 10.1016/S0006-3495(02)75363-0; Giddings TH, 2001, METHOD CELL BIOL, V67, P27; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Isaac C, 2001, J CELL SCI, V114, P4253; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pines J, 2005, NAT CELL BIOL, V7, P731, DOI 10.1038/ncb0805-731; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Worman HJ, 2000, J MEMBRANE BIOL, V177, P1, DOI 10.1007/s002320001096; WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101	34	125	127	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					827	831		10.1038/nature05170	http://dx.doi.org/10.1038/nature05170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051211				2022-12-01	WOS:000241362700044
J	Prochnow, C; Bransteitter, R; Klein, MG; Goodman, MF; Chen, XJS				Prochnow, Courtney; Bransteitter, Ronda; Klein, Michael G.; Goodman, Myron F.; Chen, Xiaojiang S.			The APOBEC-2 crystal structure and functional implications for the deaminase AID	NATURE			English	Article							INDUCED CYTIDINE DEAMINASE; ANTIVIRAL ACTIVITY; EDITING ENZYMES; RESOLUTION; MUTATIONS; MECHANISM; FAMILY; HIV-1; DNA	APOBEC-2 (APO2) belongs to the family of apolipoprotein B messenger RNA-editing enzyme catalytic ( APOBEC) polypeptides, which deaminates mRNA and single-stranded DNA(1,2). Different APOBEC members use the same deamination activity to achieve diverse human biological functions. Deamination by an APOBEC protein called activation-induced cytidine deaminase ( AID) is critical for generating high-affinity antibodies(3), and deamination by APOBEC-3 proteins can inhibit retrotransposons and the replication of retroviruses such as human immunodeficiency virus and hepatitis B virus(4-7). Here we report the crystal structure of APO2. APO2 forms a rod-shaped tetramer that differs markedly from the square-shaped tetramer of the free nucleotide cytidine deaminase, with which APOBEC proteins share considerable sequence homology. In APO2, two long alpha-helices of a monomer structure prevent the formation of a square-shaped tetramer and facilitate formation of the rod-shaped tetramer via head-to-head interactions of two APO2 dimers. Extensive sequence homology among APOBEC family members allows us to test APO2 structure-based predictions using AID. We show that AID deamination activity is impaired by mutations predicted to interfere with oligomerization and substrate access. The structure suggests how mutations in patients with hyper-IgM-2 syndrome inactivate AID, resulting in defective antibody maturation.	Univ So Calif, Los Angeles, CA 90089 USA	University of Southern California	Chen, XJS (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	xiaojiang.chen@usc.edu						Anant S, 2001, AM J PHYSIOL-CELL PH, V281, pC1904, DOI 10.1152/ajpcell.2001.281.6.C1904; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Bransteitter R, 2006, J BIOL CHEM, V281, P16833, DOI 10.1074/jbc.R600006200; Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Durandy A, 2006, CURR OPIN RHEUMATOL, V18, P369, DOI 10.1097/01.bor.0000231905.12172.b5; Franca R, 2006, MED SCI MONITOR, V12, pRA92; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Minegishi Y, 2000, CLIN IMMUNOL, V97, P203, DOI 10.1006/clim.2000.4956; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Opi S, 2006, J VIROL, V80, P4673, DOI 10.1128/JVI.80.10.4673-4682.2006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pham P, 2005, BIOCHEMISTRY-US, V44, P2703, DOI 10.1021/bi047481+; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; SMITH AA, 1994, BIOCHEMISTRY-US, V33, P6468, DOI 10.1021/bi00187a012; Teh AH, 2006, BIOCHEMISTRY-US, V45, P7825, DOI 10.1021/bi060345f; Teng BB, 1999, J LIPID RES, V40, P623; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; WANG J, IN PRESS J BIOL CHEM; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101	28	163	175	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2007	445	7126					447	451		10.1038/nature05492	http://dx.doi.org/10.1038/nature05492			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	128WD	17187054				2022-12-01	WOS:000243689500044
J	Davies, KE; Grounds, MD				Davies, Kay E.; Grounds, Miranda D.			Treating muscular dystrophy with stem cells?	CELL			English	Editorial Material							MUSCLE; MESOANGIOBLASTS	There is currently no effective treatment for the devastating muscle-wasting disease Duchenne muscular dystrophy (DMD). Cossu and colleagues report in a recent Nature paper that transplantation of mesoangioblast stem cells may hold promise for treating DMD. Further studies are required to fully evaluate the clinical potential of these blood-vessel-associated stem cells.	Univ Oxford, MRC Funct Genet Unit, Oxford, England; Univ Western Australia, Sch Anat & Human Biol, Nedlands, WA 6009, Australia	University of Oxford; University of Western Australia	Davies, KE (corresponding author), Univ Oxford, MRC Funct Genet Unit, Oxford, England.	kay.davies@anat.ox.ac.uk		Grounds, Miranda/0000-0002-4530-9402				De Luca A, 2005, AM J PATHOL, V166, P477, DOI 10.1016/S0002-9440(10)62270-5; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; Lee-Pullen TF, 2005, IUBMB LIFE, V57, P731, DOI 10.1080/15216540500352748; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Morosetti R, 2006, P NATL ACAD SCI USA, V103, P16995, DOI 10.1073/pnas.0603386103; Nowak KJ, 2004, EMBO REP, V5, P872, DOI 10.1038/sj.embor.7400221; RADLEY H, 2006, INT J BIOCHEM CELL B, DOI DOI 10.1016/BIOCEL.2006.09.009; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; SHARMA KR, 1993, NEUROLOGY, V43, P527, DOI 10.1212/WNL.43.3_Part_1.527; Stupka N, 2004, ACTA NEUROPATHOL, V107, P299, DOI 10.1007/s00401-003-0807-x	10	31	34	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1304	1306		10.1016/j.cell.2006.12.010	http://dx.doi.org/10.1016/j.cell.2006.12.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190595	Bronze			2022-12-01	WOS:000243690000010
J	Vrieseling, E; Arber, S				Vrieseling, Eline; Arber, Silvia			Target-induced transcriptional control of dendritic patterning and connectivity in motor neurons by the ETS gene Pea3	CELL			English	Article							LUMBOSACRAL SPINAL-CORD; SENSORY NEURONS; MOTONEURONS; POOLS; SPECIFICATION; INNERVATION; AFFERENTS; ARBORIZATION; EXPRESSION; BULLFROG	The apposition of axon terminals and dendrites, is critical for the control of neuronal activation, but how distinct neuronal subpopulations establish selective dendrite patterns and acquire specific presynaptic inputs remains unclear. Spinal motor neuron (MN) pools project to specific target muscles and are activated by selective synaptic inputs from group la proprioceptive afferents (IaPAs). Here, we show that MN pools with radially projecting dendrites respond to sensory stimulation with monosynaptic latency and are strikingly different from MN pools with dendrites that avoid the central gray matter, which are only activated through indirect connections. We provide genetic evidence that the induction of the ETS transcription factor Pea3 by GDNF is essential in two cervical MN pools to control dendrite patterning and selectivity of IaPA connectivity. These findings suggest that target-induced transcriptional programs control MN dendrite orientation and play a crucial role in the establishment of sensory-motor connections in the spinal cord.	Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch	Pecho-Vrieseling, Eline/AAP-7239-2020	Arber, Silvia/0000-0002-6261-250X; Pecho-Vrieseling, Eline/0000-0001-6712-775X				Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BALDISSERA F, 1981, HDB PHYSL INTEGRATIO; BAULAC M, 1981, ACTA ANAT, V109, P209; BLASER PF, 1990, DEV BRAIN RES, V57, P139, DOI 10.1016/0165-3806(90)90193-3; BROWN AG, 1978, J PHYSIOL-LONDON, V274, P111, DOI 10.1113/jphysiol.1978.sp012137; Brown AG, 1981, ORG SPINAL CORD; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; FRANK E, 1993, NEURON, V10, P779, DOI 10.1016/0896-6273(93)90194-V; FRANK E, 1988, STRATEGIES SELECTIVE; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KALB RG, 1994, DEVELOPMENT, V120, P3063; Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LICHTMAN JW, 1984, J NEUROSCI, V4, P1754; LICHTMAN JW, 1984, J NEUROSCI, V4, P1745; Liebl DJ, 1997, J NEUROSCI, V17, P9113; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Mears SC, 1997, J NEUROSCI, V17, P3128; MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; OKADO N, 1990, ANAT EMBRYOL, V182, P113; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209; Ryan JM, 1998, BRAIN BEHAV EVOLUT, V51, P90; Salie R, 2005, NEURON, V45, P189, DOI 10.1016/j.neuron.2005.01.002; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SZEKELY G, 1980, ACTA BIOL ACAD SCI H, V31, P305; Wenner P, 1995, J NEUROSCI, V15, P8191; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	43	134	136	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1439	1452		10.1016/j.cell.2006.10.042	http://dx.doi.org/10.1016/j.cell.2006.10.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190606	Bronze			2022-12-01	WOS:000243690000022
J	Aziz, MA; Wright, A; Laszlo, A; De Muynck, A; Portaels, F; Van Deun, A; Wells, C; Nunn, P; Blanc, L; Raviglione, M				Aziz, Mohamed Abdel; Wright, Abigail; Laszlo, Adalbert; De Muynck, Aime; Portaels, Francois; Van Deun, Armand; Wells, Charles; Nunn, Paul; Blanc, Leopold; Raviglione, Mario		WHO Int Union Against Tub	Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis	LANCET			English	Article							TUBERCULOSIS-CONTROL; MYCOBACTERIA; SENSITIVITY; HEALTH; TRENDS	Background The burden of tuberculosis is compounded by drug-resistant forms of the disease. This study aimed to analyse data on antituberculosis drug resistance gathered by the WHO and International Union Against Tuberculosis and Lung Disease Global Project on Anti-tuberculosis Drug Resistance Surveillance. Methods Data on drug susceptibility testing for four antituberculosis drugs-isoniazid, rifampicin, ethambutol, and streptomycin-were gathered in the third round of the Global Project (1999-2002) from surveys or ongoing surveillance in 79 countries or geographical settings. These data were combined with those from the first two rounds of the project and analyses were done. Countries that participated followed a standardised set of guidelines to ensure comparability both between and within countries. Findings The median prevalence of resistance to any of the four antituberculosis drugs in new cases of tuberculosis identified in 76 countries or geographical settings was 10.2% (range 0.0-57.1). The median prevalence of multidrug resistance in new cases was 1.0% (range 0.0-14.2). Kazakhstan, Tomsk Oblast (Russia), Karakalpakstan (Uzbekistan), Estonia, Israel, the Chinese provinces Liaoning and Henan, Lithuania, and Latvia reported prevalence of multidrug resistance above 6.5%. Trend analysis showed a significant increase in the prevalence of multidrug resistance in new cases in Tomsk Oblast (p<0.0001). Hong Kong (p=0.01) and the USA (p=0.0002) reported significant decreasing trends in multidrug resistance in new cases of tuberculosis. Interpretation Multidrug resistance represents a serious challenge for tuberculosis control in countries of the former Soviet Union and in some provinces of China. Gaps in coverage of the Global Project are substantial, and baseline information is urgently required from several countries with high tuberculosis burden to develop appropriate control interventions.	WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	World Health Organization; Institute of Tropical Medicine (ITM); Centers for Disease Control & Prevention - USA	Raviglione, M (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, CH-1211 Geneva, Switzerland.	raviglionem@who.int	ROBERT, Jérôme/C-3993-2011	ROBERT, Jérôme/0000-0002-9380-0570; RAVIGLIONE, Mario/0000-0002-9331-2067				CANETTI G, 1965, AM REV RESPIR DIS, V92, P687; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cohn DL, 1997, CLIN INFECT DIS   S1, V24, P121; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; CROFTON J, 1948, BMJ-BRIT MED J, V2, P1009, DOI 10.1136/bmj.2.4588.1009; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; *HONG KONG GOV TUB, 1964, TUBERCLE, V45, P77; KOCHI A, 1993, RES MICROBIOL, V73, P219; Maher D, 2005, CLIN CHEST MED, V26, P167, DOI 10.1016/j.ccm.2005.02.009; MAHMOUDI A, 1993, JAMA-J AM MED ASSOC, V270, P65, DOI 10.1001/jama.270.1.65; MITCHISON DA, 1950, THORAX, V4, P144; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; *PHS COOP INV, 1964, AM RESP DIS, V89, P327; PYLE MM, 1947, P STAFF M MAYO CLIN, V22, P465; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; RAVIGLIONE MC, 1997, AIDS, V11, P115; Siddiqi S. H., 1996, BACTEC 460TB SYSTEM; VESTAL AL, 1967, SCAND J RESPIR DIS, V48, P142; WHO, 2003, WHOCDSCSRRMD20033; *WHO, 2005, WHOHTMTB2005349; WHO, 2000, WHOCDSTB2000279; WHO, 2001, WHOCDSCSRDRS20012; *WHOIUATLD, 2000, WHOCDSTB200278 IUATL; *WHOIUATLD, 1997, WHOTB97229 IUATLD; *WHOIUATLD, 2004, WHOHTMTB2004343 IUAT; World Health Organization, 2006, STOP TB STRATEGY BUI; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2006, WHOHTM2006361; World Health Organization (WHO), 1998, LAB SERVICES TUBERCU; Wright A., 2006, Morbidity and Mortality Weekly Report, V55, P301; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	38	251	274	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 16	2006	368	9553					2142	2154		10.1016/S0140-6736(06)69863-2	http://dx.doi.org/10.1016/S0140-6736(06)69863-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EZ	17174706				2022-12-01	WOS:000242856900022
J	Lagouge, M; Argmann, C; Gerhart-Hines, Z; Meziane, H; Lerin, C; Daussin, F; Messadeq, N; Milne, J; Lambert, P; Elliott, P; Geny, B; Laakso, M; Puigserver, P; Auwerx, J				Lagouge, Marie; Argmann, Carmen; Gerhart-Hines, Zachary; Meziane, Hamid; Lerin, Carles; Daussin, Frederic; Messadeq, Nadia; Milne, Jill; Lambert, Philip; Elliott, Peter; Geny, Bernard; Laakso, Markku; Puigserver, Pere; Auwerx, Johan			Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha	CELL			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; MESSENGER-RNA EXPRESSION; CEREVISIAE LIFE-SPAN; ALPHA ERR-ALPHA; SKELETAL-MUSCLE; CALORIE RESTRICTION; RECEPTOR-ALPHA; SACCHAROMYCES-CEREVISIAE; OXIDATIVE-PHOSPHORYLATION; ADAPTIVE THERMOGENESIS	Diminished mitochondrial oxidative phosphorylation and aerobic capacity are associated with reduced longevity. We tested whether resveratrol (RSV), which is known to extend lifespan, impacts mitochondrial function and metabolic homeostasis. Treatment of mice with RSV significantly increased their aerobic capacity, as evidenced by their increased running time and consumption of oxygen in muscle fibers. RSV's effects were associated with an induction of genes for oxidative phosphorylation and mitochondrial biogenesis and were largely explained by an RSV-mediated decrease in PGC-1 alpha acetylation and an increase in PGC-1 alpha activity. This mechanism is consistent with RSV being a known activator of the protein deacetylase, SIRT1, and by the lack of effect of RSV in SIRT1(-/-) MEFs. Importantly, RSV treatment protected mice against diet-induced-obesity and insulin resistance. These pharmacological effects of RSV combined with the association of three Sirt1 SNPs and energy homeostasis in Finnish subjects implicates SIRT1 as a key regulator of energy and metabolic homeostasis.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; Hop Univ, Dept Resp Cardiocirculat & Exercise Physiol, F-67000 Strasbourg, France; Sirtris Pharmaceut, Cambridge, MA 02139 USA; Univ Kuopio, Dept Med, FIN-70211 Kuopio, Finland; ICS, IGBMC, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University; CHU Strasbourg; University of Eastern Finland; Institut National de la Sante et de la Recherche Medicale (Inserm)	Auwerx, J (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.	auwerx@igbmc.u-strasbg.fr	Daussin, Frederic N/G-2866-2013; Auwerx, Johan/ABE-9307-2021; Lerin, Carles/AAP-9916-2020; Daussin, Frédéric/O-7583-2019	Lerin, Carles/0000-0003-0950-4363; Daussin, Frédéric/0000-0002-4168-0044; Auwerx, Johan/0000-0002-5065-5393	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069966, P01DK059820] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK069966, DK59820] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BAUR JA, 2006, IN PRESS NATURE; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Booth FW, 2002, J PHYSIOL-LONDON, V543, P399, DOI 10.1113/jphysiol.2002.019265; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Ceddia RB, 2000, EUR J BIOCHEM, V267, P5952, DOI 10.1046/j.1432-1327.2000.01664.x; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; FERRANNINI E, 1988, AM J PHYSIOL, V255, pE946, DOI 10.1152/ajpendo.1988.255.6.E946; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim YI, 2006, DIABETES, V55, P2311, DOI 10.2337/db05-1606; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; N'Guessan B, 2004, MOL CELL BIOCHEM, V256, P267; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Virkamaki A, 2001, DIABETES, V50, P2337, DOI 10.2337/diabetes.50.10.2337; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163	58	3117	3273	10	489	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1109	1122		10.1016/j.cell.2006.11.013	http://dx.doi.org/10.1016/j.cell.2006.11.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17112576	Bronze			2022-12-01	WOS:000242991000011
J	Tsushima, Y; Sasaki, Y; Watanabe, T				Tsushima, Yoshiaki; Sasaki, Yuka; Watanabe, Takeo			Greater disruption due to failure of inhibitory control on an ambiguous distractor	SCIENCE			English	Article							PREFRONTAL CORTEX; DISSOCIATION; BLINDNESS	Considerable evidence indicates that a stimulus that is subthreshold, and thus consciously invisible, influences brain activity and behavioral performance. However, it is not clear how subthreshold stimuli are processed in the brain. We found that a task-irrelevant subthreshold coherent motion led to a stronger disturbance in task performance than did suprathreshold motion. With the subthreshold motion, activity in the visual cortex measured by functional magnetic resonance imaging was higher, but activity in the lateral prefrontal cortex was lower, than with suprathreshold motion. These results suggest that subthreshold irrelevant signals are not subject to effective inhibitory control.	Boston Univ, Dept Psychol, Boston, MA 02215 USA; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02129 USA; CALTECH, ERATO, Shimojo Implicit Brain Funct Project, Pasadena, CA 91125 USA	Boston University; Harvard University; Massachusetts General Hospital; California Institute of Technology	Watanabe, T (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	takeo@bu.edu		Tsushima, Yoshiaki/0000-0001-7818-4602; Sasaki, Yuka/0000-0002-0061-0250	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015980, R21EY017737] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR14075] Funding Source: Medline; NEI NIH HHS [R01 EY015980, R21 EY017737] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bar M, 1998, PSYCHOL SCI, V9, P464, DOI 10.1111/1467-9280.00086; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Callan AM, 2005, NEUROIMAGE, V28, P553, DOI 10.1016/j.neuroimage.2005.06.031; Chun MM, 1997, J EXP PSYCHOL HUMAN, V23, P738, DOI 10.1037/0096-1523.23.3.738; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; Fuster J., 2015, PREFRONTAL CORTEX; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mack A., 1998, INATTENTIONAL BLINDN; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Niedeggen M, 2002, COGNITIVE BRAIN RES, V13, P241, DOI 10.1016/S0926-6410(01)00122-7; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Sahraie A, 2001, VISION RES, V41, P1613, DOI 10.1016/S0042-6989(01)00065-7; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601	30	124	125	3	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1786	1788		10.1126/science.1133197	http://dx.doi.org/10.1126/science.1133197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	116WD	17170308				2022-12-01	WOS:000242833600062
J	Schmidt, AR; Ragazzi, E; Coppellotti, O; Roghi, G				Schmidt, Alexander R.; Ragazzi, Eugenio; Coppellotti, Olimpia; Roghi, Guido			A microworld in Triassic amber	NATURE			English	Article							ALPS		Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany; Univ Padua, Dept Pharmacol & Anaesthesiol, I-35131 Padua, Italy; Univ Padua, Dept Biol, I-35131 Padua, Italy; CNR, Inst Geosci & Earth Resources, I-35137 Padua, Italy; Univ Padua, Dept Geol Paleontol & Geophys, I-35137 Padua, Italy	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Padua; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); University of Padua	Schmidt, AR (corresponding author), Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany.	alexander.schmidt@museum.hu-berlin.de	Ragazzi, Eugenio/ACX-1875-2022	Ragazzi, Eugenio/0000-0002-0390-6823				Dorfelt H, 2006, PALAEONTOLOGY, V49, P1013, DOI 10.1111/j.1475-4983.2006.00582.x; Dorfelt H., 2000, HOPPEA DENKSCHRIFTEN, V61, P785; Rikkinen J, 2000, MYCOL RES, V104, P7, DOI 10.1017/S0953756299001884; Roghi G, 2006, PALAIOS, V21, P143, DOI 10.2110/palo.2005.p05-68; Roghi G, 2004, REV PALAEOBOT PALYNO, V132, P1, DOI 10.1016/j.revpalbo.2004.03.001; Schmidt AR, 2004, PALAEONTOLOGY, V47, P185, DOI 10.1111/j.0031-0239.2004.00368.x; Schonborn W, 1999, J EUKARYOT MICROBIOL, V46, P571, DOI 10.1111/j.1550-7408.1999.tb05133.x; SCHONBORN WILFRIED, 1962, LIMNOLOGICA, V1, P111; WAGGONER BM, 1994, LETHAIA, V27, P77, DOI 10.1111/j.1502-3931.1994.tb01559.x	9	76	79	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					835	835		10.1038/444835a	http://dx.doi.org/10.1038/444835a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167469	Bronze			2022-12-01	WOS:000242805400033
J	Belkhadir, Y; Chory, J				Belkhadir, Youssef; Chory, Joanne			Brassinosteroid signaling: A paradigm for steroid hormone signaling from the cell surface	SCIENCE			English	Editorial Material							RECEPTOR KINASE; ARABIDOPSIS; GROWTH; BRI1; BIOSYNTHESIS; ELONGATION		Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu	Belkhadir, Youssef/GXM-6743-2022	Belkhadir, Youssef/0000-0001-7149-7139				BELKHADIR Y, 2006, SCI STKE         OCT; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; KARLOVA R, 2006, SCI STKE, pPE36; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Li L, 2005, TRENDS PLANT SCI, V10, P266, DOI 10.1016/j.tplants.2005.04.002; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	17	117	132	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1410	1411		10.1126/science.1134040	http://dx.doi.org/10.1126/science.1134040			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138891				2022-12-01	WOS:000242406100027
J	Kueng, S; Hegemann, B; Peters, BH; Lipp, JJ; Schleiffer, A; Mechtler, K; Peters, JM				Kueng, Stephanie; Hegemann, Bjoern; Peters, Beate H.; Lipp, Jesse J.; Schleiffer, Alexander; Mechtler, Karl; Peters, Jan-Michael			Wapl controls the dynamic association of cohesin with chromatin	CELL			English	Article							MITOTIC CHROMOSOME; SISTER; SHUGOSHIN; IDENTIFICATION; ANAPHASE; XENOPUS; DNA; CONDENSATION; MAINTENANCE; COMPLEXES	Cohesin establishes sister-chromatid cohesion from S phase until mitosis or meiosis. To allow chromosome segregation, cohesion has to be dissolved. In vertebrate cells, this process is mediated in part by the protease separase, which destroys a small amount of cohesin, but most cohesin is removed from chromosomes without proteolysis. How this is achieved is poorly understood. Here, we show that the interaction between cohesin and chromatin is controlled by Wapl, a protein implicated in heterochromatin formation and tumorigenesis. Wapl is associated with cohesin throughout the cell cycle, and its depletion blocks cohesin dissociation from chromosomes during the early stages of mitosis and prevents the resolution of sister chromatids until anaphase, which occurs after a delay. Wapl depletion also increases the residence time of cohesin on chromatin in interphase. Our data indicate that Wapl is required to unlock cohesin from a particular state in which it is stably bound to chromatin.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	peters@imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019; Hegemann, Björn/A-8761-2015	Mechtler, Karl/0000-0002-3392-9946; Hegemann, Björn/0000-0002-1009-2952; Schleiffer, Alexander/0000-0001-6251-2747				Akhmedov AT, 1998, J BIOL CHEM, V273, P24088, DOI 10.1074/jbc.273.37.24088; Dobie KW, 2001, GENETICS, V157, P1623; Game JC, 2003, RADIAT RES, V160, P14, DOI 10.1667/RR3019; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; GRUBER S, 2006, IN PRESS CELL; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; GVOZDEV VA, 1975, MOL GEN GENET, V141, P269, DOI 10.1007/BF00341805; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hartman T, 2000, J CELL BIOL, V151, P613, DOI 10.1083/jcb.151.3.613; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kwiatkowski BA, 2004, EXP CELL RES, V300, P223, DOI 10.1016/j.yexcr.2004.06.028; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2005, J CELL SCI, V118, P2133, DOI 10.1242/jcs.02355; Losada A, 2000, J CELL BIOL, V150, P405, DOI 10.1083/jcb.150.3.405; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Measday V, 2005, P NATL ACAD SCI USA, V102, P13956, DOI 10.1073/pnas.0503504102; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nagase T, 1996, DNA Res, V3, P321, DOI 10.1093/dnares/3.5.321; Oikawa K, 2004, CANCER RES, V64, P3545, DOI 10.1158/0008-5472.CAN-03-3822; Panizza S, 2000, CURR BIOL, V10, P1557, DOI 10.1016/S0960-9822(00)00854-X; PERRIMON N, 1985, GENETICS, V111, P23; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Verni F, 2000, GENETICS, V154, P1693; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049	43	406	418	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					955	967		10.1016/j.cell.2006.09.040	http://dx.doi.org/10.1016/j.cell.2006.09.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17113138	Bronze			2022-12-01	WOS:000242613800013
J	Suh, EK; Yang, A; Kettenbach, A; Bamberger, C; Michaelis, AH; Zhu, Z; Elvin, JA; Bronson, RT; Crum, CP; McKeon, F				Suh, Eun-Kyung; Yang, Annie; Kettenbach, Arminja; Bamberger, Casimir; Michaelis, Ala H.; Zhu, Zhou; Elvin, Julia A.; Bronson, Roderick T.; Crum, Christopher P.; McKeon, Frank			p63 protects the female germ line during meiotic arrest	NATURE			English	Article							P53 TUMOR-SUPPRESSOR; ELEGANS P53; HOMOLOG; DROSOPHILA-P53; MIGRATION; PATHWAYS; ISOFORMS; MICE	Meiosis in the female germ line of mammals is distinguished by a prolonged arrest in prophase of meiosis I between homologous chromosome recombination and ovulation(1). How DNA damage is detected in these arrested oocytes is poorly understood, but it is variably thought to involve p53, a central tumour suppressor in mammals(2-4). While the function of p53 in monitoring the genome of somatic cells is clear, a consensus for the importance of p53 for germ line integrity has yet to emerge. Here we show that the p53 homologue p63 (refs 5, 6), and specifically the TAp63 isoform, is constitutively expressed in female germ cells during meiotic arrest and is essential in a process of DNA damage-induced oocyte death not involving p53. We also show that DNA damage induces both the phosphorylation of p63 and its binding to p53 cognate DNA sites and that these events are linked to oocyte death. Our data support a model whereby p63 is the primordial member of the p53 family and acts in a conserved process of monitoring the integrity of the female germ line, whereas the functions of p53 are restricted to vertebrate somatic cells for tumour suppression. These findings have implications for understanding female germ line fidelity, the regulation of fertility and the evolution of tumour suppressor mechanisms.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McKeon, F (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	fmckeon@hms.harvard.edu	Bamberger, Casimir/E-7356-2011; Bamberger, Tom Casimir/D-1292-2014	Bamberger, Tom Casimir/0000-0002-3830-4486; Kettenbach, Arminja/0000-0003-3979-4576				Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LANE DP, 1995, PHILOS T ROY SOC B, V347, P83, DOI 10.1098/rstb.1995.0013; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Olivier M, 2005, 25 YEARS OF P53 RESEARCH, P321, DOI 10.1007/1-4020-2922-5_14; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; PETERS H, 1970, PHILOS T R SOC B, V259, P91, DOI 10.1098/rstb.1970.0048; PETERS H, 1964, J REPROD FERTIL, V7, P37; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; YANG A, IN PRESS MOL CELL; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260	30	384	391	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					624	628		10.1038/nature05337	http://dx.doi.org/10.1038/nature05337			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17122775				2022-12-01	WOS:000242377600049
J	Kim, SA; Punshon, T; Lanzirotti, A; Li, LT; Alonso, JM; Ecker, JR; Kaplan, J; Guerinot, ML				Kim, Sun A.; Punshon, Tracy; Lanzirotti, Antonio; Li, Liangtao; Alonso, Jose M.; Ecker, Joseph R.; Kaplan, Jerry; Guerinot, Mary Lou			Localization of iron in Arabidopsis seed requires the vacuolar membrane transporter VIT1	SCIENCE			English	Article							THALIANA SEEDS; EXPRESSION; FLUORESCENCE; FERRITIN; ELEMENTS; STORAGE; CCC1	Iron deficiency is a major human nutritional problem wherever plant-based diets are common. Using synchrotron x-ray fluorescence microtomography to directly visualize iron in Arabidopsis seeds, we show that iron is localized primarily to the provascular strands of the embryo. This localization is completely abolished when the vacuolar iron uptake transporter VIT1 is disrupted. Vacuolar iron storage is also critical for seedling development because vit1-1 seedlings grow poorly when iron is limiting. We have uncovered a fundamental aspect of seed biology that will ultimately aid the development of nutrient-rich seed, benefiting both human health and agricultural productivity.	Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Univ Chicago, Consortium Adv Radiat Sources, Chicago, IL 60637 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Salk Inst Biol Studies, Plant Biol & Genom Anal Labs, La Jolla, CA 92037 USA	Dartmouth College; University of Chicago; Utah System of Higher Education; University of Utah; University of North Carolina; North Carolina State University; Salk Institute	Guerinot, ML (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	guerinot@dartmouth.edu	Alonso, Jose M/K-6826-2014; Ecker, Joseph R/B-9144-2008	Alonso, Jose M/0000-0001-7087-1571; Ecker, Joseph R/0000-0001-5799-5895; Lanzirotti, Antonio/0000-0002-7597-5924	NIDDK NIH HHS [DK 30534] Funding Source: Medline; NIEHS NIH HHS [P42 ES07373] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030534, R01DK030534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BODE HP, 1995, EUR J BIOCHEM, V228, P337; BOWMAN JL, 1994, ARABIDOPSIS ATLAS MO, P351; Busse JS, 1999, INT J PLANT SCI, V160, P1, DOI 10.1086/314098; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Goto F, 1999, NAT BIOTECHNOL, V17, P282, DOI 10.1038/7029; KUMAR S, 2000, MEGA2 MOL EVOLUTIONA; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lott JNA, 2001, CAN J BOT, V79, P1292, DOI 10.1139/cjb-79-11-1292; Lucca P, 2002, J AM COLL NUTR, V21, p184S, DOI 10.1080/07315724.2002.10719264; McNear DH, 2005, ENVIRON SCI TECHNOL, V39, P2210, DOI 10.1021/es0492034; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Pich A, 2001, PLANTA, V213, P967, DOI 10.1007/s004250100573; Punshon T, 2005, J ENVIRON QUAL, V34, P1165, DOI 10.2134/jeq2004.0461; Qu LQ, 2005, PLANTA, V222, P225, DOI 10.1007/s00425-005-1530-8; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Stuppy WH, 2003, TRENDS PLANT SCI, V8, P2, DOI 10.1016/S1360-1385(02)00004-3; Sutton SR, 2002, REV MINERAL GEOCHEM, V49, P429, DOI 10.2138/rmg.2002.49.8; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Young LW, 2006, J SYNCHROTRON RADIAT, V13, P304, DOI 10.1107/S0909049506019571	26	449	473	6	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1295	1298		10.1126/science.1132563	http://dx.doi.org/10.1126/science.1132563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17082420				2022-12-01	WOS:000242215800042
J	Simner, J; Ward, J				Simner, Julia; Ward, Jamie			Synaesthesia - The taste of words on the tip of the tongue	NATURE			English	Article							COLOR SYNAESTHESIA; ACTIVATION		Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; UCL, Dept Psychol, London WC1E 6BT, England	University of Edinburgh; University of London; University College London	Simner, J (corresponding author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	j.simner@ed.ac.uk	Ward, Jamie/F-3609-2011	Ward, Jamie/0000-0001-7007-1902; Simner, Julia/0000-0003-4789-0138				BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; KEMPEN G, 1983, COGNITION, V14, P185, DOI 10.1016/0010-0277(83)90029-X; Levy LM, 1999, J COMPUT ASSIST TOMO, V23, P499, DOI 10.1097/00004728-199907000-00002; Nunn JA, 2002, NAT NEUROSCI, V5, P371, DOI 10.1038/nn818; Rich AN, 2005, COGNITION, V98, P53, DOI 10.1016/j.cognition.2004.11.003; Ward J, 2005, PERCEPTION, V34, P611, DOI 10.1068/p5250; Ward J, 2005, COGN NEUROPSYCHOL, V22, P28, DOI 10.1080/02643290442000022; Ward J, 2003, COGNITION, V89, P237, DOI 10.1016/S0010-0277(03)00122-7; Ward J, 2006, CORTEX, V42, P264, DOI 10.1016/S0010-9452(08)70352-6; Ward J, 2006, CORTEX, V42, P129, DOI 10.1016/S0010-9452(08)70336-8	10	57	59	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					438	438		10.1038/444438a	http://dx.doi.org/10.1038/444438a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	108BQ	17122848				2022-12-01	WOS:000242215700033
J	Gullans, SR				Gullans, Steven R.			Connecting the dots using gene-expression profiles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		RxGen, New Haven, CT USA		Gullans, SR (corresponding author), RxGen, New Haven, CT USA.							Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939	2	6	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					2042	2044		10.1056/NEJMcibr065953	http://dx.doi.org/10.1056/NEJMcibr065953			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	102SG	17093257				2022-12-01	WOS:000241833000016
J	Dorrello, NV; Peschiaroli, A; Guardavaccaro, D; Colburn, NH; Sherman, NE; Pagano, M				Dorrello, N. Valerio; Peschiaroli, Angelo; Guardavaccaro, Daniele; Colburn, Nancy H.; Sherman, Nicholas E.; Pagano, Michele			S6K1- and beta TRCP-mediated degradation of PDCD4 promotes protein translation and cell growth	SCIENCE			English	Article							INITIATION-FACTOR 4A; SUPPRESSOR PDCD4; TRANSFORMATION; NUTRIENT; BINDING; KINASE; TARGET	The tumor suppressor programmed cell death protein 4 (PDCD4) inhibits the translation initiation factor eIF4A, an RNA helicase that catalyzes the unwinding of secondary structure at the 5' untranslated region (5'UTR) of messenger RNAs (mRNAs). In response to mitogens, PDCD4 was rapidly phosphorylated on Ser(67) by the protein kinase S6K1 and subsequently degraded via the ubiquitin ligase SCF beta TRCP. Expression in cultured cells of a stable PDCD4 mutant that is unable to bind beta TRCP inhibited translation of an mRNA with a structured 5' UTR, resulted in smaller cell size, and slowed down cell cycle progression. We propose that regulated degradation of PDCD4 in response to mitogens allows efficient protein synthesis and consequently cell growth.	NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; NCI, Lab Canc Prevent, Frederick, MD 21702 USA; Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA 22908 USA	New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Virginia	Pagano, M (corresponding author), NYU, Sch Med, Inst Canc, Dept Pathol, 550 1st Ave,MSB 599, New York, NY 10016 USA.	michele.pagano@med.nyu.edu		pagano, michele/0000-0003-3210-2442; PESCHIAROLI, ANGELO/0000-0001-6311-2382; Guardavaccaro, Daniele/0000-0002-4517-1765; Sherman, Nicholas/0000-0003-3206-3113	NCI NIH HHS [R01-CA76584] Funding Source: Medline; NIGMS NIH HHS [R01-GM57587] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Goke A, 2002, BIOCHEM BIOPH RES CO, V297, P78, DOI 10.1016/S0006-291X(02)02129-0; Guardavaccaro D, 2006, MOL CELL, V22, P1, DOI 10.1016/j.molcel.2006.03.017; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kang MJ, 2002, BIOCHEM BIOPH RES CO, V293, P617, DOI 10.1016/S0006-291X(02)00264-4; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200	16	532	556	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					467	471		10.1126/science.1130276	http://dx.doi.org/10.1126/science.1130276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053147				2022-12-01	WOS:000241382500043
J	Shen, YY; Wang, XF; Wu, FQ; Du, SY; Cao, Z; Shang, Y; Wang, XL; Peng, CC; Yu, XC; Zhu, SY; Fan, RC; Xu, YH; Zhang, DP				Shen, Yuan-Yue; Wang, Xiao-Fang; Wu, Fu-Qing; Du, Shu-Yuan; Cao, Zheng; Shang, Yi; Wang, Xiu-Ling; Peng, Chang-Cao; Yu, Xiang-Chun; Zhu, Sai-Yong; Fan, Ren-Chun; Xu, Yan-Hong; Zhang, Da-Peng			The Mg-chelatase H subunit is an abscisic acid receptor	NATURE			English	Article							PHYTOCHROME-CHROMOPHORE BIOSYNTHESIS; PROTEIN PHOSPHATASE 2C; BINDING PROTEIN; ARABIDOPSIS; GENE; ENCODES; MUTANT; ABI1; ACCUMULATION; REGULATOR	Abscisic acid (ABA) is a vital phytohormone that regulates mainly stomatal aperture and seed development, but ABA receptors involved in these processes have yet to be determined. We previously identified from broad bean an ABA-binding protein (ABAR) potentially involved in stomatal signalling, the gene for which encodes the H subunit of Mg-chelatase (CHLH), which is a key component in both chlorophyll biosynthesis and plastid-to-nucleus signalling. Here we show that Arabidopsis ABAR/CHLH specifically binds ABA, and mediates ABA signalling as a positive regulator in seed germination, post-germination growth and stomatal movement, showing that ABAR/CHLH is an ABA receptor. We show also that ABAR/CHLH is a ubiquitous protein expressed in both green and non-green tissues, indicating that it might be able to perceive the ABA signal at the whole-plant level.	China Agr Univ, China State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Zhang, DP (corresponding author), China Agr Univ, China State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	zhangdp@sohu.net						Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; CHAMOVITZ D, 1991, PLANT MOL BIOL, V16, P967, DOI 10.1007/BF00016069; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; FINKELSTEIN RR, 1994, PLANT J, V5, P765, DOI 10.1046/j.1365-313X.1994.5060765.x; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Guo HS, 2003, PLANT J, V34, P383, DOI 10.1046/j.1365-313X.2003.01723.x; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; HORNBERG C, 1984, NATURE, V310, P321, DOI 10.1038/310321a0; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Manfre AJ, 2006, PLANT PHYSIOL, V140, P140, DOI 10.1104/pp.105.072967; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; NAMBARA E, 1992, PLANT J, V2, P435, DOI 10.1111/j.1365-313X.1992.00435.x; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Razem FA, 2004, J BIOL CHEM, V279, P9922, DOI 10.1074/jbc.M311064200; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Walker CJ, 1997, BIOCHEM J, V327, P321; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang DP, 2002, PLANT PHYSIOL, V128, P714, DOI 10.1104/pp.010531	34	387	466	6	279	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					823	826		10.1038/nature05176	http://dx.doi.org/10.1038/nature05176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051210				2022-12-01	WOS:000241362700043
J	Shen, QH; Saijo, Y; Mauch, S; Biskup, C; Bieri, S; Keller, B; Seki, H; Ulker, B; Somssich, IE; Schulze-Lefert, P				Shen, Qian-Hua; Saijo, Yusuke; Mauch, Stefan; Biskup, Christoph; Bieri, Stephane; Keller, Beat; Seki, Hikaru; Uelker, Bekir; Somssich, Imre E.; Schulze-Lefert, Paul			Nuclear activity of MLA immune receptors links isolate-specific and basal disease-resistance responses	SCIENCE			English	Article							WRKY TRANSCRIPTION FACTORS; POWDERY MILDEW FUNGUS; PSEUDOMONAS-SYRINGAE; SIGNALING PATHWAYS; DNA-BINDING; MAP KINASE; BARLEY; ARABIDOPSIS; PLANT; PROTEINS	Plant immune responses are triggered by pattern recognition receptors that detect conserved pathogen-associated molecular patterns (PAMPs) or by resistance ( R) proteins recognizing isolate-specific pathogen effectors. We show that in barley, intracellular mildew A (MLA) R proteins function in the nucleus to confer resistance against the powdery mildew fungus. Recognition of the fungal avirulence A10 effector by MLA10 induces nuclear associations between receptor and WRKY transcription factors. The identified WRKY proteins act as repressors of PAMP-triggered basal defense. MLA appears to interfere with the WRKY repressor function, thereby de-repressing PAMP-triggered basal defense. Our findings reveal a mechanism by which these polymorphic immune receptors integrate distinct pathogen signals.	Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Univ Jena, Inst Physiol 2, D-07740 Jena, Germany; Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland	Max Planck Society; Friedrich Schiller University of Jena; University of Zurich	Schulze-Lefert, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Shen, Qian-Hua/D-2734-2013; Schulze-Lefert, Paul/B-6707-2011; Schulze-Lefert, Paul/A-7746-2008; Bruening, Stefan/B-8505-2011; Seki, Hikaru/C-9730-2017; Somssich, Imre/GLT-3738-2022; Keller, Beat/K-3093-2019	Shen, Qian-Hua/0000-0002-9446-3086; Somssich, Imre/0000-0003-3066-5794; Keller, Beat/0000-0003-2379-9225				Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Cormack RS, 2002, BBA-GENE STRUCT EXPR, V1576, P92, DOI 10.1016/S0167-4781(02)00298-1; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dewdney J, 2000, PLANT J, V24, P205, DOI 10.1046/j.1365-313x.2000.00870.x; Eckey C, 2004, PLANT MOL BIOL, V55, P1, DOI 10.1007/s11103-004-0275-2; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; GORG R, 1993, PLANT J, V3, P857, DOI 10.1111/j.1365-313X.1993.00857.x; Halterman D, 2001, PLANT J, V25, P335, DOI 10.1046/j.1365-313x.2001.00982.x; Halterman DA, 2004, PLANT J, V38, P215, DOI 10.1111/j.1365-313X.2004.02032.x; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Leister RT, 2005, PLANT CELL, V17, P1268, DOI 10.1105/tpc.104.029637; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	34	526	576	7	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1098	1103		10.1126/science.1136372	http://dx.doi.org/10.1126/science.1136372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17185563				2022-12-01	WOS:000244387600029
J	Gostin, LO				Gostin, Lawrence O.			Law as a tool to facilitate healthier lifestyles and prevent obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; PUBLIC-HEALTH; PREVALENCE; OVERWEIGHT; ADULTS; INCOME		Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; [Anonymous], FREQ ASK QUEST WHO G; [Anonymous], 2005, DIET REF INT EN CARB; Blanck H. M., 2006, Morbidity and Mortality Weekly Report, V55, P985; Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007; BURROS M, 2006, NY TIMES        1007; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Epstein RA, 2005, GEORGETOWN LAW J, V93, P1361; Finkelstein EA, 2004, OBES RES, V12, P18, DOI 10.1038/oby.2004.4; Frieden TR, 2004, AM J PUBLIC HEALTH, V94, P2059, DOI 10.2105/AJPH.94.12.2059; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; *HLTH CAN, TRANSFORMING FOOD SU; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; Jacobson MF, 2000, AM J PUBLIC HEALTH, V90, P854, DOI 10.2105/AJPH.90.6.854; Mair J.S., 2005, USE ZONING RESTRICT; Mello MM, 2006, NEW ENGL J MED, V354, P2601, DOI 10.1056/NEJMhpr060227; *NAT REST ASS, STAT FRIV LAWS LEG; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Perdue WC, 2003, AM J PUBLIC HEALTH, V93, P1390, DOI 10.2105/AJPH.93.9.1390; *TRUST AM HLTH, 2004, F FAT OB POL ARE FAI; US Department of Health and Human Services, 2000, HLTH PEOPL 2010; *US GOV ACC OFF, 2003, GAO03506; *WHO REG OFF EUR, EUR CHART COUNT OB	23	86	86	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2007	297	1					87	90		10.1001/jama.297.1.87	http://dx.doi.org/10.1001/jama.297.1.87			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	123BS	17200479	Green Published			2022-12-01	WOS:000243271900025
J	Gregori, L; Gurgel, PV; Lathrop, JT; Edwardson, P; Lambert, BC; Carbonell, RG; Burton, SJ; Hammond, DJ; Rohwer, RG				Gregori, Luisa; Gurgel, Patrick V.; Lathrop, Julia T.; Edwardson, Peter; Lambert, Brian C.; Carbonell, Ruben G.; Burton, Steven J.; Hammond, David J.; Rohwer, Robert G.			Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; TRANSFUSION; COMPONENTS; TESTS	Background Transmissible spongiform encephalopathies (TSE) can be contracted through blood transfusion. Selective adsorption of the causative agent from donated blood might be one of the best ways of managing this risk. In our study, affinity resin L13, which reduces brain-derived infectivity spiked into human red blood cell concentrate by around 4 log(10)ID(50), and its equivalent, L13A, produced on a manufacturing scale, were assessed for their ability to remove TSE infectivity endogenously present in blood. Methods 500 mL of scrapie-infected hamster whole blood was leucoreduced at full scale before passage through the affinity resins. Infectivity of whole blood, leucoreduced whole blood (challenge), and the recovered blood from each flow-through was measured by limiting dilution titration. Findings Leutcoreduction removed 72% of input infectivity. 15 of 99 animals were infected by the challenge, whereas none of the 96 or 100 animals inoculated with the final flow-throughs from either resin developed the disease after 540 days. The limit of detection of the bioassay was 0 center dot 2 infectious doses per mL. The overall reduction of the challenge infectivity was more than 1 center dot 22 log(10)ID. The results showed removal of endogenous TSE infectivity from leucoreduced whole blood by affinity ligands. The same resins adsorb normal and abnormal prion protein from human infections with variant, sporadic, and familial Creutzfeldt-jakob disease, in the presence of blood components. Interpretation TSE affinity ligands, when incorporated into appropriate devices, can be used to mitigate the risks from TSE-infected blood, blood products, and other materials exposed to TSE infectivity.	Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; ProMet BioSci Ltd, Cambridge, England; Amer Red Cross Biomed R&D, Plasma Derivat Dept, Rockville, MD USA; N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); American Red Cross; University of North Carolina; North Carolina State University	Rohwer, RG (corresponding author), Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA.	rrohwer@umaryland.edu	Gurgel, Patrick/M-9749-2019; Gurgel, Patrick/C-2181-2008					BAUMBACH GA, 1992, BIOPHARM         MAY, P24; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 2005, VOX SANG, V89, P63, DOI 10.1111/j.1423-0410.2005.00683.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; FURKA A, 1991, INT J PEPT PROT RES, V37, P487, DOI 10.1111/j.1399-3011.1991.tb00765.x; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Gregori L, 2006, TRANSFUSION, V46, P1152, DOI 10.1111/j.1537-2995.2006.00865.x; HAMMOND D, Patent No. 2004050851; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; MacGregor I, 1999, VOX SANG, V77, P88; Minor PD, 2004, VOX SANG, V86, P164, DOI 10.1111/j.0042-9007.2004.00411.x; *NAT CREUTZF JAK D, 2006, VAR CREUTZF JAK DIS; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; *US DEP HHS, 2002, GUID IND REV PREV ME; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	19	70	73	1	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 23	2006	368	9554					2226	2230		10.1016/S0140-6736(06)69897-8	http://dx.doi.org/10.1016/S0140-6736(06)69897-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189034				2022-12-01	WOS:000243076800030
J	Noguera-Troise, I; Daly, C; Papadopoulos, NJ; Coetzee, S; Boland, P; Gale, NW; Lin, HC; Yancopoulos, GD; Thurston, G				Noguera-Troise, Irene; Daly, Christopher; Papadopoulos, Nicholas J.; Coetzee, Sandra; Boland, Pat; Gale, Nicholas W.; Lin, Hsin Chieh; Yancopoulos, George D.; Thurston, Gavin			Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis	NATURE			English	Article							CLINICAL-TRIALS; VEGF-TRAP; NOTCH; VASCULATURE; MOUSE; EXPRESSION; RESISTANCE; LETHALITY; THERAPY; PROTEIN	Tumour growth requires accompanying expansion of the host vasculature, with tumour progression often correlated with vascular density. Vascular endothelial growth factor (VEGF) is the best-characterized inducer of tumour angiogenesis. We report that VEGF dynamically regulates tumour endothelial expression of Delta-like ligand 4 (Dll4), which was previously shown to be absolutely required for normal embryonic vascular development. To define Dll4 function in tumour angiogenesis, we manipulated this pathway in murine tumour models using several approaches. Here we show that blockade resulted in markedly increased tumour vascularity, associated with enhanced angiogenic sprouting and branching. Paradoxically, this increased vascularity was non-productive - as shown by poor perfusion and increased hypoxia, and most importantly, by decreased tumour growth - even for tumours resistant to anti-VEGF therapy. Thus, VEGF-induced Dll4 acts as a negative regulator of tumour angiogenesis; its blockade results in a striking uncoupling of tumour growth from vessel density, presenting a novel therapeutic approach even for tumours resistant to anti-VEGF therapies.	Regeneron Pharmaceut Inc, Res Labs, Tarrytown, NY 10591 USA	Regeneron	Thurston, G (corresponding author), Regeneron Pharmaceut Inc, Res Labs, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	Gavin.Thurston@Regeneron.com	Wang, Zegen/H-3018-2011	Daly, Christopher/0000-0003-3800-8174				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Folkman J, 1992, Semin Cancer Biol, V3, P65; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gridley T, 2001, P NATL ACAD SCI USA, V98, P5377, DOI 10.1073/pnas.101138098; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jain Rakesh K, 2005, Oncology (Williston Park), V19, P7; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Karsan A, 2005, CAN J PHYSIOL PHARM, V83, P14, DOI 10.1139/Y04-125; Kerbel RS, 2001, CANCER METAST REV, V20, P79, DOI 10.1023/A:1013172910858; Krebs LT, 2001, DEV BIOL, V238, P110, DOI 10.1006/dbio.2001.0408; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Krneta J, 2006, CANCER RES, V66, P5686, DOI 10.1158/0008-5472.CAN-05-3821; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Laskin JJ, 2005, ONCOLOGY-NY, V19, P1671; Lee CG, 2000, CANCER RES, V60, P5565; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Rudge JS, 2005, COLD SH Q B, V70, P411, DOI 10.1101/sqb.2005.70.052; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shawber CJ, 2003, ANN NY ACAD SCI, V995, P162, DOI 10.1111/j.1749-6632.2003.tb03219.x; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Thurston G, 1996, AM J PHYSIOL-HEART C, V271, pH2547, DOI 10.1152/ajpheart.1996.271.6.H2547; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	34	801	913	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1032	1037		10.1038/nature05355	http://dx.doi.org/10.1038/nature05355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183313				2022-12-01	WOS:000242971100046
J	Cromie, GA; Hyppa, RW; Taylor, AF; Zakharyevich, K; Hunter, N; Smith, GR				Cromie, Gareth A.; Hyppa, Randy W.; Taylor, Andrew F.; Zakharyevich, Kseniya; Hunter, Neil; Smith, Gerald R.			Single Holliday junctions are intermediates of meiotic recombination	CELL			English	Article							DOUBLE-STRAND BREAKS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENE CONVERSION; CROSSING-OVER; FISSION YEAST; REPLICATION ORIGINS; DNA-DAMAGE; S.-POMBE	Crossing-over between homologous chromosomes facilitates their accurate segregation at the first division of meiosis. Current models for crossing-over invoke an intermediate in which homologs are connected by two crossed-strand structures called Holliday junctions. Such double Holliday junctions are a prominent intermediate in Saccharomyces cerevisiae meiosis, where they form preferentially between homologs rather than between sister chromatids. In sharp contrast, we find that single Holliday junctions are the predominant intermediate in Schizosaccharomyces pombe meiosis. Furthermore, these single Holliday junctions arise preferentially between sister chromatids rather than between homologs. We show that Mus81 is required for Holliday junction resolution, providing further in vivo evidence that the structure-specific endonuclease Mus81-Eme1 is a Holliday junction resolvase. To reconcile these observations, we present a unifying recombination model applicable for both meiosis and mitosis in which single Holliday junctions arise from single- or double-strand breaks, lesions postulated by previous models to initiate recombination.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Fred Hutchinson Cancer Center; University of California System; University of California Davis; University of California System; University of California Davis	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,POB 19024, Seattle, WA 98109 USA.	gsmith@fhcrc.org		Smith, Gerald/0000-0002-8747-1352	NIGMS NIH HHS [R01 GM031693-25, GM074223, R01 GM031693, GM031693, R56 GM031693, R01 GM074223, R01 GM074223-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM031693, R01GM031693, R01GM074223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; BENSON FE, 1994, J BIOL CHEM, V269, P5195; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; CONNOLLY B, 1991, P NATL ACAD SCI USA, V88, P6063, DOI 10.1073/pnas.88.14.6063; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Cromie GA, 2005, GENETICS, V169, P595, DOI 10.1534/genetics.104.037176; de los Santos T, 2003, GENETICS, V164, P81; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; DEVEAUX LC, 1992, GENETICS, V130, P251; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Fogg JM, 1999, BIOCHEMISTRY-US, V38, P11349, DOI 10.1021/bi990926n; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; GRIMM C, 1994, GENETICS, V136, P41; Her C, 2001, MAMM GENOME, V12, P73, DOI 10.1007/s003350010231; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kunz C, 2004, CURR BIOL, V14, pR962, DOI 10.1016/j.cub.2004.10.043; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; MESELSON MS, 1975, P NATL ACAD SCI USA, V72, P358, DOI 10.1073/pnas.72.1.358; MUNZ P, 1994, GENETICS, V137, P701; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; RADDING CM, 1982, ANNU REV GENET, V16, P405, DOI 10.1146/annurev.ge.16.120182.002201; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; SCHUCHERT P, 1988, GENETICS, V119, P507; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Smith GR, 2003, GENETICS, V165, P2289; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TEASE C, 1979, CHROMOSOMA, V73, P75, DOI 10.1007/BF00294847; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Young JA, 2002, MOL CELL, V9, P253, DOI 10.1016/S1097-2765(02)00452-5	48	154	162	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1167	1178		10.1016/j.cell.2006.09.050	http://dx.doi.org/10.1016/j.cell.2006.09.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174892	Green Accepted, Bronze			2022-12-01	WOS:000242991000015
J	Shepherd, CB				Shepherd, Charles B.			Shark cartilage in the water - Effective legislation is already in place but is not being properly used	BRITISH MEDICAL JOURNAL			English	Letter												charlesbshepherd@lineone.net						Campbell D, 1997, BRIT MED J, V315, P625; DYER O, 1994, BRIT MED J, V308, P158, DOI 10.1136/bmj.308.6922.158; Waxman J, 2006, BRIT MED J, V333, P1129, DOI 10.1136/bmj.39037.692743.59	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 9	2006	333	7580					1222	1222		10.1136/bmj.39051.725162.3A	http://dx.doi.org/10.1136/bmj.39051.725162.3A			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	119JW	17158403	Green Published			2022-12-01	WOS:000243009600031
J	Bermejo, M; Rodriguez-Teijeiro, JD; Illera, G; Barroso, A; Vila, C; Walsh, PD				Bermejo, Magdalena; Rodriguez-Teijeiro, Jose Domingo; Illera, German; Barroso, Alex; Vila, Carles; Walsh, Peter D.			Ebola outbreak killed 5000 gorillas	SCIENCE			English	Article							DECLINE; VIRUS		Ecosyst Forestiers Afrique Cent ECOFAC, Libreville, Gabon; Univ Barcelona, Dept Anim Biol, ES-08028 Barcelona, Spain; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	University of Barcelona; Max Planck Society	Bermejo, M (corresponding author), Ecosyst Forestiers Afrique Cent ECOFAC, Box Postale 15115, Libreville, Gabon.	magda_bermejo@yahoo.es	Vila, Carles/H-4893-2013; Rodriguez-Teijeiro, Jose D/G-2768-2016; Rodríguez-Teijeiro, José Domingo/AAV-7830-2021	Vila, Carles/0000-0002-4206-5246; Rodriguez-Teijeiro, Jose D/0000-0001-7787-9293; Rodríguez-Teijeiro, José Domingo/0000-0001-7787-9293				Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Formenty P, 1999, J INFECT DIS, V179, pS120, DOI 10.1086/514296; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Oates JF, 2006, PRIMATES, V47, P102, DOI 10.1007/s10329-005-0149-5; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Sleeman JM, 2004, ORYX, V38, P136, DOI 10.1017/S0030605304000237; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566	7	254	268	18	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1564	1564		10.1126/science.1133105	http://dx.doi.org/10.1126/science.1133105			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158318				2022-12-01	WOS:000242624600031
J	Holland, RA; Thorup, K; Vonhof, MJ; Cochran, WW; Wikelski, M				Holland, Richard A.; Thorup, Kasper; Vonhof, Maarten J.; Cochran, William W.; Wikelski, Martin			Navigation - Bat orientation using Earth's magnetic field	NATURE			English	Article							PIGEONS; CUES		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Copenhagen, Inst Biol, Ctr Macroecol, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Museum Zool, DK-2100 Copenhagen, Denmark; Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; Illinois Nat Hist Survey, Champaign, IL 61820 USA	Princeton University; University of Leeds; University of Copenhagen; University of Copenhagen; Western Michigan University; Illinois Natural History Survey	Holland, RA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	rahollan@princeton.edu	Thorup, Kasper/A-4835-2013; Holland, Richard A/A-6107-2010	Thorup, Kasper/0000-0002-0320-0601; Holland, Richard A/0000-0003-4495-8061				Berthold P, 2001, BIRD MIGRATION GEN S; Bonadona F, 2000, J EXP BIOL, V203, P207; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; MICHENER MC, 1967, J EXP BIOL, V47, P99; Muheim R, 2006, J EXP BIOL, V209, P2, DOI 10.1242/jeb.01960; Neuweiler G., 2000, BIOL BATS; Simmons JA., 1995, HEARING BATS SPRINGE, P146; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487	8	106	115	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					702	702		10.1038/444702a	http://dx.doi.org/10.1038/444702a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151656				2022-12-01	WOS:000242581100043
J	Muchhala, N				Muchhala, Nathan			Nectar bat stows huge tongue in its rib cage	NATURE			English	Article							POLLINATION		Univ Miami, Dept Biol, Coral Gables, FL 33143 USA	University of Miami	Muchhala, N (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33143 USA.	muchhala@bio.miami.edu	Self, Casey J/B-6871-2011; Vazquez-Dominguez, Guillermo GVD/L-7818-2014					CHAN LK, 1995, J MAMMAL, V76, P472, DOI 10.2307/1382356; Darwin C., 1862, VARIOUS CONTRIVANCES; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fleming T.H., 2005, CONTRIBUCIONES MASTO, P163; Griffiths T. A., 1982, AM MUS NOVIT, V2742, P1, DOI DOI 10.1097/; Herrel A, 2001, J EXP BIOL, V204, P3621; Muchhala N, 2005, J MAMMAL, V86, P457, DOI 10.1644/1545-1542(2005)86[457:ANSOAC]2.0.CO;2; Peikert-Holle T., 1985, BLUTEN FLEDERMAUSE; STILES FG, 1978, AM ZOOL, V18, P715; von Helversen O, 2003, BAT ECOLOGY, P346; Winter Y, 2003, J MAMMAL, V84, P886, DOI 10.1644/BWG-032	11	61	62	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					701	702		10.1038/444701a	http://dx.doi.org/10.1038/444701a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151655				2022-12-01	WOS:000242581100042
J	Redon, R; Ishikawa, S; Fitch, KR; Feuk, L; Perry, GH; Andrews, TD; Fiegler, H; Shapero, MH; Carson, AR; Chen, WW; Cho, EK; Dallaire, S; Freeman, JL; Gonzalez, JR; Gratacos, M; Huang, J; Kalaitzopoulos, D; Komura, D; MacDonald, JR; Marshall, CR; Mei, R; Montgomery, L; Nishimura, K; Okamura, K; Shen, F; Somerville, MJ; Tchinda, J; Valsesia, A; Woodwark, C; Yang, FT; Zhang, JJ; Zerjal, T; Zhang, J; Armengol, L; Conrad, DF; Estivill, X; Tyler-Smith, C; Carter, NP; Aburatani, H; Lee, C; Jones, KW; Scherer, SW; Hurles, ME				Redon, Richard; Ishikawa, Shumpei; Fitch, Karen R.; Feuk, Lars; Perry, George H.; Andrews, T. Daniel; Fiegler, Heike; Shapero, Michael H.; Carson, Andrew R.; Chen, Wenwei; Cho, Eun Kyung; Dallaire, Stephanie; Freeman, Jennifer L.; Gonzalez, Juan R.; Gratacos, Monica; Huang, Jing; Kalaitzopoulos, Dimitrios; Komura, Daisuke; MacDonald, Jeffrey R.; Marshall, Christian R.; Mei, Rui; Montgomery, Lyndal; Nishimura, Kunihiro; Okamura, Kohji; Shen, Fan; Somerville, Martin J.; Tchinda, Joelle; Valsesia, Armand; Woodwark, Cara; Yang, Fengtang; Zhang, Junjun; Zerjal, Tatiana; Zhang, Jane; Armengol, Lluis; Conrad, Donald F.; Estivill, Xavier; Tyler-Smith, Chris; Carter, Nigel P.; Aburatani, Hiroyuki; Lee, Charles; Jones, Keith W.; Scherer, Stephen W.; Hurles, Matthew E.			Global variation in copy number in the human genome	NATURE			English	Article							SEGMENTAL DUPLICATIONS; LINKAGE DISEQUILIBRIUM; DELETION POLYMORPHISM; STRUCTURAL VARIATION; GENETIC-STRUCTURE; WIDE DETECTION; DNA; SELECTION; DISEASE; REARRANGEMENTS	Copy number variation (CNV) of DNA sequences is functionally significant but has yet to be fully ascertained. We have constructed a first-generation CNV map of the human genome through the study of 270 individuals from four populations with ancestry in Europe, Africa or Asia (the HapMap collection). DNA from these individuals was screened for CNV using two complementary technologies: single-nucleotide polymorphism (SNP) genotyping arrays, and clone-based comparative genomic hybridization. A total of 1,447 copy number variable regions (CNVRs), which can encompass overlapping or adjacent gains or losses, covering 360 megabases (12% of the genome) were identified in these populations. These CNVRs contained hundreds of genes, disease loci, functional elements and segmental duplications. Notably, the CNVRs encompassed more nucleotide content per genome than SNPs, underscoring the importance of CNV in genetic diversity and evolution. The data obtained delineate linkage disequilibrium patterns for many CNVs, and reveal marked variation in copy number among populations. We also demonstrate the utility of this resource for genetic disease studies.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Affymetrix Inc, Santa Clara, CA 95051 USA; Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; Univ Toronto, Fac Med, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Ctr Genom Regulat, Genes & Dis Program, Barcelona 08003, Catalonia, Spain; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Pediat, Edmonton, AB T6G 2H7, Canada; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Pompeu Fabra Univ, Barcelona 08003, Catalonia, Spain; Natl Genotyping Ctr, Barcelona 08003, Catalonia, Spain; Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; Harvard Univ, Sch Med, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; University of Tokyo; Affymetrix; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Brigham & Women's Hospital; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Alberta; University of Alberta; University of Chicago; Pompeu Fabra University; Japan Science & Technology Agency (JST); Harvard University; Harvard Medical School	Scherer, SW (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	steve@genet.sickkids.on.ca; meh@sanger.ac.uk	Yang, Fan/GYU-4249-2022; Andrews, Dan/ABG-4815-2020; Scherer, Stephen/B-3785-2013; zerjal, tatiana/AAO-9473-2020; Gonzalez, Juan R/B-7860-2018; Komura, Daisuke/AAF-2481-2019; Redon, Richard/F-3303-2014; MacDonald, Jeffrey Robert/GLU-2255-2022; Freeman, Jennifer/L-3838-2019; Komura, Daisuke/A-1612-2011; Valsesia, Armand/F-1724-2010; Estivill, Xavier/E-2957-2012; Estivill, Xavier/A-3125-2013	Scherer, Stephen/0000-0002-8326-1999; Gonzalez, Juan R/0000-0003-3267-2146; Komura, Daisuke/0000-0002-0038-728X; Redon, Richard/0000-0001-7751-2280; Komura, Daisuke/0000-0002-0038-728X; Estivill, Xavier/0000-0002-0723-2256; MacDonald, Jeffrey/0000-0001-5058-2393; Andrews, Dan/0000-0003-3922-6376; Valsesia, Armand/0000-0003-0746-9664; Freeman, Jennifer/0000-0002-3669-9111; Yang, Fengtang/0000-0002-3573-2354	Wellcome Trust [077009, 077014, 077008] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aradhya S, 2001, HUM MOL GENET, V10, P2557, DOI 10.1093/hmg/10.22.2557; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Bridges CB, 1936, SCIENCE, V83, P210, DOI 10.1126/science.83.2148.210; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Hurles Matthew, 2005, Human Genomics, V2, P179; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Kaufman L, 2009, FINDING GROUPS DATA; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 2006, GENOMIC DISORDERS G; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; MATISE TC, 1994, AM J HUM GENET, V54, P1110; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; NEITZ M, 1995, SCIENCE, V267, P1013, DOI 10.1126/science.7863325; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Orru S, 2005, AM J HUM GENET, V76, P164, DOI 10.1086/426948; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Pritchard JK, 2000, GENETICS, V155, P945; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sasaki K, 2004, OPHTHALMIC RES, V36, P332, DOI 10.1159/000081636; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SOKAL RR, 1994, BIOMETRY; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Turgeon D, 2003, DRUG METAB DISPOS, V31, P670, DOI 10.1124/dmd.31.5.670; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Wirtenberger M, 2005, HUM GENET, V117, P389, DOI 10.1007/s00439-005-1323-y; WONG Z, 1990, GENOMICS, V7, P222, DOI 10.1016/0888-7543(90)90544-5; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456	77	3056	3299	5	363	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					444	454		10.1038/nature05329	http://dx.doi.org/10.1038/nature05329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122850	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000242215700038
J	Pearse, JS				Pearse, John S.			Perspective - Ecological role of purple sea urchins	SCIENCE			English	Editorial Material							CALIFORNIA KELP FOREST; STRONGYLOCENTROTUS-FRANCISCANUS; COMMUNITY; RECRUITMENT; GENERALITY; PATTERNS; PACIFIC; LIVE; RED		Univ Calif Santa Cruz, Long Marine Lab, Santa Cruz, CA 95060 USA	University of California System; University of California Santa Cruz	Pearse, JS (corresponding author), Univ Calif Santa Cruz, Long Marine Lab, 100 Shaffer Rd, Santa Cruz, CA 95060 USA.	pearse@biology.ucsc.edu						Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.2307/2641070; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; EBELING AW, 1985, MAR BIOL, V84, P287, DOI 10.1007/BF00392498; EBERT TA, 1994, MAR ECOL PROG SER, V111, P41, DOI 10.3354/meps111041; Ebert TA, 2003, FISH B-NOAA, V101, P915; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Harrold C., 1987, Echinoderm Studies, V2, P137; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lafferty KD, 2004, ECOL APPL, V14, P1566, DOI 10.1890/03-5088; PEARSE JS, 1987, MAR ECOL PROG SER, V39, P275, DOI 10.3354/meps039275; Rogers-Bennett L, 2001, CONSERV BIOL, V15, P642, DOI 10.1046/j.1523-1739.2001.015003642.x; Rogers-Bennett L, 2007, DEV AQUAC FISH SCI, V37, P393, DOI 10.1016/S0167-9309(07)80083-4; Sweetnam D, 2005, CAL COOP OCEAN FISH, V46, P10; Tegner MJ, 2000, ICES J MAR SCI, V57, P579, DOI 10.1006/jmsc.2000.0715; WATANABE JM, 1991, MAR ECOL PROG SER, V71, P125, DOI 10.3354/meps071125	17	108	113	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					940	941		10.1126/science.1131888	http://dx.doi.org/10.1126/science.1131888			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095690				2022-12-01	WOS:000241896000038
J	Chan, DKY				Chan, Danel Kam Yin			Obturator hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Bankstown Hosp, Bankstown, NSW 2200, Australia		Chan, DKY (corresponding author), Bankstown Hosp, Bankstown, NSW 2200, Australia.	Daniel.chan@swsahs.nsw.gov.au							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1714	1714		10.1056/NEJMicm050862	http://dx.doi.org/10.1056/NEJMicm050862			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050895				2022-12-01	WOS:000241357300012
J	Carpenter, SR; DeFries, R; Dietz, T; Mooney, HA; Polasky, S; Reid, WV; Scholes, RJ				Carpenter, Stephen R.; DeFries, Ruth; Dietz, Thomas; Mooney, Harold A.; Polasky, Stephen; Reid, Walter V.; Scholes, Robert J.			Millennium Ecosystem Assessment: Research needs	SCIENCE			English	Editorial Material							SCIENCE; POLICY		Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Univ Maryland, Dept Geog, College Pk, MD 20742 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Michigan State Univ, Environm Sci & Policy Program, E Lansing, MI 48824 USA; Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; CSIR, ZA-0001 Pretoria, South Africa	Stanford University; University of Wisconsin System; University of Wisconsin Madison; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Michigan State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Council for Scientific & Industrial Research (CSIR) - South Africa	Mooney, HA (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	hmooney@stanford.edu	Carpenter, Stephen/AAQ-6404-2020; Polasky, Stephen/AAC-5341-2019	Scholes, Robert/0000-0001-5537-6935; Dietz, Thomas/0000-0001-9399-0784				CAMPBELL DT, 1969, AM PSYCHOL, V24, P409, DOI 10.1037/h0027982; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; John Heinz H., 2002, STAT NAT EC MEAS LAN; Kinzig AP, 2003, AMBIO, V32, P330, DOI 10.1639/0044-7447(2003)032[0330:CWUACF]2.0.CO;2; McNeely JA, 2005, ECOSYSTEMS HUMAN WEL, V3, P119; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING GL; National Research Council, 2004, VAL EC SERV BETT ENV; National Research Council, 2000, EC IND NAT; Ostrom E., 2002, DRAMA COMMONS, DOI 10.17226/10287; Sarewitz D.R., 2000, PREDICTION SCI DECIS; Sathirathai S, 2001, CONTEMP ECON POLICY, V19, P109, DOI 10.1093/cep/19.2.109; SIZER N, 2005, ECOSYSTEMS HUMAN WEL, V3, P257; York R, 2002, SOC SCI QUART, V83, P18, DOI 10.1111/1540-6237.00068	15	341	371	35	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					257	258		10.1126/science.1131946	http://dx.doi.org/10.1126/science.1131946			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093TV	17038608				2022-12-01	WOS:000241194100025
J	Grabe, M; Lai, HC; Jain, M; Jan, YN; Jan, LY				Grabe, Michael; Lai, Helen C.; Jain, Monika; Jan, Yuh Nung; Jan, Lily Yeh			Structure prediction for the down state of a potassium channel voltage sensor	NATURE			English	Article							DEPENDENT K+ CHANNEL; GATING-CHARGE; PORE DOMAIN; MOLECULAR-MOVEMENT; CRYSTAL-STRUCTURE; S4; DISPLACEMENT; KAT1	Voltage-gated potassium (Kv) channels, essential for regulating potassium uptake and cell volume in plants and electrical excitability in animals, switch between conducting and non-conducting states as a result of conformational changes in the four voltage-sensing domains (VSDs) that surround the channel pore(1\). This process, known as gating, is initiated by a cluster of positively charged residues on the fourth transmembrane segment (S4) of each VSD, which drives the VSD into a 'down state' at negative voltages and an 'up state' at more positive voltages(2). The crystal structure of Kv1.2 probably corresponds to the up state(3), but the local environment of S4 in the down state and its motion in voltage gating remains unresolved(4-6). Here we employed several conditional lethal/second-site suppressor yeast screens to determine the transmembrane packing of the VSD in the down state. This screen relies on the ability of KAT1, a eukaryotic Kv channel, to conduct potassium when its VSDs are in the down state, thereby rescuing potassium-transport-deficient yeast(7). Starting with KAT1 channels bearing conditional lethal mutations, we identified second-site suppressor mutations throughout the VSD that recover yeast growth. We then constructed a down state model of the channel using six pairs of interacting residues as structural constraints and verified this model by engineering suppressor mutations on the basis of spatial considerations. A comparison of this down state model with the up state Kv1.2 structure suggests that the VSDs undergo large rearrangements during gating, whereas the S4 segment remains positioned between the central pore and the remainder of the VSD in both states.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu	Grabe, Michael/B-3705-2009	Lai, Helen/0000-0003-4334-0243; Jan, Lily/0000-0003-3938-8498				ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Broomand A, 2003, J GEN PHYSIOL, V122, P741, DOI 10.1085/jgp.200308927; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.bi.55.070186.004513; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Hille B., 2001, ION CHANNELS EXCITAB, V3; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1016/S0022-2836(95)80064-6; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047	28	62	63	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					550	553		10.1038/nature05494	http://dx.doi.org/10.1038/nature05494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17187053				2022-12-01	WOS:000243867300046
J	Crosas, B; Hanna, J; Kirkpatrick, DS; Zhang, DP; Tone, Y; Hathaway, NA; Buecker, C; Leggett, DS; Schmidt, M; King, RW; Gygi, SP; Finley, D				Crosas, Bernat; Hanna, John; Kirkpatrick, Donald S.; Zhang, Dan Phoebe; Tone, Yoshiko; Hathaway, Nathaniel A.; Buecker, Christa; Leggett, David S.; Schmidt, Marion; King, Randall W.; Gygi, Steven P.; Finley, Daniel			Ubiquitin chains are remodeled at the proteasome by opposing ubiquitin ligase and deubiquitinating activities	CELL			English	Article							26 S-PROTEASOME; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; CONJUGATING ENZYMES; PROTEIN COMPLEXES; DEGRADATION; SUBSTRATE; IDENTIFICATION; RECEPTORS; RAD23	The ubiquitin ligase Hul5 was recently identified as a component of the proteasome, a multisubunit protease that degrades ubiquitin-protein conjugates. We report here a proteasome-dependent conjugating activity of Hul5 that endows proteasomes with the capacity to extend ubiquitin chains. hul5 mutants show reduced degradation of multiple proteasome substrates in vivo, suggesting that the polyubiquitin signal that targets substrates to the proteasome can be productively amplified at the proteasome. However, the products of Hul5 conjugation are subject to disassembly by a proteasome-bound deubiquitinating enzyme, Ubp6. A hul5 null mutation suppresses a ubp6 null mutation, suggesting that a balance of chain-extending and chain-trimming activities is required for proper proteasome function. As the association of Hul5 with proteasomes was found to be strongly stabilized by Ubp6, these enzymes may be situated in proximity to one another. We propose that through dynamic remodeling of ubiquitin chains, proteasomes actively regulate substrate commitment to degradation.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; CSIC, Inst Biol Mol Barcelona, ES-08034 Barcelona, Spain	Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu		Buecker, Christa/0000-0003-3055-2642; Kirkpatrick, Donald/0000-0003-3091-2804; King, Randall/0000-0001-7882-8180	NIGMS NIH HHS [GM65592, GM67945, GM66492] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945, R01GM065592, R01GM066492, R56GM066492] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Cagney G, 2001, PHYSIOL GENOMICS, V7, P27, DOI 10.1152/physiolgenomics.2001.7.1.27; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chuang SM, 2005, GENETICS, V171, P1477, DOI 10.1534/genetics.105.046888; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Kajava AV, 2002, J BIOL CHEM, V277, P49791, DOI 10.1074/jbc.M204982200; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Madura K, 2004, TRENDS BIOCHEM SCI, V29, P637, DOI 10.1016/j.tibs.2004.10.008; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Seeger M, 2003, J BIOL CHEM, V278, P16791, DOI 10.1074/jbc.M208281200; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tongaonkar P, 2000, MOL CELL BIOL, V20, P4691, DOI 10.1128/MCB.20.13.4691-4698.2000; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200	47	234	251	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1401	1413		10.1016/j.cell.2006.09.051	http://dx.doi.org/10.1016/j.cell.2006.09.051			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190603	Bronze			2022-12-01	WOS:000243690000019
J	Keller, LP; Bajt, S; Baratta, GA; Borg, J; Bradley, JP; Brownlee, DE; Busemann, H; Brucato, JR; Burchell, M; Colangeli, L; d'Hendecourt, L; Djouadi, Z; Ferrini, G; Flynn, G; Franchi, IA; Fries, M; Grady, MM; Graham, GA; Grossemy, F; Kearsley, A; Matrajt, G; Nakamura-Messenger, K; Mennella, V; Nittler, L; Palumbo, ME; Stadermann, FJ; Tsou, P; Rotundi, A; Sandford, SA; Snead, C; Steele, A; Wooden, D; Zolensky, M				Keller, Lindsay P.; Bajt, Sasa; Baratta, Giuseppe A.; Borg, Janet; Bradley, John P.; Brownlee, Don E.; Busemann, Henner; Brucato, John R.; Burchell, Mark; Colangeli, Luigi; d'Hendecourt, Louis; Djouadi, Zahia; Ferrini, Gianluca; Flynn, George; Franchi, Ian A.; Fries, Marc; Grady, Monica M.; Graham, Giles A.; Grossemy, Faustine; Kearsley, Anton; Matrajt, Graciela; Nakamura-Messenger, Keiko; Mennella, Vito; Nittler, Larry; Palumbo, Maria E.; Stadermann, Frank J.; Tsou, Peter; Rotundi, Alessandra; Sandford, Scott A.; Snead, Christopher; Steele, Andrew; Wooden, Diane; Zolensky, Mike			Infrared spectroscopy of comet 81P/Wild 2 samples returned by Stardust	SCIENCE			English	Article							DIFFUSE INTERSTELLAR-MEDIUM; ORGANIC-MATTER; DUST; SPECTROPHOTOMETRY; MINERALOGY	Infrared spectra of material captured from comet 81P/Wild 2 by the Stardust spacecraft reveal indigenous aliphatic hydrocarbons similar to those in interplanetary dust particles thought to be derived from comets, but with longer chain lengths than those observed in the diffuse interstellar medium. Similarly, the Stardust samples contain abundant amorphous silicates in addition to crystalline silicates such as olivine and pyroxene. The presence of crystalline silicates in Wild 2 is consistent with mixing of solar system and interstellar matter. No hydrous silicates or carbonate minerals were detected, which suggests a lack of aqueous processing of Wild 2 dust.	NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Osserv Astrofis Catania, INAF, I-95123 Catania, Italy; Inst Astrophys Spatiale, F-91405 Orsay, France; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Univ Kent, Sch Phys Sci, Canterbury CT2 7NR, Kent, England; Novaetech SRL, I-80125 Naples, Italy; SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; Open Univ, Milton Keynes MK7 6AA, Bucks, England; Nat Hist Museum, Dept Mineral, London SW7 5BD, England; NASA, Lyndon B Johnson Space Ctr, Engn Sci Contract Grp, Houston, TX 77058 USA; Washington Univ, Space Sci Lab, St Louis, MO 63160 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Napoli Parthenope, Dipartimento Sci Applicate, I-80133 Naples, Italy; NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Washington; University of Washington Seattle; Carnegie Institution for Science; Istituto Nazionale Astrofisica (INAF); University of Kent; State University of New York (SUNY) System; SUNY Plattsburgh; Open University - UK; Natural History Museum London; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Parthenope University Naples; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley	Keller, LP (corresponding author), NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci Directorate, Mail Code KR, Houston, TX 77058 USA.	lindsay.p.keller@nasa.gov	Appourchaux, Thierry/F-4692-2010; Bajt, Sasa/G-2228-2010; Bajt, Sasa/O-4695-2019; Steele, Andrew/A-3573-2013; Matrajt, Graciela/A-4812-2017; Baratta, Giuseppe/AAY-6188-2021; 1.4, ALS Beamline/I-1886-2014	Bajt, Sasa/0000-0002-7163-7602; Steele, Andrew/0000-0001-9643-2841; Busemann, Henner/0000-0002-0867-6908; Baratta, Giuseppe/0000-0002-3688-160X; Zolensky, Michael/0000-0002-3181-1303; Grady, Monica/0000-0002-4055-533X; Palumbo, MariaElisabetta/0000-0002-9122-491X; Brucato, John Robert/0000-0002-4738-5521; Colangeli, Luigi/0000-0001-6801-9152; Mennella, Vito/0000-0001-9525-895X; Burchell, Mark/0000-0002-2680-8943; Rotundi, Alessandra/0000-0001-5467-157X				Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; BRADLEY JP, 2004, TREATISE GEOCHEMISTR, V1, P1121; BREGMAN JD, 1988, ASTROPHYS J, V334, P1044, DOI 10.1086/166896; BREGMAN JD, 1987, ASTRON ASTROPHYS, V187, P616; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; CAMPINS H, 1989, ASTROPHYS J, V341, P1059, DOI 10.1086/167563; Chiar JE, 2000, ASTROPHYS J, V537, P749, DOI 10.1086/309047; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; Dartois E, 2004, ASTRON ASTROPHYS, V423, P549, DOI 10.1051/0004-6361:20047067; DISANTI MA, 1995, ICARUS, V116, P1, DOI 10.1006/icar.1995.1110; Dorschner J, 1995, ASTRON ASTROPHYS REV, V6, P271, DOI 10.1007/BF00873686; EHRENFREUND P, 1991, ASTRON ASTROPHYS, V252, P712; Flynn GJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4791, DOI 10.1016/j.gca.2003.09.001; FLYNN GJ, 2003, WORKSH COM DUST ASTR; Gardinier A, 2000, EARTH PLANET SC LETT, V184, P9, DOI 10.1016/S0012-821X(00)00300-9; Harker DE, 2002, ASTROPHYS J, V580, P579, DOI 10.1086/343091; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; KELLER LP, 2004, LUNAR PLANET SCI, V35, P1985; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Kemper F, 2005, ASTROPHYS J, V633, P534, DOI 10.1086/447764; Lisse CM, 2006, SCIENCE, V313, P635, DOI 10.1126/science.1124694; Matrajt G, 2005, ASTRON ASTROPHYS, V433, P979, DOI 10.1051/0004-6361:20041605; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Molster FJ, 2003, LECT NOTES PHYS, V609, P121; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1172; PENDLETON YJ, 1994, ASTROPHYS J, V437, P683, DOI 10.1086/175031; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Rietmeijer F.J.M., 1998, PLANETARY MAT, V36; SANDFORD SA, 1991, ASTROPHYS J, V371, P607, DOI 10.1086/169925; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Whittet DCB, 1997, ASTROPHYS J, V490, P729, DOI 10.1086/304914; Wooden DH, 1999, ASTROPHYS J, V517, P1034, DOI 10.1086/307206; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	33	145	146	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1728	1731		10.1126/science.1135796	http://dx.doi.org/10.1126/science.1135796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170293				2022-12-01	WOS:000242833600045
J	Azaele, S; Pigolotti, S; Banavar, JR; Maritan, A				Azaele, Sandro; Pigolotti, Simone; Banavar, Jayanth R.; Maritan, Amos			Dynamical evolution of ecosystems	NATURE			English	Article							NEUTRAL THEORY; VEGETATION DYNAMICS; SPECIES ABUNDANCE; BETA-DIVERSITY; FOREST; COMMUNITIES; MODEL	The assembly of an ecosystem such as a tropical forest depends crucially on the species interaction network, and the deduction of its rules is a formidably complex problem(1). In spite of this, many recent studies(2-16) using Hubbell's neutral theory of biodiversity and biogeography(2) have demonstrated that the resulting emergent macroscopic behaviour of the ecosystem at or near a stationary state shows a surprising simplicity reminiscent of many physical systems(17). Indeed the symmetry postulate(2), that the effective birth and death rates are species-independent within a single trophic level, allows one to make analytical predictions for various static distributions such as the relative species abundance(3-12), beta-diversity(13-15) and the species - area relationship(16). In contrast, there have only been a few studies of the dynamics and stability of tropical rain forests(18-20). Here we consider the dynamical behaviour of a community, and benchmark it against the exact predictions of a neutral model near or at stationarity. In addition to providing a description of the relative species abundance, our analysis leads to a quantitative understanding of the species turnover distribution and extinction times, and a measure of the temporal scales of neutral evolution. Our model gives a very good description of the large quantity of data collected in Barro Colorado Island in Panama in the period 1990 - 2000 with just three ecologically relevant parameters and predicts the dynamics of extinction of the existing species.	Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; Niels Bohr Inst, DK-2100 Copenhagen, Denmark	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Padua; University of Copenhagen; Niels Bohr Institute	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA.	banavar@psu.edu; maritan@pd.infn.it	Azaele, Sandro/B-2444-2008; Pigolotti, Simone/AAU-2395-2021; Azaele, Sandro/AAN-8986-2020; Azaele, Sandro/N-1137-2013	Pigolotti, Simone/0000-0002-6157-6906; Azaele, Sandro/0000-0002-5153-4833; Azaele, Sandro/0000-0002-5153-4833; Maritan, Amos/0000-0002-3535-7873				Abramowitz M., 1964, HDB MATH FUNCTIONS F; Adler PB, 2004, ECOLOGY, V85, P1265, DOI 10.1890/03-0602; Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; Durrett R, 1996, J THEOR BIOL, V179, P119, DOI 10.1006/jtbi.1996.0053; Etienne RS, 2005, ECOL LETT, V8, P1147, DOI 10.1111/j.1461-0248.2005.00817.x; FOSTER DR, 1993, ECOLOGY, V74, P982, DOI 10.2307/1940468; Gilbert B, 2006, AM NAT, V168, P304, DOI 10.1086/506969; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Harte J, 2003, NATURE, V424, P1006, DOI 10.1038/4241006a; Hilborn Ray, 1997, V28; Hubbell Stephen P., 2001, V32, pi; McKane A, 2000, PHYS REV E, V62, P8466, DOI 10.1103/PhysRevE.62.8466; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Pigolotti S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011916; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Sheil D, 2000, J TROP ECOL, V16, P765, DOI 10.1017/S0266467400001723; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Zillio T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098101	29	85	87	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					926	928		10.1038/nature05320	http://dx.doi.org/10.1038/nature05320			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167485				2022-12-01	WOS:000242805400055
J	Hafner, M; Schmitz, A; Grune, I; Srivatsan, SG; Paul, B; Kolanus, W; Quast, T; Kremmer, E; Bauer, I; Famulok, M				Hafner, Markus; Schmitz, Anton; Gruene, Imke; Srivatsan, Seergazhi G.; Paul, Bianca; Kolanus, Waldemar; Quast, Thomas; Kremmer, Elisabeth; Bauer, Inga; Famulok, Michael			Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; NUCLEOTIDE-EXCHANGE FACTOR; GTP-BINDING PROTEINS; GUANINE-NUCLEOTIDE; BREFELDIN-A; ARF; MICE; DISRUPTION; ACTIVATION; MECHANISM	G proteins are an important class of regulatory switches in all living systems. They are activated by guanine nucleotide exchange factors (GEFs), which facilitate the exchange of GDP for GTP(1,2). This activity makes GEFs attractive targets for modulating disease-relevant G-protein-controlled signalling networks(3-5). GEF inhibitors are therefore of interest as tools for elucidating the function of these proteins and for therapeutic intervention; however, only one small molecule GEF inhibitor, brefeldin A (BFA), is currently available(6-9). Here we used an aptamer displacement screen to identify SecinH3, a small molecule antagonist of cytohesins. The cytohesins are a class of BFA-resistant small GEFs for ADP-ribosylation factors (ARFs), which regulate cytoskeletal organization(10), integrin activation(11) or integrin signalling(12). The application of SecinH3 in human liver cells showed that insulin-receptor-complex-associated cytohesins are required for insulin signalling. SecinH3-treated mice show increased expression of gluconeogenic genes, reduced expression of glycolytic, fatty acid and ketone body metabolism genes in the liver, reduced liver glycogen stores, and a compensatory increase in plasma insulin. Thus, cytohesin inhibition results in hepatic insulin resistance. Because insulin resistance is among the earliest pathological changes in type 2 diabetes, our results show the potential of chemical biology for dissecting the molecular pathogenesis of this disease.	Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES Program Unit Chem Biol & Med Chem, D-53121 Bonn, Germany; Univ Bonn, Lab Mol Immunol, LIMES Program Unit Mol Immune & Cell Biol, D-53115 Bonn, Germany; GSF Forschungszentrum Umwelt & Gesundheit, Inst Mol Immunol, D-81377 Munich, Germany	University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Famulok, M (corresponding author), Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES Program Unit Chem Biol & Med Chem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	m.famulok@uni-bonn.de	Hafner, Markus/O-7100-2018	Hafner, Markus/0000-0002-4336-6518				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Malecki MT, 2005, DIABETES RES CLIN PR, V68, pS10, DOI 10.1016/j.diabres.2005.03.003; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mora A, 2005, BIOCHEM J, V385, P639, DOI 10.1042/BJ20041782; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Moss J, 1998, J BIOL CHEM, V273, P21431, DOI 10.1074/jbc.273.34.21431; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	30	195	205	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					941	944		10.1038/nature05415	http://dx.doi.org/10.1038/nature05415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167487				2022-12-01	WOS:000242805400059
J	Hosie, AM; Wilkins, ME; da Silva, HMA; Smart, TG				Hosie, Alastair M.; Wilkins, Megan E.; da Silva, Helena M. A.; Smart, Trevor G.			Endogenous neurosteroids regulate GABA(A) receptors through two discrete transmembrane sites	NATURE			English	Article							AMINOBUTYRIC-ACID RECEPTOR; NEUROACTIVE STEROIDS; A RECEPTOR; STRESS; BRAIN; ACCESSIBILITY; MODULATION; MECHANISMS; RESIDUES; SUBUNIT	Inhibitory neurotransmission mediated by GABA(A) receptors can be modulated by the endogenous neurosteroids, allopregnanolone and tetrahydro-deoxycorticosterone(1). Neurosteroids are synthesized de novo in the brain during stress(2), pregnancy(3) and after ethanol consumption(4), and disrupted steroid regulation of GABAergic transmission is strongly implicated in several debilitating conditions such as panic disorder, major depression, schizophrenia, alcohol dependence and catamenial epilepsy(3,5-8). Determining how neurosteroids interact with the GABA(A) receptor is a prerequisite for understanding their physiological and pathophysiological roles in the brain. Here we identify two discrete binding sites in the receptor's transmembrane domains that mediate the potentiating and direct activation effects of neurosteroids. They potentiate GABA responses from a cavity formed by the alpha-subunit transmembrane domains, whereas direct receptor activation is initiated by interfacial residues between alpha and beta subunits and is enhanced by steroid binding to the potentiation site. Thus, significant receptor activation by neurosteroids relies on occupancy of both the activation and potentiation sites. These sites are highly conserved throughout the GABA(A) receptor family, and their identification provides a unique opportunity for the development of new therapeutic, neurosteroid-based ligands and transgenic disease models of neurosteroid dysfunction.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Hosie, AM (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	alastair.hosie@ucl.ac.uk; t.smart@ucl.ac.uk		Wilkins, Megan/0000-0003-0150-4457	Medical Research Council [G0601529] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Akk G, 2005, J NEUROSCI, V25, P11605, DOI 10.1523/JNEUROSCI.4173-05.2005; Backstrom T, 2003, ANN NY ACAD SCI, V1007, P42, DOI 10.1196/annals.1286.005; Barbaccia ML, 1997, BRIT J PHARMACOL, V120, P1582, DOI 10.1038/sj.bjp.0701046; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Belelli D, 2003, J NEUROSCI, V23, P10013; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; CHEN RT, 1994, P NATL ACAD SCI USA, V91, P6069, DOI 10.1073/pnas.91.13.6069; Eser D, 2006, NEUROSCIENCE, V138, P1041, DOI 10.1016/j.neuroscience.2005.07.007; Finn DA, 2004, PHARMACOL THERAPEUT, V101, P91, DOI 10.1016/j.pharmthera.2003.10.006; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; Jung SW, 2005, J BIOL CHEM, V280, P308, DOI 10.1074/jbc.M409871200; Kumar S, 2004, PHARMACOL THERAPEUT, V101, P211, DOI 10.1016/j.pharmthera.2003.12.001; Lobo IA, 2004, J BIOL CHEM, V279, P33919, DOI 10.1074/jbc.M313941200; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Marx CE, 2006, NEUROPSYCHOPHARMACOL, V31, P1249, DOI 10.1038/sj.npp.1300952; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Reddy DS, 2003, TRENDS PHARMACOL SCI, V24, P103, DOI 10.1016/S0165-6147(03)00023-3; Rick CE, 1998, NEUROREPORT, V9, P379, DOI 10.1097/00001756-199802160-00004; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Stoffel-Wagner B, 2003, ANN NY ACAD SCI, V1007, P64, DOI 10.1196/annals.1286.007; Trudell JR, 2004, J MOL GRAPH MODEL, V23, P39, DOI 10.1016/j.jmgm.2004.03.004; Ueno S, 2004, FEBS LETT, V566, P213, DOI 10.1016/j.febslet.2004.04.030; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Zhu WJ, 1997, J NEUROSCI, V17, P4022	28	532	550	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					486	489		10.1038/nature05324	http://dx.doi.org/10.1038/nature05324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17108970				2022-12-01	WOS:000242215700046
J	Pennacchio, LA; Ahituv, N; Moses, AM; Prabhakar, S; Nobrega, MA; Shoukry, M; Minovitsky, S; Dubchak, I; Holt, A; Lewis, KD; Plajzer-Frick, I; Akiyama, J; De Val, S; Afzal, V; Black, BL; Couronne, O; Eisen, MB; Visel, A; Rubin, EM				Pennacchio, Len A.; Ahituv, Nadav; Moses, Alan M.; Prabhakar, Shyam; Nobrega, Marcelo A.; Shoukry, Malak; Minovitsky, Simon; Dubchak, Inna; Holt, Amy; Lewis, Keith D.; Plajzer-Frick, Ingrid; Akiyama, Jennifer; De Val, Sarah; Afzal, Veena; Black, Brian L.; Couronne, Olivier; Eisen, Michael B.; Visel, Axel; Rubin, Edward M.			In vivo enhancer analysis of human conserved non-coding sequences	NATURE			English	Article							EXPRESSION; GENE; MUTATIONS; FORKHEAD; DOMAINS; SALL1	Identifying the sequences that direct the spatial and temporal expression of genes and defining their function in vivo remains a significant challenge in the annotation of vertebrate genomes. One major obstacle is the lack of experimentally validated training sets. In this study, we made use of extreme evolutionary sequence conservation as a filter to identify putative gene regulatory elements, and characterized the in vivo enhancer activity of a large group of non-coding elements in the human genome that are conserved in human-pufferfish, Takifugu (Fugu) rubripes, or ultra-conserved(1) in human-mouse-rat. Wetested 167 of these extremely conserved sequences in a transgenic mouse enhancer assay. Here we report that 45% of these sequences functioned reproducibly as tissue-specific enhancers of gene expression at embryonic day 11.5. While directing expression in a broad range of anatomical structures in the embryo, the majority of the 75 enhancers directed expression to various regions of the developing nervous system. We identified sequence signatures enriched in a subset of these elements that targeted forebrain expression, and used these features to rank all 3,100 non-coding elements in the human genome that are conserved between human and Fugu. The testing of the top predictions in transgenic mice resulted in a threefold enrichment for sequences with forebrain enhancer activity. These data dramatically expand the catalogue of human gene enhancers that have been characterized in vivo, and illustrate the utility of such training sets for a variety of biological applications, including decoding the regulatory vocabulary of the human genome.	US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Pennacchio, LA (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	LAPennacchio@lbl.gov	Couronne, Olivier Couronne/G-1244-2012; Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; Eisen, Michael/0000-0002-7528-738X; Ahituv, Nadav/0000-0002-7434-8144; Black, Brian/0000-0002-6664-8913; Pennacchio, Len/0000-0002-8748-3732				Ahituv N, 2005, HUM MOL GENET, V14, P3057, DOI 10.1093/hmg/ddi338; Bard JBL, 1998, MECH DEVELOP, V74, P111, DOI 10.1016/S0925-4773(98)00069-0; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Buck A, 2001, MECH DEVELOP, V104, P143, DOI 10.1016/S0925-4773(01)00364-1; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Davidson EH, 2001, GENOMIC REGULATORY S; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; GOLDBERG ML, 1979, THESIS STANFORD U; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kurokawa D, 2004, DEVELOPMENT, V131, P3319, DOI 10.1242/dev.01220; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Zhou JM, 1998, P NATL ACAD SCI USA, V95, P13483, DOI 10.1073/pnas.95.23.13483	29	847	880	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					499	502		10.1038/nature05295	http://dx.doi.org/10.1038/nature05295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17086198	Green Submitted			2022-12-01	WOS:000242215700049
J	Chertow, DS; Tan, ET; Maslanka, SE; Schulte, J; Bresnitz, EA; Weisman, RS; Bernstein, J; Marcus, SM; Kumar, S; Malecki, J; Sobel, J; Braden, CR				Chertow, Daniel S.; Tan, Esther T.; Maslanka, Susan E.; Schulte, Joann; Bresnitz, Eddy A.; Weisman, Richard S.; Bernstein, Jeffrey; Marcus, Steven M.; Kumar, Savita; Malecki, Jean; Sobel, Jeremy; Braden, Christopher R.			Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOXIN	Context Botulism is a potentially lethal paralytic disease caused primarily by toxins of the anaerobic, spore-forming bacterium Clostridium botulinum. Although botulinum toxin A is available by prescription for cosmetic and therapeutic use, no cases of botulism with detectable serum toxin have previously been attributed to cosmetic or therapeutic botulinum toxin injections. On November 27, 2004, 4 suspected botulism case-patients with a link to cosmetic botulinum toxin injections were reported to the Centers for Disease Control and Prevention. Objective To investigate the clinical, epidemiological, and laboratory aspects of 4 suspected cases of iatrogenic botulism. Design, Setting, and Patients Case series on 4 botulism case-patients. Main Outcome Measures Clinical characteristics of the 4 case-patients, epidemiological associations, and mouse bioassay neutralization test results from case-patient specimens and a toxin sample. Results Clinical characteristics of the 4 case-patients were consistent with those of naturally occurring botulism. All case-patients had been injected with a highly concentrated, unlicensed preparation of botulinum toxin A and may have received doses 2857 times the estimated human lethal dose by injection. Pretreatment serum toxin levels in 3 of the 4 case-patients were equivalent to 21 to 43 times the estimated human lethal dose; pretreatment serum from the fourth epidemiologically linked case-patient was not available. A 100-mu g vial of toxin taken from the same manufacturer's lot as toxin administered to the case-patients contained a toxin amount sufficient to kill approximately 14 286 adults by injection if disseminated evenly. Conclusions These laboratory-confirmed cases of botulism demonstrate that clinical use of unlicensed botulinum toxin A can result in severe, life-threatening illness. Further education and regulation are needed to prevent the inappropriate marketing, sale, and clinical use of unlicensed botulinum toxin products.	Florida Dept Hlth, Bur Epidemiol, Div Dis Control, Tallahassee, FL 32399 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Foodborne Bacterial & Mycot Dis, Natl Ctr Zoonot Vectorborne & Enter Dis, Atlanta, GA USA; State New Jersey Dept Hlth & Senior Serv, Div Epidemiol Environm & Occupat Hlth, Trenton, NJ USA; Univ Miami, Miller Sch Med, Miami, FL 33152 USA; Florida Poison Informat Ctr, Miami, FL USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; New Jersey Poison Informat & Educ Syst, Newark, NJ USA; Florida Dept Hlth, Palm Beach Cty Hlth Dept, Div Epidemiol & Dis Control, W Palm Beach, FL USA	Florida Department of Health; Centers for Disease Control & Prevention - USA; University of Miami; Rutgers State University New Brunswick; Rutgers State University Medical Center; Florida Department of Health	Chertow, DS (corresponding author), Florida Dept Hlth, Bur Epidemiol, Div Dis Control, 2585 Merchants Row Blvd,Prather Bldg,Room 310F, Tallahassee, FL 32399 USA.	sindia4@hotmail.com						Bakheit AMO, 1997, J NEUROL NEUROSUR PS, V62, P198, DOI 10.1136/jnnp.62.2.198; *CDCP, SEL AG PROGR; Centers for Disease Control and Prevention, 1998, BOT US 1899 1996 HDB; Chang GY, 2003, EUR NEUROL, V49, P151, DOI 10.1159/000069073; COMELLA CL, 1992, NEUROLOGY, V42, P1307, DOI 10.1212/WNL.42.7.1307; HERRERO BA, 1967, EXP MOL PATHOL, V6, P84, DOI 10.1016/0014-4800(67)90007-X; *MICR INC, 1974, MICR HEALTHC SER DAT; Sandrock CE, 2001, CHEST, V120, P562, DOI 10.1378/chest.120.2.562; SCOTT AB, 1988, MOVEMENT DISORD, V3, P333, DOI 10.1002/mds.870030409; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4	10	90	97	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 22	2006	296	20					2476	2479		10.1001/jama.296.20.2476	http://dx.doi.org/10.1001/jama.296.20.2476			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KR	17119144	Bronze			2022-12-01	WOS:000242171000029
J	Kapanidis, AN; Margeat, E; Ho, SO; Kortkhonjia, E; Weiss, S; Ebright, RH				Kapanidis, Achillefs N.; Margeat, Emmanuel; Ho, Sam On; Kortkhonjia, Ekaterine; Weiss, Shimon; Ebright, Richard H.			Initial transcription by RNA polymerase proceeds through a DNA-scrunching mechanism	SCIENCE			English	Article							STRUCTURAL ORGANIZATION; PROMOTER CLEARANCE; ELONGATION; HOLOENZYME; BUBBLE; RELEASE	Using fluorescence resonance energy transfer to monitor distances within single molecules of abortively initiating transcription initiation complexes, we show that initial transcription proceeds through a "scrunching'' mechanism, in which RNA polymerase ( RNAP) remains fixed on promoter DNA and pulls downstream DNA into itself and past its active center. We show further that putative alternative mechanisms for RNAP active-center translocation in initial transcription, involving "transient excursions" of RNAP relative to DNA or "inchworming" of RNAP relative to DNA, do not occur. The results support a model in which a stressed intermediate, with DNA-unwinding stress and DNA-compaction stress, is formed during initial transcription, and in which accumulated stress is used to drive breakage of interactions between RNAP and promoter DNA and between RNAP and initiation factors during promoter escape.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; Univ Oxford, IRC Bionanotechnol, Oxford OX1 3PU, England; Rutgers State Univ, Dept Chem, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oxford; University of Oxford; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kapanidis, AN (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	a.kapanidis1@physics.ox.ac.uk; sweiss@chem.ucla.edu; ebright@waksman.rutgers.edu	weiss, shimon/B-4164-2009; Ebright, Richard/O-3321-2019; Margeat, Emmanuel/AAY-9167-2021	weiss, shimon/0000-0002-0720-5426; Ebright, Richard/0000-0001-8915-7140; Margeat, Emmanuel/0000-0001-6063-6420	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, R01GM069709, R37GM041376] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM041376, GM41376, R01 GM069709, R01 GM069709-01A1, R01 GM041376-18, R01 GM041376, R01 GM041376-15, R01 GM041376-16, GM069709-01, R01 GM041376-17] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Brieba LG, 2001, EMBO J, V20, P6826, DOI 10.1093/emboj/20.23.6826; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Esposito EA, 2004, J BIOL CHEM, V279, P44270, DOI 10.1074/jbc.M407688200; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Margeat E, 2006, BIOPHYS J, V90, P1419, DOI 10.1529/biophysj.105.069252; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3	29	307	315	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1144	1147		10.1126/science.1131399	http://dx.doi.org/10.1126/science.1131399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110578	Green Accepted			2022-12-01	WOS:000242045800044
J	Johnson, DM; Liebhold, AM; Tobin, PC; Bjornstad, ON				Johnson, Derek M.; Liebhold, Andrew M.; Tobin, Patrick C.; Bjornstad, Ottar N.			Allee effects and pulsed invasion by the gypsy moth	NATURE			English	Article							BIOLOGICAL INVASIONS; INSECT OUTBREAKS; NORTH-AMERICA; SPREAD; LYMANTRIIDAE; LEPIDOPTERA; DISPERSAL; DYNAMICS; POPULATIONS; SYNCHRONY	Biological invasions pose considerable threats to the world's ecosystems (1) and cause substantial economic losses (2). A prime example is the invasion of the gypsy moth in the United States, for which more than $ 194 million was spent on management and monitoring between 1985 and 2004 alone (3). The spread of the gypsy moth across eastern North America is, perhaps, the most thoroughly studied biological invasion in the world, providing a unique opportunity to explore spatiotemporal variability in rates of spread. Here we describe evidence for periodic pulsed invasions, defined as regularly punctuated range expansions interspersed among periods of range stasis. We use a theoretical model with parameter values estimated from long- term monitoring data to show how an interaction between strong Allee effects ( negative population growth at low densities) (4) and stratified diffusion ( most individuals disperse locally, but a few seed new colonies by long- range movement)(5) can explain the invasion pulses. Our results indicate that suppressing population peaks along range borders might greatly slow invasion.	Univ Louisiana, Dept Biol, Lafayette, LA 70504 USA; US Forest Serv, USDA, No Res Stn, Morgantown, WV 26505 USA; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Louisiana Lafayette; United States Department of Agriculture (USDA); United States Forest Service; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Johnson, DM (corresponding author), Univ Louisiana, Dept Biol, POB 42451, Lafayette, LA 70504 USA.	derekjohnson@louisiana.edu	Liebhold, Andrew M./C-1423-2008; Johnson, Derek/B-6409-2012; Bjornstad, Ottar N/I-4518-2012	Liebhold, Andrew M./0000-0001-7427-6534; Tobin, Patrick/0000-0003-0237-7963				Allee W., 1938, SOCIAL LIFE ANIMALS; Barbier EB, 2001, ECOL ECON, V39, P197, DOI 10.1016/S0921-8009(01)00239-7; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Deutsch C.V., 1992, GSLIB GEOSTATISTICAL; Dwyer G, 2006, AM NAT, V167, P165, DOI 10.1086/498944; Dwyer G, 2004, NATURE, V430, P341, DOI 10.1038/nature02569; Johnson DM, 2005, J ANIM ECOL, V74, P882, DOI 10.1111/j.1365-2656.2005.00980.x; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; LIEBHOLD AM, 1992, J BIOGEOGR, V19, P513, DOI 10.2307/2845770; Mayo JH, 2003, J ECON ENTOMOL, V96, P1448, DOI 10.1603/0022-0493-96.5.1448; MONTGOMERY ME, 1988, DYNAMICS FOREST INSE, P253; Neubert MG, 2000, P ROY SOC B-BIOL SCI, V267, P1603, DOI 10.1098/rspb.2000.1185; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; Royama T., 1992, ANAL POPULATION ECOL; Sharov AA, 1998, ECOL APPL, V8, P1170, DOI 10.1890/1051-0761(1998)008[1170:MOSTSO]2.0.CO;2; Sharov AA, 2002, J FOREST, V100, P30; Sharov AA, 1998, ECOL APPL, V8, P833, DOI 10.1890/1051-0761(1998)008[0833:BOMTSO]2.0.CO;2; Sharov AA, 1995, ENVIRON ENTOMOL, V24, P1529, DOI 10.1093/ee/24.6.1529; SHAROV AA, 1995, ENVIRON ENTOMOL, V24, P1239, DOI 10.1093/ee/24.5.1239; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Taylor CM, 2004, ECOLOGY, V85, P3254, DOI 10.1890/03-0640; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Tobin Patrick C., 2004, American Entomologist, V50, P200; Veit RR, 1996, AM NAT, V148, P255, DOI 10.1086/285924; Vitousek PM, 1996, AM SCI, V84, P468; Wang MH, 2001, MATH BIOSCI, V171, P83, DOI 10.1016/S0025-5564(01)00048-7; Whitmire SL, 2006, OECOLOGIA, V147, P230, DOI 10.1007/s00442-005-0271-5	30	177	183	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					361	363		10.1038/nature05242	http://dx.doi.org/10.1038/nature05242			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108964				2022-12-01	WOS:000242018300047
J	Vila-Costa, M; Simo, R; Harada, H; Gasol, JM; Slezak, D; Kiene, RP				Vila-Costa, Maria; Simo, Rafel; Harada, Hyakubun; Gasol, Josep M.; Slezak, Doris; Kiene, Ronald P.			Dimethylsulfoniopropionate uptake by marine phytoplankton	SCIENCE			English	Article							GULF-OF-MEXICO; ATMOSPHERIC SULFUR; DIMETHYL SULFIDE; NORTH-ATLANTIC; FOOD-WEB; DMSP; PROCHLOROCOCCUS; BACTERIOPLANKTON; SYNECHOCOCCUS; CYANOBACTERIA	Dimethylsulfoniopropionate (DMSP) accounts for most of the organic sulfur fluxes from primary to secondary producers in marine microbial food webs. Incubations of natural communities and axenic cultures with radio-labeled DMSP showed that dominant phytoplankton groups of the ocean, the unicellular cyanobacteria Prochlorococcus and Synechococcus and diatoms, as well as heterotrophic bacteria take up and assimilate DMSP sulfur, thus diverting a proportion of plankton-produced organic sulfur from emission into the atmosphere.	CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Barcelona 08003, Spain; Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of South Alabama	Vila-Costa, M (corresponding author), CSIC, Inst Ciencies Mar, Dept Biol Marina & Oceanog, Pg Maritim Barceloneta 37-49, Barcelona 08003, Spain.	mariavila@icm.csic.es; rsimo@icm.csic.es	Vila-Costa, Maria/L-4833-2014; Gasol, Josep M M/B-1709-2008	Vila-Costa, Maria/0000-0003-1730-8418; Gasol, Josep M M/0000-0001-5238-2387; Simo, Rafel/0000-0003-3276-7663				Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Belviso S, 2001, LIMNOL OCEANOGR, V46, P989, DOI 10.4319/lo.2001.46.4.0989; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; CORN M, 1996, BIOL ENV CHEM DMSP R; JONES RI, 1994, MARINE MICROBIAL FOOD WEBS, 1994, VOL 8, NO 1 AND 2, P87; Keller MD, 1989, ACS SYM SER, P167, DOI 10.1021/bk-1989-0393.ch011; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Kiene RP, 1998, AQUAT MICROB ECOL, V15, P39, DOI 10.3354/ame015039; Malin G, 1997, J PHYCOL, V33, P889, DOI 10.1111/j.0022-3646.1997.00889.x; Malmstrom RR, 2005, LIMNOL OCEANOGR, V50, P1924, DOI 10.4319/lo.2005.50.6.1924; Malmstrom RR, 2004, LIMNOL OCEANOGR, V49, P597, DOI 10.4319/lo.2004.49.2.0597; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; PAERL HW, 1991, APPL ENVIRON MICROB, V57, P473, DOI 10.1128/AEM.57.2.473-479.1991; Partensky F., 1999, B I OCEANOGR MONACO, V19, P457; Raven JA, 1997, LIMNOL OCEANOGR, V42, P198, DOI 10.4319/lo.1997.42.1.0198; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Simo R, 1999, NATURE, V402, P396, DOI 10.1038/46516; Simo R, 2004, CAN J FISH AQUAT SCI, V61, P673, DOI 10.1139/F04-030; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Smetacek V., 1990, P103; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Vila M, 2004, APPL ENVIRON MICROB, V70, P4648, DOI 10.1128/AEM.70.8.4648-4657.2004; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003	29	148	154	7	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					652	654		10.1126/science.1131043	http://dx.doi.org/10.1126/science.1131043			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068265				2022-12-01	WOS:000241557800049
J	Miller, SP; Lunzer, M; Dean, AM				Miller, Stephen P.; Lunzer, Mark; Dean, Antony M.			Direct demonstration of an adaptive constraint	SCIENCE			English	Article							3-ISOPROPYLMALATE DEHYDROGENASE; DEVELOPMENTAL CONSTRAINTS; NATURAL-SELECTION; ESCHERICHIA-COLI; EVOLUTION; ISOCITRATE; SPANDRELS; MECHANISM	The role of constraint in adaptive evolution is an open question. Directed evolution of an engineered beta-isopropylmalate dehydrogenase ( IMDH), with coenzyme specificity switched from nicotinamide adenine dinucleotide (NAD) to nicotinamide adenine dinucleotide phosphate ( NADP), always produces mutants with lower affinities for NADP. This result is the correlated response to selection for relief from inhibition by NADPH ( the reduced form of NADP) expected of an adaptive landscape subject to three enzymatic constraints: an upper limit to the rate of maximum turnover (k(cat)), a correlation in NADP and NADPH affinities, and a trade-off between NAD and NADP usage. Two additional constraints, high intracellular NADPH abundance and the cost of compensatory protein synthesis, have ensured the conserved use of NAD by IMDH throughout evolution. Our results show that selective mechanisms and evolutionary constraints are to be understood in terms of underlying adaptive landscapes.	Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dean, AM (corresponding author), Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.	deanx024@umn.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060611] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM060611] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS KJ, 1976, J MOL EVOL, V8, P317, DOI 10.1007/BF01739257; ANTONOVICS J, 1991, TRENDS ECOL EVOL, V6, P166, DOI 10.1016/0169-5347(91)90059-7; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Beldade P, 2002, NATURE, V416, P844, DOI 10.1038/416844a; Chen RD, 1996, P NATL ACAD SCI USA, V93, P12171, DOI 10.1073/pnas.93.22.12171; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; DYKHUIZEN D, 1978, EVOLUTION, V32, P125, DOI 10.1111/j.1558-5646.1978.tb01103.x; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; Frankino WA, 2005, SCIENCE, V307, P718, DOI 10.1126/science.1105409; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Hall BG, 2002, ANTIMICROB AGENTS CH, V46, P3035, DOI 10.1128/AAC.46.9.3035-3038.2002; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1994, STRUCTURE, V2, P1007, DOI 10.1016/S0969-2126(94)00104-9; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; KUCHNER O, 1997, TRENDS BIOTECHNOL, V58, P1; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Otten LG, 2005, BIOMOL ENG, V22, P1, DOI 10.1016/j.bioeng.2005.02.002; PENFOUND T, 1996, CELLULAR MOL BIOL, P721; Pigliucci M, 2000, TRENDS ECOL EVOL, V15, P66, DOI 10.1016/S0169-5347(99)01762-0; Rose M. R., 1996, ADAPTATION; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Teotonio H, 2000, NATURE, V408, P463, DOI 10.1038/35044070; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; ZAMENHOF S, 1967, NATURE, V216, P456, DOI 10.1038/216456a0; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	28	61	63	3	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					458	461		10.1126/science.1133479	http://dx.doi.org/10.1126/science.1133479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053145				2022-12-01	WOS:000241382500040
J	Macilwain, C				Macilwain, Colin			A firm response to AIDS	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 19	2006	443	7113					738	739		10.1038/443738a	http://dx.doi.org/10.1038/443738a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051178				2022-12-01	WOS:000241362700012
J	Oh-I, S; Shimizu, H; Satoh, T; Okada, S; Adachi, S; Inoue, K; Eguchi, H; Yamamoto, M; Imaki, T; Hashimoto, K; Tsuchiya, T; Monden, T; Horiguchi, K; Yamada, M; Mori, M				Oh-, Shinsuke, I; Shimizu, Hiroyuki; Satoh, Tetsurou; Okada, Shuichi; Adachi, Sachika; Inoue, Kinji; Eguchi, Hiroshi; Yamamoto, Masanori; Imaki, Toshihiro; Hashimoto, Koushi; Tsuchiya, Takafumi; Monden, Tsuyoshi; Horiguchi, Kazuhiko; Yamada, Masanobu; Mori, Masatomo			Identification of nesfatin-1 as a satiety molecule in the hypothalamus	NATURE			English	Article							MELANOCORTIN-4 RECEPTOR; LEPTIN RECEPTOR; BINDING PROTEIN; FOOD-INTAKE; NUCLEOBINDIN; NEFA; PATHWAY; OBESITY; CLONING; SYSTEM	The brain hypothalamus contains certain secreted molecules that are important in regulating feeding behaviour(1-3). Here we show that nesfatin, corresponding to NEFA/nucleobindin(2) (NUCB2), a secreted protein of unknown function, is expressed in the appetite-control hypothalamic nuclei in rats. Intracerebroventricular (i.c.v.) injection of NUCB2 reduces feeding. Rat cerebrospinal fluid contains nesfatin-1, an amino-terminal fragment derived from NUCB2, and its expression is decreased in the hypothalamic paraventricular nucleus under starved conditions. I.c.v. injection of nesfatin-1 decreases food intake in a dose-dependent manner, whereas injection of an antibody neutralizing nesfatin-1 stimulates appetite. In contrast, i.c.v. injection of other possible fragments processed from NUCB2 does not promote satiety, and conversion of NUCB2 to nesfatin-1 is necessary to induce feeding suppression. Chronic i.c.v. injection of nesfatin-1 reduces body weight, whereas rats gain body weight after chronic i.c.v. injection of antisense morpholino oligonucleotide against the gene encoding NUCB2. Nesfatin-1-induced anorexia occurs in Zucker rats with a leptin receptor mutation, and an anti-nesfatin-1 antibody does not block leptin-induced anorexia. In contrast, central injection of alpha-melanocyte-stimulating hormone elevates NUCB2 gene expression in the paraventricular nucleus, and satiety by nesfatin-1 is abolished by an antagonist of the melanocortin-3/4 receptor. We identify nesfatin-1 as a satiety molecule that is associated with melanocortin signalling in the hypothalamus.	Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gumma 3718511, Japan; Saitama Univ, Dept Regulat Biol, Shimo Okubo, Saitama 3788570, Japan; Teijin Pharma Ltd, Pharmaceut Discovery Res Lab, Hino, Tokyo 1918512, Japan	Gunma University; Saitama University; Teijin Pharma Limited	Mori, M (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gumma 3718511, Japan.	mmori@med.gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X				BARNIKOLWATANABE S, 1994, BIOL CHEM H-S, V375, P497, DOI 10.1515/bchm3.1994.375.8.497; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Jia DM, 2000, METABOLISM, V49, P1167, DOI 10.1053/meta.2000.8599; KANAI Y, 1993, BIOCHEM BIOPH RES CO, V196, P729, DOI 10.1006/bbrc.1993.2310; Karabinos A, 1996, MOL BIOL EVOL, V13, P990, DOI 10.1093/oxfordjournals.molbev.a025667; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; OH IS, 2005, CELL METAB, V1, P331; Petersson U, 2004, BONE, V34, P949, DOI 10.1016/j.bone.2004.01.019; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; SATO F, 1980, TETRAHEDRON LETT, V21, P2171, DOI 10.1016/S0040-4039(00)78989-1; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shimizu H, 2005, NUTR NEUROSCI, V8, P7, DOI 10.1080/10284150500047245; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	24	769	817	4	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					709	712		10.1038/nature05162	http://dx.doi.org/10.1038/nature05162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036007				2022-12-01	WOS:000241160500050
J	de Oliveira, FT; Chanda, A; Banerjee, D; Shan, XP; Mondal, S; Que, L; Bominaar, EL; Munck, E; Collins, TJ				Tiago de Oliveira, Filipe; Chanda, Arani; Banerjee, Deboshri; Shan, Xiaopeng; Mondal, Sujit; Que, Lawrence, Jr.; Bominaar, Emile L.; Muenck, Eckard; Collins, Terrence J.			Chemical and spectroscopic evidence for an Fe-V-Oxo complex	SCIENCE			English	Article							HIGH-VALENT IRON; NONHEME; MONONUCLEAR; LIGANDS	Iron(V)-oxo species have been proposed as key reactive intermediates in the catalysis of oxygen-activating enzymes and synthetic catalysts. Here, we report the synthesis of [Fe(TAML)(O)](-) in nearly quantitative yield, where TAML is a macrocyclic tetraamide ligand. Mass spectrometry, Mossbauer, electron paramagnetic resonance, and x-ray absorption spectroscopies, as well as reactivity studies and density functional theory calculations show that this long-lived (hours at -60 degrees C) intermediate is a spin S=1/2 iron(V)-oxo complex. Iron-TAML systems have proven to be efficient catalysts in the decomposition of numerous pollutants by hydrogen peroxide, and the species we characterized is a likely reactive intermediate in these reactions.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Carnegie Mellon University; University of Minnesota System; University of Minnesota Twin Cities	Que, L (corresponding author), Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA.	que@chem.umn.edu; eb7g@andrew.cmu.edu; emunck@cmu.edu; tc1u@andrew.cmu.edu	Collins, Terrence J/A-9807-2017; Tiago de Oliveira, Filipe/B-7065-2008	Collins, Terrence J/0000-0003-2611-9184; Tiago de Oliveira, Filipe/0000-0001-5149-5902	NIBIB NIH HHS [EB001475] Funding Source: Medline; NIGMS NIH HHS [GM-38767] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038767] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aliaga-Alcalde N, 2005, ANGEW CHEM INT EDIT, V44, P2908, DOI 10.1002/anie.200462368; Banerjee D, 2006, ANGEW CHEM INT EDIT, V45, P3974, DOI 10.1002/anie.200504511; Bartos MJ, 1998, COORDIN CHEM REV, V174, P361, DOI 10.1016/S0010-8545(98)00142-8; BENDIX J, 1993, INORG CHEM, V32, P2838, DOI 10.1021/ic00065a010; Bukowski MR, 2005, SCIENCE, V310, P1000, DOI 10.1126/science.1119092; Chanda A, 2006, J INORG BIOCHEM, V100, P606, DOI 10.1016/j.jinorgbio.2005.12.016; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Decker A, 2006, J INORG BIOCHEM, V100, P697, DOI 10.1016/j.jinorgbio.2006.01.013; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Ghosh A, 2005, J AM CHEM SOC, V127, P2505, DOI 10.1021/ja0460458; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Harischandra DN, 2005, J AM CHEM SOC, V127, P13776, DOI 10.1021/ja0542439; Neese F, 2006, J INORG BIOCHEM, V100, P716, DOI 10.1016/j.jinorgbio.2006.01.020; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Parsell TH, 2006, J AM CHEM SOC, V128, P8728, DOI 10.1021/ja062332v; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Sen Gupta S, 2002, SCIENCE, V296, P326, DOI 10.1126/science.1069297; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275	18	346	348	5	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					835	838		10.1126/science.1133417	http://dx.doi.org/10.1126/science.1133417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	134FN	17185561				2022-12-01	WOS:000244069000066
J	Tombola, F; Pathak, MM; Gorostiza, P; Isacoff, EY				Tombola, Francesco; Pathak, Medha M.; Gorostiza, Pau; Isacoff, Ehud Y.			The twisted ion-permeation pathway of a resting voltage-sensing domain	NATURE			English	Article							FOCUSED ELECTRIC-FIELD; SHAKER K+ CHANNEL; POTASSIUM CHANNEL; TRANSMEMBRANE MOVEMENT; SENSOR; PORE; DISPLACEMENT; ACTIVATION; MECHANISM; MODELS	Proteins containing voltage-sensing domains (VSDs) translate changes in membrane potential into changes in ion permeability or enzymatic activity(1-3). In channels, voltage change triggers a switch in conformation of the VSD, which drives gating in a separate pore domain, or, in channels lacking a pore domain, directly gates an ion pathway within the VSD4,5. Neither mechanism is well understood(6). In the Shaker potassium channel, mutation of the first arginine residue of the S4 helix to a smaller uncharged residue makes the VSD permeable to ions ('omega current') in the resting conformation ('S4 down')(7). Here we perform a structure-guided perturbation analysis of the omega conductance to map its VSD permeation pathway. We find that there are four omega pores per channel, which is consistent with one conduction path per VSD. Permeating ions from the extracellular medium enter the VSD at its peripheral junction with the pore domain, and then plunge into the core of the VSD in a curved conduction pathway. Our results provide a model of the resting conformation of the VSD.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020; Tombola, Francesco/ABA-6002-2020; Gorostiza, Pau/Q-2544-2015; Tombola, Francesco/C-7311-2011	Tombola, Francesco/0000-0002-9315-0352; Gorostiza, Pau/0000-0002-7268-5577; Isacoff, Ehud Y./0000-0003-4775-9359				Ahern CA, 2005, NEURON, V48, P25, DOI 10.1016/j.neuron.2005.08.020; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Durell SR, 2004, BIOPHYS J, V87, P2116, DOI 10.1529/biophysj.104.040618; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Minor DL, 2006, NAT STRUCT MOL BIOL, V13, P388, DOI 10.1038/nsmb0506-388; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; YU FH, 2004, SCI STKE; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	25	114	115	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					546	549		10.1038/nature05396	http://dx.doi.org/10.1038/nature05396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17187057				2022-12-01	WOS:000243867300045
J	Schade, R; Andersohn, F; Suissa, S; Haverkamp, W; Garbe, E				Schade, Rene; Andersohn, Frank; Suissa, Samy; Haverkamp, Wilhelm; Garbe, Edeltraut			Dopamine agonists and the risk of cardiac-valve regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VALVULAR HEART-DISEASE; PRACTICE RESEARCH DATABASE; PARKINSONS-DISEASE; 5-HT2B RECEPTORS; MONOAMINERGIC RECEPTOR; ANTIPARKINSON AGENTS; DIFFERENTIAL ACTIONS; MULTIPLE CLASSES; PERGOLIDE; FENFLURAMINE	BACKGROUND: Case reports and echocardiographic studies suggest that the ergot-derived dopamine agonists pergolide and cabergoline, used in the treatment of Parkinson's disease and the restless legs syndrome, may increase the risk of cardiac-valve regurgitation. METHODS: We used data from the United Kingdom General Practice Research Database to identify a population-based cohort comprising 11,417 subjects 40 to 80 years of age who were prescribed antiparkinsonian drugs between 1988 and 2005. We conducted a nested case-control analysis within this cohort in which each patient with newly diagnosed cardiac-valve regurgitation was matched with up to 25 control subjects from the cohort, according to age, sex, and year of entry into the cohort. Incidence-rate ratios for cardiac-valve regurgitation with the use of different dopamine agonists were estimated by conditional logistic-regression analysis. RESULTS: Of 31 case patients with newly diagnosed cardiac-valve regurgitation, 6 were currently exposed to pergolide, 6 were currently exposed to cabergoline, and 19 had not been exposed to any dopamine agonist within the previous year. The rate of cardiac-valve regurgitation was increased with current use of pergolide (incidence-rate ratio, 7.1; 95% confidence interval [CI], 2.3 to 22.3) and cabergoline (incidence-rate ratio, 4.9; 95% CI, 1.5 to 15.6), but not with current use of other dopamine agonists. CONCLUSIONS: In this study, use of the dopamine agonists pergolide and cabergoline was associated with an increased risk of newly diagnosed cardiac-valve regurgitation.	Charite Univ Med Berlin, Dept Clin Pharmacol, Berlin, Germany; Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany; McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol,McGill Pharmacoepidemiol Res U, Montreal, PQ, Canada	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McGill University; Royal Victoria Hospital	Schade, R (corresponding author), Charite Univ Med Berlin, Dept Clin Pharmacol, Charite Campus Mitte, Berlin, Germany.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Baseman DG, 2004, NEUROLOGY, V63, P301, DOI 10.1212/01.WNL.0000129842.49926.07; Chung EJ, 2006, MOVEMENT DISORD, V21, P586, DOI 10.1002/mds.20813; Committee on Safety of Medicines, 2003, CURRENT PROBLEMS PHA, V29, P7; Dhawan V, 2005, J NEURAL TRANSM, V112, P661, DOI 10.1007/s00702-005-0289-1; Earley CJ, 2003, NEW ENGL J MED, V348, P2103, DOI 10.1056/NEJMcp021288; Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75; Flowers CM, 2003, MAYO CLIN PROC, V78, P730, DOI 10.4065/78.6.730; Horvath J, 2004, MOVEMENT DISORD, V19, P656, DOI 10.1002/mds.20201; Jahnichen S, 2005, EUR J PHARMACOL, V513, P225, DOI 10.1016/j.ejphar.2005.03.010; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Newman-Tancredi A, 2002, J PHARMACOL EXP THER, V303, P815, DOI 10.1124/jpet.102.039883; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Peralta C, 2006, MOVEMENT DISORD, V21, P1109, DOI 10.1002/mds.20887; Pinero A, 2005, NEW ENGL J MED, V353, P1976, DOI 10.1056/NEJM200511033531822; Pritchett AM, 2002, MAYO CLIN PROC, V77, P1280, DOI 10.4065/77.12.1280; Rothman RB, 2000, CIRCULATION, V102, P2836; Serratrice Jacques, 2002, Cardiol Rev, V10, P334, DOI 10.1097/00045415-200211000-00005; Setola V, 2003, MOL PHARMACOL, V63, P1223, DOI 10.1124/mol.63.6.1223; Van Camp G, 2003, NEUROLOGY, V61, P859, DOI 10.1212/01.WNL.0000083985.00343.F2; Van Camp G, 2004, LANCET, V363, P1179, DOI 10.1016/S0140-6736(04)15945-X; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7	25	500	514	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					29	38		10.1056/NEJMoa062222	http://dx.doi.org/10.1056/NEJMoa062222			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202453				2022-12-01	WOS:000243209600006
J	Cheng, H; Dufu, K; Lee, CS; Hsu, JL; Dias, A; Reed, R				Cheng, Hong; Dufu, Kobina; Lee, Chung-Sheng; Hsu, Jeanne L.; Dias, Anusha; Reed, Robin			Human mRNA export machinery recruited to the 5 ' end of mRNA	CELL			English	Article							EXON JUNCTION COMPLEX; NONSENSE-MEDIATED DECAY; CAP-BINDING-PROTEIN; GENOME-WIDE ANALYSIS; NUCLEAR EXPORT; RIBONUCLEOPROTEIN PARTICLE; COUPLING TRANSCRIPTION; BIOCHEMICAL-ANALYSIS; MAMMALIAN-CELLS; POLYMERASE-II	Pre-mRNAs undergo splicing to remove introns, and the spliced mRNA is exported to the cytoplasm for translation. Here we investigated the mechanism for recruitment of the conserved mRNA export machinery (TREX complex) to mRNA. We show that the human TREX complex is recruited to a region near the 5' end of mRNA, with the TREX component Aly bound closest to the 5' cap. Both TREX recruitment and mRNA export require the cap, and these roles for the cap are splicing dependent. CBP80, which is bound to the cap, associates efficiently with TREX, and Aly mediates this interaction. Together, these data indicate that the CBP80-Aly interaction results in recruitment of TREX to the 5' end of mRNA, where it functions in mRNA export. As a consequence, the mRNA would be exported in a 5' to 3' direction through the nuclear pore, as observed in early electron micrographs of giant Balbiani ring mRNPs.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	rreed@hms.harvard.edu		Dufu, Kobina/0000-0001-5450-4157				Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Chan CC, 2004, RNA, V10, P200, DOI 10.1261/rna.5230104; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Dahlberg JE, 2004, CURR OPIN CELL BIOL, V16, P335, DOI 10.1016/j.ceb.2004.03.006; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Harlow L, 1988, ANTIBODIES LAB MANUA; Herold A, 2003, EMBO J, V22, P2472, DOI 10.1093/emboj/cdg233; Hirose Y, 2000, GENE DEV, V14, P1415; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; IZAURRALDE E, 1992, J CELL BIOL, V118, P1287, DOI 10.1083/jcb.118.6.1287; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; MACQUAT LE, 2000, TRANSLATIONAL CONTRO, P827; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Schell T, 2002, GENOME BIOL, V3; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Visa N, 1996, CELL, V84, P253, DOI 10.1016/S0092-8674(00)80980-0; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; Wagner E, 2002, J CELL SCI, V115, P3033; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zhou ZL, 2002, P NATL ACAD SCI USA, V99, P12203, DOI 10.1073/pnas.182427099	64	331	350	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1389	1400		10.1016/j.cell.2006.10.044	http://dx.doi.org/10.1016/j.cell.2006.10.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190602	Bronze			2022-12-01	WOS:000243690000018
J	Golinko, MS				Golinko, Michael S.			A bump in the neck	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												msg1@alum.mit.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2006	296	24					2901	2902		10.1001/jama.296.24.2901	http://dx.doi.org/10.1001/jama.296.24.2901			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120FD	17190881				2022-12-01	WOS:000243069000001
J	Jalan, R; Williams, R; Bernuau, J				Jalan, Rajiv; Williams, Roger; Bernuau, Jacques			Paracetarnol: are therapeutic doses entirely safe?	LANCET			English	Editorial Material							ACUTE LIVER-FAILURE; ACETAMINOPHEN		UCL, UCL Inst Hepatol, London WC1E 6HX, England; Hop Beaujon, APHP, Pole Malad Appareil Digest, Clichy, France	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Jalan, R (corresponding author), UCL, UCL Inst Hepatol, London WC1E 6HX, England.	r.j.jalan@ucl.ac.uk						Bernuau JR, 2004, HEPATOLOGY, V40, p499A; CRITCHLEY JAJH, 1986, BRIT J CLIN PHARMACO, V22, P649, DOI 10.1111/j.1365-2125.1986.tb02953.x; KWAN D, 1995, DIGEST DIS SCI, V40, P1951, DOI 10.1007/BF02208663; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Moynihan R, 2002, BRIT MED J, V325, P678, DOI 10.1136/bmj.325.7366.678; OGRADY JG, 1993, LANCET, V342, P273; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Polson J, 2006, GASTROENTEROLOGY, V130, pA772; PRESCOTT LF, 1983, DRUGS, V25, P290, DOI 10.2165/00003495-198325030-00002; *US FOOD DRUG ADM, 2006, CDER 2002 M DOC AUG; Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87; Yaghi Cesar, 2006, Gastroenterol Clin Biol, V30, P763, DOI 10.1016/S0399-8320(06)73311-5; Yin OQP, 2001, INT J PHARM, V222, P305, DOI 10.1016/S0378-5173(01)00712-8	13	39	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2195	2196		10.1016/S0140-6736(06)69874-7	http://dx.doi.org/10.1016/S0140-6736(06)69874-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189017				2022-12-01	WOS:000243076800009
J	Ridgway, J; Zhang, G; Wu, Y; Stawicki, S; Liang, WC; Chanthery, Y; Kowalski, J; Watts, RJ; Callahan, C; Kasman, I; Singh, M; Chien, M; Tan, C; Hongo, JAS; de Sauvage, F; Plowman, G; Yan, MH				Ridgway, John; Zhang, Gu; Wu, Yan; Stawicki, Scott; Liang, Wei-Ching; Chanthery, Yvan; Kowalski, Joe; Watts, Ryan J.; Callahan, Christopher; Kasman, Ian; Singh, Mallika; Chien, May; Tan, Christine; Hongo, Jo-Anne S.; de Sauvage, Fred; Plowman, Greg; Yan, Minhong			Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis	NATURE			English	Article							ENDOTHELIAL-CELL FUNCTION; VASCULAR DEVELOPMENT; UP-REGULATION; VEGF; DIFFERENTIATION; EXPRESSION; ANTIBODIES; LETHALITY; ARTERIAL; PATHWAY	Haploinsufficiency of DII4, a vascular-specific Notch ligand, has shown that it is essential for embryonic vascular development and arteriogenesis(1-3). Mechanistically, it is unclear how the DII4-mediated Notch pathway contributes to complex vascular processes that demand meticulous coordination of multiple signalling pathways. Here we show that DII4-mediated Notch signalling has a unique role in regulating endothelial cell proliferation and differentiation. Neutralizing DII4 with a DII4-selective antibody rendered endothelial cells hyperproliferative, and caused defective cell fate specification or differentiation both in vitro and in vivo. In addition, blocking DII4 inhibited tumour growth in several tumour models. Remarkably, antibodies against DII4 and antibodies against vascular endothelial growth factor (VEGF) had paradoxically distinct effects on tumour vasculature. Our data also indicate that DII4-mediated Notch signalling is crucial during active vascularization, but less important for normal vessel maintenance. Furthermore, unlike blocking Notch signalling globally, neutralizing DII4 had no discernable impact on intestinal goblet cell differentiation(4,5), supporting the idea that DII4-mediated Notch signalling is largely restricted to the vascular compartment. Therefore, targeting DII4 might represent a broadly efficacious and well-tolerated approach for the treatment of solid tumours.	Genentech Inc, Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; Genentech Inc, Antibody Engn, San Francisco, CA 94080 USA; Genentech Inc, Pathol, San Francisco, CA 94080 USA; Genentech Inc, Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Yan, MH (corresponding author), Genentech Inc, Tumor Biol & Angiogenesis, 1 DNA Way, San Francisco, CA 94080 USA.	minhong@gene.com	Plowman, Greg/O-8032-2019; PLOWMAN, Greg D/E-2012-2011	Plowman, Gregory D/0000-0002-6465-309X				Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 2005, EXP SUPPL, V94, P209; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200	22	761	874	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1083	1087		10.1038/nature05313	http://dx.doi.org/10.1038/nature05313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183323				2022-12-01	WOS:000242971100059
J	Barclay, RL; Vicari, JJ; Doughty, AS; Johanson, JF; Greenlaw, RL				Barclay, Robert L.; Vicari, Joseph J.; Doughty, Andrea S.; Johanson, John F.; Greenlaw, Roger L.			Colonoscopic withdrawal times and adenoma detection during screening colonoscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLORECTAL-CANCER INCIDENCE; FLEXIBLE SIGMOIDOSCOPY; MISS RATES; POLYPECTOMY; PREVENTION; EFFICACY; RECOMMENDATIONS; SURVEILLANCE; VARIABILITY; PERFORMANCE	BACKGROUND: Colonoscopy is commonly used to screen for neoplasia. To assess the performance of screening colonoscopy in everyday practice, we conducted a study of the rates of detection of adenomas and the amount of time taken to withdraw the colonoscope among endoscopists in a large community-based practice. METHODS: During a 15-month period, 12 experienced gastroenterologists performed 7882 colonoscopies, of which 2053 were screening examinations in subjects who had not previously undergone colonoscopy. We recorded the numbers, sizes, and histologic features of the neoplastic lesions detected during screening, as well as the duration of insertion and of withdrawal of the colonoscope during the procedure. We compared rates of detection of neoplastic lesions among gastroenterologists who had mean colonoscopic withdrawal times of less than 6 minutes with the rates of those who had mean withdrawal times of 6 minutes or more. According to experts, 6 minutes is the minimum length of time to allow adequate inspection during instrument withdrawal. RESULTS: Neoplastic lesions (mostly adenomatous polyps) were detected in 23.5% of screened subjects. There were large differences among gastroenterologists in the rates of detection of adenomas (range of the mean number of lesions per subject screened, 0.10 to 1.05; range of the percentage of subjects with adenomas, 9.4 to 32.7%) and in their times of withdrawal of the colonoscope from the cecum to the anus (range, 3.1 to 16.8 minutes for procedures during which no polyps were removed). As compared with colonoscopists with mean withdrawal times of less than 6 minutes, those with mean withdrawal times of 6 minutes or more had higher rates of detection of any neoplasia (28.3% vs. 11.8%, P<0.001) and of advanced neoplasia (6.4% vs. 2.6%, P=0.005). CONCLUSIONS: In this large community-based gastroenterology practice, we observed greater rates of detection of adenomas among endoscopists who had longer mean times for withdrawal of the colonoscope. The effect of variation in withdrawal times on lesion detection and the prevention of colorectal cancer in the context of widespread colonoscopic screening is not known. Ours was a preliminary study, so the generalizability and implications for clinical practice need to be determined by future studies.	Rockford Gastroenterol Associates, Rockford, IL 61107 USA; Univ Illinois, Coll Med, Rockford, IL 61107 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford	Barclay, RL (corresponding author), Rockford Gastroenterol Associates, 401 Roxbury Rd, Rockford, IL 61107 USA.	drbarclay@rockfordgi.com	Wilkins, Thad/G-2541-2010					Atkin W, 2004, GASTROENTEROLOGY, V126, P1247, DOI 10.1053/j.gastro.2004.01.023; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Barclay RL, 2004, GASTROINTEST ENDOSC, V60, P527, DOI 10.1016/S0016-5107(04)01857-7; Beam CA, 2003, J NATL CANCER I, V95, P282, DOI 10.1093/jnci/95.4.282; Bresalier R, 2002, SLEISENGER FORDTRANS, P2215; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Gupta DK, 2001, ACTA CYTOL, V45, P697, DOI 10.1159/000328290; Halligan S, 2003, CLIN RADIOL, V58, P948, DOI 10.1016/S0009-9260(03)00317-9; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Itzkowitz SH, 2002, SLEISENGER FORDTRANS, P2175; LEE YS, 1988, DIS COLON RECTUM, V31, P291, DOI 10.1007/BF02554363; Lieberman D, 2004, ANN INTERN MED, V141, P401, DOI 10.7326/0003-4819-141-5-200409070-00018; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pinsky PF, 2005, CLIN GASTROENTEROL H, V3, P792, DOI 10.1053/S1542-3565(05)00286-7; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Sanchez W, 2004, AM J GASTROENTEROL, V99, P1941, DOI 10.1111/j.1572-0241.2004.40569.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	25	985	1019	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2533	2541		10.1056/NEJMoa055498	http://dx.doi.org/10.1056/NEJMoa055498			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116BZ	17167136				2022-12-01	WOS:000242778800005
J	Strebhardt, K; Ullrich, A				Strebhardt, Klaus; Ullrich, Axel			Another look at imatinib mesylate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Goethe Univ Frankfurt, Sch Med, Dept Obstet & Gynecol, D-6000 Frankfurt, Germany; Proteos, Inst Mol & Cell Biol, Ctr Mol Med, Singapore Oncogenome Lab, Singapore, Singapore; Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany	Goethe University Frankfurt; Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Max Planck Society	Strebhardt, K (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Obstet & Gynecol, D-6000 Frankfurt, Germany.		Strebhardt, Klaus/E-8765-2011	Strebhardt, Klaus/0000-0003-2173-9763				Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664	4	15	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2481	2482		10.1056/NEJMcibr065325	http://dx.doi.org/10.1056/NEJMcibr065325			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113EO	17151370				2022-12-01	WOS:000242581400014
J	Duerr, RH; Taylor, KD; Brant, SR; Rioux, JD; Silverberg, MS; Daly, MJ; Steinhart, AH; Abraham, C; Regueiro, M; Griffiths, A; Dassopoulos, T; Bitton, A; Yang, HY; Targan, S; Datta, LW; Kistner, EO; Schumm, LP; Lee, AT; Gregersen, PK; Barmada, MM; Rotter, JI; Nicolae, DL; Cho, JH				Duerr, Richard H.; Taylor, Kent D.; Brant, Steven R.; Rioux, John D.; Silverberg, Mark S.; Daly, Mark J.; Steinhart, A. Hillary; Abraham, Clara; Regueiro, Miguel; Griffiths, Anne; Dassopoulos, Themistocles; Bitton, Alain; Yang, Huiying; Targan, Stephan; Datta, Lisa Wu; Kistner, Emily O.; Schumm, L. Philip; Lee, Annette T.; Gregersen, Peter K.; Barmada, M. Michael; Rotter, Jerome I.; Nicolae, Dan L.; Cho, Judy H.			A genome-wide association study identifies IL23R as an inflammatory bowel disease gene	SCIENCE			English	Article							ACTIVE CROHNS-DISEASE; AUTOIMMUNE INFLAMMATION; T-CELLS; IL-23; CYTOKINE; IL-12; SUSCEPTIBILITY; EXPRESSION; SUBUNIT; INTERLEUKIN-17	The inflammatory bowel diseases Crohn's disease and ulcerative colitis are common, chronic disorders that cause abdominal pain, diarrhea, and gastrointestinal bleeding. To identify genetic factors that might contribute to these disorders, we performed a genome-wide association study. We found a highly significant association between Crohn's disease and the IL23R gene on chromosome 1p31, which encodes a subunit of the receptor for the proinflammatory cytokine interleukin-23. An uncommon coding variant (rs11209026, c. 1142G> A, p. Arg381Gln) confers strong protection against Crohn's disease, and additional noncoding IL23R variants are independently associated. Replication studies confirmed IL23R associations in independent cohorts of patients with Crohn's disease or ulcerative colitis. These results and previous studies on the proinflammatory role of IL-23 prioritize this signaling pathway as a therapeutic target in inflammatory bowel disease.	Yale Univ, IBD Ctr, Sect Digest Dis, Dept Med, New Haven, CT 06519 USA; Univ Pittsburgh, Med Ctr, Sch Med,Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Div Gastroenterol, IBD Ctr, Los Angeles, CA 90048 USA; Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21231 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Univ Montreal, Montreal, PQ H1T 1C8, Canada; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; MIT, Broad Inst, Med & Populat Genet Program, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Univ Toronto, Mt Sinai Hosp, IBD Ctr, Toronto, ON M5G 1X5, Canada; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Feinstein Inst Med Res, Manhasset, NY 11030 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Yale Univ, IBD Ctr, Sect Digest Dis, Dept Genet, New Haven, CT 06519 USA	Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universite de Montreal; Universite de Montreal; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Chicago; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; Royal Victoria Hospital; Cedars Sinai Medical Center; University of Chicago; Northwell Health; University of Chicago; Yale University	Cho, JH (corresponding author), Yale Univ, IBD Ctr, Sect Digest Dis, Dept Med, S155A,300 Cedar St, New Haven, CT 06519 USA.	judy.cho@yale.edu	Daly, Mark J/B-2453-2017; Silverberg, Mark/B-4183-2008; Duerr, Richard H/B-4188-2009; Rioux, John D/A-9599-2015; Rotter, Jerome/AAY-6598-2021; Eckhardt, Erik/G-1567-2010	Daly, Mark J/0000-0002-0949-8752; Duerr, Richard H/0000-0001-6586-3905; Rioux, John D/0000-0001-7560-8326; Barmada, M Michael/0000-0002-3604-6460; Nicolae, Dan/0000-0002-0918-4630; Schumm, Phil/0000-0002-3050-2429	NIDDK NIH HHS [DK62413, P30 DK063491-039004, DK62423, DK62432, DK62429, DK62420, P30 DK063491-049004, P30 DK063491, DK62431, U01 DK062413, U01 DK062429, U01 DK062432, U01 DK062431, U01 DK062420, U01 DK062423, U01 DK062422, DK62422, P30 DK063491-019004, P30 DK063491-029004] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062431, U01DK062420, U01DK062423, U01DK062422, P30DK063491, U01DK062413, U01DK062429, U01DK062432] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2006, INFLAMM BOWEL DIS, V12, P9, DOI 10.1097/01.MIB.0000194183.92671.b6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nadeau JH, 2006, NAT GENET, V38, P1095, DOI 10.1038/ng1006-1095; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang XY, 2006, IMMUNOGENETICS, V57, P934, DOI 10.1007/s00251-005-0067-0	28	2241	2369	4	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1461	1463		10.1126/science.1135245	http://dx.doi.org/10.1126/science.1135245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17068223	Green Accepted			2022-12-01	WOS:000242406100044
J	Bradley, EH; Herrin, J; Wang, YF; Barton, BA; Webster, TR; Mattera, JA; Roumanis, SA; Curtis, JP; Nallamothu, BK; Magid, DJ; McNamara, RL; Parkosewich, J; Loeb, JM; Krumholz, HM				Bradley, Elizabeth H.; Herrin, Jeph; Wang, Yongfei; Barton, Barbara A.; Webster, Tashonna R.; Mattera, Jennifer A.; Roumanis, Sarah A.; Curtis, Jeptha P.; Nallamothu, Brahmajee K.; Magid, David J.; McNamara, Robert L.; Parkosewich, Janet; Loeb, Jerod M.; Krumholz, Harlan M.			Strategies for reducing the door-to-balloon time in acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; EMERGENCY MEDICAL-SERVICES; QUALITY-OF-CARE; PREHOSPITAL ELECTROCARDIOGRAM; NATIONAL-REGISTRY; HOSPITALS; ANGIOPLASTY; REPERFUSION; IMPROVEMENT; MORTALITY	BACKGROUND: Prompt reperfusion treatment is essential for patients who have myocardial infarction with ST-segment elevation. Guidelines recommend that the interval between arrival at the hospital and intracoronary balloon inflation (door-to-balloon time) during primary percutaneous coronary intervention should be 90 minutes or less. However, few hospitals meet this objective. We sought to identify hospital strategies that were significantly associated with a faster door-to-balloon time. METHODS: We surveyed 365 hospitals to determine whether each of 28 specific strategies was in use. We used hierarchical generalized linear models and data on patients from the Centers for Medicare and Medicaid Services to determine the association between hospital strategies and the door-to-balloon time. RESULTS: In multivariate analysis, six strategies were significantly associated with a faster door-to-balloon time. These strategies included having emergency medicine physicians activate the catheterization laboratory (mean reduction in door-to-balloon time, 8.2 minutes), having a single call to a central page operator activate the laboratory (13.8 minutes), having the emergency department activate the catheterization laboratory while the patient is en route to the hospital (15.4 minutes), expecting staff to arrive in the catheterization laboratory within 20 minutes after being paged (vs. >30 minutes) (19.3 minutes), having an attending cardiologist always on site (14.6 minutes), and having staff in the emergency department and the catheterization laboratory use real-time data feedback (8.6 minutes). Despite the effectiveness of these strategies, only a minority of hospitals surveyed were using them. CONCLUSIONS: Several specific hospital strategies are associated with a significant reduction in the door-to-balloon time in the management of myocardial infarction with ST-segment elevation.	Yale Univ, Sch Med, Yale New Haven Hosp, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Yale New Haven Hosp, Dept Med, New Haven, CT USA; Yale Univ, Sch Nursing, New Haven, CT 06536 USA; Univ Michigan, Med Ctr, Ann Arbor, MI USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Kaiser Permanente, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Joint Commiss Accreditat Healthcare Org, Oak Brook Terrace, IL USA	Yale University; Yale University; Yale University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Kaiser Permanente; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Bradley, EH (corresponding author), Yale Univ, Sch Med, Yale New Haven Hosp, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.		, Harlan/AAI-2875-2020		NHLBI NIH HHS [R01HL072575] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072575] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Aiken L., 1991, MULTIPLE REGRESSION; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Bradley EH, 2006, CIRCULATION, V113, P1079, DOI 10.1161/CIRCULATIONAHA.105.590133; Bradley EH, 2005, J AM COLL CARDIOL, V46, P1236, DOI 10.1016/j.jacc.2005.07.009; Burwen DR, 2003, ARCH INTERN MED, V163, P1430, DOI 10.1001/archinte.163.12.1430; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Canto JG, 1997, J AM COLL CARDIOL, V29, P498, DOI 10.1016/S0735-1097(96)00532-3; Canto JG, 2002, CIRCULATION, V106, P3018, DOI 10.1161/01.CIR.0000041246.20352.03; Curtis JP, 2006, J AM COLL CARDIOL, V47, P1544, DOI 10.1016/j.jacc.2005.10.077; Garvey JL, 2006, J AM COLL CARDIOL, V47, P485, DOI 10.1016/j.jacc.2005.08.072; Jacobs AK, 2006, CIRCULATION, V113, P2152, DOI 10.1161/CIRCULATIONAHA.106.174477; Jacoby Jeanne, 2005, J Invasive Cardiol, V17, P154; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P2647; *JOINT COMM ACCR H, COMPR REV DEV TEST N; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Lambrew CT, 1997, ARCH INTERN MED, V157, P2577, DOI 10.1001/archinte.157.22.2577; McNamara RL, 2006, J AM COLL CARDIOL, V47, P45, DOI 10.1016/j.jacc.2005.04.071; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Rogers WJ, 2000, J AM COLL CARDIOL, V35, P371, DOI 10.1016/S0735-1097(99)00505-7; Snijders T., 1999, MULTILEVEL ANAL INTR; Stern S, 1997, J ECON LIT, V35, P2006; Tanner M.A., 1996, TOOLS STAT INFERENCE; Thatcher Jackson L, 2003, J Invasive Cardiol, V15, P693; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	27	606	626	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2308	2320		10.1056/NEJMsa063117	http://dx.doi.org/10.1056/NEJMsa063117			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17101617				2022-12-01	WOS:000242355300006
J	Willcox, BJ; He, QM; Chen, R; Yano, K; Masaki, KH; Grove, JS; Donlon, TA; Willcox, DC; Curb, JD				Willcox, Bradley J.; He, Qimei; Chen, Randi; Yano, Katsuhiko; Masaki, Kamal H.; Grove, John S.; Donlon, Timothy A.; Willcox, D. Craig; Curb, J. David			Midlife risk factors and healthy survival in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METABOLIC SYNDROME; UNITED-STATES; JAPANESE MEN; HEART; LIFE; MORTALITY; HAWAII; PREDICTORS; MORBIDITY; LUNG	Context Healthy survival has no clear phenotypic definition, and little is known about its attributes, particularly in men. Objective To test whether midlife biological, lifestyle, and sociodemographic risk factors are associated with overall survival and exceptional survival ( free of a set of major diseases and impairments). Design, Setting, and Participants Prospective cohort study within the Honolulu Heart Program/Honolulu Asia Aging Study. A total of 5820 Japanese American middle-aged men ( mean age, 54 [ range, 45-68] years) free of morbidity and functional impairments were followed for up to 40 years (1965-2005) to assess overall and exceptional survival. Exceptional survival was defined as survival to a specified age ( 75, 80, 85, or 90 years) without incidence of 6 major chronic diseases and without physical and cognitive impairment. Main Outcome Measure Overall survival and exceptional survival. Results Of 5820 original participants, 2451 participants (42%) survived to age 85 years and 655 participants (11%) met the criteria for exceptional survival to age 85 years. High grip strength and avoidance of overweight, hyperglycemia, hypertension, smoking, and excessive alcohol consumption were associated with both overall and exceptional survival. In addition, high education and avoidance of hypertriglyceridemia were associated with exceptional survival, and lack of a marital partner was associated with mortality before age 85 years. Risk factor models based on cumulative risk factors ( survival risk score) suggest that the probability of survival to oldest age is as high as 69% with no risk factors and as low as 22% with 6 or more risk factors. The probability of exceptional survival to age 85 years was 55% with no risk factors but decreased to 9% with 6 or more risk factors Conclusion These data suggest that avoidance of certain risk factors in midlife is associated with the probability of a long and healthy life among men.	Univ Hawaii Manoa, John A Burns Sch Med, Pacific Hlth Res Inst, Honolulu, HI 96813 USA; Univ Hawaii Manoa, John A Burns Sch Med, Kuakini Med Ctr, Honolulu Heart Program, Honolulu, HI 96813 USA; Univ Hawaii Manoa, John A Burns Sch Med, Dept Geriatr Med & Med, Honolulu, HI 96813 USA; Univ Hawaii Manoa, John A Burns Sch Med, Dept Publ Hlth Sci & Epidemiol, Honolulu, HI 96813 USA; Univ Hawaii, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA; Okinawa Prefectural Univ, Coll Nursing, Okinawa, Japan	Pacific Health Research & Education Institute; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Cancer Research Center of Hawaii; University of Hawaii System	Willcox, BJ (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Pacific Hlth Res Inst, 846 S Hotel St Suite 201, Honolulu, HI 96813 USA.	bjwillcox@phrihawaii.org			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG019349, K08AG022788, R01AG027060, N01AG042149] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; BLACKWELDER WC, 1980, AM J MED, V68, P164, DOI 10.1016/0002-9343(80)90350-2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Curb JD, 2006, J AM GERIATR SOC, V54, P737, DOI 10.1111/j.1532-5415.2006.00700.x; CURB JD, 1990, J AM GERIATR SOC, V38, P827, DOI 10.1111/j.1532-5415.1990.tb01478.x; CURB JD, 1990, J GERONTOL, V45, pS206, DOI 10.1093/geronj/45.5.S206; Depp CA, 2006, AM J GERIAT PSYCHIAT, V14, P6, DOI 10.1097/01.JGP.0000192501.03069.bc; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Fontanarosa PB, 2006, JAMA-J AM MED ASSOC, V295, P440, DOI 10.1001/jama.295.4.440; Fraser GE, 2001, ARCH INTERN MED, V161, P1645, DOI 10.1001/archinte.161.13.1645; Gavrilov Leonid A, 2003, Sci Aging Knowledge Environ, V2003, pRE5, DOI 10.1126/sageke.2003.28.re5; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity, 2001, GUID DOC US IN VITR; Hosmer DW., 2000, APPL LOGISTIC REGRES, DOI DOI 10.1002/0471722146; Hsueh Willa A., 1998, American Journal of Medicine, V105, p4S, DOI 10.1016/S0002-9343(98)00205-8; KAGAN A, 1974, J CHRON DIS, V27, P345, DOI 10.1016/0021-9681(74)90014-9; Kagan A., 1996, HONOLULU HEART PROGR; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KRACH CA, 1999, CURRENT POP P23199RV; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Mark DH, 2005, JAMA-J AM MED ASSOC, V293, P1918, DOI 10.1001/jama.293.15.1918; Masoro EJ, 2006, J GERONTOL A-BIOL, V61, P14, DOI 10.1093/gerona/61.1.14; MILLER FD, 1993, INT J EPIDEMIOL, V22, P834, DOI 10.1093/ije/22.5.834; Morley JE, 2004, J GERONTOL A-BIOL, V59, P139; *NAT I AG, 2001, NIH PUBL; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nesto Richard W, 2003, Rev Cardiovasc Med, V4 Suppl 6, pS11; NHLBI Obesity Education Initiative Expert Panel on the Identi-fication E and T of O in A (US), 1998, CLIN GUID ID EV TREA; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Reed DM, 1998, AM J PUBLIC HEALTH, V88, P1463, DOI 10.2105/AJPH.88.10.1463; RODRIGUEZ BL, 1998, CARDIOVASC RISK FACT, V8, P99; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; SUZMAN R, 1985, MILBANK FUND Q, V63, P177; Tang W, 2006, DIABETES CARE, V29, P631, DOI 10.2337/diacare.29.03.06.dc05-0679; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Terry DF, 2005, J AM GERIATR SOC, V53, P1944, DOI 10.1111/j.1532-5415.2005.00465.x; United States Census Bureau, AM FACTFINDER; *US DEP HHS, 2005, HLTH PEOPL 2010, V1; Vaupel JW, 1997, PHILOS T ROY SOC B, V352, P1799, DOI 10.1098/rstb.1997.0164; White L, 1996, JAMA-J AM MED ASSOC, V276, P955, DOI 10.1001/jama.276.12.955; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6	44	163	167	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2343	2350		10.1001/jama.296.19.2343	http://dx.doi.org/10.1001/jama.296.19.2343			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104ZI	17105797	Bronze			2022-12-01	WOS:000241998700022
J	Boockvar, KS; Meier, DE				Boockvar, Kenneth S.; Meier, Diane E.			Palliative care for frail older adults - "There are things I can't do anymore that I wish I could ..."	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; INSTRUMENTAL ACTIVITIES; FUNCTIONAL DECLINE; PHYSICAL FRAILTY; CONTROLLED-TRIAL; WOMENS HEALTH; DOUBLE-BLIND; END; DISABILITY; HOSPICE	Frailty in older adults is increasingly a recognized syndrome of decline, sometimes subtle, in function and health that may be amenable to available approaches to care. Frailty manifests the following core clinical features: loss of strength, weight loss, low levels of activity, poor endurance or fatigue, and slowed performance. The presence of 3 or more of these features is associated with adverse outcomes including falls, new or worsened function impairment, hospitalization, and death. In this article, we use the case of Mrs K to describe the challenges of recognizing frailty in clinical practice, common problems and symptoms that frail older adults experience, and approaches to these issues that clinicians may incorporate into their practices. We discuss the importance of advance care planning, provider-patient communication, and appropriate palliative care and hospice referral for frail older adults. Frailty is associated with symptomatic long-term disease, decline in function, and abbreviated survival. Therefore, when frailty is severe, delivery of palliative care focused on relief of discomfort and enhancement of quality of life is highly appropriate. The application of multidisciplinary, team-based palliative approaches and of up-to-date geriatrics knowledge is beneficial for treating these patients because of the complexity of their coexisting social, psychological, and medical needs.	James J Peters Vet Affairs Med Ctr, Bronx, NY 10468 USA; CUNY Mt Sinai Sch Med, New York, NY 10029 USA; Jewish Home & Hosp, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Boockvar, KS (corresponding author), James J Peters Vet Affairs Med Ctr, 130 W Kingsbridge Rd, Bronx, NY 10468 USA.	kenneth.boockvar@mssm.edu	Boockvar, Kenneth S./H-9259-2019	Boockvar, Kenneth/0000-0003-1165-5558				Agency for Healthcare Research and Quality Centers for Disease Control, PHYS ACT OLD AM BEN; [Anonymous], 2001, J AM GERIATR SOC, V49, P664, DOI DOI 10.1046/J.1532-5415.2001.49115.X; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; Block SD, 2006, J PALLIAT MED, V9, P751, DOI 10.1089/jpm.2006.9.751; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Bookbinder M, 1996, J PAIN SYMPTOM MANAG, V12, P334, DOI 10.1016/S0885-3924(96)00204-7; Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Crotty Maria, 2004, Am J Geriatr Pharmacother, V2, P257, DOI 10.1016/j.amjopharm.2005.01.001; *CTR ADV PALL CAR, AB US; Doyle D., 1998, OXFORD TXB PALLIATIV, V2e; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Ensrud KE, 2002, J AM GERIATR SOC, V50, P1629, DOI 10.1046/j.1532-5415.2002.50453.x; Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x; Ferrell BA, 2000, CLIN GERIATR MED, V16, P853, DOI 10.1016/S0749-0690(05)70048-3; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Finlay IG, 2002, ANN ONCOL, V13, P257, DOI 10.1093/annonc/mdf668; Flint AJ, 1998, DRUG AGING, V13, P269, DOI 10.2165/00002512-199813040-00003; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Hanlon JT, 2001, J AM GERIATR SOC, V49, P200, DOI 10.1046/j.1532-5415.2001.49042.x; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Jones DM, 2004, J AM GERIATR SOC, V52, P1929, DOI 10.1111/j.1532-5415.2004.52521.x; Larsson L, 2000, DRUG AGING, V17, P303, DOI 10.2165/00002512-200017040-00006; Latham N.K., 2003, COCHRANE DB SYST REV, V2; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Lorenz KA, 2004, J AM GERIATR SOC, V52, P725, DOI 10.1111/j.1532-5415.2004.52209.x; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; Mackin RS, 2005, PSYCHIAT CLIN N AM, V28, P805, DOI 10.1016/j.psc.2005.09.009; Manfredi PL, 2000, J PAIN SYMPTOM MANAG, V20, P166, DOI 10.1016/S0885-3924(00)00163-9; Marchandin H, 2001, PATHOL BIOL, V49, P522, DOI 10.1016/S0369-8114(01)00212-7; Miller SC, 2003, J PAIN SYMPTOM MANAG, V26, P791, DOI 10.1016/S0885-3924(03)00284-7; Milne AC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003288.pub2; Morley JE, 1997, CLIN GERIATR MED, V13, P685, DOI 10.1016/s0749-0690(18)30144-7; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Morrison RS, 2003, PAIN, V103, P303, DOI 10.1016/S0304-3959(02)00458-X; Morrison RS., 2003, GERIATRIC PALLIATIVE, V1st; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; MULROW CD, 1994, JAMA-J AM MED ASSOC, V271, P519, DOI 10.1001/jama.271.7.519; *NAT COMPR CANC NE, GUID SUPP CAR PALL C; *NAT HOSP PALL CAR, 1996, MED GUID DET PROGN S; Nourhashemi F, 2001, J GERONTOL A-BIOL, V56, pM448, DOI 10.1093/gerona/56.7.M448; Pantilat SZ, 2004, JAMA-J AM MED ASSOC, V291, P2476, DOI 10.1001/jama.291.20.2476; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Rabow MW, 2004, JAMA-J AM MED ASSOC, V291, P483, DOI 10.1001/jama.291.4.483; Reuben DB, 2005, J AM GERIATR SOC, V53, P970, DOI 10.1111/j.1532-5415.2005.53307.x; Reuben DB, 2006, GERIATRICS YOUR FING; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Sarkisian CA, 2001, J AM GERIATR SOC, V49, P134, DOI 10.1046/j.1532-5415.2001.49033.x; Schatzberg AF, 2002, AM J GERIAT PSYCHIAT, V10, P541, DOI 10.1176/appi.ajgp.10.5.541; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Shanmugham B, 2005, PSYCHIAT CLIN N AM, V28, P821, DOI 10.1016/j.psc.2005.09.012; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Smith Thomas J, 2003, J Palliat Med, V6, P699, DOI 10.1089/109662103322515202; Snyder PJ, 2004, NEW ENGL J MED, V350, P440, DOI 10.1056/NEJMp038207; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; STUCK AE, 1995, NEW ENGL J MED, V333, P1184, DOI 10.1056/NEJM199511023331805; Studenski S, 2004, J AM GERIATR SOC, V52, P1560, DOI 10.1111/j.1532-5415.2004.52423.x; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; WALSTON JD, 2003, GERIATRIC PALLIATIVE; Williamson JD, 1996, J AM GERIATR SOC, V44, P1429, DOI 10.1111/j.1532-5415.1996.tb04066.x; Wolf SL, 2003, J AM GERIATR SOC, V51, P1693, DOI 10.1046/j.1532-5415.2003.51552.x; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Yeh SS, 2000, J AM GERIATR SOC, V48, P485, DOI 10.1111/j.1532-5415.2000.tb04993.x	77	65	66	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2245	2253		10.1001/jama.296.18.2245	http://dx.doi.org/10.1001/jama.296.18.2245			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	102QM	17090771				2022-12-01	WOS:000241827700025
J	Lopushinsky, SR; Urbach, DR				Lopushinsky, Steven R.; Urbach, David R.			Pneumatic dilatation and surgical myotomy for achalasia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAPAROSCOPIC HELLER MYOTOMY; INTRASPHINCTERIC BOTULINUM-TOXIN; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; ESOPHAGEAL ACHALASIA; DILATION; SURGERY; EXPERIENCE; ESOPHAGOMYOTOMY; INJECTION	Context Pneumatic dilatation and surgical (Heller) myotomy are the 2 principal methods for treatment of achalasia. There are no population-based studies comparing outcomes of these 2 treatments in typical practice settings. Objective To compare the outcomes of pneumatic dilatation and surgical myotomy for achalasia. Design, Setting, and Participants Retrospective longitudinal study using linked administrative health data in Ontario. A total of 1461 persons aged 18 years or older received treatment for achalasia between July 1991 and December 2002, 1181 (80.8%) of whom had pneumatic dilatation and 280 (19.2%) of whom had surgical myotomy as the first procedure. Main Outcome Measures Use of subsequent interventions for achalasia (pneumatic dilatation, surgical myotomy, or esophagectomy) following the first treatment during the study period, subsequent physician visits, and use of gastrointestinal medications among persons aged 65 years or older. We adjusted for confounding variables using regression models. Results The cumulative risk of any subsequent intervention for achalasia after 1, 5, and 10 years, respectively, was 36.8%, 56.2%, and 63.5% for persons treated initially with pneumatic dilatation and was 16.4%, 30.3%, and 37.5% for persons treated initially with surgical myotomy (adjusted hazard ratio [HR], 2.37; 95% confidence interval [CI], 1.86-3.02; P < .001). Differences in risk were observed only when subsequent pneumatic dilatation was included as an adverse outcome; there was no statistical difference between the 2 groups with respect to the risk of subsequent surgical myotomy or esophagectomy. Compared with persons treated initially with surgical myotomy, those treated with pneumatic dilatation were not statistically different with respect to subsequent physician visits (adjusted rate ratio, 1.01; 95% CI, 1.00-1.03), or time to use of histamine-2 receptor blockers (adjusted HR, 1.19; 95% CI, 0.79-1.80), proton pump inhibitors (HR, 1.02; 95% CI, 0.70-1.49), and prokinetic medications (HR, 0.92; 95% CI, 0.60-1.41). Conclusions Subsequent intervention after the initial treatment of achalasia is common. Although the risk of subsequent interventions among persons treated with surgical myotomy in typical practice settings is higher than previously thought, the risk of subsequent intervention is greater among persons treated with pneumatic dilatation than with surgical myotomy. This difference is attributable to the use of subsequent pneumatic dilatation rather than surgical procedures.	Univ Toronto, Dept Surg, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Hlth Network, Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Hlth Network, Div Clin Decis Making & Hlth Care, Toronto, ON, Canada; Canc Care Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cancer Care Ontario	Urbach, DR (corresponding author), Toronto Gen Hosp, 200 Elizabeth St,Room 10-NU-214, Toronto, ON M5G 2C4, Canada.	david.urbach@uhn.on.ca						ABID S, 1994, AM J GASTROENTEROL, V89, P979; Achkar E, 1995, Gastroenterologist, V3, P273; [Anonymous], 1996, PATTERNS HLTH CARE O; Bansal R, 2003, J CLIN GASTROENTEROL, V36, P209, DOI 10.1097/00004836-200303000-00005; Ben-Meir A, 2001, AM J SURG, V181, P471, DOI 10.1016/S0002-9610(01)00596-7; Bloomston Mark, 2002, JSLS, V6, P41; Bonatti H, 2005, AM J SURG, V190, P874, DOI 10.1016/j.amjsurg.2005.08.012; CSENDES A, 1989, GUT, V30, P299, DOI 10.1136/gut.30.3.299; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eckardt VF, 2004, GUT, V53, P629, DOI 10.1136/gut.2003.029298; Fernandez AF, 2003, SURG ENDOSC, V17, P153, DOI 10.1007/s00464-002-8576-5; Frantzides CT, 2004, J GASTROINTEST SURG, V8, P18, DOI 10.1016/j.gassur.2003.09.021; Ghoshal UC, 2001, DIS ESOPHAGUS, V14, P227, DOI 10.1046/j.1442-2050.2001.00189.x; JARA FM, 1979, ARCH SURG-CHICAGO, V114, P935; Karamanolis G, 2005, AM J GASTROENTEROL, V100, P270, DOI 10.1111/j.1572-0241.2005.40093.x; KATZ P, 1994, AM J GASTROENTEROL, V89, P969; Lyass S, 2003, SURG ENDOSC, V17, P554, DOI 10.1007/s00464-002-8604-5; MALTHANER RA, 1994, ANN THORAC SURG, V58, P1343, DOI 10.1016/0003-4975(94)91910-0; MEARIN F, 1993, EUR J CLIN INVEST, V23, P724, DOI 10.1111/j.1365-2362.1993.tb01292.x; Mikaeli J, 2001, ALIMENT PHARM THER, V15, P1389, DOI 10.1046/j.1365-2036.2001.01065.x; Mineo TC, 2004, EUR J CARDIO-THORAC, V25, P1089, DOI 10.1016/j.ejcts.2004.01.043; Panaccione R, 1999, GASTROINTEST ENDOSC, V50, P492, DOI 10.1016/S0016-5107(99)70071-4; Patti MG, 2003, J AM COLL SURGEONS, V196, P698, DOI 10.1016/S1072-7515(02)01837-9; PAYNE WS, 1989, ANN THORAC SURG, V48, P876, DOI 10.1016/0003-4975(89)90695-4; Podas T, 1998, AM J GASTROENTEROL, V93, P2345, DOI 10.1016/S0002-9270(98)00567-X; Ramacciato G, 2002, SURG ENDOSC, V16, P1431, DOI 10.1007/s00464-001-9215-2; Richards WO, 2004, ANN SURG, V240, P403, DOI 10.1097/01.sla.0000136940.32255.51; RICHTER JE, 1991, GASTROENTEROLOGY, V97, P1340; Rosemurgy A, 2005, ANN SURG, V241, P725, DOI 10.1097/01.sla.0000160702.31452.d5; SHIMI S, 1991, Journal of the Royal College of Surgeons of Edinburgh, V36, P152; Shoenut JP, 1997, AM J GASTROENTEROL, V92, P1109; *SOC SURG AL TRACT, 2004, J GASTROINTEST SURG, V8, P367; Spiess AE, 1998, JAMA-J AM MED ASSOC, V280, P638, DOI 10.1001/jama.280.7.638; SWANSTROM LL, 1995, SURG ENDOSC-ULTRAS, V9, P286; TRAUBE M, 1984, JAMA-J AM MED ASSOC, V252, P1733, DOI 10.1001/jama.252.13.1733; Vaezi MF, 1999, GUT, V44, P231, DOI 10.1136/gut.44.2.231; Vela MF, 2006, CLIN GASTROENTEROL H, V4, P580, DOI 10.1016/S1542-3565(05)00986-9; Vela MF, 2004, AM J GASTROENTEROL, V99, P1029, DOI 10.1111/j.1572-0241.2004.30199.x; Zaninotto G, 2004, ANN SURG, V239, P364, DOI 10.1097/01.sla.0000114217.52941.c5	39	81	84	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2227	2233		10.1001/jama.296.18.2227	http://dx.doi.org/10.1001/jama.296.18.2227			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090769	Bronze			2022-12-01	WOS:000241827700023
J	Chan, JR; Jolicoeur, C; Yamauchi, J; Elliott, J; Fawcett, JP; Ng, BK; Cayouette, M				Chan, Jonah R.; Jolicoeur, Christine; Yamauchi, Junji; Elliott, Jimmy; Fawcett, James P.; Ng, Benjamin K.; Cayouette, Michel			The polarity protein Par-3 directly interacts with p75(NTR) to regulate myelination	SCIENCE			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); SCHWANN-CELL MIGRATION; DROSOPHILA NEUROBLASTS; ELEGANS EMBRYOS; C-ELEGANS; BAZOOKA; COLOCALIZES; COMPLEX; SYSTEM	Cell polarity is critical in various cellular processes ranging from cell migration to asymmetric cell division and axon and dendrite specification. Similarly, myelination by Schwann cells is polarized, but the mechanisms involved remain unclear. Here, we show that the polarity protein Par-3 localizes asymmetrically in Schwann cells at the axon-glial junction and that disruption of Par-3 localization, by overexpression and knockdown, inhibits myelination. Additionally, we show that Par-3 directly associates and recruits the p75 neurotrophin receptor to the axon-glial junction, forming a complex necessary for myelination. Together, these results point to a critical role in the establishment of cell polarity for myelination.	Inst Rech Clin Montreal, Cellular Neurobiol Lab, Montreal, PQ H2W 1R7, Canada; Univ So Calif, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; Natl Res Inst Child Hlth & Dev, Dept Mol Pharmacol, Tokyo, Japan; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Southern California; National Center for Child Health & Development - Japan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Universite de Montreal	Chan, JR (corresponding author), Inst Rech Clin Montreal, Cellular Neurobiol Lab, Montreal, PQ H2W 1R7, Canada.	jonah.chan@usc.edu; michel.cayouette@ircm.qc.ca		Cayouette, Michel/0000-0003-4655-9048; Fawcett, Jim/0000-0003-0043-2164				Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Hung TJ, 1999, DEVELOPMENT, V126, P127; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Nance J, 2002, DEVELOPMENT, V129, P387; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yamauchi J, 2003, P NATL ACAD SCI USA, V100, P14421, DOI 10.1073/pnas.2336152100; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368	21	115	121	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					832	836		10.1126/science.1134069	http://dx.doi.org/10.1126/science.1134069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082460				2022-12-01	WOS:000241729800051
J	Matthews, EE; Zoonens, M; Engelman, DM				Matthews, Erin E.; Zoonens, Manuela; Engelman, Donald M.			Dynamic helix interactions in transmembrane signaling	CELL			English	Editorial Material							MEMBRANE-PROTEIN; ERBB RECEPTORS; DOMAIN; ACTIVATION; MECHANISM; MICELLES; BILAYER	Studying how protein transmembrane domains transmit signals across membranes is beset by unique challenges. Here, we discuss the circumstances that have led to success and reflect on what has been learned from these examples. Such efforts suggest that some of the most interesting properties of transmembrane helix interactions may be the least amenable to study by current techniques.	Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University	Engelman, DM (corresponding author), Yale Univ, Dept Chem, 266 Whitney Ave, New Haven, CT 06520 USA.	donald.engelman@yale.edu		Zoonens, Manuela/0000-0003-2648-7868				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; DILL KA, 1981, P NATL ACAD SCI USA, V78, P676, DOI 10.1073/pnas.78.2.676; Findlay HE, 2006, J PHYS-CONDENS MAT, V18, pS1281, DOI 10.1088/0953-8984/18/28/S11; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Nakamura T, 2006, BLOOD, V107, P4300, DOI 10.1182/blood-2005-11-4433; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Nollert P, 2005, PROG BIOPHYS MOL BIO, V88, P339, DOI 10.1016/j.pbiomolbio.2004.07.006; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Patargias G, 2005, J PHYS CHEM B, V109, P575, DOI 10.1021/jp046727h; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Stanley AM, 2005, J MOL BIOL, V347, P759, DOI 10.1016/j.jmb.2005.01.059; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	19	99	99	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					447	450		10.1016/j.cell.2006.10.016	http://dx.doi.org/10.1016/j.cell.2006.10.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081964	Bronze			2022-12-01	WOS:000241937000006
J	Harrington, J; Hansen, BM; Luszcz, SH; Seager, S; Deming, D; Menou, K; Cho, JYK; Richardson, LJ				Harrington, Joseph; Hansen, Brad M.; Luszcz, Statia H.; Seager, Sara; Deming, Drake; Menou, Kristen; Cho, James Y. -K.; Richardson, L. Jeremy			The phase-dependent infrared brightness of the extrasolar planet upsilon Andromedae b	SCIENCE			English	Article							THERMAL EMISSION; TRES-1; STARS	The star upsilon Andromedae is orbited by three known planets, the innermost of which has an orbital period of 4.617 days and a mass at least 0.69 that of Jupiter. This planet is close enough to its host star that the radiation it absorbs overwhelms its internal heat losses. Here, we present the 24-micrometer light curve of this system, obtained with the Spitzer Space Telescope. It shows a variation in phase with the orbital motion of the innermost planet, demonstrating that such planets possess distinct hot substellar ( day) and cold antistellar ( night) faces.	Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; NASA, Goddard Space Flight Ctr, Planetary Syst Lab, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Goddard Ctr Astrobiol, Greenbelt, MD 20771 USA; Columbia Univ, Dept Astron, New York, NY 10027 USA; Univ London, Queen Mary, Sch Math Sci, Astron Unit, London E1 4NS, England; NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University System of Florida; University of Central Florida; Cornell University; University of California System; University of California Berkeley; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University; University of London; Queen Mary University London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Hansen, BM (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	hansen@astro.ucla.edu	Harrington, Joseph/E-6250-2011					Barman TS, 2005, ASTROPHYS J, V632, P1132, DOI 10.1086/444349; Burrows A, 2005, ASTROPHYS J, V625, pL135, DOI 10.1086/431242; Butler RP, 1997, ASTROPHYS J, V474, pL115, DOI 10.1086/310444; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Cho JYK, 2003, ASTROPHYS J, V587, pL117, DOI 10.1086/375016; Cooper CS, 2005, ASTROPHYS J, V629, pL45, DOI 10.1086/444354; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2006, ASTROPHYS J, V644, P560, DOI 10.1086/503358; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Fortney JJ, 2005, ASTROPHYS J, V627, pL69, DOI 10.1086/431952; Henry GW, 2000, ASTROPHYS J, V531, P415, DOI 10.1086/308466; HORNE K, 1986, PUBL ASTRON SOC PAC, V98, P609, DOI 10.1086/131801; Kelsall T, 1998, ASTROPHYS J, V508, P44, DOI 10.1086/306380; RICHARDSON LJ, ASTROPHYS J; Rieke GH, 2004, PROC SPIE, V5487, P50, DOI 10.1117/12.551965; Seager S, 2005, ASTROPHYS J, V632, P1122, DOI 10.1086/444411; Shkolnik E, 2005, ASTROPHYS J, V622, P1075, DOI 10.1086/428037; Werner MW, 2004, ASTROPHYS J SUPPL S, V154, P1, DOI 10.1086/422992	18	177	181	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					623	626		10.1126/science.1133904	http://dx.doi.org/10.1126/science.1133904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17038587	Green Submitted			2022-12-01	WOS:000241557800039
J	Zarrin, AA; Del Vecchio, C; Tseng, E; Gleason, M; Zarin, P; Tian, M; Alt, FW				Zarrin, Ali A.; Del Vecchio, Catherine; Tseng, Eva; Gleason, Megan; Zarin, Payam; Tian, Ming; Alt, Frederick W.			Antibody class switching mediated by yeast endonuclease-generated DNA breaks	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; S-MU REGION; SOMATIC HYPERMUTATION; GENE CONVERSION; B-CELLS; RECOMBINATION; AID; MECHANISM; TRANSLOCATIONS; DELETION	Antibody class switching in activated B cells uses class switch recombination (CSR), which joins activation-induced cytidine deaminase (AID)-dependent double-strand breaks (DSBs) within two large immunoglobulin heavy chain (IgH) locus switch (S) regions that lie up to 200 kilobases apart. To test postulated roles of S regions and AID in CSR, we generated mutant B cells in which donor S mu and accepter S gamma 1 regions were replaced with yeast 1-SceI endonuclease sites. We found that site-specific 1-SceI DSBs mediate recombinational IgH locus class switching from IgM to IgG(2) without S regions or AID. We propose that CSR evolved to exploit a general DNA repair process that promotes joining of widely separated DSBs within a chromosome.	Harvard Univ, Sch Med, Childrens Hosp, CBR Inst Biomed Res,Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Texas, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; University of Texas System; University of Texas Austin	Alt, FW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, CBR Inst Biomed Res,Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu		Del Vecchio Fitz, Catherine/0000-0002-9554-411X	NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI031541] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA092625-05] Funding Source: Medline; NIAID NIH HHS [2P01AI031541-15] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470; Larson ED, 2005, CURR BIOL, V15, P470, DOI 10.1016/j.cub.2004.12.077; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Luby TM, 2001, J EXP MED, V193, P159, DOI 10.1084/jem.193.2.159; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rush JS, 2004, INT IMMUNOL, V16, P549, DOI 10.1093/intimm/dxh057; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Schrader CE, 2003, EMBO J, V22, P5893, DOI 10.1093/emboj/cdg550; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Toffolatti L, 2002, GENOMICS, V80, P523, DOI 10.1006/geno.2002.6861; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; Zarrin AA, 2005, P NATL ACAD SCI USA, V102, P2466, DOI 10.1073/pnas.0409847102; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137	30	78	84	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					377	381		10.1126/science.1136386	http://dx.doi.org/10.1126/science.1136386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17170253				2022-12-01	WOS:000243535400042
J	Pak, J; Fire, A				Pak, Julia; Fire, Andrew			Distinct populations of primary and secondary effectors during RNAi in C-elegans	SCIENCE			English	Article							GENE; INTERFERENCE; RECOGNITION; POLYMERASE; SIRNAS	RNA interference (RNAi) is a phylogenetically widespread gene-silencing process triggered by double-stranded RNA. In plants and Caenorhabditis elegans, two distinct populations of small RNAs have been proposed to participate in RNAi: "Primary siRNAs" ( derived from DICER nuclease-mediated cleavage of the original trigger) and "secondary siRNAs" [ additional small RNAs whose synthesis requires an RNA-directed RNA polymerase (RdRP)]. Analyzing small RNAs associated with ongoing RNAi in C. elegans, we found that secondary siRNAs constitute the vast majority. The bulk of secondary siRNAs exhibited structure and sequence indicative of a biosynthetic mode whereby each molecule derives from an independent de novo initiation by RdRP. Analysis of endogenous small RNAs indicated that a fraction derive from a biosynthetic mechanism that is similar to that of secondary siRNAs formed during RNAi, suggesting that small antisense transcripts derived from cellular messenger RNAs by RdRP activity may have key roles in cellular regulation.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Fire, A (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	afire@stanford.edu		Fire, Andrew/0000-0001-6217-8312	NIGMS NIH HHS [R01 GM037706, R01-GM-37706] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Cerutti H, 2003, TRENDS GENET, V19, P39, DOI 10.1016/S0168-9525(02)00010-0; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; NEU HC, 1964, J BIOL CHEM, V239, P2927; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Van Houdt H, 2003, PLANT PHYSIOL, V131, P245, DOI 10.1104/pp.009407; VAUCHERET H, 2005, SCI STKE, pPE43, DOI DOI 10.1126/STKE.3002005PE42; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3	26	431	445	5	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2007	315	5809					241	244		10.1126/science.1132839	http://dx.doi.org/10.1126/science.1132839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124XZ	17124291				2022-12-01	WOS:000243407400047
J	Imboden, M; Swan, H; Denjoy, I; Van Langen, IM; Latinen-Forsblom, PJ; Napolitano, C; Fressart, V; Breithardt, G; Berthet, M; Priori, S; Hainque, B; Wilde, AAM; Schulze-Bahr, E; Feingold, J; Guicheney, P				Imboden, Medea; Swan, Heikki; Denjoy, Isabelle; Marijke Van Langen, Irene; Latinen-Forsblom, Paivi Johanna; Napolitano, Carlo; Fressart, Veronique; Breithardt, Guenter; Berthet, Myriam; Priori, Silvia; Hainque, Bernard; Wilde, Arthur Arnold Maria; Schulze-Bahr, Eric; Feingold, Josue; Guicheney, Pascale			Female predominance and transmission distortion in the long-QT syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-COURSE; RISK-FACTOR; DE-POINTES; GENDER; AGE; SEGREGATION; LQTS	BACKGROUND: Congenital long-QT syndrome is a disorder resulting in ventricular arrhythmias and sudden death. The most common forms of the long-QT syndrome, types 1 and 2, are caused by mutations in the potassium-channel genes KCNQ1 and KCNH2, respectively. Although inheritance of the long-QT syndrome is autosomal dominant, female predominance has often been observed and has been attributed to an increased susceptibility to cardiac arrhythmias in women. We investigated the possibility of an unbalanced transmission of the deleterious trait. METHODS: We investigated the distribution of alleles for the long-QT syndrome in 484 nuclear families with type 1 disease and 269 nuclear families with type 2 disease, all with fully genotyped offspring. The families were recruited in five European referral centers for the long-QT syndrome. Mutation segregation, sex ratio, and parental transmission were analyzed after correction for single ascertainment. RESULTS: Classic mendelian inheritance ratios were not observed in the offspring of either female carriers of the long-QT syndrome type 1 or male and female carriers of the long-QT syndrome type 2. Among the 1534 descendants, the proportion of genetically affected offspring was significantly greater than that expected according to mendelian inheritance: 870 were carriers of a mutation (57%), and 664 were noncarriers (43%, P<0.001). Among the 870 carriers, the allele for the long-QT syndrome was transmitted more often to female offspring (476 [55%]) than to male offspring (394 [45%], P=0.005). Increased maternal transmission of the long-QT syndrome mutations to daughters was also observed, possibly contributing to the excess of female patients with autosomal dominant long-QT syndrome. CONCLUSIONS: Positive selection of the mutated alleles that cause the long-QT syndrome leads to transmission distortion, with increased proportions of mutation carriers among the offspring of affected families. Alleles for the long-QT syndrome are more often transmitted to daughters than to sons.	Univ Paris 06, Assistance Publ Hop Paris,Inst Federatif Rech 14, Inst Myol, INSERM, Paris, France; Hop Lariboisiere, Assistance Publ Hop Paris, Serv Cardiol, F-75475 Paris, France; Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris, Serv Biochim, F-75634 Paris, France; Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris, Dept Genet, F-75634 Paris, France; Univ Zurich, Dept Mol Epidemiol, Inst Social & Prevent Med, Zurich, Switzerland; Univ Helsinki, Dept Med, Helsinki, Finland; Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Expt & Mol Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands; Univ Pavia, I-27100 Pavia, Italy; Fdn Salvatore Maugeri, Ist Ric & Cura Carattere Sci, Mol Cardiol Labs, Pavia, Italy; Univ Munster, Dept Mol Cardiol, Leibniz Inst Arteriosclerosis Res, D-4400 Munster, Germany; Hosp Univ Munster, Dept Cardiol & Angiol, Munster, Germany	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; University of Zurich; University of Helsinki; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Munster; University of Munster	Imboden, M (corresponding author), Grp Hosp Pitie Salpetriere, Inst Myol, INSERM, U582, 47 Blvd Hop, F-75013 Paris, France.	imboden@medgen.unizh.ch	Priori, Silvia G G/A-6116-2014; Priori, Silvia G/ABH-6894-2020; Guicheney, Pascale/D-1034-2017; napolitano, carlo/ABI-4608-2020; Napolitano, Carlo/K-4760-2016	Priori, Silvia G G/0000-0001-6877-0288; Priori, Silvia G/0000-0001-6877-0288; Guicheney, Pascale/0000-0002-7663-2050; napolitano, carlo/0000-0002-7643-4628; Napolitano, Carlo/0000-0002-7643-4628; van Langen, Irene/0000-0002-0960-7154	Telethon [GGP04066] Funding Source: Medline	Telethon(Fondazione Telethon)		Conrath CE, 2002, CARDIOVASC RES, V53, P770, DOI 10.1016/S0008-6363(01)00477-1; Drici MD, 2001, DRUG SAFETY, V24, P575, DOI 10.2165/00002018-200124080-00002; Fodstad H, 2004, ANN MED, V36, P53, DOI 10.1080/17431380410032689; Gould TD, 1998, HUM MOL GENET, V7, P483, DOI 10.1093/hmg/7.3.483; HASHIBA K, 1992, ANN NY ACAD SCI, V644, P142, DOI 10.1111/j.1749-6632.1992.tb31008.x; Hashiba K, 1987, Heart Vessels Suppl, V2, P47; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jiang S, 1998, GENOMICS, V53, P395, DOI 10.1006/geno.1998.5511; Kimbrough J, 2001, CIRCULATION, V104, P557, DOI 10.1161/hc3001.093501; Lehmann MH, 1997, J AM COLL CARDIOL, V29, P93, DOI 10.1016/S0735-1097(96)00454-8; Lehmann MH, 1996, CIRCULATION, V94, P2535, DOI 10.1161/01.CIR.94.10.2535; Li C, 1961, HUMAN GENETICS PRINC; Locati EH, 1998, CIRCULATION, V97, P2237, DOI 10.1161/01.CIR.97.22.2237; Lyon MF, 2003, ANNU REV GENET, V37, P393, DOI 10.1146/annurev.genet.37.110801.143030; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; Magee AC, 1998, J MED GENET, V35, P1045, DOI 10.1136/jmg.35.12.1045; MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590; Malloy K J, 1999, J Gend Specif Med, V2, P37; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schollen E, 2004, J MED GENET, V41, P877, DOI 10.1136/jmg.2004.022350; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; StrambaBadiale M, 1997, EUR HEART J, V18, P1000; ZAREBA W, 1995, J AM COLL CARDIOL, V26, P1685, DOI 10.1016/0735-1097(95)60383-2; Zareba W, 2003, J AM COLL CARDIOL, V42, P103, DOI 10.1016/S0735-1097(03)00554-0; Zareba W, 1998, NEW ENGL J MED, V339, P960, DOI 10.1056/NEJM199810013391404; Zollner S, 2004, AM J HUM GENET, V74, P62, DOI 10.1086/381131	29	59	64	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2006	355	26					2744	2751		10.1056/NEJMoa042786	http://dx.doi.org/10.1056/NEJMoa042786			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120UA	17192539	Green Accepted, Bronze			2022-12-01	WOS:000243110500006
J	Taylor, S; Barragan, A; Su, C; Fux, B; Fentress, SJ; Tang, K; Beatty, WL; El Hajj, H; Jerome, M; Behnke, MS; White, M; Wootton, JC; Sibley, LD				Taylor, S.; Barragan, A.; Su, C.; Fux, B.; Fentress, S. J.; Tang, K.; Beatty, W. L.; El Hajj, H.; Jerome, M.; Behnke, M. S.; White, M.; Wootton, J. C.; Sibley, L. D.			A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii	SCIENCE			English	Article							PARASITOPHOROUS VACUOLE; INTRACELLULAR PARASITE; STRAINS; INFECTION; REVEALS; OVERPRODUCTION; RECOMBINATION; TRANSMISSION; APOPTOSIS; LINEAGES	Toxoplasma gondii strains differ dramatically in virulence despite being genetically very similar. Genetic mapping revealed two closely adjacent quantitative trait loci on parasite chromosome VIIa that control the extreme virulence of the type I lineage. Positional cloning identified the candidate virulence gene ROP18, a highly polymorphic serine-threonine kinase that was secreted into the host cell during parasite invasion. Transfection of the virulent ROP18 allele into a nonpathogenic type III strain increased growth and enhanced mortality by 4 to 5 logs. These attributes of ROP18 required kinase activity, which revealed that secretion of effectors is a major component of parasite virulence.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA; Karolinska Inst, Swedish Inst Infect Dis Control, Dept Med, S-14186 Stockholm, Sweden; Karolinska Inst, Ctr Infect Med, Dept Med, S-14186 Stockholm, Sweden; Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; Univ Montpellier 2, UMR 5539, CNRS, F-34095 Montpellier 5, France; Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	Washington University (WUSTL); Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; University of Tennessee System; University of Tennessee Knoxville; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Montana State University System; Montana State University Bozeman; National Institutes of Health (NIH) - USA	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA.	sibley@borcim.wustl.edu	Behnke, Michael S/R-8839-2016; Su, Chunlei/M-1892-2013; Sibley, L. David/C-4616-2008; Barragan, Antonio/AAL-8618-2020; White, Michael/A-4978-2012; Fux, Blima/AAO-2941-2020; Barragan, Antonio/P-6278-2015	Behnke, Michael S/0000-0002-4668-8109; Su, Chunlei/0000-0001-8392-7108; Barragan, Antonio/0000-0001-7746-9964; Barragan, Antonio/0000-0001-7746-9964; Fux, Blima/0000-0002-5038-3551	Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [P20 RR-020185] Funding Source: Medline; NIAID NIH HHS [AI44600, AI36629, AI059176] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059176, R01AI036629, R01AI044600] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000026] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Denkers EY, 2004, IMMUNOL REV, V201, P191, DOI 10.1111/j.0105-2896.2004.00180.x; Doerig C, 2005, BBA-PROTEINS PROTEOM, V1754, P132, DOI 10.1016/j.bbapap.2005.08.027; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; El Hajj H, 2006, PROTEOMICS, V6, P5773, DOI 10.1002/pmic.200600187; ELHAJJ H, IN PRESS PLOS PATHOG; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; Gavrilescu LC, 2001, J IMMUNOL, V167, P902, DOI 10.4049/jimmunol.167.2.902; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; Joynson DH, 2001, TOXOPLASMOSIS COMPRE; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099	29	393	425	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1776	1780		10.1126/science.1133643	http://dx.doi.org/10.1126/science.1133643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170305				2022-12-01	WOS:000242833600059
J	Offit, K; Sagi, M; Hurley, K				Offit, Kenneth; Sagi, Michal; Hurley, Karen			Preimplantation genetic diagnosis for cancer syndromes - A new challenge for preventive medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PGD		Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Psychiat, New York, NY 10021 USA; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org						*AM MED ASS, E 2 12 GEN COUNS AMA; BARUCH S, 2006, FERTIL STERIL; Braude P, 2006, NEW ENGL J MED, V355, P541, DOI 10.1056/NEJMp068139; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; *CHURCH ENGL, HUM GEN CONS; de Wert G, 2005, HUM REPROD, V20, P3261, DOI 10.1093/humrep/dei222; Eugster A, 1999, SOC SCI MED, V48, P575, DOI 10.1016/S0277-9536(98)00386-4; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; *GEN PUBL POL CTR, 2004, REPR GEN TEST ISS OP; Hamann HA, 2005, PSYCHOSOM MED, V67, P766, DOI 10.1097/01.psy.0000181273.74398.d7; *J HOPK U, ONL MEND INH MAN DAT; Kalfoglou AL, 2005, FERTIL STERIL, V83, P1612, DOI 10.1016/j.fertnstert.2005.01.090; Kalfoglou AL, 2005, REPROD BIOMED ONLINE, V11, P486, DOI 10.1016/S1472-6483(10)61145-5; Kuliev A, 2006, REPROD BIOMED ONLINE, V12, P328, DOI 10.1016/S1472-6483(10)61005-X; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Offit K, 2004, JAMA-J AM MED ASSOC, V292, P1469, DOI 10.1001/jama.292.12.1469; Offit K, 2006, J CLIN ONCOL, V24, P4775, DOI 10.1200/JCO.2006.06.6100; Ola B, 2006, CURR OPIN OBSTET GYN, V18, P440, DOI 10.1097/01.gco.0000233940.82296.49; President's Council on Bioethics Eugenics and Inequality, REPR RESP REG NEW BI; Smith KR, 2004, CANCER EPIDEM BIOMAR, V13, P733; Thornhill AR, 2005, HUM REPROD, V20, P35, DOI 10.1093/humrep/deh579; van Asperen CJ, 2002, J MED GENET, V39, P410, DOI 10.1136/jmg.39.6.410; Verlinsky Y, 2004, FERTIL STERIL, V82, P292, DOI 10.1016/j.fertnstert.2003.09.082	24	58	58	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2727	2730		10.1001/jama.296.22.2727	http://dx.doi.org/10.1001/jama.296.22.2727			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164459				2022-12-01	WOS:000242765700028
J	Paltiel, AD; Walensky, RP; Schackman, BR; Seage, GR; Mercincavage, LM; Weinstein, MC; Freedberg, KA				Paltiel, A. David; Walensky, Rochelle P.; Schackman, Bruce R.; Seage, George R., III; Mercincavage, Lauren M.; Weinstein, Milton C.; Freedberg, Kenneth A.			Expanded HIV screening in the United States: Effect on clinical outcomes, HIV transmission, and costs	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COMBINATION ANTIRETROVIRAL THERAPY; RISK BEHAVIORS; VIRAL LOAD; PREVENTION; INFECTION; HEALTH; IMPACT; CARE; SEX	Background: An extensive literature supports expanded HIV screening in the United States. However, the question of whom to test and how frequently remains controversial. Objective: To inform the design of HIV screening programs by identifying combinations of screening frequency and HIV prevalence and incidence at which screening is cost-effective. Design: Cost-effectiveness analysis linking simulation models of HIV screening to published reports of HIV transmission risk, with and without antiretroviral therapy. Data Sources: Published randomized trials, observational cohorts, national cost and service utilization surveys, the Red Book, and previous modeling results. Target Population: U.S. communities with low to moderate HIV prevalence (0.05% to 1.0%) and annual incidence (0.0084% to 0.12%). Time Horizon: Lifetime. Perspective: Societal. Interventions: One-time and increasingly frequent voluntary HIV screening of all adults using a same-day rapid test. Outcome Measures: HIV infections detected, secondary transmissions averted, quality-adjusted survival, lifetime medical costs, and societal cost-effectiveness, reported in discounted 2004 dollars per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: Under moderately favorable assumptions regarding the effect of HIV patient care on secondary transmission, routine HIV screening in a population with HIV prevalence of 1.0% and annual incidence of 0.12% had incremental cost-effectiveness ratios of $30800/QALY (one-time screening), $32300/QALY (screening every 5 years), and $55500/QALY (screening every 3 years). In settings with HIV prevalence of 0.10% and annual incidence of 0.014%, one-time screening produced cost-effectiveness ratios of $60700/QALY. Results of Sensitivity Analysis: The cost-effectiveness of screening policies varied within a narrow range as assumptions about the effect of screening on secondary transmission varied from favorable to unfavorable. Assuming moderately favorable effects of antiretroviral therapy on transmission, cost-effectiveness ratios remained below $50000/QALY in settings with HIV prevalence as low as 0.20% for routine HIV screening on a one-time basis and at prevalences as low as 0.45% and annual incidences as low as 0.0075% for screening every 5 years. Limitations: This analysis does not address the difficulty of determining the prevalence and incidence of undetected HIV infection in a given patient population. Conclusions: Routine, rapid HIV testing is recommended for all adults except in settings where there is evidence that the prevalence of undiagnosed HIV infection is below 0.2%.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Cornell Univ, Weill Med Coll, New York, NY USA	Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Cornell University	Paltiel, AD (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	david.paltiel@yale.edu	Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932; Walensky, Rochelle P./0000-0002-8795-379X; Paltiel, A. David/0000-0002-4861-3290	NIAID NIH HHS [R01AI42006, R01 AI042006, P30 AI042851, K24 AI062476, K23 AI001794, K23AI01794, K24AI062476, P30AI42851] Funding Source: Medline; NIDA NIH HHS [R01 DA015612, K01DA0717179, R01DA015612, K01 DA017179] Funding Source: Medline; NIMH NIH HHS [R01 MH065869, R01MH65869] Funding Source: Medline; PHS HHS [S1396-20/21] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI001794, R01AI042006, K24AI062476, P30AI042851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, K01DA017179, R01DA015612] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDERSON R M, 1991; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; Barroso PF, 2000, ANN INTERN MED, V133, P280, DOI 10.7326/0003-4819-133-4-200008150-00012; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brawley OW, 1997, CANCER-AM CANCER SOC, V80, P1857, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1857::AID-CNCR26>3.0.CO;2-3; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; *CDCP, 2005, HIV AIDS UPD GLANC H; *CDCP, 2004, HIV AIDS SPEC SURV R; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; Chou R, 2005, ANN INTERN MED, V143, P55, DOI 10.7326/0003-4819-143-1-200507050-00010; Cohen C, 2005, CURR MED RES OPIN, V21, P1683, DOI 10.1185/030079905X65439; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; COSTELLO D, 2005, LOS ANGELES TIM 1219, pF1; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Demmer C, 2002, J COMMUN HEALTH, V27, P63, DOI 10.1023/A:1013884310983; DUMON J, 2006, 13 C RETR OPP INF DE; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; EDDY DM, 1988, JAMA-J AM MED ASSOC, V259, P1512, DOI 10.1001/jama.259.10.1512; Ekwueme DU, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00115-6; Farnham PG, 1996, PUBLIC HEALTH REP, V111, P44; Frame P S, 1998, J Am Board Fam Pract, V11, P87; FRASER C, 2006, 13 C RETR OPP INF DE; Freedberg KA, 1999, ARCH INTERN MED, V159, P1994, DOI 10.1001/archinte.159.17.1994; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; GLYNN MK, 2005, 2005 NAT HIV PREV C; Gold MR., 1996, COST EFFECTIVENESS H; GRAHAM S, 2006, 13 C RETR OPP INF DE; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; *I CLIN RES HLTH P, COMPR TAB COST UT RA; JACOBSON LP, 2004, INT C AIDS, V15; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Kelly JA, 1998, AIDS, V12, pF91, DOI 10.1097/00002030-199810000-00001; Kimmel AD, 2005, ANTIVIR THER, V10, P41; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MCCORMICK A, 2005, ANTIMICROBIAL USE TR; McGowan JP, 2004, CLIN INFECT DIS, V38, P122, DOI 10.1086/380128; *MED AG HLTH RES Q, 2005, MED EXP PAN SURV; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Meltzer D, 2000, MED CARE, V38, P679, DOI 10.1097/00005650-200006000-00009; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; OSTER G, 1987, JAMA-J AM MED ASSOC, V258, P2381, DOI 10.1001/jama.258.17.2381; OTTEN MW, 1993, AM J PUBLIC HEALTH, V83, P529, DOI 10.2105/AJPH.83.4.529; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; PEREZPENA R, 2005, NY TIMES        0606, pB1; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Samet JH, 2001, AIDS, V15, P77, DOI 10.1097/00002030-200101050-00012; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scheer S, 2001, LANCET, V357, P432, DOI 10.1016/S0140-6736(00)04007-1; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Stolte G, 2002, Euro Surveill, V7, P19; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; U.S. Preventive Services Task Force, 2002, SCREEN COL CANC REC; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008; Valdiserri RO, 2004, AIDS EDUC PREV, V16, P426, DOI 10.1521/aeap.16.5.426.48738; Varghese B, 1999, AIDS, V13, P1745, DOI 10.1097/00002030-199909100-00019; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; VIANI R, 2006, 13 C RETR OPP INF DE; Walensky RP, 2005, MED DECIS MAKING, V25, P321, DOI 10.1177/0272989X05276955; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Webster RD, 2003, JAIDS-J ACQ IMM DEF, V33, P223, DOI 10.1097/00126334-200306010-00018; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008	72	154	161	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					797	806		10.7326/0003-4819-145-11-200612050-00004	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114PE	17146064				2022-12-01	WOS:000242677300001
J	Wilkinson, P; French, R; Kane, R; Lachowycz, K; Stephenson, J; Grundy, C; Jacklin, P; Kingori, P; Stevens, M; Wellings, K				Wilkinson, Paul; French, Rebecca; Kane, Ras; Lachowycz, Kate; Stephenson, Judith; Grundy, Chris; Jacklin, Paul; Kingori, Patricia; Stevens, Maryjane; Wellings, Kaye			Teenage conceptions, abortions, and births in England, 1994-2003, and the national teenage pregnancy strategy	LANCET			English	Article							CHILDBEARING; POVERTY; BRITAIN; TRENDS	Background The aim of this study was to quantify the change in the number of conceptions and abortions among women younger than 18 years in England in relation to the government's national teenage pregnancy strategy. Methods We undertook geographic analysis of data for 148 top-tier local authority areas. The main outcomes were changes in under-18 conceptions, abortions, and births between the 5-year period before implementation of the strategy (1994-98) and the period immediately after implementation (1999-2003). Findings The number of teenage conceptions peaked in 1998, then declined after the implementation in 1999 of the teenage pregnancy strategy. Under-18 conception rates fell by an average of 2.0% (95% CI 1.8 to 2.2) per year between 1998 and 2003, below the rate needed to achieve the target of 50% reduction by 2010. The net change between 1994-98 and 1999-2003 was a fall in conceptions of 3.2% (2.6 to 3.9) or 1.4 per 1000 women aged 15-17 years, a rise in abortions of 7.5% (6.5 to 8.6) or 1.4 per 1000, and a fall in births of 10.6% (9.9 to 11.3) or 2.8 per 1000. The change in the number of conceptions was greater in deprived and more rural areas, and in those with lower educational attainment. The change was greater in areas where services and access to them were poorer, but greater where more strategy-related resources had been targeted. Interpretation The decline in under-18 conception and birth rates since 1998 and evidence that the declines have been greatest in areas receiving higher amounts of strategy-related funding provides limited evidence of the effect of England's national teenage pregnancy strategy. The full effect of local prevention will be clear only with longer observation, and substantial further progress is needed to remedy England's historically poor international position in teenage conceptions.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; UCL, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Wellings, K (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	kaye.wellings@lshtm.ac.uk	Kane, Ros/K-6855-2013	Kane, Ros/0000-0002-6926-2530; Wilkinson, Paul/0000-0001-7456-259X				BABB P, 1993, POPULATION TRENDS, V74, P12; Bonell CP, 2003, J EPIDEMIOL COMMUN H, V57, P871, DOI 10.1136/jech.57.11.871; BOTTING B, 1998, POPULATION TRENDS, V93, P9; da Silva AAM, 2003, PAEDIATR PERINAT EP, V17, P332, DOI 10.1046/j.1365-3016.2003.00515.x; Hamlyn Cathy, 2002, J Fam Health Care, V12, P71; Hobcraft J, 2001, BRIT J SOCIOL, V52, P495; *ISD SCOTL, TEEN PREGN TEEN PREG; KANE R, 1999, REDUCING RATE TEENAG; Loto O M, 2004, J Obstet Gynaecol, V24, P395, DOI 10.1080/01443610410001685529; McCulloch A, 2001, J EPIDEMIOL COMMUN H, V55, P16, DOI 10.1136/jech.55.1.16; McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199; Nanchahal K, 2005, J EPIDEMIOL COMMUN H, V59, P828, DOI 10.1136/jech.2004.026021; *ODPM NEIGHB REN U, 2001, ENGL IND DEPR 2004 S; *OFF NAT STAT, 2001, POPULATION TRENDS, V103, P84; Paton D, 2002, J HEALTH ECON, V21, P207, DOI 10.1016/S0167-6296(01)00115-1; SHARP S, 1998, STATA TECH B, V7, P148; Singh S, 2000, FAM PLANN PERSPECT, V32, P14, DOI 10.2307/2648144; SMITH T, 1993, BRIT MED J, V306, P1232, DOI 10.1136/bmj.306.6887.1232; *SOC EXCL UN, 1999, TEEN PREGN; *TEEN PREGN UN, RES EV TEEN PREGN ST; Wellings K, 1999, J ROY SOC MED, V92, P277, DOI 10.1177/014107689909200603; Wood R, 1997, Popul Trends, P5	22	38	38	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1879	1886		10.1016/S0140-6736(06)69777-8	http://dx.doi.org/10.1016/S0140-6736(06)69777-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126720				2022-12-01	WOS:000242345900029
J	Janssen, BJC; Christodoulidou, A; McCarthy, A; Lambris, JD; Gros, P				Janssen, Bert J. C.; Christodoulidou, Agni; McCarthy, Andrew; Lambris, John D.; Gros, Piet			Structure of C3b reveals conformational changes that underlie complement activity	NATURE			English	Article							3RD COMPONENT; FACTOR-H; BINDING-SITE; RECEPTOR 2; IMMUNITY; CR-1; C-3; IDENTIFICATION; PATHOGENS; RESIDUES	Resistance to infection and clearance of cell debris in mammals depend on the activation of the complement system, which is an important component of innate and adaptive immunity(1,2). Central to the complement system is the activated form of C3, called C3b, which attaches covalently to target surfaces(3) to amplify complement response, label cells for phagocytosis and stimulate the adaptive immune response. C3b consists of 1,560 amino-acid residues and has 12 domains. It binds various proteins and receptors to effect its functions(4). However, it is not known how C3 changes its conformation into C3b and thereby exposes its many binding sites. Here we present the crystal structure at 4-angstrom resolution of the activated complement protein C3b and describe the conformational rearrangements of the 12 domains that take place upon proteolytic activation. In the activated form the thioester is fully exposed for covalent attachment to target surfaces and is more than 85 angstrom away from the buried site in native C3 (ref. 5). Marked domain rearrangements in the alpha-chain present an altered molecular surface, exposing hidden and cryptic sites that are consistent with known putative binding sites of factor B and several complement regulators. The structural data indicate that the large conformational changes in the proteolytic activation and regulation of C3 take place mainly in the first conversion step, from C3 to C3b. These insights are important for the development of strategies to treat immune disorders that involve complement-mediated inflammation.	Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, NL-3584 CH Utrecht, Netherlands; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Utrecht University; University of Pennsylvania; European Molecular Biology Laboratory (EMBL)	Gros, P (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Fac Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.gros@chem.uu.nl	Lambris, John/Q-5633-2018; McCarthy, Andrew A/A-5926-2013; Gros, Piet/AAD-6452-2019; Janssen, Bert/I-3338-2016; Gros, Piet/I-5569-2016	Lambris, John/0000-0002-9370-5776; McCarthy, Andrew A/0000-0003-4478-0136; Gros, Piet/0000-0002-7782-2585; Janssen, Bert/0000-0002-8101-8370; Gros, Piet/0000-0002-7782-2585				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; DAOUDAKI ME, 1988, J IMMUNOL, V140, P1577; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHELSON Z, 1984, J IMMUNOL, V132, P1430; HARRISON RA, 1980, MOL IMMUNOL, V17, P219, DOI 10.1016/0161-5890(80)90074-7; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Inal JM, 2002, J IMMUNOL, V168, P5213, DOI 10.4049/jimmunol.168.10.5213; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kolln J, 2004, J IMMUNOL, V173, P5540, DOI 10.4049/jimmunol.173.9.5540; LAMBRIS JD, 1988, IMMUNOL TODAY, V9, P387, DOI 10.1016/0167-5699(88)91240-6; LAMBRIS JD, 1988, J BIOL CHEM, V263, P12147; LAMBRIS JD, 1980, J EXP MED, V152, P1625, DOI 10.1084/jem.152.6.1625; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; Mastellos D, 2002, TRENDS IMMUNOL, V23, P485, DOI 10.1016/S1471-4906(02)02287-1; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; OKEEFE MC, 1988, J BIOL CHEM, V263, P12690; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; PANGBURN MK, 1983, J IMMUNOL, V131, P1930; ROSS GD, 1982, J IMMUNOL, V129, P2051; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; TANIGUCHISIDLE A, 1994, J IMMUNOL, V153, P5285; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; [No title captured]	30	278	294	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					213	216		10.1038/nature05172	http://dx.doi.org/10.1038/nature05172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17051160	Green Published			2022-12-01	WOS:000241867200042
J	Van Heuverswyn, F; Li, YY; Neel, C; Bailes, E; Keele, BF; Liu, WM; Loul, S; Butel, C; Liegeois, F; Bienvenue, Y; Ngolle, EM; Sharp, PM; Shaw, GM; Delaporte, E; Hahn, BH; Peeters, M				Van Heuverswyn, Fran; Li, Yingying; Neel, Cecile; Bailes, Elizabeth; Keele, Brandon F.; Liu, Weimin; Loul, Severin; Butel, Christelle; Liegeois, Florian; Bienvenue, Yanga; Ngolle, Eitel Mpoudi; Sharp, Paul M.; Shaw, George M.; Delaporte, Eric; Hahn, Beatrice H.; Peeters, Martine			Human immunodeficiency viruses - SIV infection in wild gorillas	NATURE			English	Article							CHIMPANZEES		Univ Montpellier 1, UMR145, Inst Rech Dev, F-34394 Montpellier 5, France; Univ Montpellier 1, Dept Int Hlth, F-34394 Montpellier, France; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England; Projet Prevent Sida Cameroun PRESICA, Yaounde, Cameroon; Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Hosp Montpellier, Dept Trop & Infect Dis, F-34295 Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Nottingham; Howard Hughes Medical Institute; Universite de Montpellier; CHU de Montpellier	Van Heuverswyn, F (corresponding author), Univ Montpellier 1, UMR145, Inst Rech Dev, F-34394 Montpellier 5, France.	martine.peeters@mpl.ird.fr	Sharp, Paul/Y-3787-2019; Florian, Liegeois/D-3798-2013; Delaporte, Eric/J-5397-2018; Sharp, Paul M/GPX-1497-2022; Sharp, Paul M/F-5783-2010	Florian, Liegeois/0000-0003-1048-0661; Delaporte, Eric/0000-0002-1822-9853; Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Hahn, Beatrice/0000-0002-9400-9887				Bibollet-Ruche F, 2004, J VIROL, V78, P7748, DOI 10.1128/JVI.78.14.7748-7762.2004; Butynski Thomas M., 2001, P3; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Matthews A, 2004, PRIMATES, V45, P15, DOI 10.1007/s10329-003-0058-4; Meder A, 1999, GORILLA J, V18, P11; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Stanford CB, 2003, INT J PRIMATOL, V24, P901, DOI 10.1023/A:1024689008159; USONGO L, 2001, GORILLA J, V22, P29	8	227	236	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					164	164		10.1038/444164a	http://dx.doi.org/10.1038/444164a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093443				2022-12-01	WOS:000241867200031
J	Weidle, PJ; Wamai, N; Solberg, P; Liechty, C; Sendagala, S; Were, W; Mermin, J; Buchacz, K; Behumbiize, P; Ransom, RL; Bunnell, R				Weidle, Paul J.; Wamai, Nafuna; Solberg, Peter; Liechty, Cheryl; Sendagala, Sam; Were, Willy; Mermin, Jonathan; Buchacz, Kate; Behumbiize, Prosper; Ransom, Ray L.; Bunnell, Rebecca			Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SOUTH-AFRICA; DRUG-RESISTANCE; EXPERIENCE; KHAYELITSHA; OUTCOMES; ADULTS; COUNT	Background Poverty and limited health services in rural Africa present barriers to adherence to antiretroviral therapy that necessitate innovative options other than facility-based methods for delivery and monitoring of such therapy. We assessed adherence to antiretroviral therapy in a cohort of HIV-infected people in a home-based AIDS care programme that provides the therapy and other AIDS care, prevention, and support services in rural Uganda. Methods HIV-infected individuals with advanced HIV disease or a CD4-cell count of less than 250 cells per mu L were eligible for antiretroviral therapy. Adherence interventions included group education, personal adherence plans developed with trained counsellors, a medicine companion, and weekly home delivery of antiretroviral therapy by trained lay field officers. We analysed factors associated with pill count adherence (PCA) of less than 95%, medication possession ratio (MPR) of less than 95%, and HIV viral load of 1000 copies per mL or more at 6 months (second quarter) and 12 months (fourth quarter) of follow-up. Findings 987 adults who had received no previous antiretroviral therapy (median CD4-cell count 124 cells per mu L, median viral load 217 000 copies per mL) were enrolled between July, 2003, and May, 2004. PICA of less than 95% was calculated for 0.7-2.6% of participants in any quarter and MPR of less than 95% for 3.3-11.1%. Viral load was below 1000 copies per mL for 894 (98%) of 913 participants in the second quarter and for 860 (96%) of 894 of participants in the fourth quarter. In separate multivariate models, viral load of at least 1000 copies per mL was associated with both PICA below 95% (second quarter odds ratio 10.6 [95% CI 2.45-45.7]; fourth quarter 14.5 [2.51-83.6]) and MPR less than 95% (second quarter 9.44 [3.40-26.2]; fourth quarter 10.5 [4.22-25.9]). Interpretation Good adherence and response to antiretroviral therapy can be achieved in a home-based AIDS care Programme in a resource-limited rural African setting. Health-care systems must continue to implement, evaluate, and modify interventions to overcome barriers to comprehensive AIDS care programmes, especially the barriers to adherence with antiretroviral therapy.	Ctr Dis Control & Prevent, Epidemiol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Global Programme AIDS, Ctr Dis Control & Prevent Uganda, Entebbe, Uganda; Univ Calif San Francisco, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Weidle, PJ (corresponding author), Ctr Dis Control & Prevent, Epidemiol Branch, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd,MS E-45, Atlanta, GA 30333 USA.	pweidle@cdc.gov	Mermin, Jonathan/J-9847-2012					Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Colebunders R, 2005, PLOS MED, V2, P941, DOI 10.1371/journal.pmed.0020276; Demeester R, 2005, JAIDS-J ACQ IMM DEF, V40, P113, DOI 10.1097/01.qai.0000176590.68430.59; Dezii C M, 2001, Manag Care, V10, P42; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Gill CJ, 2005, AIDS, V19, P1243, DOI 10.1097/01.aids.0000180094.04652.3b; *GLOB FUND FIGHT A, 2005, FORC CHANG GLOB FUND; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; *HOR POP COUNC INT, 2004, ADH ANT THER AD GUID; Kabugo C, 2005, JAIDS-J ACQ IMM DEF, V38, P578, DOI 10.1097/01.qai.0000134742.26338.2f; Laurent C, 2005, CLIN INFECT DIS, V41, P108, DOI 10.1086/430712; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lule JR, 2005, AM J TROP MED HYG, V73, P926, DOI 10.4269/ajtmh.2005.73.926; Macharia DK, 2003, AIDS, V17, P938, DOI 10.1097/00002030-200304110-00028; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Office of the US Global AIDS Coordinator, 2004, PRES EM PLAN AIDS RE; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tassie JM, 2003, AIDS, V17, P1995, DOI 10.1097/00002030-200309050-00023; Turner BJ, 2002, J INFECT DIS, V185, pS143, DOI 10.1086/340197; Uganda Bureau of Statistics, 2005, 2005 STAT ABSTR; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2003, WHO UNAIDS UNV PLAN; World Health Organization, 2003, SCAL ANT THER RES LT	30	171	172	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1587	1594		10.1016/S0140-6736(06)69118-6	http://dx.doi.org/10.1016/S0140-6736(06)69118-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084759				2022-12-01	WOS:000242180900028
J	Frey, S; Richter, RP; Goerlich, D				Frey, Steffen; Richter, Ralf P.; Goerlich, Dirk			FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties	SCIENCE			English	Article							STRUCTURAL BASIS; IMPORTIN-BETA; NUCLEOCYTOPLASMIC TRANSPORT; COMPLEX; NUCLEOPORINS; DOMAIN; TRAFFICKING; DOCKING; REGION; EXPORT	Nuclear pore complexes permit rapid passage of cargoes bound to nuclear transport receptors, but otherwise suppress nucleocytoplasmic fluxes of inert macromolecules >= 30 kilodaltons. To explain this selectivity, a sieve structure of the permeability barrier has been proposed that is created through reversible cross-linking between Phe and Gly (FG) - rich nucleoporin repeats. According to this model, nuclear transport receptors overcome the size limit of the sieve and catalyze their own nuclear pore-passage by a competitive disruption of adjacent inter-repeat contacts, which transiently opens adjoining meshes. Here, we found that phenylalanine-mediated inter-repeat interactions indeed cross-link FG-repeat domains into elastic and reversible hydrogels. Furthermore, we obtained evidence that such hydrogel formation is required for viability in yeast.	Univ Heidelberg ZMBH, Zentrum Mol Biol, D-69120 Heidelberg, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Univ Heidelberg, Inst Phys Chem, D-69120 Heidelberg, Germany; Max Planck Inst Met Res, D-70569 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg; Max Planck Society	Goerlich, D (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, INF 282, D-69120 Heidelberg, Germany.	dg@zmbh.uni-heidelberg.de	Richter, Ralf Peter/B-3343-2013; Görlich, Dirk/B-8296-2017; Li, Chia Cheng/D-9906-2015	Richter, Ralf Peter/0000-0003-3071-2837; Görlich, Dirk/0000-0002-4343-5210; Steffen, Frey/0000-0002-5134-9961				Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; NEHRBASS U, 1990, CELL, V61, P979, DOI 10.1016/0092-8674(90)90063-K; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout Michael P., 1994, Trends in Cell Biology, V4, P357, DOI 10.1016/0962-8924(94)90085-X; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156	24	419	422	4	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2006	314	5800					815	817		10.1126/science.1132516	http://dx.doi.org/10.1126/science.1132516			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082456	Green Published			2022-12-01	WOS:000241729800046
J	Gruber, S; Arumugam, P; Katou, Y; Kuglitsch, D; Helmhart, W; Shirahige, K; Nasmyth, K				Gruber, Stephan; Arumugam, Prakash; Katou, Yuki; Kuglitsch, Daria; Helmhart, Wolfgang; Shirahige, Katsuhiko; Nasmyth, Kim			Evidence that loading of cohesin onto chromosomes involves opening of its SMC hinge	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; ATP HYDROLYSIS; COMPLEX; DNA; PROTEINS; ARCHITECTURE; BINDING; YEAST; REPLICATION; ACTIVATION	Cohesin is a multisubunit complex that mediates sister-chromatid cohesion. Its Smc1 and Smc3 subunits possess ABC-like ATPases at one end of 50 nm long coiled coils. At the other ends are pseudosymmetrical hinge domains that interact to create V-shaped Smc1/Smc3 heterodimers. N- and C-terminal domains within cohesin's kleisin subunit Scc1 bind to Smc3 and Smc1 ATPase heads respectively, thereby creating a huge tripartite ring. It has been suggested that cohesin associates with chromosomes by trapping DNA within its ring. Opening of the ring due to cleavage of Scc1 by separase destroys sister-chromatid cohesion and triggers anaphase. We show that cohesin's hinges are not merely dimerization domains. They are essential for cohesin's association with chromosomes, which is blocked by artificially holding hinge domains together but not by preventing Scc1's dissociation from SMC ATPase heads. Our results suggest that entry of DNA into cohesin's ring requires transient dissociation of Smc1 and Smc3 hinge domains.	Inst Mol Pathol, A-1030 Vienna, Austria; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Tokyo Inst Technol, Ctr Gene Res, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Oxford; Tokyo Institute of Technology	Nasmyth, K (corresponding author), Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	kim.nasmyth@bioch.ox.ac.uk	Arumugam, Prakash/AAZ-6422-2020; Gruber, Stephan/AFC-4848-2022; Gruber, Stephan/G-5686-2012	Arumugam, Prakash/0000-0001-6217-8128; Gruber, Stephan/0000-0002-0150-0395; Nasmyth, Kim/0000-0001-7030-4403; Shirahige, Katsuhiko/0000-0002-7862-1144				Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Arumugam P, 2003, CURR BIOL, V13, P1941, DOI 10.1016/j.cub.2003.10.036; Arumugam P, 2006, CURR BIOL, V16, P1998, DOI 10.1016/j.cub.2006.09.002; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Barsky D, 2005, CURR BIOL, V15, pR989, DOI 10.1016/j.cub.2005.11.047; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; Lorenz A, 2003, EUKARYOT CELL, V2, P856, DOI 10.1128/EC.2.5.856-866.2003; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4	29	212	213	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					523	537		10.1016/j.cell.2006.08.048	http://dx.doi.org/10.1016/j.cell.2006.08.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081975	Bronze			2022-12-01	WOS:000241937000017
J	Bourlat, SJ; Juliusdottir, T; Lowe, CJ; Freeman, R; Aronowicz, J; Kirschner, M; Lander, ES; Thorndyke, M; Nakano, H; Kohn, AB; Heyland, A; Moroz, LL; Copley, RR; Telford, MJ				Bourlat, Sarah J.; Juliusdottir, Thorhildur; Lowe, Christopher J.; Freeman, Robert; Aronowicz, Jochanan; Kirschner, Mark; Lander, Eric S.; Thorndyke, Michael; Nakano, Hiroaki; Kohn, Andrea B.; Heyland, Andreas; Moroz, Leonid L.; Copley, Richard R.; Telford, Maximilian J.			Deuterostome phylogeny reveals monophyletic chordates and the new phylum Xenoturbellida	NATURE			English	Article							EVOLUTION; ANIMALS; PLATYHELMINTHES; ENTEROPNEUSTA; UROCHORDATE; CHARACTERS; FLATWORMS; EPIDERMIS; COLLAGEN; SYSTEMS	Deuterostomes comprise vertebrates, the related invertebrate chordates (tunicates and cephalochordates) and three other invertebrate taxa: hemichordates, echinoderms and Xenoturbella(1). The relationships between invertebrate and vertebrate deuterostomes are clearly important for understanding our own distant origins. Recent phylogenetic studies of chordate classes and a sea urchin have indicated that urochordates might be the closest invertebrate sister group of vertebrates, rather than cephalochordates, as traditionally believed(2-5). More remarkable is the suggestion that cephalochordates are closer to echinoderms than to vertebrates and urochordates, meaning that chordates are paraphyletic(2). To study the relationships among all deuterostome groups, we have assembled an alignment of more than 35,000 homologous amino acids, including new data from a hemichordate, starfish and Xenoturbella. We have also sequenced the mitochondrial genome of Xenoturbella. We support the clades Olfactores ( urochordates and vertebrates) and Ambulacraria ( hemichordates and echinoderms(6)). Analyses using our new data, however, do not support a cephalochordate and echinoderm grouping and we conclude that chordates are monophyletic. Finally, nuclear and mitochondrial data place Xenoturbella as the sister group of the two ambulacrarian phyla(1). As such, Xenoturbella is shown to be an independent phylum, Xenoturbellida, bringing the number of living deuterostome phyla to four.	UCL, Dept Biol, London WC1E 6BT, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Royal Swedish Acad Sci, Kristineberg Marine Res Stn, S-45034 Fiskebackskil, Sweden; Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA	University of London; University College London; University of Oxford; Wellcome Centre for Human Genetics; University of Chicago; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Royal Swedish Academy of Sciences; State University System of Florida; University of Florida	Telford, MJ (corresponding author), UCL, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	m.telford@ucl.ac.uk	Bourlat, Sarah/A-5232-2009; Bourlat, Sarah/AAR-2251-2020; Telford, Maximilian J/B-7178-2008	Bourlat, Sarah/0000-0003-0218-0298; Telford, Maximilian J/0000-0002-3749-5620; Heyland, Andreas/0000-0002-7592-4473; Moroz, Leonid/0000-0002-1333-3176; Lowe, Christopher/0000-0002-7789-8643; Freeman, Robert/0000-0003-1463-9748	Biotechnology and Biological Sciences Research Council [BB/C509866/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aguinaldo AMA, 1998, AM ZOOL, V38, P878; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FRANZEN A, 1987, ZOOL SCR, V16, P9, DOI 10.1111/j.1463-6409.1987.tb00046.x; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; JEFFERIES RPS, 1991, CIBA F SYMP, V162, P94; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; JOBB G, 2006, TREEFINDER VERSION M; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Oda H, 2002, EVOL DEV, V4, P426, DOI 10.1046/j.1525-142X.2002.02031.x; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; PARDOS F, 1988, ACTA ZOOL-STOCKHOLM, V69, P1, DOI 10.1111/j.1463-6395.1988.tb00895.x; PEDERSEN KJ, 1988, ACTA ZOOL-STOCKHOLM, V69, P231, DOI 10.1111/j.1463-6395.1988.tb00920.x; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; PHILLIPE H, IN PRESS TRENDS ECOL; Raikova OI, 2000, ZOOMORPHOLOGY, V120, P107, DOI 10.1007/s004350000028; REISINGER ERICH, 1960, ZEITSCHR WISS ZOOL, V164, P188; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Rychel AL, 2006, MOL BIOL EVOL, V23, P541, DOI 10.1093/molbev/msj055; Stach T, 2005, J MAR BIOL ASSOC UK, V85, P1519, DOI 10.1017/S0025315405012725; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; TELFORD MJ, 1993, MOL BIOL EVOL, V10, P660; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Wada H, 2006, EVOL DEV, V8, P370, DOI 10.1111/j.1525-142X.2006.00109.x; WEICHERT CK, 1965, ANATOMY CHORDATES; Westblad E., 1949, ARK ZOOL, V1, P3; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Yokobori S, 2003, J MOL EVOL, V57, P574, DOI 10.1007/s00239-003-2511-9	30	398	411	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					85	88		10.1038/nature05241	http://dx.doi.org/10.1038/nature05241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17051155				2022-12-01	WOS:000241701500050
J	Goley, ED; Ohkawa, T; Mancuso, J; Woodruff, JB; D'Alessio, JA; Cande, WZ; Volkman, LE; Welch, MD				Goley, Erin D.; Ohkawa, Taro; Mancuso, Joel; Woodruff, Jeffrey B.; D'Alessio, Joseph A.; Cande, W. Zacheus; Volkman, Loy E.; Welch, Matthew D.			Dynamic nuclear actin assembly by Arp2/3 complex and a baculovirus WASP-like protein	SCIENCE			English	Article							WASP/SCAR PROTEINS; CYTOCHALASIN-D; CELLS; NUCLEOPOLYHEDROVIRUS	Diverse bacterial and viral pathogens induce actin polymerization in the cytoplasm of host cells to facilitate infection. Here, we describe a pathogenic mechanism for promoting dynamic actin assembly in the nucleus to enable viral replication. The baculovirus Autographa californica multiple nucleopolyhedrovirus induced nuclear actin polymerization by translocating the host actin-nucleating Arp2/3 complex into the nucleus, where it was activated by p78/83, a viral Wiskott-Aldrich syndrome protein (WASP)-like protein. Nuclear actin assembly by p78/83 and Arp2/3 complex was essential for viral progeny production. Recompartmentalizing dynamic host actin may represent a conserved mode of pathogenesis and reflect viral manipulation of normal functions of nuclear actin.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Welch, MD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	welch@berkeley.edu		Goley, Erin/0000-0002-8518-2303	NIAID NIH HHS [AI054693] Funding Source: Medline; NIGMS NIH HHS [R01 GM059609-07, R01 GM059609, GM59609] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bohnsack MT, 2006, NAT CELL BIOL, V8, P257, DOI 10.1038/ncb1357; CHARLTON CA, 1993, VIROLOGY, V197, P245, DOI 10.1006/viro.1993.1585; CHARLTON CA, 1991, J VIROL, V65, P1219, DOI 10.1128/JVI.65.3.1219-1227.1991; Feierbach B, 2006, PLOS PATHOG, V2, P763, DOI 10.1371/journal.ppat.0020085; HESS RT, 1989, J INVERTEBR PATHOL, V53, P169, DOI 10.1016/0022-2011(89)90005-0; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Machesky LM, 2001, TRENDS CELL BIOL, V11, P286, DOI 10.1016/S0962-8924(01)02009-8; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Nie YC, 2006, VIRUS RES, V116, P129, DOI 10.1016/j.virusres.2005.09.007; Ohkawa T, 2002, J VIROL, V76, P12281, DOI 10.1128/JVI.76.23.12281-12289.2002; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; POSSEE RD, 1991, VIROLOGY, V185, P229, DOI 10.1016/0042-6822(91)90770-C; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; VOLKMAN LE, 1987, VIROLOGY, V156, P32, DOI 10.1016/0042-6822(87)90433-8; VOLKMAN LE, 1988, VIROLOGY, V163, P547, DOI 10.1016/0042-6822(88)90295-4; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133	18	139	157	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					464	467		10.1126/science.1133348	http://dx.doi.org/10.1126/science.1133348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053146				2022-12-01	WOS:000241382500042
J	Morello, R; Bertin, TK; Chen, YQ; Hicks, J; Tonachini, L; Monticone, M; Castagnola, P; Rauch, F; Glorieux, FH; Vranka, J; Bachinger, HP; Pace, JM; Schwarze, U; Byers, PH; Weis, M; Fernandes, RJ; Eyre, DR; Yao, ZQ; Boyce, BF; Lee, B				Morello, Roy; Bertin, Terry K.; Chen, Yuqing; Hicks, John; Tonachini, Laura; Monticone, Massimiliano; Castagnola, Patrizio; Rauch, Frank; Glorieux, Francis H.; Vranka, Janice; Bachinger, Hans Peter; Pace, James M.; Schwarze, Ulrike; Byers, Peter H.; Weis, MaryAnn; Fernandes, Russell J.; Eyre, David R.; Yao, Zhenqing; Boyce, Brendan F.; Lee, Brendan			CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta	CELL			English	Article							CARTILAGE ASSOCIATED PROTEIN; BASEMENT-MEMBRANE COLLAGEN; BONE HISTOMORPHOMETRY; CDNA CLONING; TRIPLE-HELIX; I COLLAGEN; FORM; GENE; PROCOLLAGEN; EXPRESSION	Prolyl hydroxylation is a critical posttranslational modification that affects structure, function, and turnover of target proteins. Prolyl 3-hydroxylation occurs at only one position in the triple-helical domain of fibrillar collagen chains, and its biological significance is unknown. CRTAP shares homology with a family of putative prolyl 3-hydroxylases (P3Hs), but it does not contain their common dioxygenase domain. Loss of Crtap in mice causes an osteo-chondrodysplasia characterized by severe osteoporosis and decreased osteoid production. CRTAP can form a complex with P3H1 and cyclophilin B (CYPB), and Crtap(-/-) bone and cartilage collagens show decreased prolyl 3-hydroxylation. Moreover, mutant collagen shows evidence of overmodification, and collagen fibrils in mutant skin have increased diameter consistent with altered fibrillogenesis. In humans, CRTAP mutations are associated with the clinical spectrum of recessive osteogenesis imperfecta, including the type II and VII forms. Hence, dysregulation of prolyl 3-hydroxylation is a mechanism for connective tissue disease.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Texas Childrens Hosp, Houston, TX 77030 USA; Ist Nazl Ric Canc, I-16132 Genoa, Italy; Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada; McGill Univ, Montreal, PQ, Canada; Shriners Hosp Children, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14627 USA; Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Genoa; IRCCS AOU San Martino IST; McGill University; McGill University; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Rochester; Howard Hughes Medical Institute	Lee, B (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.tmc.edu	Rauch, Frank/D-1554-2009; Castagnola, Patrizio/H-2029-2012	Castagnola, Patrizio/0000-0003-2008-9199; Rauch, Frank/0000-0002-6261-0360; Byers, Peter H./0000-0001-7786-7030	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510, R01AR036794, R37AR037318, R01AR041223, R01AR037318, R03AR051459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR036794, AR43510, R03 AR052896, AR41223, AR051459, AR37318, R37 AR037318] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline; NIDCR NIH HHS [DE01771] Funding Source: Medline; NIEHS NIH HHS [ES11253] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Aravind L, 2001, GENOME BIOL, V2; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; BERG RA, 1973, BIOCHEMISTRY-US, V12, P3395, DOI 10.1021/bi00742a005; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Byers P.H., 2002, CONNECTIVE TISSUE HE, P285; Castagnola P, 1997, J CELL SCI, V110, P1351; COHN DH, 1990, AM J HUM GENET, V46, P591; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Dreyer SD, 1998, CLIN GENET, V54, P464; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Eyre DR, 2004, CLIN ORTHOP RELAT R, pS118, DOI 10.1097/01.blo.0000144855.48640.b9; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Kaul SC, 2000, ONCOGENE, V19, P3576, DOI 10.1038/sj.onc.1203696; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028; Kuznetsova NV, 2004, MATRIX BIOL, V23, P101, DOI 10.1016/j.matbio.2004.03.002; Labuda M, 2002, BONE, V31, P19, DOI 10.1016/S8756-3282(02)00808-6; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; MAJAMAA K, 1981, BIOCHEM J, V196, P203, DOI 10.1042/bj1960203; MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289; Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200; Morello R, 2001, NAT GENET, V27, P205, DOI 10.1038/84853; Morello R, 1999, MATRIX BIOL, V18, P319, DOI 10.1016/S0945-053X(99)00002-5; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pepin M, 1997, PRENATAL DIAG, V17, P559, DOI 10.1002/(SICI)1097-0223(199706)17:6<559::AID-PD111>3.3.CO;2-7; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; Rauch F, 2000, BONE, V26, P581, DOI 10.1016/S8756-3282(00)00269-6; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Tonachini L, 2004, J CELL PHYSIOL, V201, P470, DOI 10.1002/jcp.20126; Tonachini L, 1999, CYTOGENET CELL GENET, V87, P191, DOI 10.1159/000015463; TRYGGVASON K, 1979, BIOCHEM J, V178, P127, DOI 10.1042/bj1780127; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Wassnehove-McCarthy DJ, 1999, J BIOL CHEM, V274, P25004, DOI 10.1074/jbc.274.35.25004; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200	44	366	384	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					291	304		10.1016/j.cell.2006.08.039	http://dx.doi.org/10.1016/j.cell.2006.08.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055431	Bronze			2022-12-01	WOS:000241827100017
J	Loose, C; Jensen, K; Rigoutsos, I; Stephanopoulos, G				Loose, Christopher; Jensen, Kyle; Rigoutsos, Isidore; Stephanopoulos, Gregory			A linguistic model for the rational design of antimicrobial peptides	NATURE			English	Article							SEQUENCES; MEMBRANE; DATABASE	Antimicrobial peptides (AmPs) are small proteins that are used by the innate immune system to combat bacterial infection in multicellular eukaryotes(1). There is mounting evidence that these peptides are less susceptible to bacterial resistance than traditional antibiotics and could form the basis for a new class of therapeutic agents(2). Here we report the rational design of new AmPs that show limited homology to naturally occurring proteins but have strong bacteriostatic activity against several species of bacteria, including Staphylococcus aureus and Bacillus anthracis. These peptides were designed using a linguistic model of natural AmPs: we treated the amino-acid sequences of natural AmPs as a formal language and built a set of regular grammars to describe this language. We used this set of grammars to create new, unnatural AmP sequences. Our peptides conform to the formal syntax of natural antimicrobial peptides but populate a previously unexplored region of protein sequence space.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Agrivida, Cambridge, MA 02139 USA; IBM Corp, Div Res, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Massachusetts Institute of Technology (MIT); Harvard University; International Business Machines (IBM)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu	Rigoutsos, Isidore/C-5381-2012	Rigoutsos, Isidore/0000-0003-1529-8631				Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589; Hancock R. E. W., 2002, Current Drug Targets - Infectious Disorders, V2, P79, DOI 10.2174/1568005024605855; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Jurafsky D., 2000, SPEECH LANGUAGE PROC; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; MAIZEL JV, 1981, P NATL ACAD SCI-BIOL, V78, P7665, DOI 10.1073/pnas.78.12.7665; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Tiozzo E, 1998, BIOCHEM BIOPH RES CO, V249, P202, DOI 10.1006/bbrc.1998.9114; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	19	168	185	10	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					867	869		10.1038/nature05233	http://dx.doi.org/10.1038/nature05233			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051220				2022-12-01	WOS:000241362700054
J	Okie, S				Okie, Susan			Stem-cell politics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Abbott A, 2006, NATURE, V443, P12, DOI 10.1038/443012a; KLIMANSKAYA I, HUMAN EMBRYONIC STEM	2	10	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1633	1635		10.1056/NEJMp068206	http://dx.doi.org/10.1056/NEJMp068206			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096DN	17050884				2022-12-01	WOS:000241357300001
J	Budnitz, DS; Pollock, DA; Weidenbach, KN; Mendelsohn, AB; Schroeder, TJ; Annest, JL				Budnitz, Daniel S.; Pollock, Daniel A.; Weidenbach, Kelly N.; Mendelsohn, Aaron B.; Schroeder, Thomas J.; Annest, Joseph L.			National surveillance of emergency department visits for outpatient adverse drug events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GEOGRAPHIC-VARIATION; MYOCARDIAL-INFARCTION; AMBULATORY-CARE; SAFETY; INJURIES; ERRORS	Context Adverse drug events are common and often preventable causes of medical injuries. However, timely, nationally representative information on outpatient adverse drug events is limited. Objective To describe the frequency and characteristics of adverse drug events that lead to emergency department visits in the United States. Design, Setting, and Participants Active surveillance from January 1, 2004, through December 31, 2005, through the National Electronic Injury Surveillance System Cooperative Adverse Drug Event Surveillance project. Main Outcome Measures National estimates of the numbers, population rates, and severity (measured by hospitalization) of individuals with adverse drug events treated in emergency departments. Results Over the 2-year study period, 21 298 adverse drug event cases were reported, producing weighted annual estimates of 701 547 individuals (95% confidence interval [CI], 509 642-893 452) or 2.4 individuals per 1000 population(95% CI, 1.7-3.0) treated in emergency departments. Of these cases, 3487 individuals required hospitalization (annual estimate, 117 318 [16.7%]; 95% CI, 13.1%-20.3%). Adverse drug events accounted for 2.5% (95% CI, 2.0%-3.1%) of estimated emergency department visits for all unintentional injuries and 6.7% (95% CI, 4.7%-8.7%) of those leading to hospitalization and accounted for 0.6% of estimated emergency department visits for all causes. Individuals aged 65 years or older were more likely than younger individuals to sustain adverse drug events (annual estimate, 4.9 vs 2.0 per 1000; rate ratio [RR], 2.4; 95% CI, 1.8-3.0) and more likely to require hospitalization (annual estimate, 1.6 vs 0.23 per 1000; RR, 6.8; 95% CI, 4.3-9.2). Drugs for which regular outpatient monitoring is used to prevent acute toxicity accounted for 41.5% of estimated hospitalizations overall (1381 cases; 95% CI, 30.9%-52.1%) and 54.4% of estimated hospitalizations among individuals aged 65 years or older (829 cases; 95% CI, 45.0%-63.7%). Conclusions Adverse drug events among outpatients that lead to emergency department visits are an important cause of morbidity in the United States, particularly among individuals aged 65 years or older. Ongoing, population-based surveillance can help monitor these events and target prevention strategies.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Coordinating Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Off Stat & Programming, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA; US FDA, Off Drug Safety, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA; US Consumer Prod Safety Commiss, Bethesda, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Budnitz, DS (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Coordinating Ctr Infect Dis, 1600 Clifton Rd NE,Mailstop A-24, Atlanta, GA 30333 USA.	dbudnitz@cdc.gov		Mendelsohn, Aaron/0000-0002-0560-1177; Budnitz, Daniel/0000-0002-0136-2623				Ahmad SR, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P135; Bates DW, 1998, JAMA-J AM MED ASSOC, V279, P1216, DOI 10.1001/jama.279.15.1216; Booth GL, 2005, DIABETES CARE, V28, P1045, DOI 10.2337/diacare.28.5.1045; Budnitz DS, 2007, PHARMACOEPIDEM DR S, V16, P160, DOI 10.1002/pds.1242; Budnitz DS, 2005, ANN EMERG MED, V45, P197, DOI 10.1016/j.annemergmed.2004.09.020; Carter JS, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P116; Centers for Disease Control and Prevention, 2005, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P380; Classen D, 2003, JAMA-J AM MED ASSOC, V289, P1154, DOI 10.1001/jama.289.9.1154; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; *CTR MED MED SERV, TOOLK HLTH CAR PROF; Dubois RW, 2002, HEALTH AFFAIR, V21, P240, DOI 10.1377/hlthaff.21.1.240; *FDA, 2005, EL OR BOOK; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gandhi TK, 2005, J GEN INTERN MED, V20, P837, DOI 10.1111/j.1525-1497.2005.0194.x; General Accounting Office, 2000, ADV DRUG EV MAGN HLT; Graham JD, 1997, JAMA-J AM MED ASSOC, V278, P1418, DOI 10.1001/jama.278.17.1418; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hafner JW, 2002, ANN EMERG MED, V39, P258, DOI 10.1067/mem.2002.121401; Havranek EP, 2004, ARCH INTERN MED, V164, P1186, DOI 10.1001/archinte.164.11.1186; *ICH POINTS CONS W, 2003, MED DRA TERM SEL POI; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Layde PM, 2002, JAMA-J AM MED ASSOC, V287, P1993, DOI 10.1001/jama.287.15.1993; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Lopez J, 2004, AM J HYPERTENS, V17, P1095, DOI 10.1016/j.amjhyper.2004.07.015; Morimoto T, 2004, QUAL SAF HEALTH CARE, V13, P306, DOI 10.1136/qshc.2004.010611; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Raebel MA, 2006, AM J MANAG CARE, V12, P268; Richter ED, 2006, ANNU REV PUBL HEALTH, V27, P125, DOI 10.1146/annurev.publhealth.27.021405.102225; Rodgers GB, 1996, JAMA-J AM MED ASSOC, V275, P1661, DOI 10.1001/jama.275.21.1661; Schroeder T, 2001, NATL ELECT INJURY SU; SHOJANIA KG, 2001, EVID REP TECHNOL ASS, V43, P87; *SLON EP CTR, 2004, PATT MED US US 2004; Strom BL, 2003, PHARMACOEPIDEM DR S, V12, P653, DOI 10.1002/pds.859; Tierney WM, 2003, NEW ENGL J MED, V348, P1587, DOI 10.1056/NEJMe030026; Trim JC, 2003, J HOSP INFECT, V53, P237, DOI 10.1053/jhin.2002.1378; *US BUR CENS, 2000, ANN EST POP SEX 5 YE; *US BUR CENS, 2000, ANN EST POP SEL AG G; *US CONS PROD SAF, 2002, NAT EL INJ SURV SYST; van Walraven C, 2006, CHEST, V129, P1155, DOI 10.1378/chest.129.5.1155; Vervloet D, 1998, BRIT MED J, V316, P1511, DOI 10.1136/bmj.316.7143.1511; Weingart SN, 2005, ARCH INTERN MED, V165, P234, DOI 10.1001/archinte.165.2.234; Zed PJ, 2005, J PHARM PRACT, V18, P329, DOI 10.1177/0897190005280049; Zhan CL, 2005, JT COMM J QUAL PATIE, V31, P372, DOI 10.1016/S1553-7250(05)31050-6	46	596	614	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1858	1866		10.1001/jama.296.15.1858	http://dx.doi.org/10.1001/jama.296.15.1858			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	095ST	17047216	Bronze			2022-12-01	WOS:000241329300028
J	Joensuu, H				Joensuu, Heikki			Sunitinib for imatinib-resistant GIST	LANCET			English	Editorial Material							GASTROINTESTINAL STROMAL TUMORS; EFFICACY; MESYLATE; SAFETY; KIT		Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00014 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Joensuu, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Oncol, Haartmaninkatu 4, FIN-00014 Helsinki, Finland.	heikki.joensuu@hus.fi		Joensuu, Heikki/0000-0003-0281-2507				Bono P, 2004, BLOOD, V103, P2929, DOI 10.1182/blood-2003-10-3443; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; DEMETRI GD, LANCET; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Wardelmann E, 2006, CLIN CANCER RES, V12, P1743, DOI 10.1158/1078-0432.CCR-05-1211	7	46	48	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 14	2006	368	9544					1303	1304		10.1016/S0140-6736(06)69489-0	http://dx.doi.org/10.1016/S0140-6736(06)69489-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096PA	17046443				2022-12-01	WOS:000241388100004
J	Wadman, M				Wadman, Meredith			When the party's over	NATURE			English	News Item																		Wadman M, 2005, NATURE, V437, P618, DOI 10.1038/437618a; [No title captured]	2	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2007	445	7123					13	13		10.1038/445013a	http://dx.doi.org/10.1038/445013a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17203035				2022-12-01	WOS:000243225100009
J	Kim, PM; Lu, LJ; Xia, Y; Gerstein, MB				Kim, Philip M.; Lu, Long J.; Xia, Yu; Gerstein, Mark B.			Relating three-dimensional structures to protein networks provides evolutionary insights	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; NUMBER; MODULARITY; DEPENDENCE; DATABASE; BIOLOGY; GENOME	Most studies of protein networks operate on a high level of abstraction, neglecting structural and chemical aspects of each interaction. Here, we characterize interactions by using atomic-resolution information from three-dimensional protein structures. We find that some previously recognized relationships between network topology and genomic features ( e. g., hubs tending to be essential proteins) are actually more reflective of a structural quantity, the number of distinct binding interfaces. Subdividing hubs with respect to this quantity provides insight into their evolutionary rate and indicates that additional mechanisms of network growth are active in evolution ( beyond effective preferential attachment through gene duplication).	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; Boston Univ, Dept Chem, Boston, MA 02215 USA	Yale University; Yale University; Yale University; Boston University	Gerstein, MB (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	mark.gerstein@yale.edu	Xia, Yu/W-6150-2019; lu, lu/HGA-0894-2022	Xia, Yu/0000-0002-5596-5518; 	NCRR NIH HHS [RR19895] Funding Source: Medline; NHLBI NIH HHS [N01-HV-28186] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028186] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bloom JD, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-21; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Espadaler J, 2005, P NATL ACAD SCI USA, V102, P7151, DOI 10.1073/pnas.0500831102; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-13; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; KIM PM, 2003, THESIS MIT CAMBRIDGE, P1; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdar WSJ, 2001, PROTEINS, V42, P108; VAZQUEZ A, 2003, PHYS REV E, V67; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wuchty S, 2004, GENOME RES, V14, P1310, DOI 10.1101/gr.2300204	30	380	383	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1938	1941		10.1126/science.1136174	http://dx.doi.org/10.1126/science.1136174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185604				2022-12-01	WOS:000242996800053
J	Mehta, MP; Baross, JA				Mehta, Mausmi P.; Baross, John A.			Nitrogen fixation at 92 degrees C by a hydrothermal vent archaeon	SCIENCE			English	Article							MIDOCEAN RIDGE SUBSEAFLOOR; METHANOSARCINA-BARKERI 227; FUNCTIONAL-ORGANIZATION; STRUCTURAL GENES; EVOLUTION; SEA; DIVERSITY; PROTEINS; HABITAT; CLONING	A methanogenic archaeon isolated from deep-sea hydrothermal vent fluid was found to reduce N-2 to NH3 at up to 92 degrees C, which is 28 degrees C higher than the current upper temperature limit of biological nitrogen fixation. The 16S ribosomal RNA gene of the hyperthermophilic nitrogen fixer, designated FS406-22, was 99% similar to that of non-nitrogen fixing Methanocaldococcus jannaschii DSM 2661. At its optimal growth temperature of 90 degrees C, FS406-22 incorporated N-15(2) and expressed nifH messenger RNA. This increase in the temperature limit of nitrogen fixation could reveal a broader range of conditions for life in the subseafloor biosphere and other nitrogen-limited ecosystems than previously estimated.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Mehta, MP (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	mausmi@alum.mit.edu						Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; BELAY N, 1984, NATURE, V312, P286, DOI 10.1038/312286a0; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Butterfield DA, 2004, GEOPH MONOG SERIES, V144, P269, DOI 10.1029/144GM17; Charlou JL, 2000, CHEM GEOL, V171, P49, DOI 10.1016/S0009-2541(00)00244-8; CHIEN YT, 1994, J BACTERIOL, V176, P6590, DOI 10.1128/JB.176.21.6590-6598.1994; Chien YT, 1996, J BACTERIOL, V178, P143, DOI 10.1128/jb.178.1.143-148.1996; Chien YT, 2000, J BACTERIOL, V182, P3247, DOI 10.1128/JB.182.11.3247-3253.2000; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dodsworth JA, 2006, P NATL ACAD SCI USA, V103, P9779, DOI 10.1073/pnas.0602278103; GILBERT LA, 2004, THESIS U WASHINGTON; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; Kasting JF, 2002, SCIENCE, V296, P1066, DOI 10.1126/science.1071184; KENNICUTT MC, 1995, MICR EXTREM UNUSUAL, P275; Leigh JA, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P7; Leigh JA, 2000, PROKARYOTIC NITROGEN FIXATION, P657; Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Pruis MJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013977; RAU GH, 1981, NATURE, V289, P484, DOI 10.1038/289484a0; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; SOUILLARD N, 1989, MOL MICROBIOL, V3, P541, DOI 10.1111/j.1365-2958.1989.tb00200.x; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Summit M, 2001, P NATL ACAD SCI USA, V98, P2158, DOI 10.1073/pnas.051516098; YOUNG JPW, 1992, BIOL NITROGEN FIXATI, P43; [No title captured]	28	150	159	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1783	1786		10.1126/science.1134772	http://dx.doi.org/10.1126/science.1134772			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170307				2022-12-01	WOS:000242833600061
J	Lewis, RF; Carey, JP				Lewis, Richard F.; Carey, John P.			Abnormal eye movements associated with unilateral loss of vestibular function	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Lewis, RF (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.	richard_lewis@meei.harvard.edu							0	6	6	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					E26	E26		10.1056/NEJMicm031134	http://dx.doi.org/10.1056/NEJMicm031134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167131				2022-12-01	WOS:000242778800010
J	Pallansch, MA; Sandhu, HS				Pallansch, Mark A.; Sandhu, Hardeep S.			The eradication of polio - Progress and challenges	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Pallansch, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.							[Anonymous], 2006, MMWR MORB MORTAL WKL, V55, P145; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; Samba E, 2004, NEW ENGL J MED, V350, P645, DOI 10.1056/NEJMp038210	3	49	52	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2508	2511		10.1056/NEJMp068200	http://dx.doi.org/10.1056/NEJMp068200			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167133	Bronze			2022-12-01	WOS:000242778800002
J	Liu, ZP; Neff, RA; Berg, DK				Liu, Zhaoping; Neff, Robert A.; Berg, Darwin K.			Sequential interplay of nicotinic and GABAergic signaling guides neuronal development	SCIENCE			English	Article							CILIARY GANGLION NEURONS; ACETYLCHOLINE-RECEPTOR; GABA; INTERNEURONS; HIPPOCAMPUS; CIRCUITS; CULTURE; MICE; DIFFERENTIATION; EXPRESSION	GABA (gamma-aminobutyric acid), the major inhibitory transmitter in the brain, goes through a transitory phase of excitation during development. The excitatory phase promotes neuronal growth and integration into circuits. We show here that spontaneous nicotinic cholinergic activity is responsible for terminating GABAergic excitation and initiating inhibition. It does so by changing chloride transporter levels, shifting the driving force on GABA-induced currents. The timing of the transition is critical, because the two phases of GABAergic signaling provide contrasting developmental instructions. Synergistic with nicotinic excitation, GABAergic inhibition constrains neuronal morphology and innervation. The results reveal a multitiered activity-dependent strategy controlling neuronal development.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Berg, DK (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dberg@ucsd.edu	liu, zhao/GXV-6141-2022	Neff, Robert/0000-0002-7550-4348	NINDS NIH HHS [NS035469, NS012601] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035469, R01NS012601] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams CE, 2002, DEV BRAIN RES, V139, P175, DOI 10.1016/S0165-3806(02)00547-3; Alkondon M, 1999, J NEUROSCI, V19, P2693; Bansal A, 2000, J NEUROSCI, V20, P7672; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Chen M, 2001, J NEUROBIOL, V47, P265, DOI 10.1002/neu.1034; DRYER SE, 1994, PROG NEUROBIOL, V43, P281, DOI 10.1016/0301-0082(94)90003-5; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; Kasyanov AM, 2004, P NATL ACAD SCI USA, V101, P3967, DOI 10.1073/pnas.0305974101; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Le Magueresse C, 2006, J PHYSIOL-LONDON, V576, P533, DOI 10.1113/jphysiol.2006.117572; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; MCEACHERN AE, 1985, J NEUROSCI, V5, P2690; Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015	28	171	177	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1610	1613		10.1126/science.1134246	http://dx.doi.org/10.1126/science.1134246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158331				2022-12-01	WOS:000242624600046
J	Bao, SD; Wu, QL; McLendon, RE; Hao, YL; Shi, Q; Hjelmeland, AB; Dewhirst, MW; Bigner, DD; Rich, JN				Bao, Shideng; Wu, Qiulian; McLendon, Roger E.; Hao, Yueling; Shi, Qing; Hjelmeland, Anita B.; Dewhirst, Mark W.; Bigner, Darell D.; Rich, Jeremy N.			Glioma stem cells promote radioresistance by preferential activation of the DNA damage response	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN-TUMORS; IN-VITRO; CHECKPOINTS; IDENTIFICATION; CANCER; REPAIR; UNIQUE; ATM	Ionizing radiation represents the most effective therapy for glioblastoma ( World Health Organization grade IV glioma), one of the most lethal human malignancies(1), but radiotherapy remains only palliative(2) because of radioresistance. The mechanisms underlying tumour radioresistance have remained elusive. Here we show that cancer stem cells contribute to glioma radioresistance through preferential activation of the DNA damage checkpoint response and an increase in DNA repair capacity. The fraction of tumour cells expressing CD133 (Prominin-1), a marker for both neural stem cells and brain cancer stem cells(3-6), is enriched after radiation in gliomas. In both cell culture and the brains of immunocompromised mice, CD133-expressing glioma cells survive ionizing radiation in increased proportions relative to most tumour cells, which lack CD133. CD133-expressing tumour cells isolated from both human glioma xenografts and primary patient glioblastoma specimens preferentially activate the DNA damage checkpoint in response to radiation, and repair radiation-induced DNA damage more effectively than CD133-negative tumour cells. In addition, the radioresistance of CD133-positive glioma stem cells can be reversed with a specific inhibitor of the Chk1 and Chk2 checkpoint kinases. Our results suggest that CD133-positive tumour cells represent the cellular population that confers glioma radioresistance and could be the source of tumour recurrence after radiation. Targeting DNA damage checkpoint response in cancer stem cells may overcome this radioresistance and provide a therapeutic model for malignant brain cancers.	Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Rich, JN (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	rich0001@mc.duke.edu	Rich, Jeremy/AAM-1445-2021; Dewhirst, Mark/Q-1302-2019	Dewhirst, Mark/0000-0003-3459-6546				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Carr AM, 2002, DNA REPAIR, V1, P983, DOI 10.1016/S1568-7864(02)00165-9; Curman D, 2001, J BIOL CHEM, V276, P17914, DOI 10.1074/jbc.M100728200; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GARDEN AS, 1991, RADIOTHER ONCOL, V20, P99, DOI 10.1016/0167-8140(91)90143-5; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; IZANT JG, 1983, J CELL BIOL, V96, P424, DOI 10.1083/jcb.96.2.424; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Marin L, 2003, CYTOM PART A, V51A, P107, DOI 10.1002/cyto.a.10007; Oostendorp RAJ, 1999, LEUKEMIA, V13, P499, DOI 10.1038/sj.leu.2401373; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	27	4490	4733	25	639	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					756	760		10.1038/nature05236	http://dx.doi.org/10.1038/nature05236			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17051156				2022-12-01	WOS:000242581100060
J	Meskhidze, N; Nenes, A				Meskhidze, Nicholas; Nenes, Athanasios			Phytoplankton and cloudiness in the Southern Ocean	SCIENCE			English	Article							SECONDARY ORGANIC AEROSOLS; MARINE BOUNDARY-LAYER; NONMETHANE HYDROCARBONS; DIMETHYL SULFIDE; CAPE GRIM; ISOPRENE; PARAMETERIZATION; MODEL; GEORGIA; FLUXES	The effect of ocean biological productivity on marine clouds is explored over a large phytoplankton bloom in the Southern Ocean with the use of remotely sensed data. Cloud droplet number concentration over the bloom was twice what it was away from the bloom, and cloud effective radius was reduced by 30%. The resulting change in the short-wave radiative flux at the top of the atmosphere was - 15 watts per square meter, comparable to the aerosol indirect effect over highly polluted regions. This observed impact of phytoplankton on clouds is attributed to changes in the size distribution and chemical composition of cloud condensation nuclei. We propose that secondary organic aerosol, formed from the oxidation of phytoplankton-produced isoprene, can affect chemical composition of marine cloud condensation nuclei and influence cloud droplet number. Model simulations support this hypothesis, indicating that 100% of the observed changes in cloud properties can be attributed to the isoprene secondary organic aerosol.	Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Meskhidze, N (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA.	nmeskhidze@ncsu.edu	Nenes, Athanasios/ABE-6478-2020	Nenes, Athanasios/0000-0003-3873-9970; Meskhidze, Nicholas/0000-0001-5628-8777				Andreae MO, 1999, J GEOPHYS RES-ATMOS, V104, P21695, DOI 10.1029/1999JD900283; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Bian HS, 2002, J ATMOS CHEM, V41, P281, DOI 10.1023/A:1014980619462; BONSANG B, 1992, GEOPHYS RES LETT, V19, P1129, DOI 10.1029/92GL00083; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Bretherton CS, 2004, B AM METEOROL SOC, V85, P967, DOI 10.1175/BAMS-85-7-967; Broadgate WJ, 1997, GEOPHYS RES LETT, V24, P2675, DOI 10.1029/97GL02736; CHARLSON RJ, 1992, SCIENCE, V255, P423, DOI 10.1126/science.255.5043.423; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Chylek P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025397; Claeys M, 2004, SCIENCE, V303, P1173, DOI 10.1126/science.1092805; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Decesari S, 2006, ATMOS CHEM PHYS, V6, P375, DOI 10.5194/acp-6-375-2006; Gille ST, 2005, J ATMOS OCEAN TECH, V22, P1353, DOI 10.1175/JTECH1789.1; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Heald CL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023831; Hegg DA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018909; Helmig D, 1998, J GEOPHYS RES-ATMOS, V103, P25519, DOI 10.1029/98JD01023; Henze DK, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025976; JONES A, 1994, NATURE, V370, P450, DOI 10.1038/370450a0; Kamykowski D, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001640; Kaufman YJ, 2005, P NATL ACAD SCI USA, V102, P11207, DOI 10.1073/pnas.0505191102; Korb RE, 2004, DEEP-SEA RES PT I, V51, P721, DOI 10.1016/j.dsr.2004.02.006; Lawrence MG, 2005, B AM METEOROL SOC, V86, P225, DOI 10.1175/BAMS-86-2-225; Le Clainche Y, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002947; Lim HJ, 2005, ENVIRON SCI TECHNOL, V39, P4441, DOI 10.1021/es048039h; Lin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017141; MARTIN GM, 1994, J ATMOS SCI, V51, P1823, DOI 10.1175/1520-0469(1994)051<1823:TMAPOE>2.0.CO;2; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; MATSUNAGA SN, 2005, ATMOS CHEM PHYS DISC, V5, P11143, DOI DOI 10.5194/ACPD-5-11143-2005; Menon S, 2002, J ATMOS SCI, V59, P692, DOI 10.1175/1520-0469(2002)059<0692:GSOTAI>2.0.CO;2; Meredith MP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018039; Meskhidze N, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005082; Meskhidze N, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005703; Meskhidze N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018035; MESKHIDZE N, UNPUB; Middlebrook AM, 1998, J GEOPHYS RES-ATMOS, V103, P16475, DOI 10.1029/97JD03719; MILNE PJ, 1995, MAR CHEM, V48, P237, DOI 10.1016/0304-4203(94)00059-M; Moore RM, 1999, J GEOPHYS RES-OCEANS, V104, P11163, DOI 10.1029/1998JC900073; MOORE RM, 1994, GEOPHYS RES LETT, V21, P2507, DOI 10.1029/94GL02363; NAKAJIMA T, 1991, J ATMOS SCI, V48, P728, DOI 10.1175/1520-0469(1991)048<0728:DOTOTA>2.0.CO;2; Ng NL, 2006, ENVIRON SCI TECHNOL, V40, P2283, DOI 10.1021/es052269u; O'Dowd CD, 2004, NATURE, V431, P676, DOI 10.1038/nature02959; Palmer PI, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022592; Pszenny AAP, 1999, J GEOPHYS RES-ATMOS, V104, P21785, DOI 10.1029/1999JD900114; Shao HF, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004286; Shaw SL, 2003, MAR CHEM, V80, P227, DOI 10.1016/S0304-4203(02)00101-9; SLINGO A, 1989, J ATMOS SCI, V46, P1419, DOI 10.1175/1520-0469(1989)046<1419:AGPFTS>2.0.CO;2; Son SH, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025065; Surratt JD, 2006, J PHYS CHEM A, V110, P9665, DOI 10.1021/jp061734m; Wang W, 2005, RAPID COMMUN MASS SP, V19, P1343, DOI 10.1002/rcm.1940; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Ward P, 2005, DEEP-SEA RES PT I, V52, P421, DOI 10.1016/j.dsr.2004.10.003; WHITBY KT, 1978, ATMOS ENVIRON, V12, P135, DOI 10.1016/0004-6981(78)90196-8; WINGENTER O, 2005, SOLAS NEWS ISSUE, P5; Wingenter OW, 2004, P NATL ACAD SCI USA, V101, P8537, DOI 10.1073/pnas.0402744101; Yokouchi Y, 1999, J GEOPHYS RES-ATMOS, V104, P8067, DOI 10.1029/1998JD100013; Yum SS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003864	58	246	253	9	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1419	1423		10.1126/science.1131779	http://dx.doi.org/10.1126/science.1131779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17082422				2022-12-01	WOS:000242406100031
J	Raichle, ME				Raichle, Marcus E.			The brain's dark energy	SCIENCE			English	Editorial Material							CORTEX		Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL)	Raichle, ME (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	gitlin@kids.wustl.edu						Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gilbert D., 2006, STUMBLING HAPPINESS; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hawkins J, 2004, INTELLIGENCE; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; JAMES W, 1890, PRINCIPLES PSYCHOL, V2, P103; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Llinas R.R., 2001, I VORTEX NEURONS SEL; Olshausen B. A., 2003, VISUAL NEUROSCIENCES, P1603; PETERS A, 1994, CEREB CORTEX, V4, P215, DOI 10.1093/cercor/4.3.215; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819	12	303	317	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1249	1250		10.1126/science.1134405	http://dx.doi.org/10.1126/science.1134405			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	108BR	17124311				2022-12-01	WOS:000242215800027
J	Kandun, IN; Wibisono, H; Sedyaningsih, ER; Yusharmen; Hadisoedarsuno, W; Purba, W; Santoso, H; Septiawati, C; Tresnaningsih, E; Heriyanto, B; Yuwono, D; Harun, S; Soeroso, S; Giriputra, S; Blair, PJ; Jeremijenko, A; Kosasih, H; Putnam, SD; Samaan, G; Silitonga, M; Chan, KH; Poon, LLM; Lim, W; Klimov, A; Lindstrom, S; Guan, Y; Donis, R; Katz, J; Cox, N; Peiris, M; Uyeki, TM				Kandun, I. Nyoman; Wibisono, Hariadi; Sedyaningsih, Endang R.; Yusharmen; Hadisoedarsuno, Widarso; Purba, Wilfried; Santoso, Hari; Septiawati, Chita; Tresnaningsih, Erna; Heriyanto, Bambang; Yuwono, Djoko; Harun, Syahrial; Soeroso, Santoso; Giriputra, Sardikin; Blair, Patrick J.; Jeremijenko, Andrew; Kosasih, Herman; Putnam, Shannon D.; Samaan, Gina; Silitonga, Marlinggom; Chan, K. H.; Poon, Leo L. M.; Lim, Wilina; Klimov, Alexander; Lindstrom, Stephen; Guan, Yi; Donis, Ruben; Katz, Jacqueline; Cox, Nancy; Peiris, Malik; Uyeki, Timothy M.			Three Indonesian clusters of H5N1 virus infection in 2005	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLUENZA-A H5N1; HUMAN-DISEASE	Background: Since 2003, the widespread ongoing epizootic of avian influenza A (H5N1) among poultry and birds has resulted in human H5N1 cases in 10 countries. The first case of H5N1 virus infection in Indonesia was identified in July 2005. Methods: We investigated three clusters of Indonesian cases with at least two ill persons hospitalized with laboratory evidence of H5N1 virus infection from June through October 2005. Epidemiologic, clinical, and virologic data on these patients were collected and analyzed. Results: Severe disease occurred among all three clusters, including deaths in two clusters. Mild illness in children was documented in two clusters. The median age of the eight patients was 8.5 years (range, 1 to 38). Four patients required mechanical ventilation, and four of the eight patients (50%) died. In each cluster, patients with H5N1 virus infection were members of the same family, and most lived in the same home. In two clusters, the source of H5N1 virus infection in the index patient was not determined. Virus isolates were available for one patient in each of two clusters, and molecular sequence analyses determined that the isolates were clade 2 H5N1 viruses of avian origin. Conclusions: In 2005 in Indonesia, clusters of human infection with clade 2 H5N1 viruses included mild, severe, and fatal cases among family members.	Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; Directorate Gen Dis Control & Environm Hlth, Jakarta, Indonesia; Natl Inst Hlth Res & Dev, Jakarta, Indonesia; Infect Dis Hosp Rumah Sakit Penyakit Infeksi Suli, N Jakarta, Indonesia; USN, Med Res Unit 2, Jakarta, Indonesia; WHO, Jakarta, Indonesia; Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; Dept Hlth, Hong Kong, Hong Kong, Peoples R China	Centers for Disease Control & Prevention - USA; National Institute of Health Research & Development - Indonesia; University of 19 November Kolaka; World Health Organization; University of Hong Kong	Uyeki, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Mail Stop A-32, Atlanta, GA 30333 USA.	tuyeki@cdc.gov	Poon, Leo/AAP-6887-2020; Chan, Kwok Hung/ABD-5399-2021; Poon, Leo Lit Man/C-4382-2009; Putnam, Shan D/F-2345-2013	Poon, Leo Lit Man/0000-0002-9101-7953; Putnam, Shan D/0000-0001-8353-4400; Jeremijenko, Andrew Martin/0000-0002-0375-2713; Guan, Yi/0000-0001-6057-9243				[Anonymous], 2005, WHO REC US RAP TEST; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Le QM, 2005, NATURE, V438, P754, DOI 10.1038/438754b; *OFF INT EP, 2004, HIGH PATH AV INFL IN; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; *WHO, 2006, WHO RAP ADV GUID PHA; *WHO, 2006, WHO CAS DEF HUM INF; *WHO, 2005, AV INFL SIT IND UPD; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; 2006, WKLY EPIDEMIOL REC, V81, P183	23	266	287	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2186	2194		10.1056/NEJMoa060930	http://dx.doi.org/10.1056/NEJMoa060930			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	107KQ	17124016				2022-12-01	WOS:000242170900005
J	Tang, C; Iwahara, J; Clore, GM				Tang, Chun; Iwahara, Junji; Clore, G. Marius			Visualization of transient encounter complexes in protein-protein association	NATURE			English	Article							PHOSPHORYL TRANSFER COMPLEX; NMR STRUCTURES; ENHANCEMENT; BINDING; DNA; BARNASE; DOMAIN	Kinetic data on a number of protein - protein associations have provided evidence for the initial formation of a pre- equilibrium encounter complex that subsequently relaxes to the final stereospecific complex (1). Site- directed mutagenesis(2 - 4) and brownian dynamics simulations(5 - 7) have suggested that the rate of association can be modulated by perturbations in charge distribution outside the direct interaction surfaces. Furthermore, rate enhancement through non- specific binding may occur by either a reduction in dimensionality(8) or the presence of a short- range, non- specific attractive potential(9). Here, using paramagnetic relaxation enhancement, we directly demonstrate the existence and visualize the distribution of an ensemble of transient, non- specific encounter complexes under equilibrium conditions for a relatively weak protein - protein complex between the amino- terminal domain of enzyme I and the phosphocarrier protein HPr. Neither the stereospecific complex(10) alone nor any single alternative conformation can account fully for the intermolecular paramagnetic relaxation enhancement data. Restrained rigid- body simulated annealing refinement against the paramagnetic relaxation enhancement data enables us to obtain an atomic probability distribution map of the non- specific encounter complex ensemble that qualitatively correlates with the electrostatic surface potentials on the interacting proteins. Qualitatively similar results are presented for two other protein - protein complexes.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Tang, Chun/P-4060-2019; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Tang, Chun/0000-0001-6477-6500; Iwahara, Junji/0000-0003-4732-2173	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029043] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam G., 1968, STRUCTURAL CHEM MOL, P198; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; Cornilescu G, 2002, J BIOL CHEM, V277, P42289, DOI 10.1074/jbc.M207314200; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; EBRIGHT YW, 1992, BIOCHEMISTRY-US, V31, P10664, DOI 10.1021/bi00159a004; Fersht A, 1999, STRUCTURE MECH PROTE; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; NORTHRUP SH, 1988, SCIENCE, V241, P67, DOI 10.1126/science.2838904; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Postma P.W., 1996, ESCHERICHIA COLI SAL, P1149; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2002, J BIOMOL NMR, V23, P221, DOI 10.1023/A:1019875223132; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Spaar A, 2006, BIOPHYS J, V90, P1913, DOI 10.1529/biophysj.105.075507; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Williams DC, 2005, J BIOL CHEM, V280, P20775, DOI 10.1074/jbc.M501986200; Zhou HX, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178101	28	332	342	0	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					383	386		10.1038/nature05201	http://dx.doi.org/10.1038/nature05201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17051159				2022-12-01	WOS:000242018300052
J	Ngai, JT; Srivastava, DS				Ngai, Jacqueline T.; Srivastava, Diane S.			Predators accelerate nutrient cycling in a bromeliad ecosystem	SCIENCE			English	Article							FOOD-WEB; FISH		Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Ngai, JT (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	ngai@zoology.ubc.ca						Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; POWER ME, 1990, SCIENCE, V250, P811, DOI 10.1126/science.250.4982.811; Ruetz CR, 2002, OECOLOGIA, V132, P307, DOI 10.1007/s00442-002-0953-1; SHORT TM, 1992, FRESHWATER BIOL, V27, P91, DOI 10.1111/j.1365-2427.1992.tb00526.x; Tewfik A, 2005, ECOLOGY, V86, P2726, DOI 10.1890/04-1537; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2	8	108	110	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					963	963		10.1126/science.1132598	http://dx.doi.org/10.1126/science.1132598			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095695				2022-12-01	WOS:000241896000043
J	Steinbrook, R				Steinbrook, Robert			Medicare and erythropoietic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						[Anonymous], 2006, USRDS 2006 ANN DAT R; *FDA PUBL HLTH ADV, 2006, EP ALF MARK PROCR EP; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Steinbrook R, 2006, LANCET, V368, P2191, DOI 10.1016/S0140-6736(06)69707-9	4	35	35	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					4	6		10.1056/NEJMp068296	http://dx.doi.org/10.1056/NEJMp068296			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202449				2022-12-01	WOS:000243209600002
J	O'Donnell, M				O'Donnell, Michael			The night Bernard Shaw taught us a lesson	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mod@doctors.org.uk						GUINNESS A, 2000, COMMONPLACE BOOK, P29; ODONNELL M, 2005, MADNESS CREATIVITY L, P45; SHAW B, 1946, DOCTORS DILEMMA, P104; Skelton JR, 2005, BRIT J GEN PRACT, V55, P40	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2006	333	7582					1338	1340		10.1136/bmj.39062.728900.55	http://dx.doi.org/10.1136/bmj.39062.728900.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185735	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000243160700032
J	Koelle, K; Cobey, S; Grenfell, B; Pascual, M				Koelle, Katia; Cobey, Sarah; Grenfell, Bryan; Pascual, Mercedes			Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans	SCIENCE			English	Article							SEQUENCE SPACE; VIRUS; PROTEIN; DYNAMICS; HEMAGGLUTININ; EMERGENCE; MORTALITY; MODEL; DRIFT; IDENTIFICATION	Human influenza A ( subtype H3N2) is characterized genetically by the limited standing diversity of its hemagglutinin and antigenically by clusters that emerge and replace each other within 2 to 8 years. By introducing an epidemiological model that allows for differences between the genetic and antigenic properties of the virus's hemagglutinin, we show that these patterns can arise from cluster-specific immunity alone. Central to the formulation is a genotype-to-phenotype mapping, based on neutral networks, with antigenic phenotypes, not genotypes, determining the degree of strain cross-immunity. The model parsimoniously explains well-known, as well as previously unremarked, features of interpandemic influenza dynamics and evolution. It captures the observed boom-and-bust pattern of viral evolution, with periods of antigenic stasis during which genetic diversity grows, and with episodic contraction of this diversity during cluster transitions.	Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Penn State Univ, Dept Biol, Mueller Lab 208, Eberly Coll Sci, University Pk, PA 16802 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Koelle, K (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 2019 Kraus Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	kkoelle@psu.edu						Babajide A, 2001, J THEOR BIOL, V212, P35, DOI 10.1006/jtbi.2001.2343; Barnett L, 1998, FROM ANIM ANIMAT, P18; Bastolla U, 1999, J THEOR BIOL, V200, P49, DOI 10.1006/jtbi.1999.0975; BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Crowe SR, 2006, VACCINE, V24, P452, DOI 10.1016/j.vaccine.2005.07.090; Douglas RG, 1975, INFLUENZA VIRUSES IN, P375; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; GILL PW, 1977, MED J AUSTRALIA, V2, P761, DOI 10.5694/j.1326-5377.1977.tb99276.x; Girvan M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031915; Gog JR, 2003, P NATL ACAD SCI USA, V100, P11143, DOI 10.1073/pnas.1830296100; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; GREENE SK, 2004, P INT C OPT CONTR IN, V5, P795; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Huynen MA, 1996, J MOL EVOL, V43, P165; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; KAUFFMAN SA, 1991, J THEOR BIOL, V149, P467, DOI 10.1016/S0022-5193(05)80094-3; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LAU KF, 1990, P NATL ACAD SCI USA, V87, P638, DOI 10.1073/pnas.87.2.638; Li H, 1996, SCIENCE, V273, P666, DOI 10.1126/science.273.5275.666; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; MEIKLEJOHN G, 1978, J INFECT DIS, V138, P618, DOI 10.1093/infdis/138.5.618; Nakajima K, 2005, J VIROL, V79, P6472, DOI 10.1128/JVI.79.10.6472-6477.2005; Nakajima S, 2000, VIROLOGY, V274, P220, DOI 10.1006/viro.2000.0453; Newman MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1333, DOI 10.1098/rspb.1998.0438; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Sato K, 2004, EPIDEMIOL INFECT, V132, P399, DOI 10.1017/S0950268803001821; Schuster P, 1999, PHYSICA D, V133, P427, DOI 10.1016/S0167-2789(99)00076-7; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Van Nimwegen E, 2000, B MATH BIOL, V62, P799, DOI 10.1006/bulm.2000.0180; van Nimwegen E, 1999, THEOR COMPUT SCI, V229, P41, DOI 10.1016/S0304-3975(99)00119-X; vanNimwegen E, 1997, PHYS LETT A, V229, P144, DOI 10.1016/S0375-9601(97)00192-8; WAGNER A, 2005, ROBUSTNESS EVOLVABIL, P223; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	49	334	345	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1898	1903		10.1126/science.1132745	http://dx.doi.org/10.1126/science.1132745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185596				2022-12-01	WOS:000242996800040
J	Lincoln, GA; Clarke, IJ; Hut, RA; Hazlerigg, DG				Lincoln, Gerald A.; Clarke, Iain J.; Hut, Roelof A.; Hazlerigg, David G.			Characterizing a mammalian circannual pacemaker	SCIENCE			English	Article							BEETLE ANTHRENUS-VERBASCI; PITUITARY-GLAND; PROLACTIN SECRETION; REPRODUCTIVE RHYTHM; MELATONIN SIGNAL; SYRIAN-HAMSTER; SEASONAL TIMER; CYCLES; PHOTOPERIOD; SHEEP	Many species express endogenous cycles in physiology and behavior that allow anticipation of the seasons. The anatomical and cellular bases of these circannual rhythms have not been defined. Here, we provide strong evidence using an in vivo Soay sheep model that the circannual regulation of prolactin secretion, and its associated biology, derive from a pituitary-based timing mechanism. Circannual rhythm generation is seen as the product of the interaction between melatonin-regulated timer cells and adjacent prolactin- secreting cells, which together function as an intrapituitary "pacemaker-slave" timer system. These new insights open the way for a molecular analysis of long-term timing mechanisms.	Univ Edinburgh, Ctr Reprod Biol, Edinburgh EH3 9EW, Midlothian, Scotland; Queens Med Res Inst, Edinburgh, Midlothian, Scotland; Univ Groningen, Dept Chronobiol, Haren, Netherlands; Monash Univ, Dept Physiol, Melbourne, Vic 3168, Australia; Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	University of Edinburgh; University of Edinburgh; University of Groningen; Monash University; University of Aberdeen	Lincoln, GA (corresponding author), Univ Edinburgh, Ctr Reprod Biol, Edinburgh EH3 9EW, Midlothian, Scotland.	g.lincoln@hrsu.mrc.ac.uk	Hut, Roelof A./I-3483-2012	Clarke, Iain/0000-0002-6613-2757	MRC [G0600678] Funding Source: UKRI; Medical Research Council [G0600678] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bockers TM, 1997, ENDOCRINOLOGY, V138, P4101, DOI 10.1210/en.138.10.4101; Carmichael M S, 1986, J Biol Rhythms, V1, P277, DOI 10.1177/074873048600100402; Gwinner, 2012, CIRCANNUAL RHYTHMS E; GWINNER E, 2001, FRONTIERS LIFE, V4, P193; Hazlerigg DG, 2004, CURR BIOL, V14, P334, DOI 10.1016/j.cub.2004.01.057; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Johnston JD, 2003, FASEB J, V17, P810, DOI 10.1096/fj.02-0837com; Johnston JD, 2003, GEN COMP ENDOCR, V134, P182, DOI 10.1016/S0016-6480(03)00248-X; KARSCH FJ, 1989, BIOL REPROD, V41, P1034, DOI 10.1095/biolreprod41.6.1034; Kondo N, 2006, CELL, V125, P161, DOI 10.1016/j.cell.2006.03.017; LEDERC GM, 2005, ENDOCRINOLOGY, V146, P2782; Lincoln G, 1999, ADV EXP MED BIOL, V460, P137; Lincoln GA, 2005, ENDOCRINOLOGY, V146, P3782, DOI 10.1210/en.2005-0132; Lincoln GA, 2003, BIOL REPROD, V69, P1416, DOI 10.1095/biolreprod.103.017673; Lincoln GA, 1997, BIOL REPROD, V57, P460, DOI 10.1095/biolreprod57.2.460; LINCOLN GA, 1989, J REPROD FERTIL, V85, P687, DOI 10.1530/jrf.0.0850687; LINCOLN GA, 1994, J NEUROENDOCRINOL, V6, P251, DOI 10.1111/j.1365-2826.1994.tb00580.x; Lincoln GA, 1998, COMP BIOCHEM PHYS C, V119, P283, DOI 10.1016/S0742-8413(98)00017-6; Malpaux B, 2001, J BIOL RHYTHM, V16, P336, DOI 10.1177/074873001129002051; MARTINET L, 1992, J REPROD FERTIL, V95, P325, DOI 10.1530/jrf.0.0950325; McFerran DW, 2001, ENDOCRINOLOGY, V142, P3255, DOI 10.1210/en.142.7.3255; Miyazaki Y, 2005, J COMP PHYSIOL A, V191, P883, DOI 10.1007/s00359-005-0012-6; Nisimura T, 2002, BIOL RHYTHM RES, V33, P255, DOI 10.1076/brhm.33.3.255.8264; PENGELLY ET, 1974, CIRCANNUAL CLOCKS, P89; Stirland JA, 2001, J NEUROENDOCRINOL, V13, P147, DOI 10.1046/j.1365-2826.2001.00611.x; THRUN LA, 1995, J BIOL RHYTHM, V10, P42, DOI 10.1177/074873049501000104; Williams LM, 1997, J NEUROENDOCRINOL, V9, P639, DOI 10.1046/j.1365-2826.1997.00625.x; WOODFILL CJI, 1994, BIOL REPROD, V50, P965, DOI 10.1095/biolreprod50.4.965; Zucker Irving, 2001, Handbook of Behavioral Neurobiology, V12, P509	29	171	171	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1941	1944		10.1126/science.1132009	http://dx.doi.org/10.1126/science.1132009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185605				2022-12-01	WOS:000242996800054
J	Nackley, AG; Shabalina, SA; Tchivileva, IE; Satterfield, K; Korchynskyi, O; Makarov, SS; Maixner, W; Diatchenko, L				Nackley, A. G.; Shabalina, S. A.; Tchivileva, I. E.; Satterfield, K.; Korchynskyi, O.; Makarov, S. S.; Maixner, W.; Diatchenko, L.			Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure	SCIENCE			English	Article							PAIN PATIENTS; GENE; COMT; POLYMORPHISMS; TRANSLATION; PREDICTION; PATTERN	Catechol-O-methyltransferase (COMT) is a key regulator of pain perception, cognitive function, and affective mood. Three common haplotypes of the human COMT gene, divergent in two synonymous and one nonsynonymous position, code for differences in COMT enzymatic activity and are associated with pain sensitivity. Haplotypes divergent in synonymous changes exhibited the largest difference in COMT enzymatic activity, due to a reduced amount of translated protein. The major COMT haplotypes varied with respect to messenger RNA local stem-loop structures, such that the most stable structure was associated with the lowest protein levels and enzymatic activity. Site-directed mutagenesis that eliminated the stable structure restored the amount of translated protein. These data highlight the functional significance of synonymous variations and suggest the importance of haplotypes over single-nucleotide polymorphisms for analysis of genetic variations.	Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC 27599 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Univ N Carolina, Thurston Arthrit Ctr, Chapel Hill, NC 27599 USA; Attagene Inc, Res Triangle Pk, NC 27560 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; University of North Carolina; University of North Carolina Chapel Hill	Diatchenko, L (corresponding author), Univ N Carolina, Ctr Neurosensory Disorders, Chapel Hill, NC 27599 USA.	lbdiatch@email.unc.edu	Korchynskyi, Olexandr/ADA-6398-2022; Shabalina, Svetlana/N-8939-2013	Shabalina, Svetlana/0000-0003-2272-7473; Korchynskyi, Olexandr/0000-0002-4557-4003	NIDCR NIH HHS [R01 DE016558] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Funke B, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-19; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Mannisto PT, 1999, PHARMACOL REV, V51, P593; MARBACH JJ, 1976, J DENT RES, V55, P711, DOI 10.1177/00220345760550043801; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9; Ogurtsov AY, 2006, BIOINFORMATICS, V22, P1317, DOI 10.1093/bioinformatics/btl083; Oroszi G, 2004, PHARMACOGENOMICS, V5, P1037, DOI 10.1517/14622416.5.8.1037; Puga I, 2005, ENDOCRINOLOGY, V146, P2210, DOI 10.1210/en.2004-1366; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; SCHMITTGEN TD, 1994, J BIOL CHEM, V269, P16269; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shalev A, 2002, ENDOCRINOLOGY, V143, P2541, DOI 10.1210/en.143.7.2541; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; Winterer G, 2003, BRAIN RES REV, V43, P134, DOI 10.1016/S0165-0173(03)00205-4; Yampolsky LY, 2005, HUM MOL GENET, V14, P3191, DOI 10.1093/hmg/ddi350; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	681	782	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1930	1933		10.1126/science.1131262	http://dx.doi.org/10.1126/science.1131262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185601				2022-12-01	WOS:000242996800050
J	Danilczyk, U; Sarao, R; Remy, C; Benabbas, C; Stange, G; Richter, A; Arya, S; Pospisilik, JA; Singer, D; Camargo, SMR; Makrides, V; Ramadan, T; Verrey, F; Wagner, CA; Penninger, JM				Danilczyk, Ursula; Sarao, Renu; Remy, Christine; Benabbas, Chahira; Stange, Gerti; Richter, Andreas; Arya, Sudha; Pospisilik, J. Andrew; Singer, Dustin; Camargo, Simone M. R.; Makrides, Victoria; Ramadan, Tamara; Verrey, Francois; Wagner, Carsten A.; Penninger, Josef M.			Essential role for collectrin in renal amino acid transport	NATURE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; KIDNEY; ACE2	Angiotensin-converting enzyme 2 (ACE2) is a regulator of the renin angiotensin system involved in acute lung failure, cardiovascular functions and severe acute respiratory syndrome (SARS) infections in mammals(1-3). A gene encoding a homologue to ACE2, termed collectrin (Tmem27), has been identified in immediate proximity to the ace2 locus(4). The in vivo function of collectrin was unclear. Here we report that targeted disruption of collectrin in mice results in a severe defect in renal amino acid uptake owing to downregulation of apical amino acid transporters in the kidney. Collectrin associates with multiple apical transporters and defines a novel group of renal amino acid transporters. Expression of collectrin in Xenopus oocytes and Madin-Darby canine kidney (MDCK) cells enhances amino acid transport by the transporter B-0 AT1. These data identify collectrin as a key regulator of renal amino acid uptake.	Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; Univ Vienna, Ctr Ecol, Dept chem Ecol & Ecosyst Res, A-1090 Vienna, Austria; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Vienna; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Penninger, JM (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	wagnerca@access.unizh.ch; josef.penninger@imba.oeaw.ac.at	makrides, victoria/GSN-6210-2022; Richter, Andreas/D-8483-2012; Penninger, Josef M/I-6860-2013	Richter, Andreas/0000-0003-3282-4808; Penninger, Josef M/0000-0002-8194-3777; Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824				Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Bauch C, 2003, J BIOL CHEM, V278, P1316, DOI 10.1074/jbc.M210449200; Bergeron A, 2003, M S-MED SCI, V19, P976, DOI 10.1051/medsci/20031910976; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Camargo SMR, 2005, PFLUG ARCH EUR J PHY, V451, P338, DOI 10.1007/s00424-005-1455-x; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Endo F, 2003, J NUTR, V133, p2063S, DOI 10.1093/jn/133.6.2063S; Feliubadalo L, 2003, HUM MOL GENET, V12, P2097, DOI 10.1093/hmg/ddg228; FOMEO E, 2006, AM J PHYSIOL-RENAL, V290, pF376; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; KENNY AJ, 1982, PHYSIOL REV, V62, P91, DOI 10.1152/physrev.1982.62.1.91; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; KOWALCZUK S, 2005, BIOCH J MAR, V15, P417; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; MALATHI P, 1979, BIOCHIM BIOPHYS ACTA, V554, P259, DOI 10.1016/0005-2736(79)90023-3; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Ristic Z, 2006, AM J PHYSIOL-RENAL, V290, pF880, DOI 10.1152/ajprenal.00319.2005; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Verrey F, 2005, ANNU REV PHYSIOL, V67, P557, DOI 10.1146/annurev.physiol.67.031103.153949; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; Zhang H, 2001, J BIOL CHEM, V276, P17132, DOI 10.1074/jbc.M006723200	23	160	164	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1088	1091		10.1038/nature05475	http://dx.doi.org/10.1038/nature05475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17167413				2022-12-01	WOS:000242971100060
J	Kuba, H; Ishii, TM; Ohmori, H				Kuba, Hiroshi; Ishii, Takahiro M.; Ohmori, Harunori			Axonal site of spike initiation enhances auditory coincidence detection	NATURE			English	Article							ACTION-POTENTIAL INITIATION; CEREBELLAR PURKINJE NEURONS; NUCLEUS LAMINARIS; BRAIN-STEM; SYNAPTIC DEPRESSION; PYRAMIDAL NEURONS; TIME DIFFERENCES; BARN OWL; CHICKEN; SOUND	Neurons initiate spikes in the axon initial segment or at the first node in the axon(1-4). However, it is not yet understood how the site of spike initiation affects neuronal activity and function. In nucleus laminaris of birds, neurons behave as coincidence detectors for sound source localization and encode interaural time differences (ITDs) separately at each characteristic frequency (CF)(5-7). Here we show, in nucleus laminaris of the chick, that the site of spike initiation in the axon is arranged at a distance from the soma, so as to achieve the highest ITD sensitivity at each CF. Na+ channels were not found in the soma of high-CF (2.5-3.3 kHz) and middle-CF (1.0-2.5 kHz) neurons but were clustered within a short segment of the axon separated by 20-50 mu m from the soma; in low-CF (0.4-1.0 kHz) neurons they were clustered in a longer stretch of the axon closer to the soma. Thus, neurons initiate spikes at a more remote site as the CF of neurons increases. Consequently, the somatic amplitudes of both orthodromic and antidromic spikes were small in high-CF and middle-CF neurons and were large in low-CF neurons. Computer simulation showed that the geometry of the initiation site was optimized to reduce the threshold of spike generation and to increase the ITD sensitivity at each CF. Especially in high-CF neurons, a distant localization of the spike initiation site improved the ITD sensitivity because of electrical isolation of the initiation site from the soma and dendrites, and because of reduction of Na+-channel inactivation by attenuating the temporal summation of synaptic potentials through the low-pass filtering along the axon.	Kyoto Univ, Fac Med, Dept Physiol, Kyoto 6068501, Japan	Kyoto University	Ohmori, H (corresponding author), Kyoto Univ, Fac Med, Dept Physiol, Kyoto 6068501, Japan.	ohmori@nbiol.med.kyoto-u.ac.jp	Kuba, Hiroshi/I-7519-2014	Ohmori, Harunori/0000-0002-4319-4947				Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; CARR CE, 1993, BRAIN RES, V628, P330, DOI 10.1016/0006-8993(93)90975-S; CARR CE, 1990, J NEUROSCI, V10, P3227; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; Kuba H, 2003, J PHYSIOL-LONDON, V552, P611, DOI 10.1113/jphysiol.2003.041574; Kuba H, 2002, J PHYSIOL-LONDON, V540, P529, DOI 10.1113/jphysiol.2001.013365; Kuba H, 2002, EUR J NEUROSCI, V15, P984, DOI 10.1046/j.1460-9568.2002.01933.x; Kuba H, 2005, J NEUROSCI, V25, P1924, DOI 10.1523/JnEUROSCI.4428-04.2005; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Pena JL, 1996, J NEUROSCI, V16, P7046; Rasband MN, 2000, J PHYSIOL-LONDON, V525, P63, DOI 10.1111/j.1469-7793.2000.00063.x; Rathouz M, 1998, J NEUROPHYSIOL, V80, P2824, DOI 10.1152/jn.1998.80.6.2824; Reyes AD, 1996, J NEUROSCI, V16, P993; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; RUBEL EW, 1975, J COMP NEUROL, V164, P411, DOI 10.1002/cne.901640403; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Simon JZ, 1999, NEUROCOMPUTING, V26-7, P263, DOI 10.1016/S0925-2312(99)00020-X; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Yamada R, 2005, J NEUROSCI, V25, P8867, DOI 10.1523/JNEUROSCI.2541-05.2005	28	158	158	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1069	1072		10.1038/nature05347	http://dx.doi.org/10.1038/nature05347			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17136099				2022-12-01	WOS:000242971100056
J	Seelig, G; Soloveichik, D; Zhang, DY; Winfree, E				Seelig, Georg; Soloveichik, David; Zhang, David Yu; Winfree, Erik			Enzyme-free nucleic acid logic circuits	SCIENCE			English	Article							GENE-EXPRESSION; ALLOSTERIC RIBOZYMES; DNA; RIBOREGULATORS; MACHINE	Biological organisms perform complex information processing and control tasks using sophisticated biochemical circuits, yet the engineering of such circuits remains ineffective compared with that of electronic circuits. To systematically create complex yet reliable circuits, electrical engineers use digital logic, wherein gates and subcircuits are composed modularly and signal restoration prevents signal degradation. We report the design and experimental implementation of DNA-based digital logic circuits. We demonstrate AND, OR, and NOT gates, signal restoration, amplification, feedback, and cascading. Gate design and circuit construction is modular. The gates use single-stranded nucleic acids as inputs and outputs, and the mechanism relies exclusively on sequence recognition and strand displacement. Biological nucleic acids such as microRNAs can serve as inputs, suggesting applications in biotechnology and bioengineering.	CALTECH, Dept Computat & Neural Syst, Pasadena, CA 91125 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; CALTECH, Dept Comp Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Winfree, E (corresponding author), CALTECH, Dept Computat & Neural Syst, Pasadena, CA 91125 USA.	winfree@caltech.edu	Winfree, Erik/L-4002-2013	Winfree, Erik/0000-0002-5899-7523				Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Hagiya M, 2006, NAT COMP SER, P293, DOI 10.1007/3-540-30296-4_18; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; LEE CS, 1970, J MOL BIOL, V48, P1, DOI 10.1016/0022-2836(70)90215-9; Levy M, 2003, P NATL ACAD SCI USA, V100, P6416, DOI 10.1073/pnas.1130145100; MULLER DE, 1963, ASYNCHRONOUS LOGICS, P289; Penchovsky R, 2005, NAT BIOTECHNOL, V23, P1424, DOI 10.1038/nbt1155; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Seelig G, 2006, J AM CHEM SOC, V128, P12211, DOI 10.1021/ja0635635; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Von Neumann J., 1956, ANN MATH STUD, V34, P43; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Yurke B, 1999, BIOSYSTEMS, V52, P165, DOI 10.1016/S0303-2647(99)00043-X	22	1029	1106	30	519	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1585	1588		10.1126/science.1132493	http://dx.doi.org/10.1126/science.1132493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158324				2022-12-01	WOS:000242624600038
J	Sick, S; Reinker, S; Timmer, J; Schlake, T				Sick, Stefanie; Reinker, Stefan; Timmer, Jens; Schlake, Thomas			WNT and DKK determine hair follicle spacing through a reaction-diffusion mechanism	SCIENCE			English	Article							BETA-CATENIN; EXPRESSION; PATHWAY; TARGET; MICE; SKIN; MORPHOGENESIS; TRANSCRIPTION; TOOTH; LEF1	Mathematical reaction-diffusion models have been suggested to describe formation of animal pigmentation patterns and distribution of epidermal appendages. However, the crucial signals and in vivo mechanisms are still elusive. Here we identify WNT and its inhibitor DKK as primary determinants of murine hair follicle spacing, using a combined experimental and computational modeling approach. Transgenic DKK overexpression reduces overall appendage density. Moderate suppression of endogenous WNT signaling forces follicles to form clusters during an otherwise normal morphogenetic program. These results confirm predictions of a WNT/DKK-specific mathematical model and provide in vivo corroboration of the reaction-diffusion mechanism for epidermal appendage formation.	Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany	Max Planck Society; University of Freiburg	Schlake, T (corresponding author), Max Planck Inst Immunbiol, Stubeweg 51, D-79108 Freiburg, Germany.	schlake@immunbio.mpg.de						Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Atit R, 2003, DEV CELL, V4, P231, DOI 10.1016/S1534-5807(03)00021-2; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chang CH, 2004, MECH DEVELOP, V121, P157, DOI 10.1016/j.mod.2003.12.004; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Dry FW, 1926, J GENET, V16, P287, DOI 10.1007/BF02983004; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Nonchev S, 1996, DEVELOPMENT, V122, P543; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	25	409	456	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1447	1450		10.1126/science.1130088	http://dx.doi.org/10.1126/science.1130088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17082421				2022-12-01	WOS:000242406100040
J	Yusupova, G; Jenner, L; Rees, B; Moras, D; Yusupov, M				Yusupova, Gulnara; Jenner, Lasse; Rees, Bernard; Moras, Dino; Yusupov, Marat			Structural basis for messenger RNA movement on the ribosome	NATURE			English	Article							ANGSTROM RESOLUTION; ESCHERICHIA-COLI; TRANSLATION INITIATION; CRYSTAL-STRUCTURES; BINDING SITE; SUBUNIT; SEQUENCES; CODON	Translation initiation is a major determinant of the overall expression level of a gene(1 - 3). The translation of functionally active protein requires the messenger RNA to be positioned on the ribosome such that the start/ initiation codon will be read first and in the correct frame. Little is known about the molecular basis for the interaction of mRNA with the ribosome at different states of translation. Recent crystal structures of the ribosomal subunits(4 - 8), the empty 70S ribosome(9) and the 70S ribosome containing functional ligands(10 - 13) have provided information about the general organization of the ribosome and its functional centres. Here we compare the X- ray structures of eight ribosome complexes modelling the translation initiation, post- initiation and elongation states. In the initiation and post- initiation complexes, the presence of the Shine - Dalgarno ( SD) duplex causes strong anchoring of the 5' end of mRNA onto the platform of the 30S subunit, with numerous interactions between mRNA and the ribosome. Conversely, the 5' end of the ' elongator' mRNA lacking SD interactions is flexible, suggesting a different exit path for mRNA during elongation. After the initiation of translation, but while an SD interaction is still present, mRNA moves in the 3' -->5' direction with simultaneous clockwise rotation and lengthening of the SD duplex, bringing it into contact with ribosomal protein S2.	Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Yusupov, M (corresponding author), Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.	marat@titus.u-strasbg.fr	Yusupov, Marat/I-6126-2013; Yusupova, Gulnara/E-1877-2014; Jenner, Lasse/H-1584-2017	Yusupov, Marat/0000-0001-5544-0597; Jenner, Lasse/0000-0003-3917-8853				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CANONACO MA, 1989, EUR J BIOCHEM, V182, P501, DOI 10.1111/j.1432-1033.1989.tb14856.x; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DRAPER DE, 1996, ESCHERICHIA COLI SAL, P902; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Jenner L, 2005, SCIENCE, V308, P120, DOI 10.1126/science.1105639; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; LATEANA A, 1995, RNA, V1, P772; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rees B, 2005, ACTA CRYSTALLOGR D, V61, P1299, DOI [10.1107/S0907444905019591, 10.1107/S0904777905019591]; RINGQUIST S, 1992, MOL MICROBIOL, V6, P1219, DOI 10.1111/j.1365-2958.1992.tb01561.x; RINKEAPPEL J, 1994, NUCLEIC ACIDS RES, V22, P3018, DOI 10.1093/nar/22.15.3018; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SCHURR T, 1993, NUCLEIC ACIDS RES, V21, P4019, DOI 10.1093/nar/21.17.4019; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	25	203	210	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					391	394		10.1038/nature05281	http://dx.doi.org/10.1038/nature05281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17051149				2022-12-01	WOS:000242018300054
J	Aury, JM; Jaillon, O; Duret, L; Noel, B; Jubin, C; Porcel, BM; Segurens, B; Daubin, V; Anthouard, V; Aiach, N; Arnaiz, O; Billaut, A; Beisson, J; Blanc, I; Bouhouche, K; Camara, F; Duharcourt, S; Guigo, R; Gogendeau, D; Katinka, M; Keller, AM; Kissmehl, R; Klotz, C; Koll, F; Le Mouel, A; Lepere, G; Malinsky, S; Nowacki, M; Nowak, JK; Plattner, H; Poulain, J; Ruiz, F; Serrano, V; Zagulski, M; Dessen, P; Betermier, M; Weissenbach, J; Scarpelli, C; Schachter, V; Sperling, L; Meyer, E; Cohen, J; Wincker, P				Aury, Jean-Marc; Jaillon, Olivier; Duret, Laurent; Noel, Benjamin; Jubin, Claire; Porcel, Betina M.; Segurens, Beatrice; Daubin, Vincent; Anthouard, Veronique; Aiach, Nathalie; Arnaiz, Olivier; Billaut, Alain; Beisson, Janine; Blanc, Isabelle; Bouhouche, Khaled; Camara, Francisco; Duharcourt, Sandra; Guigo, Roderic; Gogendeau, Delphine; Katinka, Michael; Keller, Anne-Marie; Kissmehl, Roland; Klotz, Catherine; Koll, France; Le Mouel, Anne; Lepere, Gersende; Malinsky, Sophie; Nowacki, Mariusz; Nowak, Jacek K.; Plattner, Helmut; Poulain, Julie; Ruiz, Francoise; Serrano, Vincent; Zagulski, Marek; Dessen, Philippe; Betermier, Mireille; Weissenbach, Jean; Scarpelli, Claude; Schaechter, Vincent; Sperling, Linda; Meyer, Eric; Cohen, Jean; Wincker, Patrick			Global trends of whole-genome duplications revealed by the ciliate Paramecium tetraurelia	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; YEAST GENOME; GENE; EVOLUTION; ARABIDOPSIS; EUKARYOTES; SEQUENCES; ELIMINATION	The duplication of entire genomes has long been recognized as having great potential for evolutionary novelties, but the mechanisms underlying their resolution through gene loss are poorly understood. Here we show that in the unicellular eukaryote Paramecium tetraurelia, a ciliate, most of the nearly 40,000 genes arose through at least three successive whole-genome duplications. Phylogenetic analysis indicates that the most recent duplication coincides with an explosion of speciation events that gave rise to the P. aurelia complex of 15 sibling species. We observed that gene loss occurs over a long timescale, not as an initial massive event. Genes from the same metabolic pathway or protein complex have common patterns of gene loss, and highly expressed genes are over-retained after all duplications. The conclusion of this analysis is that many genes are maintained after whole-genome duplication not because of functional innovation but because of gene dosage constraints.	Genoscope, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Ecole Normale Super, Genet Mol Lab, CNRS, UMR 8541, F-75005 Paris, France; Univ Pompeu Fabra, Ctr Genom Regulat, Inst Municipal Invest Med, Barcelona, Catalonia, Spain; Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Polish Acad Sci, Inst Biochem & Biophys, DNA Sequencing Lab, PL-02106 Warsaw, Poland; Inst Gustave Roussy, Lab Genomes & Canc, FRE 2939, CNRS, F-94805 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Konstanz; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy	Wincker, P (corresponding author), Genoscope, 2 Rue Gaston Cremieux,CP5706, F-91057 Evry, France.	pwincker@genoscope.cns.fr	Aury, Jean-Marc/N-1621-2019; Nowacki, Mariusz/E-4485-2011; Jaillon, Olivier/GRY-6287-2022; Guigo, Roderic/D-1303-2010; Ferreira, Francisco Câmara/G-9841-2015; Duharcourt, Sandra/ABD-4460-2020; Bouhouche, khaled/AGR-4456-2022; Sperling, Linda/C-9734-2014	Aury, Jean-Marc/0000-0003-1718-3010; Nowacki, Mariusz/0000-0003-4894-2905; Guigo, Roderic/0000-0002-5738-4477; Ferreira, Francisco Câmara/0000-0002-1971-5466; Duharcourt, Sandra/0000-0002-8913-8799; Jaillon, Olivier/0000-0002-7237-9596; Poulain, Julie/0000-0002-8744-3116; Sperling, Linda/0000-0002-7772-4774; Betermier, Mireille/0000-0002-5407-6292; Porcel, Betina/0000-0003-0169-5302; Daubin, Vincent/0000-0001-8269-9430; Duret, Laurent/0000-0003-2836-3463; ARNAIZ, Olivier/0000-0002-9626-1015; Noel, Benjamin/0000-0002-5830-3253; lepere, gersende/0000-0002-4609-7587; Meyer, Eric/0000-0002-3161-8597; Nowak, Jacek/0000-0003-2569-4080				Andalis AA, 2004, GENETICS, V167, P1109, DOI 10.1534/genetics.104.029256; BERGER JD, 1978, J CELL BIOL, V76, P116, DOI 10.1083/jcb.76.1.116; Betermier M, 2004, RES MICROBIOL, V155, P399, DOI 10.1016/j.resmic.2004.01.017; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Coleman AW, 2005, J EUKARYOT MICROBIOL, V52, P68, DOI 10.1111/j.1550-7408.2005.3327r.x; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; de Loubresse NG, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-4; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dubrana K, 2000, CHROMOSOMA, V109, P460, DOI 10.1007/s004120000108; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fokin SI, 2004, EUR J PROTISTOL, V40, P225, DOI 10.1016/j.ejop.2004.02.001; Force A, 1999, GENETICS, V151, P1531; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Howe KL, 2002, GENOME RES, V12, P1418, DOI 10.1101/gr.149502; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Le Mouel A, 2003, EUKARYOT CELL, V2, P1076, DOI 10.1128/EC.2.5.1076-1090.2003; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Ruiz F, 2000, CURR BIOL, V10, P1451, DOI 10.1016/S0960-9822(00)00804-6; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Sonneborn TM, 1974, HDB GENETICS PLANTS, V2, P469, DOI DOI 10.1007/978-1-4684-2994-7_20; Veitia RA, 2005, PLANT CELL, V17, P4, DOI 10.1105/tpc.104.170130; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zagulski M, 2004, CURR BIOL, V14, P1397, DOI 10.1016/j.cub.2004.07.029	48	597	677	3	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					171	178		10.1038/nature05230	http://dx.doi.org/10.1038/nature05230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17086204	hybrid, Green Published			2022-12-01	WOS:000241867200033
J	Friedman, A; Perrimon, N				Friedman, Adam; Perrimon, Norbert			A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling	NATURE			English	Article							MAP KINASE; DROSOPHILA; PROTEIN; PATHWAY; RAS; PHOSPHATASE; ACTIVATION; CANCER; PHOSPHORYLATION; PROGRESSION	Receptor tyrosine kinase (RTK) signalling through extracellular-signal-regulated kinases ( ERKs) has pivotal roles during metazoan development, underlying processes as diverse as fate determination, differentiation, proliferation, survival, migration and growth. Abnormal RTK/ERK signalling has been extensively documented to contribute to developmental disorders and disease, most notably in oncogenic transformation by mutant RTKs(1) or downstream pathway components such as Ras and Raf(2). Although the core RTK/ERK signalling cassette has been characterized by decades of research using mammalian cell culture and forward genetic screens in model organisms, signal propagation through this pathway is probably regulated by a larger network of moderate, context-specific proteins. The genes encoding these proteins may not have been discovered through traditional screens owing, in particular, to the requirement for visible phenotypes. To obtain a global view of RTK/ERK signalling, we performed an unbiased, RNA interference (RNAi), genome-wide, high-throughput screen in Drosophila cells using a novel, quantitative, cellular assay monitoring ERK activation. Here we show that ERK pathway output integrates a wide array of conserved cellular processes. Further analysis of selected components - in multiple cell types with different RTK ligands and oncogenic stimuli - validates and classifies 331 pathway regulators. The relevance of these genes is highlighted by our isolation of a Ste20-like kinase and a PPM-family phosphatase that seem to regulate RTK/ERK signalling in vivo and in mammalian cells. Novel regulators that modulate specific pathway outputs may be selective targets for drug discovery.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X				Arevolo JC, 2006, J BIOL CHEM, V281, P1001, DOI 10.1074/jbc.M504163200; Asha H, 2003, GENETICS, V163, P203; Baril C, 2006, DEV BIOL, V294, P232, DOI 10.1016/j.ydbio.2006.02.046; Chang FM, 2003, INT J ONCOL, V22, P469; Chen X, 2003, DEV CELL, V4, P179, DOI 10.1016/S1534-5807(03)00024-8; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Gabay L, 1997, DEVELOPMENT, V124, P3535; Halfar K, 2001, DEVELOPMENT, V128, P1687; Hilger RA, 2002, ONKOLOGIE, V25, P511, DOI 10.1159/000068621; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jordan KC, 2005, DEV DYNAM, V232, P709, DOI 10.1002/dvdy.20318; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lipsick JS, 2004, GENE DEV, V18, P2837, DOI 10.1101/gad.1274804; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Roignant JY, 2006, GENE DEV, V20, P795, DOI 10.1101/gad.1390506; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Sung V, 2003, CANCER RES, V63, P3356; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	30	172	176	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					230	234		10.1038/nature05280	http://dx.doi.org/10.1038/nature05280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17086199				2022-12-01	WOS:000241867200046
J	English, CM; Adkins, MW; Carson, JJ; Churchill, MEA; Tyler, JK				English, Christine M.; Adkins, Melissa W.; Carson, Joshua J.; Churchill, Mair E. A.; Tyler, Jessica K.			Structural basis for the histone chaperone activity of Asf1	CELL			English	Article							NUCLEOSOME CORE PARTICLE; ASSEMBLY FACTOR-I; CRYSTAL-STRUCTURE; DNA-REPLICATION; S-PHASE; CHROMATIN; ACTIVATION; DEPOSITION; COMPLEX; H3	Anti-silencing function 1 (Asf1) is a highly conserved chaperone of histones H3/H4 that assembles or disassembles chromatin during transcription, replication, and repair. The structure of the globular domain of Asf1 bound to H3/H4 determined by X-ray crystallography to a resolution of 1.7 angstrom shows how Asf1 binds the H3/H4 heterodimer, enveloping the C terminus of histone H3 and physically blocking formation of the H3/H4 heterotetramer. Unexpectedly, the C terminus of histone H4 that forms a mini-beta sheet with histone H2A in the nucleosome undergoes a major conformational change upon binding to Asf1 and adds a beta strand to the Asf1 0 sheet sandwich. Interactions with both H3 and H4 were required for Asf1 histone chaperone function in vivo and in vitro. The Asf1-H3/H4 structure suggests a "strand-capture" mechanism whereby the H4 tail acts as a lever to facilitate chromatin disassembly/assembly that may be used ubiquitously by histone chaperones.	Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Churchill, MEA (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	mair.churchill@uchsc.edu; jessica.tyler@uchsc.edu	Churchill, Mair E. A./C-5549-2014	Churchill, Mair E. A./0000-0003-0862-235X; Tyler, Jessica/0000-0001-9765-1659	NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079154, R01GM064475] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA095641] Funding Source: Medline; NIGMS NIH HHS [R01 GM079154-01A1, R01 GM079154, GM064475, R01 GM064475] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DeSilva H, 1998, GENETICS, V148, P657; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hansen C, 2003, CURR OPIN STRUC BIOL, V13, P538, DOI 10.1016/j.sbi.2003.09.010; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; MOSS T, 1976, BIOCHEMISTRY-US, V15, P2261, DOI 10.1021/bi00656a003; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Nakatani Y, 2004, COLD SPRING HARB SYM, V69, P273, DOI 10.1101/sqb.2004.69.273; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Namboodiri VMH, 2003, STRUCTURE, V11, P175, DOI 10.1016/S0969-2126(03)00007-8; Padmanabhan B, 2005, J BIOCHEM, V138, P821, DOI 10.1093/jb/mvi182; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Santisteban MS, 1997, EMBO J, V16, P2493, DOI 10.1093/emboj/16.9.2493; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; TAMBURINI B, 2006, GENETICS; Tamburini BA, 2005, EUKARYOT CELL, V4, P1583, DOI 10.1128/EC.4.9.1583-1590.2005; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Xu EY, 2005, MOL CELL BIOL, V25, P1846, DOI 10.1128/MCB.25.5.1846-1859.2005	47	330	337	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					495	508		10.1016/j.cell.2006.08.047	http://dx.doi.org/10.1016/j.cell.2006.08.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081973	Bronze, Green Accepted			2022-12-01	WOS:000241937000015
J	Patel, PR; Larson, AK; Castel, AD; Ganova-Raeva, LM; Myers, RA; Roup, BJ; Farrell, KP; Edwards, L; Nainan, O; Krick, JP; Blythe, D; Fiore, AE; Roche, JC				Patel, Priti R.; Larson, A. Kirsten; Castel, Amanda D.; Ganova-Raeva, Lilia M.; Myers, Robert A.; Roup, Brenda J.; Farrell, Katherine P.; Edwards, Leslie; Nainan, Omana; Krick, John P.; Blythe, David; Fiore, Anthony E.; Roche, Jeffrey C.			Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NOSOCOMIAL TRANSMISSION; COMPOUNDING PHARMACY; UNITED-STATES; OUTBREAK; PREVALENCE; WARD; HCV	Context Nuclear pharmacies prepare radiopharmaceutical products for use in common diagnostic procedures, including myocardial perfusion studies. Hepatitis C virus (HCV) transmission has not been reported previously in the setting of nuclear imaging studies. Objective To investigate an outbreak of acute HCV infection identified among patients who underwent myocardial perfusion studies on October 15, 2004, using an injected radiopharmaceutical. Design, Setting, and Patients Outbreak investigation including molecular epidemiology and pharmacy site investigation at outpatient cardiology clinics and a nuclear pharmacy in Maryland. Ninety patients who received injections drawn from select radiopharmaceutical vials prepared on October 14-15, 2004, at a single nuclear pharmacy were offered testing for bloodborne pathogens. Pharmacy procedures were reviewed and HCV quasi species analysis was performed. Main Outcome Measures Hepatitis C virus infection and quasispecies sequence similarity. Results Sixteen patients with acute HCV infection were identified from 3 separate clinics. All patients received radiopharmaceutical injections drawn from a single pharmacy vial ( vial 1). None of the 59 tested patients who received doses from 6 other vials had acute HCV infection. Blood from a potential source patient with HCV and human immunodeficiency virus (HIV) infection was processed for a radiolabeled white blood cell study in the pharmacy 12 hours before vial 1 was prepared. The HCV quasispecies sequences from this potential source patient were nearly identical to those from cases (97.8%-98.5% similarity). No acute HIV infections were identified. Pharmacy practices that could have led to blood cross-contamination included reuse of needles and syringes during dilutions and use of common flow hoods for some steps in the preparation of sterile and blood-derived products. Conclusions Sixteen persons acquired HCV infection from a blood-contaminated radiopharmaceutical. The source and practices that could have facilitated breaks in aseptic technique were identified at the pharmacy. Nuclear pharmacies that handle biological products should follow appropriate aseptic technique to prevent contamination of sterile radiopharmaceuticals.	Ctr Dis Control & Prevent, Off Workforce & Career Dev, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; Anne Arundel Cty Dept Hlth, Annapolis, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene	Patel, PR (corresponding author), Ctr Dis Control & Prevent, Off Workforce & Career Dev, 1600 Clifton Rd,MS A-31, Atlanta, GA 30333 USA.	ppatel@cdc.gov	Fiore, Anthony/AAO-8956-2020					Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; *AM PHARM ASS SECT, NUCL PHARM COMP GUID; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P269; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Callahan RJ, 1996, SEMIN NUCL MED, V26, P85, DOI 10.1016/S0001-2998(96)80029-8; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P1109; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P901; Ciesielski Carol A., 1997, American Journal of Medicine, V102, P115, DOI 10.1016/S0002-9343(97)00076-4; Civen R, 2006, CLIN INFECT DIS, V43, P831, DOI 10.1086/507336; Cody SH, 2002, ARCH INTERN MED, V162, P345, DOI 10.1001/archinte.162.3.345; Comstock RD, 2004, INFECT CONT HOSP EP, V25, P576, DOI 10.1086/502442; de Oliveira AM, 2005, ANN INTERN MED, V142, P898, DOI 10.7326/0003-4819-142-11-200506070-00007; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Forns X, 2005, HEPATOLOGY, V41, P115, DOI 10.1002/hep.20515; Furusyo N, 2004, INFECT CONT HOSP EP, V25, P584, DOI 10.1086/502443; Held MR, 2006, PEDIATRICS, V118, pE212, DOI 10.1542/peds.2005-2617; Janowski MC, 2005, INF DIS SOC AM 43 AN; Kastango Eric S Mba Rph Fashp, 2002, Int J Pharm Compd, V6, P404; Kastango ES, 2004, AM J HEALTH-SYST PH, V61, P1928, DOI 10.1093/ajhp/61.18.1928; Krause G, 2003, INFECT CONT HOSP EP, V24, P122, DOI 10.1086/502176; KRAWCZYNSKI K, 2003, 54 ANN M AM SOC STUD; Lagging LM, 2002, SCAND J INFECT DIS, V34, P580, DOI 10.1080/00365540110080926; Massari M, 2001, J CLIN MICROBIOL, V39, P2860, DOI 10.1128/JCM.39.8.2860-2863.2001; *MED INF DIV IMV, 2005 NUCL MED MARK S; Morris AM, 2003, AM J HEALTH-SYST PH, V60, P2567, DOI 10.1093/ajhp/60.24.2567; National Association of Boards of Pharmacy, MOD STAT PHARM ACT M; Newton DW, 2003, AM J PHARM EDUC, V67, P12; Pegues DA, 2006, CLIN INFECT DIS, V43, P838, DOI 10.1086/507341; Perz JF, 2005, J CLIN MICROBIOL, V43, P5316, DOI 10.1128/JCM.43.10.5316-5318.2005; *PURD U DIV NUCL P, LIST NUCL PHARM US; Ridzon R, 1997, NEW ENGL J MED, V336, P919, DOI 10.1056/NEJM199703273361304; Sabra K, 2003, AM J HEALTH-SYST PH, V60, P1593, DOI 10.1093/ajhp/60.15.1593; Silini E, 2002, HAEMATOLOGICA, V87, P1200; SUNENSHINE RH, 2005, INF DIS SOC AM 43 AN; Trissel LA, 2003, AM J HEALTH-SYST PH, V60, P432, DOI 10.1093/ajhp/60.5.432; United States Pharmacopeia Inc, 2004, PHARM COMP STER PREP, P2461; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935; Young D, 2003, AM J HEALTH-SYST PH, V60, P2402, DOI 10.1093/ajhp/60.23.2402; Young D, 2002, AM J HEALTH-SYST PH, V59, P2261, DOI 10.1093/ajhp/59.23.2261	41	45	48	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					2005	2011		10.1001/jama.296.16.2005	http://dx.doi.org/10.1001/jama.296.16.2005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098BL	17062864				2022-12-01	WOS:000241495300023
J	Halme, DG; Kessler, DA				Halme, Dina Gould; Kessler, David A.			FDA regulation of stem-cell-based therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION; FEEDERS; LINES		Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Halme, DG (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.							Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; BACH FH, 1968, LANCET, V2, P1364; *DEP HLTH HUM SERV, MED PRIV NAT STAND P; Food and Drug Administration, 2003, GUID REV INSTR TEMPL; *FOOD DRUG ADM, 2006, INDS APPR COMPL CGMP; *FOOD DRUG ADM, 2001, PHS GUID INF DIS ISS; *FOOD DRUG ADM, 1993, FED RED, V58, P53248; *FOOD DRUG ADM, 2004, GUID IND EL DET DON; GATTI RA, 1968, LANCET, V2, P1366; Genbacev O, 2005, FERTIL STERIL, V83, P1517, DOI 10.1016/j.fertnstert.2005.01.086; Holden C, 2002, SCIENCE, V297, P1647; KESSLER DA, 1993, NEW ENGL J MED, V329, P1169, DOI 10.1056/NEJM199310143291607; Lanza R., 2004, HDB STEM CELLS 2 VOL, V2; Lawrenz B, 2004, CYTOTHERAPY, V6, P212, DOI 10.1080/14653240410006031; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lo B, 2005, STEM CELLS, V23, P1454, DOI 10.1634/stemcells.2005-0324; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; National Institutes of Health, 2001, STEM CELLS SCI PROGR; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Thomson JA, 1998, SCIENCE, V282, P1827; U.S. FOOD & DRUG ADMIN, 1997, PROPOSED APPROACH RE, P19	22	276	296	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1730	1735		10.1056/NEJMhpr063086	http://dx.doi.org/10.1056/NEJMhpr063086			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	096DN	17050899				2022-12-01	WOS:000241357300017
J	Okie, S				Okie, Susan			Single-cell storm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		MANNIES J, 2006, ST LOUIS POST D 0907, pD3; Smith JO, 2006, NAT BIOTECHNOL, V24, P391, DOI 10.1038/nbt0406-391	2	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1634	1637		10.1056/NEJMp068224	http://dx.doi.org/10.1056/NEJMp068224			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050885				2022-12-01	WOS:000241357300002
J	Huang, HJ; Regan, KM; Lou, ZK; Chen, JJ; Tindall, DJ				Huang, Haojie; Regan, Kevin M.; Lou, Zhenkun; Chen, Junjie; Tindall, Donald J.			CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage	SCIENCE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; CELL-CYCLE REGULATION; PROSTATE-CANCER; CHECKPOINT; INSTABILITY; ACTIVATION; EXPRESSION; SURVIVAL; KINASE; LIGAND	The function of cyclin-dependent kinase 2 (CDK2) is often abolished after DNA damage. The inhibition of CDK2 plays a central role in DNA damage - induced cell cycle arrest and DNA repair. However, whether CDK2 also influences the survival of cells under genotoxic stress is unknown. Forkhead box O (FOXO) transcription factors are emerging as key regulators of cell survival. CDK2 specifically phosphorylated FOXO1 at serine-249 (Ser(249)) in vitro and in vivo. Phosphorylation of Ser249 resulted in cytoplasmic localization and inhibition of FOXO1. This phosphorylation was abrogated upon DNA damage through the cell cycle checkpoint pathway that is dependent on the protein kinases Chk1 and Chk2. Moreover, silencing of FOXO1 by small interfering RNA diminished DNA damage - induced death in both p53-deficient and p53-proficient cells. This effect was reversed by restored expression of FOXO1 in a manner depending on phosphorylation of Ser249. Functional interaction between CDK2 and FOXO1 provides a mechanism that regulates apoptotic cell death after DNA strand breakage.	Mayo Clin Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Urol, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Oncol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Tindall, DJ (corresponding author), Mayo Clin Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	tindall.donald@mayo.edu			NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060920, R01DK065236] Funding Source: NIH RePORTER; NCI NIH HHS [CA91956] Funding Source: Medline; NIDDK NIH HHS [DK65236, DK60920] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chatterjee D, 2001, CANCER RES, V61, P7148; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fan R, 2004, CANCER RES, V64, P8526, DOI 10.1158/0008-5472.CAN-04-1601; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Paquet C, 2004, APOPTOSIS, V9, P815, DOI 10.1023/B:APPT.0000045791.55282.91; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836	20	265	273	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					294	297		10.1126/science.1130512	http://dx.doi.org/10.1126/science.1130512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038621				2022-12-01	WOS:000241194100040
J	Haag-Liautard, C; Dorris, M; Maside, X; Macaskill, S; Halligan, DL; Charlesworth, B; Keightley, PD				Haag-Liautard, Cathy; Dorris, Mark; Maside, Xulio; Macaskill, Steven; Halligan, Daniel L.; Charlesworth, Brian; Keightley, Peter D.			Direct estimation of per nucleotide and genomic deleterious mutation rates in Drosophila	NATURE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; EVOLUTION; RECOMBINATION; ACCUMULATION; FITNESS; DNA; INSERTIONS; SEX	Spontaneous mutations are the source of genetic variation required for evolutionary change, and are therefore important for many aspects of evolutionary biology. For example, the divergence between taxa at neutrally evolving sites in the genome is proportional to the per nucleotide mutation rate, u (ref. 1), and this can be used to date speciation events by assuming a molecular clock. The overall rate of occurrence of deleterious mutations in the genome each generation (U) appears in theories of nucleotide divergence and polymorphism(2), the evolution of sex and recombination(3), and the evolutionary consequences of inbreeding(2). However, estimates of U based on changes in allozymes(4) or DNA sequences(5) and fitness traits are discordant(6-8). Here we directly estimate u in Drosophila melanogaster by scanning 20 million bases of DNA from three sets of mutation accumulation lines by using denaturing high-performance liquid chromatography(9). From 37 mutation events that we detected, we obtained a mean estimate for u of 8.4 x 10(-9) per generation. Moreover, we detected significant heterogeneity in u among the three mutation-accumulation-line genotypes. By multiplying u by an estimate of the fraction of mutations that are deleterious in natural populations of Drosophila(10), we estimate that U is 1.2 per diploid genome. This high rate suggests that selection against deleterious mutations may have a key role in explaining patterns of genetic variation in the genome, and help to maintain recombination and sexual reproduction.	Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Keightley, PD (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	keightley.drosmutrate@spambob.net	Maside, Xulio/AAA-6551-2019; Maside, Xulio/AAU-8864-2020; Halligan, Daniel/H-4459-2011	Halligan, Daniel/0000-0003-4726-6343; Maside, Xulio/0000-0002-4494-8616	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Crow J.F., 1983, Genetics and Biology of Drosophila, V3c, P1; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Dobson-Stone C, 2000, EUR J HUM GENET, V8, P24, DOI 10.1038/sj.ejhg.5200409; Fernandez J, 1996, GENETICS, V143, P829; Fry JD, 2004, GENETICS, V166, P797, DOI 10.1534/genetics.166.2.797; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Houle D, 2004, GENET RES, V83, P7, DOI 10.1017/S0016672303006505; Keightley PD, 1999, GENETICS, V153, P515; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; Kimura M., 1983, NEUTRAL THEORY MOL E; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Loewe L, 2006, BIOL LETTERS, V2, P426, DOI 10.1098/rsbl.2006.0481; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Maside X, 2001, GENET RES, V78, P121, DOI 10.1017/S0016672301005201; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; MUKAI T, 1977, P NATL ACAD SCI USA, V74, P2514, DOI 10.1073/pnas.74.6.2514; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; Oefner PJ, 2002, J CHROMATOGR B, V782, P27, DOI 10.1016/S1570-0232(02)00700-6; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Ravnik-Glavac M, 2002, HUM MUTAT, V19, P374, DOI 10.1002/humu.10065; Salathe M, 2006, ECOL LETT, V9, P941, DOI 10.1111/j.1461-0248.2006.00942.x; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; WOODRUFF RC, 1984, HEREDITY, V53, P223, DOI 10.1038/hdy.1984.78	30	280	282	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					82	85		10.1038/nature05388	http://dx.doi.org/10.1038/nature05388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17203060				2022-12-01	WOS:000243225100040
J	Gavin, AL; Hoebe, K; Duong, B; Ota, T; Martin, C; Beutler, B; Nemazee, D				Gavin, Amanda L.; Hoebe, Kasper; Duong, Bao; Ota, Takayuki; Martin, Christopher; Beutler, Bruce; Nemazee, David			Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling	SCIENCE			English	Article							ACTIVATE B-CELLS; INTERFERON-GAMMA; HOST-RESISTANCE; ENGAGEMENT; IMMUNITY; PATHWAY; MICE	Innate immune signals mediated by Toll-like receptors (TLRs) have been thought to contribute considerably to the antibody-enhancing effects of vaccine adjuvants. However, we report here that mice deficient in the critical signaling components for TLR mount robust antibody responses to T cell-dependent antigen given in four typical adjuvants: alum, Freund's complete adjuvant, Freund's incomplete adjuvant, and monophosphoryl-lipid A/trehalose dicorynomycolate adjuvant. We conclude that TLR signaling does not account for the action of classical adjuvants and does not fully explain the action of a strong adjuvant containing a TLR ligand. This may have important implications in the use and development of vaccine adjuvants.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Kellogg Sch Sci & Technol, Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Nemazee, D (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nemazee@scripps.edu	Ota, Takayuki/Q-5528-2017	Ota, Takayuki/0000-0001-6249-0664; Hoebe, Kasper/0000-0002-3626-8098	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007606, R01AI050241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044809] Funding Source: NIH RePORTER; NIAID NIH HHS [T32AI07606, AI050241] Funding Source: Medline; NIGMS NIH HHS [R01GM44809, R01 GM044809] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON J, 1972, TRANSPLANT REV-DENMA, V11, P131; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; FINKELMAN FD, 1991, J EXP MED, V174, P1179, DOI 10.1084/jem.174.5.1179; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Janssen E, 2006, IMMUNITY, V24, P787, DOI 10.1016/j.immuni.2006.03.024; Kaisho T, 2002, INT IMMUNOL, V14, P695, DOI 10.1093/intimm/dxf039; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Nemazee D, 2006, NATURE, V441, pE4, DOI 10.1038/nature04875; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1992, J EXP MED, V175, P1367, DOI 10.1084/jem.175.5.1367; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	17	452	467	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1936	1938		10.1126/science.1135299	http://dx.doi.org/10.1126/science.1135299			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185603	Green Accepted			2022-12-01	WOS:000242996800052
J	Ahmed, MF; Ahuja, S; Alauddin, M; Hug, SJ; Lloyd, JR; Pfaff, A; Pichler, T; Saltikov, C; Stute, M; van Geen, A				Ahmed, M. F.; Ahuja, S.; Alauddin, M.; Hug, S. J.; Lloyd, J. R.; Pfaff, A.; Pichler, T.; Saltikov, C.; Stute, M.; van Geen, A.			Epidemiology - Ensuring safe drinking water in Bangladesh	SCIENCE			English	Editorial Material							CHILDRENS INTELLECTUAL FUNCTION; GROUNDWATER DYNAMICS; WEST-BENGAL; ARAIHAZAR; EXPOSURE; RELIABILITY; AQUIFERS; RELEASE; SHALLOW		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Bangladesh Univ Engn & Technol, Dhaka 1000, Bangladesh; Ahuja Consulting, Calabash, NC 28467 USA; Wagner Coll, Dept Chem, Staten Isl, NY 10301 USA; Swiss Fed Inst Aquat Sci & Technol, Dept Water Resources & Drinking Water, CH-8600 Dubendorf, Switzerland; Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; Columbia Univ, Earth Inst, New York, NY 10027 USA; Univ S Florida, Dept Geol, Tampa, FL 33620 USA; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Columbia Univ Barnard Coll, Dept Environm Sci, New York, NY 10027 USA	Columbia University; Bangladesh University of Engineering & Technology (BUET); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Manchester; Columbia University; State University System of Florida; University of South Florida; University of California System; University of California Santa Cruz; Columbia University	van Geen, A (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	avangeen@ldeo.columbia.edu		Thomas, Pichler/0000-0003-3327-2451; Lloyd, Jonathan/0000-0002-0719-0498	Engineering and Physical Sciences Research Council [GR/S30207/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ahmed M.F., 2005, RISK ASSESSMENT ARSE; CHAKRABORTY AK, 1987, INDIAN J MED RES, V85, P326; Charlet L, 2006, ELEMENTS, V2, P91, DOI 10.2113/gselements.2.2.91; Dhar RK, 1997, CURR SCI INDIA, V73, P48; Gelman A, 2004, RISK ANAL, V24, P1597, DOI 10.1111/j.0272-4332.2004.00553.x; Harvey CF, 2006, CHEM GEOL, V228, P112, DOI 10.1016/j.chemgeo.2005.11.025; Hossain MA, 2005, ENVIRON SCI TECHNOL, V39, P4300, DOI 10.1021/es048703u; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Kinniburgh D. G., 2001, WC0019 BGS; Klump S, 2006, ENVIRON SCI TECHNOL, V40, P243, DOI 10.1021/es051284w; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Opar A, 2007, HEALTH PLACE, V13, P164, DOI 10.1016/j.healthplace.2005.11.004; Polizzotto ML, 2005, P NATL ACAD SCI USA, V102, P18819, DOI 10.1073/pnas.0509539103; Ravenscroft P, 2005, HYDROGEOL J, V13, P727, DOI 10.1007/s10040-003-0314-0; Sarker M. M. H, 2005, REPORT DEV ARSENIC D; SCHOENFELD A, 2006, THESIS COLUMBIA U NE; van Geen A, 2006, SCI TOTAL ENVIRON, V367, P769, DOI 10.1016/j.scitotenv.2006.01.030; Van Geen A, 2005, ENVIRON SCI TECHNOL, V39, P299, DOI 10.1021/es0491073; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Williams PN, 2005, ENVIRON SCI TECHNOL, V39, P5531, DOI 10.1021/es0502324; Zheng Y, 2005, GEOCHIM COSMOCHIM AC, V69, P5203, DOI 10.1016/j.gca.2005.06.001	22	205	207	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1687	1688		10.1126/science.1133146	http://dx.doi.org/10.1126/science.1133146			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	116WD	17170279				2022-12-01	WOS:000242833600030
J	Petruk, S; Sedkov, Y; Riley, KM; Hodgson, J; Schweisguth, F; Hirose, S; Jaynes, JB; Brock, HW; Mazo, A				Petruk, Svetlana; Sedkov, Yurii; Riley, Kristen M.; Hodgson, Jacob; Schweisguth, Francois; Hirose, Susumu; Jaynes, James B.; Brock, Hugh W.; Mazo, Alexander			Transcription of bxd noncoding RNAs promoted by trithorax represses Ubx in cis by transcriptional interference	CELL			English	Article							DROSOPHILA BITHORAX COMPLEX; HISTONE METHYLTRANSFERASE COMPLEX; GROUP RESPONSE ELEMENTS; HOX GENE-EXPRESSION; POLYCOMB-GROUP; HOMEOTIC GENE; INTERGENIC TRANSCRIPTION; ULTRABITHORAX; MAINTENANCE; PROTEINS	Much of the genome is transcribed into long noncoding RNAs (ncRNAs). Previous data suggested that bithoraxoid (bxd) ncRNAs of the Drosophila bithorax complex (BX-C) prevent silencing of Ultrabithorax (Ubx) and recruit activating proteins of the trithorax group (trxG) to their maintenance elements (MEs). We found that, surprisingly, Ubx and several bxd ncRNAs are expressed in nonoverlapping patterns in both embryos and imaginal discs, suggesting that transcription of these ncRNAs is associated with repression, not activation, of Ubx. Our data rule out siRNA or miRNA-based mechanisms for repression by bxd ncRNAs. Rather, ncRNA transcription itself, acting in cis, represses Ubx. The Trithorax complex TAC1 binds the Ubx coding region in nuclei expressing Ubx, and the bxd region in nuclei not expressing Ubx. We propose that TAC1 promotes the mosaic pattern of Ubx expression by facilitating transcriptional elongation of bxd ncRNAs, which represses Ubx transcription.	Thomas Jefferson Univ, Dept Biochem, Philadelphia, PA 19107 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Ecole Normale Super, CNRS, UMR 8542, Paris, France; Natl Inst Genet, Dept Dev Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan	Jefferson University; University of British Columbia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Mazo, A (corresponding author), Thomas Jefferson Univ, Dept Biochem, Philadelphia, PA 19107 USA.	mazo@mail.tju.edu	Hirose, Susumu/I-8865-2019	Jaynes, James/0000-0001-7943-794X	NCI NIH HHS [P01 CA050507, 5P01CA50507] Funding Source: Medline; NHLBI NIH HHS [T32-HL07780, T32 HL007780] Funding Source: Medline; NIGMS NIH HHS [1R01GM075141, R01 GM075141, R01 GM050231, R01 GM050231-09A2, 2R01GM50231] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA050507] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075141, R01GM050231] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bender W, 2002, DEVELOPMENT, V129, P4923; BROWER DL, 1987, DEVELOPMENT, V101, P83; CARROLL SB, 1988, GENE DEV, V2, P350, DOI 10.1101/gad.2.3.350; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; CUMBERLEDGE S, 1990, P NATL ACAD SCI USA, V87, P3259, DOI 10.1073/pnas.87.9.3259; Dzitoyeva S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-33; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; GOODRICH JA, 1991, TRENDS BIOCHEM SCI, V16, P394, DOI 10.1016/0968-0004(91)90162-O; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Hogga I, 2002, DEVELOPMENT, V129, P4915; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; IRISH VF, 1989, EMBO J, V8, P1527, DOI 10.1002/j.1460-2075.1989.tb03537.x; IRVINE KD, 1991, DEVELOPMENT, V111, P407; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; KUZIN B, 1994, GENE DEV, V8, P2478, DOI 10.1101/gad.8.20.2478; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; MULLER J, 1991, EMBO J, V10, P3147, DOI 10.1002/j.1460-2075.1991.tb04876.x; Pallavi SK, 2003, DEVELOPMENT, V130, P4931, DOI 10.1242/dev.00719; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; PIRROTTA V, 1995, GENETICS, V141, P1439; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; SANCHEZHERRERO E, 1989, DEVELOPMENT, V107, P321; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Sen GL, 2006, FASEB J, V20, P1293, DOI 10.1096/fj.06-6014rev; Shimojima T, 2003, GENE DEV, V17, P1605, DOI 10.1101/gad.1086803; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; SOTO MC, 1995, GENETICS, V140, P231; STRUHL G, 1985, EMBO J, V4, P3259, DOI 10.1002/j.1460-2075.1985.tb04075.x; Tillib S, 1999, MOL CELL BIOL, V19, P5189; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	48	220	231	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1209	1221		10.1016/j.cell.2006.10.039	http://dx.doi.org/10.1016/j.cell.2006.10.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174895	Green Accepted, Bronze			2022-12-01	WOS:000242991000018
J	Cox, JJ; Reimann, F; Nicholas, AK; Thornton, G; Roberts, E; Springell, K; Karbani, G; Jafri, H; Mannan, J; Raashid, Y; Al-Gazali, L; Hamamy, H; Valente, EM; Gorman, S; Williams, R; McHale, DP; Wood, JN; Gribble, FM; Woods, CG				Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey			An SCN9A channelopathy causes congenital inability to experience pain	NATURE			English	Article							CLOSED-STATE INACTIVATION; NA(V)1.7 SODIUM-CHANNELS; OF-FUNCTION MUTATION; ALPHA-SUBUNIT; INDIFFERENCE; INSENSITIVITY; EXPRESSION; CURRENTS; PN1	The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype. In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3. This region contains the gene SCN9A, encoding the alpha-subunit of the voltage-gated sodium channel, Na(v)1.7, which is strongly expressed in nociceptive neurons. Sequence analysis of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X). We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Na(v)1.7 with sodium channel beta(1) and beta(2) subunits in HEK293 cells. In cells expressing mutant Nav1.7, the currents were no greater than background. Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans. These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.	Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 OXY, England; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 OXY, England; St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Gene Tech Lab 146 1, Lahore, Pakistan; Fatima Jinah Med Coll, Dept Paediat, Lahore, Pakistan; King Edward Med Univ, Dept Obstet & Gynaecol, Lahore, Pakistan; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates; Natl Ctr Diabet Endocrinol & Genet, Amman, Jordan; CSS Mendel, I-00168 Rome, Italy; IRCCS CSS, San Giovanni Rotondo, Italy; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England; Pfizer Ltd, Global Res & Dev, Sandwich Labs, Sandwich CT13 9NJ, Kent, England; UCL, Dept Biol, Mol Nocicept Grp, London WC1E 6BT, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; United Arab Emirates University; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Pfizer; University of London; University College London	Woods, CG (corresponding author), Addenbrookes Hosp, Dept Med Genet, Wellcome MRC Bldg, Cambridge CB2 OXY, England.	cw347@cam.ac.uk	Valente, Enza Maria/G-2942-2017; Cox, James/R-1910-2016; woods, christopher g/A-1361-2010	Valente, Enza Maria/0000-0002-0600-6820; Reimann, Frank/0000-0001-9399-6377; Nicholas, Adeline/0000-0002-7124-629X; Gribble, Fiona/0000-0002-4232-2898	MRC [G9717869] Funding Source: UKRI; Medical Research Council [G9717869] Funding Source: Medline; Wellcome Trust [057964, 071187] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Akopian AN, 1996, TRENDS NEUROSCI, V19, P240, DOI 10.1016/0166-2236(96)10030-8; Amir R, 2006, J PAIN, V7, pS1, DOI 10.1016/j.jpain.2006.01.444; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Blair NT, 2002, J NEUROSCI, V22, P10277; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dearborn GV, 1932, J NERV MENT DIS, V75, P612; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; DYCK PJ, 1983, BRAIN, V106, P373, DOI 10.1093/brain/106.2.373; Han CY, 2006, ANN NEUROL, V59, P553, DOI 10.1002/ana.20776; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Klein CJ, 2003, ANN NEUROL, V53, P417, DOI 10.1002/ana.10469; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; LANDRIEU P, 1990, ANN NEUROL, V27, P574, DOI 10.1002/ana.410270520; Nagasako EM, 2003, PAIN, V101, P213, DOI 10.1016/S0304-3959(02)00482-7; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nassar MA, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-24; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	28	1034	1164	6	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					894	898		10.1038/nature05413	http://dx.doi.org/10.1038/nature05413			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167479	Green Accepted			2022-12-01	WOS:000242805400048
J	Marris, E				Marris, Emma			Drink the best and drive the rest	NATURE			English	News Item																		De Oliveira MED, 2005, BIOSCIENCE, V55, P593, DOI 10.1641/0006-3568(2005)055[0593:EAFECD]2.0.CO;2; MACEDO IDC, 2004, ASSESSMENT GREENHOUS	2	49	52	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					670	672		10.1038/444670a	http://dx.doi.org/10.1038/444670a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151627				2022-12-01	WOS:000242581100014
J	Huang, J; Perez-Burgos, L; Placek, BJ; Sengupta, R; Richter, M; Dorsey, JA; Kubicek, S; Opravil, S; Jenuwein, T; Berger, SL				Huang, Jing; Perez-Burgos, Laura; Placek, Brandon J.; Sengupta, Roopsha; Richter, Mario; Dorsey, Jean A.; Kubicek, Stefan; Opravil, Susanne; Jenuwein, Thomas; Berger, Shelley L.			Repression of p53 activity by Smyd2-mediated methylation	NATURE			English	Article							LYSINE METHYLATION; HISTONE; METHYLTRANSFERASE; TRANSCRIPTION; HETEROCHROMATIN; DEACETYLASE; PATHWAY	Specific sites of lysine methylation on histones correlate with either activation or repression of transcription(1-3). The tumour suppressor p53 ( refs 4 - 7) is one of only a few non-histone proteins known to be regulated by lysine methylation(8). Here we report a lysine methyltransferase, Smyd2, that methylates a previously unidentified site, Lys 370, in p53. This methylation site, in contrast to the known site Lys 372, is repressing to p53-mediated transcriptional regulation. Smyd2 helps to maintain low concentrations of promoter-associated p53. We show that reducing Smyd2 concentrations by short interfering RNA enhances p53-mediated apoptosis. We find that Set9-mediated methylation of Lys 372 inhibits Smyd2-mediated methylation of Lys 370, providing regulatory cross-talk between post-translational modifications. In addition, we show that the inhibitory effect of Lys 372 methylation on Lys 370 methylation is caused, in part, by blocking the interaction between p53 and Smyd2. Thus, similar to histones, p53 is subject to both activating and repressing lysine methylation. Our results also predict that Smyd2 may function as a putative oncogene by methylating p53 and repressing its tumour suppressive function.	Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	The Wistar Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Berger, SL (corresponding author), Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA.	berger@wistar.org	Huang, Jing/A-2566-2009; Kubicek, Stefan/C-2089-2017	Huang, Jing/0000-0002-7163-5156; Kubicek, Stefan/0000-0003-0855-8343; Berger, Shelley/0000-0001-5398-4400				Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Kent JR, 2004, J VIROL, V78, P10178, DOI 10.1128/JVI.78.18.10178-10186.2004; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Olivier Magali, 2004, IARC Sci Publ, P247; Prives C, 1999, J PATHOL, V187, P112; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	15	455	478	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					629	632		10.1038/nature05287	http://dx.doi.org/10.1038/nature05287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17108971				2022-12-01	WOS:000242377600050
J	Hilborn, R; Arcese, P; Borner, M; Hando, J; Hopcraft, G; Loibooki, M; Mduma, S; Sinclair, ARE				Hilborn, Ray; Arcese, Peter; Borner, Markus; Hando, Justin; Hopcraft, Grant; Loibooki, Martin; Mduma, Simon; Sinclair, Anthony R. E.			Effective enforcement in a conservation area	SCIENCE			English	Article									Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; Univ British Columbia, Ctr Appl Conservat Res, Vancouver, BC VLT 1Z4, Canada; Frankfurt Zool Soc, Arusha, Tanzania; Tanzania Natl Pks, Arusha, Tanzania; Tanzanian Wildlife Res Inst, Arusha, Tanzania; Univ British Columbia, Ctr Biodivers Res, Vancouver, BC VLT 1Z4, Canada; Univ Groningen, NL-9750 AA Haren, Netherlands	University of Washington; University of Washington Seattle; University of British Columbia; University of British Columbia; University of Groningen	Hilborn, R (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	rayh@u.washington.edu	Hilborn, Ray W/D-6332-2013					DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; Hofer H., 1995, SERENGETI, P332, DOI DOI 10.1186/1471-2148-9-253; MUPHREE MW, 2004, PARKS TRANSITION, P217; Newmark WD, 2000, BIOSCIENCE, V50, P585, DOI 10.1641/0006-3568(2000)050[0585:CWIAIC]2.0.CO;2; THIRGOOD S, IN PRESS SERENGETI, V3; [No title captured]	6	229	233	1	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2006	314	5803					1266	1266		10.1126/science.1132780	http://dx.doi.org/10.1126/science.1132780			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124316				2022-12-01	WOS:000242215800033
J	Madin, JS; Connolly, SR				Madin, Joshua S.; Connolly, Sean R.			Ecological consequences of major hydrodynamic disturbances on coral reefs	NATURE			English	Article							RESILIENCE; ECOSYSTEMS; TSUNAMI	A recent tsunami(1,2) and an apparent increase in the frequency of severe tropical storms(3-5) underscore the need to understand and predict the ecological consequences of major hydrodynamic disturbances(6). Reef corals provide the habitat structure that sustains the high biodiversity of tropical reefs(7), and thus provide the foundation for the ecosystem goods and services that are critical to many tropical societies(6,8). Here we integrate predictions from oceanographic models(9) with engineering theory, to predict the dislodgement of benthic reef corals during hydrodynamic disturbances. This generalizes earlier work(10,11), by incorporating colonies of any shape and by explicitly examining the effects of hydrodynamic gradients on coral assemblage structure. Afield test shows that this model accurately predicts changes in the mechanical vulnerability of coral colonies, and thus their size and shape, with distance from the reef crest. This work provides a general framework for understanding and predicting the effects of hydrodynamic disturbances on coral reef communities; such disturbances have a major role in determining species zonation(12,13) and coexistence(14) on coral reefs, and are critical determinants of how coral assemblages will respond to changes in the frequency and intensity of tropical storms associated with a changing climate(3-5,15).	James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; James Cook Univ N Queensland, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	James Cook University; James Cook University; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Madin, JS (corresponding author), James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	madin@nceas.ucsb.edu	Connolly, Sean R./E-7773-2011	Connolly, Sean R./0000-0003-1537-0859; Madin, Joshua/0000-0002-5005-6227				Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Baird AH, 2005, CURR BIOL, V15, P1926, DOI 10.1016/j.cub.2005.09.036; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DENNY M, 1995, ECOL MONOGR, V65, P371, DOI 10.2307/2963496; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Done T., 1983, PERSPECTIVES CORAL R, P107; DONE TJ, 1996, FUNCTIONAL ROLES BIO, P393; ELSNER JB, 1999, HURRICANES N ATLANTI, P339; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Hoyos CD, 2006, SCIENCE, V312, P94, DOI 10.1126/science.1123560; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Kench PS, 1998, CORAL REEFS, V17, P155, DOI 10.1007/s003380050110; Liu PLF, 2005, SCIENCE, V308, P1595, DOI 10.1126/science.1110730; Madin JS, 2006, CORAL REEFS, V25, P635, DOI 10.1007/s00338-006-0137-2; Madin JS, 2005, CORAL REEFS, V24, P630, DOI 10.1007/s00338-005-0042-0; MASSEL SR, 1993, CORAL REEFS, V12, P153, DOI 10.1007/BF00334475; MASSEL SR, 1999, FLUID MECH MARINE EC, P428; MERIAM JL, 1986, ENG MECH; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; ROSENBERG CS, 1975, SIGNS, V1, P1; TAYLOR HM, 1994, INTRO STOCHASTIC MOD, P36; Wainwright SA, 1982, MECH DESIGN ORGANISM; WATSON RT, 2001, 3 ASSESSMENT REPORT	24	227	232	5	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					477	480		10.1038/nature05328	http://dx.doi.org/10.1038/nature05328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122855				2022-12-01	WOS:000242215700044
J	Samanta, MP; Tongprasit, W; Istrail, S; Cameron, RA; Tu, Q; Davidson, EH; Stolc, V				Samanta, Manoj P.; Tongprasit, Waraporn; Istrail, Sorin; Cameron, R. Andrew; Tu, Qiang; Davidson, Eric H.; Stolc, Viktor			Report - The transcriptome of the sea urchin embryo	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; GENOME; IDENTIFICATION; ARRAY	The sea urchin Strongylocentrotus purpuratus is a model organism for study of the genomic control circuitry underlying embryonic development. We examined the complete repertoire of genes expressed in the S. purpuratus embryo, up to late gastrula stage, by means of high-resolution custom tiling arrays covering the whole genome. We detected complete spliced structures even for genes known to be expressed at low levels in only a few cells. At least 11,000 to 12,000 genes are used in embryogenesis. These include most of the genes encoding transcription factors and signaling proteins, as well as some classes of general cytoskeletal and metabolic proteins, but only a minor fraction of genes encoding immune functions and sensory receptors. Thousands of small asymmetric transcripts of unknown function were also detected in intergenic regions throughout the genome. The tiling array data were used to correct and authenticate several thousand gene models during the genome annotation process.	NASA, Ames Genome Res Facil, Moffett Field, CA 94035 USA; Systemix Inst, Los Altos, CA 94024 USA; Brown Univ, Providence, RI 02912 USA; CALTECH, Pasadena, CA 91125 USA; Eloret Corp, Sunnyvale, CA 94086 USA	National Aeronautics & Space Administration (NASA); Brown University; California Institute of Technology	Stolc, V (corresponding author), NASA, Ames Genome Res Facil, Moffett Field, CA 94035 USA.	vstolc@arc.nasa.gov	Tu, Qiang/AAJ-1582-2020	Tu, Qiang/0000-0002-7579-8315; Cameron, R. Andrew/0000-0003-3947-6041	NICHD NIH HHS [HD-37105] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Biemar F, 2006, P NATL ACAD SCI USA, V103, P12763, DOI 10.1073/pnas.0604484103; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Davidson E. H., 1986, GENE ACTIVITY EARLY; Davidson EH, 1998, DEVELOPMENT, V125, P3269; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Howard-Ashby M, 2006, DEV BIOL, V300, P27, DOI 10.1016/j.ydbio.2006.10.016; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; MATERNA SC, IN PRESS DEV BIOL, DOI DOI 10.1016/J.YDBIO.2006.08.32; Peterson KJ, 1997, BIOESSAYS, V19, P623, DOI 10.1002/bies.950190713; Raible F, 2006, DEV BIOL, V300, P461, DOI 10.1016/j.ydbio.2006.08.070; Ransick A, 2002, DEV BIOL, V246, P132, DOI 10.1006/dbio.2002.0607; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Yuh CH, 2002, DEV BIOL, V246, P148, DOI 10.1006/dbio.2002.0618	17	60	62	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					960	962		10.1126/science.1131898	http://dx.doi.org/10.1126/science.1131898			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095694				2022-12-01	WOS:000241896000042
J	Branzei, D; Sollier, J; Liberi, G; Zhao, XL; Maeda, D; Seki, M; Enomoto, T; Ohta, K; Foiani, M				Branzei, Dana; Sollier, Julie; Liberi, Giordano; Zhao, Xiaolan; Maeda, Daisuke; Seki, Masayuki; Enomoto, Takemi; Ohta, Kunihiro; Foiani, Marco			Ubc9-and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks	CELL			English	Article							UBIQUITIN-CONJUGATING ENZYME; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; BLOOMS-SYNDROME; SUMO LIGASE; GENE ENCODES; RECOMBINATION; PROTEIN; HELICASE; SRS2	The Ubc9 SUMO-conjugating enzyme and the Siz1 SUMO ligase sumoylate several repair and recombination proteins, including PCNA. Sumoylated PCNA binds Srs2, a helicase counteracting certain recombination events. Here we show that ubc9 mutants depend on checkpoint, recombination, and replication genes for growth. ubc9 cells maintain stalled-fork stability but exhibit a Rad51-dependent accumulation of cruciform structures during replication of damaged templates. Mutations in the Mms21 SUMO ligase resemble the ubc9 mutations. However, siz1, srs2, or pcna mutants altered in sumoylation do not exhibit the ubc9/mms21 phenotype. Like ubc9/mms21 mutants, sgs1 and top3 mutants also accumulate X molecules at damaged forks, and Sgs1/BLM is sumoylated. We propose that Ubc9 and Mms21 act in concert with Sgs1 to resolve the X structures formed during replication. Our results indicate that Ubc9- and Mms21-mediated sumoylation functions as a regulatory mechanism, different from that of replication checkpoints, to prevent pathological accumulation of cruciform structures at damaged forks.	Univ Degli Studi Milano, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; Univ Degli Studi Milano, Dept Biomed Sci & Biotechnol, I-20139 Milan, Italy; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Tohoku Univ, Mol Cell Biol Lab, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Tohoku Univ, 21st Century COE Program, Sendai, Miyagi 9808578, Japan; RIKEN, Discovery Res Inst, Genet Syst Regulat Lab, Wako, Saitama 3510198, Japan	IFOM - FIRC Institute of Molecular Oncology; Memorial Sloan Kettering Cancer Center; Tohoku University; Tohoku University; RIKEN	Branzei, D (corresponding author), Univ Degli Studi Milano, FIRC Inst Mol Oncol Fdn, Via Adamello 16, I-20139 Milan, Italy.	dana.branzei@ifom-ieo-campus.it	Foiani, Marco/M-8234-2014; Branzei, Dana/A-2806-2015; Branzei, Dana/GOG-9093-2022; LIBERI, GIORDANO/AAY-7273-2020	Foiani, Marco/0000-0003-4795-834X; Branzei, Dana/0000-0002-0544-4888; Branzei, Dana/0000-0002-0544-4888; LIBERI, GIORDANO/0000-0003-3160-2242; Zhao, Xiaolan/0000-0002-8302-6905	NCI NIH HHS [P30 CA-08478-41] Funding Source: Medline; Telethon [GGP030412] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telethon(Fondazione Telethon)		ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Branzei D, 2004, GENES CELLS, V9, P1031, DOI 10.1111/j.1365-2443.2004.00787.x; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; HORIUCHI T, 1994, J BACTERIOL, V176, P4656, DOI 10.1128/JB.176.15.4656-4663.1994; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kawabe Y, 2000, J BIOL CHEM, V275, P20963, DOI 10.1074/jbc.C000273200; Khakhar RR, 2003, TRENDS CELL BIOL, V13, P493, DOI 10.1016/S0962-8924(03)00171-5; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Maeda D, 2004, DNA REPAIR, V3, P335, DOI 10.1016/j.dnarep.2003.11.011; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Mo YY, 2005, EXPERT OPIN THER TAR, V9, P1203, DOI 10.1517/14728222.9.6.1203; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Onoda F, 2000, MUTAT RES-DNA REPAIR, V459, P203, DOI 10.1016/S0921-8777(99)00071-3; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; PRAKASH S, 1977, GENETICS, V87, P229; Reid RJD, 2002, METHOD ENZYMOL, V350, P258; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; RONG L, 1991, GENETICS, V127, P75; Rothstein R, 1995, GENOME RES, V5, P421, DOI 10.1101/gr.5.5.421; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Shen ZY, 1996, GENOMICS, V37, P183, DOI 10.1006/geno.1996.0540; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; Stead K, 2003, J CELL BIOL, V163, P729, DOI 10.1083/jcb.200305080; Sugimoto K, 1997, MOL CELL BIOL, V17, P5905, DOI 10.1128/MCB.17.10.5905; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; WANG JC, 1991, J BIOL CHEM, V266, P6659; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; YAKAHASHI Y, 2006, GENETICS, V172, P783; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	58	234	236	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					509	522		10.1016/j.cell.2006.08.050	http://dx.doi.org/10.1016/j.cell.2006.08.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081974	Bronze			2022-12-01	WOS:000241937000016
J	Leslie, M				Leslie, Mitchell			Jumpstarting research into neglected diseases	CELL			English	Editorial Material								Unwilling to wait and hope for a cure, patients suffering from rare or little-studied diseases and their families are galvanizing research efforts and driving innovative approaches to develop new treatments.											0	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					443	445		10.1016/j.cell.2006.10.022	http://dx.doi.org/10.1016/j.cell.2006.10.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081963	Bronze			2022-12-01	WOS:000241937000005
J	Polo, SE; Roche, D; Almouzni, G				Polo, Sophie E.; Roche, Daniele; Almouzni, Genevieve			New histone incorporation marks sites of UV repair in human cells	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; ASSEMBLY FACTOR-I; NEWLY SYNTHESIZED HISTONES; DNA-REPLICATION INVITRO; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; VARIANT H3.3; HUMAN ASF1; CHROMATIN; DAMAGE	Chromatin organization is compromised during the repair of DNA damage. It remains unknown how and to what extent epigenetic information is preserved in vivo. A central question is whether chromatin reorganization involves recycling of parental histones or new histone incorporation. Here, we devise an approach to follow new histone deposition upon UV irradiation in human cells. We show that new H3.1 histones get incorporated in vivo at repair sites. Remarkably we find that H3.1, which is deposited during S phase, is also incorporated outside of S phase. Histone deposition is dependent on nucleotide excision repair (NER), indicating that it occurs at a postrepair stage. The histone chaperone chromatin assembly factor 1 (CAF-1) is directly involved in the histone deposition process in vivo. We conclude that chromatin restoration after damage cannot rely simply on histone recycling. New histone incorporation at repair sites both challenges epigenetic stability and possibly contributes to damage memory.	Inst Curie, Lab Nucl Dynam & Genome Plast, UMR 218 CNRS, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Almouzni, G (corresponding author), Inst Curie, Lab Nucl Dynam & Genome Plast, UMR 218 CNRS, 26 Rue Ulm, F-75248 Paris 05, France.	genevieve.almouzni@curie.fr	Almouzni, Genevieve/ABG-1029-2021	Almouzni, Genevieve/0000-0001-5570-0723; Polo, Sophie/0000-0003-4821-9354				Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Conconi A, 2005, MOL CELL BIOL, V25, P9773, DOI 10.1128/MCB.25.22.9773-9783.2005; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Gaillard PHL, 1997, EMBO J, V16, P6281, DOI 10.1093/emboj/16.20.6281; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Game JC, 1999, GENETICS, V151, P485; Gerard A, 2006, METHOD ENZYMOL, V409, P358, DOI 10.1016/S0076-6879(05)09021-X; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Gunjan A, 2005, BIOCHIMIE, V87, P625, DOI 10.1016/j.biochi.2005.02.008; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaufman Paul D., 2006, V47, P121; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lewis LK, 2005, NUCLEIC ACIDS RES, V33, P4928, DOI 10.1093/nar/gki806; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Little JB, 2003, ONCOGENE, V22, P6978, DOI 10.1038/sj.onc.1206988; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Polo SE, 2004, CANCER RES, V64, P2371, DOI 10.1158/0008-5472.CAN-03-2893; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; THIRIET C, 1995, ELECTROPHORESIS, V16, P357, DOI 10.1002/elps.1150160161; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; VAQUERO A, 2003, SCI AGING KNOWLEDGE, V14, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0	64	201	205	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					481	493		10.1016/j.cell.2006.08.049	http://dx.doi.org/10.1016/j.cell.2006.08.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081972	Bronze			2022-12-01	WOS:000241937000014
J	Huber, C; Wachterschauser, G				Huber, Claudia; Waechterschaeuser, Guenter			alpha-hydroxy and alpha-amino acids under possible hadean, volcanic origin-of-life conditions	SCIENCE			English	Article							HYDROTHERMAL CONDITIONS; ABIOTIC SYNTHESIS; SULFUR-COMPOUNDS; IRON SULFIDE; EVOLUTION; SURFACES	To test the theory of a chemoautotrophic origin of life in a volcanic, hydrothermal setting, we explored mechanisms for the buildup of bio-organic compounds by carbon fixation on catalytic transition metal precipitates. We report the carbon monoxide - dependent formation of carbon-fixation products, including an ordered series of alpha-hydroxy and alpha-amino acids of the general formula R-CHA-COOH (where R is H, CH3, C2H5, or HOCH2 and A is OH or NH2) by carbon fixation at 80 degrees to 120 degrees C, catalyzed by nickel or nickel, iron precipitates with carbonyl, cyano, and methylthio ligands as carbon sources, with or without sulfido ligands. Calcium or magnesium hydroxide was added as a pH buffer. The results narrow the gap between biochemistry and volcanic geochemistry and open a new gateway for the exploration of a volcanic, hydrothermal origin of life.	Tech Univ Munich, Dept Organ Chem & Biochem, D-85747 Garching, Germany	Technical University of Munich	Wachterschauser, G (corresponding author), 209 Mill Race Dr, Chapel Hill, NC 27514 USA.	gwmunich@yahoo.com						Amend JP, 1998, SCIENCE, V281, P1659, DOI 10.1126/science.281.5383.1659; Armstrong FA, 2005, PHILOS T ROY SOC A, V363, P937, DOI 10.1098/rsta.2004.1528; BECK MT, 1987, PURE APPL CHEM, V59, P1703, DOI 10.1351/pac198759121703; Cockell CS, 2006, PHILOS T R SOC B, V361, P1845, DOI 10.1098/rstb.2006.1908; Cody GD, 2000, SCIENCE, V289, P1337, DOI 10.1126/science.289.5483.1337; Colin N., 1984, MINERAL MAG, V48, P237; DEGENS ET, 1989, PERSPECTIVES BIOGEOC, P308; Dorr M, 2003, ANGEW CHEM INT EDIT, V42, P1540, DOI 10.1002/anie.200250371; FERRIS JP, 1984, TETRAHEDRON, V40, P1093, DOI 10.1016/S0040-4020(01)99315-9; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; HAZEN RM, 1978, AM MINERAL, V63, P885; Heinen W, 1996, ORIGINS LIFE EVOL B, V26, P131, DOI 10.1007/BF01809852; HENNET RJC, 1992, NATURWISSENSCHAFTEN, V79, P361, DOI 10.1007/BF01140180; HOLLOWAY JR, 1994, REV MINERAL, V30, P187; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; HUME DN, 1950, J AM CHEM SOC, V72, P4423, DOI 10.1021/ja01166a022; Jauregui-Haza UJ, 2004, LAT AM APPL RES, V34, P71; Martin W, 2003, PHILOS T R SOC LON B, V358, P27; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; MILLER SL, 1957, BIOCHIM BIOPHYS ACTA, V23, P480, DOI 10.1016/0006-3002(57)90366-9; MUKHIN L, 1974, NATURE, V251, P50, DOI 10.1038/251050a0; Russell MJ, 2004, TRENDS BIOCHEM SCI, V29, P358, DOI 10.1016/j.tibs.2004.05.007; Seewald JS, 2006, GEOCHIM COSMOCHIM AC, V70, P446, DOI 10.1016/j.gca.2005.09.002; SHOCK EL, 1992, ORIGINS LIFE EVOL B, V22, P67, DOI 10.1007/BF01808019; Wachtershauser G, 2000, SCIENCE, V289, P1307, DOI 10.1126/science.289.5483.1307; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Wachtershauser G, 2006, PHILOS T R SOC B, V361, P1787, DOI 10.1098/rstb.2006.1904; ZENKEVICH VA, 1991, VULKANOL SEISMOL, V3, P19; Zolotov M, 1999, J GEOPHYS RES-PLANET, V104, P14033, DOI 10.1029/1998JE000627	31	134	140	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					630	632		10.1126/science.1130895	http://dx.doi.org/10.1126/science.1130895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068257				2022-12-01	WOS:000241557800041
J	Roberts, LM; Pattison, H; Roalfe, A; Franklyn, J; Wilson, S; Hobbs, R; Parle, JV				Roberts, Lesley M.; Pattison, Helen; Roalfe, Andrea; Franklyn, Jayne; Wilson, Sue; Hobbs, Richard; Parle, James V.			Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction?	ANNALS OF INTERNAL MEDICINE			English	Article							L-THYROXINE TREATMENT; MINI-MENTAL STATE; MAJOR DEPRESSION; HOSPITAL ANXIETY; HYPOTHYROIDISM; POPULATION; SYMPTOMS; DISEASE; ADULTS; MANAGEMENT	Background: Widespread use of automated sensitive assays for thyroid hormones and thyroid-stimulating hormone (TSH) has increased identification of mild thyroid dysfunction, especially in elderly patents. The clinical significance of this dysfunction, however, remains uncertain, and associations with cognitive impairment, depression, and anxiety are unconfirmed. Objective: To determine the association between mild thyroid dysfunction and cognition, depression, and anxiety in elderly persons. Design: Cross-sectional study. Associations were explored through mixed-model analyses. Setting: Primary care practices in central England. Patients: 5865 patients 65 years of age or older with no known thyroid disease who were recruited from primary care registers. Measurements: Serum TSH and free thyroxine (T-4) were measured. Depression and anxiety were assessed by using the Hospital Anxiety and Depression Scale (HADS), and cognitive functioning was established by using the Middlesex Elderly Assessment of Mental State and the Folstein Mini-Mental State Examination. Comorbid conditions, medication use, and sociodemographic profiles were recorded. Results: 295 patients met the criteria for subclinical thyroid dysfunction (127 were hyperthyroid, and 168 were hypothyroid). After confounding variables were controlled for, statistically significant associations were seen between anxiety (HADS score) and TSH level (P = 0.013) and between cognition and both TSH and free T-4 levels. The magnitude of these associations lacked clinical relevance: A 50-mlU/L increase in the TSH level was associated with a 1-point reduction in the HADS anxiety score, and a 1-point increase in the Mini-Mental State Examination score was associated with an increase of 50 mlU/L in the TSH level or 25 pmol/L in the free T-4 level. Limitations: Because of the low participation rate, low prevalence of subclinical thyroid dysfunction, and other unidentified recruitment biases, participants may not be representative of the elderly population. Conclusions: After the confounding effects of comorbid conditions and use of medication were controlled for, subclinical thyroid dysfunction was not associated with depression, anxiety, or cognition.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Roberts, LM (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	l.m.roberts@bham.ac.uk	Pattison, Helen/D-2702-2009	Pattison, Helen/0000-0002-9483-4342; hobbs, richard/0000-0001-7976-7172				Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Bono G, 2004, ACTA NEUROL SCAND, V110, P59, DOI 10.1111/j.1600-0404.2004.00262.x; Bravo G, 1997, INT J GERIATR PSYCH, V12, P1008, DOI 10.1002/(SICI)1099-1166(199710)12:10<1008::AID-GPS676>3.0.CO;2-A; Brown ES, 1998, HARVARD REV PSYCHIAT, V5, P239, DOI 10.3109/10673229809000307; Efron B., 1993, MONOGRAPHS STAT APPL, DOI 10.1007/978-1-4899-4541-9; Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421; Engum A, 2002, ACTA PSYCHIAT SCAND, V106, P27, DOI 10.1034/j.1600-0447.2002.01250.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gharib H, 2005, THYROID, V15, P24, DOI 10.1089/thy.2005.15.24; GIFT AG, 1989, INT J NURS STUD, V26, P281, DOI 10.1016/0020-7489(89)90009-6; Golding E., 1989, MIDDLESEX ELDERLY AS; Gonen MS, 2004, ENDOCR J, V51, P311, DOI 10.1507/endocrj.51.311; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; HAGGERTY JJ, 1993, AM J PSYCHIAT, V150, P508; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Kong WM, 2002, AM J MED, V112, P348, DOI 10.1016/S0002-9343(02)01022-7; Luboshitzky R, 1996, ISRAEL J MED SCI, V32, P60; MONZANI F, 1993, CLIN INVESTIGATOR, V71, P367; Noble M. G., 2004, ENGLISH INDICES DEPR; *OFF NAT STAT, 2001, CENS NAT REP ENG WAL; *OFF NAT STAT, 2000, KEY HLTH STAT GEN PR; OSTERWEIL D, 1992, J AM GERIATR SOC, V40, P325, DOI 10.1111/j.1532-5415.1992.tb02130.x; Patten SB, 2005, CAN J PSYCHIAT, V50, P195, DOI 10.1177/070674370505000402; Ringel MD, 2005, J CLIN ENDOCR METAB, V90, P588, DOI 10.1210/jc.2004-2173; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stern RA, 1995, COMPREHENSIVE TXB PS, P241; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; van Boxtel MPJ, 2004, PSYCHONEUROENDOCRINO, V29, P891, DOI 10.1016/j.psyneuen.2003.08.002; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	173	178	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 17	2006	145	8					573	581		10.7326/0003-4819-145-8-200610170-00006	http://dx.doi.org/10.7326/0003-4819-145-8-200610170-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	095NX	17043339				2022-12-01	WOS:000241315700003
J	Pinkett, HW; Lee, AT; Lum, P; Locher, KP; Rees, DC				Pinkett, H. W.; Lee, A. T.; Lum, P.; Locher, K. P.; Rees, D. C.			An inward-facing conformation of a putative metal-chelate-type ABC transporter	SCIENCE			English	Article							BINDING CASSETTE DIMER; ATP-BINDING; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; MECHANISM; ARCHITECTURE; SUBUNIT; DOMAINS; CHANNEL; MEMBRANE	The crystal structure of a putative metal-chelate-type adenosine triphosphate (ATP)-binding cassette (ABC) transporter encoded by genes HI1470 and HI1471 of Haemophilus influenzae has been solved at 2.4 angstrom resolution. The permeation pathway exhibits an inward-facing conformation, in contrast to the outward-facing state previously observed for the homologous vitamin B-12 importer BtuCD. Although the structures of both HI1470/1 and BtuCD have been solved in nucleotide-free states, the pairs of ABC subunits in these two structures differ by a translational shift in the plane of the membrane that coincides with a repositioning of the membrane-spanning subunits. The differences observed between these ABC transporters involve relatively modest rearrangements and may serve as structural models for inward- and outward-facing conformations relevant to the alternating access mechanism of substrate translocation.	CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, Pasadena, CA 91125 USA; ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	California Institute of Technology; Howard Hughes Medical Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rees, DC (corresponding author), CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, MC 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu	Pinkett, Heather Wendy/M-9235-2014		NIGMS NIH HHS [GM45162] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045162, R01GM045162] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Crosa JH., 2004, IRON TRANSPORT BACTE; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; HEISCHMANN RD, 1995, SCIENCE, V269, P496; Holland I. B., 2003, ABC PROTEINS BACTERI; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1016/S0378-1097(99)00411-5; Jones PM, 2002, P NATL ACAD SCI USA, V99, P12639, DOI 10.1073/pnas.152439599; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Pornillos O, 2006, FEBS LETT, V580, P358, DOI 10.1016/j.febslet.2005.12.054; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	32	235	242	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2007	315	5810					373	377		10.1126/science.1133488	http://dx.doi.org/10.1126/science.1133488			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17158291				2022-12-01	WOS:000243535400041
J	Lee, JY; Yang, W				Lee, Jae Young; Yang, Wei			UvrD helicase unwinds DNA one base pair at a time by a two-part power stroke	CELL			English	Article							ESCHERICHIA-COLI UVRD; SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; REP HELICASE; STEP-SIZE; ATP HYDROLYSIS; RECBCD ENZYME; PCRA HELICASE; GENE-PRODUCT; DUPLEX DNA	Helicases use the energy derived from nucleoside triphosphate hydrolysis to unwind double helices in essentially every metabolic pathway involving nucleic acids. Earlier crystal structures have suggested that DNA helicases translocate along a single-stranded DNA in an inchworm fashion, We report here a series of crystal structures of the UvrD helicase complexed with DNA and ATP hydrolysis intermediates. These structures reveal that ATP binding alone leads to unwinding of 1 base pair by directional rotation and translation of the DNA duplex, and ADP and Pi release leads to translocation of the developing single strand. Thus DNA unwinding is achieved by a two-part power stroke in a combined wrench-and-inchworm mechanism. The rotational angle and translational distance of DNA define the unwinding step to be 1 base pair per ATP hydrolyzed. Finally, a gateway for ssDNA translocation and an alternative strand-displacement mode may explain the varying step sizes reported previously.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [Z01 DK036119-10] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036119] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDELMONEM M, 1977, EUR J BIOCHEM, V79, P33, DOI 10.1111/j.1432-1033.1977.tb11780.x; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Bruger AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; GEORGE JW, 1994, J MOL BIOL, V235, P424, DOI 10.1006/jmbi.1994.1003; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; HICKSON ID, 1983, MOL GEN GENET, V190, P265, DOI 10.1007/BF00330649; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; LOHMAN TM, 2003, ENERGY COUPLING MOL, P304; Lucius AL, 2004, J MOL BIOL, V339, P751, DOI 10.1016/j.jmb.2004.04.010; Macris MA, 2005, BIOCHEM SOC T, V33, P1447, DOI 10.1042/BST0331447; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.biochem.59.1.289; MATSON SW, 1987, J BIOL CHEM, V262, P2066; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; OGAWA H, 1968, MOL GEN GENET, V101, P227, DOI 10.1007/BF00271625; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Rasnik I, 2004, J MOL BIOL, V336, P395, DOI 10.1016/j.jmb.2003.12.031; RICHET E, 1976, J BIOL CHEM, V251, P808; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; VANDEPUT.P, 1965, MUTAT RES, V2, P97, DOI 10.1016/0027-5107(65)90041-2; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2003, BIOESSAYS, V25, P1168, DOI 10.1002/bies.10369; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P783, DOI 10.1073/pnas.71.3.783; Zhang G, 1998, J BACTERIOL, V180, P377, DOI 10.1128/JB.180.2.377-387.1998	52	292	294	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1349	1360		10.1016/j.cell.2006.10.049	http://dx.doi.org/10.1016/j.cell.2006.10.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190599	Green Accepted, Bronze			2022-12-01	WOS:000243690000015
J	Martins, CP; Brown-Swigart, L; Evan, GI				Martins, Carla P.; Brown-Swigart, Lamorna; Evan, Gerard I.			Modeling the therapeutic efficacy of p53 restoration in tumors	CELL			English	Article							DNA-DAMAGE; C-MYC; INDUCED TUMORIGENESIS; P53-DEFICIENT MICE; SMALL MOLECULES; APOPTOSIS; LYMPHOMAGENESIS; SUPPRESSOR; ACTIVATION; CANCER	Although restoration of p53 function is an attractive tumor-specific therapeutic strategy, it remains unclear whether p53 loss is required only for transition through early bottlenecks in tumorigenesis or also for maintenance of established tumors. To explore the efficacy of p53 reinstatement as a tumor therapy, we used a reversibly switchable p53 knockin (KI) mouse model that permits modulation of p53 status from wild-type to knockout, at will. Using the well-characterized E mu-myc lymphoma model, we show that p53 is spontaneously activated when restored in established E mu-myc lymphomas in vivo, triggering rapid apoptosis and conferring a significant increase in survival. Nonetheless, reimposition of p53 function potently selects for emergence of p53-resistant tumors through inactivation of p19(ARF) or p53. Our study provides important insights into the nature and timing of p53-activating signals in established tumors and how resistance to p53 evolves, which will aid in the optimization of p53-based tumor therapies.	Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Evan, GI (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA.	gevan@cc.ucsf.edu			NCI NIH HHS [R01 CA100193] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100193] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; CHRISTOPHOROU M, 2006, IN PRESS NATURE, P53; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Del Toro Gustavo, 2005, Clin Adv Hematol Oncol, V3, P54; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HSU B, 1995, ONCOGENE, V11, P175; Kamijo T, 1999, CANCER RES, V59, P2464; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Khan SH, 2000, P NATL ACAD SCI USA, V97, P3266, DOI 10.1073/pnas.050560997; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li YX, 2004, ONCOGENE, V23, P7355, DOI 10.1038/sj.onc.1207957; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; MOORE JP, 1987, ONCOGENE RES, V2, P65; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Ring D, 2001, J SHOULDER ELB SURG, V10, P501, DOI 10.1067/mse.2001.118414; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sigal A, 2000, CANCER RES, V60, P6788; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vassilev LT, 2005, J MED CHEM, V48, P4491, DOI 10.1021/jm058174k; Vater CA, 1996, ONCOGENE, V13, P739; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	39	476	492	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1323	1334		10.1016/j.cell.2006.12.007	http://dx.doi.org/10.1016/j.cell.2006.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17182091	Bronze			2022-12-01	WOS:000243690000013
J	Bailey, MS; de Silva, HJ				Bailey, Mark S.; de Silva, H. Janaka			Sri Lankan sanni masks: an ancient classification of disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									Army Med Directorate, Surrey GU15 4NP, England; Univ Kelaniya, Dept Med, Ragama, Sri Lanka	University Kelaniya	Bailey, MS (corresponding author), Army Med Directorate, Surrey GU15 4NP, England.	mark@ramc.org	Bailey, Mark S./D-3854-2013	Bailey, Mark S./0000-0003-4840-5093				Bartlett A, 1989, Int J Soc Psychiatry, V35, P245, DOI 10.1177/002076408903500305; Kapferer B., 2005, TOVIL EXORCISM HEALI; Kapferer Bruce, 1991, CELEBRATION DEMONS E; OBEYESEKERE G, 1969, COMP STUD SOC HIST, V11, P174, DOI 10.1017/S0010417500005260; PERTOLD O, 1930, CEREMONIAL DANCES SI; Wijesuriya B., 2001, TRADITIONAL SINHALES; Wirz Paul, 1954, EXORCISM ART HEALING	7	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1327	1328		10.1136/bmj.39055.445417.BE	http://dx.doi.org/10.1136/bmj.39055.445417.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185730	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000243160700027
J	Steinbrook, R				Steinbrook, Robert			Haernoglobin concentrations in chronic kidney disease	LANCET			English	Editorial Material									Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; VA Outcomes Grp, White River Jct, VT 05009 USA	Dartmouth College; VA Outcomes Group	Steinbrook, R (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA.	rsteinbrook@attglobal.net						*AMG, 2006, AR SINGL DARB ALF; *AMG, 2006, EP EP ALF REC PROD I; [Anonymous], 2006, USRDS 2006 ANN DAT R; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; COTTER D, 2006, HLTH AFF MILWOOD, V26, P1249; COYNE DW, IN PRESS CLIN J AM S; *DAVITA, 2005 ANN REP; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; *NAT KIDN FDN, 2006, AM J KIDNEY DIS S, V27, pS11; *NAT KIDN FDN, 2005 ANN REP; *NAT KIDN FDN, 2006, KIDN DIS OUTC QUAL I; *ORTH BIOT PROD, 2006, PROCR EP ALF; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003967.pub2	14	28	30	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2191	2193		10.1016/S0140-6736(06)69707-9	http://dx.doi.org/10.1016/S0140-6736(06)69707-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189015				2022-12-01	WOS:000243076800007
J	Vajdic, CM; McDonald, SP; McCredie, MRE; van Leeuwen, MT; Stewart, JH; Law, M; Chapman, JR; Webster, AC; Kaldor, JM; Grulich, AE				Vajdic, Claire M.; McDonald, Stephen P.; McCredie, Margaret R. E.; van Leeuwen, Marina T.; Stewart, John H.; Law, Matthew; Chapman, Jeremy R.; Webster, Angela C.; Kaldor, John M.; Grulich, Andrew E.			Cancer incidence before and after kidney transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; RENAL-TRANSPLANTATION; RISK; INFECTION; DIALYSIS; PEOPLE; VIRUS; AIDS	Context Immune suppression after organ transplantation is associated with a markedly increased risk of nonmelanoma skin cancer and a few virus-associated cancers. Although it is generally accepted that other cancers do not occur at increased rates, there have been few long-term population-based cohort studies performed. Objective To compare the incidence of cancer in patients receiving immune suppression after kidney transplantation with incidence in the same population in 2 periods before receipt of immune suppression: during dialysis and during end-stage kidney disease before renal replacement therapy (RRT). Design, Setting, and Participants A population-based cohort study of 28 855 patients with end-stage kidney disease who received RRT, with 273 407 person-years of follow-up. Incident cancers (1982-2003) were ascertained by record linkage between the Australia and New Zealand Dialysis and Transplant Registry and the Australian National Cancer Statistics Clearing House. Main Outcome Measure Standardized incidence ratios (SIRs) of cancer, using age-specific, sex-specific, calendar year - specific, and state/territory-specific population cancer incidence rates. Results The overall incidence of cancer, excluding nonmelanoma skin cancer and those cancers known to frequently cause end-stage kidney disease, was markedly increased after transplantation (n= 1236; SIR, 3.27; 95% confidence interval [CI], 3.09-3.46). In contrast, cancer incidence was only slightly increased during dialysis ( n= 870; SIR, 1.35; 95% CI, 1.27-1.45) and before RRT ( n= 689; SIR, 1.16; 95% CI, 1.08-1.25). After transplantation, cancer occurred at significantly increased incidence at 25 sites, and risk exceeded 3-fold at 18 of these sites. Most of these cancers were of known or suspected viral etiology. Conclusions Kidney transplantation is associated with a marked increase in cancer risk at a wide variety of sites. Because SIRs for most types of cancer were not increased before transplantation, immune suppression may be responsible for the increased risk. These data suggest a broader than previously appreciated role of the interaction between the immune system and common viral infections in the etiology of cancer.	Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; Queen Elizabeth Hosp, Australia & New Zealand Dialysis & Transplant Reg, Adelaide, SA, Australia; Univ Adelaide, Discipline Med, Adelaide, SA, Australia; Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; Univ Sydney, Westmead Hosp, Millennium Inst, Ctr Transplant & Renal Res, Sydney, NSW 2006, Australia	University of New South Wales Sydney; Kirby Institute; University of Adelaide; University of Adelaide; University of Otago; University of Sydney	Vajdic, CM (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, 376 Victoria St,Level 2, Darlinghurst, NSW 2010, Australia.	cvajdic@nchecr.unsw.edu.au	Kaldor, John M/D-4545-2011; van Leeuwen, Marina T/AAQ-5339-2021; Vajdic, Claire/AAP-5940-2020; McDonald, Stephen/G-4010-2013; Webster, Angela/J-2186-2012	van Leeuwen, Marina T/0000-0002-1570-2852; McDonald, Stephen/0000-0001-6103-1386; Webster, Angela/0000-0001-7509-0512; Law, Matthew/0000-0002-3540-8837; Vajdic, Claire/0000-0002-3612-8298				*AIHW, 2005, 57 AIHW PHE; *AIHW AACR, 2001, CANC SER, V19; *AIHW AACR, 2004, CANC SER, V28; [Anonymous], 1994, IARC MON EV CARC RIS, V61; [Anonymous], 1997, IARC MON EV CARC RIS, V70; [Anonymous], 2004, INT RUL MULT PRIM CA; [Anonymous], 1996, IARC MON EV CARC RIS; [Anonymous], 2002, CANC INCIDENCE 5 CON; Birkeland SA, 2000, LANCET, V355, P1886, DOI 10.1016/S0140-6736(00)02298-4; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Girndt M, 2001, KIDNEY INT, V59, pS206, DOI 10.1046/j.1523-1755.2001.59780206.x; GOLDBLUM SE, 1980, ANN INTERN MED, V93, P597, DOI 10.7326/0003-4819-93-4-597; Grulich AE, 1999, AIDS, V13, P839, DOI 10.1097/00002030-199905070-00014; Grulich AE, 2002, AIDS, V16, P1155, DOI 10.1097/00002030-200205240-00009; Grulich AE, 1996, J EPIDEMIOL BIOSTAT, V1, P207; *IARC, 1994, IARC MON EV CARC RIS, V59; *IARC, 1995, IARC MON EV CARC RIS, V64; JARO MA, 1995, STAT MED, V14, P491, DOI 10.1002/sim.4780140510; Kinlen L J, 1992, IARC Sci Publ, P237; Li YM, 2002, AM J EPIDEMIOL, V155, P153, DOI 10.1093/aje/155.2.153; MAYNE ST, 2006, CANC EPIDEMIOLOGY PR, P686; MCDONALD SP, 2005, ANZDATA REG REPORT 2; Mitsuishi T, 2005, CANCER LETT, V222, P139, DOI 10.1016/j.canlet.2004.09.019; PORT FK, 1989, AM J KIDNEY DIS, V14, P119, DOI 10.1016/S0272-6386(89)80187-8; *S AUSTR CANC REG, 2000, EP CANC S AUSTR; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Winkelspecht B, 1997, NEPHROL DIAL TRANSPL, V12, P2099, DOI 10.1093/ndt/12.10.2099; World Health Organization, 1992, INT STAT CLASS DIS 1	31	789	804	4	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2823	2831		10.1001/jama.296.23.2823	http://dx.doi.org/10.1001/jama.296.23.2823			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179459	Bronze			2022-12-01	WOS:000242826400024
J	Gilchrist, A; Au, CE; Hiding, J; Bell, AW; Fernandez-Rodriguez, J; Lesimple, S; Nagaya, H; Roy, L; Gosline, SJC; Hallett, M; Paiement, J; Kearney, RE; Nilsson, T; Bergeron, JJM				Gilchrist, Annalyn; Au, Catherine E.; Hiding, Johan; Bell, Alexander W.; Fernandez-Rodriguez, Julia; Lesimple, Souad; Nagaya, Hisao; Roy, Line; Gosline, Sara J. C.; Hallett, Michael; Paiement, Jacques; Kearney, Robert E.; Nilsson, Tommy; Bergeron, John J. M.			Quantitative proteomics analysis of the secretory pathway	CELL			English	Article							CLATHRIN-COATED VESICLES; ENDOPLASMIC-RETICULUM; PROTEIN EXPRESSION; MEMBRANE-PROTEINS; GOLGI-APPARATUS; COMPLEX; COPI; LOCALIZATION; TRAFFICKING; REVEALS	We report more than 1400 proteins of the secretory-pathway proteome and provide spatial information on the relative presence of each protein in the rough and smooth ER Golgi cisternae and Golgi-derived COPT vesicles. The data support a role for COPT vesicles in recycling and cisternal maturation, showing that Golgi-resident proteins are present at a higher concentration than secretory cargo. Of the 1400 proteins, 345 were identified as previously uncharacterized. Of these, 230 had their subcellular location deduced by proteomics. This study provides a comprehensive catalog of the ER and Golgi proteomes with insight into their identity and function.	McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; McGill Univ, McGill Ctr Bioinformat, Sch Comp Sci, Montreal, PQ H3A 2B4, Canada; McGill Univ, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada; Gothenburg Univ, Inst Biomed, Dept Med & Clin Genet, S-41390 Gothenburg, Sweden; Gothenburg Univ, Sahlgrenska Acad, Proteom Ctr, S-41390 Gothenburg, Sweden; Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; McGill University; University of Gothenburg; University of Gothenburg; Universite de Montreal	Bergeron, JJM (corresponding author), McGill Univ, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	john.bergeron@mcgill.ca	Kearney, Robert E/D-3917-2012; Bergeron, John/AAW-1893-2021	Hallett, Michael/0000-0001-6738-6786; Fernandez-Rodriguez, Julia/0000-0003-4522-0966; Kearney, Robert/0000-0002-5107-6190; Gosline, Sara/0000-0002-6534-4774				Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; DAHAN S, 1994, J CELL BIOL, V127, P1859, DOI 10.1083/jcb.127.6.1859; Dominguez M, 1999, J CELL BIOL, V145, P673, DOI 10.1083/jcb.145.4.673; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Girard M, 2005, MOL CELL PROTEOMICS, V4, P1145, DOI 10.1074/mcp.M500043-MCP200; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Goolsby KM, 2003, NUCLEIC ACIDS RES, V31, P5644, DOI 10.1093/nar/gkg768; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Hay JC, 1996, J BIOL CHEM, V271, P5671, DOI 10.1074/jbc.271.10.5671; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; KARTBERG F, 2005, CELL BIOL LAB HDB, P45; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; MARINEZMENARGUE.JA, 2001, J CELL BIOL, V155, P1213; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; PAIEMENT J, 2005, CELL BIOL LAB HDB, P41; Peng RW, 2005, THESCIENTIFICWORLDJO, V5, P471, DOI 10.1100/tsw.2005.53; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Scott M, 2004, BIOINFORMATICS, V20, P937, DOI 10.1093/bioinformatics/bth010; Scott MS, 2004, GENOME RES, V14, P1957, DOI 10.1101/gr.2650004; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711	45	350	367	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1265	1281		10.1016/j.cell.2006.10.036	http://dx.doi.org/10.1016/j.cell.2006.10.036			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174899	Bronze			2022-12-01	WOS:000242991000022
J	McKeegan, KD; Aleon, J; Bradley, J; Brownlee, D; Busemann, H; Butterworth, A; Chaussidon, M; Fallon, S; Floss, C; Gilmour, J; Gounelle, M; Graham, G; Guan, YB; Heck, PR; Hoppe, P; Hutcheon, ID; Huth, J; Ishii, H; Ito, M; Jacobsen, SB; Kearsley, A; Leshin, LA; Liu, MC; Lyon, I; Marhas, K; Marty, B; Matrajt, G; Meibom, A; Messenger, S; Mostefaoui, S; Mukhopadhyay, S; Nakamura-Messenger, K; Nittler, L; Palma, R; Pepin, RO; Papanastassiou, DA; Robert, F; Schlutter, D; Snead, CJ; Stadermann, FJ; Stroud, R; Tsou, P; Westphal, A; Young, ED; Ziegler, K; Zimmermann, L; Zinner, E				McKeegan, Kevin D.; Aleon, Jerome; Bradley, John; Brownlee, Donald; Busemann, Henner; Butterworth, Anna; Chaussidon, Marc; Fallon, Stewart; Floss, Christine; Gilmour, Jamie; Gounelle, Matthieu; Graham, Giles; Guan, Yunbin; Heck, Philipp R.; Hoppe, Peter; Hutcheon, Ian D.; Huth, Joachim; Ishii, Hope; Ito, Motoo; Jacobsen, Stein B.; Kearsley, Anton; Leshin, Laurie A.; Liu, Ming-Chang; Lyon, Ian; Marhas, Kuljeet; Marty, Bernard; Matrajt, Graciela; Meibom, Anders; Messenger, Scott; Mostefaoui, Smail; Mukhopadhyay, Sujoy; Nakamura-Messenger, Keiko; Nittler, Larry; Palma, Russ; Pepin, Robert O.; Papanastassiou, Dimitri A.; Robert, Francois; Schlutter, Dennis; Snead, Christopher J.; Stadermann, Frank J.; Stroud, Rhonda; Tsou, Peter; Westphal, Andrew; Young, Edward D.; Ziegler, Karen; Zimmermann, Laurent; Zinner, Ernst			Isotopic compositions of cometary matter returned by Stardust	SCIENCE			English	Article							INTERPLANETARY DUST PARTICLES; CRYSTALLINE SILICATES; HALE-BOPP; OXYGEN ISOTOPES; ORGANIC-MATTER; METEORITES; NITROGEN; PRESOLAR; ORIGIN; RATIOS	Hydrogen, carbon, nitrogen, and oxygen isotopic compositions are heterogeneous among comet 81P/Wild 2 particle fragments; however, extreme isotopic anomalies are rare, indicating that the comet is not a pristine aggregate of presolar materials. Nonterrestrial nitrogen and neon isotope ratios suggest that indigenous organic matter and highly volatile materials were successfully collected. Except for a single O-17-enriched circumstellar stardust grain, silicate and oxide minerals have oxygen isotopic compositions consistent with solar system origin. One refractory grain is O-16-enriched, like refractory inclusions in meteorites, suggesting that Wild 2 contains material formed at high temperature in the inner solar system and transported to the Kuiper belt before comet accretion.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Ctr Spectrometrie Nucl & Spectrometrie Masse, F-91405 Orsay, France; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94550 USA; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; Washington Univ, Dept Phys, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; Museum Natl Hist Nat, Lab Etud Mat Extraterr, F-75005 Paris, France; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Max Planck Inst Chem, Particle Chem Dept, D-55128 Mainz, Germany; NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Astromat Res Explorat Sci Directorate, Houston, TX 77058 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Nat Hist Museum, Dept Mineral, Impacts & Astromat Res Ctr, London SW7 5BD, England; NASA, Goddard Space Flight Ctr, Sci & Explorat Directorate, Greenbelt, MD 20771 USA; Jacobs Sverdrup, Houston, TX 77058 USA; Minnesota State Univ, Dept Phys & Astron, Mankato, MN 56001 USA; Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; CALTECH, Jet Prop Lab, Div Sci, Pasadena, CA 91109 USA; USN, Res Lab, Washington, DC 20375 USA	University of California System; University of California Los Angeles; UDICE-French Research Universities; Universite Paris Saclay; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Washington; University of Washington Seattle; Carnegie Institution for Science; University of California System; University of California Berkeley; Universite de Lorraine; Washington University (WUSTL); University of Manchester; Museum National d'Histoire Naturelle (MNHN); California Institute of Technology; Max Planck Society; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Harvard University; Imperial College London; Natural History Museum London; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Minnesota State Colleges & Universities; Minnesota State University Mankato; University of Minnesota System; University of Minnesota Twin Cities; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of Defense; United States Navy; Naval Research Laboratory	McKeegan, KD (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	mckeegan@ess.ucla.edu	Liu, Ming-Chang/D-1885-2010; Stroud, Rhonda/GQZ-0151-2022; Stroud, Rhonda M./C-5503-2008; Chaussidon, Marc/E-7067-2017; Heck, Philipp R/AAU-1433-2021; McKeegan, Kevin D/A-4107-2008; Stroud, Rhonda M/S-4584-2018; Matrajt, Graciela/A-4812-2017; Jacobsen, Stein/ABA-1063-2021; Heck, Philipp/C-6092-2012; Hoppe, Peter/B-3032-2015; Fallon, Stewart J/G-6645-2011; Jacobsen, Stein/B-1759-2013; Gilmour, Jamie/G-7515-2011	Liu, Ming-Chang/0000-0003-4030-5258; Stroud, Rhonda/0000-0001-5242-8015; Stroud, Rhonda M./0000-0001-5242-8015; Heck, Philipp R/0000-0002-6319-2594; McKeegan, Kevin D/0000-0002-1827-729X; Stroud, Rhonda M/0000-0001-5242-8015; Jacobsen, Stein/0000-0003-2164-0720; Hoppe, Peter/0000-0003-3681-050X; Fallon, Stewart J/0000-0002-8064-5903; Young, Edward/0000-0002-1299-0801; Gilmour, Jamie/0000-0003-1990-8636; Marhas, Kuljeet/0000-0002-3375-3047; Meibom, Anders/0000-0002-4542-2819; Ishii, Hope/0000-0002-7976-5078; Butterworth, Anna/0000-0002-6439-1472; Busemann, Henner/0000-0002-0867-6908	Science and Technology Facilities Council [PP/E000894/1] Funding Source: researchfish; STFC [PP/E000894/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Aleon J, 2003, GEOCHIM COSMOCHIM AC, V67, P3773, DOI [10.1016/S0016-7037(03)00170-4, 10.1016/S0016-7037(00)00170-4]; Aleon M, 2001, GEOCHIM COSMOCHIM AC, V65, P4399, DOI 10.1016/S0016-7037(01)00720-7; Arpigny C, 2003, SCIENCE, V301, P1522, DOI 10.1126/science.1086711; Bar-Nun A, 1998, ASTROPHYS SPACE SC L, V227, P353, DOI 10.1007/978-94-011-5252-5_15; Bockelee-Morvan D, 2002, ASTRON ASTROPHYS, V384, P1107, DOI 10.1051/0004-6361:20020086; Bouwman J, 2003, ASTRON ASTROPHYS, V401, P577, DOI 10.1051/0004-6361:20030043; Bouwman J, 2001, ASTRON ASTROPHYS, V375, P950, DOI 10.1051/0004-6361:20010878; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; Clayton DD, 2004, ANNU REV ASTRON ASTR, V42, P39, DOI 10.1146/annurev.astro.42.053102.134022; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.ea.21.050193.000555; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; Floss C, 2006, GEOCHIM COSMOCHIM AC, V70, P2371, DOI 10.1016/j.gca.2006.01.023; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Hashizume K, 2004, ASTROPHYS J, V600, P480, DOI 10.1086/379637; HUISEMEKERS D, 2005, ASTRON ASTROPHYS, V440, pL21; Jehin E, 2004, ASTROPHYS J, V613, pL161, DOI 10.1086/425254; Jessberger EK, 1999, SPACE SCI REV, V90, P91, DOI 10.1023/A:1005233727874; Jewitt DC, 1997, SCIENCE, V278, P90, DOI 10.1126/science.278.5335.90; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; LIFFMAN K, 1995, ICARUS, V116, P275, DOI 10.1006/icar.1995.1126; MCKEEGAN KD, 1987, SCIENCE, V237, P1468, DOI 10.1126/science.237.4821.1468; McKeegan KD, 2001, REV MINERAL GEOCHEM, V43, P279, DOI 10.2138/gsrmg.43.1.279; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2003, SPACE SCI REV, V106, P155, DOI 10.1023/A:1024637704533; MESSENGER S, 1997, AIP C P, V402, P545; Molster F, 2005, SPACE SCI REV, V119, P3, DOI 10.1007/s11214-005-8066-x; Nittler LR, 1997, AIP CONF PROC, P59, DOI 10.1063/1.51767; Owen T, 2003, SPACE SCI REV, V106, P121, DOI 10.1023/A:1024633603624; ROBERT F, 1982, GEOCHIM COSMOCHIM AC, V46, P81, DOI 10.1016/0016-7037(82)90293-9; Shu FH, 1996, SCIENCE, V271, P1545, DOI 10.1126/science.271.5255.1545; van Boekel R, 2004, NATURE, V432, P479, DOI 10.1038/nature03088; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	33	329	331	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1724	1728		10.1126/science.1135992	http://dx.doi.org/10.1126/science.1135992			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170292				2022-12-01	WOS:000242833600044
J	Behrenfeld, MJ; O'Malley, RT; Siegel, DA; McClain, CR; Sarmiento, JL; Feldman, GC; Milligan, AJ; Falkowski, PG; Letelier, RM; Boss, ES				Behrenfeld, Michael J.; O'Malley, Robert T.; Siegel, David A.; McClain, Charles R.; Sarmiento, Jorge L.; Feldman, Gene C.; Milligan, Allen J.; Falkowski, Paul G.; Letelier, Ricardo M.; Boss, Emmanuel S.			Climate-driven trends in contemporary ocean productivity	NATURE			English	Article							EL-NINO; EQUATORIAL PACIFIC; EXPORT PRODUCTION; WORLDS OCEANS; PERIOD	Contributing roughly half of the biosphere's net primary production (NPP)(1,2), photosynthesis by oceanic phytoplankton is a vital link in the cycling of carbon between living and inorganic stocks. Each day, more than a hundred million tons of carbon in the form of CO2 are fixed into organic material by these ubiquitous, microscopic plants of the upper ocean, and each day a similar amount of organic carbon is transferred into marine ecosystems by sinking and grazing. The distribution of phytoplankton biomass and NPP is defined by the availability of light and nutrients ( nitrogen, phosphate, iron). These growth-limiting factors are in turn regulated by physical processes of ocean circulation, mixed-layer dynamics, upwelling, atmospheric dust deposition, and the solar cycle. Satellite measurements of ocean colour provide a means of quantifying ocean productivity on a global scale and linking its variability to environmental factors. Here we describe global ocean NPP changes detected from space over the past decade. The period is dominated by an initial increase in NPP of 1,930 teragrams of carbon a year (Tg C yr(-1)), followed by a prolonged decrease averaging 190 Tg C yr(-1). These trends are driven by changes occurring in the expansive stratified low-latitude oceans and are tightly coupled to coincident climate variability. This link between the physical environment and ocean biology functions through changes in upper-ocean temperature and stratification, which influence the availability of nutrients for phytoplankton growth. The observed reductions in ocean productivity during the recent post-1999 warming period provide insight on how future climate change can alter marine food webs.	Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; Oregon State Univ, Coll Oceanog & Atmospher Sci, Corvallis, OR 97331 USA; Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Univ Maine, Sch Marine Sci, Orono, ME 04469 USA	Oregon State University; Oregon State University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Maine System; University of Maine Orono	Behrenfeld, MJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, 2082 Cordley Hall, Corvallis, OR 97331 USA.	mjb@science.oregonstate.edu	Smith, Christa/G-3187-2010; Boss, Emmanuel/C-5765-2009; Boss, Emmanuel/AAF-2336-2019; Letelier, Ricardo/A-6953-2009; Siegel, David A/C-5587-2008	Boss, Emmanuel/0000-0002-8334-9595; Boss, Emmanuel/0000-0002-8334-9595; Letelier, Ricardo/0000-0003-3376-4026; 				Bailey SW, 2006, REMOTE SENS ENVIRON, V102, P12, DOI 10.1016/j.rse.2006.01.015; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Le Quere C, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000920; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; MOREL A, 1989, LIMNOL OCEANOGR, V34, P1545, DOI 10.4319/lo.1989.34.8.1545; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Siegel DA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002527; Turk D, 2001, SCIENCE, V293, P471, DOI 10.1126/science.1056449; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; WOLTER K, 1987, J CLIM APPL METEOROL, V26, P540, DOI 10.1175/1520-0450(1987)026<0540:TSOISC>2.0.CO;2; Wolter K, 1993, P 17 CLIM DIAGN WORK, P52	26	1478	1537	53	1098	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					752	755		10.1038/nature05317	http://dx.doi.org/10.1038/nature05317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151666				2022-12-01	WOS:000242581100059
J	Schmidt, D; Jiang, QX; MacKinnon, R				Schmidt, Daniel; Jiang, Qiu-Xing; MacKinnon, Roderick			Phospholipids and the origin of cationic gating charges in voltage sensors	NATURE			English	Article							DEPENDENT K+ CHANNEL; CRYSTAL-STRUCTURE; ACTIVATION; MEMBRANE	Cells communicate with their external environment through physical and chemical processes that take place in the cell-surrounding membrane. The membrane serves as a barrier as well as a special environment in which membrane proteins are able to carry out important processes. Certain membrane proteins have the ability to detect the membrane voltage and regulate ion conduction or enzyme activity(1,2). Such voltage-dependent processes rely on the action of protein domains known as voltage sensors, which are embedded inside the cell membrane and contain an excess of positively charged amino acids, which react to an electric field. How does the membrane create an environment suitable for voltage sensors? Here we show under a variety of conditions that the function of a voltage-dependent K+ channel is dependent on the negatively charged phosphodiester of phospholipid molecules. A non-voltage-dependent K+ channel does not exhibit the same dependence. The data lead us to propose that the phospholipid membrane, by providing stabilizing interactions between positively charged voltage-sensor arginine residues and negatively charged lipid phosphodiester groups, provides an appropriate environment for the energetic stability and operation of the voltage-sensing machinery. We suggest that the usage of arginine residues in voltage sensors is an adaptation to the phospholipid composition of cell membranes.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu	Jiang, Qiu-Xing/AAI-8579-2020; Jiang, Qiu-Xing/ABF-1143-2021		NIGMS NIH HHS [R01 GM043949] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campbell RB, 2001, BBA-BIOMEMBRANES, V1512, P27, DOI 10.1016/S0005-2736(01)00290-5; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hui KY, 2003, J GEN PHYSIOL, V122, P63, DOI 10.1085/jgp.200308842; ISRAELACHVILI JN, 1991, INTERMOLECULAR SURFA, P366; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; MacDonald RC, 1999, BIOPHYS J, V77, P2612, DOI 10.1016/S0006-3495(99)77095-5; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; Miller C., 1986, ION CHANNEL RECONSTI; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; SUN TY, 1994, BIOCHEMISTRY-US, V33, P9992, DOI 10.1021/bi00199a024	20	336	341	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					775	779		10.1038/nature05416	http://dx.doi.org/10.1038/nature05416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17136096				2022-12-01	WOS:000242581100064
J	McDonel, P; Jans, J; Peterson, BK; Meyer, BJ				McDonel, Patrick; Jans, Judith; Peterson, Brant K.; Meyer, Barbara J.			Clustered DNA motifs mark X chromosomes for repression by a dosage compensation complex	NATURE			English	Article							CONDENSIN SUBUNIT; GENE; HETEROCHROMATIN	Gene expression in metazoans is regulated not only at the level of individual genes but also in a coordinated manner across large chromosomal domains ( for example centromeres, telomeres and imprinted gene clusters(1-3)) and along entire chromosomes ( for example X-chromosome dosage compensation(4-6)). The primary DNA sequence usually specifies the regulation of individual genes, but the nature of cis-acting information that controls genes over large regions has been elusive: higher-order DNA structure, specific histone modifications, subnuclear compartmentalization and primary DNA sequence are possibilities. One paradigm of chromosome-wide gene regulation is Caenorhabditis elegans dosage compensation in which a large dosage compensation complex (DCC) is targeted to both X chromosomes of hermaphrodites to repress transcript levels by half(6). This essential process equalizes X-linked gene expression between the sexes (XO males and XX hermaphrodites). Here we report the discovery and dissection of cis-acting sites that mark nematode X chromosomes as targets for gene repression by the DCC. These rex ( recruitment element on X) sites are widely dispersed along X and reside in promoters, exons and intergenic regions. rex sites share at least two distinct motifs that act in combination to recruit the DCC. Mutating these motifs severely reduces or abolishes DCC binding in vivo, demonstrating the importance of primary DNA sequence in chromosome-wide regulation. Unexpectedly, the motifs are not enriched on X, but altering motif numbers within rex sites demonstrates that motif co-occurrence in unusually high densities is essential for optimal DCC recruitment. Thus, X-specific repression is established through sequences not specific to X. The distribution of common motifs provides the foundation for repression along an entire chromosome.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, 16 Barker Hall, Berkeley, CA 94720 USA.	bjmeyer@berkeley.edu		Jans, Judith/0000-0003-0960-6263; Peterson, Brant/0000-0002-0433-3035; Meyer, Barbara/0000-0002-6530-4588	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030702] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM030702, R01 GM030702-28] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Bailey T.L., 1994, P 2 INT C INT SYST M, V2, P28; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Cobbe N, 2006, GENETICS, V172, P991, DOI 10.1534/genetics.105.050567; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Dahlsveen IK, 2006, PLOS GENET, V2, P104, DOI 10.1371/journal.pgen.0020005; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Dej KJ, 2004, GENETICS, V168, P895, DOI 10.1534/genetics.104.030908; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; MEYER BJ, 2005, X CHROMOSOME DOSAGE; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Nusinow DA, 2005, CURR OPIN GENET DEV, V15, P206, DOI 10.1016/j.gde.2005.02.002; Reik W, 2004, COLD SPRING HARB SYM, V69, P29, DOI 10.1101/sqb.2004.69.29; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002	21	78	83	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					614	618		10.1038/nature05338	http://dx.doi.org/10.1038/nature05338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17122774	Green Accepted			2022-12-01	WOS:000242377600047
J	Serra, HG; Duvick, L; Zu, T; Carlson, K; Stevens, S; Jorgensen, N; Lysholm, A; Burright, E; Zoghbi, HY; Clark, HB; Andresen, JM; Orr, HT				Serra, Heliane G.; Duvick, Lisa; Zu, Tao; Carlson, Kerri; Stevens, Sam; Jorgensen, Nathan; Lysholm, Alana; Burright, Eric; Zoghbi, Huda Y.; Clark, H. Brent; Andresen, J. Michael; Orr, Harry T.			ROR alpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice	CELL			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; ORPHAN NUCLEAR RECEPTOR; POLYGLUTAMINE-INDUCED DISEASE; STAGGERER MUTANT MICE; LONG-TERM DEPRESSION; TRANSGENIC MICE; NEURODEGENERATIVE DISORDER; EXPRESSION ANALYSIS; DEFICIENT MICE; AXH DOMAIN	Spinocerebellar ataxia type 1 (SCA1) is one of nine inherited, typically adult onset, polyglutamine neurodegenerative diseases. To examine whether development impacts SCA1, we used a conditional transgenic mouse model of SCA1 to delay the postnatal expression of mutant ATXN1 until after completion of cerebellar development. Delayed postnatal expression of mutant ATXN1 led to a substantial reduction in severity of disease in adults in comparison with early postnatal gene expression. This was linked to a destabilization of ROR alpha, a transcription factor critical for cerebellar development. In SCA1 mice, there was a depletion of ROR alpha and a reduction in expression of genes controlled by ROR alpha. Partial loss of RORa enhanced mutant ATXN1 pathogenicity. Additionally, evidence points to the existence of a complex containing ATXN1, ROR alpha, and the ROR alpha coactivator Tip60. These studies indicate ROR alpha and Tip60 have a role in SCA1 and suggest a mechanism by which compromising cerebellar development contributes to severity of neurodegeneration in an adult.	Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Orr, HT (corresponding author), Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA.	orrxx002@umn.edu		Zoghbi, Huda/0000-0002-0700-3349; Andresen, J. Michael/0000-0002-8791-1266; Orr, Harry/0000-0001-6118-741X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699, R01NS022920, R01NS045667, R37NS022920] Funding Source: NIH RePORTER; NINDS NIH HHS [NS45667, NS22920, NS27699] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Airaksinen MS, 1997, P NATL ACAD SCI USA, V94, P1488, DOI 10.1073/pnas.94.4.1488; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; Banfi S, 1996, HUM MOL GENET, V5, P33, DOI 10.1093/hmg/5.1.33; Boukhtouche F, 2006, J NEUROSCI, V26, P1531, DOI 10.1523/JNEUROSCI.4636-05.2006; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Burright EN, 1997, HUM MOL GENET, V6, P513, DOI 10.1093/hmg/6.4.513; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; Clark HB, 2000, J NEUROPATH EXP NEUR, V59, P265, DOI 10.1093/jnen/59.4.265; Clark HB, 1997, J NEUROSCI, V17, P7385; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Hadj-Sahraoui N, 2001, DEV BRAIN RES, V126, P201, DOI 10.1016/S0165-3806(01)00095-5; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; HATTEN ME, 1978, NATURE, V276, P504, DOI 10.1038/276504a0; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311, DOI 10.1177/002215540405200302; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LANDIS DMD, 1978, J COMP NEUROL, V179, P831, DOI 10.1002/cne.901790408; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; MATSUMOTO M, 1996, NATURE, V379, P169; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Moraitis AN, 2003, J BIOL CHEM, V278, P52511, DOI 10.1074/jbc.M308152200; Nakagawa S, 1997, NEUROSCI RES, V28, P177, DOI 10.1016/S0168-0102(97)00042-4; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; Skinner PJ, 2002, NEUROMOL MED, V1, P33, DOI 10.1385/NMM:1:1:33; Skinner PJ, 1997, NATURE, V389, P971, DOI 10.1038/40153; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; TSUDA H, 2005, IN PRESS CELL; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	50	159	163	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					697	708		10.1016/j.cell.2006.09.036	http://dx.doi.org/10.1016/j.cell.2006.09.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110330	Bronze			2022-12-01	WOS:000242330600017
J	Ginsburg, PB				Ginsburg, Paul B.			Recalibrating Medicare payments for inpatient care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Studying Hlth Syst Change, Washington, DC USA		Ginsburg, PB (corresponding author), Ctr Studying Hlth Syst Change, Washington, DC USA.							BERENSON RA, 2006, HLTH AFFAIRS    0725; GINSBURG PB, 2005, PRICE ISNT RIGHT INA; *MED PAYM ADV COMM, 2005, REP C PHYS OWN SPEC; 2006, FED REG, V71, P47915	4	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2061	2064		10.1056/NEJMp068203	http://dx.doi.org/10.1056/NEJMp068203			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104YU	17108339				2022-12-01	WOS:000241997300001
J	McCarthy, EP; Ngo, LH; Roetzheim, RG; Chirikos, TN; Li, DL; Drews, RE; Iezzoni, LI				McCarthy, Ellen P.; Ngo, Long H.; Roetzheim, Richard G.; Chirikos, Thomas N.; li, Dongn Li; Drews, Reed E.; Iezzoni, Lisa I.			Disparities in breast cancer treatment and survival for women with disabilities	ANNALS OF INTERNAL MEDICINE			English	Article							20-YEAR FOLLOW-UP; OLDER WOMEN; CONSERVING SURGERY; STAGE-I; CONSERVATION THERAPY; AXILLARY DISSECTION; CARCINOMA TREATMENT; RADICAL-MASTECTOMY; RANDOMIZED-TRIAL; PATTERNS	Background: Breast-conserving surgery combined with axillary lymph node dissection and radiotherapy or mastectomy are definitive treatments for women with early-stage breast cancer. Little is known about breast cancer treatment for women with disabilities. Objective: To compare initial treatment for early-stage breast cancer between women with and without disabilities and to examine the association of treatment differences and survival. Design:Retrospective cohort study. Setting: 11 Surveillance, Epidemiology, and End Results (SEER) Program tumor registries. Participants: 100 311 women who received a diagnosis of stage I to IIIA breast cancer at 21 to 64 years of age from 1988 to 1999. Women who qualified for Social Security Disability Insurance (SSDI) and Medicare at breast cancer diagnosis were considered disabled. Measurements: Receipt of breast-conserving surgery versus mastectomy. For women who had breast-conserving surgery (n = 49 166), the authors examined receipt of radiotherapy and axillary lymph node dissection. Survival was measured from diagnosis until death or until 31 December 2001. Results: Women with SSDI and Medicare coverage had lower rates of breast-conserving surgery than other women (43.2% vs. 49.2%; adjusted relative risk, 0.80 [95% Cl, 0.76 to 0.84]). Among women who had breast-conserving surgery, women with SSDI and Medicare coverage were less likely than other women to receive radiotherapy (adjusted relative risk, 0.83 [Cl, 0.77 to 0.90]) and axillary lymph node dissection (adjusted relative risk, 0.81 [Cl, 0.74 to 0.90]). Women with SSDI and Medicare coverage had lower survival rates than those of other women in all-cause mortality (adjusted hazard ratio, 2.02 [Cl, 1.88 to 2.16]) and breast cancer-specific mortality (adjusted hazard ratio, 1.31 [Cl, 1.18 to 1.45]). Results were similar after adjustment for treatment differences. Limitations: Findings are limited to women who qualified for SSDI and Medicare. No data on adjuvant chemotherapy and hormonal therapy were available, and details about the underlying disability were lacking. Conclusions: Women with disabilities had higher breast cancer mortality rates and were less likely to undergo standard therapy after breast-conserving surgery than other women. Differences in treatment did not explain the differences in breast cancer mortality rates.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	McCarthy, EP (corresponding author), Harvard Univ, Sch Med, Div Gen Med & Primary Care, Beth Israel Deaconess Med Ctr,Dept Med, 1309 Beacon St,Suite 220, Brookline, MA 02444 USA.	emccarth@bidmc.harvard.edu	Roetzheim, Richard/J-4696-2012		NCI NIH HHS [R01 CA100029, R01 CA100029-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE O, 1995, NEW ENGL J MED, V333, P1444; Albain KS, 1996, J CLIN ONCOL, V14, P3009, DOI 10.1200/JCO.1996.14.11.3009; Asch Adrienne, 1988, WOMEN DISABILITIES E, P1; Basnett Ian, 2001, HDB DISABILITY STUDI, P450; Brown P, 2004, SOCIOL HEALTH ILL, V26, P50, DOI 10.1111/j.1467-9566.2004.00378.x; Buchholz TA, 2006, J CLIN ONCOL, V24, P361, DOI 10.1200/JCO.2005.02.3127; Caban ME, 2002, CANCER-AM CANCER SOC, V94, P1391, DOI 10.1002/cncr.10369; Cooper GS, 2002, MED CARE, V40, P43; Du XL, 2002, BREAST CANCER RES TR, V72, P23, DOI 10.1023/A:1014908802632; Du XL, 2001, J CLIN ONCOL, V19, P1455, DOI 10.1200/JCO.2001.19.5.1455; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Eddey GE, 2005, ACAD MED, V80, P706, DOI 10.1097/00001888-200507000-00019; Edge SB, 2002, CANCER, V94, P2534, DOI 10.1002/cncr.10540; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; FLANDERS WD, 1987, J CHRON DIS, V40, P697, DOI 10.1016/0021-9681(87)90106-8; GERHART KA, 1994, ANN EMERG MED, V23, P807, DOI 10.1016/S0196-0644(94)70318-3; Gill C., 2001, HDB DISABILITY STUDI, P351, DOI DOI 10.4135/9781412976251.N14; Goodwin JS, 2004, J AM GERIATR SOC, V52, P106, DOI 10.1111/j.1532-5415.2004.52018.x; Guadagnoli E, 1998, CANCER-AM CANCER SOC, V83, P302, DOI 10.1002/(SICI)1097-0142(19980715)83:2<302::AID-CNCR14>3.0.CO;2-X; Guadagnoli E, 1998, J CLIN ONCOL, V16, P101, DOI 10.1200/JCO.1998.16.1.101; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; Hiotis K, 2005, CANCER-AM CANCER SOC, V103, P892, DOI 10.1002/cncr.20853; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; IEZZONI L, 2003, WHEN WALKING FAILS M; Iezzoni L., 2006, MORE RAMPS GUIDE IMP; Iezzoni LI, 2003, ARCH INTERN MED, V163, P2085, DOI 10.1001/archinte.163.17.2085; Iezzoni LI, 2002, MILBANK Q, V80, P347, DOI 10.1111/1468-0009.t01-1-00007; IEZZONI LI, 2003, RISK ADJUSTMENT MEAS, P363; Joslyn SA, 2002, CANCER, V95, P1759, DOI 10.1002/cncr.10827; Keating NL, 2002, J CLIN ONCOL, V20, P1473, DOI 10.1200/JCO.20.6.1473; Lantz PM, 2005, HEALTH SERV RES, V40, P745, DOI 10.1111/j.1475-6773.2005.00383.x; Lanz NK, 2004, J CLIN ONCOL, V22, P3091, DOI 10.1200/JCO.2004.09.069; Lee E, 2013, STAT METHODS SURVIVA; LICHTER AS, 1992, J CLIN ONCOL, V10, P976, DOI 10.1200/JCO.1992.10.6.976; LIJEGREN G, 1994, JNCI-J NATL CANCER I, V86, P717; Maggard MA, 2005, ANN SURG ONCOL, V12, P41, DOI 10.1007/s10434-004-1168-y; Maly RC, 2004, J AM GERIATR SOC, V52, P1138, DOI 10.1111/j.1532-5415.2004.52312.x; Mandelblatt JS, 2000, CANCER, V89, P561, DOI 10.1002/1097-0142(20000801)89:3<561::AID-CNCR11>3.0.CO;2-A; MCCARTHY EP, 2006, HLTH SERV RES   0817, P17; Michalski TA, 1997, CANCER-AM CANCER SOC, V79, P314; MORRIS J, 1996, PRIDE AGAINST PREJUD; National Comprehensive Cancer Network, 2006, CLIN PRACT GUID ONC; Office of the Surgeon General (US) Office on Disability (US), 2005, SURG GEN CALL ACTION; Olkin R., 1999, WHAT PSYCHOTHERAPIST; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Pierce LJ, 2005, INT J RADIAT ONCOL, V62, P183, DOI 10.1016/j.ijrobp.2004.09.019; POTOSKY AL, 1993, MED CARE, V31, P732; Prehn AW, 2002, CANCER, V95, P2268, DOI 10.1002/cncr.10965; Roetzheim RG, 2000, CANCER-AM CANCER SOC, V89, P2202, DOI 10.1002/1097-0142(20001201)89:11<2202::AID-CNCR8>3.0.CO;2-L; SARRAZIN D, 1984, CANCER, V53, P1209, DOI 10.1002/1097-0142(19840301)53:5<1209::AID-CNCR2820530531>3.0.CO;2-Y; SATARIANO ER, 1992, AM J PUBLIC HEALTH, V82, P195, DOI 10.2105/AJPH.82.2.195; SCHACHTER H, 2004, AHRQ PUBLICATION; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; *US SOC SEC ADM, 2003, ANN STAT S 2003 BALT; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Warren JL, 2002, MED CARE, V40, P3; White J, 2003, CANCER-AM CANCER SOC, V97, P893, DOI 10.1002/cncr.11141	58	96	97	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					637	645		10.7326/0003-4819-145-9-200611070-00005	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	100ZD	17088576	Green Accepted			2022-12-01	WOS:000241707800001
J	Conti, B; Sanchez-Alavez, M; Winsky-Sommerer, R; Morale, MC; Lucero, J; Brownell, S; Fabre, V; Huitron-Resendiz, S; Henriksen, S; Zorrilla, EP; de Lecea, L; Bartfai, T				Conti, Bruno; Sanchez-Alavez, Manuel; Winsky-Sommerer, Raphaelle; Morale, Maria Concetta; Lucero, Jacinta; Brownell, Sara; Fabre, Veronique; Huitron-Resendiz, Salvador; Henriksen, Steven; Zorrilla, Eric P.; de Lecea, Luis; Bartfai, Tamas			Transgenic mice with a reduced core body temperature have an increased life span	SCIENCE			English	Article							DIETARY RESTRICTION; DROSOPHILA-MELANOGASTER; OREXIN-A; HYPOTHALAMUS; NEURONS; THERMOREGULATION; HYPOCRETINS; MORTALITY; DISEASE; GROWTH	Reduction of core body temperature has been proposed to contribute to the increased life span and the antiaging effects conferred by calorie restriction (CR). Validation of this hypothesis has been difficult in homeotherms, primarily due to a lack of experimental models. We report that transgenic mice engineered to overexpress the uncoupling protein 2 in hypocretin neurons (Hcrt-UCP2) have elevated hypothalamic temperature. The effects of local temperature elevation on the central thermostat resulted in a 0.3 degrees to 0.5 degrees C reduction of the core body temperature. Fed ad libitum, Hcrt-UCP2 transgenic mice had the same caloric intake as their wild-type littermates but had increased energy efficiency and a greater median life span (12% increase in males; 20% increase in females). Thus, modest, sustained reduction of core body temperature prolonged life span independent of altered diet or CR.	Scripps Res Inst, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA; Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Conti, B (corresponding author), Scripps Res Inst, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA.	bconti@scripps.edu	de Lecea, Luis/B-3171-2009; Morale, Maria Concetta/D-5847-2017; de Lecea, Luis/ABE-4005-2021	de Lecea, Luis/0000-0002-8921-5942; Morale, Maria Concetta/0000-0003-0624-7234; de Lecea, Luis/0000-0002-8921-5942; Sanchez-Alavez, Manuel/0000-0002-8164-8452; Fabre, Veronique/0000-0003-3230-9435; Conti, Bruno/0000-0002-9185-5201	NIMH NIH HHS [MH58543] Funding Source: Medline; NINDS NIH HHS [NS043501] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043501] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Austad SN, 2003, AGING CELL, V2, P201, DOI 10.1046/j.1474-9728.2003.00053.x; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Chen HC, 2003, AM J PHYSIOL-ENDOC M, V284, pE213, DOI 10.1152/ajpendo.00248.2002; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Duffy PH, 1997, ENVIRON RES, V73, P242, DOI 10.1006/enrs.1997.3714; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Jaszberenyi M, 2002, REGUL PEPTIDES, V104, P55, DOI 10.1016/S0167-0115(01)00339-1; KOIZUMI A, 1992, J NUTR, V122, P1446, DOI 10.1093/jn/122.7.1446; LIU RK, 1966, NATURE, V212, P1277, DOI 10.1038/2121277a0; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mattson MP, 2000, BRAIN RES, V886, P47, DOI 10.1016/S0006-8993(00)02790-6; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; MIQUEL J, 1976, MECH AGEING DEV, V5, P347, DOI 10.1016/0047-6374(76)90034-8; Monda M, 2004, BRAIN RES, V1018, P265, DOI 10.1016/j.brainres.2004.05.084; Parmar MKB, 1995, SURVIVAL ANAL PRACTI; Partridge L, 2005, MECH AGEING DEV, V126, P35, DOI 10.1016/j.mad.2004.09.017; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Sutcliffe JG, 2002, NAT REV NEUROSCI, V3, P339, DOI 10.1038/nrn808; Szekely M, 2002, REGUL PEPTIDES, V104, P47, DOI 10.1016/S0167-0115(01)00348-2; Tatar Marc, 2001, P128; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yoshimichi G, 2001, EXP BIOL MED, V226, P468, DOI 10.1177/153537020122600513; Zhu HY, 1999, BRAIN RES, V842, P224, DOI 10.1016/S0006-8993(99)01827-2	29	259	275	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					825	828		10.1126/science.1132191	http://dx.doi.org/10.1126/science.1132191			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082459				2022-12-01	WOS:000241729800049
J	Howard, EC; Henriksen, JR; Buchan, A; Reisch, CR; Buergmann, H; Welsh, R; Ye, WY; Gonzalez, JM; Mace, K; Joye, SB; Kiene, RP; Whitman, WB; Moran, MA				Howard, Erinn C.; Henriksen, James R.; Buchan, Alison; Reisch, Chris R.; Buergmann, Helmut; Welsh, Rory; Ye, Wenying; Gonzalez, Jose M.; Mace, Kimberly; Joye, Samantha B.; Kiene, Ronald P.; Whitman, William B.; Moran, Mary Ann			Bacterial taxa that limit sulfur flux from the ocean	SCIENCE			English	Article							MARINE BACTERIOPLANKTON; DIMETHYLSULFONIOPROPIONATE; DMSP; SEA; DIMETHYLSULFIDE; ALGAE	Flux of dimethylsulfide (DMS) from ocean surface waters is the predominant natural source of sulfur to the atmosphere and influences climate by aerosol formation. Marine bacterioplankton regulate sulfur flux by converting the precursor dimethylsulfoniopropionate (DMSP) either to DMS or to sulfur compounds that are not climatically active. Through the discovery of a glycine cleavage T-family protein with DMSP methyltransferase activity, marine bacterioplankton in the Roseobacter and SAR11 taxa were identified as primary mediators of DMSP demethylation to methylmercaptopropionate. One-third of surface ocean bacteria harbor a DMSP demethylase homolog and thereby route a substantial fraction of global marine primary production away from DMS formation and into the marine microbial food web.	Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; Univ La Laguna, Dept Microbiol, Tenerife 38071, Spain; Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville; Universidad de la Laguna; University of South Alabama; Dauphin Island Sea Lab	Moran, MA (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	mmoran@uga.edu	Moran, Mary Ann/B-6939-2012; Burgmann, Helmut/E-8804-2011; Whitman, William/AAC-5896-2020; Gonzalez, Jose M./C-3333-2013; Buchan, Alison/A-9401-2010	Burgmann, Helmut/0000-0002-5651-5906; Gonzalez, Jose M./0000-0002-9926-3323; Joye, Samantha/0000-0003-1610-451X; Whitman, William/0000-0003-1229-0423; Henriksen, James/0000-0003-2485-0889; Moran, Mary Ann/0000-0002-0702-8167				ANDREAE MO, 1990, MAR CHEM, V30, P1, DOI 10.1016/0304-4203(90)90059-L; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Kettle AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P399, DOI 10.1029/1999GB900004; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vila M, 2004, APPL ENVIRON MICROB, V70, P4648, DOI 10.1128/AEM.70.8.4648-4657.2004; VISSCHER PT, 1992, MAR ECOL PROG SER, V89, P293, DOI 10.3354/meps089293; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168	20	243	265	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					649	652		10.1126/science.1130657	http://dx.doi.org/10.1126/science.1130657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068264				2022-12-01	WOS:000241557800048
J	Dar-Nimrod, I; Heine, SJ				Dar-Nimrod, Ilan; Heine, Steven J.			Exposure to scientific theories affects women's math performance	SCIENCE			English	Article							STEREOTYPE THREAT		Univ British Columbia, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Heine, SJ (corresponding author), Univ British Columbia, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	heine@psych.ubc.ca	Dar Nimrod, Ilan/C-9746-2011; Heine, Steven/C-6975-2011; Dar-Nimrod, Ilan/AAX-2441-2020	Dar-Nimrod, Ilan/0000-0003-2308-3673	NIMH NIH HHS [R01 MH60155-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060155] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aronson J, 2002, J EXP SOC PSYCHOL, V38, P113, DOI 10.1006/jesp.2001.1491; Monterosso J, 2005, ETHICS BEHAV, V15, P139, DOI 10.1207/s15327019eb1502_4; Prentice DA, 2006, PSYCHOL SCI, V17, P129, DOI 10.1111/j.1467-9280.2006.01675.x; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; SUMMERS LH, 2005, NBER C DIV SCI ENG W	6	179	180	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					435	435		10.1126/science.1131100	http://dx.doi.org/10.1126/science.1131100			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	096MW	17053140				2022-12-01	WOS:000241382500032
J	Park, B; Lee, S; Kim, E; Cho, K; Riddell, SR; Cho, S; Ahn, K				Park, Boyoun; Lee, Sungwook; Kim, Eunkyung; Cho, Kwangmin; Riddell, Stanley R.; Cho, Sunglim; Ahn, Kwangseog			Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing	CELL			English	Article							PROTEIN DISULFIDE-ISOMERASE; TAP-TRANSLOCATED PEPTIDES; ENDOPLASMIC-RETICULUM; LOADING COMPLEX; OXIDOREDUCTASE ERP57; BOND FORMATION; HLA-DM; MOLECULES; OPTIMIZATION; DEGRADATION	Activated CD8(+) T cells discriminate infected and tumor cells from normal self by recognizing MHC class I-bound peptides on the surface of antigen-presenting cells. The mechanism by which MHC class I molecules select optimal peptides against a background of prevailing suboptimal peptides and in a considerably proteolytic ER environment remained unknown. Here, we identify protein disulfide isomerase (PDI), an enzyme critical to the formation of correct disulfide bonds in proteins, as a component of the peptide-loading complex. We show that PDI stabilizes a peptide-receptive site by regulating the oxidation state of the disulfide bond in the MHC peptide-binding groove, a function that is essential for selecting optimal peptides. Furthermore, we demonstrate that human cytomegalovirus US3 protein inhibits CD8(+) T cell recognition by mediating PDI degradation, verifying the functional relevance of PDI-catalyzed peptide editing in controlling intracellular pathogens. These results establish a link between thiol-based redox regulation and antigen processing.	Seoul Natl Univ, Dept Biol Sci, Natl Creat Res Ctr Antigen Presentat, Seoul 151747, South Korea; Korea Univ, Coll Life Sci, Seoul 136701, South Korea; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Res Ctr Funct Cellulom, Seoul 151747, South Korea	Seoul National University (SNU); Korea University; Fred Hutchinson Cancer Center	Ahn, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Natl Creat Res Ctr Antigen Presentat, Seoul 151747, South Korea.	ksahn@snu.ac.kr	Lee, Sungwook/K-3697-2013	CHO, KWANGMIN/0000-0001-6764-1425				Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Antoniou AN, 2002, EMBO J, V21, P2655, DOI 10.1093/emboj/21.11.2655; Bahk YY, 2004, PROTEOMICS, V4, P3299, DOI 10.1002/pmic.200400980; Bangia N, 1999, EUR J IMMUNOL, V29, P1858, DOI 10.1002/(SICI)1521-4141(199906)29:06<1858::AID-IMMU1858>3.0.CO;2-C; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Dick TP, 2004, CELL MOL LIFE SCI, V61, P547, DOI 10.1007/s00018-003-3271-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Lammert E, 1997, EUR J IMMUNOL, V27, P1685, DOI 10.1002/eji.1830270714; Lehner PJ, 2003, IMMUNITY, V18, P315, DOI 10.1016/S1074-7613(03)00061-X; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; MOMBURG F, 1994, J EXP MED, V179, P1613, DOI 10.1084/jem.179.5.1613; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X; Montoya M, 1999, J IMMUNOL, V163, P1914; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Park BY, 2004, IMMUNITY, V20, P71, DOI 10.1016/S1074-7613(03)00355-8; PIMESKOSKI A, 2004, J BIOL CHEM, V279, P10374; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sijts AJAM, 1997, J EXP MED, V185, P1403, DOI 10.1084/jem.185.8.1403; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Spee P, 1997, EUR J IMMUNOL, V27, P2441, DOI 10.1002/eji.1830270944; Tector M, 1997, MOL IMMUNOL, V34, P401, DOI 10.1016/S0161-5890(97)00045-X; WARBURTON RJ, 1994, HUM IMMUNOL, V39, P261, DOI 10.1016/0198-8859(94)90269-0; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200	43	137	147	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					369	382		10.1016/j.cell.2006.08.041	http://dx.doi.org/10.1016/j.cell.2006.08.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055437	Bronze			2022-12-01	WOS:000241827100023
J	Nakabachi, A; Yamashita, A; Toh, H; Ishikawa, H; Dunbar, HE; Moran, NA; Hattori, M				Nakabachi, Atsushi; Yamashita, Atsushi; Toh, Hidehiro; Ishikawa, Hajime; Dunbar, Helen E.; Moran, Nancy A.; Hattori, Masahira			The 160-kilobase genome of the bacterial endosymbiont Carsonella	SCIENCE			English	Article									RIKEN, Environm Mol Biol Lab, Wako, Saitama 3510198, Japan; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Kitasato Univ, Kitasato Inst Life Sci, Kanagawa 2288555, Japan; Kitasato Inst, Ctr Basic Res, Minato Ku, Tokyo 1088641, Japan; Univ Air, Sch Gen Educ, Chiba 2618586, Japan; Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan; RIKEN, Genom Sci Ctr, Genome Core Technol Facil, Kanagawa 2300045, Japan	RIKEN; University of Arizona; Kitasato University; University of Tokyo; RIKEN	Nakabachi, A (corresponding author), RIKEN, Environm Mol Biol Lab, Wako, Saitama 3510198, Japan.	bachi@email.arizona.edu; hattori@k.u-tokyo.ac.jp	Moran, Nancy A/G-1591-2010; Hattori, Masahira/AAD-3785-2019; Nakabachi, Atsushi/H-1661-2011; Puigbò, Pere/A-2214-2008	Nakabachi, Atsushi/0000-0003-0281-1723; 					0	379	429	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					267	267		10.1126/science.1134196	http://dx.doi.org/10.1126/science.1134196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038615				2022-12-01	WOS:000241194100032
J	Kimchi-Sarfaty, C; Oh, JM; Kim, IW; Sauna, ZE; Calcagno, AM; Ambudkar, SV; Gottesman, MM				Kimchi-Sarfaty, Chava; Oh, Jung Mi; Kim, In-Wha; Sauna, Zuben E.; Calcagno, Anna Maria; Ambudkar, Suresh V.; Gottesman, Michael M.			A "silent" polymorphism in the MDR1 gene changes substrate specificity	SCIENCE			English	Article							SYNONYMOUS CODON USAGE; SINGLE-NUCLEOTIDE POLYMORPHISMS; MULTIDRUG-RESISTANCE GENE; P-GLYCOPROTEIN; MESSENGER-RNA; IN-VIVO; EXPRESSION; LINKAGE		NCI, Cell Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gottesman, MM (corresponding author), US FDA, Ctr Biol Evaluat & Res, 29 Lincoln Dr,Room 316, Bethesda, MD 20892 USA.	kimchi@cber.fda.gov; jmoh@snu.ac.kr; mgottesman@nih.gov	Calcagno, Anna Maria/A-5617-2012; Sauna, Zuben E./AAA-7149-2019; Ambudkar, Suresh V/L-1317-2016	Calcagno, Anna Maria/0000-0002-0804-2753; Kimchi-Sarfaty, Chava/0000-0002-9355-8585	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010030, Z01BC010030] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adzhubei AA, 1996, FEBS LETT, V399, P78, DOI 10.1016/S0014-5793(96)01287-2; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Anthony V, 2002, CURR PROTEIN PEPT SC, V3, P485, DOI 10.2174/1389203023380503; Bercovitch L, 2004, J AM ACAD DERMATOL, V51, pS13, DOI 10.1016/j.jaad.2004.01.015; Brunak S, 1996, PROTEINS, V25, P237, DOI 10.1002/(SICI)1097-0134(199606)25:2<237::AID-PROT9>3.3.CO;2-Y; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Drescher S, 2002, BRIT J CLIN PHARMACO, V53, P526, DOI 10.1046/j.1365-2125.2002.01591.x; Frittitta L, 2001, DIABETES, V50, P1952, DOI 10.2337/diabetes.50.8.1952; Goto M, 2002, PHARMACOGENETICS, V12, P451, DOI 10.1097/00008571-200208000-00005; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gribar JJ, 2000, J MEMBRANE BIOL, V173, P203, DOI 10.1007/s002320001020; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Horinouchi M, 2002, PHARMACEUT RES, V19, P1581, DOI 10.1023/A:1020433422259; Kimchi-Sarfaty C, 2002, MOL PHARMACOL, V62, P1, DOI 10.1124/mol.62.1.1; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Perloff MD, 2001, BRIT J PHARMACOL, V134, P1601, DOI 10.1038/sj.bjp.0704399; Ruth A, 2001, BIOCHEMISTRY-US, V40, P4332, DOI 10.1021/bi001373f; Salama NN, 2006, J PHARM SCI-US, V95, P2293, DOI 10.1002/jps.20717; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shen LX, 1999, P NATL ACAD SCI USA, V96, P7871, DOI 10.1073/pnas.96.14.7871; SIEMION IZ, 1994, BIOSYSTEMS, V33, P139, DOI 10.1016/0303-2647(94)90053-1; Supek F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-182; Tang K, 2002, PHARMACOGENETICS, V12, P437, DOI 10.1097/00008571-200208000-00004; Tran HTT, 2005, MOL GENET METAB, V85, P213, DOI 10.1016/j.ymgme.2005.03.006; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Xie T, 1998, FEBS LETT, V434, P93	29	1852	2107	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					525	528		10.1126/science.1135308	http://dx.doi.org/10.1126/science.1135308			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17185560	Green Published			2022-12-01	WOS:000243726600050
J	Gutierrez, E; Wiggins, D; Fielding, B; Gould, AP				Gutierrez, Eugenio; Wiggins, David; Fielding, Barbara; Gould, Alex P.			Specialized hepatocyte-like cells regulate Drosophila lipid metabolism	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; FAT STORAGE; BETA-OXIDATION; EGF RECEPTOR; MELANOGASTER; ACIDS; TRIACYLGLYCEROL; RESCUE; GROWTH; TISSUE	Lipid metabolism is essential for growth and generates much of the energy needed during periods of starvation. In Drosophila, fasting larvae release large quantities of lipid from the fat body but it is unclear how and where this is processed. Here we identify the oenocyte as the principal cell type accumulating lipid droplets during starvation. Tissue-specific manipulations of the Slimfast amino-acid channel, the Lsd2 fat-storage regulator and the Brummer lipase indicate that oenocytes act downstream of the fat body. In turn, oenocytes are required for depleting stored lipid from the fat body during fasting. Hence, lipid-metabolic coupling between the fat body and oenocytes is bidirectional. When food is plentiful, oenocytes have critical roles in regulating growth, development and feeding behaviour. In addition, they specifically express many different lipid-metabolizing proteins, including Cyp4g1, an omega-hydroxylase regulating triacylglycerol composition. These findings provide evidence that some lipid-processing functions of the mammalian liver are performed in insects by oenocytes.	Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Natl Inst Med Res, MRC, London NW7 1AA, England	University of Oxford; MRC National Institute for Medical Research	Gould, AP (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	agould@nimr.mrc.ac.uk	Gould, Alex/A-7479-2010; Gould, Alex/M-5353-2019	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985	MRC [MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117584237] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Beadle GW, 1938, BIOL BULL-US, V75, P447, DOI 10.2307/1537573; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brodu V, 2004, DEV CELL, V7, P885, DOI 10.1016/j.devcel.2004.10.016; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Burdge GC, 2000, BRIT J NUTR, V84, P781; BUTTERWORTH FM, 1965, J EXP ZOOL, V158, P141, DOI 10.1002/jez.1401580203; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Dantuma NP, 1999, J LIPID RES, V40, P973; Dean R.L., 1985, P155; DUERDEN JM, 1988, BIOCHEM J, V255, P929, DOI 10.1042/bj2550929; Elstob PR, 2001, DEVELOPMENT, V128, P723; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; GRISWOLD CM, 1993, GENETICS, V134, P781; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Keeley L.L., 1985, P211; KOLLER G, 1928, BIOL REV, V4, P269; KOSCHEVNIKOV G, 2000, Z ANZ, V23, P657; Landois L, 1865, Z WISS ZOOL, V15, P371; LAWRENCE PA, 1986, J EMBRYOL EXP MORPH, V91, P251; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee CS, 2003, INSECT BIOCHEM MOLEC, V33, P761, DOI 10.1016/S0965-1748(03)00066-3; Lillie RD, 1944, STAIN TECHNOL, V19, P55, DOI 10.3109/10520294409105827; Martin JF, 2000, MECH DEVELOP, V92, P155, DOI 10.1016/S0925-4773(99)00338-X; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Riddiford Lynn M., 1993, P899; Rusten TE, 2001, DEVELOPMENT, V128, P711; Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7; SUNDSETH SS, 1990, BIOCHEM J, V265, P213, DOI 10.1042/bj2650213; Teixeira L, 2003, MECH DEVELOP, V120, P1071, DOI 10.1016/S0925-4773(03)00158-8; TORNANCAK P, 2002, GENOME BIOL, V3, DOI UNSP RESEARCH0088; Ueyama M, 2005, INSECT BIOCHEM MOLEC, V35, P911, DOI 10.1016/j.ibmb.2005.03.007; Wanders RJA, 2003, ADV EXP MED BIOL, V544, P293; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wigglesworth VB, 1933, Q J MICROSC SCI, V76, P269; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Yu ST, 2003, CURR MOL MED, V3, P561, DOI 10.2174/1566524033479537; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zinke I, 1999, DEVELOPMENT, V126, P5275	49	286	291	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 18	2007	445	7125					275	280		10.1038/nature05382	http://dx.doi.org/10.1038/nature05382			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17136098				2022-12-01	WOS:000243504700036
J	Stuart, LM; Boulais, J; Charriere, GM; Hennessy, EJ; Brunet, S; Jutras, I; Goyette, G; Rondeau, C; Letarte, S; Huang, H; Ye, P; Morales, F; Kocks, C; Bader, JS; Desjardins, M; Ezekowitz, RAB				Stuart, L. M.; Boulais, J.; Charriere, G. M.; Hennessy, E. J.; Brunet, S.; Jutras, I.; Goyette, G.; Rondeau, C.; Letarte, S.; Huang, H.; Ye, P.; Morales, F.; Kocks, C.; Bader, J. S.; Desjardins, M.; Ezekowitz, R. A. B.			A systems biology analysis of the Drosophila phagosome	NATURE			English	Article							INTERACTION NETWORKS; PROTEIN NETWORKS; PHAGOCYTOSIS; EXOCYST; MACROPHAGES; IDENTIFICATION; EFFECTOR; RECEPTOR; EXOCYTOSIS; CONFIDENCE	Phagocytes have a critical function in remodelling tissues during embryogenesis and thereafter are central effectors of immune defence(1,2). During phagocytosis, particles are internalized into 'phagosomes', organelles from which immune processes such as microbial destruction and antigen presentation are initiated(3). Certain pathogens have evolved mechanisms to evade the immune system and persist undetected within phagocytes, and it is therefore evident that a detailed knowledge of this process is essential to an understanding of many aspects of innate and adaptive immunity. However, despite the crucial role of phagosomes in immunity, their components and organization are not fully defined. Here we present a systems biology analysis of phagosomes isolated from cells derived from the genetically tractable model organism Drosophila melanogaster and address the complex dynamic interactions between proteins within this organelle and their involvement in particle engulfment. Proteomic analysis identified 617 proteins potentially associated with Drosophila phagosomes; these were organized by protein - protein interactions to generate the 'phagosome interactome', a detailed protein - protein interaction network of this subcellular compartment. These networks predicted both the architecture of the phagosome and putative biomodules. The contribution of each protein and complex to bacterial internalization was tested by RNA-mediated interference and identified known components of the phagocytic machinery. In addition, the prediction and validation of regulators of phagocytosis such as the 'exocyst'(4), a macromolecular complex required for exocytosis but not previously implicated in phagocytosis, validates this strategy. In generating this 'systems-based model', we show the power of applying this approach to the study of complex cellular processes and organelles and expect that this detailed model of the phagosome will provide a new framework for studying host pathogen interactions and innate immunity.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lab Dev Immunol, Boston, MA 02114 USA; Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada; Johns Hopkins Univ, Dept Biomed Engn & High Throughput Biol Ctr, Baltimore, MD 21218 USA; McGill Univ, Fac Med, Dept Biomed Engn, Montreal, PQ H3A 2B4, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Edinburgh; Universite de Montreal; Johns Hopkins University; McGill University	Stuart, LM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lab Dev Immunol, 55 Fruit St, Boston, MA 02114 USA.	lstuart@partners.org	Hennessy, Elizabeth/AAJ-4800-2021; Bader, Joel/A-1818-2009; Boulais, jonathan/Y-4019-2019; Charriere, Guillaume/Z-1574-2019; Charriere, Guillaume M/O-8317-2014	Hennessy, Elizabeth/0000-0002-1231-5777; Bader, Joel/0000-0002-6020-4625; Charriere, Guillaume/0000-0002-4796-1488; Charriere, Guillaume M/0000-0002-4796-1488; Goyette, Guillaume/0000-0003-3277-568X; Huang, Hailiang/0000-0003-1461-5762; Desjardins, Michel/0000-0002-5684-5980; Boulais, Jonathan/0000-0003-1848-0068	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Asthana S, 2004, GENOME RES, V14, P1170, DOI 10.1101/gr.2203804; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Bader JS, 2003, BIOINFORMATICS, V19, P1869, DOI 10.1093/bioinformatics/btg358; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Clandinin TR, 2005, NEURON, V46, P164, DOI 10.1016/j.neuron.2005.04.003; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Cox D, 2000, P NATL ACAD SCI USA, V97, P680, DOI 10.1073/pnas.97.2.680; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Desjardins M, 2003, NAT REV IMMUNOL, V3, P280, DOI 10.1038/nri1053; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gold ES, 2000, IMMUNITY, V12, P285, DOI 10.1016/S1074-7613(00)80181-8; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Uetz P, 2005, FEBS LETT, V579, P1821, DOI 10.1016/j.febslet.2005.02.001; Vidal M, 2005, FEBS LETT, V579, P1834, DOI 10.1016/j.febslet.2005.02.030; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	29	175	182	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2007	445	7123					95	101		10.1038/nature05380	http://dx.doi.org/10.1038/nature05380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17151602				2022-12-01	WOS:000243225100043
J	Moretti, A; Caron, L; Nakano, A; Lam, JT; Bernshausen, A; Chen, YH; Qyang, YB; Bu, L; Sasaki, M; Martin-Puig, S; Sun, YF; Evans, SM; Laugwitz, KL; Chien, KR				Moretti, Alessandra; Caron, Leslie; Nakano, Atsushi; Lam, Jason T.; Bernshausen, Alexandra; Chen, Yinhong; Qyang, Yibing; Bu, Lei; Sasaki, Mika; Martin-Puig, Silvia; Sun, Yunfu; Evans, Sylvia M.; Laugwitz, Karl-Ludwig; Chien, Kenneth R.			Multipotent embryonic Isl1(+) progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification	CELL			English	Article							CONGENITAL HEART-DISEASE; STEM-CELLS; SECONDARY HEART; HEMATOPOIETIC STEM; PROTEIN ISL-1; ARTERIAL POLE; CLONAL ORIGIN; FIELD; VASCULOGENESIS; REGENERATION	Cardiogenesis requires the generation of endothelial, cardiac, and smooth muscle cells, thought to arise from distinct embryonic precursors. We use genetic fate-mapping studies to document that isl1(+) precursors from the second heart field can generate each of these diverse cardiovascular cell types in vivo. Utilizing embryonic stem (ES) cells, we clonally amplified a cellular hierarchy of isl1(+) cardiovascular progenitors, which resemble the developmental precursors in the embryonic heart. The transcriptional signature of isl1(+)/Nkx2.5(+)/flk1(+) defines a multipotent cardiovascular progenitor, which can give rise to cells of all three lineages. These studies document a developmental paradigm for cardiogenesis, where muscle and endothelial lineage diversification arises from a single cell-level decision of a multipotent isl1(+) cardiovascular progenitor cell (MICP). The discovery of ES cell-derived MICPs suggests a strategy for cardiovascular tissue regeneration via their isolation, renewal, and directed differentiation into specific mature cardiac, pacemaker, smooth muscle, and endothelial cell types.	Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-81675 Munich, Germany; Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Skaggs Sch Pharm, La Jolla, CA 92093 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Technical University of Munich; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charles River Pl CPZN 3208,185 Cambridge St, Boston, MA 02114 USA.	kchien@partners.org	Caron, Leslie/AAE-3511-2022; Evans, Sylvia/G-1980-2015; Bu, Lei/F-4461-2011; Moretti, Alessandra/O-9271-2015	Caron, Leslie/0000-0003-4118-2974; Moretti, Alessandra/0000-0001-5782-7832; Martin-Puig, Silvia/0000-0003-3048-6729; Qyang, Yibing/0000-0002-0332-2449; BU, LEI/0000-0003-4476-2157				Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; Choi K, 1998, DEVELOPMENT, V125, P725; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Epstein JA, 2000, DEVELOPMENT, V127, P1869; ERMA M, 2006, BLOOD, V107, P111; ERNA M, 2003, GENE DEV, V17, P380; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Gourdie RG, 1998, P NATL ACAD SCI USA, V95, P6815, DOI 10.1073/pnas.95.12.6815; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; LIDA M, 2005, FASEB J, V19, P371; Manner J, 2001, CELLS TISSUES ORGANS, V169, P89, DOI 10.1159/000047867; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schwartz RS, 2006, NEW ENGL J MED, V355, P1189, DOI 10.1056/NEJMp068180; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; THOR S, 1991, NEURON, V7, P881, DOI 10.1016/0896-6273(91)90334-V; VERZI MP, 2005, DEV BIOL, V342, P798; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje	49	749	801	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1151	1165		10.1016/j.cell.2006.10.029	http://dx.doi.org/10.1016/j.cell.2006.10.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17123592	Bronze			2022-12-01	WOS:000242991000014
J	Bendell, J				Bendell, Johanna			Optimum chemotherapy for metastatic colorectal cancer	LANCET			English	Editorial Material							FLUOROURACIL PLUS LEUCOVORIN; RANDOMIZED CONTROLLED-TRIAL; OXALIPLATIN; IRINOTECAN; INTERGROUP; GERCOR; BOLUS		Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Bendell, J (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	bende007@mc.duke.edu						deGramont A, 1997, J CLIN ONCOL, V15, P808, DOI 10.1200/JCO.1997.15.2.808; FALCONE A, 2006, J CLIN ONCOL S, V24, P3513; FUCHS C, 2006, J CLIN ONCOL, V24, P3506; Goldberg RM, 2006, J CLIN ONCOL, V24, P3347, DOI 10.1200/JCO.2006.06.1317; Goldberg RM, 2002, J CLIN ONCOL, V20, P4591, DOI 10.1200/JCO.2002.03.039; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; HOCHSTER H, 2006, 2006 GASTR CANC S SA; Maindrault-Goebel F., 2006, J CLIN ONCOL, V24, P3504, DOI [10.1200/jco.2006.24.18_suppl.3504, DOI 10.1200/JCO.2006.24.18_SUPPL.3504]; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113	11	7	8	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2006	368	9552					2039	2041		10.1016/S0140-6736(06)69818-8	http://dx.doi.org/10.1016/S0140-6736(06)69818-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	114JY	17161715				2022-12-01	WOS:000242663700006
J	Tilman, D; Hill, J; Lehman, C				Tilman, David; Hill, Jason; Lehman, Clarence			Carbon-negative biofuels from low-input high-diversity grassland biomass	SCIENCE			English	Article							ECOSYSTEM; ENERGY; CROPS; SWITCHGRASS; BIODIESEL; DYNAMICS; NITROGEN; ETHANOL	Biofuels derived from low-input high-diversity (LIHD) mixtures of native grassland perennials can provide more usable energy, greater greenhouse gas reductions, and less agrichemical pollution per hectare than can corn grain ethanol or soybean biodiesel. High-diversity grasslands had increasingly higher bioenergy yields that were 238% greater than monoculture yields after a decade. LIHD biofuels are carbon negative because net ecosystem carbon dioxide sequestration (4.4 megagram hectare(-1) year(-1) of carbon dioxide in soil and roots) exceeds fossil carbon dioxide release during biofuel production (0.32 megagram hectare(-1) year(-1)). Moreover, LIHD biofuels can be produced on agriculturally degraded lands and thus need to neither displace food production nor cause loss of biodiversity via habitat destruction.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@umn.edu	Tilman, David/ABD-5309-2021; Hill, Jason/A-8919-2008	Hill, Jason/0000-0001-7609-6713				Berndes G, 2002, GLOBAL ENVIRON CHANG, V12, P253, DOI 10.1016/S0959-3780(02)00040-7; Camill P, 2004, ECOL APPL, V14, P1680, DOI 10.1890/03-5273; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Fedoroff NV, 1999, P NATL ACAD SCI USA, V96, P5903, DOI 10.1073/pnas.96.11.5903; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gallagher PW, 2003, ENVIRON RESOUR ECON, V24, P335, DOI 10.1023/A:1023630823210; Hamelinck CN, 2004, ENERGY, V29, P1743, DOI 10.1016/j.energy.2004.01.002; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Hoogwijk M, 2003, BIOMASS BIOENERG, V25, P119, DOI 10.1016/S0961-9534(02)00191-5; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Keoleian GA, 2005, CRIT REV PLANT SCI, V24, P385, DOI 10.1080/07352680500316334; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Knops JMH, 2000, ECOLOGY, V81, P88, DOI 10.1890/0012-9658(2000)081[0088:DOSNAC]2.0.CO;2; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Mann M, 2001, CLEAN PROD PROCESS, V3, P81, DOI DOI 10.1007/S100980100109; Outlaw J, 2005, AGR PRODUCER CONSUME; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Sheehan John, 2003, Journal of Industrial Ecology, V7, P117; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; *US DEP EN EN INF, 2006, DOEEIA0484; *USDA NAT AGR STAT, 2006, AGR CHEM US 2004 200; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413; Zhang Y, 2003, BIORESOURCE TECHNOL, V89, P1, DOI 10.1016/S0960-8524(03)00040-3	28	1222	1261	12	671	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1598	1600		10.1126/science.1133306	http://dx.doi.org/10.1126/science.1133306			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158327				2022-12-01	WOS:000242624600042
J	Wassarman, KM; Saecker, RM				Wassarman, Karen M.; Saecker, Ruth M.			Synthesis-mediated release of a small RNA inhibitor of RNA polymerase	SCIENCE			English	Article							ESCHERICHIA-COLI; LID ELEMENT; TRANSCRIPTION; ELONGATION; PROMOTER; REGULATORS; STRAND	Noncoding small RNAs regulate gene expression in all organisms, in some cases through direct association with RNA polymerase ( RNAP). Here we report that the mechanism of 6S RNA inhibition of transcription is through specific, stable interactions with the active site of Escherichia coli RNAP that exclude promoter DNA binding. In fact, the DNA-dependent RNAP uses bound 6S RNA as a template for RNA synthesis, producing 14- to 20-nucleotide RNA products (pRNA). These results demonstrate that 6S RNA is functionally engaged in the active site of RNAP. Synthesis of pRNA destabilizes 6S RNA-RNAP complexes leading to release of the pRNA-6S RNA hybrid. In vivo, 6S RNA-directed RNA synthesis occurs during outgrowth from the stationary phase and likely is responsible for liberating RNAP from 6S RNA in response to nutrient availability.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wassarman, KM (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	wassarman@bact.wisc.edu			NIGMS NIH HHS [GM67955, R01 GM067955, GM23467] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023467, R01GM067955, R37GM023467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN CR, 1994, P NATL ACAD SCI USA, V91, P3784, DOI 10.1073/pnas.91.9.3784; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; BIEBRICH.CK, 1973, P NATL ACAD SCI USA, V70, P934, DOI 10.1073/pnas.70.3.934; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Gopal V, 1999, J MOL BIOL, V290, P411, DOI 10.1006/jmbi.1999.2836; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Kettenberger H, 2006, NAT STRUCT MOL BIOL, V13, P44, DOI 10.1038/nsmb1032; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Massirer KB, 2006, BIOESSAYS, V28, P449, DOI 10.1002/bies.20406; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Pelchat M, 2002, BIOCHEMISTRY-US, V41, P6561, DOI 10.1021/bi025595k; Schroeder LA, 2005, J BIOL CHEM, V280, P17422, DOI 10.1074/jbc.M501281200; Severinova E, 1996, J MOL BIOL, V263, P637, DOI 10.1006/jmbi.1996.0604; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Trotochaud AE, 2006, J BACTERIOL, V188, P3936, DOI 10.1128/JB.00079-06; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wettich A, 2001, BIOCHEMISTRY-US, V40, P3308, DOI 10.1021/bi002756g; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zenkin N, 2006, NATURE, V439, P617, DOI 10.1038/nature04337	25	131	134	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1601	1603		10.1126/science.1134830	http://dx.doi.org/10.1126/science.1134830			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158328				2022-12-01	WOS:000242624600043
J	Nakamura-Messenger, K; Messenger, S; Keller, LP; Clemett, SJ; Zolensky, ME				Nakamura-Messenger, Keiko; Messenger, Scott; Keller, Lindsay P.; Clemett, Simon J.; Zolensky, Michael E.			Organic globules in the Tagish Lake meteorite: Remnants of the protosolar disk	SCIENCE			English	Article							MOLECULAR-CLOUD MATERIAL; DEUTERIUM FRACTIONATION; NITROGEN; CARBON; MATTER; ABUNDANCES; CHONDRITE; CHEMISTRY; ICE	Coordinated transmission electron microscopy and isotopic measurements of organic globules in the Tagish Lake meteorite shows that they have elevated ratios of nitrogen-15 to nitrogen-14 (1.2 to 2 times terrestrial) and of deuterium to hydrogen (2.5 to 9 times terrestrial). These isotopic anomalies are indicative of mass fractionation during chemical reactions at extremely low temperatures ( 10 to 20 kelvin), characteristic of cold molecular clouds and the outer protosolar disk. The globules probably originated as organic ice coatings on preexisting grains that were photochemically processed into refractory organic matter. The globules resemble cometary carbon, hydrogen, oxygen, and nitrogen (CHON) particles, suggesting that such grains were important constituents of the solar system starting materials.	NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA; NASA, Lyndon B Johnson Space Ctr, ESC Grp Jacobs Sverdrup, Houston, TX 77058 USA; NASA, Lyndon B Johnson Space Ctr, ESC Grp ERC Inc, Houston, TX 77058 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Nakamura-Messenger, K (corresponding author), NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Astromat Res & Explorat Sci Directorate, Houston, TX 77058 USA.	keiko.nakamura-1@nasa.gov		Zolensky, Michael/0000-0002-3181-1303				Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Alexander CMO, 1998, METEORIT PLANET SCI, V33, P603, DOI 10.1111/j.1945-5100.1998.tb01667.x; Bernstein MP, 2003, ASTROPHYS J, V582, pL25, DOI 10.1086/345941; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; CLAUS G, 1961, NATURE, V192, P594, DOI 10.1038/192594a0; Cody GD, 2005, GEOCHIM COSMOCHIM AC, V69, P1085, DOI 10.1016/j.gca.2004.08.031; Dworkin JP, 2001, P NATL ACAD SCI USA, V98, P815, DOI 10.1073/pnas.98.3.815; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; Fomenkova MN, 1999, SPACE SCI REV, V90, P109, DOI 10.1023/A:1005237828783; GARVIE LAJ, 2006, LUNAR PLANET SCI, V37; Gibb EL, 2004, ASTROPHYS J SUPPL S, V151, P35, DOI 10.1086/381182; Grady MM, 2002, METEORIT PLANET SCI, V37, P713, DOI 10.1111/j.1945-5100.2002.tb00851.x; Hiroi T, 2001, SCIENCE, V293, P2234, DOI 10.1126/science.1063734; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; KERRIDGE JF, 1985, GEOCHIM COSMOCHIM AC, V49, P1707, DOI 10.1016/0016-7037(85)90141-3; LACY JH, 1998, APJ, V501, P105; LANGER WD, 1989, ASTROPHYS J SUPPL S, V69, P241, DOI 10.1086/191313; Li AG, 1997, ASTRON ASTROPHYS, V323, P566; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 1997, AIP CONF PROC, P545, DOI 10.1063/1.53336; MILLAR TJ, 1989, ASTROPHYS J, V340, P906, DOI 10.1086/167444; Nakamura K., 2002, INT J ASTROBIOL, V1, P179, DOI DOI 10.1017/; Pizzarello S., METEORITES EARLY SOL; Rodgers SD, 2004, MON NOT R ASTRON SOC, V352, P600, DOI 10.1111/j.1365-2966.2004.07953.x; Tielens AGGM, 1997, AIP CONF PROC, P523, DOI 10.1063/1.53335; Zinner EK, 2005, TREATISE GEOCHEM, V1, P17; Zolensky M., 1988, METEORITES EARLY SOL, P114; ZOLENSKY ME, 1989, ICARUS, V78, P411, DOI 10.1016/0019-1035(89)90188-7	29	195	197	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1439	1442		10.1126/science.1132175	http://dx.doi.org/10.1126/science.1132175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138898				2022-12-01	WOS:000242406100037
J	Pelletier, L; O'Toole, E; Schwager, A; Hyman, AA; Muller-Reichert, T				Pelletier, Laurence; O'Toole, Eileen; Schwager, Anne; Hyman, Anthony A.; Mueller-Reichert, Thomas			Centriole assembly in Caenorhabditis elegans	NATURE			English	Article							C-ELEGANS; CENTROSOME DUPLICATION; PROTEIN SPD-2; CELL-DIVISION; CYCLE; RECRUITMENT; GENES; ROLES; SAS-4; RNAI	Centrioles are necessary for flagella and cilia formation(1,2), cytokinesis(3,4), cell-cycle control(5) and centrosome organization/ spindle assembly(6). They duplicate once per cell cycle, but the mechanisms underlying their duplication remain unclear. Here we show using electron tomography of staged C. elegans one-cell embryos that daughter centriole assembly begins with the formation and elongation of a central tube followed by the peripheral assembly of nine singlet microtubules. Tube formation and elongation is dependent on the SAS-5 and SAS-6 proteins, whereas the assembly of singlet microtubules onto the central tube depends on SAS-4. We further show that centriole assembly is triggered by an upstream signal mediated by SPD-2 and ZYG-1. These results define a structural pathway for the assembly of a daughter centriole and should have general relevance for future studies on centriole assembly in other organisms.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab 3D Electron Microscopy Cells, Boulder, CO 80309 USA	Max Planck Society; University of Colorado System; University of Colorado Boulder	Pelletier, L (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	pelletie@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Pelletier, Laurence/F-8858-2013	Hyman, Anthony A/0000-0003-3664-154X; 				Azimzadeh J., 2004, CENTROSOMES DEV DIS, P93; Briggs LJ, 2004, CURR BIOL, V14, pR611, DOI 10.1016/j.cub.2004.07.041; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; DIPPELL RV, 1968, P NATL ACAD SCI USA, V61, P461, DOI 10.1073/pnas.61.2.461; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Leidel S, 2005, DEV CELL, V9, P317, DOI 10.1016/j.devcel.2005.08.004; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; MULLERREICHERT T, METH CELL BIOL, V79, P99; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; O'Connell KF, 1998, GENETICS, V149, P1303; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; O'Toole ET, 2003, J CELL BIOL, V163, P451, DOI 10.1083/jcb.200304035; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; ROBBINS E, 1968, J CELL BIOL, V36, P329, DOI 10.1083/jcb.36.2.329; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	29	289	294	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2006	444	7119					619	623		10.1038/nature05318	http://dx.doi.org/10.1038/nature05318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136092				2022-12-01	WOS:000242377600048
J	Wagner, PJ; Kosnik, MA; Lidgard, S				Wagner, Peter J.; Kosnik, Matthew A.; Lidgard, Scott			Abundance distributions imply elevated complexity of post-Paleozoic marine ecosystems	SCIENCE			English	Article							PERMIAN MASS EXTINCTION; COMMUNITIES; DIVERSITY; ASSEMBLAGES; INCREASE; EVENNESS; SHELF	Likelihood analyses of 1176 fossil assemblages of marine organisms from Phanerozoic (i.e., Cambrian to Recent) assemblages indicate a shift in typical relative-abundance distributions after the Paleozoic. Ecological theory associated with these abundance distributions implies that complex ecosystems are far more common among Meso-Cenozoic assemblages than among the Paleozoic assemblages that preceded them. This transition coincides not with any major change in the way fossils are preserved or collected but with a shift from communities dominated by sessile epifaunal suspension feeders to communities with elevated diversities of mobile and infaunal taxa. This suggests that the end-Permian extinction permanently altered prevailing marine ecosystem structure and precipitated high levels of ecological complexity and alpha diversity in the Meso-Cenozoic.	Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	Field Museum of Natural History (Chicago); James Cook University	Wagner, PJ (corresponding author), Field Museum Nat Hist, Dept Geol, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	pwagner@fmnh.org	Wagner, Peter/A-5514-2009; Kosnik, Matthew A./P-9632-2019; Kosnik, Matthew/G-2312-2010	Wagner, Peter/0000-0002-9083-9787; Kosnik, Matthew A./0000-0001-5380-7041; Kosnik, Matthew/0000-0001-5380-7041				ABERHAN M, 1994, PALAIOS, V9, P516, DOI 10.2307/3515126; Ausich W.I., 1985, P255; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; BAMBACH RK, 1983, BIOTIC INTERACTIONS, P719; Burnham K.P., 2002, MODEL SELECTION MULT, DOI DOI 10.1007/B97636; Bush AM, 2004, J GEOL, V112, P625, DOI 10.1086/424576; Buzas MA, 2005, PALEOBIOLOGY, V31, P199, DOI 10.1666/0094-8373(2005)031[0199:ORAEWA]2.0.CO;2; Clapham ME, 2006, PALAIOS, V21, P431, DOI 10.2110/palo.2005.P05-017R; Edwards AWF, 1992, LIKELIHOOD EXPANDED; Erwin D.H., 2006, EXTINCTION LIFE EART; Foote M, 2006, PALEOBIOLOGY, V32, P345, DOI 10.1666/05062.1; Fraiser ML, 2005, CR PALEVOL, V4, P583, DOI 10.1016/j.crpv.2005.02.002; FRONTIER S, 1985, OCEANOGR MAR BIOL, V23, P253; Gray J.S., 1987, P53; Hubbell Stephen P., 2001, V32, pi; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; Knoll AH, 1996, SCIENCE, V273, P452, DOI 10.1126/science.273.5274.452; Kosnik MA, 2006, EVOL ECOL RES, V8, P195; Kowalewski M, 2006, PALEOBIOLOGY, V32, P533, DOI 10.1666/05074.1; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Olszewski TD, 2004, NATURE, V428, P738, DOI 10.1038/nature02464; Powell MG, 2002, GEOLOGY, V30, P331, DOI 10.1130/0091-7613(2002)030<0331:IIEASA>2.0.CO;2; RAUP DM, 1991, ANAL PALEOBIOLOGY, V4, P136; Roopnarine PD, 2006, PALEOBIOLOGY, V32, P1; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Royall R.M., 1997, STAT EVIDENCE LIKELI, VFirst; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190	28	135	142	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1289	1292		10.1126/science.1133795	http://dx.doi.org/10.1126/science.1133795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124319				2022-12-01	WOS:000242215800040
J	Takamori, S; Holt, M; Stenius, K; Lemke, EA; Gronborg, M; Riedel, D; Urlaub, H; Schenck, S; Brugger, B; Ringler, P; Muller, SA; Rammner, B; Grater, F; Hub, JS; De Groot, BL; Mieskes, G; Moriyama, Y; Klingauf, J; Grubmuller, H; Heuser, J; Wieland, F; Jahn, R				Takamori, Shigeo; Holt, Matthew; Stenius, Katinka; Lemke, Edward A.; Gronborg, Mads; Riedel, Dietmar; Urlaub, Henning; Schenck, Stephan; Bruegger, Britta; Ringler, Philippe; Mueller, Shirley A.; Rammner, Burkhard; Graeter, Frauke; Hub, Jochen S.; De Groot, Bert L.; Mieskes, Gottfried; Moriyama, Yoshinori; Klingauf, Juergen; Grubmueller, Helmut; Heuser, John; Wieland, Felix; Jahn, Reinhard			Molecular anatomy of a trafficking organelle	CELL			English	Article							VESICULAR GLUTAMATE TRANSPORTER; CLATHRIN-COATED VESICLES; SYNAPTIC VESICLES; SYNAPSIN-I; PROTEIN-I; MEMBRANE; SNARE; IDENTIFICATION; DEFINES; BRAIN	Membrane traffic in eukaryotic cells involves transport of vesicles that bud from a donor compartment and fuse with an acceptor compartment. Common principles of budding and fusion have emerged, and many of the proteins involved in these events are now known. However, a detailed picture of an entire trafficking organelle is not yet available. Using synaptic vesicles as a model, we have now determined the protein and lipid composition; measured vesicle size, density, and mass; calculated the average protein and lipid mass per vesicle; and determined the copy number of more than a dozen major constituents. A model has been constructed that integrates all quantitative data and includes structural models of abundant proteins. Synaptic vesicles are dominated by proteins, possess a surprising diversity of trafficking proteins, and, with the exception of the V-ATPase that is present in only one to two copies, contain numerous copies of proteins essential for membrane traffic and neurotransmitter uptake.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Electron Microscopy Lab, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Lab Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Lab Biomol Dynam, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Heidelberg Univ, Dept Biochem, D-69120 Heidelberg, Germany; Univ Basel, Bioctr, Maurice E Muller Inst High Resolut Electron M, CH-4056 Basel, Switzerland; Scimotion, D-22765 Hamburg, Germany; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Lab Membrane Biochem, Okayama 7008530, Japan; Washington Univ, Dept Cell Biol, St Louis, MO 63110 USA	Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Max Planck Society; Yale University; Ruprecht Karls University Heidelberg; University of Basel; Okayama University; Washington University (WUSTL)	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Hub, Jochen/M-6230-2015; Holt, Matthew/AAJ-1813-2020; Gräter, Frauke/D-3450-2009; Lemke, Edward A/J-3337-2015	Hub, Jochen/0000-0001-7716-1767; Holt, Matthew/0000-0002-8958-4027; Gräter, Frauke/0000-0003-2891-3381; Lemke, Edward A/0000-0002-0634-0503; Jahn, Reinhard/0000-0003-1542-3498				Ahnert-Hilger G, 2004, REV PHYSIOL BIOCH P, V150, P140, DOI 10.1007/s10254-003-0020-2; Antonin W, 2000, J NEUROSCI, V20, P5724, DOI 10.1523/JNEUROSCI.20-15-05724.2000; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, P331; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRISSON A, 1984, J CELL BIOL, V99, P1202, DOI 10.1083/jcb.99.4.1202; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; GOELZ SE, 1981, P NATL ACAD SCI-BIOL, V78, P2130, DOI 10.1073/pnas.78.4.2130; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hartinger J, 1996, ANAL BIOCHEM, V240, P126, DOI 10.1006/abio.1996.0339; HEUSER J, 1989, J ELECTRON MICR TECH, V13, P244, DOI 10.1002/jemt.1060130310; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JAHN R, 1984, P NATL ACAD SCI-BIOL, V81, P1684, DOI 10.1073/pnas.81.6.1684; JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251; Janz R, 1998, J NEUROSCI, V18, P9269; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; Muller JD, 2003, METHOD ENZYMOL, V361, P69; MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; NAGY A, 1976, BRAIN RES, V109, P285, DOI 10.1016/0006-8993(76)90531-X; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; Peters R, 2003, ANNU REV BIOPH BIOM, V32, P47, DOI 10.1146/annurev.biophys.32.110601.142429; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pothos EN, 2000, J NEUROSCI, V20, P7297; Reigada D, 2003, P NATL ACAD SCI USA, V100, P3485, DOI 10.1073/pnas.0336914100; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STADLER H, 1984, EMBO J, V3, P3333, DOI 10.1002/j.1460-2075.1984.tb02300.x; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takamori S, 2000, J NEUROSCI, V20, P4904; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; VONMOLLARD GF, 1994, J BIOL CHEM, V269, P10971; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Wilkens S, 2005, MICRON, V36, P109, DOI 10.1016/j.micron.2004.10.002; Williams J, 1997, NEURON, V18, P683, DOI 10.1016/S0896-6273(00)80308-6; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101	63	1573	1601	1	229	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					831	846		10.1016/j.cell.2006.10.030	http://dx.doi.org/10.1016/j.cell.2006.10.030			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110340	Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000242330600027
J	Mbanya, JC; Kengne, AP; Assah, F				Mbanya, Jean Claude; Kengne, Andre Pascal; Assah, Felix			Diabetes care in Africa	LANCET			English	Editorial Material							MELLITUS		Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England	University of Yaounde I; University of Sydney; University of Cambridge	Mbanya, JC (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.	jcmbanya@yahoo.co.uk	Kengne, Andre Pascal/ABB-3696-2020; Mbanya, Jean Claude N/T-5147-2018	Kengne, Andre Pascal/0000-0002-5183-131X; Mbanya, Jean Claude N/0000-0001-9651-8653				Beran D, 2005, DIABETES CARE, V28, P2136, DOI 10.2337/diacare.28.9.2136; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Cruickshank JK, 2001, INT J EPIDEMIOL, V30, P111, DOI 10.1093/ije/30.1.111; Dagogo-Jack S, 2006, J NATL MED ASSOC, V98, P415; Elrayah H, 2005, DIABETES RES CLIN PR, V70, P159, DOI 10.1016/j.diabres.2005.03.034; Gill GV, 2005, DIABETIC MED, V22, P1642, DOI 10.1111/j.1464-5491.2005.01712.x; *INT DIAB FED, 2003, DIAT ATL; Kamel N M, 1999, East Mediterr Health J, V5, P974; KAUSHIK LR, 2004, DIABETES VOICE, V49, P32; Kengne AP, 2005, CIRCULATION, V112, P3592, DOI 10.1161/CIRCULATIONAHA.105.544312; Motala AA, 2002, DIABETES-METAB RES, V18, pS14, DOI 10.1002/dmrr.284; Sobngwi E, 2001, DIABETES METAB, V27, P628	12	30	30	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1628	1629		10.1016/S0140-6736(06)69673-6	http://dx.doi.org/10.1016/S0140-6736(06)69673-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	106KI	17098063				2022-12-01	WOS:000242099000006
J	Davidson, EH				Davidson, Eric H.			Perspective - The sea urchin genome: Where will it lead us?	SCIENCE			English	Editorial Material							REGULATORY NETWORK		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Davidson, EH (corresponding author), CALTECH, Div Biol, 156-29, Pasadena, CA 91125 USA.	davidson@caltech.edu						Boveri T., 1902, Verb Ges Wurzburg, Vxxxv, P67; Davidson E. H., 2006, REGULATORY GENOME GE; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; MATERNA SC, 2006, DEV BIOL, DOI DOI 10.1016/4.DBIO.2006.09.033; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609	7	40	40	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					939	940		10.1126/science.1136252	http://dx.doi.org/10.1126/science.1136252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095689				2022-12-01	WOS:000241896000037
J	Morse, SS; Garwin, RL; Olsiewski, PJ				Morse, Stephen S.; Garwin, Richard L.; Olsiewski, Paula J.			Public health - Next flu pandemic: What to do until the vaccine arrives?	SCIENCE			English	Editorial Material							NONPHARMACEUTICAL INTERVENTIONS; INFLUENZA; TRANSMISSION		Columbia Univ, Dept Epidemiol, New York, NY 10032 USA; Columbia Univ, Ctr Publ Hlth Preparedness, Natl Ctr Disaster Preparedness, Mailman Sch Publ Hlth, New York, NY 10032 USA; IBM Res Labs, Yorktown Hts, NY 10598 USA; Alfred P Sloan Fdn, New York, NY 10111 USA	Columbia University; Columbia University	Morse, SS (corresponding author), Columbia Univ, Dept Epidemiol, New York, NY 10032 USA.	ssm20@columbia.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NIAID NIH HHS [5U54AI057158-02] Funding Source: Medline; PHS HHS [U90/CCU224241] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALEDORT JE, 2006, WR408DHHS RAND; BARRY J, 2004, GREAT INFLUENZA; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; *COL U MAILM SCH P, 2006, WORKSH PERS WORKPL P; Crosby A.W, 1989, AM FORGOTTEN PANDEMI; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Hitchcock PJ, 2006, BIOSECUR BIOTERROR, V4, P41, DOI 10.1089/bsp.2006.4.41; *HOM SEC COUNC DEP, 2005, NAT STRAT PAND INFL; Institute of Medicine Committee on the Development of Reusable Facemasks for Use During an Influenza Pandemic, 2006, REUS FAC INFL PAND F; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; LEDERBERG J, 1992, EMERGING INFECT MICR, P156; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426	17	32	32	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					929	929		10.1126/science.1135823	http://dx.doi.org/10.1126/science.1135823			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095681				2022-12-01	WOS:000241896000030
J	Gomez-Ospina, N; Tsuruta, F; Barreto-Chang, O; Hu, L; Dolmetsch, R				Gomez-Ospina, Natalia; Tsuruta, Fuminori; Barreto-Chang, Odmara; Hu, Linda; Dolmetsch, Ricardo			The C terminus of the L-type voltage-gated calcium channel Ca(v)1.2 encodes a transcription factor	CELL			English	Article							RNA-POLYMERASE-II; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; SUBCELLULAR-DISTRIBUTION; BINDING DOMAIN; SUBUNIT; PHOSPHORYLATION; ALPHA(1C); SURVIVAL; FAMILY	Voltage-gated calcium channels play a central role in regulating the electrical and biochemical properties of neurons and muscle cells. One of the ways in which calcium channels regulate long-lasting neuronal properties is by activating signaling pathways that control gene expression, but the mechanisms that link calcium channels to the nucleus are not well understood. We report that a C-terminal fragment of Ca(v)1.2, an L-type voltage-gated calcium channel (LTC), translocates to the nucleus and regulates transcription. We show that this calcium channel associated transcription regulator (CCAT) binds to a nuclear protein, associates with an endogenous promoter, and regulates the expression of a wide variety of endogenous genes important for neuronal signaling and excitability. The nuclear localization of CCAT is regulated both developmentally and by changes in intracellular calcium. These findings provide evidence that voltage-gated calcium channels can directly activate transcription and suggest a mechanism linking voltage-gated channels to the function and differentiation of excitable cells.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Stanford University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Dolmetsch, R (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, 299 Campus Dr, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu		Gomez-Ospina, Natalia/0000-0002-6740-1154; Barreto Chang, Odmara/0000-0002-4781-404X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048564] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS048564] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies TC, 1996, DEV GENET, V18, P234, DOI 10.1002/(SICI)1520-6408(1996)18:3&lt;234::AID-DVG4&gt;3.0.CO;2-A; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DEJONGH KS, 1994, J NEUROCHEM, V63, P1558, DOI 10.1046/j.1471-4159.1994.63041558.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gerhardstein BL, 2000, J BIOL CHEM, V275, P8556, DOI 10.1074/jbc.275.12.8556; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guldenagel M, 2000, J COMP NEUROL, V425, P193; Haase H, 2000, J CELL BIOCHEM, V76, P695, DOI 10.1002/(SICI)1097-4644(20000315)76:4<695::AID-JCB17>3.0.CO;2-Q; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Helguera G, 2002, BBA-GEN SUBJECTS, V1569, P59, DOI 10.1016/S0304-4165(01)00234-3; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; HULME JT, 2006, P NATL ACAD SCI USA, V576, P87; Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080; Kubodera T, 2003, NEUROSCI LETT, V341, P74, DOI 10.1016/S0304-3940(03)00156-3; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Venance L, 2004, J PHYSIOL-LONDON, V559, P215, DOI 10.1113/jphysiol.2004.065672; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Xia ZG, 1996, J NEUROSCI, V16, P5425; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	42	275	279	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 3	2006	127	3					591	606		10.1016/j.cell.2006.10.017	http://dx.doi.org/10.1016/j.cell.2006.10.017			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081980	Bronze, Green Accepted			2022-12-01	WOS:000241937000022
J	Kawane, K; Ohtani, M; Miwa, K; Kizawa, T; Kanbara, Y; Yoshioka, Y; Yoshikawa, H; Nagata, S				Kawane, Kohki; Ohtani, Mayumi; Miwa, Keiko; Kizawa, Takuji; Kanbara, Yoshiyuki; Yoshioka, Yoshichika; Yoshikawa, Hideki; Nagata, Shigekazu			Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; THERAPY; SERUM; EXPRESSION; RECEPTORS; BETA; MICE	A large amount of chromosomal DNA is degraded during programmed cell death and definitive erythropoiesis(1). DNase II is an enzyme that digests the chromosomal DNA of apoptotic cells and nuclei expelled from erythroid precursor cells after macrophages have engulfed them(1,2). Here we show that DNase II-/- IFN-IR-/- mice and mice with an induced deletion of the DNase II gene develop a chronic polyarthritis resembling human rheumatoid arthritis. A set of cytokine genes was strongly activated in the affected joints of these mice, and their serum contained high levels of anti-cyclic citrullinated peptide antibody, rheumatoid factor and matrix metalloproteinase-3. Early in the pathogenesis, expression of the gene encoding tumour necrosis factor (TNF)-alpha was upregulated in the bone marrow, and administration of anti-TNF-alpha antibody prevented the development of arthritis. These results indicate that if macrophages cannot degrade mammalian DNA from erythroid precursors and apoptotic cells, they produce TNF-alpha, which activates synovial cells to produce various cytokines, leading to the development of chronic polyarthritis.	Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Orthopaed, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Integrat Biol Labs, Genet Lab, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Suita, Osaka 5650871, Japan; Iwate Med Univ, Adv Med Sci Res Ctr, High Field Magnet Resonance Imaging Res Inst, Takizawa 0200173, Japan	Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST); Iwate Medical University	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nagata@genetic.med.osaka-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019; Yoshioka, Yoshichika/D-1929-2009	Nagata, Shigekazu/0000-0001-9758-8426; Kawane, Kohki/0000-0003-1125-9483				Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Brennan FM, 1997, BRIT J RHEUMATOL, V36, P643; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Deng GM, 1999, NAT MED, V5, P702, DOI 10.1038/9554; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347; FUJII I, 1990, ANN RHEUM DIS, V49, P497, DOI 10.1136/ard.49.7.497; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; MANICOURT DH, 1995, ARTHRITIS RHEUM, V38, P1031, DOI 10.1002/art.1780380803; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Ramprasad MP, 1996, P NATL ACAD SCI USA, V93, P14833, DOI 10.1073/pnas.93.25.14833; SAXNE T, 1988, ARTHRITIS RHEUM, V31, P1041, DOI 10.1002/art.1780310816; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Williams-Simons L, 1999, TRANSGENIC RES, V8, P253, DOI 10.1023/A:1008994831937; Yokota S, 2005, ARTHRITIS RHEUM, V52, P818, DOI 10.1002/art.20944; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	29	341	352	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					998	1002		10.1038/nature05245	http://dx.doi.org/10.1038/nature05245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066036				2022-12-01	WOS:000241523400056
J	Li, QX; Ali, MA; Cohen, JI				Li, Qingxue; Ali, Mir A.; Cohen, Jeffrey I.			Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread	CELL			English	Article							AMYLOID BETA-PROTEIN; GLYCOPROTEIN-I; MONOCLONAL-ANTIBODIES; POLIOVIRUS RECEPTOR; MANNOSE 6-PHOSPHATE; HEPARAN-SULFATE; ENTRY; DEGRADATION; GE; FUSION	Varicella-zoster virus (VZV) causes chickenpox and shingles. While varicella is likely spread as cell-free virus to susceptible hosts, the virus is transmitted by cell-to-cell spread in the body and in vitro. Since VZV glycoprotein E (gE) is essential for virus infection, we postulated that gE binds to a cellular receptor. We found that insulin-degrading enzyme (IDE) interacts with gE through its extracellular domain. Downregulation of IDE by siRNA, or blocking of IDE with antibody, with soluble IDE protein extracted from liver, or with bacitracin inhibited VZV infection. Cell-to-cell spread of virus was also impaired by blocking IDE. Transfection of cell lines impaired for VZV infection with a plasmid expressing human IDE resulted in increased entry and enhanced infection with cell-free and cell-associated virus. These studies indicate that IDE is a cellular receptor for both cell-free and cell-associated VZV.	NIH, Med Virol Sect, Lab Clin Infect Dis, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Cohen, JI (corresponding author), NIH, Med Virol Sect, Lab Clin Infect Dis, Bldg 10, Bethesda, MD 20892 USA.	jcohen@niaid.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000430, ZIAAI000430] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKIYAMA H, 1988, BIOCHEM BIOPH RES CO, V155, P914, DOI 10.1016/S0006-291X(88)80583-7; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Arvin A, 2001, FIELDS VIROLOGY, P2731; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; CAI WZ, 1991, J VIROL, V65, P4078, DOI 10.1128/JVI.65.8.4078-4090.1991; Chen JJ, 2004, CELL, V119, P915, DOI 10.1016/j.cell.2004.11.007; Cocchi F, 1998, J VIROL, V72, P9992, DOI 10.1128/JVI.72.12.9992-10002.1998; Cohen JI, 1997, J VIROL, V71, P6913, DOI 10.1128/JVI.71.9.6913-6920.1997; Cohen JI, 1998, J INFECT DIS, V177, P293, DOI 10.1086/514210; Cohen JI, 2001, FIELDS VIROLOGY, P2707; Cole NL, 2003, REV MED VIROL, V13, P207, DOI 10.1002/rmv.377; Collins WJ, 2003, J VIROL, V77, P2686, DOI 10.1128/JVI.77.4.2686-2695.2003; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dingwell KS, 1998, J VIROL, V72, P8933, DOI 10.1128/JVI.72.11.8933-8942.1998; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; DUCKWORTH WC, 1974, DIABETES, V23, P536, DOI 10.2337/diab.23.6.536; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GABEL CA, 1989, J VIROL, V63, P4264, DOI 10.1128/JVI.63.10.4264-4276.1989; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GOLDFINE ID, 1984, DIABETES, V33, P64, DOI 10.2337/diabetes.33.1.64; Hambleton S, 2004, CELL MOL LIFE SCI, V61, P3047, DOI 10.1007/s00018-004-4269-7; Hamel FG, 1997, BBA-PROTEIN STRUCT M, V1338, P207, DOI 10.1016/S0167-4838(96)00202-6; HAMEL FG, 1991, DIABETES, V40, P438; Kimura H, 1997, VIROLOGY, V233, P382, DOI 10.1006/viro.1997.8625; KUO WL, 1993, ENDOCRINOLOGY, V132, P604, DOI 10.1210/en.132.2.604; Kurochkin IV, 1998, FEBS LETT, V427, P153, DOI 10.1016/S0014-5793(98)00422-0; Kwon H, 2006, J VIROL, V80, P138, DOI 10.1128/JVI.80.1.138-148.2006; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lopez M, 2001, J VIROL, V75, P5684, DOI 10.1128/JVI.75.12.5684-5691.2001; LOWRY PW, 1992, J GEN VIROL, V73, P811, DOI 10.1099/0022-1317-73-4-811; Maresova L, 2001, J VIROL, V75, P9483, DOI 10.1128/JVI.75.19.9483-9492.2001; MISBIN RI, 1989, DIABETES, V38, P152, DOI 10.2337/diabetes.38.2.152; Mo CJ, 2002, VIROLOGY, V304, P176, DOI 10.1006/viro.2002.1556; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; MULLER D, 1991, EUR J BIOCHEM, V202, P285, DOI 10.1111/j.1432-1033.1991.tb16374.x; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Santos RA, 2000, VIROLOGY, V275, P306, DOI 10.1006/viro.2000.0507; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SMITH TW, 1987, NORC REPORTER, V1, P4; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Wu L, 1997, ARCH VIROL, V142, P349, DOI 10.1007/s007050050081; YASO S, 1987, DIABETOLOGIA, V30, P27, DOI 10.1007/BF01788903; Zerboni L, 2000, VIROLOGY, V270, P278, DOI 10.1006/viro.2000.0304; ZHU ZL, 1995, P NATL ACAD SCI USA, V92, P3546, DOI 10.1073/pnas.92.8.3546	50	106	116	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					305	316		10.1016/j.cell.2006.08.046	http://dx.doi.org/10.1016/j.cell.2006.08.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055432	Green Published, Bronze			2022-12-01	WOS:000241827100018
J	Papassotiropoulos, A; Stephan, DA; Huentelman, MJ; Hoerndli, FJ; Craig, DW; Pearson, JV; Huynh, KD; Brunner, F; Corneveaux, J; Osborne, D; Wollmer, MA; Aerni, A; Coluccia, D; Hanggi, J; Mondadori, CRA; Buchmann, A; Reiman, EM; Caselli, RJ; Henke, K; de Quervain, DJF				Papassotiropoulos, Andreas; Stephan, Dietrich A.; Huentelman, Matthew J.; Hoerndli, Frederic J.; Craig, David W.; Pearson, John V.; Huynh, Kim-Dung; Brunner, Fabienne; Corneveaux, Jason; Osborne, David; Wollmer, M. Axel; Aerni, Amanda; Coluccia, Daniel; Haenggi, Juergen; Mondadori, Christian R. A.; Buchmann, Andreas; Reiman, Eric M.; Caselli, Richard J.; Henke, Katharina; de Quervain, Dominique J. -F.			Common KIBRA alleles are associated with human memory performance	SCIENCE			English	Article							PROTEIN-KINASE-C; POPULATION STRATIFICATION; POLYMORPHISM; HIPPOCAMPUS; ACTIVATION; COGNITION	Human memory is a polygenic trait. We performed a genome-wide screen to identify memory-related gene variants. A genomic locus encoding the brain protein KIBRA was significantly associated with memory performance in three independent, cognitively normal cohorts from Switzerland and the United States. Gene expression studies showed that KIBRA was expressed in memory-related brain structures. Functional magnetic resonance imaging detected KIBRA allele dependent differences in hippocampal activations during memory retrieval. Evidence from these experiments suggests a role for KIBRA in human memory.	Univ Zurich, Div Psychiat Res, CH-8057 Zurich, Switzerland; Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; Univ Arizona, Dept Psychiat, Phoenix, AZ 85006 USA; Univ Arizona, Banner Alzheimers Inst, Phoenix, AZ 85006 USA; Mayo Clin, Dept Psychol, Scottsdale, AZ 85259 USA	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix; University of Arizona; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix	Papassotiropoulos, A (corresponding author), Univ Zurich, Div Psychiat Res, CH-8057 Zurich, Switzerland.	papas@bli.unizh.ch; dstephan@tgen.org	Pearson, John/AAT-4211-2020; Craig, David Wesley/K-6961-2019; Wollmer, Marc A/B-5038-2009; Pearson, John V/F-2249-2011	Craig, David Wesley/0000-0003-2040-1955; Pearson, John V/0000-0003-0904-4598; , Andreas/0000-0001-6981-9389; Hanggi, Jurgen/0000-0001-8124-6018; Papassotiropoulos, Andreas/0000-0002-2210-9651; de Quervain, Dominique/0000-0001-7131-2464	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL086528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01-HL086528-01] Funding Source: Medline; NIA NIH HHS [P30AG19610] Funding Source: Medline; NIMH NIH HHS [R01MH057899] Funding Source: Medline; NINDS NIH HHS [U24NS051872] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Caselli RJ, 2004, NEUROLOGY, V62, P1990, DOI 10.1212/01.WNL.0000129533.26544.BF; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Craig DW, 2005, EXPERT REV MOL DIAGN, V5, P159, DOI 10.1586/14737159.5.2.159; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Kelsoe JR, 2004, INT REV PSYCHIATR, V16, P294, DOI 10.1080/09540260400014385; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Milner B, 1972, Clin Neurosurg, V19, P421; Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; ROSENBERG SJ, 1984, J CLIN PSYCHOL, V40, P785, DOI 10.1002/1097-4679(198405)40:3<785::AID-JCLP2270400325>3.0.CO;2-4; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Schacter D., 1994, MEMORY SYSTEMS; Schork NJ, 2001, ADV GENET, V42, P299, DOI 10.1016/S0065-2660(01)42030-X; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921	27	307	329	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					475	478		10.1126/science.1129837	http://dx.doi.org/10.1126/science.1129837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053149	Green Submitted			2022-12-01	WOS:000241382500045
J	Perez-Brocal, V; Gil, R; Ramos, S; Lamelas, A; Postigo, M; Michelena, JM; Silva, FJ; Moya, A; Latorre, A				Perez-Brocal, Vicente; Gil, Rosario; Ramos, Silvia; Lamelas, Araceli; Postigo, Marina; Manuel Michelena, Jose; Silva, Francisco J.; Moya, Andres; Latorre, Amparo			A small microbial genome: The end of a long symbiotic relationship?	SCIENCE			English	Article							ENDOSYMBIONT BUCHNERA; ACYRTHOSIPHON-PISUM; APHID; EVOLUTION; BACTERIA; SEQUENCE	Intracellular bacteria are characterized by genome reduction. The 422,434 - base pair genome of Buchnera aphidicola BCc, primary endosymbiont of the aphid Cinara cedri, is similar to 200 kilobases smaller than the previously sequenced B. aphidicola genomes. B. aphidicola BCc has lost most metabolic functions, including the ability to synthesize the essential amino acid tryptophan and riboflavin. In addition, most retained genes are evolving rapidly. Possibly, B. aphidicola BCc is losing its symbiotic capacity and is being complemented ( and might be replaced) by the highly abundant coexisting secondary symbiont.	Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia 46071, Spain; Univ Valencia, Dept Genet, E-46100 Valencia, Spain; CSIC, INTA, Ctr Astrobiol, Madrid 28850, Spain; Univ Valencia, Dept Zool, E-46100 Valencia, Spain	University of Valencia; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Valencia	Latorre, A (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Apartado Postal 22085, Valencia 46071, Spain.	amparo.latorre@uv.es	Lamelas Cabello, Araceli/B-6129-2015; Latorre, Amparo/E-4997-2015; Gil, Rosario/R-6932-2018; Silva, Francisco/ABF-7144-2021; Cabello, Araceli Lamelas/Q-6726-2018; Postigo, Marina/Y-6210-2019; Moya, Andrés/A-8190-2008; Cabello, Araceli Lamelas/AAC-6066-2019; Perez Brocal, Vicente/K-3627-2014	Latorre, Amparo/0000-0002-9146-7284; Gil, Rosario/0000-0002-9397-1003; Silva, Francisco/0000-0002-6911-6541; Cabello, Araceli Lamelas/0000-0002-1939-5642; Moya, Andrés/0000-0002-2867-1119; Cabello, Araceli Lamelas/0000-0002-1939-5642; Perez Brocal, Vicente/0000-0002-1927-9676				Clark MA, 1999, MOL BIOL EVOL, V16, P1586, DOI 10.1093/oxfordjournals.molbev.a026071; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; FUKATSU T, 1992, J INSECT PHYSIOL, V38, P765, DOI 10.1016/0022-1910(92)90029-D; Gil R, 2006, GENE, V370, P17, DOI 10.1016/j.gene.2005.10.043; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Gomez-Valero L, 2004, J BACTERIOL, V186, P6626, DOI 10.1128/JB.186.19.6626-6633.2004; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Remaudiere G, 1997, CATALOGUE APHIDIDAE; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	15	255	410	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					312	313		10.1126/science.1130441	http://dx.doi.org/10.1126/science.1130441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038625				2022-12-01	WOS:000241194100045
J	Zheng, Y; Danilenko, DM; Valdez, P; Kasman, I; Eastham-Anderson, J; Wu, JF; Ouyang, WJ				Zheng, Yan; Danilenko, Dimitry M.; Valdez, Patricia; Kasman, Ian; Eastham-Anderson, Jeffrey; Wu, Jianfeng; Ouyang, Wenjun			Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis	NATURE			English	Article							CYTOTOXIC T-LYMPHOCYTE; PSORIASIS-VULGARIS; DENDRITIC CELLS; EPIDERMAL DIFFERENTIATION; HUMAN KERATINOCYTES; INTERFERON-GAMMA; TRANSGENIC MICE; GROWTH-FACTOR; FACTOR-ALPHA; EXPRESSION	Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of the epidermis ( acanthosis), infiltration of leukocytes into both the dermis and epidermis, and dilation and growth of blood vessels(1). The underlying cause of the epidermal acanthosis in psoriasis is still largely unknown. Recently, interleukin (IL)-23, a cytokine involved in the development of IL-17-producing T helper cells (T(H)17 cells)(2,3), was found to have a potential function in the pathogenesis of psoriasis(4,5). Here we show that IL-22 is preferentially produced by T(H)17 cells and mediates the acanthosis induced by IL-23. We found that IL-23 or IL-6 can directly induce the production of IL-22 from both murine and human naive T cells. However, the production of IL-22 and IL-17 from T(H)17 cells is differentially regulated. Transforming growth factor-beta, although crucial for IL-17 production, actually inhibits IL-22 production. Furthermore, IL-22 mediates IL-23-induced acanthosis and dermal inflammation through the activation of Stat3 ( signal transduction and activators of transcription 3) in vivo. Our results suggest that T(H)17 cells, through the production of both IL-22 and IL-17, might have essential functions in host defence and in the pathogenesis of autoimmune diseases such as psoriasis. IL-22, as an effector cytokine produced by T cells, mediates the crosstalk between the immune system and epithelial cells.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	ouyang.wenjun@gene.com	Ouyang, Wenjun/ABA-8763-2020; Zheng, Yan/A-6993-2008	Zheng, Yan/0000-0002-7002-277X; Ouyang, Wenjun/0000-0002-1811-5864; Danilenko, Dimitry/0000-0002-8326-1921				Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Kopp T, 2001, J INVEST DERMATOL, V117, P618, DOI 10.1046/j.1523-1747.2001.01441.x; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; NESTLE FO, 1994, J CLIN INVEST, V94, P202, DOI 10.1172/JCI117308; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; SCHLAAK JF, 1994, J INVEST DERMATOL, V102, P145, DOI 10.1111/1523-1747.ep12371752; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503	30	1443	1568	1	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					648	651		10.1038/nature05505	http://dx.doi.org/10.1038/nature05505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17187052				2022-12-01	WOS:000244039400044
J	Murray, JD; Karas, BJ; Sato, S; Tabata, S; Amyot, L; Szczyglowski, K				Murray, Jeremy D.; Karas, Bogumil J.; Sato, Shusei; Tabata, Satoshi; Amyot, Lisa; Szczyglowski, Krzysztof			A cytokinin perception mutant colonized by Rhizobium in the absence of nodule organogenesis	SCIENCE			English	Article							LEGUME LOTUS-JAPONICUS; RECEPTOR-LIKE KINASE; NODULATION FACTOR; FUNGAL SYMBIOSIS; ROOT DEVELOPMENT; BACTERIAL; INDUCTION; ENOD40; EXPRESSION; MELILOTI	In legumes, Nod-factor signaling by rhizobia initiates the development of the nitrogen-fixing nodule symbiosis, but the direct cell division stimulus that brings about nodule primordia inception in the root cortex remains obscure. We showed that Lotus japonicus plants homozygous for a mutation in the HYPERINFECTED 1 (HIT1) locus exhibit abundant infection-thread formation but fail to initiate timely cortical cell divisions in response to rhizobial signaling. We demonstrated that the corresponding gene encodes a cytokinin receptor that is required for the activation of the nodule inception regulator Nin and nodule organogenesis.	Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, London, ON N5V 4T3, Canada; Kazusa DNA Res Inst, Chiba 2920812, Japan	Agriculture & Agri Food Canada; Kazusa DNA Research Institute	Szczyglowski, K (corresponding author), Agr & Agri Food Canada, So Crop Protect & Food Res Ctr, 1391 Sandford St, London, ON N5V 4T3, Canada.	szczyglowskik@agr.gc.ca	Murray, Jeremy D./F-8409-2011; Sato, Shusei/A-3616-2015	Murray, Jeremy D./0000-0003-3000-9199; Sato, Shusei/0000-0002-0293-5366				Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; Fang YW, 1998, PLANT PHYSIOL, V116, P53, DOI 10.1104/pp.116.1.53; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; Gronlund M, 2005, MOL PLANT MICROBE IN, V18, P414, DOI 10.1094/MPMI-18-0414; HIRSCH AM, 1989, P NATL ACAD SCI USA, V86, P1244, DOI 10.1073/pnas.86.4.1244; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Kanamori N, 2006, P NATL ACAD SCI USA, V103, P359, DOI 10.1073/pnas.0508883103; Karas B, 2005, PLANT PHYSIOL, V137, P1331, DOI 10.1104/pp.104.057513; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lohar DP, 2004, PLANT J, V38, P203, DOI 10.1111/j.1365-313X.2004.02038.x; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Minami E, 1996, PLANT J, V10, P23, DOI 10.1046/j.1365-313X.1996.10010023.x; Murray J, 2006, MOL PLANT MICROBE IN, V19, P1082, DOI 10.1094/MPMI-19-1082; Oldroyd GED, 2005, PLANT PHYSIOL, V137, P1205, DOI 10.1104/pp.104.057661; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; Tirichine L, 2006, MOL PLANT MICROBE IN, V19, P373, DOI 10.1094/MPMI-19-0373; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862	29	353	369	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					101	104		10.1126/science.1132514	http://dx.doi.org/10.1126/science.1132514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17110535				2022-12-01	WOS:000243259100046
J	Temple, R; Stockbridge, NL				Temple, Robert; Stockbridge, Norman L.			BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective	ANNALS OF INTERNAL MEDICINE			English	Article							ISOSORBIDE DINITRATE; MORTALITY; HYDRALAZINE; RACE	Critics of the U. S. Food and Drug Administration (FDA) approval of the fixed combination of hydralazine hydrochloride, 37.5 mg, and isosorbide dinitrate, 20 mg, for treating heart failure in black patients have suggested that data were insufficient to distinguish treatment effects in black and white people; that distinctions based on race, rather than pathophysiology, were scientifically unreasonable; and that a "race-based" approval could be a commercial ploy to avoid a more expensive and prolonged full evaluation of a drug. The criticisms acknowledge that data supporting the approval came from a well-designed clinical trial in which self-identified black patients with heart failure who took hydralazine hydrochloride-isosorbide dinitrate with standard therapy experienced a statistically significant 43% (95% CI, 11% to 63%) reduction in mortality compared with those who took only the standard therapy. The criticisms do not always recognize that the decision to conduct the trial in only black patients reflected careful analyses of 2 previous trials in racially mixed patient populations that compared hydralazine hydrochloride-isosorbide dinitrate with placebo or with enalapril. Both trials showed little or no overall effect of hydralazine hydrochloride-isosorbide dinitrate in the mostly white patient population but hinted at a substantial effect in subsets of black patients. Perhaps most critically, the criticisms do not appreciate the urgency of strong scientific evidence of a substantial survival benefit in black patients. A serious attempt to avoid race-based approval by mandating study of a mixed population to identify a possible white patient-responder subset, particularly without a plausible hypothesis as to what that subset might be, would have required years of work, many thousands of patients, and wholly unreasonable delay in approval of a treatment whose effectiveness had been well-documented in the group for which it was intended.	US FDA, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Temple, R (corresponding author), US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	robert.temple@fda.hhs.gov						[Anonymous], 1990, Lancet, V336, P1; Avorn J, 2005, NEW ENGL J MED, V353, P969, DOI 10.1056/NEJMp058174; Bloche MG, 2004, NEW ENGL J MED, V351, P2035, DOI 10.1056/NEJMp048271; Brown NJ, 1996, CLIN PHARMACOL THER, V60, P8, DOI 10.1016/S0009-9236(96)90161-7; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; Cohn JN, 1998, NEW ENGL J MED, V339, P1810, DOI 10.1056/NEJM199812173392503; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; Food and Drug Administration HHS, 2006, Fed Regist, V71, P3921; Haga SB, 2006, J AM COLL CARDIOL, V48, P12, DOI 10.1016/j.jacc.2006.04.017; Harty L, 2006, J CLIN PHARMACOL, V46, P405, DOI 10.1177/0091270005286028; JUST H, 1995, CIRCULATION S1, V92, P722; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; *NITROMED INC, 2005, BIDIL; PACKER M, 1993, CIRCULATION, V88, P301; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Perry G, 1997, NEW ENGL J MED, V336, P525; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; TEMPLE RJ, 1994, COMMUN STAT THEORY, V23, P499, DOI 10.1080/03610929408831269; U.S. Food and Drug Administration, 1993, Fed Regist, V58, P39406; U. S. Food and Drug Administration, 1988, GUID FORM CONT CLIN; *US FDA, 1989, GUID STUD DRUGS LIK; *US FDA, 2005, P US FDA CTR DRUG EV; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	26	80	80	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2007	146	1					57	W9		10.7326/0003-4819-146-1-200701020-00010	http://dx.doi.org/10.7326/0003-4819-146-1-200701020-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188BK	17200223				2022-12-01	WOS:000247893300008
J	Collier, J				Collier, Joe			Getting new drugs to market: how individuals,could do this without leaving their desks	BRITISH MEDICAL JOURNAL			English	Editorial Material									St George Hosp, Sch Med, Dept Basic Med Sci, London SW17 0RE, England	St Georges University London	Collier, J (corresponding author), St George Hosp, Sch Med, Dept Basic Med Sci, London SW17 0RE, England.	jcollier@sgul.ac.uk						Henry D, 2002, LANCET, V360, P1590, DOI 10.1016/S0140-6736(02)11527-3; JACK A, 2006, FINANCIAL TIMES 0929	2	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1315	1317		10.1136/bmj.39055.610764.47	http://dx.doi.org/10.1136/bmj.39055.610764.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185722	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000243160700020
J	Gompert, Z; Fordyce, JA; Forister, ML; Shapiro, AM; Nice, CC				Gompert, Zachariah; Fordyce, James A.; Forister, Matthew L.; Shapiro, Arthur M.; Nice, Chris C.			Homoploid hybrid speciation in an extreme habitat	SCIENCE			English	Article							HYBRIDIZATION; DIVERSIFICATION; BUTTERFLIES; LYCAENIDAE; LYCAEIDES; ORIGINS	According to theory, homoploid hybrid speciation, which is hybrid speciation without a change in chromosome number, is facilitated by adaptation to a novel or extreme habitat. Using molecular and ecological data, we found that the alpine-adapted butterflies in the genus Lycaeides are the product of hybrid speciation. The alpine populations possess a mosaic genome derived from both L. melissa and L. idas and are differentiated from and younger than their putative parental species. As predicted, adaptive traits may allow for persistence in the environmentally extreme alpine habitat and reproductively isolate these populations from their parental species.	Texas State Univ, Dept Biol, Populat & Conservat Biol Program, San Marcos, TX 78666 USA; Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89512 USA; Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	Texas State University System; Texas State University San Marcos; University of Tennessee System; University of Tennessee Knoxville; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Davis	Nice, CC (corresponding author), Texas State Univ, Dept Biol, Populat & Conservat Biol Program, San Marcos, TX 78666 USA.	ccnice@txstate.edu		Gompert, Zachariah/0000-0003-2248-2488; Fordyce, James/0000-0002-2731-0418				Anderson EC, 2002, GENETICS, V160, P1217; Arnold ML, 1997, NATURAL HYBRIDIZATIO; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Coyne J.A., 2004, SPECIATION; DEMARAIS BD, 1992, COPEIA, P697; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Fordyce JA, 2003, ECOL LETT, V6, P23, DOI 10.1046/j.1461-0248.2003.00389.x; Fordyce JA, 2002, J EVOLUTION BIOL, V15, P871, DOI 10.1046/j.1420-9101.2002.00432.x; Forister ML, 2006, ANN ENTOMOL SOC AM, V99, P933, DOI 10.1603/0013-8746(2006)99[933:EMVAPA]2.0.CO;2; Grant V., 1981, PLANT SPECIATION; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Lomolino M.V., 2006, BIOGEOGRAPHY; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Nabokov V., 1949, Bulletin of the Museum of Comparative Zoology Harvard, V101, P479; Nice CC, 2005, MOL ECOL, V14, P1741, DOI 10.1111/j.1365-294X.2005.02527.x; Nice CC, 2002, ECOL ENTOMOL, V27, P702, DOI 10.1046/j.1365-2311.2002.00458.x; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Schelly R, 2006, MOL PHYLOGENET EVOL, V38, P426, DOI 10.1016/j.ympev.2005.04.023; Schwarz D, 2005, NATURE, V436, P546, DOI 10.1038/nature03800; Scott JA, 1986, BUTTERFLIES N AM NAT; Scriber JM, 2005, ENTOMOL EXP APPL, V115, P247, DOI 10.1111/j.1570-7458.2005.00285.x; STANFORD RE, 1996, ATLAS W US BUTTERFLI	24	227	234	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1923	1925		10.1126/science.1135875	http://dx.doi.org/10.1126/science.1135875			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17138866				2022-12-01	WOS:000242996800047
J	Wong, YN; Mitra, N; Hudes, G; Localio, R; Schwartz, JS; Wan, F; Montagnet, C; Armstrong, K				Wong, Yu-Ning; Mitra, Nandita; Hudes, Gary; Localio, Russell; Schwartz, J. Sanford; Wan, Fei; Montagnet, Chantal; Armstrong, Katrina			Survival associated with treatment vs observation of localized prostate cancer in elderly men (Reprinted from JAMA, vol 296, 2006)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPARING RADICAL PROSTATECTOMY; QUALITY-OF-LIFE; CONSERVATIVE MANAGEMENT; OUTCOMES; COMORBIDITY; POPULATION; BIAS; SUBCLASSIFICATION; INTERVENTION; CARCINOMA	Context Prostate-specific antigen screening has led to an increase in the diagnosis and treatment of localized prostate cancer. However, the role of active treatment of low- and intermediate-risk disease in elderly men is controversial. Objective To estimate the association between treatment ( with radiation therapy or radical prostatectomy) compared with observation and overall survival in men with low- and intermediate-risk prostate cancer. Design and Setting Observational US cohort from Surveillance, Epidemiology, and End Results Medicare data. Patients At total of 44 630 men aged 65 to 80 years who were diagnosed between 1991 and 1999 with organ-confined, well-or moderately differentiated prostate cancer and who had survived more than a year past diagnosis. Patients were followed up until death or study end ( December 31, 2002). Patients were classified as having received treatment ( n= 32 022) if they had claims for radical prostatectomy or radiation therapy during the first 6 months after diagnosis. They were classified as having received observation ( n= 12 608) if they did not have claims for radical prostatectomy, radiation, or hormonal therapy. Patients who received only hormonal therapy were excluded. Main Outcome Measure Overall survival. Results At the end of the 12-year study period, 4663 men ( 37%) in the observational group and 7639 men ( 23.8%) in the treatment group had died. The treatment group had longer 5- and 10-year survival than the observation group. After using propensity scores to adjust for potential confounders ( tumor characteristics, demographics, and comorbidities), there was a statistically significant survival advantage associated with treatment ( hazard ratio, 0.69; 95% confidence interval, 0.66-0.72). A benefit associated with treatment was seen in all subgroups examined, including older men ( aged 75-80 years at diagnosis), black men, and men with low- risk disease. Conclusions This study suggests a survival advantage is associated with active treatment for low- and intermediate-risk prostate cancer in elderly men aged 65 to 80 years. Because observational data cannot completely adjust for potential selection bias and confounding, these results must be validated in randomized controlled trials of alternative management strategies in elderly men with localized prostate cancer.	Fox Chase Canc Ctr, Div Populat Sci, Philadelphia, PA 19111 USA; Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA; Univ Penn, Dept Biostat & Epidemiol, Div Gen Internal Med, Philadelphia, PA 19104 USA; Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Wong, YN (corresponding author), Fox Chase Canc Ctr, Div Populat Sci, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Y_Wong@fccc.edu			NATIONAL CANCER INSTITUTE [R25CA057708, P50CA105641] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K30RR022255] Funding Source: NIH RePORTER; NCI NIH HHS [P50-CA105641, R25 CA057708] Funding Source: Medline; NCRR NIH HHS [K30 RR022255] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Alibhai SMH, 2005, JNCI-J NATL CANCER I, V97, P1525, DOI 10.1093/jnci/dji313; Beissner RS, 2002, UROLOGY, V59, P721, DOI 10.1016/S0090-4295(02)01531-5; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; BRIGANTI A, 2006, EUR UROL, V175, P721; Chang KP, 2004, J BONE MINER RES, V19, P532, DOI 10.1359/JBMR.040109; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Chodak GW, 2002, UROLOGY, V60, P201, DOI 10.1016/S0090-4295(02)01677-1; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Donovan J, 2003, Health Technol Assess, V7, P1; Etzioni R, 2002, J NATL CANCER I, V94, P981; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Harlan SR, 2003, J UROLOGY, V170, P1804, DOI 10.1097/01.ju.0000091641.34674.11; Hoffman RM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-27; Hoffman RM, 2003, CANCER, V97, P1653, DOI 10.1002/cncr.11233; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Houterman S, 2006, CRIT REV ONCOL HEMAT, V58, P60, DOI 10.1016/j.critrevonc.2005.08.003; Kim-Sing C, 2004, INT J RADIAT ONCOL, V60, P463, DOI 10.1016/j.ijrobp.2004.03.004; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; LuYao GL, 1997, LANCET, V349, P906, DOI 10.1016/S0140-6736(96)09380-4; MITRA N, 2005, U PENNSYLVANIA BIOST; *NAT COMPR CANC NE, 2006, PROST CANC CLIN PRAC; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; Potters L, 2005, J UROLOGY, V173, P1562, DOI 10.1097/01.ju.0000154633.73092.8e; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Shipley WU, 1999, JAMA-J AM MED ASSOC, V281, P1598, DOI 10.1001/jama.281.17.1598; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Spillman BC, 2004, MILBANK Q, V82, P157, DOI 10.1111/j.0887-378X.2004.00305.x; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; WILT TJ, 1994, J UROLOGY, V152, P1910, DOI 10.1016/S0022-5347(17)32413-8; WONG YN, 2006, 4A7A, V296	36	225	226	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2683	2693		10.1001/jama.296.22.2683	http://dx.doi.org/10.1001/jama.296.22.2683			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164454	Bronze			2022-12-01	WOS:000242765700023
J	Ehebauer, M; Hayward, P; Arias, AM				Ehebauer, Matthias; Hayward, Penelope; Arias, Alfonso Martinez			Notch, a universal arbiter of cell fate decisions	SCIENCE			English	Editorial Material							SEGMENTATION; ENDOCYTOSIS; INHIBITION; DROSOPHILA; PATHWAY; GENES		Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge; University of Cambridge	Arias, AM (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	ama11@hermes.cam.ac.uk	Martinez Arias, Alfonso/F-1966-2010	Ehebauer, Matthias/0000-0002-3148-8390	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; EHEBAUER M, 2006, SCI STKE         AUG; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Kopan R, 2002, J CELL SCI, V115, P1095; Lai EC, 2002, EMBO REP, V3, P840, DOI 10.1093/embo-reports/kvf170; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SIMPSON P, 1990, DEVELOPMENT, V109, P509; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	19	149	167	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1414	1415		10.1126/science.1134042	http://dx.doi.org/10.1126/science.1134042			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138893				2022-12-01	WOS:000242406100029
J	Bilezikian, JP				Bilezikian, John P.			Osteonecrosis of the jaw - Do biphosphonates pose a risk?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Bilezikian, JP (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.							Cabanillas ME, 2005, J BONE MINER RES, V20, pS211; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Polizzotto MN, 2006, BRIT J HAEMATOL, V132, P114, DOI 10.1111/j.1365-2141.2005.05833.x; Shane E, 2006, J BONE MINER RES, V21, P1503, DOI 10.1359/JBMR.060712; Woo SB, 2006, ANN INTERN MED, V145, P235, DOI 10.7326/0003-4819-145-10-200611210-00023; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009	6	199	214	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2278	2281		10.1056/NEJMp068157	http://dx.doi.org/10.1056/NEJMp068157			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	110CG	17135582				2022-12-01	WOS:000242355300003
J	Corder, R; Mullen, W; Khan, NQ; Marks, SC; Wood, EG; Carrier, MJ; Crozier, A				Corder, R.; Mullen, W.; Khan, N. Q.; Marks, S. C.; Wood, E. G.; Carrier, M. J.; Crozier, A.			Red wine procyanidins and vascular health	NATURE			English	Article							BEER		Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; Univ Glasgow, Inst Biomed & Life Sci, Plant Prod & Human Nutr Grp, Glasgow G12 8QQ, Lanark, Scotland	University of London; Queen Mary University London; University of Glasgow	Corder, R (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England.	r.corder@qmul.ac.uk	Mullen, William/GWC-8078-2022; Crozier, Alan/H-6642-2017; Corder, Roger/H-2588-2012; Marks, Serena/F-2867-2010	Crozier, Alan/0000-0001-7581-6782; Corder, Roger/0000-0003-1712-6841; Mullen, William/0000-0002-5685-1563				Auger C, 2004, J AGR FOOD CHEM, V52, P5297, DOI 10.1021/jf040125d; Corder R, 2001, NATURE, V414, P863, DOI 10.1038/414863a; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; FITZPATRICK DF, 1993, AM J PHYSIOL, V265, pH774; Hashimoto M, 2001, AM J CARDIOL, V88, P1457, DOI 10.1016/S0002-9149(01)02137-3; Kris-Etherton PM, 2002, CURR OPIN LIPIDOL, V13, P41, DOI 10.1097/00041433-200202000-00007; Poulain M, 2004, EXP GERONTOL, V39, P1423, DOI 10.1016/j.exger.2004.06.016; Renaud SC, 1999, ARCH INTERN MED, V159, P1865, DOI 10.1001/archinte.159.16.1865; Shoji T, 2006, J AGR FOOD CHEM, V54, P884, DOI 10.1021/jf052260b; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x	10	257	276	1	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					566	566		10.1038/444566a	http://dx.doi.org/10.1038/444566a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136085	Bronze			2022-12-01	WOS:000242377600033
J	Kaiser, CM; Chang, HC; Agashe, VR; Lakshmipathy, SK; Etchells, SA; Hayer-Hartl, M; Hartl, FU; Barral, JM				Kaiser, Christian M.; Chang, Hung-Chun; Agashe, Vishwas R.; Lakshmipathy, Sathish K.; Etchells, Stephanie A.; Hayer-Hartl, Manajit; Hartl, F. Ulrich; Barral, Jose M.			Real-time observation of trigger factor function on translating ribosomes	NATURE			English	Article							SIGNAL-RECOGNITION PARTICLE; ESCHERICHIA-COLI RIBOSOME; MOLECULAR CHAPERONES; NASCENT POLYPEPTIDE; CRYSTAL-STRUCTURE; AMINO-ACID; IN-VIVO; PROTEINS; BINDING; SRP	The contribution of co-translational chaperone functions to protein folding is poorly understood. Ribosome-associated trigger factor (TF) is the first molecular chaperone encountered by nascent polypeptides in bacteria. Here we show, using fluorescence spectroscopy to monitor TF function and structural rearrangements in real time, that TF interacts with ribosomes and translating polypeptides in a dynamic reaction cycle. Ribosome binding stabilizes TF in an open, activated conformation. Activated TF departs from the ribosome after a mean residence time of similar to 10 s, but may remain associated with the elongating nascent chain for up to 35 s, allowing entry of a new TF molecule at the ribosome docking site. The duration of nascent-chain interaction correlates with the occurrence of hydrophobic motifs in translating polypeptides, reflecting a high aggregation propensity. These findings can explain how TF prevents misfolding events during translation and may provide a paradigm for the regulation of nucleotide-independent chaperones.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA	Max Planck Society; University of Texas System; University of Texas Medical Branch Galveston	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; jmbarral@utmb.edu	Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; zhang, hong jun/0000-0003-0030-8323				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Baram D, 2005, P NATL ACAD SCI USA, V102, P12017, DOI 10.1073/pnas.0505581102; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bremer H, 1996, ESCHERICHIA COLI SAL, P1553; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Creighton T. E., 1984, PROTEINS STRUCTURES, V2nd; Deuerling E, 2004, CRIT REV BIOCHEM MOL, V39, P261, DOI 10.1080/10409230490892496; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Ludlam AV, 2004, P NATL ACAD SCI USA, V101, P13436, DOI 10.1073/pnas.0405868101; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; MICHALSKI CJ, 1973, EUR J BIOCHEM, V33, P481, DOI 10.1111/j.1432-1033.1973.tb02706.x; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Raine A, 2004, BIOCHIMIE, V86, P495, DOI 10.1016/j.biochi.2004.05.004; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Schroder GF, 2004, COMPUT PHYS COMMUN, V158, P150, DOI 10.1016/j.cpc.2004.02.001; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; SPEDDING G, 1990, RIBOSOMES PROTEIN SY, P1; STRYER L, 1968, SCIENCE, V162, P526, DOI 10.1126/science.162.3853.526; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	44	173	175	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					455	460		10.1038/nature05225	http://dx.doi.org/10.1038/nature05225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17051157				2022-12-01	WOS:000242215700039
J	Smith, NM; Shay, DK				Smith, Nicole M.; Shay, David K.			Influenza vaccination for elderly people and their care workers	LANCET			English	Editorial Material							RESPIRATORY SYNCYTIAL VIRUS; EFFICACY		Ctr Dis Control & Prevent, Influenza Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Shay, DK (corresponding author), Ctr Dis Control & Prevent, Influenza Branch, Atlanta, GA 30333 USA.	dks4@cdc.gov		Shay, David/0000-0001-9619-4820				[Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; Beyer WEP, 2006, VACCINE, V24, P6602, DOI 10.1016/j.vaccine.2006.05.038; Cochrane AL, 1972, EFFECTIVENESS EFFICI; EDMONDSON WP, 1971, AM J EPIDEMIOL, V93, P480, DOI 10.1093/oxfordjournals.aje.a121282; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Monto AS, 1999, J ANTIMICROB CHEMOTH, V44, P23, DOI 10.1093/jac/44.suppl_2.23; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Rudenko LG, 2000, VACCINE, V19, P308, DOI 10.1016/S0264-410X(00)00153-5; Thomas RE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005187.pub2; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	13	6	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1752	1753		10.1016/S0140-6736(06)69713-4	http://dx.doi.org/10.1016/S0140-6736(06)69713-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113407				2022-12-01	WOS:000242225400008
J	Verdun, RE; Karlseder, J				Verdun, Ramiro E.; Karlseder, Jan			The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres	CELL			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; POLYMERASE-ALPHA; IN-VITRO; S-PHASE; G-TAILS; MAMMALIAN TELOMERES; FLAP ENDONUCLEASE-1; CHECKPOINT PROTEIN	Telomeres protect chromosome ends from being detected as lesions and from triggering DNA damage checkpoints. Paradoxically, telomere function depends on checkpoint proteins such as ATM and ATR, but a molecular model explaining this seemingly contradictory relationship has been missing so far. Here we show that the DNA damage machinery acts on telomeres in at least two independent steps. First, the ATR-dependent machinery is recruited to telomeres before telomere replication is completed, likely in response to single-stranded DNA resulting from replication fork stalling. Second, after replication, telomeres attract ATM and the homologous recombination (HR) machinery. In vivo and in vitro results suggest that the HR machinery is required for formation of a telomere-specific structure at chromosome ends after replication. Our results suggest that telomere ends need to be recognized as DNA damage to complete end replication and to acquire a structure that is essential for function.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Karlseder, J (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	karlseder@salk.edu			NIGMS NIH HHS [R01 GM06525] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Dahlen M, 1998, MOL BIOL CELL, V9, P611, DOI 10.1091/mbc.9.3.611; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Fan XQ, 1997, MOL BIOL CELL, V8, P2145, DOI 10.1091/mbc.8.11.2145; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; Henry-Mowatt J, 2003, MOL CELL, V11, P1109, DOI 10.1016/S1097-2765(03)00132-1; Ivanov EL, 1996, GENETICS, V142, P693; Jaco I, 2003, MOL CELL BIOL, V23, P5572, DOI 10.1128/MCB.23.16.5572-5580.2003; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Le S, 1999, GENETICS, V152, P143; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Liu JS, 2003, MUTAT RES-FUND MOL M, V532, P215, DOI 10.1016/j.mrfmmm.2003.08.018; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Muftuoglu M, 2006, CANCER RES, V66, P113, DOI 10.1158/0008-5472.CAN-05-2742; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Stansel RM, 2001, EMBO J, V20, P5532; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Takata H, 2005, MOL CELL, V17, P573, DOI 10.1016/j.molcel.2005.01.014; Takata H, 2004, MOL CELL, V14, P515, DOI 10.1016/S1097-2765(04)00262-X; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Varley H, 2002, NAT GENET, V30, P301, DOI 10.1038/ng834; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Vespa L, 2005, GENE DEV, V19, P2111, DOI 10.1101/gad.1333805; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; WELLINGER RJ, 1993, COLD SPRING HARB SYM, V58, P725, DOI 10.1101/SQB.1993.058.01.080; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	68	266	271	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					709	720		10.1016/j.cell.2006.09.034	http://dx.doi.org/10.1016/j.cell.2006.09.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110331	Bronze			2022-12-01	WOS:000242330600018
J	Wang, XD; Venable, J; LaPointe, P; Hutt, DM; Koulov, AV; Coppinger, J; Gurkan, C; Kellner, W; Matteson, J; Plutner, H; Riordan, JR; Kelly, JW; Yates, JR; Balch, WE				Wang, Xiaodong; Venable, John; LaPointe, Paul; Hutt, Darren M.; Koulov, Atanas V.; Coppinger, Judith; Gurkan, Cemal; Kellner, Wendy; Matteson, Jeanne; Plutner, Helen; Riordan, John R.; Kelly, Jeffery W.; Yates, John R., III; Balch, William E.			Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; QUALITY-CONTROL; MOLECULAR CHAPERONES; ATPASE ACTIVITY; PROTEIN; DEGRADATION; ACTIVATION; DISEASE; ER; CONTRIBUTES	The pathways that distinguish transport of folded and misfolded cargo through the exocytic (secretory) pathway of eukaryotic cells remain unknown. Using proteomics to assess global cystic fibrosis (CF) transmembrane conductance regulator (CFTR) protein interactions (the CFTR interactome), we show that Hsp90 cochaperones modulate Hsp90-dependent stability of CFTR protein folding in the endoplasmic reticulum (ER). Cell-surface rescue of the most common disease variant that is restricted to the ER, Delta F508, can be initiated by partial siRNA silencing of the Hsp90 cochaperone ATPase regulator Aha1. We propose that failure of Delta F508 to achieve an energetically favorable fold in response to the steady-state dynamics of the chaperone folding environment (the "chaperome") is responsible for the pathophysiology of CF. The activity of cargo-associated chaperome components may be a common mechanism regulating folding for ER exit, providing a general framework for correction of misfolding disease.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27510 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill	Yates, JR (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyates@scripps.edu; webalch@scripps.edu	Gurkan, Cemal/S-5751-2016	Gurkan, Cemal/0000-0001-7379-4559; LaPointe, Paul/0000-0002-5465-1795; coppinger, judith/0000-0001-6813-9840; Koulov, Atanas/0000-0003-0262-7002	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, R01GM045678] Funding Source: NIH RePORTER; NCRR NIH HHS [RR11823] Funding Source: Medline; NHLBI NIH HHS [R01 HL079442] Funding Source: Medline; NIDDK NIH HHS [DK51870] Funding Source: Medline; NIGMS NIH HHS [GM45678, GM78654, GM42336] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Amaral MD, 2006, J INHERIT METAB DIS, V29, P477, DOI 10.1007/s10545-006-0251-x; Cutting GR, 2005, ANNU REV GENOM HUM G, V6, P237, DOI 10.1146/annurev.genom.6.080604.162254; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Kelly JW, 2006, NAT CHEM BIOL, V2, P224, DOI 10.1038/nchembio0506-224; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Moyer B D, 2001, Expert Opin Ther Targets, V5, P165, DOI 10.1517/14728222.5.2.165; Nielsen JV, 2004, GENOMICS, V83, P181, DOI 10.1016/j.ygeno.2003.07.001; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qu BH, 1997, J BIOL CHEM, V272, P15739, DOI 10.1074/jbc.272.25.15739; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Welsh MJ, 1998, NAT STRUCT BIOL, V5, P167, DOI 10.1038/nsb0398-167; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	39	489	500	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					803	815		10.1016/j.cell.2006.09.043	http://dx.doi.org/10.1016/j.cell.2006.09.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110338	Bronze			2022-12-01	WOS:000242330600025
J	Baur, JA; Pearson, KJ; Price, NL; Jamieson, HA; Lerin, C; Kalra, A; Prabhu, VV; Allard, JS; Lopez-Lluch, G; Lewis, K; Pistell, PJ; Poosala, S; Becker, KG; Boss, O; Gwinn, D; Wang, MY; Ramaswamy, S; Fishbein, KW; Spencer, RG; Lakatta, EG; Le Couteur, D; Shaw, RJ; Navas, P; Puigserver, P; Ingram, DK; de Cabo, R; Sinclair, DA				Baur, Joseph A.; Pearson, Kevin J.; Price, Nathan L.; Jamieson, Hamish A.; Lerin, Carles; Kalra, Avash; Prabhu, Vinayakumar V.; Allard, Joanne S.; Lopez-Lluch, Guillermo; Lewis, Kaitlyn; Pistell, Paul J.; Poosala, Suresh; Becker, Kevin G.; Boss, Olivier; Gwinn, Dana; Wang, Mingyi; Ramaswamy, Sharan; Fishbein, Kenneth W.; Spencer, Richard G.; Lakatta, Edward G.; Le Couteur, David; Shaw, Reuben J.; Navas, Placido; Puigserver, Pere; Ingram, Donald K.; de Cabo, Rafael; Sinclair, David A.			Resveratrol improves health and survival of mice on a high-calorie diet	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; REPLICATIVE LIFE-SPAN; GENE SET ENRICHMENT; MITOCHONDRIAL BIOGENESIS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; RESTRICTION MIMETICS; COACTIVATOR PGC-1; DEFICIENT MICE; C-ELEGANS	Resveratrol ( 3,5,4'- trihydroxystilbene) extends the lifespan of diverse species including Saccharomyces cerevisiae, Caenorhabditis elegans and Drosophila melanogaster. In these organisms, lifespan extension is dependent on Sir2, a conserved deacetylase proposed to underlie the beneficial effects of caloric restriction. Here we show that resveratrol shifts the physiology of middle- aged mice on a high- calorie diet towards that of mice on a standard diet and significantly increases their survival. Resveratrol produces changes associated with longer lifespan, including increased insulin sensitivity, reduced insulin- like growth factor- 1 ( IGF- I) levels, increased AMP- activated protein kinase ( AMPK) and peroxisome proliferator- activated receptor-gamma coactivator 1 alpha ( PGC- 1 alpha) activity, increased mitochondrial number, and improved motor function. Parametric analysis of gene set enrichment revealed that resveratrol opposed the effects of the high- calorie diet in 144 out of 153 significantly altered pathways. These data show that improving general health in mammals using small molecules is an attainable goal, and point to new approaches for treating obesity- related disorders and diseases of ageing.	Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA; NIA, Res Resources Branch, NIH, Baltimore, MD 21224 USA; NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA; NIA, Clin Invest Lab, Res Resources Branch, Gerontol Res Ctr,NIH, Baltimore, MD 21224 USA; Univ Sydney, ANZAC Res Inst, Concord, NSW 2139, Australia; Univ Sydney, Ctr Educ, Concord, NSW 2139, Australia; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Univ Pablo Olavide, CSIC, Ctr andaluz Biol Desarrollo, Seville 41013, Spain; Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA; Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Louisiana State Univ, Pennington Biomed Res Ctr, Nutr Neurosci & Aging Lab, Baton Rouge, LA 70808 USA	Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Sydney; ANZAC Research Institute; University of Sydney; Johns Hopkins University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Salk Institute; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	de Cabo, R (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	deCaboRa@grc.nia.nih.gov; david_sinclair@hms.harvard.edu	Lerin, Carles/AAP-9916-2020; Lakatta, Edward G/AAL-1447-2020; Sharan, Ramaswamy/H-4469-2019; Research Institute, ANZAC/CAE-9030-2022; de Cabo, Rafael Carlos/J-5230-2016; wang, mingyi/L-8370-2017; de Cabo, Rafael/E-7996-2010; Baur, Joseph A/D-8163-2011; Lopez-Lluch, Guillermo/N-4742-2014; Fishbein, Kenneth/AAN-2595-2021; NAVAS, PLACIDO/R-5943-2019; de Cabo, Rafael/J-5230-2016	Lerin, Carles/0000-0003-0950-4363; de Cabo, Rafael Carlos/0000-0003-2830-5693; wang, mingyi/0000-0001-6412-369X; de Cabo, Rafael/0000-0003-2830-5693; Lopez-Lluch, Guillermo/0000-0001-9830-8502; Fishbein, Kenneth/0000-0002-6353-4603; NAVAS, PLACIDO/0000-0002-4115-7966; Hardell, Kaitlyn/0000-0002-5502-8145; Le Couteur, David/0000-0002-4227-5817; Lakatta, Edward/0000-0002-4772-0035; Becker, Kevin/0000-0002-6794-6656; Baur, Joseph/0000-0001-8262-6549; de Cabo, Rafael/0000-0002-3354-2442; Sinclair, David/0000-0002-9936-436X; Price, Nathan/0000-0002-2821-9608	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000864, Z01AG000381, R01AG019972, Z01AG000368, R01AG019719, R01AG028730, P01AG027916, R37AG028730, Z01AG000302] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG027916, R01 AG028730, R01 AG019972, R37 AG028730, R01 AG019719] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hipkiss AR, 2006, ANN NY ACAD SCI, V1067, P361, DOI 10.1196/annals.1354.051; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; HOWITZ KT, 2006, HDB BIOL AGING, P63; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Jarolim S, 2004, FEMS YEAST RES, V5, P169, DOI 10.1016/j.femsyr.2004.06.015; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li ZP, 2005, SURG CLIN N AM, V85, P681, DOI 10.1016/j.suc.2005.04.006; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Olsen A, 2006, SCIENCE, V312, P1381, DOI 10.1126/science.1124981; OLSHANSKY SJ, 2005, HLTH AFF MILLWOOD S2, V24, pWR589; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Raval AP, 2006, J CEREBR BLOOD F MET, V26, P1141, DOI 10.1038/sj.jcbfm.9600262; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Scrocchi LA, 1998, ENDOCRINOLOGY, V139, P3127, DOI 10.1210/en.139.7.3127; Siebler J, 2006, WORLD J GASTROENTERO, V12, P2161; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Wilsey J, 2004, J ENDOCRINOL, V181, P297, DOI 10.1677/joe.0.1810297; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu XW, 1996, AM J PHYSIOL-ENDOC M, V271, pE903, DOI 10.1152/ajpendo.1996.271.5.E903; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	44	3367	3543	26	757	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					337	342		10.1038/nature05354	http://dx.doi.org/10.1038/nature05354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17086191	Green Accepted, Green Submitted			2022-12-01	WOS:000242018300041
J	Caliezi, C; Reber, P				Caliezi, Christoph; Reber, Peter			Fibromuscular dysplasia of the renal artery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Lindenhofspital, CH-3001 Bern, Switzerland		Caliezi, C (corresponding author), Lindenhofspital, CH-3001 Bern, Switzerland.	christoph.caliezi@lindenhofspital.ch							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 16	2006	355	20					2131	2131		10.1056/NEJMicm053293	http://dx.doi.org/10.1056/NEJMicm053293			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104YU	17108345				2022-12-01	WOS:000241997300009
J	Maki, DG				Maki, Dennis G.			Don't eat the spinach - Controlling foodborne infectious disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ESCHERICHIA-COLI		Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.							*CDCP, 2006, E COLI O157 H7 OUTBR; Diez-Gonzalez F, 1998, SCIENCE, V281, P1666, DOI 10.1126/science.281.5383.1666; Osterholm MT, 2004, NEW ENGL J MED, V350, P1898, DOI 10.1056/NEJMsb032657; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; 2006, MMWR MORB MORTAL WKL, V55, P392	5	43	44	2	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 9	2006	355	19					1952	1955		10.1056/NEJMp068225	http://dx.doi.org/10.1056/NEJMp068225			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	102SG	17093245	Bronze			2022-12-01	WOS:000241833000002
J	Shin, JS; Ebersold, M; Pypaert, M; Delamarre, L; Hartley, A; Mellman, I				Shin, Jeoung-Sook; Ebersold, Melanie; Pypaert, Marc; Delamarre, Lelia; Hartley, Adam; Mellman, Ira			Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination	NATURE			English	Article							RECEPTOR TYROSINE KINASES; INVARIANT CHAIN; DOWN-REGULATION; ANTIGEN PRESENTATION; IN-VIVO; ENDOCYTOSIS; COMPLEX; PROTEIN; DEGRADATION; TRANSPORT	Dendritic cells have a unique function in the immune response owing to their ability to stimulate immunologically naive T lymphocytes(1). In response to microbial and inflammatory stimuli, dendritic cells enhance their capacity for antigen presentation by a process of terminal differentiation, termed maturation(2,3). The conversion of immature to mature dendritic cells is accompanied by a marked cellular reorganization, including the redistribution of major histocompatibility complex class II molecules (MHC II) from late endosomal and lysosomal compartments to the plasma membrane(4-7) and the downregulation of some forms of endocytosis, which has been thought to slow the clearance of MHC II from the surface(8-11). The relative extent to which these or other mechanisms contribute to the regulation of surface MHC II remains unclear, however. Here we find that the MHC II beta-chain cytoplasmic tail is ubiquitinated in mouse immature dendritic cells. Although only partly required for the sequestration of MHC II in multivesicular bodies, this modification is essential for endocytosis. Notably, ubiquitination of MHC II ceased upon maturation, resulting in the accumulation of MHC II at the cell surface. Dendritic cells thus exhibit a unique ability to regulate MHC II surface expression by selectively controlling MHC II ubiquitination.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Immunobiol Sect, New Haven, CT 06520 USA	Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.	ira.mellman@yale.edu	Mellman, Ira/ABG-5896-2020					Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Colledge L, 2002, EUR J IMMUNOL, V32, P3246, DOI 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Pathak SS, 2001, J IMMUNOL, V167, P632, DOI 10.4049/jimmunol.167.2.632; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; SALAMERO J, 1990, EMBO J, V9, P3489, DOI 10.1002/j.1460-2075.1990.tb07557.x; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Zhong GM, 1997, J EXP MED, V185, P429, DOI 10.1084/jem.185.3.429	29	200	227	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					115	118		10.1038/nature05261	http://dx.doi.org/10.1038/nature05261			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17051151				2022-12-01	WOS:000241701500057
J	Whitney, CG; Pilishvili, T; Farley, MM; Schaffner, W; Craig, AS; Lynfield, R; Nyquist, AC; Gershman, KA; Vazquez, M; Bennett, NM; Reingold, A; Thomas, A; Glode, MP; Zell, ER; Jorgensen, JH; Beall, B; Schuchat, A				Whitney, Cynthia G.; Pilishvili, Tamor; Farley, Monica M.; Schaffner, William; Craig, Allen S.; Lynfield, Ruth; Nyquist, Ann-Christine; Gershman, Kenneth A.; Vazquez, Marietta; Bennett, Nancy M.; Reingold, Arthur; Thomas, Ann; Glode, Mary P.; Zell, Elizabeth R.; Jorgensen, James H.; Beall, Bernard; Schuchat, Anne			Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study	LANCET			English	Article							STREPTOCOCCUS-PNEUMONIAE; IMMUNOGENICITY; EFFICACY; CHILDREN; SAFETY; SURVEILLANCE; TOLERABILITY; CORRELATE; ADULTS; ERA	Background When seven-valent pneumococcal conjugate vaccine was introduced in the USA, many children were vaccinated on schedules that differed from those tested in clinical trials. Our aim was to assess the effectiveness of the vaccine against various pneumococcal serotypes, and to measure the effectiveness of the recommended dose schedule and of catch-up and incomplete schedules. Methods Invasive disease, defined as isolation of pneumococcus from a sterile site, was identified in children aged 3-59 months through the US Centers for Disease Control and Prevention's Active Bacterial Core surveillance. We tested isolates for serotype and antimicrobial susceptibility. Three controls, matched for age and zip code were selected for each case. We calculated the matched odds ratio for vaccination using conditional logistic regression, controlling for underlying conditions. Vaccine effectiveness was calculated as one minus the adjusted matched odds ratio times 100%. Findings We enrolled 782 cases and 2512 controls. Effectiveness of one or more doses against vaccine serotypes was 96% (95% CI 93-98) in healthy children and 81% (57-92) in those with coexisting disorders. It was 76% (63-85) against infections that were not susceptible to penicillin. Vaccination prevented disease caused by all seven vaccine serotypes, and by vaccine-related serotype 6A. Several schedules were more protective than no vaccination; three infant doses with a booster were more protective against vaccine-type disease than were three infant doses alone (p=0.0323). Interpretation The seven-valent pneumococcal conjugate vaccine prevents invasive disease in both healthy and chronically ill children. The vaccine is effective when used with various non-standard schedules.	Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Emory Univ, Dept Med, Vet Affairs Med Ctr, Atlanta, GA 30322 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Tennessee Dept Hlth, Nashville, TN USA; Minnesota Dept Hlth, Minneapolis, MN USA; Childrens Hosp, Denver, CO 80218 USA; Colorado Dept Publ Hlth & Environm, Denver, CO USA; Yale Univ, Dept Pediat, New Haven, CT 06520 USA; Univ Rochester, Dept Med, Rochester, NY USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Oregon State Publ Hlth Div, Portland, OR USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Vanderbilt University; Tennessee Department Health; Minnesota Department of Health (MHD); Children's Hospital Colorado; Colorado Department of Public Health & Environment; Yale University; University of Rochester; University of California System; University of California Berkeley; University of Texas System; University of Texas Health San Antonio	Whitney, CG (corresponding author), 1600 Clifton Rd NE,Mailstop C23, Atlanta, GA 30333 USA.	cwhitney@cdc.gov						Abramson JS, 2000, PEDIATRICS, V106, P362; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Black S, 2004, PEDIATR INFECT DIS J, V23, P485, DOI 10.1097/01.inf.0000129685.04847.94; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1140; *CLIN LAB STAND I, 2006, PERF STAND ANT SUSC; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; Doern GV, 2005, CLIN INFECT DIS, V41, P139, DOI 10.1086/430906; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Esposito S, 2005, VACCINE, V23, P1703, DOI 10.1016/j.vaccine.2004.09.029; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Jodar L, 2003, VACCINE, V21, P3265, DOI 10.1016/S0264-410X(03)00230-5; Jokinen JT, 2004, J INFECT DIS, V190, P545, DOI 10.1086/422531; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kayhty H, 2005, PEDIATR INFECT DIS J, V24, P108, DOI 10.1097/01.inf.0000151022.92222.be; KLUGMAN KP, 1908, NEW ENGL J MED, V349, P1341; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; *PNEUM MOL EP NETW, PNEUM MOL EP NETW; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney Cynthia G, 2004, Semin Pediatr Infect Dis, V15, P86, DOI 10.1053/j.spid.2004.01.011; *WHO, 2003, WKLY EPIDEMIOL REC, V14, P110; WOODIN KA, 1995, ARCH PEDIAT ADOL MED, V149, P845, DOI 10.1001/archpedi.1995.02170210019003	32	448	465	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 28	2006	368	9546					1495	1502		10.1016/S0140-6736(06)69637-2	http://dx.doi.org/10.1016/S0140-6736(06)69637-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099GZ	17071283	Green Submitted			2022-12-01	WOS:000241582700027
J	Hsieh, CH; Reiss, CS; Hunter, JR; Beddington, JR; May, RM; Sugihara, G				Hsieh, Chih-hao; Reiss, Christian S.; Hunter, John R.; Beddington, John R.; May, Robert M.; Sugihara, George			Fishing elevates variability in the abundance of exploited species	NATURE			English	Article							NATURAL-POPULATIONS; AGE STRUCTURE; GADUS-MORHUA; LIFE-HISTORY; COD; RECRUITMENT; IMPACTS; FISHES	The separation of the effects of environmental variability from the impacts of fishing has been elusive, but is essential for sound fisheries management(1-7). We distinguish environmental effects from fishing effects by comparing the temporal variability of exploited versus unexploited fish stocks living in the same environments. Using the unique suite of 50-year-long larval fish surveys from the California Cooperative Oceanic Fisheries Investigations(4) we analyse fishing as a treatment effect in a long-term ecological experiment. Here we present evidence from the marine environment that exploited species exhibit higher temporal variability in abundance than unexploited species. This remains true after accounting for life-history effects, abundance, ecological traits and phylogeny. The increased variability of exploited populations is probably caused by fishery-induced truncation of the age structure, which reduces the capacity of populations to buffer environmental events(1,5,8,9). Therefore, to avoid collapse, fisheries must be managed not only to sustain the total viable biomass but also to prevent the significant truncation of age structure(1,5,8,9). The double jeopardy of fishing to potentially deplete stock sizes and, more immediately, to amplify the peaks and valleys of population variability(7), calls for a precautionary management approach(10,11).	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, La Jolla, CA 92037 USA; Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Biol, London SW7 2AZ, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA; Imperial College London; University of Oxford	Sugihara, G (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gsugihara@ucsd.edu	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272				Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; BEDDINGTON JR, 1977, SCIENCE, V197, P463, DOI 10.1126/science.197.4302.463; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Cury PA, 2005, ICES J MAR SCI, V62, P307, DOI 10.1016/j.icesjms.2005.02.003; FAO, 2003, FAO TECHN GUID RE S2, P1, DOI DOI 10.1017/CB09781107415324.004; *FAO UN, 2005, REV STAT WORLD MAR F; Finney BP, 2002, NATURE, V416, P729, DOI 10.1038/416729a; Hilborn R, 2001, CAN J FISH AQUAT SCI, V58, P99, DOI 10.1139/cjfas-58-1-99; Hsieh CH, 2005, PROG OCEANOGR, V67, P160, DOI 10.1016/j.pocean.2005.05.002; Hsieh CH, 2005, NATURE, V435, P336, DOI 10.1038/nature03553; Hutchings JA, 2005, PHILOS T R SOC B, V360, P315, DOI 10.1098/rstb.2004.1586; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; HUTCHINGS JA, 1993, CAN J FISH AQUAT SCI, V50, P2468, DOI 10.1139/f93-271; LAMBERT TC, 1987, MAR ECOL PROG SER, V39, P209, DOI 10.3354/meps039209; Little R. J., 2002, STAT ANAL MISSING DA, VSecond, P164; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Marteinsdottir G, 1998, J FISH BIOL, V52, P1241, DOI 10.1006/jfbi.1998.0670; MAY RM, 1978, MATH BIOSCI, V42, P219, DOI 10.1016/0025-5564(78)90097-4; Mertz G, 1996, CAN J FISH AQUAT SCI, V53, P1618, DOI 10.1139/cjfas-53-7-1618; Mertz G., 1994, Fisheries Oceanography, V3, P1, DOI 10.1111/j.1365-2419.1994.tb00043.x; Murawski SA, 2001, ICES J MAR SCI, V58, P1002, DOI 10.1006/jmsc.2001.1097; MURPHY GI, 1967, ECOLOGY, V48, P731, DOI 10.2307/1933730; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; PIMM SL, 1991, BALANCE NATURE ECOLO, P39; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SHEPHERD JG, 1990, PHILOS T ROY SOC B, V330, P151, DOI 10.1098/rstb.1990.0189; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242	30	433	451	4	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					859	862		10.1038/nature05232	http://dx.doi.org/10.1038/nature05232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051218				2022-12-01	WOS:000241362700052
J	Ribeil, JA; Zermati, Y; Vandekerckhove, J; Cathelin, S; Kersual, J; Dussiot, M; Coulon, S; Moura, IC; Zeuner, A; Kirkegaard-Sorensen, T; Varet, B; Solary, E; Garrido, C; Hermine, O				Ribeil, Jean-Antoine; Zermati, Yael; Vandekerckhove, Julie; Cathelin, Severine; Kersual, Joelle; Dussiot, Michael; Coulon, Severine; Moura, Ivan Cruz; Zeuner, Ann; Kirkegaard-Sorensen, Thomas; Varet, Bruno; Solary, Eric; Garrido, Carmen; Hermine, Olivier			Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1	NATURE			English	Article							TRANSCRIPTION FACTOR GATA-1; ERYTHROID-DIFFERENTIATION; NEGATIVE REGULATION; CASPASE ACTIVATION; APAF-1 APOPTOSOME; CELL-SURVIVAL; CYTOCHROME-C; MATURATION; PROLIFERATION; PROGENITORS	Caspase-3 is activated during both terminal differentiation and erythropoietin-starvation-induced apoptosis of human erythroid precursors. The transcription factor GATA-1, which performs an essential function in erythroid differentiation(1,2) by positively regulating promoters of erythroid and anti-apoptotic genes(3-6), is cleaved by caspases in erythroid precursors undergoing cell death upon erythropoietin starvation or engagement of the death receptor Fas(7,8). In contrast, by an unknown mechanism, GATA-1 remains uncleaved when these cells undergo terminal differentiation upon stimulation with Epo(9-11). Here we show that during differentiation, but not during apoptosis, the chaperone protein Hsp70 protects GATA-1 fromcaspase-mediated proteolysis. At the onset of caspase activation, Hsp70 co-localizes and interacts with GATA-1 in the nucleus of erythroid precursors undergoing terminal differentiation. In contrast, erythropoietin starvation induces the nuclear export of Hsp70 and the cleavage of GATA-1. In an in vitro assay, Hsp70 protects GATA-1 from caspase-3-mediated proteolysis through its peptide-binding domain. The use of RNA-mediated interference to decrease the Hsp70 content of erythroid precursors cultured in the presence of erythropoietin leads to GATA-1 cleavage, a decrease in haemoglobin content, downregulation of the expression of the anti-apoptotic protein Bcl-X-L, and cell death by apoptosis. These effects are abrogated by the transduction of a caspase-resistant GATA-1 mutant. Thus, in erythroid precursors undergoing terminal differentiation, Hsp70 prevents active caspase-3 from cleaving GATA-1 and inducing apoptosis.	Univ Paris 05, Inst Federat Necker, CNRS,UMR 8147, Fac Med, F-75270 Paris, France; INSERM, UMR 517, F-21079 Dijon, France; Ist Super Sanita, Dept Hematol & Oncol, I-00161 Rome, Italy; Danish Canc Soc, Inst Canc Biol, Dept Apoptosis, DK-2100 Copenhagen, Denmark; Univ Paris 05, Assistance Publ Hop Paris, F-75270 Paris, France; Fac Med, Dept Hematol, F-75270 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); Istituto Superiore di Sanita (ISS); Danish Cancer Society; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Universite de Franche-Comte	Hermine, O (corresponding author), Univ Paris 05, Inst Federat Necker, CNRS,UMR 8147, Fac Med, F-75270 Paris, France.	zermati@igr.fr; hermine@necker.fr	Ribeil, Jean-Antoine/AAK-7979-2020; Ribeil, Jean-Antoine/F-7896-2017; Garrido, Carolina/GWM-5557-2022; Hermine, Olivier/Q-7072-2018; Zeuner, Ann/K-8607-2016; Moura, Ivan C/A-9510-2013; Garrido, carmen/G-1633-2018; Cruz Moura, Ivan/A-9510-2013; Zeuner, Ann/A-8529-2010	Ribeil, Jean-Antoine/0000-0002-4549-4783; Ribeil, Jean-Antoine/0000-0002-5733-9123; Moura, Ivan C/0000-0002-2977-0354; Garrido, carmen/0000-0003-1368-1493; Cruz Moura, Ivan/0000-0002-8418-2803; Solary, Eric/0000-0002-8629-1341; Zeuner, Ann/0000-0002-8295-3715; Hermine, Olivier/0000-0003-2574-3874				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Gregoli PA, 1999, J CELL PHYSIOL, V178, P133, DOI 10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kolbus A, 2002, J EXP MED, V196, P1347, DOI 10.1084/jem.20020562; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Munugalavadla V, 2005, MOL CELL BIOL, V25, P6747, DOI 10.1128/MCB.25.15.6747-6759.2005; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; WINNING RS, 1988, DEV BIOL, V128, P111, DOI 10.1016/0012-1606(88)90272-2; Zermati Y, 2000, EXP HEMATOL, V28, P885, DOI 10.1016/S0301-472X(00)00488-4; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247	24	200	214	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					102	105		10.1038/nature05378	http://dx.doi.org/10.1038/nature05378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167422				2022-12-01	WOS:000243225100044
J	Bukanov, NO; Smith, LA; Klinger, KW; Ledbetter, SR; Ibraghimov-Beskrovnaya, O				Bukanov, Nikolay O.; Smith, Laurie A.; Klinger, Katherine W.; Ledbetter, Steven R.; Ibraghimov-Beskrovnaya, Oxana			Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine	NATURE			English	Article							CELL-CYCLE; R-ROSCOVITINE; IN-VITRO; PROTEIN; PROGRESSION; ENCODES; GENE; APOPTOSIS; PATHWAY; KINASE	Polycystic kidney diseases (PKDs) are primarily characterized by the growth of fluid-filled cysts in renal tubules leading to end-stage renal disease(1-3). Mutations in the PKD1 or PKD2 genes lead to autosomal dominant PKD (ADPKD), a slowly developing adult form(4,5). Autosomal recessive polycystic kidney disease results from mutations in the PKHD1 gene, affects newborn infants and progresses very rapidly(6,7). No effective treatment is currently available for PKD. A previously unrecognized site of subcellular localization was recently discovered for all proteins known to be disrupted in PKD: primary cilia(8,9). Because ciliary functions seem to be involved in cell cycle regulation, disruption of proteins associated with cilia or centrioles may directly affect the cell cycle and proliferation, resulting in cystic disease(10-12). We therefore reasoned that the dysregulated cell cycle may be the most proximal cause of cystogenesis, and that intervention targeted at this point could provide significant therapeutic benefit for PKD. Here we show that treatment with the cyclin-dependent kinase (CDK) inhibitor (R)-roscovitine does indeed yield effective arrest of cystic disease in jck and cpk mouse models of PKD. Continuous daily administration of the drug is not required to achieve efficacy; pulse treatment provides a robust, long-lasting effect, indicating potential clinical benefits for a lifelong therapy. Molecular studies of the mechanism of action reveal effective cell-cycle arrest, transcriptional inhibition and attenuation of apoptosis. We found that roscovitine is active against cysts originating from different parts of the nephron, a desirable feature for the treatment of ADPKD, in which cysts form in multiple nephron segments. Our results indicate that inhibition of CDK is a new and effective approach to the treatment of PKD.	Genzyme Corp, Cell Biol, Framingham, MA 01701 USA; Genzyme Corp, Genet & Genom, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation; Sanofi-Aventis; Genzyme Corporation	Ibraghimov-Beskrovnaya, O (corresponding author), Genzyme Corp, Cell Biol, 5 Mt Rd, Framingham, MA 01701 USA.	oxana.beskrovnaya@genzyme.com						Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Ecder T, 2002, KIDNEY INT, V61, P1220, DOI 10.1046/j.1523-1755.2002.00250.x; Ecder Tevfik, 2004, Expert Rev Cardiovasc Ther, V2, P369, DOI 10.1586/14779072.2.3.369; Guzi Timothy, 2004, Curr Opin Investig Drugs, V5, P1311; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Lin L, 2006, CELL DEATH DIFFER, V13, P141, DOI 10.1038/sj.cdd.4401717; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Smith LA, 2006, J AM SOC NEPHROL, V17, P2821, DOI 10.1681/ASN.2006020136; Sweeney WE, 2003, KIDNEY INT, V64, P1310, DOI 10.1046/j.1523-1755.2003.00232.x; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Tao YX, 2005, P NATL ACAD SCI USA, V102, P6954, DOI 10.1073/pnas.0408518102; Tirado OM, 2005, CANCER RES, V65, P9320, DOI 10.1158/0008-5472.CAN-05-1276; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Verdaguer E, 2004, NEUROCHEM INT, V44, P251, DOI 10.1016/S0197-0186(03)00147-5; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; WELLING LW, 1996, RENAL PATHOLOGY, P1828; Wilson PD, 2004, INT J BIOCHEM CELL B, V36, P1868, DOI 10.1016/j.biocel.2004.03.012; WOO DDL, 1994, NATURE, V368, P750, DOI 10.1038/368750a0	30	208	236	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					949	952		10.1038/nature05348	http://dx.doi.org/10.1038/nature05348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17122773				2022-12-01	WOS:000242805400061
J	Bethard, S				Bethard, Suzanne			Taking my poison	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sbethard@stanford.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2006	296	22					2657	2658		10.1001/jama.296.22.2657	http://dx.doi.org/10.1001/jama.296.22.2657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	115WY	17164443				2022-12-01	WOS:000242765700001
J	Low, HH; Lowe, J				Low, Harry H.; Loewe, Jan			A bacterial dynamin-like protein	NATURE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; MECHANOCHEMICAL ENZYME DYNAMIN; GTP-BINDING PROTEINS; CRYSTAL-STRUCTURE; MITOCHONDRIAL FUSION; DOMAIN; HOMOLOGY; CONSTRICTION; MORPHOLOGY; ASSEMBLES	Dynamins form a superfamily of large mechano-chemical GTPases that includes the classical dynamins and dynamin-like proteins (DLPs)(1). They are found throughout the Eukarya, functioning in core cellular processes such as endocytosis and organelle division(1). Many bacteria are predicted by sequence to possess large GTPases with the same multidomain architecture that is found in DLPs(2). Mechanistic dissection of dynamin family members has been impeded by a lack of high-resolution structural data currently restricted to the GTPase(3,4) and pleckstrin homology(5) domains, and the dynamin-related human guanylate-binding protein(6). Here we present the crystal structure of a cyanobacterial DLP in both nucleotide-free and GDP-associated conformation. The bacterial DLP shows dynamin-like qualities, such as helical self-assembly and tubulation of a lipid bilayer. In vivo, it localizes to the membrane in a manner reminiscent of FZL(7), a chloroplast-specific dynamin-related protein with which it shares sequence similarity. Our results provide structural and mechanistic insight that may be relevant across the dynamin superfamily. Concurrently, we show compelling similarity between a cyanobacterial and chloroplast DLP that, given the endosymbiotic ancestry of chloroplasts(8), questions the evolutionary origins of dynamins.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lowe, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	jyl@mrc-lmb.cam.ac.uk	Löwe, Jan/B-3882-2011; Low, Harry/T-4482-2019; Löwe, Jan/X-6998-2019	Lowe, Jan/0000-0002-5218-6615	MRC [MC_U105184326] Funding Source: UKRI; Medical Research Council [MC_U105184326] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Gao H, 2006, P NATL ACAD SCI USA, V103, P6759, DOI 10.1073/pnas.0507287103; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Klockow B, 2002, EMBO J, V21, P240, DOI 10.1093/emboj/21.3.240; McFadden GI, 1999, CURR OPIN PLANT BIOL, V2, P513, DOI 10.1016/S1369-5266(99)00025-4; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Santel A, 2001, J CELL SCI, V114, P867; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Stock D, 2005, PROG BIOPHYS MOL BIO, V88, P311, DOI 10.1016/j.pbiomolbio.2004.07.009; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TUMA PL, 1994, J BIOL CHEM, V269, P30842; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	28	167	174	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					766	769		10.1038/nature05312	http://dx.doi.org/10.1038/nature05312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17122778				2022-12-01	WOS:000242581100062
J	Bokel, C; Schwabedissen, A; Entchev, E; Renaud, O; Gonzalez-Gaitan, M				Boekel, Christian; Schwabedissen, Anja; Entchev, Eugeni; Renaud, Olivier; Gonzalez-Gaitan, Marcos			Sara endosomes and the maintenance of Dpp signaling levels across mitosis	SCIENCE			English	Article							TGF-BETA RECEPTOR; MORPHOGEN GRADIENT; DROSOPHILA; CELLS; TRANSDUCTION; APOPTOSIS; PROTEIN; CLATHRIN; RAB11	During development, cells acquire positional information by reading the concentration of morphogens. In the developing fly wing, a gradient of the transforming growth factor - beta ( TGF- beta) type morphogen decapentaplegic ( Dpp) is transduced into a gradient of concentration of the phosphorylated form of the R-Smad transcription factor Mad. The endosomal protein Sara ( Smad anchor for receptor activation) recruits R-Smads for phosphorylation by the type I TGF- beta receptor. We found that Sara, Dpp, and its type I receptor Thickveins were targeted to a subpopulation of apical endosomes in the developing wing epithelial cells. During mitosis, the Sara endosomes and the receptors therein associated with the spindle machinery to segregate into the two daughter cells. Daughter cells thereby inherited equal amounts of signaling molecules and thus retained the Dpp signaling levels of the mother cell.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland	Max Planck Society; University of Geneva; University of Geneva	Gonzalez-Gaitan, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	marcos.gonzalez@biochem.unige.ch	Bökel, Christian/F-6355-2010; Entchev, Eugeni V/D-2606-2009	Bökel, Christian/0000-0001-6603-6557; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; Renaud, Olivier/0000-0003-0187-6680; Entchev, Eugeni/0000-0003-0744-5929				Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821; Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Bennett D, 2002, NAT GENET, V31, P419, DOI 10.1038/ng938; Bourillot PY, 2002, DEVELOPMENT, V129, P2167; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dyson S, 1998, CELL, V93, P557, DOI 10.1016/S0092-8674(00)81185-X; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gonzallez-Gaitan M, 2003, NAT REV MOL CELL BIO, V4, P213, DOI 10.1038/nrm1053; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Jullien J, 2005, GENE DEV, V19, P2682, DOI 10.1101/gad.341605; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Milan M, 1996, P NATL ACAD SCI USA, V93, P11687, DOI 10.1073/pnas.93.21.11687; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Weigmann K, 1999, DEVELOPMENT, V126, P3823; Winkler S, 2005, GENOME RES, V15, P718, DOI 10.1101/gr.3721805	24	83	85	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1135	1139		10.1126/science.1132524	http://dx.doi.org/10.1126/science.1132524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110576				2022-12-01	WOS:000242045800042
J	Dame, RT; Noom, MC; Wuite, GJL				Dame, Remus T.; Noom, Maarten C.; Wuite, Gijs J. L.			Bacterial chromatin organization by H-NS protein unravelled using dual DNA manipulation	NATURE			English	Article							SINGLE MOLECULES; RNA-POLYMERASE; REVEALS; DOMAIN; FORCE; OLIGOMERIZATION; ASSOCIATION; COMPACTION; REPRESSES	Both prokaryotic and eukaryotic organisms contain DNA bridging proteins, which can have regulatory or architectural functions (1). The molecular and mechanical details of such proteins are hard to obtain, in particular if they involve non- specific interactions. The bacterial nucleoid consists of hundreds of DNA loops, shaped in part by non- specific DNA bridging proteins such as histone-like nucleoid structuring protein ( H- NS), leucine- responsive regulatory protein ( Lrp) and SMC ( structural maintenance of chromosomes) proteins(2,3). We have developed an optical tweezers instrument that can independently handle two DNA molecules, which allows the systematic investigation of protein- mediated DNA - DNA interactions. Here we use this technique to investigate the abundant non- specific nucleoid- associated protein H- NS, and show that H- NS is dynamically organized between two DNA molecules in register with their helical pitch. Our optical tweezers also allow us to carry out dynamic force spectroscopy on non- specific DNA binding proteins and thereby to determine an energy landscape for the H- NS - DNA interaction. Our results explain how the bacterial nucleoid can be effectively compacted and organized, but be dynamic in nature and accessible to DNA- tracking motor enzymes. Finally, our experimental approach is widely applicable to other DNA bridging proteins, as well as to complex DNA interactions involving multiple DNA molecules.	Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Ctr Laser, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Dame, RT (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	rtdame@nat.vu.nl	Dame, Remus/A-8570-2008; Dame, Remus T./E-1941-2014; Dame, Remus/AAT-2989-2020	Dame, Remus T./0000-0001-9863-1692; Dame, Remus/0000-0001-9863-1692; wuite, gijs/0000-0002-5706-043X				Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Camacho CJ, 2001, P NATL ACAD SCI USA, V98, P10636, DOI 10.1073/pnas.181147798; Ceschini S, 2000, J BIOL CHEM, V275, P729, DOI 10.1074/jbc.275.2.729; Dame RT, 2005, J BACTERIOL, V187, P1845, DOI 10.1128/JB.187.5.1845-1848.2005; Dame RT, 2003, BIOPHYS J, V85, P4146, DOI 10.1016/S0006-3495(03)74826-7; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; Deng S, 2005, MOL MICROBIOL, V57, P1511, DOI 10.1111/j.1365-2958.2005.04796.x; Dole S, 2004, MOL MICROBIOL, V52, P589, DOI 10.1111/j.1365-2958.2004.04001.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Eckel R, 2005, ANGEW CHEM INT EDIT, V44, P3921, DOI 10.1002/anie.200500152; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; JOHNSON RC, 2005, MAJOR NUCLEOID PROTE; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; ONO S, 2005, BIOCHEM J, V15, P203; Rimsky S, 2004, CURR OPIN MICROBIOL, V7, P109, DOI 10.1016/j.mib.2004.02.001; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Schroder O, 2000, J MOL BIOL, V298, P737, DOI 10.1006/jmbi.2000.3708; Shin M, 2005, GENE DEV, V19, P2388, DOI 10.1101/gad.1316305; SHINDO H, 1995, FEBS LETT, V360, P125, DOI 10.1016/0014-5793(95)00079-O; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902	30	268	275	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					387	390		10.1038/nature05283	http://dx.doi.org/10.1038/nature05283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108966				2022-12-01	WOS:000242018300053
J	Shepherd, GM				Shepherd, Gordon M.			Smell images and the flavour system in the human brain	NATURE			English	Review							RAT OLFACTORY-BULB; ORBITOFRONTAL CORTEX; ODOR MAPS; TASTE; REPRESENTATIONS; SENSITIVITY; ORTHONASAL; RETRONASAL; PERCEPTION; DISCRIMINATION	Flavour perception is one of the most complex of human behaviours. It involves almost all of the senses, particularly the sense of smell, which is involved through odour images generated in the olfactory pathway. In the human brain, the perceptual systems are closely linked to systems for learning, memory, emotion and language, so distributed neural mechanisms contribute to food preference and food cravings. Greater recognition of the role of the brain's flavour system and its connection with eating behaviour is needed for a deeper understanding of why people eat what they do, and to generate better recommendations about diet and nutrition.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University	Shepherd, GM (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	gordon.shepherd@yale.edu						Acree T. E., 2004, Handbook of flavor characterization. Sensory analysis, chemistry, and physiology, P83; ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; [Anonymous], 2004, FOOD COOKING SCI LOR; Bartoshuk LM, 2004, FOOD QUAL PREFER, V15, P617, DOI 10.1016/j.foodqual.2004.05.007; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carpino S, 2004, J DAIRY SCI, V87, P816, DOI 10.3168/jds.S0022-0302(04)73226-9; CORRIHER SO, 1997, COOK WISE; Crasto C, 2002, NUCLEIC ACIDS RES, V30, P354, DOI 10.1093/nar/30.1.354; Deibler K., 2003, HDB FLAVOR CHARACTER; DUFFY VB, 1995, J AM DIET ASSOC, V95, P879, DOI 10.1016/S0002-8223(95)00244-8; Duffy VB, 1999, CHEM SENSES, V24, P671, DOI 10.1093/chemse/24.6.671; FARB P, 1980, CONSUMING PASSIONS; Gietzen DW, 2006, TRENDS NEUROSCI, V29, P91, DOI 10.1016/j.tins.2005.12.007; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Johnson BA, 2005, J COMP NEUROL, V483, P192, DOI 10.1002/cne.20415; Koza BJ, 2005, CHEM SENSES, V30, P643, DOI 10.1093/chemse/bji057; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; Laska M, 2006, BEHAV BRAIN RES, V167, P349, DOI 10.1016/j.bbr.2005.09.022; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; LICITRA G, 2004, CHEESE ART 2004 RAGU; Linster C, 2003, NEUROBIOL LEARN MEM, V80, P302, DOI 10.1016/S1074-7427(03)00078-9; Lorig TS, 1999, NEUROSCI BIOBEHAV R, V23, P391, DOI 10.1016/S0149-7634(98)00041-4; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Morrot G, 2001, BRAIN LANG, V79, P309, DOI 10.1006/brln.2001.2493; MOZELL MM, 1969, ARCH OTOLARYNGOL, V90, P367; MURPHY C, 1977, SENS PROCESS, V1, P204; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Pelchat ML, 2002, PHYSIOL BEHAV, V76, P347, DOI 10.1016/S0031-9384(02)00757-6; Quignon P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r83; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; ROLLS ET, 2006, NEUROPSYCHOLOGI 0622; Ross RS, 2005, LEARN MEMORY, V12, P302, DOI 10.1101/lm.91605; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Scalera G, 1997, BEHAV NEUROSCI, V111, P633, DOI 10.1037/0735-7044.111.3.633; Shepherd GM, 2005, CHEM SENSES, V30, pI3, DOI 10.1093/chemse/bjh085; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; SHEPHERDBARR K, 1998, AUTO BIOGRAPHY STUDI, V13, P40; Small DM, 2005, NEURON, V47, P593, DOI 10.1016/j.neuron.2005.07.022; Small DM, 2004, J NEUROPHYSIOL, V92, P1892, DOI 10.1152/jn.00050.2004; SMITH DV, 1993, MECH TASTE TRANSDUCT, P265; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; STEINER JE, 1974, ANN NY ACAD SCI, V237, P229, DOI 10.1111/j.1749-6632.1974.tb49858.x; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Sun BC, 2005, CHEM SENSES, V30, P693, DOI 10.1093/chemse/bji062; Taylor AJ, 2000, FOOD CHEM, V71, P327, DOI 10.1016/S0308-8146(00)00182-5; This H, 2005, NAT MATER, V4, P5, DOI 10.1038/nmat1303; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Wrangham R, 2003, COMP BIOCHEM PHYS A, V136, P35, DOI 10.1016/S1095-6433(03)00020-5; Xu FQ, 2000, J COMP NEUROL, V422, P489, DOI 10.1002/1096-9861(20000710)422:4<489::AID-CNE1>3.0.CO;2-#; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	58	289	294	12	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					316	321		10.1038/nature05405	http://dx.doi.org/10.1038/nature05405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108956				2022-12-01	WOS:000242018300038
J	Laurie, NA; Donovan, SL; Shih, CS; Zhang, JK; Mills, N; Fuller, C; Teunisse, A; Lam, S; Ramos, Y; Mohan, A; Johnson, D; Wilson, M; Rodriguez-Galindo, C; Quarto, M; Francoz, S; Mendrysa, SM; Guy, RK; Marine, JC; Jochemsen, AG; Dyer, MA				Laurie, Nikia A.; Donovan, Stacy L.; Shih, Chie-Schin; Zhang, Jiakun; Mills, Nicholas; Fuller, Christine; Teunisse, Amina; Lam, Suzanne; Ramos, Yolande; Mohan, Adithi; Johnson, Dianna; Wilson, Matthew; Rodriguez-Galindo, Carlos; Quarto, Micaela; Francoz, Sarah; Mendrysa, Susan M.; Guy, R. Kiplin; Marine, Jean-Christophe; Jochemsen, Aart G.; Dyer, Michael A.			Inactivation of the p53 pathway in retinoblastoma	NATURE			English	Article							TUMOR-SUPPRESSOR; RETINAL DEVELOPMENT; MDM2; CELL; CANCER; RB; DEATH; AMPLIFICATION; ACTIVATION; INHIBITORS	Most human tumours have genetic mutations in their Rb and p53 pathways, but retinoblastoma is thought to be an exception. Studies suggest that retinoblastomas, which initiate with mutations in the gene retinoblastoma 1 ( RB1), bypass the p53 pathway because they arise from intrinsically death-resistant cells during retinal development. In contrast to this prevailing theory, here we show that the tumour surveillance pathway mediated by Arf, MDM2, MDMX and p53 is activated after loss of RB1 during retinogenesis. RB1-deficient retinoblasts undergo p53-mediated apoptosis and exit the cell cycle. Subsequently, amplification of the MDMX gene and increased expression of MDMX protein are strongly selected for during tumour progression as a mechanism to suppress the p53 response in RB1-deficient retinal cells. Our data provide evidence that the p53 pathway is inactivated in retinoblastoma and that this cancer does not originate from intrinsically death-resistant cells as previously thought. In addition, they support the idea that MDMX is a specific chemotherapeutic target for treating retinoblastoma.	St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Surg, Div Ophthalmol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Leiden Univ, Med Ctr, Dept Mol & Cell Biol, NL-2300 RC Leiden, Netherlands; Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; FIRC Inst Mol Oncol, I-20139 Milan, Italy; Flanders Interuniv Biotechnol, Lab Mol Canc Biol, B-9052 Ghent, Belgium; Purdue Univ, W Lafayette, IN 47907 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Tennessee System; University of Tennessee Health Science Center; IFOM - FIRC Institute of Molecular Oncology; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dyer, MA (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Marine, Jean-Christophe/K-3292-2016; Marine, Jean Christophe/J-2237-2015; Guy, Rodney/J-7107-2013; Ramos, Yolande F. M./C-3774-2018; Dyer, Michael/N-8134-2018; Rodriguez-Galindo, Carlos/N-8071-2018; Francoz, Sarah/K-4328-2014	Marine, Jean-Christophe/0000-0003-2433-9837; Guy, Rodney/0000-0002-9638-2060; Ramos, Yolande F. M./0000-0003-1459-413X; Francoz, Sarah/0000-0002-6589-4207				Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Dang JJ, 2002, CANCER RES, V62, P1222; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Donovan SL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-14; Dyer MA, 2005, PLOS MED, V2, P971, DOI 10.1371/journal.pmed.0020332; Dyer MA, 2005, NAT REV CANCER, V5, P91, DOI 10.1038/nrc1545; DYER MA, IN PRESS CLIN OCULAR, pCH66; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; KASTAN MB, 1991, CANCER RES, V51, P6304; Kastan MB, 2001, ACTA ONCOL, V40, P686; Kato MV, 1996, CANCER LETT, V106, P75, DOI 10.1016/0304-3835(96)04305-4; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Lu F, 2006, J COMB CHEM, V8, P315, DOI 10.1021/cc050142v; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McKenzie PP, 2002, MOL CANCER THER, V1, P1097; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Nork TM, 1997, ARCH OPHTHALMOL-CHIC, V115, P213, DOI 10.1001/archopht.1997.01100150215011; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Prives C, 1999, J PATHOL, V187, P112; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Yang YL, 2005, CANCER CELL, V7, P547, DOI 10.1016/j.ccr.2005.04.029; Zhang JK, 2004, CELL CYCLE, V3, P952	36	462	481	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					61	66		10.1038/nature05194	http://dx.doi.org/10.1038/nature05194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080083				2022-12-01	WOS:000241701500044
J	Wenseleers, T; Ratnieks, FLW				Wenseleers, Tom; Ratnieks, Francis L. W.			Enforced altruism in insect societies	NATURE			English	Article							EVOLUTION; COOPERATION		Catholic Univ Louvain, Inst Zool, B-3000 Louvain, Belgium; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Universite Catholique Louvain; University of Sheffield	Wenseleers, T (corresponding author), Catholic Univ Louvain, Inst Zool, Naamsestr 59, B-3000 Louvain, Belgium.	tom.wenseleers@bio.kuleuven.be	Wenseleers, Tom/J-3960-2013	Wenseleers, Tom/0000-0002-1434-861X	Natural Environment Research Council [NE/C512310/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Frank SA, 2003, EVOLUTION, V57, P693; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Levitt SD, 1997, AM ECON REV, V87, P270; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Wenseleers T, 2004, AM NAT, V164, pE154, DOI 10.1086/425223; Wenseleers T, 2004, J EVOLUTION BIOL, V17, P1035, DOI 10.1111/j.1420-9101.2004.00751.x; WENSELEERS T, AM NAT, V168	10	142	147	2	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					50	50		10.1038/444050a	http://dx.doi.org/10.1038/444050a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080081	Green Published, Bronze			2022-12-01	WOS:000241701500038
J	Fischbach, MA; Walsh, CT				Fischbach, Michael A.; Walsh, Christopher T.			Biochemistry - Directing biosynthesis	SCIENCE			English	Editorial Material							PEPTIDE ANTIBIOTICS; ESCHERICHIA-COLI; ASSEMBLY-LINE		Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Fischbach, MA (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	christopher_walsh@hms.harvard.edu		Fischbach, Michael/0000-0003-3079-8247				Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Gallimore AR, 2006, CHEM BIOL, V13, P453, DOI 10.1016/j.chembiol.2006.01.013; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Kohli RM, 2002, NATURE, V418, P658, DOI 10.1038/nature00907; Kopp F, 2006, BIOCHEMISTRY-US, V45, P10474, DOI 10.1021/bi0609422; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Miao V, 2006, CHEM BIOL, V13, P269, DOI 10.1016/j.chembiol.2005.12.012; Murata M, 2000, NAT PROD REP, V17, P293, DOI 10.1039/a901979k; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; *ROYAL SOC CHEM, 2004, ROYAL SOC CHEM C DIR; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Watanabe K, 2006, NAT CHEM BIOL, V2, P423, DOI 10.1038/nchembio803; Wenzel SC, 2005, CHEM BIOL, V12, P349, DOI 10.1016/j.chembiol.2004.12.012; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607	15	17	18	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					603	605		10.1126/science.1132692	http://dx.doi.org/10.1126/science.1132692			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068249				2022-12-01	WOS:000241557800031
J	Tarchini, B; Duboule, D; Kmita, M				Tarchini, Basile; Duboule, Denis; Kmita, Marie			Regulatory constraints in the evolution of the tetrapod limb anterior-posterior polarity	NATURE			English	Article							POSITIVE FEEDBACK LOOP; SONIC-HEDGEHOG; VERTEBRATE LIMB; HOXD COMPLEX; GENES; ZPA; BUD; EXPRESSION; FORELIMB; GROWTH	The anterior to posterior (A - P) polarity of the tetrapod limb is determined by the confined expression of Sonic hedgehog (Shh) at the posterior margin of developing early limb buds(1,2), under the control of HOX proteins encoded by gene members of both the HoxA and HoxD clusters(3-6). Here, we use a set of partial deletions to show that only the last four Hox paralogy groups can elicit this response: that is, precisely those genes whose expression is excluded from most anterior limb bud cells owing to their collinear transcriptional activation. We propose that the limb A - P polarity is produced as a collateral effect of Hox gene collinearity, a process highly constrained by its crucial importance during trunk development. In this view, the co-option of the trunk collinear mechanism, along with the emergence of limbs, imposed an A - P polarity to these structures as the most parsimonious solution. This in turn further contributed to stabilize the architecture and operational mode of this genetic system.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Natl Res Ctr Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.	denis.duboule@zoo.unige.ch	kmita, marie/AAU-9620-2020	duboule, denis/0000-0001-9961-2960; Tarchini, Basile/0000-0003-2708-6273; Kmita, Marie/0000-0003-4021-0478				Capellini TD, 2006, DEVELOPMENT, V133, P2263, DOI 10.1242/dev.02395; CHARITE J, 1994, CELL, V78, P589, DOI 10.1016/0092-8674(94)90524-X; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; COATES MI, 1994, DEVELOPMENT S, V120, P169; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; INOUYE M, 1976, Congenital Anomalies, V16, P171; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Kmita M, 2000, GENE DEV, V14, P198; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Tarchini B, 2005, GENE DEV, V19, P2862, DOI 10.1101/gad.351105; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	27	97	101	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 26	2006	443	7114					985	988		10.1038/nature05247	http://dx.doi.org/10.1038/nature05247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066034				2022-12-01	WOS:000241523400053
J	Simon, GE				Simon, Gregory E.			The antidepressant quandray - Considering suicide risk whem treating adolescent depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	Group Health Cooperative	Simon, GE (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA.							Gibbons RD, 2006, AM J PSYCHIAT, V163, P1898, DOI 10.1176/appi.ajp.163.11.1898; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; National Committee for Quality Assurance, 2006, STAT HLTH CAR QUAL 2; ROSACK J, 2004, PSYCHIAT NEWS, V39, P9; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41	5	21	22	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2006	355	26					2722	2723		10.1056/NEJMp068270	http://dx.doi.org/10.1056/NEJMp068270			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	120UA	17192536				2022-12-01	WOS:000243110500003
J	Bradbeer, C; Soni, S; Ekbote, A; Martin, T				Bradbeer, C.; Soni, S.; Ekbote, A.; Martin, T.			You're not going to give me the umbrella, are you?	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Thomas Hosp, Dept Genitourinary Med, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	Bradbeer, C (corresponding author), St Thomas Hosp, Dept Genitourinary Med, London SE1 7EH, England.	caroline.bradbeer@gstt.nhs.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1287	1288		10.1136/bmj.39043.717245.F7	http://dx.doi.org/10.1136/bmj.39043.717245.F7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185709	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000243160700007
J	Walden, WE; Selezneva, AI; Dupuy, J; Volbeda, A; Fontecilla-Camps, JC; Theil, EC; Volz, K				Walden, William E.; Selezneva, Anna I.; Dupuy, Jerome; Volbeda, Anne; Fontecilla-Camps, Juan C.; Theil, Elizabeth C.; Volz, Karl			Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA	SCIENCE			English	Article							ELEMENT-BINDING-PROTEIN; RECEPTOR MESSENGER-RNA; RESPONSIVE ELEMENT; CYTOSOLIC ACONITASE; MOLECULAR CONTROL; RECOGNITION; METABOLISM; LOCALIZATION; LOOP/BULGE; REGION	Iron regulatory protein 1 (IRP1) binds iron-responsive elements (IREs) in messenger RNAs (mRNAs), to repress translation or degradation, or binds an iron-sulfur cluster, to become a cytosolic aconitase enzyme. The 2.8 angstrom resolution crystal structure of the IRP1: ferritin H IRE complex shows an open protein conformation compared with that of cytosolic aconitase. The extended, L-shaped IRP1 molecule embraces the IRE stem-loop through interactions at two sites separated by similar to 30 angstroms, each involving about a dozen protein: RNA bonds. Extensive conformational changes related to binding the IRE or an iron-sulfur cluster explain the alternate functions of IRP1 as an mRNA regulator or enzyme.	Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; Univ Grenoble 1, Inst Biol Struct Jean Pierre Horowitz, IBS, Lab Cristallog & Cristallog Prot, F-38207 Grenoble, France; Univ Grenoble 1, CEA, F-38207 Grenoble, France; Univ Grenoble 1, CNRS, F-38207 Grenoble, France; Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; Univ Calif Berkeley, Dept Nutr Sci & Mol Toxicol, Berkeley, CA 94720 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Volz, K (corresponding author), Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	kvolz@uic.edu	Dupuy, Jerome/AAD-3438-2020	Dupuy, Jerome/0000-0002-2721-5365; Volbeda, Anne/0000-0002-6038-0979	NIDDK NIH HHS [DK20251, DK47281] Funding Source: Medline; NIGMS NIH HHS [GM47522] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047281, R01DK020251, R56DK020251, R37DK020251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047522] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; Beuning PJ, 1999, BIOPOLYMERS, V52, P1; Brazzolotto X, 2002, J BIOL CHEM, V277, P11995, DOI 10.1074/jbc.M110938200; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Gdaniec Z, 1998, BIOCHEMISTRY-US, V37, P1505, DOI 10.1021/bi9719814; Gegout V, 1999, J BIOL CHEM, V274, P15052, DOI 10.1074/jbc.274.21.15052; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; Haasnoot PCJ, 2003, P NATL ACAD SCI USA, V100, P12596, DOI 10.1073/pnas.2135413100; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; Henderson ER, 1996, J BIOL CHEM, V271, P4900; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Kaldy P, 1999, EMBO J, V18, P6073, DOI 10.1093/emboj/18.21.6073; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2002, J BIOL CHEM, V277, P2373, DOI 10.1074/jbc.C100614200; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KIKINIS Z, 1995, NUCLEIC ACIDS RES, V23, P4190, DOI 10.1093/nar/23.20.4190; Laing LG, 1996, BIOCHEMISTRY-US, V35, P13586, DOI 10.1021/bi961310q; *MOL SIM INC, 1997, QUANTA; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; Schlegl J, 1997, RNA, V3, P1159; Selezneva AI, 2006, ACTA CRYSTALLOGR F, V62, P249, DOI 10.1107/S1744309106004192; SWENSON GR, 1994, NUCLEIC ACIDS RES, V22, P2627, DOI 10.1093/nar/22.13.2627; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; TOUAULT TA, 2006, NAT CHEM BIOL, V2, P406	37	213	219	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1903	1908		10.1126/science.1133116	http://dx.doi.org/10.1126/science.1133116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185597				2022-12-01	WOS:000242996800041
J	Chai, Q; Arndt, JW; Dong, M; Tepp, WH; Johnson, EA; Chapman, ER; Stevens, RC				Chai, Qing; Arndt, Joseph W.; Dong, Min; Tepp, William H.; Johnson, Eric A.; Chapman, Edwin R.; Stevens, Raymond C.			Structural basis of cell surface receptor recognition by botulinum neurotoxin B	NATURE			English	Article							H-CC-DOMAIN; CRYSTAL-STRUCTURE; SYNAPTOTAGMIN-I; BINDING-SITES; TETANUS; TOXIN; IDENTIFICATION; GANGLIOSIDES; FRAGMENT; GT1B	Botulinum neurotoxins (BoNTs) are potent bacterial toxins that cause paralysis at femtomolar concentrations 1 by blocking neurotransmitter release. A 'double receptor' model has been proposed in which BoNTs recognize nerve terminals via interactions with both gangliosides and protein receptors that mediate their entry(2). Of seven BoNTs (subtypes A-G), the putative receptors for BoNT/A(3,4), BoNT/B-5,B-6 and BoNT/G(7) have been identified, but the molecular details that govern recognition remain undefined. Here we report the crystal structure of full-length BoNT/B in complex with the synaptotagmin II (Syt-II) recognition domain at 2.6 angstrom resolution. The structure of the complex reveals that Syt-II forms a short helix that binds to a hydrophobic groove within the binding domain of BoNT/B. In addition, mutagenesis of amino acid residues within this interface on Syt-II affects binding of BoNT/B. Structural and sequence analysis reveals that this hydrophobic groove is conserved in the BoNT/G and BoNT/B subtypes, but varies in other clostridial neurotoxins. Furthermore, molecular docking studies using the ganglioside G(T1b) indicate that its binding site is more extensive than previously proposed and might form contacts with both BoNT/B and synaptotagmin. The results provide structural insights into how BoNTs recognize protein receptors and reveal a promising target for blocking toxin-receptor recognition.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Food Res Inst, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA	Scripps Research Institute; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chapman@physiology.wisc.edu; stevens@scripps.edu	Stevens, Raymond/K-7272-2015; Taylor, Graham/A-4027-2012	Stevens, Raymond/0000-0002-4522-8725; Chapman, Edwin/0000-0001-9787-8140				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2004, BIOCHEMISTRY-US, V43, P2209, DOI 10.1021/bi035844k; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Ginalski K, 2000, FEBS LETT, V482, P119, DOI 10.1016/S0014-5793(00)01954-2; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nishiki T, 1996, NEUROSCI LETT, V208, P105, DOI 10.1016/0304-3940(96)12557-X; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Simpson LL, 2000, BIOCHIMIE, V82, P943, DOI 10.1016/S0300-9084(00)01169-X; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weis WI, 1997, CURR OPIN STRUC BIOL, V7, P624, DOI 10.1016/S0959-440X(97)80070-X; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200	29	162	172	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1096	1100		10.1038/nature05411	http://dx.doi.org/10.1038/nature05411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17167418				2022-12-01	WOS:000242971100062
J	Daniels, MA; Teixeiro, E; Gill, J; Hausmann, B; Roubaty, D; Holmberg, K; Werlen, G; Hollander, GA; Gascoigne, NRJ; Palmer, E				Daniels, Mark A.; Teixeiro, Emma; Gill, Jason; Hausmann, Barbara; Roubaty, Dominique; Holmberg, Kaisa; Werlen, Guy; Hollaender, Georg A.; Gascoigne, Nicholas R. J.; Palmer, Ed			Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling	NATURE			English	Article							T-CELL-RECEPTOR; THYMOCYTE POSITIVE SELECTION; CLASS-I MOLECULES; NEGATIVE SELECTION; CD4(+)CD8(+) THYMOCYTES; ANTIGEN-RECEPTOR; IMMUNE-RESPONSE; LIGAND; SELF; CD8	A healthy individual can mount an immune response to exogenous pathogens while avoiding an autoimmune attack on normal tissues. The ability to distinguish between self and non-self is called 'immunological tolerance' and, for T lymphocytes, involves the generation of a diverse pool of functional T cells through positive selection and the removal of overtly self-reactive thymocytes by negative selection during T-cell ontogeny. To elucidate how thymocytes arrive at these cell fate decisions, here we have identified ligands that define an extremely narrow gap spanning the threshold that distinguishes positive from negative selection. We show that, at the selection threshold, a small increase in ligand affinity for the T-cell antigen receptor leads to a marked change in the activation and subcellular localization of Ras and mitogen-activated protein kinase ( MAPK) signalling intermediates and the induction of negative selection. The ability to compartmentalize signalling molecules differentially in the cell endows the thymocyte with the ability to convert a small change in analogue input ( affinity) into a digital output ( positive versus negative selection) and provides the basis for establishing central tolerance.	Univ Basel Hosp, Dept Res, Lab Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland; Univ Childrens Hosp basel, Ctr Biomed, CH-4058 Basel, Switzerland; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of Basel; University of Basel; Scripps Research Institute; Rutgers State University New Brunswick	Palmer, E (corresponding author), Univ Basel Hosp, Dept Res, Lab Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland.	ed.palmer@unibas.ch		Hollander, Georg/0000-0002-8790-0874; Gill, Jason/0000-0003-0955-6470; Daniels, Mark/0000-0002-5175-9901				Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Bommhardt U, 2000, J IMMUNOL, V164, P2326, DOI 10.4049/jimmunol.164.5.2326; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Germain RN, 2001, J BIOL CHEM, V276, P35223, DOI 10.1074/jbc.R100025200; Goldrath AW, 1997, IMMUNITY, V6, P633, DOI 10.1016/S1074-7613(00)80351-9; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Hare KJ, 1999, J IMMUNOL, V162, P3978; Hare KJ, 1999, SEMIN IMMUNOL, V11, P3, DOI 10.1006/smim.1998.0151; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Liu CP, 1998, P NATL ACAD SCI USA, V95, P4522, DOI 10.1073/pnas.95.8.4522; Liu XL, 2003, J EXP MED, V197, P363, DOI 10.1084/jem.20021698; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rosette C, 2001, IMMUNITY, V15, P59, DOI 10.1016/S1074-7613(01)00173-X; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; Sommers CL, 2004, BIOESSAYS, V26, P61, DOI 10.1002/bies.10384; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Teixeiro E, 2004, IMMUNITY, V21, P515, DOI 10.1016/j.immuni.2004.08.014; Teixeiro E, 2002, J BIOL CHEM, V277, P3993, DOI 10.1074/jbc.M107797200; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Williams CB, 1999, J EXP MED, V189, P1531, DOI 10.1084/jem.189.10.1531; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	50	431	438	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2006	444	7120					724	729		10.1038/nature05269	http://dx.doi.org/10.1038/nature05269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17086201				2022-12-01	WOS:000242581100052
J	Shelton, JD				Shelton, James D.			Confessions of a condom lover	LANCET			English	Editorial Material							HIV INCIDENCE; RISK; POPULATION; PREVALENCE; BEHAVIOR; AFRICA		US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, JD (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	JShelton@USAID.GOV						Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; [Anonymous], 2003, KEN DEM HLTH SURV 20; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; Kajubi P, 2005, JAIDS-J ACQ IMM DEF, V40, P77, DOI 10.1097/01.qai.0000157391.63127.b2; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Shelton JD, 2006, LANCET, V367, P1120, DOI 10.1016/S0140-6736(06)68436-5; Shelton JD, 2001, BRIT MED J, V323, P139, DOI 10.1136/bmj.323.7305.139; Shisana O, 2002, S AFRICAN NATL HIV P; SHISANA O, 2005, S AFRICAN NATL PREVA; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Underwood Carol, 2006, J Adolesc Health, V38, P55; DEMOGRAPHIC HLTH SUR	15	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1947	1949		10.1016/S0140-6736(06)69787-0	http://dx.doi.org/10.1016/S0140-6736(06)69787-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141688				2022-12-01	WOS:000242593300009
J	Wildenberg, GA; Dohn, MR; Carnahan, RH; Davis, MA; Lobdell, NA; Settleman, J; Reynolds, AB				Wildenberg, Gregg A.; Dohn, Michael R.; Carnahan, Robert H.; Davis, Michael A.; Lobdell, Nichole A.; Settleman, Jeffrey; Reynolds, Albert B.			p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho	CELL			English	Article							P120 CATENIN; FAMILY GTPASES; ACTIN CYTOSKELETON; INHIBITION; MODULATION; EXPRESSION; P120RASGAP; PROTEIN; ABL	Integration of receptor tyrosine kinase, integrin, and cadherin activities is crucial for normal cell growth, motility, and adhesion. Here, we describe roles for p120-catenin (p120) and p190RhoGAP that coordinate crosstalk between these systems and regulate cadherin function. Surprisingly, PDGFR-induced actin remodeling in NIH3T3 cells is blocked in the absence of p120, and the cells are partially transformed via constitutive activation of Rho. We have traced the mechanism to unexpected codependent roles for p120 and p190RhoGAP in regulating Rac-dependent antagonism of Rho. Receptor-induced Rac activity causes translocation of p190RhoGAP to adherens junctions (AJs), where it couples to the cadherin complex via interaction with p120. AJ formation is dependent on this p120-p190RhoGAP interaction and fails altogether if either of these proteins are compromised. We propose that Rac activation links diverse signaling systems to AJ assembly by controlling transient p190RhoGAP interactions with p120 and localized inhibition of Rho.	Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University	Reynolds, AB (corresponding author), Vanderbilt Univ, Dept Canc Biol, 438 Preston Bldg, Nashville, TN 37232 USA.	al.reynolds@vanderbilt.edu	Carnahan, Robert H/N-7429-2013	Carnahan, Robert H/0000-0001-5230-1532; Davis, Michael/0000-0002-5406-4128	NATIONAL CANCER INSTITUTE [T32CA009592, R01CA111947, R01CA055724] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA111947, R01-CA55724, T32 CA009592, CA04-013] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang X, 2004, J CELL BIOL, V165, P87, DOI 10.1083/jcb.200307109; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Grosheva I, 2001, J CELL SCI, V114, P695; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jaffe AB, 2002, ADV CANCER RES, V84, P57, DOI 10.1016/S0065-230X(02)84003-9; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Sharma SV, 1998, ONCOGENE, V17, P271, DOI 10.1038/sj.onc.1201921; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Vincent S, 1999, EUR J CELL BIOL, V78, P539, DOI 10.1016/S0171-9335(99)80019-3; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Wrobel CN, 2004, J CELL BIOL, V165, P263, DOI 10.1083/jcb.200309102; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	36	311	317	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					1027	1039		10.1016/j.cell.2006.09.046	http://dx.doi.org/10.1016/j.cell.2006.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129786	Green Submitted, Bronze			2022-12-01	WOS:000242613800018
J	Bartkova, J; Rezaei, N; Liontos, M; Karakaidos, P; Kletsas, D; Issaeva, N; Vassiliou, LVF; Kolettas, E; Niforou, K; Zoumpourlis, VC; Takaoka, M; Nakagawa, H; Tort, F; Fugger, K; Johansson, F; Sehested, M; Andersen, CL; Dyrskjot, L; Orntoft, T; Lukas, J; Kittas, C; Helleday, T; Halazonetis, TD; Bartek, J; Gorgoulis, VG				Bartkova, Jirina; Rezaei, Nousin; Liontos, Michalis; Karakaidos, Panagiotis; Kletsas, Dimitris; Issaeva, Natalia; Vassiliou, Leandros-Vassilios F.; Kolettas, Evangelos; Niforou, Katerina; Zoumpourlis, Vassilis C.; Takaoka, Munenori; Nakagawa, Hiroshi; Tort, Frederic; Fugger, Kasper; Johansson, Fredrik; Sehested, Maxwell; Andersen, Claus L.; Dyrskjot, Lars; Orntoft, Torben; Lukas, Jiri; Kittas, Christos; Helleday, Thomas; Halazonetis, Thanos D.; Bartek, Jiri; Gorgoulis, Vassilis G.			Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints	NATURE			English	Article							PREMATURE SENESCENCE; CELLULAR SENESCENCE; HUMAN-CELLS; REPLICATION; ATM; P53; SUPPRESSION; INSTABILITY; P16(INK4A); ACTIVATION	Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest(1,2), whereas a second barrier is mediated by oncogene-induced senescence(3-6). The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; Univ Athens, Sch Med, Dept Histol & Embryol, GR-11527 Athens, Greece; Demokritos Natl Ctr Sci Res, Inst Biol, GR-15310 Athens, Greece; Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; Univ Ioannina, Sch Med, Dept Physiol, GR-45110 Ioannina, Greece; Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, GR-11635 Athens, Greece; Univ Penn, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA; Univ Copenhagen Hosp, Dept Pathol, DK-2100 Copenhagen, Denmark; Aarhus Univ Hosp, Dept Clin Biochem, DK-8200 Aarhus N, Denmark; Univ Sheffield, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland	The Wistar Institute; Danish Cancer Society; Danish Cancer Society; Athens Medical School; National & Kapodistrian University of Athens; National Centre of Scientific Research "Demokritos"; Stockholm University; University of Ioannina; National Hellenic Research Foundation; University of Pennsylvania; University of Copenhagen; Aarhus University; University of Sheffield; University of Geneva	Halazonetis, TD (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	Thanos.Halazonetis@molbio.unige.ch; jb@cancer.dk	Bartek, Jiri/G-5870-2014; Fugger, Kasper/J-1231-2014; Kletsas, Dimitris/F-6953-2010; Halazonetis, Thanos/D-7923-2011; Issaeva, Natalia/K-4577-2019; Helleday, Thomas/D-5224-2013; Andersen, Claus L/C-1477-2017; Gorgoulis, Vassilis/AAD-3630-2019; Kolettas, Evangelos/AAY-5009-2021; Liontos, Michalis/ABA-7587-2020; Dyrskjot, Lars/H-4922-2012; Liontos, Michalis/AAF-1965-2019; Karakaidos, Panagiotis/AAR-5858-2020; Andersen, Claus Lindbjerg/A-9217-2012	Fugger, Kasper/0000-0001-9811-3983; Gorgoulis, Vassilis/0000-0001-9001-4112; Kolettas, Evangelos/0000-0002-5820-487X; Liontos, Michalis/0000-0001-7192-4575; Karakaidos, Panagiotis/0000-0002-1156-4755; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Helleday, Thomas/0000-0002-7384-092X; Tort, Frederic/0000-0003-2733-1603; Issaeva, Natalia/0000-0001-5483-6610; Dyrskjot, Lars/0000-0001-7061-9851; Lukas, Jiri/0000-0001-9087-506X; Kletsas, Dimitris/0000-0002-9828-3963				Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMICCO R, IN PRESS NATURE; Ferbeyre G, 2000, GENE DEV, V14, P2015; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Katsanakis KD, 2002, MOL MED, V8, P624, DOI 10.1007/BF03402173; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Sarkaria JN, 1999, CANCER RES, V59, P4375; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHIBUYA EK, 1993, MOL BIOL CELL, V4, P781, DOI 10.1091/mbc.4.8.781; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932; Zgheib O, 2005, RADIOTHER ONCOL, V76, P119, DOI 10.1016/j.radonc.2005.06.026	30	1428	1471	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					633	637		10.1038/nature05268	http://dx.doi.org/10.1038/nature05268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136093				2022-12-01	WOS:000242377600051
J	Cheong, I; Huang, X; Bettegowda, C; Diaz, LA; Kinzler, KW; Zhou, SB; Vogelstein, B				Cheong, Ian; Huang, Xin; Bettegowda, Chetan; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Zhou, Shibin; Vogelstein, Bert			A bacterial protein enhances the release and efficacy of liposomal cancer drugs	SCIENCE			English	Article							BACTERIOLYTIC THERAPY; EXPERIMENTAL-TUMORS; ENDOTHELIAL-CELLS	Clostridium novyi-NT is an anaerobic bacterium that can infect hypoxic regions within experimental tumors. Because C. novyi-NT lyses red blood cells, we hypothesized that its membrane-disrupting properties could be exploited to enhance the release of liposome-encapsulated drugs within tumors. Here, we show that treatment of mice bearing large, established tumors with C. novyi-NT plus a single dose of liposomal doxorubicin often led to eradication of the tumors. The bacterial factor responsible for the enhanced drug release was identified as a previously unrecognized protein termed liposomase. This protein could potentially be incorporated into diverse experimental approaches for the specific delivery of chemotherapeutic agents to tumors.	Johns Hopkins Kimmel Comprehens Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Kimmel Comprehens Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Zhou, SB (corresponding author), Johns Hopkins Kimmel Comprehens Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA.	sbzhou@jhmi.edu; vogelbe@jhmi.edu	Diaz, Luis A/A-6018-2008	Cheong, Ian/0000-0002-3062-6878; Diaz, Luis/0000-0002-7079-8914	NCI NIH HHS [CA062924] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Barbe S, 2006, J APPL MICROBIOL, V101, P571, DOI 10.1111/j.1365-2672.2006.02886.x; BETTEGWODA C, IN PRESS NAT BIOTECH; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Drummond DC, 1999, PHARMACOL REV, V51, P691; Fang J, 2003, ADV EXP MED BIOL, V519, P29; Govindan SV, 2005, TECHNOL CANCER RES T, V4, P375, DOI 10.1177/153303460500400406; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Ryan RM, 2006, BIOESSAYS, V28, P84, DOI 10.1002/bies.20336; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Thurston G, 1998, J CLIN INVEST, V101, P1401, DOI 10.1172/JCI965; VONHOFF DD, 2006, CANC MED, P600; Yamamoto M, 2005, TECHNOL CANCER RES T, V4, P315, DOI 10.1177/153303460500400402	18	122	135	6	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1308	1311		10.1126/science.1130651	http://dx.doi.org/10.1126/science.1130651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124324				2022-12-01	WOS:000242215800046
J	Halic, M; Blau, M; Becker, T; Mielke, T; Pool, MR; Wild, K; Sinning, I; Beckmann, R				Halic, Mario; Blau, Michael; Becker, Thomas; Mielke, Thorsten; Pool, Martin R.; Wild, Klemens; Sinning, Irmgard; Beckmann, Roland			Following the signal sequence from ribosomal tunnel exit to signal recognition particle	NATURE			English	Article							ESCHERICHIA-COLI; ELECTRON-MICROSCOPY; TRIGGER FACTOR; CRYSTAL-STRUCTURE; NASCENT MEMBRANE; PROTEIN; SRP; RECEPTOR; CORE; VISUALIZATION	Membrane and secretory proteins can be co-translationally inserted into or translocated across the membrane 1. This process is dependent on signal sequence recognition on the ribosome by the signal recognition particle (SRP), which results in targeting of the ribosome-nascent-chain complex to the protein-conducting channel at the membrane(2,3). Here we present an ensemble of structures at subnanometre resolution, revealing the signal sequence both at the ribosomal tunnel exit and in the bacterial and eukaryotic ribosome-SRP complexes. Molecular details of signal sequence interaction in both prokaryotic and eukaryotic complexes were obtained by fitting high-resolution molecular models. The signal sequence is presented at the ribosomal tunnel exit in an exposed position ready for accommodation in the hydrophobic groove of the rearranged SRP54 M domain. Upon ribosome binding, the SRP54 NG domain also undergoes a conformational rearrangement, priming it for the subsequent docking reaction with the NG domain of the SRP receptor. These findings provide the structural basis for improving our understanding of the early steps of co-translational protein sorting.	Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany; Max Planck Inst Mol Genet, USN, UltraStructureNetwork, D-14195 Berlin, Germany; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	University of Munich; Max Planck Society; University of Manchester; Ruprecht Karls University Heidelberg	Beckmann, R (corresponding author), Univ Munich, Dept Chem & Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	beckmann@lmb.uni-muenchen.de	Halic, Mario/X-2163-2018; Pool, Martin R./AAB-9181-2021; Sinning, Irmgard/A-2982-2010	Pool, Martin R./0000-0003-3071-1535; 	Biotechnology and Biological Sciences Research Council [C20431] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Buskiewicz I, 2005, J MOL BIOL, V351, P417, DOI 10.1016/j.jmb.2005.06.023; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Houben ENG, 2005, J CELL BIOL, V170, P27, DOI 10.1083/jcb.200503035; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Schlunzen F, 2005, STRUCTURE, V13, P1685, DOI 10.1016/j.str.2005.08.007; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	29	157	163	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					507	511		10.1038/nature05326	http://dx.doi.org/10.1038/nature05326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17086193	Green Published			2022-12-01	WOS:000242215700051
J	Morimoto, RI				Morimoto, Richard I.			Clinical implications of basic research: Stress, aging, and neurodegenerative disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEAT-SHOCK FACTOR; CAENORHABDITIS-ELEGANS		Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA	Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA.				NIGMS NIH HHS [R37 GM038109] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hsu AL, 2003, SCIENCE, V300, P2033; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099	5	58	61	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 23	2006	355	21					2254	2255		10.1056/NEJMcibr065573	http://dx.doi.org/10.1056/NEJMcibr065573			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107KQ	17124027				2022-12-01	WOS:000242170900017
J	Han, JH; Gong, P; Reddig, K; Mitra, MY; Guo, P; Li, HS				Han, Junhai; Gong, Ping; Reddig, Keith; Mitra, Mirna; Guo, Peiyi; Li, Hong-Sheng			The fly CAMTA transcription factor potentiates deactivation of rhodopsin, a G protein-coupled light receptor	CELL			English	Article							PHOTOTRANSDUCTION CASCADE; DROSOPHILA PHOTORECEPTORS; VISUAL TRANSDUCTION; SIGNALING PATHWAYS; BINDING PROTEIN; GENE-EXPRESSION; DELETED REGION; BETA-ARRESTIN; RAT-BRAIN; IN-VIVO	Control of membrane-receptor activity is required not only for the accuracy of sensory responses, but also to protect cells from excitotoxicity. Here we report the isolation of two noncomplementary fly mutants with slow termination of photoresponses. Genetic and electrophysiological analyses of the mutants revealed a defect in the deactivation of rhodopsin, a visual G protein-coupled receptor (GPCR). The mutant gene was identified as the calmodulinbinding transcription activator (dCAMTA). The known rhodopsin regulator Arr2 does not mediate this visual function of dCAMTA. A genome-wide screen identified five dCAMTA target genes. Of these, overexpression of the F box gene dFbxl4 rescued the mutant phenotypes. We further showed that dCAMTA is stimulated in vivo through interaction with the Ca2+ sensor calmodulin. Our data suggest that calmodulin/ CAMTA/Fbxl4 may mediate a long-term feedback regulation of the activity of Ca2+ -Stimulating GPCRs, which could prevent cell damage due to extra Ca2+ influx.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Li, HS (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	hong-sheng.li@umassmed.edu			NIA NIH HHS [R01-AG022508] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG022508] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bird GS, 2004, CURR MOL MED, V4, P291, DOI 10.2174/1566524043360681; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Chen B, 1998, GENETICS, V149, P157; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Cruzalegui FH, 2000, CELL MOL LIFE SCI, V57, P402, DOI 10.1007/PL00000702; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Fan XL, 2003, NEUROSCIENCE, V117, P383, DOI 10.1016/S0306-4522(02)00930-2; Gudermann T, 2000, N-S ARCH PHARMACOL, V361, P345, DOI 10.1007/s002109900208; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hurle MA, 2001, J NEUROCHEM, V77, P486, DOI 10.1046/j.1471-4159.2001.00268.x; Ikura M, 2002, BIOESSAYS, V24, P625, DOI 10.1002/bies.10105; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Katoh M, 2003, INT J ONCOL, V23, P1219; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Oyama N, 2005, CIRC J, V69, P987, DOI 10.1253/circj.69.987; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reddy ASN, 2000, BIOCHEM BIOPH RES CO, V279, P762, DOI 10.1006/bbrc.2000.4032; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Scott K, 1997, TRENDS BIOCHEM SCI, V22, P350, DOI 10.1016/S0968-0004(97)01100-6; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; WASHBURN T, 1989, J BIOL CHEM, V264, P15464; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xu H, 2004, EMBO J, V23, P811, DOI 10.1038/sj.emboj.7600112; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200	45	58	60	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 17	2006	127	4					847	858		10.1016/j.cell.2006.09.030	http://dx.doi.org/10.1016/j.cell.2006.09.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110341	Bronze			2022-12-01	WOS:000242330600028
J	Wang, YC; Zhang, YJ; Ha, Y				Wang, Yongcheng; Zhang, Yingjiu; Ha, Ya			Crystal structure of a rhomboid family intramembrane protease	NATURE			English	Article							CAENORHABDITIS-ELEGANS; SUBSTRATE-SPECIFICITY; DROSOPHILA RHOMBOID-1; SIGNAL PEPTIDASE; TNF-ALPHA; PROTEOLYSIS; CLEAVAGE; MECHANISM; REVEALS; SERINE	Escherichia coli GlpG is an integral membrane protein that belongs to the widespread rhomboid protease family. Rhomboid proteases, like site-2 protease (S2P) and gamma-secretase, are unique in that they cleave the transmembrane domain of other membrane proteins. Here we describe the 2.1 angstrom resolution crystal structure of the GlpG core domain. This structure contains six transmembrane segments. Residues previously shown to be involved in catalysis, including a Ser-His dyad, and several water molecules are found at the protein interior at a depth below the membrane surface. This putative active site is accessible by substrate through a large 'V-shaped' opening that faces laterally towards the lipid, but is blocked by a half-submerged loop structure. These observations indicate that, in intramembrane proteolysis, the scission of peptide bonds takes place within the hydrophobic environment of the membrane bilayer. The crystal structure also suggests a gating mechanism for GlpG that controls substrate access to its hydrophilic active site.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DE SB, 1999, NATURE, V398, P518; Fersht A, 1999, STRUCTURE MECH PROTE; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Koonin E.V., 2003, GENOME BIOL, V4, P19, DOI 10.1186/gb-2003-4-3-r19; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LI X, 1996, NEURON, V17; Li XJ, 1998, P NATL ACAD SCI USA, V95, P7109, DOI 10.1073/pnas.95.12.7109; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Opitz C, 2002, EMBO J, V21, P1577, DOI 10.1093/emboj/21.7.1577; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Tjalsma H, 2000, J BIOL CHEM, V275, P25102, DOI 10.1074/jbc.M002676200; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Wasserman JD, 2000, GENE DEV, V14, P1651; WEI YY, 1995, NAT STRUCT BIOL, V2, P218, DOI 10.1038/nsb0395-218; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123; ZHOU GW, 1994, SCIENCE, V265, P1059, DOI 10.1126/science.8066444; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	49	282	291	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2006	444	7116					179	183		10.1038/nature05255	http://dx.doi.org/10.1038/nature05255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17051161				2022-12-01	WOS:000241867200034
J	He, LM; Wu, XS; Mohan, R; Wu, LG				He, Liming; Wu, Xin-Sheng; Mohan, Raja; Wu, Ling-Gang			Two modes of fusion pore opening revealed by cell-attached recordings at a synapse	NATURE			English	Article							TRANSMITTER RELEASE; VESICLES; CAPACITANCE; SINGLE; ENDOCYTOSIS; MEMBRANE; MODULATION; EXOCYTOSIS; DIFFUSION; PROTEINS	Fusion of a vesicle with the cell membrane opens a pore that releases transmitter to the extracellular space(1-3). The pore can either dilate fully so that the vesicle collapses completely, or close rapidly to generate 'kiss-and-run' fusion(1,2,4-7). The size of the pore determines the release rate(2). At synapses, the size of the fusion pore is unclear, 'kiss-and-run' remains controversial(8-15), and the ability of 'kiss-and-run' fusion to generate rapid synaptic currents(16,17) is questionable(18). Here, by recording fusion pore kinetics during single vesicle fusion, we found both full collapse and 'kiss-and-run' fusion at calyx-type synapses. For full collapse, the initial fusion pore conductance (G(p)) was usually > 375 pS and increased rapidly at >= 299 pS ms(-1). 'Kiss-and-run' fusion was seen as a brief capacitance flicker (< 2 s) with G(p) > 288 pS for most flickers, but within 15 - 288 pS for the remaining flickers. Large G(p) (> 288 pS) might discharge transmitter rapidly and thereby cause rapid synaptic currents, whereas small Gp might generate slow and small synaptic currents. These results show that 'kiss-and-run' fusion occurs at synapses and that it can generate rapid postsynaptic currents, and suggest that various fusion pore sizes help to control the kinetics and amplitude of synaptic currents.	NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wu, LG (corresponding author), NINDS, 35 Convent Dr,Bldg 35,Room 2B-1012, Bethesda, MD 20892 USA.	wul@ninds.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003009, ZIANS003009] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ALMERS W, 1991, ANN NY ACAD SCI, V635, P318, DOI 10.1111/j.1749-6632.1991.tb36502.x; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Debus K, 2000, BIOPHYS J, V78, P2983, DOI 10.1016/S0006-3495(00)76837-8; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Lindau M, 2003, BBA-MOL CELL RES, V1641, P167, DOI 10.1016/S0167-4889(03)00085-5; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; Satzler K, 2002, J NEUROSCI, V22, P10567; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Stiles JR, 2001, SYNAPSES, P681; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631	30	154	162	2	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					102	105		10.1038/nature05250	http://dx.doi.org/10.1038/nature05250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17065984				2022-12-01	WOS:000241701500054
J	Hauptman, PJ; Schnitzler, MA; Swindle, J; Burroughs, TE				Hauptman, Paul J.; Schnitzler, Mark A.; Swindle, Jason; Burroughs, Thomas E.			Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; NATRIURETIC PEPTIDE; TEMPORAL TRENDS; DOBUTAMINE; IMPACT; PHARMACOTHERAPIES; MANAGEMENT; PHYSICIANS; MILRINONE	Context The rate of adoption of new therapies for cardiovascular diseases following the publication of favorable clinical trial results has been studied; however, less is known about the rates of de-adoption of a drug when negative studies are published. Objective To evaluate the use of nesiritide before and after March and April 2005 publications in 2 high-impact journals that suggested an increased risk of renal failure and mortality with intravenous nesiritide for acute decompensated heart failure. Design, Setting, and Patients Analysis of a large prospective hospital database, developed for quality and utilization benchmarking, of 491 acute care US hospitals at which 385 627 inpatient admissions occurred with a primary International Classification of Diseases, Ninth Revision (ICD-9) code for heart failure between January and August 2001 (prior to nesiritide release) and January 2004 to December 2005 (before and after publication periods). In addition, any patient admitted who received nesiritide in the absence of a primary or secondary heart failure code was evaluated for potential off-label use of the drug. Main Outcome Measure Use of nesiritide and other intravenous vasoactive therapy among patients admitted with heart failure. Results Nesiritide use decreased from a peak of 16.6% (2351 of 14 167 admissions) in March 2005 to 5.6% (611 of 10 822 admissions) in December 2005 (P < .001). Among those patients treated with nesiritide, the mean duration of treatment changed minimally, from 2.3 to 2.1 days. Although the use of inotropes also decreased during the period under study, the changes were more modest; furthermore, of those patients who were prescribed intravenous vasoactive therapy, a higher percentage were prescribed inotropes after publication (3272 [ 21.5%] of 15 193 patients from January-April 2005 vs 5750 [29.6%] of 19 445 patients from May-December 2005, P < .001). The use of nesiritide, in the absence of an ICD-9 heart failure code, was small. Conclusions Rapid de-adoption of nesiritide occurred following 2 publications suggesting risk with the drug. Further analyses are required to evaluate the consequences of these changes on patient outcomes and to anticipate how publications of adverse findings can influence practice.	St Louis Univ, Sch Med, Div Cardiol, St Louis, MO USA; St Louis Univ, Sch Med, Ctr Outcomes Res, St Louis, MO USA; St Louis Univ, Sch Med, Dept Med, St Louis, MO 63104 USA	Saint Louis University; Saint Louis University; Saint Louis University	Hauptman, PJ (corresponding author), St Louis Univ Hosp, Div Cardiol, FDT-15,3635 Vista Ave, St Louis, MO 63110 USA.	hauptmpj@slu.edu			NATIONAL INSTITUTE ON AGING [R01AG021515] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG021515-04, R01 AG021515] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM COLL CARD AM H, ACC AHA 2005 GUID UP; Bayram M, 2005, AM J CARDIOL, V96, p47G, DOI 10.1016/j.amjcard.2005.07.021; Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; Burger AJ, 2002, AM HEART J, V144, P1102, DOI 10.1067/mhj.2002.125620; Col NF, 1996, ARCH INTERN MED, V156, P54, DOI 10.1001/archinte.156.1.54; Colucci WS, 2000, NEW ENGL J MED, V343, P246, DOI 10.1056/NEJM200007273430403; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Ewy GA, 1999, J AM COLL CARDIOL, V33, P572; Felker GM, 2001, AM HEART J, V142, P932, DOI 10.1067/mhj.2001.119611; FRIEDMAN L, 1983, CONTROL CLIN TRIALS, V4, P513, DOI 10.1016/0197-2456(83)90032-6; Gambassi G, 2000, AM HEART J, V139, P85, DOI 10.1016/S0002-8703(00)90313-2; Hamann J, 2004, AM J PSYCHIAT, V161, P1301, DOI 10.1176/appi.ajp.161.7.1301; HENSLEY SJ, 2006, WALL STREET J   0125, pA3; HORTON DP, 2005, COMMUNICATION   0713; Hussain Z, 2006, J CARD FAIL, V12, P343, DOI 10.1016/j.cardfail.2006.02.005; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kesselhelm AS, 2006, HEALTH AFFAIR, V25, P1095, DOI 10.1377/hlthaff.25.4.1095; Kim N, 2005, J GEN INTERN MED, V20, P1026, DOI 10.1111/j.1525-1497.2005.0221.x; Kizer JR, 1999, AM HEART J, V137, P79, DOI 10.1016/S0002-8703(99)70462-X; Kozyrskyj AL, 2004, CAN MED ASSOC J, V171, P139, DOI 10.1503/cmaj.1031629; LAMAS GA, 1992, NEW ENGL J MED, V327, P241, DOI 10.1056/NEJM199207233270405; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Masoudi FA, 2004, CIRCULATION, V110, P724, DOI 10.1161/01.CIR.0000138934.28340.ED; McDermontt MM, 1997, AM HEART J, V134, P901, DOI 10.1016/S0002-8703(97)80013-0; O'Connor CM, 1999, AM HEART J, V138, P78, DOI 10.1016/S0002-8703(99)70250-4; Oliva F, 1999, AM HEART J, V138, P247, DOI 10.1016/S0002-8703(99)70108-0; PACKER M, 1993, J AM COLL CARDIOL, V22, pA119, DOI 10.1016/0735-1097(93)90474-F; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rich MW, 1998, AM HEART J, V135, P367, DOI 10.1016/S0002-8703(98)70309-6; Roumie CL, 2005, AM J MED, V118, P641, DOI 10.1016/j.amjmed.2005.02.013; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; Shaya Fadia T, 2005, Manag Care Interface, V18, P27; Smith NL, 2004, AM HEART J, V148, P710, DOI 10.1016/j.ahj.2004.04.002; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Stafford RS, 2004, JAMA-J AM MED ASSOC, V291, P54, DOI 10.1001/jama.291.1.54; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Topol EJ, 2005, NEW ENGL J MED, V353, P113, DOI 10.1056/NEJMp058139; Tu K, 2003, CAN MED ASSOC J, V168, P553; *US DEP HHS, 2001, CARD REN DRUGS ADV C; Watkins C, 2003, QUAL SAF HEALTH CARE, V12, P29, DOI 10.1136/qhc.12.1.29; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531; Young JB, 2005, J AM COLL CARDIOL, V46, P505, DOI 10.1016/j.jacc.2005.05.014; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	45	43	46	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1877	1884		10.1001/jama.296.15.1877	http://dx.doi.org/10.1001/jama.296.15.1877			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095ST	17047218	Bronze, Green Accepted			2022-12-01	WOS:000241329300030
J	Jones, WD; Cayirlioglu, P; Kadow, IG; Vosshall, LB				Jones, Walton D.; Cayirlioglu, Pelin; Kadow, Ilona Grunwald; Vosshall, Leslie B.			Two chemosensory receptors together mediate carbon dioxide detection in Drosophila	NATURE			English	Article							ANTENNAL LOBE; MELANOGASTER; RESPONSES; BEHAVIOR; NEURONS; MOSQUITOS; SENSILLA; OXYGEN	Blood-feeding insects, including the malaria mosquito Anopheles gambiae, use highly specialized and sensitive olfactory systems to locate their hosts. This is accomplished by detecting and following plumes of volatile host emissions, which include carbon dioxide (CO2)(1). CO2 is sensed by a population of olfactory sensory neurons in the maxillary palps of mosquitoes(2,3) and in the antennae of the more genetically tractable fruitfly, Drosophila melanogaster(4). The molecular identity of the chemosensory CO2 receptor, however, remains unknown. Here we report that CO2-responsive neurons in Drosophila co-express a pair of chemosensory receptors, Gr21a and Gr63a, at both larval and adult life stages. We identify mosquito homologues of Gr21a and Gr63a, GPRGR22 and GPRGR24, and show that these are co-expressed in A. gambiae maxillary palps. We show that Gr21a and Gr63a together are sufficient for olfactory CO2-chemosensation in Drosophila. Ectopic expression of Gr21a and Gr63a together confers CO2 sensitivity on CO2-insensitive olfactory neurons, but neither gustatory receptor alone has this function. Mutant flies lacking Gr63a lose both electrophysiological and behavioural responses to CO2. Knowledge of the molecular identity of the insect olfactory CO2 receptors may spur the development of novel mosquito control strategies designed to take advantage of this unique and critical olfactory pathway. This in turn could bolster the worldwide fight against malaria and other insect-borne diseases.	Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10021 USA; Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Rockefeller University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA.	leslie@mail.rockefeller.edu	Jones, Walton/A-2417-2011	Jones, Walton/0000-0001-8642-627X; Vosshall, Leslie/0000-0002-6060-8099; Grunwald Kadow, Ilona/0000-0002-9085-4274				Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; SOUTHWICK EE, 1987, J INSECT PHYSIOL, V33, P623, DOI 10.1016/0022-1910(87)90130-2; Stange G, 1999, MICROSC RES TECHNIQ, V47, P416, DOI 10.1002/(SICI)1097-0029(19991215)47:6<416::AID-JEMT5>3.0.CO;2-X; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8	29	439	466	12	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2007	445	7123					86	90		10.1038/nature05466	http://dx.doi.org/10.1038/nature05466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167414				2022-12-01	WOS:000243225100041
J	Bibbins-Domingo, K; Fernandez, A				Bibbins-Domingo, Kirsten; Fernandez, Alicia			BiDil for heart failure in black patients: Implications of the U.S. Food and Drug Administration approval	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; ISOSORBIDE DINITRATE; RACIAL DISPARITIES; RANDOMIZED-TRIAL; RACE; HYDRALAZINE; MANAGEMENT; COMMITTEE; OUTCOMES; DISEASE	In 2005, the combination of hydralazine hydrochloride and isosorbide dinitrate was approved by the U. S. Food and Drug Administration (FDA) for treating heart failure in black patients. In departing from its long history of approving drugs for general clinical indications without regard to demographic classification, the FDA cited the need to address racial disparities in health as an important contributor to their decision. The authors argue that this decision, although perhaps well-intentioned, was based on flawed scientific interpretation of trial results that claimed differential drug response by race and ignored the considerable literature on the cause of racial disparities in health and health care. Because of its potential impact on future drug approvals, the FDA's decision is a setback in the scientific and policy discourse on medical therapeutics and race and specifically hinders the efforts aimed at eliminating health and health care disparities.	Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Internal Med, Box 1364, San Francisco, CA 94143 USA.	bibbinsk@medicine.ucsf.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095] Funding Source: NIH RePORTER; NCRR NIH HHS [K23 RR01832401] Funding Source: Medline; NHLBI NIH HHS [N01-HC-95095] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; ALEXANDER M, 1995, JAMA-J AM MED ASSOC, V274, P1037, DOI 10.1001/jama.274.13.1037; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; BROOKS J, 2006, HATTIESBURG AM  0718; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; CARLSON RJ, 2005, HLTH AFF MILLWO 1011; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Dries DL, 1999, NEW ENGL J MED, V340, P609, DOI 10.1056/NEJM199902253400804; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Hjalmarson A, 1999, LANCET, V353, P2001; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Kahn J, 2005, NAT GENET, V37, P655, DOI 10.1038/ng0705-655; Kahn J, 2003, PERSPECT BIOL MED, V46, P473, DOI 10.1353/pbm.2003.0087; KAHN J, 2005, HASTING CENT REP, V35; Kahn JD, 2005, BRIT MED J, V330, P1508, DOI 10.1136/bmj.330.7506.1508-a; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; Kalinowski L, 2004, CIRCULATION, V109, P2511, DOI 10.1161/01.CIR.0000129087.81352.7A; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Lillie-Blanton M, 2004, J AM COLL CARDIOL, V44, P503, DOI 10.1016/j.jacc.2004.04.043; Mathew J, 2005, AM HEART J, V150, P968, DOI 10.1016/j.ahj.2005.03.060; Meade TW, 1998, LANCET, V351, P233; Moran AE, 2005, NEW ENGL J MED, V352, P1041; NAINGGOLAN L, 2006, HEART WIRE      0711; *NIH, 2005, INCL WOM MIN PART RE; Nissen SE, 2005, CIRCULATION, V112, P2043, DOI 10.1161/CIRCULATIONAHA.105.573105; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P2517, DOI 10.1001/jama.289.19.2517; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; SANKAR P, 2005, HLTH AFF MILLWO 1011; SAUL S, 2006, NY TIMES        0522; Saul Stephanie, 2005, N Y Times Web, pC4; Saul Stephanie, 2005, N Y Times Web, pC3; Schneider EC, 2001, ANN INTERN MED, V135, P328, DOI 10.7326/0003-4819-135-5-200109040-00009; Sehgal AR, 2004, HYPERTENSION, V43, P566, DOI 10.1161/01.HYP.0000118019.28487.9c; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; *US FDA, 2005, SUMM MIN CARD REN DR; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	49	34	34	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2007	146	1					52	W8		10.7326/0003-4819-146-1-200701020-00009	http://dx.doi.org/10.7326/0003-4819-146-1-200701020-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188BK	17200222				2022-12-01	WOS:000247893300007
J	Botuyan, MV; Lee, J; Ward, IM; Kim, JE; Thompson, JR; Chen, JJ; Mer, G				Botuyan, Maria Victoria; Lee, Joseph; Ward, Irene M.; Kim, Ja-Eun; Thompson, James R.; Chen, Junjie; Mer, Georges			Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair	CELL			English	Article							DOUBLE-STRAND BREAKS; CHECKPOINT PROTEIN CRB2; TANDEM BRCT DOMAINS; H4 LYS-20; LYSINE METHYLATION; HISTIDINE KINASES; CRYSTAL-STRUCTURE; SILENT CHROMATIN; TUDOR DOMAIN; H3 TAIL	Histone lysine methylation has been linked to the recruitment of mammalian DNA repair factor 53BP1 and putative fission yeast homolog Crb2 to DNA double-strand breaks (DSBs), but how histone recognition is achieved has not been established. Here we demonstrate that this link occurs through direct binding of 53BP1 and Crb2 to histone H4. Using X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, we show that, despite low amino acid sequence conservation, both 53BP1 and Crb2 contain tandem tudor domains that interact with histone H4 specifically dimethylated at Lys20 (W-K20me2). The structure of 53BP1/H4-K20me2 complex uncovers a unique five-residue 53BP1 binding cage, remarkably conserved in the structure of Crb2, that best accommodates a dimethyllysine but excludes a trimethyllysine, thus explaining the methylation state-specific recognition of H4-K20. This study reveals an evolutionarily conserved molecular mechanism of targeting DNA repair proteins to DSBs by direct recognition of H4-K20me2.	Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Physiol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Chen, JJ (corresponding author), Mayo Clin, Coll Med, Dept Oncol, Rochester, MN 55905 USA.	junjie.chen@yale.edu; mer.georges@mayo.edu	Mer, Georges/AAT-4946-2021; Kim, Ja-Eun/AAI-1896-2020	Mer, Georges/0000-0002-1900-1578; Kim, Ja-Eun/0000-0002-9132-1277	NCI NIH HHS [R01 CA100109, R01 CA109449, CA100109] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109449, R01CA100109] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Charier G, 2004, STRUCTURE, V12, P1551, DOI 10.1016/j.str.2004.06.014; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Du LL, 2004, J BIOL CHEM, V279, P38409, DOI 10.1074/jbc.M403326200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; FUJITAKI JM, 1981, BIOCHEMISTRY-US, V20, P3658, DOI 10.1021/bi00515a055; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; MAVRI J, 1994, PROTEINS, V18, P381, DOI 10.1002/prot.340180408; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura TM, 2005, MOL CELL BIOL, V25, P10721, DOI 10.1128/MCB.25.24.10721-10730.2005; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; SMITH DL, 1973, NATURE, V246, P103, DOI 10.1038/246103a0; Steeg PS, 2003, CANCER LETT, V190, P1, DOI 10.1016/S0304-3835(02)00499-8; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905	53	746	767	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1361	1373		10.1016/j.cell.2006.10.043	http://dx.doi.org/10.1016/j.cell.2006.10.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190600	Green Accepted, Bronze			2022-12-01	WOS:000243690000016
J	Hanauer, DI; Jacobs-Sera, D; Pedulla, ML; Cresawn, SG; Hendrix, RW; Hatfull, GF				Hanauer, David I.; Jacobs-Sera, Deborah; Pedulla, Marisa L.; Cresawn, Steven G.; Hendrix, Roger W.; Hatfull, Graham F.			Teaching scientific inquiry	SCIENCE			English	Editorial Material							SCIENCE; PHAGE		Indiana Univ Penn, Dept English, Grad Program Composit & TESOL, Indiana, PA 15705 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Montana, Dept Biol Sci, Butte, MT 59701 USA	Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Montana System; University of Montana	Hanauer, DI (corresponding author), Indiana Univ Penn, Dept English, Grad Program Composit & TESOL, Indiana, PA 15705 USA.	hanauer@iup.edu; gfh@pitt.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051975] Funding Source: NIH RePORTER; NCRR NIH HHS [RR16455] Funding Source: Medline; NIGMS NIH HHS [GM51975] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2006, AM LAB REP INV HIGH; Dunbar K., 1995, NATURE INSIGHT, P365, DOI DOI 10.1016/S0193-3973(99)00050-7; Dunbar K., 1997, CREATIVE THOUGHT INV, P461, DOI [DOI 10.1037/10227-017, 10.1037/10227-017]; HANAUER D, 2006, AM ASS APPL LING C M; Hanauer D., 2006, SCI DISCOURSE MULTIL; Harris Richard, 1997, LANDMARK ESSAYS RHET; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Ivezic Z, 2001, ASTRON J, V122, P2749, DOI 10.1086/323452; KUHN D, 1993, SCI EDUC, V77, P319, DOI 10.1002/sce.3730770306; Lemke J.A., 1990, TALKING SCI LANGUAGE; Lewis Jennifer R, 2002, Cell Biol Educ, V1, P26, DOI 10.1187/cbe.02-02-0003; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; National Research Council (NRC), 1996, NAT SCI ED STAND; NOTT M, 1995, INT J SCI EDUC, V17, P399, DOI 10.1080/0950069950170310; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pfund C, 2006, SCIENCE, V311, P473, DOI 10.1126/science.1123806; Prelli LawrenceJ., 1989, RHETORIC SCI INVENTI; QIN Y, 1990, COGNITIVE SCI, V14, P281, DOI 10.1207/s15516709cog1402_4; Seymour E, 2004, SCI EDUC, V88, P493, DOI 10.1002/sce.10131	20	93	93	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1880	1881		10.1126/science.1136796	http://dx.doi.org/10.1126/science.1136796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	119EY	17185586				2022-12-01	WOS:000242996800030
J	Small, GW; Kepe, V; Ercoli, LM; Siddarth, P; Bookheimer, SY; Miller, KJ; Lavretsky, H; Burggren, AC; Cole, GM; Vinters, HV; Thompson, PM; Huang, SC; Satyamurthy, N; Phelps, ME; Barrio, JR				Small, Gary W.; Kepe, Vladimir; Ercoli, Linda M.; Siddarth, Prabha; Bookheimer, Susan Y.; Miller, Karen J.; Lavretsky, Helen; Burggren, Alison C.; Cole, Greg M.; Vinters, Harry V.; Thompson, Paul M.; Huang, S. -C.; Satyamurthy, N.; Phelps, Michael E.; Barrio, Jorge R.			PET of brain amyloid and tau in mild cognitive impairment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; PLAQUES; DEMENTIA; CLASSIFICATION; BINDING; TANGLES; HEALTH; RISK; AGE	BACKGROUND Amyloid senile plaques and tau neurofibrillary tangles are neuropathological hallmarks of Alzheimer's disease that accumulate in the cortical regions of the brain in persons with mild cognitive impairment who are at risk for Alzheimer's disease. Noninvasive methods to detect these abnormal proteins are potentially useful in developing surrogate markers for drug discovery and diagnostics. METHODS We enrolled 83 volunteers with self-reported memory problems who had undergone neurologic and psychiatric evaluation and positron-emission tomography ( PET). On the basis of cognitive testing, 25 volunteers were classified as having Alzheimer's disease, 28 as having mild cognitive impairment, and 30 as having no cognitive impairment ( healthy controls). PET was performed after injection of 2-(1-{6-[(2-[F-18] fluoroethyl) ( methyl) amino]-2-naphthyl} ethylidene) malononitrile (FDDNP), a molecule that binds to plaques and tangles in vitro. All subjects also underwent 2- deoxy-2-[ F-18] fluoro-D-glucose (FDG) PET, and 72 underwent magnetic resonance imaging (MRI). RESULTS Global values for FDDNP-PET binding ( average of the values for the temporal, parietal, posterior cingulate, and frontal regions) were lower in the control group than in the group with mild cognitive impairment ( P< 0.001), and the values for binding in the group with mild cognitive impairment were lower than in the group with Alzheimer's disease ( P< 0.001). FDDNP-PET binding differentiated among the diagnostic groups better than did metabolism on FDG-PET or volume on MRI. CONCLUSIONS FDDNP-PET scanning can differentiate persons with mild cognitive impairment from those with Alzheimer's disease and those with no cognitive impairment. This technique is potentially useful as a noninvasive method to determine regional cerebral patterns of amyloid plaques and tau neurofibrillary tangles.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; Univ Calif Los Angeles, Brain Mapping Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Lab Neuro Imaging, Los Angeles, CA USA; Univ Calif Los Angeles, Alzheimers Dis Ctr, Los Angeles, CA USA; Univ Calif Los Angeles, Ctr Aging, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Small, GW (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Suite 88-201,760 Westwood Plaza, Los Angeles, CA 90024 USA.	gsmall@mednet.ucla.edu	Lavretsky, Helen/M-5711-2015; Thompson, Paul M/C-4194-2018	Lavretsky, Helen/0000-0001-9990-5085; Thompson, Paul M/0000-0002-4720-8867; Bookheimer, Susan/0000-0002-3417-5891	NCRR NIH HHS [M01-RR00865] Funding Source: Medline; NIA NIH HHS [AG10123, AG13308, MH/AG58156, P50AG16570, P01AG025831] Funding Source: Medline; NIMH NIH HHS [MH52453, K23 MH001948] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052453, K23MH001948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013308, P30AG010123, P50AG016570, P01AG025831] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agdeppa ED, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0004.2001; Agdeppa ED, 2003, NEUROSCIENCE, V117, P723, DOI 10.1016/S0306-4522(02)00907-7; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890423349; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; De Jager CA, 2005, NEUROCASE, V11, P72, DOI 10.1080/13554790490896820; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gilewski M.J., 1986, CLIN MEMORY ASSESSME, P93, DOI [10.1037/10057-008, DOI 10.1037/10057-008]; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kepe V, 2006, P NATL ACAD SCI USA, V103, P702, DOI 10.1073/pnas.0510237103; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Korf ESC, 2004, NEUROLOGY, V63, P94, DOI 10.1212/01.WNL.0000133114.92694.93; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A, V3; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lopez OL, 2006, J NEUROL NEUROSUR PS, V77, P159, DOI 10.1136/jnnp.2004.045567; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; SMALL GW, 1989, ARCH GEN PSYCHIAT, V46, P527; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SMALL GW, 2004, 9 INT C ALZH DIS REL; Stoub TR, 2005, NEUROLOGY, V64, P1520, DOI 10.1212/01.WNL.0000160089.43264.1A; Talairach J., 1988, COPLANAR STEREOTAXIC, P5; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Verhoeff NPLG, 2004, AM J GERIAT PSYCHIAT, V12, P584, DOI 10.1176/appi.ajgp.12.6.584; Vinters HV, 2004, CLIN NEUROSCI RES, V3, P413, DOI 10.1016/j.cnr.2004.04.007; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	32	523	550	0	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2652	2663		10.1056/NEJMoa054625	http://dx.doi.org/10.1056/NEJMoa054625			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182990				2022-12-01	WOS:000242956200006
J	Saeij, JPJ; Boyle, JP; Coller, S; Taylor, S; Sibley, LD; Brooke-Powell, ET; Ajioka, JW; Boothroyd, JC				Saeij, J. P. J.; Boyle, J. P.; Coller, S.; Taylor, S.; Sibley, L. D.; Brooke-Powell, E. T.; Ajioka, J. W.; Boothroyd, J. C.			Polymorphic secreted kinases are key virulence factors in toxoplasmosis	SCIENCE			English	Article							POPULATION BIOLOGY; PARASITE GENOTYPE; GONDII; STRAINS; RECOMBINATION; LINEAGES; DISEASE; GENOME; IL-12; HOST	The majority of known Toxoplasma gondii isolates from Europe and North America belong to three clonal lines that differ dramatically in their virulence, depending on the host. To identify the responsible genes, we mapped virulence in F-1 progeny derived from crosses between type II and type III strains, which we introduced into mice. Five virulence ( VIR) loci were thus identified, and for two of these, genetic complementation showed that a predicted protein kinase (ROP18 and ROP16, respectively) is the key molecule. Both are hypervariable rhoptry proteins that are secreted into the host cell upon invasion. These results suggest that secreted kinases unique to the Apicomplexa are crucial in the host-pathogen interaction.	Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Stanford University; Washington University (WUSTL); University of Cambridge	Boothroyd, JC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu	Sibley, L. David/C-4616-2008	Saeij, Jeroen/0000-0003-0289-7109; Boothroyd, John C./0000-0001-9719-745X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005093, R01AI021423, F32AI060306, R01AI036629, R01AI041014, R37AI021423, R01AI059176, R01AI045806] Funding Source: NIH RePORTER; NIAID NIH HHS [AI059176, AI05093, R01 AI021423, AI30230, F32AI60306, AI36629, 1R01AI045806-01A1, R01 AI021423-20, AI41014, AI21423, R01 AI036629] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; ELHAJJ H, IN PRESS PLOS PATHOG; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Honore S, 2000, PATHOL BIOL, V48, P541; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; Li L, 2003, GENOME RES, V13, P443, DOI 10.1101/gr.693203; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; SAEIJ JP, IN PRESS NATURE; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; SIBLEY LD, 1992, GENETICS, V132, P1003; SIBLEY LD, 1992, MOL BIOCHEM PARASIT, V51, P291, DOI 10.1016/0166-6851(92)90079-Y; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Wille U, 2002, INFECT IMMUN, V70, P6940, DOI 10.1128/IAI.70.12.6940-6947.2002	26	409	435	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1780	1783		10.1126/science.1133690	http://dx.doi.org/10.1126/science.1133690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170306	Green Accepted			2022-12-01	WOS:000242833600060
J	Wang, D; Bushnell, DA; Westover, KD; Kaplan, CD; Kornberg, RD				Wang, Dong; Bushnell, David A.; Westover, Kenneth D.; Kaplan, Craig D.; Kornberg, Roger D.			Structural basis of transcription: Role of the trigger loop in substrate specificity and catalysis	CELL			English	Article							RNA-POLYMERASE-II; RIBONUCLEIC-ACID POLYMERASE; ESCHERICHIA-COLI; DEOXYRIBONUCLEIC ACID; ELONGATION COMPLEX; BETA' SUBUNIT; ACTIVE-CENTER; SECONDARY CHANNEL; MICROCIN J25; ANGSTROM RESOLUTION	New structures of RNA polymerase II (pol II) transcribing complexes reveal a likely key to transcription. The trigger loop swings beneath a correct nucleoside triphosphate (NTP) in the nucleotide addition site, closing off the active center and forming an extensive network of interactions with the NTP base, sugar, phosphates, and additional pol II residues. A histidine side chain in the trigger loop, precisely positioned by these interactions, may literally "trigger" phosphodiester bond formation. Recognition and catalysis are thus coupled, ensuring the fidelity of transcription.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu	Wang, Dong/C-8943-2012; Westover, Ken/AAZ-1795-2020; Kaplan, Craig/AAO-4500-2021	Westover, Ken/0000-0003-3653-5923; Kaplan, Craig/0000-0002-7518-695X	NCI NIH HHS [T32 CA009151] Funding Source: Medline; NIGMS NIH HHS [R01 GM049985, GM49985, R37 GM036659, GM36559] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036659, R01GM049985] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERT DA, 1985, J BIOL CHEM, V260, P679; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Archambault J, 1998, J BACTERIOL, V180, P2590, DOI 10.1128/JB.180.10.2590-2598.1998; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; CHAMBERLIN M, 1962, P NATL ACAD SCI USA, V48, P81, DOI 10.1073/pnas.48.1.81; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Delgado MA, 2001, J BACTERIOL, V183, P4543, DOI 10.1128/JB.183.15.4543-4550.2001; Ederth J, 2006, J MOL BIOL, V356, P1163, DOI 10.1016/j.jmb.2005.11.080; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; FOX CF, 1964, J BIOL CHEM, V239, P175; FURTH JJ, 1962, J BIOL CHEM, V237, P2611; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; HEKMATPANAH DS, 1991, MOL CELL BIOL, V11, P5781, DOI 10.1128/MCB.11.11.5781; Ito K, 1996, MOL GEN GENET, V251, P699, DOI 10.1007/BF02174119; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; KORNBERG A, 1992, DNA REPLICATION, P54; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; LINDSLEY JE, 1994, BIOCHEMISTRY-US, V33, P764, DOI 10.1021/bi00169a018; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palangat M, 2004, J MOL BIOL, V341, P429, DOI 10.1016/j.jmb.2004.06.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reichard P, 1985, Basic Life Sci, V31, P33; RHODES G, 1974, J BIOL CHEM, V249, P6675; SILVERMAN RB, 2000, ORGANIC CHEM ENZYME, P85; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; Symersky J, 2006, J BIOL CHEM, V281, P1309, DOI 10.1074/jbc.C500405200; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Thuillier V, 1996, EMBO J, V15, P618, DOI 10.1002/j.1460-2075.1996.tb00394.x; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; WEILBAECHER R, 1994, GENE DEV, V8, P2913, DOI 10.1101/gad.8.23.2913; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YANG XF, 1995, J BIOL CHEM, V270, P23930, DOI 10.1074/jbc.270.41.23930; Yuzenkova J, 2002, J BIOL CHEM, V277, P50867, DOI 10.1074/jbc.M209425200; Zakharova N, 1998, J BIOL CHEM, V273, P24912, DOI 10.1074/jbc.273.38.24912; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l	59	348	358	2	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					941	954		10.1016/j.cell.2006.11.023	http://dx.doi.org/10.1016/j.cell.2006.11.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129781	Green Accepted, Bronze			2022-12-01	WOS:000242613800012
J	Ule, J; Stefani, G; Mele, A; Ruggiu, M; Wang, XN; Taneri, B; Gaasterland, T; Blencowe, BJ; Darnell, RB				Ule, Jernej; Stefani, Giovanni; Mele, Aldo; Ruggiu, Matteo; Wang, Xuning; Taneri, Bahar; Gaasterland, Terry; Blencowe, Benjamin J.; Darnell, Robert B.			An RNA map predicting Nova-dependent splicing regulation	NATURE			English	Article							TRACT-BINDING-PROTEIN; PRE-MESSENGER-RNA; RICH ELEMENTS; HNRNP A1; U1 SNRNP; IN-VIVO; IDENTIFICATION; EXON; ENHANCER; COMPLEX	Nova proteins are neuron-specific alternative splicing factors. We have combined bioinformatics, biochemistry and genetics to derive an RNA map describing the rules by which Nova proteins regulate alternative splicing. This map revealed that the position of Nova binding sites (YCAY clusters) in a pre-messenger RNA determines the outcome of splicing. The map correctly predicted Nova's effect to inhibit or enhance exon inclusion, which led us to examine the relationship between the map and Nova's mechanism of action. Nova binding to an exonic YCAY cluster changed the protein complexes assembled on pre-mRNA, blocking U1 snRNP ( small nuclear ribonucleoprotein) binding and exon inclusion, whereas Nova binding to an intronic YCAY cluster enhanced spliceosome assembly and exon inclusion. Assays of splicing intermediates of Nova-regulated transcripts in mouse brain revealed that Nova preferentially regulates removal of introns harbouring ( or closest to) YCAY clusters. These results define a genome-wide map relating the position of a cis-acting element to its regulation by an RNA binding protein, namely that Nova binding to YCAY clusters results in a local and asymmetric action to regulate spliceosome assembly and alternative splicing in neurons.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Computat Genom, New York, NY 10021 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Rockefeller University; University of Toronto	Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Ule, Jernej/C-6315-2013; Darnell, Robert B/B-9022-2008; Stefani, Giovanni/P-6179-2015	Ule, Jernej/0000-0002-2452-4277; Darnell, Robert B/0000-0002-5134-8088; Stefani, Giovanni/0000-0002-8782-6811; Ruggiu, Matteo/0000-0002-6404-1210	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BARABINO SML, 1990, CELL, V63, P293, DOI 10.1016/0092-8674(90)90162-8; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Carlo T, 1996, RNA, V2, P342; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Chou MY, 1999, MOL CELL BIOL, V19, P69; Cook HL, 2005, CURR BIOL, V15, P974, DOI 10.1016/j.cub.2005.04.034; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gee SL, 2000, BLOOD, V95, P692, DOI 10.1182/blood.V95.2.692; Gersappe A, 1999, MOL CELL BIOL, V19, P364; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; LANG KM, 1987, MOL CELL BIOL, V7, P3428, DOI 10.1128/MCB.7.10.3428; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Query CC, 1997, MOL CELL BIOL, V17, P2944, DOI 10.1128/MCB.17.5.2944; Ryder SP, 2004, NAT STRUCT MOL BIOL, V11, P20, DOI 10.1038/nsmb706; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; TARN WY, 1994, GENE DEV, V8, P2704, DOI 10.1101/gad.8.22.2704; TSAI MJ, 1980, CELL, V22, P219, DOI 10.1016/0092-8674(80)90170-1; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	50	389	396	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					580	586		10.1038/nature05304	http://dx.doi.org/10.1038/nature05304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17065982				2022-12-01	WOS:000242377600040
J	Lakha, F; Glasier, A				Lakha, Fatim; Glasier, Anna			Unintended pregnancy and use of emergency contraception among a large cohort of women attending for antenatal care or abortion in Scotland	LANCET			English	Article							ADVANCED PROVISION; KNOWLEDGE; REDUCE; PERCEPTION; PILLS	Background Unintended pregnancy is common. Although many unintended pregnancies end in induced abortion, up to a third. of those proceeding to birth might be unplanned. Some of these pregnancies could be prevented by emergency contraception. We have sought to establish how many pregnancies ending in either childbirth or abortion are unintended, and what proportion of women use emergency contraception to try to prevent pregnancy. Methods 291018 women who attended an Edinburgh hospital for antenatal care and 907 attending for abortion fully completed a self-administered questionnaire including a validated measure of pregnancy intention and questions about emergency contraceptive use. Findings 814 (89.7%) of 907 pregnancies among women requesting abortion were unintended compared with only 250 (8.6%) among 2908 women who planned to continue pregnancy However, only 1909 (65.6%) of continuing pregnancies were intended. The rest of the women were ambivalent about pregnancy intention. In women who continued with their pregnancies intendedness was related to age, with unintended pregnancy most probable in young women (p<0.0001). Emergency contraception was used by 113 (11.8%) of women who requested abortion but only 40 (1%) of those planning to continue pregnancy. in those whose pregnancy was continuing, the proportions reporting use of emergency contraception were higher in young women than in older women and in those who reported that their pregnancies were unintended than in those who meant to become pregnant (both p<0.0001). Interpretation Unintended pregnancy is common, even among women planning to continue pregnancy. However, EC use is low even among women with no intention of conceiving, and is thus unlikely to reduce unintended pregnancy rates. Rather, we need to find ways to improve the use of regular contraception.	NHS Lothian, Family Planning Serv, Edinburgh EH4 1NL, Midlothian, Scotland; Univ Edinburgh, Sch Clin Sci & Community Hlth, Edinburgh, Midlothian, Scotland; Univ London, London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London, England	University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Glasier, A (corresponding author), NHS Lothian, Family Planning Serv, 18 Dean Terrace, Edinburgh EH4 1NL, Midlothian, Scotland.	Anna.Glasier@lpct.scot.nhs.uk		Lakha, Fatim/0000-0003-1865-4419				Aneblom G, 2002, BJOG-INT J OBSTET GY, V109, P155, DOI 10.1016/S1470-0328(02)01239-9; Arora N, 2005, J FAM PLAN REPROD H, V31, P294, DOI 10.1783/147118905774480626; Aziken ME, 2003, INT FAM PLAN PERSPEC, V29, P84, DOI 10.2307/3181062; Baird DT, 1999, BRIT MED J, V319, P969, DOI 10.1136/bmj.319.7215.969; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Dawe F, 2004, CONTRACEPTION SEXUAL; FLEISSIG A, 1991, BRIT MED J, V302, P147, DOI 10.1136/bmj.302.6769.147; Free C, 2002, BMJ-BRIT MED J, V325, P1393, DOI 10.1136/bmj.325.7377.1393; Garg M, 2001, J FAM PLAN REPROD H, V27, P77, DOI 10.1783/147118901101195290; Glasier A, 2004, CONTRACEPTION, V69, P361, DOI 10.1016/j.contraception.2004.01.002; Gordon AF, 1999, BRIT J FAM PLAN, V24, P121; Grimes D, 1998, LANCET, V352, P428; Hu XY, 2005, CONTRACEPTION, V72, P111, DOI 10.1016/j.contraception.2005.02.004; JOHNSTON TA, 1985, BRIT MED J, V290, P1040, DOI 10.1136/bmj.290.6474.1040-a; Jones RK, 2002, PERSPECT SEX REPRO H, V34, P294, DOI 10.2307/3097748; Lo SST, 2004, HUM REPROD, V19, P2404, DOI 10.1093/humrep/deh425; Marston C, 2005, BRIT MED J, V331, P271, DOI 10.1136/bmj.38519.440266.8F; Moreau C, 2005, CONTRACEPTION, V71, P202, DOI 10.1016/j.contraception.2004.09.004; *NAT I HLTH CLIN E, LONG ACT REV CONTR; Potter L, 1996, FAM PLANN PERSPECT, V28, P154, DOI 10.2307/2136191; Rosenberg M, 1999, AM J OBSTET GYNECOL, V180, pS276, DOI 10.1016/S0002-9378(99)70718-0; Schunmann C, 2006, CONTRACEPTION, V73, P520, DOI 10.1016/j.contraception.2005.12.009; Smallbone S. W., 2005, CHILDREN YOUNG PEOPL, P6; TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857; von Hertzen H, 2002, LANCET, V360, P1803, DOI 10.1016/S0140-6736(02)11767-3; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4	26	115	117	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1782	1787		10.1016/S0140-6736(06)69737-7	http://dx.doi.org/10.1016/S0140-6736(06)69737-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113427				2022-12-01	WOS:000242225400031
J	Grassly, NC; Fraser, C; Wenger, J; Deshpande, JM; Sutter, RW; Heymann, DL; Aylward, RB				Grassly, Nicholas C.; Fraser, Christophe; Wenger, Jay; Deshpande, Jagadish M.; Sutter, Roland W.; Heymann, David L.; Aylward, R. Bruce			New strategies for the elimination of polio from India	SCIENCE			English	Article							VACCINE; EFFICACY; POLIOMYELITIS; IMMUNOGENICITY; ERADICATION; POPULATION; TRIVALENT; DIARRHEA	The feasibility of global polio eradication is being questioned as a result of continued transmission in a few localities that act as sources for outbreaks elsewhere. Perhaps the greatest challenge is in India, where transmission has persisted in Uttar Pradesh and Bihar despite high coverage with multiple doses of vaccine. We estimate key parameters governing the seasonal epidemics in these areas and show that high population density and poor sanitation cause persistence by not only facilitating transmission of poliovirus but also severely compromising the efficacy of the trivalent vaccine. We analyze strategies to counteract this and show that switching to monovalent vaccine may finally interrupt virus transmission.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; World Hlth Org, Natl Polio Surveillance Project, New Delhi, India; Enterovirus Res Ctr, Bombay, Maharashtra, India; World Hlth Org, Global Polio Eradicat Initiat, Geneva, Switzerland	Imperial College London; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre; World Health Organization	Grassly, NC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London, England.	n.grassly@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Grassly, Nicholas C/C-6381-2008	Fraser, Christophe/0000-0003-2399-9657; Grassly, Nicholas C/0000-0001-6067-4507; Deshpande, Jagadish/0000-0001-5194-0375				ANDERSON R M, 1991; Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; BALRAJ V, 1990, INT J EPIDEMIOL, V19, P711, DOI 10.1093/ije/19.3.711; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P238; CIRNE MD, 1995, J INFECT DIS, V171, P1097, DOI 10.1093/infdis/171.5.1097; DEIVANAYAGAM N, 1993, B WORLD HEALTH ORGAN, V71, P307; EAM DJD, 2000, SCIENCE, V287, P667; Huttly SRA, 1997, B WORLD HEALTH ORGAN, V75, P163; JOHN TJ, 1976, B WORLD HEALTH ORGAN, V54, P115; KIMFARLEY RJ, 1989, B WORLD HEALTH ORGAN, V67, P663; MARTINES J, 1993, DIS CONTROL PRIORITI, P91; MELNICK JL, 1953, AM J HYG, V58, P207, DOI 10.1093/oxfordjournals.aje.a119602; PAL SR, 1966, INDIAN J MED RES, V54, P507; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Paul Y, 2005, VACCINE, V23, P3097, DOI 10.1016/j.vaccine.2004.10.049; PENTTINEN K, 1961, ANN MED EXP BIOL FEN, V39, P195; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; Sharma B, 1986, Indian J Pathol Microbiol, V29, P101; Sutter R. W., 2004, VACCINES, P651; Thacker Naveen, 2004, Indian Journal of Pediatrics, V71, P241, DOI 10.1007/BF02724277; Webster P, 2005, LANCET, V366, P359, DOI 10.1016/S0140-6736(05)67008-0	24	191	201	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1150	1153		10.1126/science.1130388	http://dx.doi.org/10.1126/science.1130388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110580				2022-12-01	WOS:000242045800046
J	Kowarik, M; Numao, S; Feldman, MF; Schulz, BL; Callewaert, N; Kiermaier, E; Catrein, I; Aebi, M				Kowarik, Michael; Numao, Shin; Feldman, Mario F.; Schulz, Benjamin L.; Callewaert, Nico; Kiermaier, Eva; Catrein, Ina; Aebi, Markus			N-linked glycosylation of folded proteins by the bacterial oligosaccharyltransferase	SCIENCE			English	Article							GREEN FLUORESCENT PROTEIN; ENDOPLASMIC-RETICULUM; CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; TAT PATHWAY; COMPLEX; TRANSLOCATION; TRANSFERASE; SPECIFICITY; RECOGNITION	N-linked protein glycosylation is found in all domains of life. In eukaryotes, it is the most abundant protein modification of secretory and membrane proteins, and the process is coupled to protein translocation and folding. We found that in bacteria, N-glycosylation can occur independently of the protein translocation machinery. In an in vitro assay, bacterial oligosaccharyltransferase glycosylated a folded endogenous substrate protein with high efficiency and folded bovine ribonuclease A with low efficiency. Unfolding the eukaryotic substrate greatly increased glycosylation. We propose that in the bacterial system, glycosylation sites are located in flexible parts of folded proteins, whereas the eukaryotic cotranslational glycosylation evolved to a mechanism presenting the substrate in a flexible form before folding.	ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland; ETH, Zurich Glycom Initiat, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Aebi, M (corresponding author), ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland.	aebi@micro.biol.ethz.ch	Schulz, Benjamin L/B-3911-2009; Feldman, Mario/A-2637-2014	Schulz, Benjamin L/0000-0002-4823-7758; Feldman, Mario/0000-0003-4497-0976; Kiermaier, Eva/0000-0001-6165-5738; Callewaert, Nico/0000-0003-2069-6917; Numao, Shin/0000-0002-6204-7117				Abedi MR, 1998, NUCLEIC ACIDS RES, V26, P623, DOI 10.1093/nar/26.2.623; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; Chen W, 2000, MOL BIOL CELL, V11, P765, DOI 10.1091/mbc.11.2.765; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Liu Y L, 1994, Bioorg Med Chem, V2, P1133, DOI 10.1016/S0968-0896(00)82065-9; Ritter C, 2000, NAT STRUCT BIOL, V7, P278; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; WORMALD MR, 1991, EUR J BIOCHEM, V198, P131, DOI 10.1111/j.1432-1033.1991.tb15995.x; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	22	181	199	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1148	1150		10.1126/science.1134351	http://dx.doi.org/10.1126/science.1134351			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110579				2022-12-01	WOS:000242045800045
J	Lefebvre, P; Silink, M				Lefebvre, Pierre; Silink, Martin			Diabetes fights for recognition	LANCET			English	Editorial Material									Int Diabet Federat, B-1000 Brussels, Belgium		Lefebvre, P (corresponding author), Int Diabet Federat, B-1000 Brussels, Belgium.							[Anonymous], 2006, GLOB STRAT DIET PHYS; *INT DIAB FED, 2006, DIAB ATL; *INT DIAB FED, 2006, WORLD DIAB DAY; Lobstein T., 2004, OBES REV, V5, P4, DOI [DOI 10.1111/J.1467-789X.2004.00133.X, 10.1111/j.1467-789X.2004.00133.x]; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; WHO, 2006, PREV CHRON DIS VIT I	6	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 11	2006	368	9548					1625	1626		10.1016/S0140-6736(06)69671-2	http://dx.doi.org/10.1016/S0140-6736(06)69671-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	106KI	17098061				2022-12-01	WOS:000242099000004
J	Jorgensen, BB; D'Hondt, S				Jorgensen, Bo Barker; D'Hondt, Steven			Ecology - A starving majority deep beneath the seafloor	SCIENCE			English	Editorial Material							SUBSEAFLOOR SEDIMENTS; PROKARYOTES; BIOSPHERE		Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	Max Planck Society; University of Rhode Island	Jorgensen, BB (corresponding author), Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany.	bjoergen@mpi-bremen.de; dhondt@gso.uri.edu	Jorgensen, Bo B/C-2214-2013	Jorgensen, Bo B/0000-0001-9398-8027				Amend JP, 2005, PALAEOGEOGR PALAEOCL, V219, P131, DOI 10.1016/j.palaeo.2004.10.018; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Holm NG, 2001, EARTH PLANET SC LETT, V191, P1, DOI 10.1016/S0012-821X(01)00397-1; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Jorgensen B. B., 2006, P OCEAN DRILLING PRO, V201, P1, DOI DOI 10.2973/0DP.PR0C.SR.201.101.2006; Lin LH, 2005, GEOCHIM COSMOCHIM AC, V69, P893, DOI 10.1016/j.gca.2004.07.032; Mauclaire L, 2004, GEOBIOLOGY, V2, P217, DOI 10.1111/j.1472-4677.2004.00035.x; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Smith DC, 2000, GEOMICROBIOL J, V17, P207; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	15	77	81	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					932	934		10.1126/science.1133796	http://dx.doi.org/10.1126/science.1133796			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	103OG	17095684				2022-12-01	WOS:000241896000033
J	Maurer, K; McKeith, I; Cummings, J; Ames, D; Burns, A				Maurer, Konrad; McKeith, Ian; Cummings, Jeffrey; Ames, David; Burns, Alistair			Has the management of Alzheimer's disease changed over the past 100 years?	LANCET			English	Editorial Material							DEMENTIA		Univ Manchester, Wythenshawe Hosp, Div Psychiat, Manchester M23 9PL, Lancs, England; Univ Hosp Frankfurt Main, Dept Psychiat Psychosomat & Psychotherapy, Frankfurt, Germany; Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; Univ Melbourne, Melbourne, Vic, Australia	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Newcastle University - UK; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Melbourne	Burns, A (corresponding author), Univ Manchester, Wythenshawe Hosp, Div Psychiat, Manchester M23 9PL, Lancs, England.	Alistair.Burns@manchester.ac.uk	McKeith, Ian/AAH-3382-2021	Burns, Alistair/0000-0002-9837-0645; McKeith, Ian/0000-0002-9250-0568				Curran S, 2005, INT J GERIATR PSYCH, V20, P842, DOI 10.1002/gps.1365; Doody RS, 2001, NEUROLOGY, V56, P1154, DOI 10.1212/WNL.56.9.1154; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Maurer K, 1997, LANCET, V349, P1546, DOI 10.1016/S0140-6736(96)10203-8; Maurer K, 2003, ALZHEIMER LIFE PHYS; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934	6	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2006	368	9547					1619	1621		10.1016/S0140-6736(06)69663-3	http://dx.doi.org/10.1016/S0140-6736(06)69663-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084762				2022-12-01	WOS:000242180900031
J	Berkefeld, H; Sailer, CA; Bildl, W; Rohde, V; Thumfart, JO; Eble, S; Klugbauer, N; Reisinger, E; Bischofberger, J; Oliver, D; Knaus, HG; Schulte, U; Fakler, B				Berkefeld, Henrike; Sailer, Claudia A.; Bildl, Wolfgang; Rohde, Volker; Thumfart, Joerg-Oliver; Eble, Silke; Klugbauer, Norbert; Reisinger, Ellen; Bischofberger, Josef; Oliver, Dominik; Knaus, Hans-Guenther; Schulte, Uwe; Fakler, Bernd			BKCa-Cav channel complexes mediate rapid and localized Ca2+-activated K+ signaling	SCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; RAT CHROMAFFIN CELLS; CA2+ CHANNELS; CALCIUM-CHANNELS; TRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; NERVE-TERMINALS; NEUROTRANSMITTER RELEASE; SPIKE REPOLARIZATION; PYRAMIDAL NEURONS	Large-conductance calcium- and voltage-activated potassium channels (BKCa) are dually activated by membrane depolarization and elevation of cytosolic calcium ions (Ca2+). Under normal cellular conditions, BKCa channel activation requires Ca2+ concentrations that typically occur in close proximity to Ca2+ sources. We show that BKCa channels affinity-purified from rat brain are assembled into macromolecular complexes with the voltage-gated calcium channels Cav1.2 (L-type), Cav2.1 (P/Q-type), and Cav2.2 (N-type). Heterologously expressed BKCa-Cav complexes reconstitute a functional "Ca2+ nanodomain" where Ca2+ influx through the Cav channel activates BKCa in the physiological voltage range with submillisecond kinetics. Complex formation with distinct Cav channels enables BKCa-mediated membrane hyperpolarization that controls neuronal firing pattern and release of hormones and transmitters in the central nervous system.	Logopharm GmbH, D-79104 Freiburg, Germany; Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Med Univ Innsbruck, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; Univ Freiburg, Inst Pharmacol & Toxicol, D-79104 Freiburg, Germany	University of Freiburg; Medical University of Innsbruck; University of Freiburg	Fakler, B (corresponding author), Logopharm GmbH, Hermann Herder Str 7, D-79104 Freiburg, Germany.	u.schulte@logopharm.com; bernd.fakler@physiologie.uni-freiburg.de	Oliver, Dominik/F-5845-2013; Thumfart, Joerg O/F-9741-2013	Oliver, Dominik/0000-0002-8368-0923; Thumfart, Joerg O/0000-0001-7647-9888; Reisinger, Ellen/0000-0003-3739-7569; Bischofberger, Josef/0000-0002-4006-1663				ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cavelier P, 2003, CEREBELLUM, V2, P196, DOI 10.1080/14734220310016141; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Davies PJ, 1999, J NEUROPHYSIOL, V82, P818, DOI 10.1152/jn.1999.82.2.818; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; GOLA M, 1993, NEURON, V10, P689, DOI 10.1016/0896-6273(93)90170-V; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Knaus HG, 1996, J NEUROSCI, V16, P955; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LATORRE R, 1982, P NATL ACAD SCI-BIOL, V79, P805, DOI 10.1073/pnas.79.3.805; Lingle C J, 1996, Ion Channels, V4, P261; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; Matveev V, 2004, BIOPHYS J, V86, P2691, DOI 10.1016/S0006-3495(04)74324-6; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Prakriya M, 1999, J NEUROPHYSIOL, V81, P2267, DOI 10.1152/jn.1999.81.5.2267; Prakriya M, 2000, J NEUROPHYSIOL, V84, P1123, DOI 10.1152/jn.2000.84.3.1123; Protti DA, 1997, PFLUG ARCH EUR J PHY, V434, P406, DOI 10.1007/s004240050414; Raffaelli G, 2004, J PHYSIOL-LONDON, V557, P147, DOI 10.1113/jphysiol.2004.062661; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; SAKURAI T, 1995, J BIOL CHEM, V270, P21234, DOI 10.1074/jbc.270.36.21234; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STORM JF, 1987, BRAIN RES, V435, P387, DOI 10.1016/0006-8993(87)91631-3; Sun XL, 2003, J NEUROSCI, V23, P3639; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wanner SG, 1999, BIOCHEMISTRY-US, V38, P5392, DOI 10.1021/bi983040c; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Xie C, 2005, J GEN PHYSIOL, V126, P205, DOI 10.1085/jgp.200509293; Yazejian B, 1997, J NEUROSCI, V17, P2990	42	279	284	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2006	314	5799					615	620		10.1126/science.1132915	http://dx.doi.org/10.1126/science.1132915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068255				2022-12-01	WOS:000241557800037
J	Schaap, P; Winckler, T; Nelson, M; Alvarez-Curto, E; Elgie, B; Hagiwara, H; Cavender, J; Milano-Curto, A; Rozen, DE; Dingermann, T; Mutzel, R; Baldauf, SL				Schaap, Pauline; Winckler, Thomas; Nelson, Michaela; Alvarez-Curto, Elisa; Elgie, Barrie; Hagiwara, Hiromitsu; Cavender, James; Milano-Curto, Alicia; Rozen, Daniel E.; Dingermann, Theodor; Mutzel, Rupert; Baldauf, Sandra L.			Molecular phylogeny and evolution of morphology in the social amoebas	SCIENCE			English	Article							DICTYOSTELIUM-DISCOIDEUM	The social amoebas (Dictyostelia) display conditional multicellularity in a wide variety of forms. Despite widespread interest in Dictyostelium discoideum as a model system, almost no molecular data exist from the rest of the group. We constructed the first molecular phylogeny of the Dictyostelia with parallel small subunit ribosomal RNA and alpha-tubulin data sets, and we found that dictyostelid taxonomy requires complete revision. A mapping of characters onto the phylogeny shows that the dominant trend in dictyostelid evolution is increased size and cell type specialization of fruiting structures, with some complex morphologies evolving several times independently. Thus, the latter may be controlled by only a few genes, making their underlying mechanisms relatively easy to unravel.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland; Univ Jena, Lehrstuhl Pharmazeut Biol, D-07743 Jena, Germany; Tokyo Natl Sci Museum, Tsukuba Bot Garden, Dept Bot, Tsukuba, Ibaraki 3050005, Japan; Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; Univ Frankfurt, Inst Pharmazeut Biol, D-60439 Frankfurt, Germany; ZAFES, Frankfurt, Germany; Free Univ Berlin, Inst Biol, Fachbereich Biol Chem Pharm, D-14195 Berlin, Germany	University of York - UK; University of Dundee; Friedrich Schiller University of Jena; National Museum of Nature and Science; University System of Ohio; Ohio University; Goethe University Frankfurt; Free University of Berlin	Baldauf, SL (corresponding author), Univ York, Dept Biol, Box 373, York YO10 5YW, N Yorkshire, England.	slb14@york.ac.uk	Schaap, Pauline/M-5355-2019; Schaap, Pauline/A-3682-2009; Rozen, Daniel/M-9896-2014; Dingermann, Theodor/M-6970-2014	Schaap, Pauline/0000-0003-4500-2555; Schaap, Pauline/0000-0003-4500-2555; Rozen, Daniel/0000-0002-7772-0239; Baldauf, Sandra/0000-0003-4485-6671; Dingermann, Theodor/0000-0002-2788-1085	Biotechnology and Biological Sciences Research Council [COD16760, BB/D013453/1] Funding Source: Medline; Wellcome Trust [076618, 057137] Funding Source: Medline; BBSRC [BB/D013453/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alvarez-Curto E, 2005, P NATL ACAD SCI USA, V102, P6385, DOI 10.1073/pnas.0502238102; Bonner JT, 2004, EVOLUTION, V58, P1883; Brefeld O., 1869, ABH SENCKENB NAT, V7, P85; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; HAGIWARA H, 1989, TAXONOMIC STUDY JAPA, P131; Kessin RH., 2001, DICTYOSTELIUM EVOLUT; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; Nikolaev SI, 2005, PROTIST, V156, P191, DOI 10.1016/j.protis.2005.03.002; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Raper K. B., 1984, DICTYOSTELIDS; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087	11	188	193	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					661	663		10.1126/science.1130670	http://dx.doi.org/10.1126/science.1130670			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068267	Green Accepted			2022-12-01	WOS:000241557800052
J	Kramer, MS; Rouleau, J; Baskett, TF; Joseph, KS				Kramer, Michael S.; Rouleau, Jocelyn; Baskett, Thomas F.; Joseph, K. S.		Maternal Hlth Study Grp Canadian P	Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study	LANCET			English	Article							UNITED-STATES; MORTALITY	Background Amniotic-fluid embolism is a rare, but serious and often fatal maternal complication of delivery, of which the cause is unknown. We undertook an epidemiological study to investigate the association between amniotic-fluid embolism and medical induction of labour. Methods We used a population-based cohort of 3 million hospital deliveries in Canada between 1991 and 2002 to assess the associations between overall and fatal rates of amniotic-fluid embolism and medical and surgical induction, maternal age, fetal presentation, mode of delivery, and pregnancy and labour complications. Findings Total rate of amniotic-fluid embolism was 14.8 per 100000 multiple-birth deliveries and 6.0 per 100 000 singleton deliveries (odds ratio 2.5 [95% CI 0.9-6.2]). Of the 180 cases of amniotic-fluid embolism in women with singleton deliveries during the study period, 24 (13%) were fatal. We saw no significant temporal increase in occurrence of amniotic-fluid embolism for total or fatal cases. Medical induction of labour nearly doubled the risk of overall cases of amniotic-fluid embolism (adjusted odds ratio 1.8 [1.3-2.7]), and the association was stronger for fatal cases (crude odds ratio 3.5 [1.5-8.4]). Maternal age of 35 years or older, Caesarean or instrumental vaginal delivery, polyhydramnios, cervical laceration or uterine rupture, placenta previa or abruption, eclampsia, and fetal distress were also associated with an increased risk. Interpretation Medical induction of labour seems to increase the risk of amniotic-fluid embolism. Although the absolute excess risk is low, women and physicians should be aware of this risk when making decisions about elective labour induction.	Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada; McGill Univ, Fac Med, Dept Paediat, Montreal, PQ, Canada; McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Publ Hlth Agcy Canada, Infant Hlth Sect, Div Surveillance & Epidemiol, Ottawa, ON, Canada; Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS, Canada; IWK Hlth Ctr, Halifax, NS, Canada; Dalhousie Univ, Dept Paediat, Halifax, NS, Canada	McGill University; McGill University; McGill University; Public Health Agency of Canada; Dalhousie University; Dalhousie University; Dalhousie University	Kramer, MS (corresponding author), Montreal Childrens Hosp, 2300 Tupper St Les Tourelles, Montreal, PQ H3H 1P3, Canada.	michael.kramer@mcgill.ca		Joseph, K.S./0000-0003-2317-5607				ATRASH HK, 1990, OBSTET GYNECOL, V76, P1055; Benson MD, 1996, AM J OBSTET GYNECOL, V175, P737; BURROWS A, 1995, AUST NZ J OBSTET GYN, V35, P245, DOI 10.1111/j.1479-828X.1995.tb01973.x; Clark S L, 1990, Obstet Gynecol Surv, V45, P360, DOI 10.1097/00006254-199006000-00003; CLARK SL, 1995, AM J OBSTET GYNECOL, V172, P1159; GEOGHEGAN FJ, 1964, J OBSTET GYN BR COMM, V71, P673; Gilbert WM, 1999, OBSTET GYNECOL, V93, P973, DOI 10.1016/S0029-7844(99)00004-6; GREGORY MG, 1973, OBSTET GYNECOL, V42, P236; HANKINS GDV, 1993, AM J OBSTET GYNECOL, V168, P1113, DOI 10.1016/0002-9378(93)90355-M; Health Canada, 2004, SPEC REP MAT MORT SE; HOGBERG U, 1985, GYNECOL OBSTET INVES, V20, P130; Kirby RS, 2004, BIRTH-ISS PERINAT C, V31, P148, DOI 10.1111/j.0730-7659.2004.00294.x; LEWIS G, 2004, WHY MOTHERS DIE 2000, P96; MORGAN M, 1979, ANAESTHESIA, V34, P20, DOI 10.1111/j.1365-2044.1979.tb04862.x; Robillard J, 2005, AM J OBSTET GYNECOL, V193, P1508, DOI 10.1016/j.ajog.2005.03.022; Tuffnell DJ, 2005, BJOG-INT J OBSTET GY, V112, P1625, DOI 10.1111/j.1471-0528.2005.00770.x; Turner Linda A, 2002, Chronic Dis Can, V23, P22; Turner Linda A, 2002, Chronic Dis Can, V23, P31; Wagner M, 2005, PAEDIATR PERINAT EP, V19, P173, DOI 10.1111/j.1365-3016.2005.00630.x; Weiwen Y, 2000, OBSTET GYNECOL, V95, p38S; Wen S W, 1997, Chronic Dis Can, V18, P113; Wen S W, 2001, Chronic Dis Can, V22, P1	22	116	124	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 21	2006	368	9545					1444	1448		10.1016/S0140-6736(06)69607-4	http://dx.doi.org/10.1016/S0140-6736(06)69607-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	097PA	17055946				2022-12-01	WOS:000241459100032
J	Xing, Y; Xu, YH; Chen, Y; Jeffrey, PD; Chao, Y; Lin, Z; Li, Z; Strack, S; Stock, JB; Shi, YG				Xing, Yongna; Xu, Yanhui; Chen, Yu; Jeffrey, Philip D.; Chao, Yang; Lin, Zheng; Li, Zhu; Strack, Stefan; Stock, Jeffry B.; Shi, Yigong			Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins	CELL			English	Article							SMALL-T-ANTIGEN; REGULATORY-A-SUBUNIT; PP2A CATALYTIC SUBUNIT; MOLECULAR-CLONING; TRUNCATED ISOFORM; CRYSTAL-STRUCTURE; SIMIAN VIRUS-40; ALPHA SUBUNIT; SERINE/THREONINE PHOSPHATASES; CARBOXYL METHYLATION	The serine/threonine phosphatase protein phosphatase 2A (PP2A) plays an essential role in many aspects of cellular functions and has been shown to be an important tumor suppressor. The core enzyme of PP2A comprises a 65 kDa scaffolding subunit and a 36 kDa catalytic subunit. Here we report the crystal structures of the PP2A core enzyme bound to two of its inhibitors, the tumor-inducing agents okadaic acid and microcystin-LR, at 2.6 and 2.8 angstrom resolution, respectively. The catalytic subunit recognizes one end of the elongated scaffolding subunit by interacting with the conserved ridges of HEAT repeats 11-15. Formation of the core enzyme forces the scaffolding subunit to undergo pronounced structural rearrangement. The scaffolding subunit exhibits considerable conformational flexibility, which is proposed to play an essential role in PP2A function. These structures, together with biochemical analyses, reveal significant insights into PP2A function and serve as a framework for deciphering the diverse roles of PP2A in cellular physiology.	Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	Princeton University; University of Iowa	Shi, YG (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.	ygshi@princeton.edu	Xu, Yanhui/D-5119-2019	Shi, Yigong/0000-0003-2030-168X; Strack, Stefan/0000-0002-6175-7280; Jeffrey, Philip/0000-0002-4351-5341; Li, Zhu/0000-0003-1536-9401				Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ARINO J, 1988, P NATL ACAD SCI USA, V85, P4252, DOI 10.1073/pnas.85.12.4252; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; COHEN PTW, 1990, FEBS LETT, V268, P355, DOI 10.1016/0014-5793(90)81285-V; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; EGLOFF MP, 1995, J MOL BIOL, V254, P942, DOI 10.1006/jmbi.1995.0667; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; GREEN DD, 1987, P NATL ACAD SCI USA, V84, P4880, DOI 10.1073/pnas.84.14.4880; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Harada Ken-Ichi, 1996, Natural Toxins, V4, P277; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ito A, 2003, AM J PATHOL, V162, P81, DOI 10.1016/S0002-9440(10)63800-X; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOSHI B, 1990, J VIROL, V64, P5649, DOI 10.1128/JVI.64.11.5649-5651.1990; Kita A, 2002, STRUCTURE, V10, P715, DOI 10.1016/S0969-2126(02)00764-5; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Koma YI, 2004, HISTOL HISTOPATHOL, V19, P391, DOI 10.14670/HH-19.391; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Maynes JT, 2001, J BIOL CHEM, V276, P44078, DOI 10.1074/jbc.M107656200; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; MUMBY M, 1995, SEMIN CANCER BIOL, V6, P229, DOI 10.1006/scbi.1995.0030; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; RUEDIGER R, 1994, J VIROL, V68, P123, DOI 10.1128/JVI.68.1.123-129.1994; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; RUEDIGER R, 1992, MOL CELL BIOL, V12, P4872, DOI 10.1128/MCB.12.11.4872; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Ruediger R, 1997, VIROLOGY, V238, P432, DOI 10.1006/viro.1997.8873; SCHEIDTMANN KH, 1991, MOL CELL BIOL, V11, P1996, DOI 10.1128/MCB.11.4.1996; STONE SR, 1987, BIOCHEMISTRY-US, V26, P7215, DOI 10.1021/bi00397a003; Suzuki K, 2003, INT J ONCOL, V23, P1263; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; TAKATA K, 2000, BREED RES, V2, P11; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Ueno Y, 1996, CARCINOGENESIS, V17, P1317, DOI 10.1093/carcin/17.6.1317; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; WALTER G, 1989, P NATL ACAD SCI USA, V86, P8669, DOI 10.1073/pnas.86.22.8669; WALTER G, 1990, P NATL ACAD SCI USA, V87, P2521, DOI 10.1073/pnas.87.7.2521; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; YANG SI, 1991, MOL CELL BIOL, V11, P1988, DOI 10.1128/MCB.11.4.1988; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185	59	250	275	3	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					341	353		10.1016/j.cell.2006.09.025	http://dx.doi.org/10.1016/j.cell.2006.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055435	Bronze			2022-12-01	WOS:000241827100021
J	Edozien, LC				Edozien, Leroy C.			Controversy - NHS maternity units should not encourage commercial banking of umbilical cord blood	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BACKTRACKING LEUKEMIA; TRANSPLANTATION		St Marys Hosp, Manchester M13 0JH, Lancs, England	University of Manchester	Edozien, LC (corresponding author), St Marys Hosp, Manchester M13 0JH, Lancs, England.	Leroy.Edozien@cmmc.nhs.uk		Edozien, Leroy/0000-0002-1815-7300				*AM COLL OBST GYN, 1997, INT J GYNECOL OBSTET, V58, P257; [Anonymous], 2002, RCM Midwives, V5, P422; [Anonymous], 1999, Pediatrics, V104, P116; Armson BA, 2005, J OBSTET GYNAECOL CA, V27, P263; *CELLS LTD, 2005, INF BOOKL; DERBYSHIRE D, 2004, DAILY TELEGRAPH 0217; Ecker JL, 2005, OBSTET GYNECOL, V105, P1282, DOI 10.1097/01.AOG.0000166162.45300.6a; *EUR GROUP ETH SCI, 2004, ETH ASP UMB CORD BLO; Fisk NM, 2005, PLOS MED, V2, P87, DOI 10.1371/journal.pmed.0020044; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Johnson FL, 1997, J PEDIAT HEMATOL ONC, V19, P183, DOI 10.1097/00043426-199705000-00001; Moise KJ, 2005, OBSTET GYNECOL, V106, P1393, DOI 10.1097/01.AOG.0000188388.84901.e4; Munzer SR, 2001, J PEDIAT HEMATOL ONC, V23, P203, DOI 10.1097/00043426-200105000-00004; Nakagawa R, 2004, TRANSFUSION, V44, P262, DOI 10.1111/j.1537-2995.2004.00645.x; *NAT CONS ETH COMM, 2002, OP NUMB 74 UMB CORD; Pafumi C, 2002, GYNECOL OBSTET INVES, V54, P73, DOI 10.1159/000067714; Rabe H, 2004, COCHRANE DB SYST REV, V18, DOI [DOI 10.1002/14651858.CD003248.PUB2, 10.1002/14651858.CD003248.pub2]; Rocha V, 2000, NEW ENGL J MED, V342, P1846, DOI 10.1056/NEJM200006223422501; Rogers I, 2004, BEST PRACT RES CL OB, V18, P893, DOI 10.1016/j.bpobgyn.2004.06.004; Rowley JD, 1998, NAT MED, V4, P150, DOI 10.1038/nm0298-150; Royal College of Obstetricians and Gynaecologists, 2006, 2 ROYAL COLL OBST GY; Solves P, 2003, ACTA OBSTET GYN SCAN, V82, P439; Warwick R, 2004, BEST PRACT RES CL OB, V18, P995, DOI 10.1016/j.bpobgyn.2004.07.003	23	20	21	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2006	333	7572					801	804		10.1136/bmj.38950.628519.68	http://dx.doi.org/10.1136/bmj.38950.628519.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	099AX	17038739	Green Published			2022-12-01	WOS:000241566000019
J	Nelson, CM; VanDuijn, MM; Inman, JL; Fletcher, DA; Bissell, MJ				Nelson, Celeste M.; VanDuijn, Martijn M.; Inman, Jamie L.; Fletcher, Daniel A.; Bissell, Mina J.			Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures	SCIENCE			English	Article							GROWTH-FACTOR-BETA; GLAND; MOUSE; FORM; BUD; PROLIFERATION; TGF-BETA-1; MODEL	The treelike structures of many organs, including the mammary gland, are generated by branching morphogenesis, a reiterative process of branch initiation and invasion from a preexisting epithelium. Using a micropatterning approach to control the initial three-dimensional structure of mouse mammary epithelial tubules in culture, combined with an algorithm to quantify the extent of branching, we found that the geometry of tubules dictates the position of branches. We predicted numerically and confirm experimentally that branches initiate at sites with a local minimum in the concentration of autocrine inhibitory morphogens, such as transforming growth factor - beta. These results reveal that tissue geometry can control organ morphogenesis by defining the local cellular microenvironment, a finding that has relevance to control of invasion and metastasis.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bissell, MJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	cmnelson@lbl.gov; mjbissell@lbl.gov	Nelson, Celeste/AAT-7612-2021	Nelson, Celeste/0000-0001-9973-8870; van Duijn, Martijn/0000-0002-6654-994X	NCI NIH HHS [R37 CA064786, R01 CA064786, R01 CA064786-10, CA57621, R01 CA057621-10, R01 CA057621, CA64786] Funding Source: Medline; NIGMS NIH HHS [R01 GM072736, R01 GM072736-05, GM72736] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA064786, R01CA057621, R01CA064786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072736] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; Bush KT, 2004, DEV BIOL, V266, P285, DOI 10.1016/j.ydbio.2003.10.023; Chen C.L., UNPUB; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Daniel CW, 1999, J MAMMARY GLAND BIOL, V4, P3, DOI 10.1023/A:1018796301609; Ewan KB, 2002, AM J PATHOL, V160, P2081, DOI 10.1016/S0002-9440(10)61158-3; Fata JE, 1999, DEV BIOL, V211, P238, DOI 10.1006/dbio.1999.9313; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; FAULKIN LJ, 1960, J NATL CANCER I, V24, P953; Gilles C, 1999, J CELL SCI, V112, P4615; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; Hirai Y, 1998, J CELL BIOL, V140, P159, DOI 10.1083/jcb.140.1.159; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Ingber DE, 2005, P NATL ACAD SCI USA, V102, P11571, DOI 10.1073/pnas.0505939102; LAWRENCE DA, 1984, J CELL PHYSIOL, V121, P184, DOI 10.1002/jcp.1041210123; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; RITVOS O, 1995, MECH DEVELOP, V50, P229, DOI 10.1016/0925-4773(94)00342-K; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; SERRA R, 1994, DEVELOPMENT, V120, P2153; SILBERSTEIN GB, 1987, SCIENCE, V237, P291, DOI 10.1126/science.3474783; Simian M, 2001, DEVELOPMENT, V128, P3117; Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577; Tang MD, 2003, J AM CHEM SOC, V125, P12988, DOI 10.1021/ja037677h; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Weaver M, 2000, DEVELOPMENT, V127, P2695; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090	30	459	470	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2006	314	5797					298	300		10.1126/science.1131000	http://dx.doi.org/10.1126/science.1131000			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038622	Green Accepted, Green Submitted			2022-12-01	WOS:000241194100041
J	Pillitteri, LJ; Sloan, DB; Bogenschutz, NL; Torii, KU				Pillitteri, Lynn Jo; Sloan, Daniel B.; Bogenschutz, Naomi L.; Torii, Keiko U.			Termination of asymmetric cell division and differentiation of stomata	NATURE			English	Article							MYOD FAMILY; SELAGINELLA; POLARITY	Stomata consist of a pair of guard cells that mediate gas and water-vapour exchange between plants and the atmosphere. Stomatal precursor cells - meristemoids - possess a transient stem-cell-like property and undergo several rounds of asymmetric divisions before further differentiation. Here we report that the Arabidopsis thaliana basic helix - loop - helix ( bHLH) protein MUTE is a key switch for meristemoid fate transition. In the absence of MUTE, meristemoids abort after excessive asymmetric divisions and fail to differentiate stomata. Constitutive overexpression of MUTE directs the entire epidermis to adopt guard cell identity. MUTE has two paralogues: FAMA, a regulator of guard cell morphogenesis, and SPEECHLESS (SPCH). We show that SPCH directs the first asymmetric division that initiates stomatal lineage. Together, SPCH, MUTE and FAMA bHLH proteins control stomatal development at three consecutive steps: initiation, meristemoid differentiation and guard cell morphogenesis. Our findings highlight the roles of closely related bHLHs in cell type differentiation in plants and animals.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Japan Science & Technology Agency (JST)	Torii, KU (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	ktorii@u.washington.edu	Sloan, Daniel/D-4152-2011; TORII, KEIKO U./A-6041-2013	TORII, KEIKO U./0000-0002-6168-427X; Sloan, Daniel/0000-0002-3618-0897				Bailey PC, 2003, PLANT CELL, V15, P2497, DOI 10.1105/tpc.151140; Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; BROWN RC, 1985, AM J BOT, V72, P1914, DOI 10.2307/2443608; Buck MJ, 2003, J MOL EVOL, V56, P742, DOI 10.1007/s00239-002-2449-3; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; DENGLER NG, 1983, AM J BOT, V70, P193, DOI 10.2307/2443263; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Geisler MJ, 2003, PLANTA, V216, P571; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; POETHIG RS, 2006, ENHANCER TRAPS; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3	24	320	357	6	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					501	505		10.1038/nature05467	http://dx.doi.org/10.1038/nature05467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17183267				2022-12-01	WOS:000243867300035
J	Swanson, SJ; Snider, C; Braden, CR; Boxrud, D; Wunschmann, A; Rudroff, JA; Lockett, J; Smith, KE				Swanson, Stephen J.; Snider, Cynthia; Braden, Christopher R.; Boxrud, David; Wuenschmann, Arno; Rudroff, Jo Ann; Lockett, Jana; Smith, Kirk E.			Multidrug-resistant Salmonella enterica serotype typhimurium associated with pet rodents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	43rd Annual Meeting of the Infectious-Diseases-Society-of-America	OCT 06-09, 2005	San Francisco, CA	Infect Dis Soc Amer			NONTYPHOIDAL SALMONELLA; COLONIZATION RESISTANCE; UNITED-STATES; INFECTIONS; ILLNESS; FEED; MICE; TRANSPORTATION; OUTBREAK; BURDEN	BACKGROUND: An estimated 1.4 million salmonella infections occur annually in the United States. The majority of these infections are foodborne, but many are acquired by contact with animals. In August 2004, isolates of Salmonella enterica serotype Typhimurium, which were indistinguishable from one another by pulsed-field gel electrophoresis (PFGE), were obtained from eight hamsters from a Minnesota pet distributor. We conducted an investigation to determine whether human cases of salmonella could be linked to this rodent-borne strain. METHODS: To identify cases of human infection with S. enterica serotype Typhimurium potentially related to pet rodents, we reviewed salmonella PFGE patterns submitted to the National Molecular Subtyping Network for Foodborne Disease Surveillance. Patients with isolates matching the hamster strain were interviewed about exposure to pet rodents. Implicated rodents were traced to pet stores, distributors, and breeders. RESULTS: We identified matching S. enterica serotype Typhimurium isolates from 28 patients in whom the onset of illness occurred between December 2003 and September 2004. Of 22 patients (or in the case of children, their parents) interviewed, 13 patients (59%) in 10 states reported exposure to pet hamsters, mice, or rats, and 2 (9%) had secondary infections. The median age of the 15 patients with primary or secondary rodent exposure was 16 years, and 6 patients (40%) were hospitalized. Thirteen associated pet stores supplied by seven distributors were identified in 10 states. No single source of the rodents was identified. The outbreak strain of S. enterica serotype Typhimurium was cultured from a patient's pet mouse and from seven hamsters from pet stores. Closely related S. enterica serotype Typhimurium isolates were cultured from rodent cages and reusable transport containers at a pet distributor. Human, rodent, and environmental isolates were resistant to ampicillin, chloramphenicol, streptomycin, sulfisoxazole, and tetracycline. CONCLUSIONS: Pet rodents probably are an underrecognized source of human salmonella infection.	Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Atlanta, GA USA; Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Minnesota Dept Hlth, Publ Hlth Lab, St Paul, MN USA; Minnesota Dept Hlth, Acute Dis Invest & Control Sect, St Paul, MN USA; Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; Missouri Dept Hlth & Senior Serv, Jefferson City, MO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Minnesota Department of Health (MHD); University of Minnesota System; University of Minnesota Twin Cities	Swanson, SJ (corresponding author), Hennepin Cty Med Ctr, Dept Pediat, Mail Code G7,701 Pk Ave, Minneapolis, MN 55415 USA.	stephen.swanson@co.hennepin.mn.us						*AM VET MED ASS, 2004, JUD THER US ANT SCHA; Bartram MT, 1940, J INFECT DIS, V67, P222, DOI 10.1093/infdis/67.3.222; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; FISH NA, 1968, CAN MED ASSOC J, V99, P418; Foodborne and Diarrheal Diseases Branch DoBaMD; National Center for Infectious Diseases Centers for Disease Control and Prevention, 2000, STAND MOL SUBT FOODB; Gupte AR, 2003, APPL ENVIRON MICROB, V69, P6669, DOI 10.1128/AEM.69.11.6669-6675.2003; HABERMANN RT, 1958, J NATL CANCER I, V20, P933; Healing T D, 1991, CDR (Lond Engl Rev), V1, pR114; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; Isaacson RE, 1999, AM J VET RES, V60, P1155; LATOUR PB, 1981, AM J VET RES, V42, P2105; Lawson AJ, 2002, EMERG INFECT DIS, V8, P434; LIPSKY S, 1995, JAMA-J AM MED ASSOC, V274, P294; Martin LJ, 2004, J INFECT DIS, V189, P377, DOI 10.1086/381270; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; MILLER CP, 1963, J INFECT DIS, V113, P59, DOI 10.1093/infdis/113.1.59; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; OWEN RA, 1983, AM J VET RES, V44, P46; PETRIE GF, 1910, P ROY SOC MED, V4, P70; QUE JU, 1985, INFECT IMMUN, V48, P169, DOI 10.1128/IAI.48.1.169-174.1985; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; SPARROW S, 1980, J SMALL ANIM PRACT, V21, P1, DOI 10.1111/j.1748-5827.1980.tb01208.x; STEFFEN EK, 1983, LAB ANIM SCI, V33, P454; VANDERWAAIJ D, 1968, J INFECT DIS, V118, P32, DOI 10.1093/infdis/118.1.32; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Varma JK, 2005, J INFECT DIS, V191, P554, DOI 10.1086/427263; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Welch H, 1941, AM J PUBLIC HEALTH N, V31, P332, DOI 10.2105/AJPH.31.4.332; WILLIAMS JE, 1978, AVIAN DIS, V22, P742, DOI 10.2307/1589652; Woodward DL, 1997, J CLIN MICROBIOL, V35, P2786, DOI 10.1128/JCM.35.11.2786-2790.1997; 2000, MMWR MORB MORTAL WKL, V49, P297; 2001, MMWR MORB MORTAL WKL, V50, P701; 2003, MMWR MORB MORTAL WKL, V52, P1206; 2005, MMWR MORB MORTAL WKL, V54, P429	35	55	64	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					21	28		10.1056/NEJMoa060465	http://dx.doi.org/10.1056/NEJMoa060465			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202452				2022-12-01	WOS:000243209600005
J	Zanettini, R; Antonini, A; Gatto, G; Gentile, R; Tesei, S; Pezzoli, G				Zanettini, Renzo; Antonini, Angelo; Gatto, Gemma; Gentile, Rosa; Tesei, Silvana; Pezzoli, Gianni			Valvular heart disease and the use of dopamine agonists for Parkinson's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITRAL REGURGITATION; 5-HT2B RECEPTORS; PERGOLIDE; VALVE; DETERMINANTS; VALVULOPATHY; FENFLURAMINE; DYSFUNCTION; PREVALENCE	BACKGROUND: Ergot-derived dopamine receptor agonists, often used in the treatment of Parkinson's disease, have been associated with an increased risk of valvular heart disease. METHODS: We performed an echocardiographic prevalence study in 155 patients taking dopamine agonists for Parkinson's disease (pergolide, 64 patients; cabergoline, 49; and non-ergot-derived dopamine agonists, 42) and 90 control subjects. Valve regurgitation was assessed according to American Society of Echocardiography recommendations. The mitral-valve tenting area was also measured and used as a quantitative index for leaflet stiffening and apical displacement of leaflet coaptation. RESULTS: Clinically important regurgitation (moderate to severe, grade 3 to 4) in any valve was found with significantly greater frequency in patients taking pergolide (23.4%) or cabergoline (28.6%) but not in patients taking non-ergot-derived dopamine agonists (0%), as compared with control subjects (5.6%). The relative risk for moderate or severe valve regurgitation in the pergolide group was 6.3 for mitral regurgitation (P=0.008), 4.2 for aortic regurgitation (P=0.01), and 5.6 for tricuspid regurgitation (P=0.16); corresponding relative risks in the cabergoline group were 4.6 (P=0.09), 7.3 (P<0.001), and 5.5 (P=0.12). The mean mitral tenting area was significantly greater in ergot-treated patients and showed a linear relationship with the severity of mitral regurgitation. Patients treated with ergot derivatives who had grade 3 to 4 regurgitation of any valve had received a significantly higher mean cumulative dose of pergolide or cabergoline than had patients with lower grades. CONCLUSIONS: The frequency of clinically important valve regurgitation was significantly increased in patients taking pergolide or cabergoline, but not in patients taking non-ergot-derived dopamine agonists, as compared with control subjects. These findings should be considered in evaluating the risk-benefit ratio of treatment with ergot derivatives.	Ist Clin Perfezionamento, Cardiac Rehabil Unit, I-20126 Milan, Italy; Ist Clin Perfezionamento, Parkinson Inst, I-20126 Milan, Italy		Zanettini, R (corresponding author), Ist Clin Perfezionamento, Cardiac Rehabil Unit, Via Bignami 1, I-20126 Milan, Italy.	cardriab@icp.mi.it	Antonini, Angelo/H-9726-2019	Antonini, Angelo/0000-0003-1040-2807; Pezzoli, Gianni/0000-0003-4665-6710				Baseman DG, 2004, NEUROLOGY, V63, P301, DOI 10.1212/01.WNL.0000129842.49926.07; Botero M, 2002, J CLIN ANESTH, V14, P57, DOI 10.1016/S0952-8180(01)00353-1; Chaudhuri KR, 2004, MOVEMENT DISORD, V19, P1522, DOI 10.1002/mds.20330; Flowers CM, 2003, MAYO CLIN PROC, V78, P730, DOI 10.4065/78.6.730; Horvath J, 2004, MOVEMENT DISORD, V19, P656, DOI 10.1002/mds.20201; Jahnichen S, 2005, EUR J PHARMACOL, V513, P225, DOI 10.1016/j.ejphar.2005.03.010; Jollis JG, 2000, CIRCULATION, V101, P2071, DOI 10.1161/01.CIR.101.17.2071; Lancellotti P, 2003, J AM COLL CARDIOL, V42, P1921, DOI 10.1016/j.jacc.2003.04.002; Pinero A, 2005, NEW ENGL J MED, V353, P1976, DOI 10.1056/NEJM200511033531822; Rascol O, 2004, MOVEMENT DISORD, V19, P611, DOI 10.1002/mds.20202; REDFIELD MM, 1992, ANN INTERN MED, V117, P50, DOI 10.7326/0003-4819-117-1-50; Rothman RB, 2000, CIRCULATION, V102, P2836; Serratrice Jacques, 2002, Cardiol Rev, V10, P334, DOI 10.1097/00045415-200211000-00005; Shively BK, 1999, CIRCULATION, V100, P2161, DOI 10.1161/01.CIR.100.21.2161; Srichai MB, 2005, ANN THORAC SURG, V80, P170, DOI 10.1016/j.athoracsur.2005.01.068; Van Camp G, 2003, NEUROLOGY, V61, P859, DOI 10.1212/01.WNL.0000083985.00343.F2; Van Camp G, 2004, LANCET, V363, P1179, DOI 10.1016/S0140-6736(04)15945-X; YOCK PG, 1984, CIRCULATION, V70, P657, DOI 10.1161/01.CIR.70.4.657; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	19	574	592	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					39	46		10.1056/NEJMoa054830	http://dx.doi.org/10.1056/NEJMoa054830			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202454	Bronze			2022-12-01	WOS:000243209600007
J	Fonarow, GC; Abraham, WT; Albert, NM; Stough, WG; Gheorghiade, M; Greenberg, BH; O'Connor, CM; Pieper, K; Sun, JL; Yancy, C; Young, JB				Fonarow, Gregg C.; Abraham, William T.; Albert, Nancy M.; Stough, Wendy Gattis; Gheorghiade, Mihai; Greenberg, Barry H.; O'Connor, Christopher M.; Pieper, Karen; Sun, Jie Lena; Yancy, Clyde; Young, James B.		OPTIMIZE-HF Investigators	Association between performance measures and clinical outcomes for patients hospitalized with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; MORTALITY; CARVEDILOL; INFARCTION; RATES	Context Assessment of quality of care in heart failure has focused on the development and use of process-based performance measures, with the presumption that these processes are associated with improved clinical outcomes. However, this link remains largely untested. Objective To examine the relationship between current American College of Cardiology/ American Heart Association (ACC/AHA) performance measures for patients hospitalized with heart failure and relevant clinical outcomes. Design, Setting, and Patients The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure, a registry and performance improvement program for patients hospitalized with heart failure. Sixty- to ninety-day postdischarge follow-up data were prospectively collected from 5791 patients at 91 US hospitals in a prespecified 10% sample between March 2003 and December 2004. Mean patient age was 72.0 years, 51% were male, 78% were white, and 42% had ischemic etiology. Multivariable and propensity-adjusted analyses were performed to assess the process-outcome relationship for each performance measure in eligible patients. Additionally, we evaluated the process-outcome link of a potential performance measure for beta-blockade at discharge among eligible patients hospitalized with heart failure. Main Outcome Measures Sixty- to ninety-day mortality and combined mortality/ rehospitalization rates. Results Mortality during follow-up was 8.6% and mortality/ rehospitalization was 36.2%. None of the 5 ACC/AHA heart failure performance measures was significantly associated with reduced early mortality risk, and only angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use at discharge was associated with 60- to 90-day postdischarge mortality or rehospitalization. beta-Blockade at the time of hospital discharge, currently not a heart failure performance measure, was strongly associated with reduced risk of mortality ( hazard ratio, 0.48; 95% confidence interval, 0.30-0.79; P=.004) and mortality/ rehospitalization during follow-up. Conclusions Current heart failure performance measures, aside from prescription of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker at discharge, have little relationship to patient mortality and combined mortality/ rehospitalization in the first 60 to 90 days after discharge. Additional measures and better methods for identifying and validating heart failure performance measures may be needed to accurately assess and improve care of patients with heart failure.	Univ Calif Los Angeles, Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90095 USA; Ohio State Univ, Columbus, OH 43210 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Duke Univ, Med Ctr, Durham, NC USA; Duke Clin Res Inst, Durham, NC USA; Campbell Univ, Sch Pharm, Dept Clin Res, Res Triangle Pk, NC USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; Duke University; Duke University; Campbell University; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Diego; Baylor University; Baylor University Medical Center	Fonarow, GC (corresponding author), Univ Calif Los Angeles, Med Ctr, Ahmanson UCLA Cardiomyopathy Ctr, 10833 LeConte Ave,Room 47-123 CHS, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014; Stough, Wendy G/R-4287-2016	Fonarow, Gregg C/0000-0002-3192-8093; Stough, Wendy G/0000-0001-8290-1205				American Heart Association, 2006, HEART DIS STROK STAT; [Anonymous], 2005, J AM COLL CARDIOL, V46, P1144, DOI 10.1016/j.jacc.2005.07.012; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Bufalino V, 2006, CIRCULATION, V113, P1151, DOI 10.1161/CIRCULATIONAHA.105.171760; Fonarow GC, 2004, AM J CARDIOL, V93, p77B, DOI 10.1016/j.amjcard.2004.01.030; Fonarow GC, 2005, ARCH INTERN MED, V165, P1469, DOI 10.1001/archinte.165.13.1469; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Granger CB, 2005, AM J MED, V118, P858, DOI 10.1016/j.amjmed.2005.01.070; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Hjalmarson A, 1999, LANCET, V353, P2001; Houston TK, 2005, AM J MED, V118, P269, DOI 10.1016/j.amjmed.2004.12.007; Hunt SA, ACC AHA 2005 GUIDELI; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P2647; *JOINT COMM ACCR H, 2006, SPEC MAN NAT HOSP QU; *JOINT COMM ACCR H, 2006, FACTS ORYX HOSP COR; Koelling TM, 2004, AM HEART J, V147, P74, DOI 10.1016/j.ahj.2003.07.021; Koelling TM, 2005, CIRCULATION, V111, P179, DOI 10.1161/01.CIR.0000151811.53450.B8; Krum H, 2003, JAMA-J AM MED ASSOC, V289, P712, DOI 10.1001/jama.289.6.712; Krumholz HM, 2000, CIRCULATION, V101, pE122, DOI 10.1161/01.CIR.101.12.e122; Lappe JM, 2004, ANN INTERN MED, V141, P446, DOI 10.7326/0003-4819-141-6-200409210-00010; Lechat P, 1999, LANCET, V353, P9; Luthi JC, 2002, INT J QUAL HEALTH C, V14, P15, DOI 10.1093/intqhc/14.1.15; Luthi JC, 2003, INT J QUAL HEALTH C, V15, P413, DOI 10.1093/intqhc/mzg055; Masoudi FA, 2004, CIRCULATION, V110, P724, DOI 10.1161/01.CIR.0000138934.28340.ED; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Rich Michael W, 2002, Heart Fail Rev, V7, P89; Senni M, 1999, J AM COLL CARDIOL, V33, P164, DOI 10.1016/S0735-1097(98)00523-3; Shivkumar K, 1996, PROG CARDIOVASC DIS, V38, P337, DOI 10.1016/S0033-0620(96)80018-1; Spertus JA, 2005, J AM COLL CARDIOL, V45, P1147, DOI 10.1016/j.jacc.2005.03.011	34	381	386	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2007	297	1					61	70		10.1001/jama.297.1.61	http://dx.doi.org/10.1001/jama.297.1.61			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	123BS	17200476				2022-12-01	WOS:000243271900022
J	Kuo, CT; Mirzadeh, Z; Soriano-Navarro, M; Rasin, M; Wang, D; Shen, J; Sestan, N; Garcia-Verdugo, J; Alvarez-Buylla, A; Jan, LY; Jan, YN				Kuo, Chay T.; Mirzadeh, Zaman; Soriano-Navarro, Mario; Rasin, Mladen; Wang, Denan; Shen, Jie; Sestan, Nenad; Garcia-Verdugo, Jose; Alvarez-Buylla, Arturo; Jan, Lily Y.; Jan, Yuh-Nung			Postnatal deletion of numb/numblike reveals repair and remodeling capacity in the subventricular neurogenic niche	CELL			English	Article							PROGENITOR-CELL MAINTENANCE; RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; ADULT BRAIN; CORTICAL NEUROGENESIS; NEURONAL MIGRATION; SONIC HEDGEHOG; NUMB; MOUSE; ZONE	Neural stem cells are retained in the postnatal subventricular zone (SVZ), a specialized neurogenic niche with unique cytoarchitecture and cell-cell contacts. Although the SVZ stem cells continuously regenerate, how they and the niche respond to local changes is unclear. Here we generated nestin-creER(tm) transgenic mice with inducible Cre recombinase in the SVZ and removed Numb/Numblike, key regulators of embryonic neurogenesis from postnatal SVZ progenitors and ependymal cells. This resulted in severe damage to brain lateral ventricle integrity and identified roles for Numb/Numblike in regulating ependymal wall integrity and SVZ neuroblast survival. Surprisingly, the ventricular damage was eventually repaired: SVZ reconstitution and ventricular wall remodeling were mediated by progenitors that escaped Numb deletion. Our results show a self-repair mechanism in the mammalian brain and may have implications for both niche plasticity in other areas of stem cell biology and the therapeutic use of neural stem cells in neurodegenerative diseases.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; Univ Valencia, Unidad Asociada Ctr Invest Principe Felipe, Lab Morfol Celular, Valencia 46013, Spain; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Prince Felipe Research Center; University of Valencia; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Jan, Yuh Nung/0000-0003-1367-6299; Soriano Navarro, Mario/0000-0002-7245-2095; Jan, Lily/0000-0003-3938-8498	NICHD NIH HHS [R01 HD045481] Funding Source: Medline; NIMH NIH HHS [R01 MH084234] Funding Source: Medline; NINDS NIH HHS [R37 NS040929, 5 R01 NS047200, NS28478, R01 NS047200] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028478, R01NS047200, R37NS040929, R01NS028478, R37NS028478] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Campbell K, 2005, NEURON, V46, P373, DOI 10.1016/j.neuron.2005.04.014; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Chambers CB, 2001, DEVELOPMENT, V128, P689; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lindvall O, 2004, STROKE, V35, P2691, DOI 10.1161/01.STR.0000143323.84008.f4; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Morhenn VB, 2004, EXP DERMATOL, V13, P505, DOI 10.1111/j.0906-6705.2004.00186.x; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sharp CD, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-28; Shen Q, 2002, DEVELOPMENT, V129, P4843; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	41	168	182	2	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 15	2006	127	6					1253	1264		10.1016/j.cell.2006.10.041	http://dx.doi.org/10.1016/j.cell.2006.10.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174898	Green Accepted, Bronze			2022-12-01	WOS:000242991000021
J	Sawada, Y; Tamada, M; Dubin-Thaler, BJ; Cherniavskaya, O; Sakai, R; Tanaka, S; Sheetz, MP				Sawada, Yasuhiro; Tamada, Masako; Dubin-Thaler, Benjamin J.; Cherniavskaya, Oksana; Sakai, Ryuichi; Tanaka, Sakae; Sheetz, Michael P.			Force sensing by mechanical extension of the Src family kinase substrate p130Cas	CELL			English	Article							CRK-ASSOCIATED SUBSTRATE; FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; CELL-MIGRATION; IN-VIVO; V-SRC; PROTEIN; DOMAIN; ACTIVATION; P130(CAS)	How physical force is sensed by cells and transduced into cellular signaling pathways is poorly understood. Previously, we showed that tyrosine phosphorylation of p130Cas (Cas) in a cytoskeletal complex is involved in force-dependent activation of the small GTPase Rap1. Here, we mechanically extended bacterially expressed Cas substrate domain protein (CasSD) in vitro and found a remarkable enhancement of phosphorylation by Src family kinases with no apparent change in kinase activity. Using an antibody that recognized extended CasSD in vitro, we observed Cas extension in intact cells in the peripheral regions of spreading cells, where higher traction forces are expected and where phosphorylated Cas was detected, suggesting that the in vitro extension and phosphorylation of CasSD are relevant to physiological force transduction. Thus, we propose that Cas acts as a primary force sensor, transducing force into mechanical extension and thereby priming phosphorylation and activation of downstream signaling.	Columbia Univ, Dept Sci Biol, New York, NY 10027 USA; Natl Canc Ctr, Res Inst, Growth Factor Div, Chuo Ku, Tokyo 1040045, Japan; Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan	Columbia University; National Cancer Center - Japan; University of Tokyo	Sawada, Y (corresponding author), Columbia Univ, Dept Sci Biol, Sherman Fairchild Ctr Room 715,MC 2416,1212 Amste, New York, NY 10027 USA.	ys454-ind@umin.ac.jp	Sakai, Ryuichi/R-7741-2017; Sawada, Yasuhiro/H-8044-2012; Tanaka, Sakae/Y-3061-2019	Sawada, Yasuhiro/0000-0003-0625-3335; Tanaka, Sakae/0000-0001-9210-9414; Sakai, Ryuichi/0000-0001-6833-1103	NIBIB NIH HHS [R01 EB001480-03, R01 EB001480] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001480] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; BOUGERET C, 1993, ONCOGENE, V8, P1241; Briknarova K, 2005, J BIOL CHEM, V280, P21908, DOI 10.1074/jbc.M501258200; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chien S, 2005, FRONT BIOSCI-LANDMRK, V10, P1985, DOI 10.2741/1673; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Fisher TE, 1999, TRENDS BIOCHEM SCI, V24, P379, DOI 10.1016/S0968-0004(99)01453-X; Fonseca PM, 2004, CELL SIGNAL, V16, P621, DOI 10.1016/j.cellsig.2003.10.004; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Harte MT, 1996, J BIOL CHEM, V271, P13649, DOI 10.1074/jbc.271.23.13649; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Missbach M, 1999, BONE, V24, P437, DOI 10.1016/S8756-3282(99)00020-4; Miyake I, 2005, ONCOGENE, V24, P3206, DOI 10.1038/sj.onc.1208523; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sakakibara A, 2002, J CELL SCI, V115, P4915, DOI 10.1242/jcs.00207; Sawada Y, 2001, J CELL SCI, V114, P1221; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Tang DD, 2003, HYPERTENSION, V42, P858, DOI 10.1161/01.HYP.0000085333.76141.33; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Wisniewska M, 2005, J MOL BIOL, V347, P1005, DOI 10.1016/j.jmb.2005.02.017; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	44	692	705	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					1015	1026		10.1016/j.cell.2006.09.044	http://dx.doi.org/10.1016/j.cell.2006.09.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129785	Green Accepted, Bronze			2022-12-01	WOS:000242613800017
J	Roumagnac, P; Weill, FX; Dolecek, C; Baker, S; Brisse, S; Chinh, NT; Le, TAH; Acosta, CJ; Farrar, J; Dougan, G; Achtman, M				Roumagnac, Philippe; Weill, Francois-Xavier; Dolecek, Christiane; Baker, Stephen; Brisse, Sylvain; Chinh, Nguyen Tran; Le, Thi Anh Hong; Acosta, Camilo J.; Farrar, Jeremy; Dougan, Gordon; Achtman, Mark			Evolutionary history of Salmonella Typhi	SCIENCE			English	Article							ESCHERICHIA-COLI; FEVER; POLYMORPHISMS; RESISTANCE; DYNAMICS; BACILLUS; STRAINS	For microbial pathogens, phylogeographic differentiation seems to be relatively common. However, the neutral population structure of Salmonella enterica serovar Typhi reflects the continued existence of ubiquitous haplotypes over millennia. In contrast, clinical use of fluoroquinolones has yielded at least 15 independent gyrA mutations within a decade and stimulated clonal expansion of haplotype H58 in Asia and Africa. Yet, antibiotic-sensitive strains and haplotypes other than H58 still persist despite selection for antibiotic resistance. Neutral evolution in Typhi appears to reflect the asymptomatic carrier state, and adaptive evolution depends on the rapid transmission of phenotypic changes through acute infections.	Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany; Inst Pasteur, Unite Biodivers Bacteries Pathogenes Emergentes, F-75724 Paris 15, France; Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Inst Natl Hyg & Epidemiol, Hanoi 1000, Vietnam; Int Vaccine Inst, Seoul 151600, South Korea	Max Planck Society; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford; Wellcome Trust Sanger Institute; International Vaccine Institute	Achtman, M (corresponding author), Max Planck Inst Infekt Biol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	achtman@mpiib-berlin.mpg.de	Farrar, Jeremy J./HGA-7610-2022; Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108; Weill, Francois-Xavier/0000-0001-9941-5799; Farrar, Jeremy/0000-0002-2700-623X; Achtman, Mark/0000-0001-6815-0070; Baker, Stephen/0000-0003-1308-5755	Wellcome Trust [076962] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Baas Becking L. G. M, 1934, GEOBIOLOGIE INLEIDIN; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; FRANKEL G, 1989, EMBO J, V8, P3149, DOI 10.1002/j.1460-2075.1989.tb08468.x; Fraser C, 2005, P NATL ACAD SCI USA, V102, P1968, DOI 10.1073/pnas.0406993102; Funk DJ, 2001, GENETICS, V157, P477; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mortimer PP, 1999, LANCET, V353, P1354, DOI 10.1016/S0140-6736(98)11315-6; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Rodrigues C, 2002, CLIN INFECT DIS, V34, P126, DOI 10.1086/323019; Threlfall EJ, 2001, EMERG INFECT DIS, V7, P448, DOI 10.3201/eid0703.017315; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026; Zhu PX, 2001, P NATL ACAD SCI USA, V98, P5234, DOI 10.1073/pnas.061386098	25	254	265	5	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2006	314	5803					1301	1304		10.1126/science.1134933	http://dx.doi.org/10.1126/science.1134933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BR	17124322	Green Accepted			2022-12-01	WOS:000242215800044
J	Hongay, CF; Grisafi, PL; Galitski, T; Fink, GR				Hongay, Cintia F.; Grisafi, Paula L.; Galitski, Timothy; Fink, Gerald R.			Antisense transcription controls cell fate in Saccharomyces cerevisiae	CELL			English	Article							GENE-EXPRESSION; INVASIVE GROWTH; MESSENGER-RNA; YEAST; GENOME; PROTEIN; DNA; TRANSPOSITION; INTERFERENCE; CASSETTES	Entry into meiosis is a key developmental decision. We show here that meiotic entry in Saccharomyces cerevisiae is controlled by antisense-mediated regulation of IME4, a gene required for initiating meiosis. In MATa/alpha diploids the antisense IME4 transcript is repressed by binding of the a1/alpha 2 heterodimer at a conserved site located downstream of the IME4 coding sequence. MAT a/alpha diploids that produce IME4 antisense transcript have diminished sense transcription and fail to initiate meiosis. Haploids that produce the sense transcript have diminished antisense transcription and manifest several diploid phenotypes. Our data are consistent with transcription interference as a regulatory mechanism at the IME4 locus that determines cell fate.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; Inst Syst Biol, Seattle, WA 98103 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Institute for Systems Biology (ISB)	Fink, GR (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02139 USA.	gfink@wi.mit.edu			NIGMS NIH HHS [5F32GM077738, R01 GM040266-23, R01 GM35010-23] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, R01GM035010, F32GM077738] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Chen XN, 1997, NUCLEIC ACIDS RES, V25, P682, DOI 10.1093/nar/25.3.682; Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; FRASER RSS, 1975, EUR J BIOCHEM, V60, P477, DOI 10.1111/j.1432-1033.1975.tb21026.x; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jin YS, 1999, MOL CELL BIOL, V19, P585; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; KLECKNER N, 1990, ANNU REV CELL BIOL, V6, P297, DOI 10.1146/annurev.cb.06.110190.001501; Lau NC, 2003, SCI AM, V289, P34, DOI 10.1038/scientificamerican0803-34; Ma Zhong-Liang, 2003, Acta Genetica Sinica, V30, P693; Madhani HD, 1999, P NATL ACAD SCI USA, V96, P12530, DOI 10.1073/pnas.96.22.12530; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; MIYAJIMA I, 1987, CELL, V50, P1011, DOI 10.1016/0092-8674(87)90167-X; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Palecek SP, 2000, GENETICS, V156, P1005; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Purnapatre K, 2005, MOL CELL BIOL, V25, P440, DOI 10.1128/MCB.25.1.440-450.2005; ROSE MD, 1990, METHODS YEAST GENETI; Samanta MP, 2006, P NATL ACAD SCI USA, V103, P4192, DOI 10.1073/pnas.0507669103; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	36	268	273	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					735	745		10.1016/j.cell.2006.09.038	http://dx.doi.org/10.1016/j.cell.2006.09.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110333	Bronze			2022-12-01	WOS:000242330600020
J	Losos, JB; Schoener, TW; Langerhans, RB; Spiller, DA				Losos, Jonathan B.; Schoener, Thomas W.; Langerhans, R. Brian; Spiller, David A.			Rapid temporal reversal in predator-driven natural selection	SCIENCE			English	Article							POPULATIONS; LIZARD		Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Calif Davis, Sect Ecol & Evolut, Davis, CA 95616 USA	Washington University (WUSTL); University of California System; University of California Davis	Losos, JB (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	jlosos@oeb.harvard.edu	Langerhans, R. Brian/A-4431-2008; Langerhans, R. Brian/ABE-6246-2021; Rohlf, F J/A-8710-2008					Irschick DJ, 1999, AM NAT, V154, P293, DOI 10.1086/303239; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schoener TW, 2002, ECOL MONOGR, V72, P383, DOI 10.1890/0012-9615(2002)072[0383:POACAL]2.0.CO;2; Thorpe RS, 2005, AM NAT, V165, P495, DOI 10.1086/428408; Williams E.E., 1983, P326	7	110	111	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 17	2006	314	5802					1111	1111		10.1126/science.1133584	http://dx.doi.org/10.1126/science.1133584			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110568				2022-12-01	WOS:000242045800034
J	Wang, JL; Rao, S; Chu, JL; Shen, XH; Levasseur, DN; Theunissen, TW; Orkin, SH				Wang, Jianlong; Rao, Sridhar; Chu, Jianlin; Shen, Xiaohua; Levasseur, Dana N.; Theunissen, Thorold W.; Orkin, Stuart H.			A protein interaction network for pluripotency of embryonic stem cells	NATURE			English	Article							TRANSCRIPTION FACTORS; POZ/BTB PROTEIN; MOUSE EMBRYOS; ES CELLS; NANOG; GENE; EXPRESSION; COMPLEX; DIFFERENTIATION; CULTURES	Embryonic stem ( ES) cells are pluripotent(1,2) and of therapeutic potential in regenerative medicine(3,4). Understanding pluripotency at the molecular level should illuminate fundamental properties of stem cells and the process of cellular reprogramming. Through cell fusion the embryonic cell phenotype can be imposed on somatic cells, a process promoted by the homeodomain protein Nanog(5), which is central to the maintenance of ES cell pluripotency(6,7). Nanog is thought to function in concert with other factors such as Oct4 ( ref. 8) and Sox2 ( ref. 9) to establish ES cell identity. Here we explore the protein network in which Nanog operates in mouse ES cells. Using affinity purification of Nanog under native conditions followed by mass spectrometry, we have identified physically associated proteins. In an iterative fashion we also identified partners of several Nanog- associated proteins ( including Oct4), validated the functional relevance of selected newly identified components and constructed a protein interaction network. The network is highly enriched for nuclear factors that are individually critical for maintenance of the ES cell state and co- regulated on differentiation. The network is linked to multiple co- repressor pathways and is composed of numerous proteins whose encoding genes are putative direct transcriptional targets of its members. This tight protein network seems to function as a cellular module dedicated to pluripotency.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Wang, Jianlong/AAG-9425-2020; Wang, Jianlong/GQR-1191-2022	Wang, Jianlong/0000-0002-1317-6457; Theunissen, Thorold/0000-0001-6943-7858				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Korutla L, 2005, J NEUROCHEM, V94, P786, DOI 10.1111/j.1471-4159.2005.03206.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Law DJ, 1999, BIOCHEM BIOPH RES CO, V262, P113, DOI 10.1006/bbrc.1999.1180; Lee JW, 2005, STEM CELLS, V23, P738, DOI 10.1634/stemcells.2004-0375; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mackler SA, 2003, NEUROSCIENCE, V121, P355, DOI 10.1016/S0306-4522(03)00376-2; Mackler SA, 2000, J NEUROSCI, V20, P6210, DOI 10.1523/JNEUROSCI.20-16-06210.2000; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Prelle K, 2002, ANAT HISTOL EMBRYOL, V31, P169, DOI 10.1046/j.1439-0264.2002.00388.x; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thompson JR, 2002, MOL CELL ENDOCRINOL, V195, P119, DOI 10.1016/S0303-7207(02)00180-6	28	841	889	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2006	444	7117					364	368		10.1038/nature05284	http://dx.doi.org/10.1038/nature05284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17093407				2022-12-01	WOS:000242018300048
J	Dewan, A; Liu, MG; Hartman, S; Zhang, SSM; Liu, DTL; Zhao, C; Tam, POS; Chan, WM; Lam, DSC; Snyder, M; Barnstable, C; Pang, CP; Hoh, J				DeWan, Andrew; Liu, Mugen; Hartman, Stephen; Zhang, Samuel Shao-Min; Liu, David T. L.; Zhao, Connie; Tam, Pancy O. S.; Chan, Wai Man; Lam, Dennis S. C.; Snyder, Michael; Barnstable, Colin; Pang, Chi Pui; Hoh, Josephine			HTRA1 promoter polymorphism in wet age-related macular degeneration	SCIENCE			English	Article							COMPLEMENT FACTOR-H; RISK; SUSCEPTIBILITY; GENE; ASSOCIATION; JAPANESE; CHINESE; DISEASE; VARIANT; CFH	Age-related macular degeneration (AMD), the most common cause of irreversible vision loss in individuals aged older than 50 years, is classified as either wet (neovascular) or dry (nonneovascular). Inherited variation in the complement factor H gene is a major risk factor for drusen in dry AMD. Here we report that a single-nucleotide polymorphism in the promoter region of HTRA1, a serine protease gene on chromosome 10q26, is a major genetic risk factor for wet AMD. A whole-genome association mapping strategy was applied to a Chinese population, yielding a P value of < 10(-11). Individuals with the risk-associated genotype were estimated to have a likelihood of developing wet AMD 10 times that of individuals with the wild-type genotype.	Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; Rockefeller Univ, Genom Resource Ctr, New York, NY 10021 USA	Yale University; Yale University; Yale University; Chinese University of Hong Kong; Rockefeller University	Hoh, J (corresponding author), Yale Univ, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	josephine.hoh@yale.edu	Barnstable, Colin/ABB-4822-2021; Lam, Dennis/AAL-1211-2020; Barnstable, Colin/GLU-9219-2022; Pang, Chi P/I-5388-2014	DeWan, Andrew/0000-0002-7679-8704; Barnstable, Colin/0000-0002-7011-4068; Snyder, Michael/0000-0003-0784-7987				Baum L, 2003, OPHTHALMOLOGICA, V217, P111, DOI 10.1159/000068553; Bird AC, 2003, EYE, V17, P457, DOI 10.1038/sj.eye.6700562; Chang TS, 1999, CAN J OPHTHALMOL, V34, P266; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Gotoh N, 2006, HUM GENET, V120, P139, DOI 10.1007/s00439-006-0187-0; Grassi MA, 2006, HUM MUTAT, V27, P921, DOI 10.1002/humu.20359; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Okamoto H, 2006, MOL VIS, V12, P156; Pang CP, 2000, OPHTHALMOLOGICA, V214, P289, DOI 10.1159/000027506; Postel EA, 2006, OPHTHALMOLOGY, V113, P1504, DOI 10.1016/j.ophtha.2006.02.049; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Sandberg MA, 1998, OPHTHALMOLOGY, V105, P441, DOI 10.1016/S0161-6420(98)93025-1; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Uyama M, 2000, BRIT J OPHTHALMOL, V84, P1018, DOI 10.1136/bjo.84.9.1018; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YUZAWA M, 1991, JPN J OPHTHALMOL, V35, P87	24	667	728	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					989	992		10.1126/science.1133807	http://dx.doi.org/10.1126/science.1133807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17053108				2022-12-01	WOS:000241896000052
J	Hyde, JS; Linn, MC				Shibley Hyde, Janet; Linn, Marcia C.			Diversity - Gender similarities in mathematics and science	SCIENCE			English	Editorial Material							SEX-DIFFERENCES; ACHIEVEMENT; AGGRESSION; BELIEFS		Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA	University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley	Hyde, JS (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	jshyde@wisc.edu						[Anonymous], NATIONS REPORT CARD; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bergmann B., 1996, DEFENSE AFFIRMATIVE; CERAULO S, 1999, J CHEM EDUC, V76, P615; Cohen J., 2013, STAT POWER ANAL BEHA, DOI 10.4324/9780203771587; EAGLY AH, 1995, PSYCHOL BULL, V117, P125, DOI 10.1037/0033-2909.117.1.125; EAGLY AH, 1986, PSYCHOL BULL, V100, P309, DOI 10.1037/0033-2909.100.3.309; EATON WO, 1986, PSYCHOL BULL, V100, P19, DOI 10.1037/0033-2909.100.1.19; Gurian M., 2003, BOYS GIRLS LEARN DIF; Handelsman J, 2005, SCIENCE, V309, P1190, DOI 10.1126/science.1113252; HYDE JS, 1990, PSYCHOL BULL, V107, P139, DOI 10.1037/0033-2909.107.2.139; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; HYDE JS, 1984, DEV PSYCHOL, V20, P722, DOI 10.1037/0012-1649.20.4.722; Hyde JS, 1986, PSYCHOL GENDER ADV M; LINN MC, 1998, ED RES, V27, P15; LUMMIS M, 1990, DEV PSYCHOL, V26, P254, DOI 10.1037/0012-1649.26.2.254; National Science Foundation, 2004, WOM MIN PERS DIS SCI; Nosek BA, 2002, J PERS SOC PSYCHOL, V83, P44, DOI 10.1037//0022-3514.83.1.44; Nosek BA, 2002, GROUP DYN-THEOR RES, V6, P101, DOI 10.1037//1089-2699.6.1.101; Seymour E., 1997, TALKING LEAVING; STEVENSON HW, 1993, SCIENCE, V259, P53, DOI 10.1126/science.8418494; Streitmatter J. L., 1999, GIRLS ONLY MAKING CA; Tai RH, 2006, SCIENCE, V312, P1143, DOI 10.1126/science.1128690; Walters AE, 1998, ORGAN BEHAV HUM DEC, V76, P1, DOI 10.1006/obhd.1998.2797; Warrington M, 2001, OXFORD REV EDUC, V27, P339, DOI 10.1080/03054980120067393; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594	27	141	143	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					599	600		10.1126/science.1132154	http://dx.doi.org/10.1126/science.1132154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098XT	17068246				2022-12-01	WOS:000241557800028
J	Wang, Y; Jorda, M; Jones, PL; Maleszka, R; Ling, X; Robertson, HM; Mizzen, CA; Peinado, MA; Robinson, GE				Wang, Ying; Jorda, Mireia; Jones, Peter L.; Maleszka, Ryszard; Ling, Xu; Robertson, Hugh M.; Mizzen, Craig A.; Peinado, Miguel A.; Robinson, Gene E.			Functional CpG methylation system in a social insect	SCIENCE			English	Article							DNA METHYLATION; DROSOPHILA; COMPLEX; EXPRESSION; GENES; MI-2	DNA methylation systems are well characterized in vertebrates, but methylation in Drosophila melanogaster and other invertebrates remains controversial. Using the recently sequenced honey bee genome, we present a bioinformatic, molecular, and biochemical characterization of a functional DNA methylation system in an insect. We report on catalytically active orthologs of the vertebrate DNA methyltransferases Dnmt1 and Dnmt3a and b, two isoforms that contain a methyl-DNA binding domain, genomic 5-methyl-deoxycytosine, and CpG-methylated genes. The honey bee provides an opportunity to study the roles of methylation in social contexts.	Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; IDIBELL Canc Res Inst, Lhospitalet De Llobregat 08907, Catalonia, Spain; Australian Natl Univ, Res Sch Biol Sci, Visual Sci & Australian Res Council Ctr Mol Genet, Canberra, ACT, Australia; Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Australian National University; University of Illinois System; University of Illinois Urbana-Champaign	Robinson, GE (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	generobi@life.uiuc.edu	Maleszka, Ryszard/A-6078-2008; Jordà, Mireia/Z-4519-2019; Blow, joe/C-8616-2009; Peinado, Miguel A./A-5591-2008	Maleszka, Ryszard/0000-0003-1855-555X; Peinado, Miguel A./0000-0002-4090-793X; Jorda, Mireia/0000-0003-3709-1850				Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Frigola J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e28; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Haig D, 2000, ANNU REV ECOL SYST, V31, P9, DOI 10.1146/annurev.ecolsys.31.1.9; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; *HON BEE GEN SEQ C, IN PRESS NATURE; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Marhold J, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-20; Marhold J, 2004, DEVELOPMENT, V131, P6033, DOI 10.1242/dev.01531; Queller DC, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-15; Ramsahoye Bernard H, 2002, Methods Mol Biol, V200, P17; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664	19	237	255	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					645	647		10.1126/science.1135213	http://dx.doi.org/10.1126/science.1135213			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068262				2022-12-01	WOS:000241557800046
J	St-Pierre, J; Drori, S; Uldry, M; Silvaggi, JM; Rhee, J; Jager, S; Handschin, C; Zheng, KN; Lin, JD; Yang, WL; Simon, DK; Bachoo, R; Spiegelman, BM				St-Pierre, Julie; Drori, Stavit; Uldry, Marc; Silvaggi, Jessica M.; Rhee, James; Jager, Sibylle; Handschin, Christoph; Zheng, Kangni; Lin, Jiandie; Yang, Wenli; Simon, David K.; Bachoo, Robert; Spiegelman, Bruce M.			Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators	CELL			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; HEPATIC GLUCONEOGENESIS; ENDOTHELIAL-CELLS; REDOX REGULATION; PGC-1-ALPHA; MUSCLE; MPTP; DISRUPTION; EXPRESSION; INDUCTION	PPAR gamma coactivator 1 alpha (PGC-1 alpha) is a potent stimulator of mitochondrial biogenesis and respiration. Since the mitochondrial electron transport chain is the main producer of reactive oxygen species (ROS) in most cells, we examined the effect of PGC-1 alpha on the metabolism of ROS. PGC-1 alpha is coinduced with several key ROS-detoxifying enzymes upon treatment of cells with an oxidative stressor; studies with RNAi or null cells indicate that PGC-1 alpha is required for the induction of many ROS-detoxifying enzymes, including GPx1 and SOD2. PGC-1 alpha null mice are much more sensitive to the neurodegenerative effects of MPTP and kainic acid, oxidative stressors affecting the substantia. nigra and hippocampus, respectively. Increasing PGC-1 alpha levels dramatically protects neural cells in culture from oxidative-stressor-mediated death. These studies reveal that PGC-1 alpha is a broad and powerful regulator of ROS metabolism, providing a potential target for the therapeutic manipulation of these important endogenous toxins.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Spiegelman, BM (corresponding author), Univ Montreal, Inst Rech Immunol & Canc, Pavill Marcelle Coutu,2950 Chem Polytech, Montreal, PQ H3T 1J4, Canada.	bruce_spiegelman@dfci.harvard.edu	Handschin, Christoph/E-6886-2015; Rhee, James/V-9973-2019; St-Pierre, Julie/AGB-3651-2022	Handschin, Christoph/0000-0003-0603-1097; St-Pierre, Julie/0000-0002-2815-7099; Jager, Sibylle/0000-0001-8102-7149	NIDDK NIH HHS [P30 DK040561-11, DK54477, P30 DK040561] Funding Source: Medline; NINDS NIH HHS [K02 NS4311] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054477, P30DK040561, R01DK054477] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Brown GC, 2001, IUBMB LIFE, V52, P189, DOI 10.1080/15216540152845993; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Przedborski S, 2000, RESTOR NEUROL NEUROS, V16, P135; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Schapira AHV, 1998, BBA-BIOENERGETICS, V1366, P225, DOI 10.1016/S0005-2728(98)00115-7; SINGER TP, 1990, FEBS LETT, V274, P1, DOI 10.1016/0014-5793(90)81315-F; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	42	1683	1728	7	145	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					397	408		10.1016/j.cell.2006.09.024	http://dx.doi.org/10.1016/j.cell.2006.09.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055439	Bronze			2022-12-01	WOS:000241827100025
J	Swallen, SF; Kearns, KL; Mapes, MK; Kim, YS; McMahon, RJ; Ediger, MD; Wu, T; Yu, L; Satija, S				Swallen, Stephen F.; Kearns, Kenneth L.; Mapes, Marie K.; Kim, Yong Seol; McMahon, Robert J.; Ediger, M. D.; Wu, Tian; Yu, Lian; Satija, Sushil			Organic glasses with exceptional thermodynamic and kinetic stability	SCIENCE			English	Article							SUPERCOOLED LIQUIDS; STRUCTURAL RELAXATION; AROMATIC HYDROCARBONS; PHYSICAL PROPERTIES; HEAT-CAPACITY; TRANSITION; TEMPERATURE; FORMERS; PARADOX	Vapor deposition has been used to create glassy materials with extraordinary thermodynamic and kinetic stability and high density. For glasses prepared from indomethacin or 1,3-bis-(1-naphthyl)-5(2-naphthyl) benzene, stability is optimized when deposition occurs on substrates at a temperature of 50 K below the conventional glass transition temperature. We attribute the substantial improvement in thermodynamic and kinetic properties to enhanced mobility within a few nanometers of the glass surface during deposition. This technique provides an efficient means of producing glassy materials that are low on the energy landscape and could affect technologies such as amorphous pharmaceuticals.	Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA; Natl Inst Stand & Technol, Ctr Neutron Res, Gaithersburg, MD 20899 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Institute of Standards & Technology (NIST) - USA	Ediger, MD (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	ediger@chem.wisc.edu	Ediger, Mark/AGZ-4130-2022; McMahon, Robert J./AAR-3868-2020	Ediger, Mark/0000-0003-4715-8473; 				Angell CA, 1997, J RES NATL INST STAN, V102, P171, DOI 10.6028/jres.102.013; Bell RC, 2003, J AM CHEM SOC, V125, P5176, DOI 10.1021/ja0291437; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Ediger MD, 1996, J PHYS CHEM-US, V100, P13200, DOI 10.1021/jp953538d; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Faupel F, 2003, REV MOD PHYS, V75, P237, DOI 10.1103/RevModPhys.75.237; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Huang DH, 2003, J CHEM PHYS, V119, P3590, DOI 10.1063/1.1599271; Ishii K, 2003, J PHYS CHEM B, V107, P876, DOI 10.1021/jp0260604; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Kawana S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021501; KEDDIE JL, 1994, FARADAY DISCUSS, V98, P219, DOI 10.1039/fd9949800219; Kovacs A. J., 1964, FORTSCH HOCHPOLYM FO, V3, P394, DOI DOI 10.1007/BFB0050366; MAGILL JH, 1967, J CHEM PHYS, V47, P2802, DOI 10.1063/1.1712301; Matyushov DV, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1949211; PLAZEK DJ, 1966, J CHEM PHYS, V45, P3038, DOI 10.1063/1.1728059; Richert R, 2003, J CHEM PHYS, V118, P1828, DOI 10.1063/1.1531587; Saksaengwijit A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.235701; Speedy RJ, 2003, BIOPHYS CHEM, V105, P411, DOI 10.1016/S0301-4622(03)00105-4; STILLINGER FH, 1995, SCIENCE, V267, P1935, DOI 10.1126/science.267.5206.1935; STILLINGER FH, 1988, J CHEM PHYS, V88, P7818, DOI 10.1063/1.454295; Swallen SF, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191492; TAKEDA K, 1995, J PHYS CHEM-US, V99, P1602, DOI 10.1021/j100005a035; Tanaka H, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025701; Tanaka H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011505; TURNBULL D, 1981, METALL TRANS A, V12, P695, DOI 10.1007/BF02648333; Whitaker CM, 1996, J PHYS CHEM-US, V100, P1081, DOI 10.1021/jp9529329	27	544	547	8	294	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2007	315	5810					353	356		10.1126/science.1135795	http://dx.doi.org/10.1126/science.1135795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126SI	17158289				2022-12-01	WOS:000243535400034
J	Kroeger, A; Nathan, MB				Kroeger, Axel; Nathan, Michael B.			Dengue: setting the global research agenda	LANCET			English	Editorial Material							CLASSIFICATION		UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva 27, Switzerland; Dept Control Neglected Trop Dis Vector Ecol & Man, CH-1211 Geneva 27, Switzerland	The World Bank; World Health Organization	Kroeger, A (corresponding author), UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva 27, Switzerland.	kroegera@who.int		Kroeger, Axel/0000-0001-8438-2904				Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Focks DA, 2006, MULTICOUNTRY STUDY A; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; *UN, WORLD URB PRSP 2001; *WORLD HLTH ASS, DENG FEV DENG HAEM F	6	60	63	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2193	2195		10.1016/S0140-6736(06)69873-5	http://dx.doi.org/10.1016/S0140-6736(06)69873-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189016				2022-12-01	WOS:000243076800008
J	Niedernhofer, LJ; Garinis, GA; Raams, A; Lalai, AS; Robinson, AR; Appeldoorn, E; Odijk, H; Oostendorp, R; Ahmad, A; Van Leeuwen, W; Theil, AF; Vermeulen, W; van der Horst, GTJ; Meinecke, P; Kleijer, WJ; Vijg, J; Jaspers, NGJ; Hoeijmakers, JHJ				Niedernhofer, Laura J.; Garinis, George A.; Raams, Anja; Lalai, Astrid S.; Robinson, Andria Rasile; Appeldoorn, Esther; Odijk, Hanny; Oostendorp, Roos; Ahmad, Anwaar; Van Leeuwen, Wibeke; Theil, Arjan F.; Vermeulen, Wim; van der Horst, Gijsbertus T. J.; Meinecke, Peter; Kleijer, Wim J.; Vijg, Jan; Jaspers, Nicolaas G. J.; Hoeijmakers, Jan H. J.			A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis	NATURE			English	Article							PIGMENTOSUM GROUP-F; DNA-REPAIR DEFECTS; XERODERMA-PIGMENTOSUM; LIFE-SPAN; GROWTH-HORMONE; NUCLEAR ABNORMALITIES; GENOMIC INSTABILITY; CALORIC RESTRICTION; GENE; MICE	XPF-ERCC1 endonuclease is required for repair of helix-distorting DNA lesions and cytotoxic DNA interstrand crosslinks. Mild mutations in XPF cause the cancer-prone syndrome xeroderma pigmentosum. A patient presented with a severe XPF mutation leading to profound crosslink sensitivity and dramatic progeroid symptoms. It is not known how unrepaired DNA damage accelerates ageing or its relevance to natural ageing. Here we show a highly significant correlation between the liver transcriptome of old mice and a mouse model of this progeroid syndrome. Expression data from XPF-ERCC1-deficient mice indicate increased cell death and anti-oxidant defences, a shift towards anabolism and reduced growth hormone/insulin-like growth factor 1 (IGF1) signalling, a known regulator of lifespan. Similar changes are seen in wild-type mice in response to chronic genotoxic stress, caloric restriction, or with ageing. We conclude that unrepaired cytotoxic DNA damage induces a highly conserved metabolic response mediated by the IGF1/insulin pathway, which re-allocates resources from growth to somatic preservation and life extension. This highlights a causal contribution of DNA damage to ageing and demonstrates that ageing and end-of-life fitness are determined both by stochastic damage, which is the cause of functional decline, and genetics, which determines the rates of damage accumulation and decline.	Erasmus Univ, Med Ctr, Ctr Biomed Genet Med Genet Ctr, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Expt Radiol, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Univ Pittsburgh, Sch Med, Inst Canc, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Altonaer kinderkrankenhaus, Abt Med Genet, D-22763 Hamburg, Germany; Buck Inst Age Res, Novato, CA 94945 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf; Buck Institute for Research on Aging	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Med Ctr, Ctr Biomed Genet Med Genet Ctr, Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.hoeijmakers@erasmusmc.nl	van der Horst, Gijsbertus TJ/E-3661-2015; Hoeijmakers, Jan/AAX-6972-2021; Garinis, George A./B-2943-2012; Vermeulen, Wim/W-8708-2019	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Garinis, George A./0000-0002-3200-5004; Vermeulen, Wim/0000-0003-3616-734X	NATIONAL CANCER INSTITUTE [K22CA111525] Funding Source: NIH RePORTER; NCI NIH HHS [K22 CA111525] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; Bootsma D., 2001, METABOLIC MOL BASES, V1, P677; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dolle MET, 2006, MUTAT RES-FUND MOL M, V596, P22, DOI 10.1016/j.mrfmmm.2005.11.008; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Ghoshal AK, 2000, P SOC EXP BIOL MED, V225, P128, DOI 10.1046/j.1525-1373.2000.22516.x; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Huang Q, 2001, TOXICOL SCI, V63, P196, DOI 10.1093/toxsci/63.2.196; Kasai H, 1998, CARCINOGENESIS, V19, P1459, DOI 10.1093/carcin/19.8.1459; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587; Kirkwood TBL, 2000, HUM EXP TOXICOL, V19, P338, DOI 10.1191/096032700678816025; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEE PDK, 1993, P SOC EXP BIOL MED, V204, P4; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lombardi G, 2005, J Endocrinol Invest, V28, P99; Maccormick RE, 2006, MED HYPOTHESES, V67, P212, DOI 10.1016/j.mehy.2006.01.045; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matsumura Y, 1998, HUM MOL GENET, V7, P969, DOI 10.1093/hmg/7.6.969; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Miller RA, 2005, SCIENCE, V310, P441, DOI 10.1126/science.310.5747.441; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]; Muller EE, 1999, PHYSIOL REV, V79, P511, DOI 10.1152/physrev.1999.79.2.511; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Sijbers AM, 1998, J INVEST DERMATOL, V110, P832, DOI 10.1046/j.1523-1747.1998.00171.x; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; Spindler SR, 2005, MECH AGEING DEV, V126, P960, DOI 10.1016/j.mad.2005.03.016; Takahashi Y, 2003, BBA-MOL CELL BIOL L, V1631, P265, DOI 10.1016/S1388-1981(03)00038-6; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Tsodikov OV, 2005, P NATL ACAD SCI USA, V102, P11236, DOI 10.1073/pnas.0504341102; VANDERPLUIJM I, IN PRESS PLOS BIOL, DOI DOI 10.1037/JOURNAL.PBIO.0050002; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	49	515	525	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1038	1043		10.1038/nature05456	http://dx.doi.org/10.1038/nature05456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183314				2022-12-01	WOS:000242971100047
J	Wang, TJ; Gona, P; Larson, MG; Tofler, GH; Levy, D; Newton-Cheh, C; Jacques, PF; Rifai, N; Selhub, J; Robins, SJ; Benjamin, EJ; D'Agostino, RB; Vasan, RS				Wang, Thomas J.; Gona, Philimon; Larson, Martin G.; Tofler, Geoffrey H.; Levy, Daniel; Newton-Cheh, Christopher; Jacques, Paul F.; Rifai, Nader; Selhub, Jacob; Robins, Sander J.; Benjamin, Emelia J.; D'Agostino, Ralph B.; Vasan, Ramachandran S.			Multiple biomarkers for the prediction of first major cardiovascular events and death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; PLASMINOGEN-ACTIVATOR INHIBITOR; DENSITY-LIPOPROTEIN CHOLESTEROL; BRAIN NATRIURETIC PEPTIDE; CONVENTIONAL RISK-FACTORS; MYOCARDIAL-INFARCTION; PHOSPHOLIPASE A(2); FOLLOW-UP; PLASMA	BACKGROUND: Few investigations have evaluated the incremental usefulness of multiple biomarkers from distinct biologic pathways for predicting the risk of cardiovascular events. METHODS: We measured 10 biomarkers in 3209 participants attending a routine examination cycle of the Framingham Heart Study: the levels of C-reactive protein, B-type natriuretic peptide, N-terminal pro-atrial natriuretic peptide, aldosterone, renin, fibrinogen, d-dimer, plasminogen-activator inhibitor type 1, and homocysteine; and the urinary albumin-to-creatinine ratio. RESULTS: During follow-up (median, 7.4 years), 207 participants died and 169 had a first major cardiovascular event. In Cox proportional-hazards models adjusting for conventional risk factors, the following biomarkers most strongly predicted the risk of death (each biomarker is followed by the adjusted hazard ratio per 1 SD increment in the log values): B-type natriuretic peptide level (1.40), C-reactive protein level (1.39), the urinary albumin-to-creatinine ratio (1.22), homocysteine level (1.20), and renin level (1.17). The biomarkers that most strongly predicted major cardiovascular events were B-type natriuretic peptide level (adjusted hazard ratio, 1.25 per 1 SD increment in the log values) and the urinary albumin-to-creatinine ratio (1.20). Persons with ``multimarker'' scores (based on regression coefficients of significant biomarkers) in the highest quintile as compared with those with scores in the lowest two quintiles had elevated risks of death (adjusted hazard ratio, 4.08; P<0.001) and major cardiovascular events (adjusted hazard ratio, 1.84; P=0.02). However, the addition of multimarker scores to conventional risk factors resulted in only small increases in the ability to classify risk, as measured by the C statistic. CONCLUSIONS: For assessing risk in individual persons, the use of the 10 contemporary biomarkers that we studied adds only moderately to standard risk factors.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Div Cardiol, Boston, MA 02114 USA; Framingham Heart Dis Epidemiol Study, Framingham, MA USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; Royal N Shore Hosp, Sydney, NSW, Australia; NHLBI, Bethesda, MD 20892 USA; Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer Dept Agr, Boston, MA 02111 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Lab Med, Boston, MA 02115 USA; Boston Univ, Sch Med, Boston Med Ctr, Prevent Med & Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Boston Med Ctr, Div Endocrinol Nutr & Diabet, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Framingham Heart Study; Boston University; Royal North Shore Hospital; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University; United States Department of Agriculture (USDA); Harvard University; Boston Children's Hospital; Harvard Medical School; Boston Medical Center; Boston University; Boston Medical Center; Boston University	Wang, TJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Div Cardiol, GRB-800,55 Fruit St, Boston, MA 02114 USA.	tjwang@partners.org	Levy, Daniel/ABF-6873-2021; Gona, Philimon/K-1477-2019; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Benjamin, Emelia/E-7103-2011	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Robins, Sander/0000-0002-3735-8415; Benjamin, Emelia/0000-0003-4076-2336; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048157, K24HL004334, R01HL076784, K23HL074077] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL-076784, N01-HC-25195, K23-HL-074077, R01-HL-48157, 2K24-HL-04334] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alderman MH, 1997, AM J HYPERTENS, V10, P1, DOI 10.1016/S0895-7061(96)00301-9; ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Best LG, 2005, CIRCULATION, V112, P1289, DOI 10.1161/CIRCULATIONAHA.104.489260; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COX DR, 1972, J R STAT SOC B, V34, P187; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P2848; Danesh J, 2001, CIRCULATION, V103, P2323; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Festa A, 2003, CIRCULATION, V108, P1822, DOI 10.1161/01.CIR.0000091339.70120.53; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; FRANCIS RB, 1988, AM HEART J, V115, P776, DOI 10.1016/0002-8703(88)90878-2; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Greenland P, 2005, ARCH INTERN MED, V165, P2454, DOI 10.1001/archinte.165.21.2454; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hoekstra T, 2004, THROMB HAEMOSTASIS, V91, P861, DOI 10.1160/TH03-08-0546; Hoogeveen EK, 2000, CIRCULATION, V101, P1506, DOI 10.1161/01.CIR.101.13.1506; KANNEL WB, 1987, NIH PUBLICATION; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Koenig W, 2004, CIRCULATION, V110, P1903, DOI 10.1161/01.CIR.0000143377.53389.C8; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tice JA, 2003, AM J MED, V114, P199, DOI 10.1016/S0002-9343(02)01497-3; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	40	988	1069	0	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2631	2639		10.1056/NEJMoa055373	http://dx.doi.org/10.1056/NEJMoa055373			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182988				2022-12-01	WOS:000242956200004
J	Kieffer, SW; Lu, XL; Bethke, CM; Spencer, JR; Marshak, S; Navrotsky, A				Kieffer, Susan W.; Lu, Xinli; Bethke, Craig M.; Spencer, John R.; Marshak, Stephen; Navrotsky, Alexandra			A clathrate reservoir hypothesis for Enceladus' south polar plume	SCIENCE			English	Article							GAS-PRODUCTION; HYDRATE; ICE; WELL	We hypothesize that active tectonic processes in the south polar terrain of Enceladus, the 500-kilometer-diameter moon of Saturn, are creating fractures that cause degassing of a clathrate reservoir to produce the plume documented by the instruments on the Cassini spacecraft. Advection of gas and ice transports energy, supplied at depth as latent heat of clathrate decomposition, to shallower levels, where it reappears as latent heat of condensation of ice. The plume itself, which has a discharge rate comparable to Old Faithful Geyser in Yellowstone National Park, probably represents small leaks from this massive advective system.	Univ Illinois, Dept Geol, Urbana, IL 61801 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Univ Calif Davis, Thermochem Facil, Davis, CA 95616 USA; Univ Calif Davis, NEAT, ORU, Davis, CA 95616 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Davis; University of California System; University of California Davis	Kieffer, SW (corresponding author), Univ Illinois, Dept Geol, 1301 W Green St, Urbana, IL 61801 USA.	skieffer@uiuc.edu						Brown RH, 2006, SCIENCE, V311, P1425, DOI 10.1126/science.1121031; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Hong H, 2003, J CAN PETROL TECHNOL, V42, P45, DOI 10.2118/03-11-05; Ji C, 2001, CHEM ENG SCI, V56, P5801, DOI 10.1016/S0009-2509(01)00265-2; Kargel JS, 2006, SCIENCE, V311, P1389, DOI 10.1126/science.1124495; KIEFFER SW, 1989, REV GEOPHYS, V27, P28; Kuhs WF, 1997, J INCLUS PHENOM MOL, V29, P65, DOI 10.1023/A:1007960217691; Laufer D, 2005, ICARUS, V178, P248, DOI 10.1016/j.icarus.2005.04.019; Longhi J, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002552; Lu X, 2004, THESIS U AUCKLAND AU; Lu XL, 2006, GEOTHERMICS, V35, P409, DOI 10.1016/j.geothermics.2006.07.001; Lu XL, 2005, GEOTHERMICS, V34, P389, DOI 10.1016/j.geothermics.2005.05.001; LUNINE JI, 1985, ASTROPHYS J SUPPL S, V58, P493, DOI 10.1086/191050; MILLER SL, 1969, SCIENCE, V165, P489, DOI 10.1126/science.165.3892.489; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Sloan E. D., 1997, CLATHRATE HYDRATES N; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Tian F.H., UNPUB; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Wilder JW, 2002, J PHYS CHEM B, V106, P6298, DOI 10.1021/jp014256i	21	115	117	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1764	1766		10.1126/science.1133519	http://dx.doi.org/10.1126/science.1133519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170301				2022-12-01	WOS:000242833600055
J	Kumar, KA; Sano, G; Boscardin, S; Nussenzweig, RS; Nussenzweig, MC; Zavala, F; Nussenzweig, V				Kumar, Kota Arun; Sano, Gen-ichiro; Boscardin, Silvia; Nussenzweig, Ruth S.; Nussenzweig, Michel C.; Zavala, Fidel; Nussenzweig, Victor			The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites	NATURE			English	Article							LIVER-STAGES; T-CELLS; MALARIA; IMMUNITY; VACCINE; TRANSCRIPTOME; IMMUNIZATION; INFECTION; VIRULENCE; EPITOPES	Malaria infection starts when mosquitoes inject sporozoites into the skin. The parasites enter the blood stream and make their way to the liver where they develop into the exo-erythrocytic forms (EEFs). Immunization with irradiated sporozoites (IrSp) leads to robust protection against malaria infection in rodents(1), monkeys(2) and humans(3) by eliciting antibodies to circumsporozoite protein (CS) that inhibit sporozoite infectivity, and T cells that destroy the EEFs(4). To study the role of non-CS antigens in protection, we produced CS transgenic mice that were tolerant to CS T-cell epitopes. Here we show that in the absence of T-cell-dependent immune responses to CS, protection induced by immunization with two doses of IrSp was greatly reduced. Thus, although hundreds of other Plasmodium genes are expressed in sporozoites(5) and EEFs(6), CS is a dominant protective antigen. Nevertheless, sterile immunity could be obtained by immunization of CS transgenics with three doses of IrSp.	NYU, Sch Med, Dept Pathol, Michael Heidelberger Div Immunol, New York, NY 10016 USA; Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Inst, New York, NY 10021 USA; NYU, Sch Med, Dept Med & Mol Parasitol, New York, NY 10016 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	New York University; Keio University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; New York University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kumar, KA (corresponding author), NYU, Sch Med, Dept Pathol, Michael Heidelberger Div Immunol, New York, NY 10016 USA.	arun.kumar@med.nyu.edu	Boscardin, Silvia Beatriz/C-3397-2012; Nussenzweig, Michel/AAE-7292-2019	Boscardin, Silvia Beatriz/0000-0002-7845-7110; 				Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Bruna-Romero O, 2001, INT J PARASITOL, V31, P1499, DOI 10.1016/S0020-7519(01)00265-X; Carvalho LH, 2001, J IMMUNOL METHODS, V252, P207, DOI 10.1016/S0022-1759(01)00331-3; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 1998, NAT MED, V4, P1351, DOI 10.1038/3934; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; SANO G, 1994, MOL BIOCHEM PARASIT, V63, P265, DOI 10.1016/0166-6851(94)90062-0; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; SINNIS P, 1994, J EXP MED, V180, P297, DOI 10.1084/jem.180.1.297; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Tao D, 2005, J EXP MED, V201, P201, DOI 10.1084/jem.20041526; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Wang QA, 2004, MOL BIOCHEM PARASIT, V137, P161, DOI 10.1016/j.molbiopara.2004.06.001; Wang Q, 2005, PLOS PATHOG, V1, P72, DOI 10.1371/journal.ppat.0010009; WEISS WR, 1989, J IMMUNOL, V143, P4263; WIZEL B, 1995, J EXP MED, V182, P1435, DOI 10.1084/jem.182.5.1435	30	204	215	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					937	940		10.1038/nature05361	http://dx.doi.org/10.1038/nature05361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17151604				2022-12-01	WOS:000242805400058
J	Rosenthal, E				Rosenthal, Elisabeth			HIV injustice in Libya - Scapegoating foreign medical professionals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NOSOCOMIAL OUTBREAK											MONTAGNIER L, COMMUNICATION; Visco-Comandini U, 2002, AIDS RES HUM RETROV, V18, P727, DOI 10.1089/088922202760072366; Yerly S, 2001, J INFECT DIS, V184, P369, DOI 10.1086/322036	3	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2006	355	24					2505	2508		10.1056/NEJMp068241	http://dx.doi.org/10.1056/NEJMp068241			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	116BZ	17167132	Bronze			2022-12-01	WOS:000242778800001
J	Kang, SW; Rane, NS; Kim, SJ; Garrison, JL; Taunton, J; Hegde, RS				Kang, Sang-Wook; Rane, Neena S.; Kim, Soo Jung; Garrison, Jennifer L.; Taunton, Jack; Hegde, Ramanujan S.			Substrate-specific translocational attenuation during ER stress defines a pre-emptive quality control pathway	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; UNFOLDED PROTEIN RESPONSE; PRION PROTEIN; COTRANSLATIONAL TRANSLOCATION; CHANNEL; CYTOSOL; PRP; NEURODEGENERATION; DEGRADATION	Eukaryotic proteins entering the secretory pathway are translocated into the ER by signal sequences that vary widely in primary structure. We now provide a functional rationale for this long-observed sequence diversity by demonstrating that differences among signals facilitate substrate-selective modulation of protein translocation. We find that during acute ER stress, translocation of secretory and membrane proteins is rapidly and transiently attenuated in a signal sequence-selective manner. Their cotranslational rerouting to the cytosol for degradation reduces the burden of misfolded substrates entering the ER and represents a pathway for pre-emptive quality control (pQC). Bypassing the pQC pathway for the prion protein increases its rate of aggregation in the ER lumen during prolonged stress and renders cells less capable of viable recovery. Conversely, pharmacologically augmenting pQC during ER stress proved protective. Thus, protein translocation is a physiologically regulated process that is utilized for pQC as part of the ER stress response.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; Korea Res Inst Biosci & Biotechnol, Funct Genom Res Ctr, Taejon 305333, South Korea; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California San Francisco	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, 18 Lib Dr,Bldg 18T,Room 101, Bethesda, MD 20892 USA.	hegder@mail.nih.gov		Hegde, Ramanujan/0000-0001-8338-852X; Kang, Sang-Wook/0000-0002-8000-4823	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008835, Z01HD008752] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [R01 GM071434-04] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hegde RS, 1998, CELL, V92, P621, DOI 10.1016/S0092-8674(00)81130-7; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kim SJ, 2002, MOL BIOL CELL, V13, P3775, DOI 10.1091/mbc.E02-05-0293; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Kim SJ, 2001, J BIOL CHEM, V276, P26132, DOI 10.1074/jbc.M101638200; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.e04-06-0508; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; ORSI A, 2006, J BIOL CHEM, V13, P2067; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Williams EJB, 2000, GENE, V253, P313, DOI 10.1016/S0378-1119(00)00233-X; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	32	211	212	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					999	1013		10.1016/j.cell.2006.10.032	http://dx.doi.org/10.1016/j.cell.2006.10.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129784	Green Accepted, Bronze			2022-12-01	WOS:000242613800016
J	Bongard, J; Zykov, V; Lipson, H				Bongard, Josh; Zykov, Victor; Lipson, Hod			Resilient machines through continuous self-modeling	SCIENCE			English	Article							EVOLUTION; ROBOTS	Animals sustain the ability to operate after injury by creating qualitatively different compensatory behaviors. Although such robustness would be desirable in engineered systems, most machines fail in the face of unexpected damage. We describe a robot that can recover from such change autonomously, through continuous self-modeling. A four-legged machine uses actuation-sensation relationships to indirectly infer its own structure, and it then uses this self-model to generate forward locomotion. When a leg part is removed, it adapts the self-models, leading to the generation of alternative gaits. This concept may help develop more robust machines and shed light on self-modeling in animals.	Cornell Univ, Ithaca, NY 14853 USA	Cornell University	Bongard, J (corresponding author), Univ Vermont, Dept Comp Sci, Burlington, VT 05405 USA.	josh.bongard@uvm.edu						Alpaydin E., 2004, INTRO MACHINE LEARNI; Arkin R. C., 1998, BEHAV BASED ROBOTICS; Bongard J, 2005, J MACH LEARN RES, V6, P1651; Bongard JC, 2005, IEEE T EVOLUT COMPUT, V9, P361, DOI 10.1109/TEVC.2005.850293; BROOKS RA, 1992, FROM ANIM ANIMAT, P3; Caccavale F, 2002, FAULT DIAGNOSIS FAUL; Christaller T., 1999, Artificial Life and Robotics, V3, P221, DOI 10.1007/BF02481184; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Edelman Gerald M., 1989, REMEMBERED PRESENT B; Full RJ, 1999, J EXP BIOL, V202, P3325; Hornby GS, 2005, IEEE T ROBOT, V21, P402, DOI 10.1109/TRO.2004.839222; Keymeulen D, 1998, ARTIF LIFE, V4, P359, DOI 10.1162/106454698568648; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; Kouchmeshky B, 2007, INT J NUMER METH ENG, V69, P1085, DOI 10.1002/nme.1803; KOZLOWSKI K, 1998, MODELLING IDENTIFICA; Ljung L., 1999, SYSTEM IDENTIFICATIO; Mahdavi SH, 2006, AUTON ROBOT, V20, P149, DOI 10.1007/s10514-006-5941-6; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; PFEIFER R, 2002, INT J COGNITION TECH, V1, P125; Saranli U, 2001, INT J ROBOT RES, V20, P616, DOI 10.1177/02783640122067570; Scheier C, 1999, UNDERSTANDING INTELL; Sciavicco L., 2001, MODELLING CONTROL RO; Seung H. S., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P287, DOI 10.1145/130385.130417; Thrun S, 2005, PROBABILISTIC ROBOTI; Verschure PFMJ, 2003, NATURE, V425, P620, DOI 10.1038/nature02024; VISINSKY ML, 1994, RELIAB ENG SYST SAFE, V46, P139, DOI 10.1016/0951-8320(94)90132-5; Webb B, 2001, BEHAV BRAIN SCI, V24, P1033, DOI 10.1017/S0140525X01220123; Zilberstein S, 2002, LECT NOTES ARTIF INT, V2466, P270	30	414	419	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1118	1121		10.1126/science.1133687	http://dx.doi.org/10.1126/science.1133687			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110570				2022-12-01	WOS:000242045800036
J	Yigit, E; Batista, PJ; Bei, YX; Pang, KM; Chen, CCG; Tolia, NH; Joshua-Tor, L; Mitani, S; Simard, MJ; Mello, CC				Yigit, Erbay; Batista, Pedro J.; Bei, Yanxia; Pang, Ka Min; Chen, Chun-Chieh G.; Tolia, Niraj H.; Joshua-Tor, Leemor; Mitani, Shohei; Simard, Martin J.; Mello, Craig C.			Analysis of the C-elegans argonaute family reveals that distinct argonautes act sequentially during RNAi	CELL			English	Article							GENETIC INTERFERENCE; PROTEIN; DSRNA; PIWI; POLYMERASE; GERMLINE; HETEROCHROMATIN; MAINTENANCE; INITIATION; HELICASE	Argonaute (AGO) proteins interact with small RNAs to mediate gene silencing. C. elegans contains 27 AGO genes, raising the question of what roles these genes play in RNAi and related gene-silencing pathways. Here we describe 31 deletion alleles representing all of the previously uncharacterized AGO genes. Analysis of single- and multiple-AGO mutant strains reveals functions in several pathways, including (1) chromosome segregation, (2) fertility, and (3) at least two separate steps in the RNAi pathway. We show that RDE-1 interacts with trigger-derived sense and antisense RNAs to initiate RNAi, while several other AGO proteins interact with amplified siRNAs to mediate downstream silencing. Overexpression of downstream AGOs enhances silencing, suggesting that these proteins are limiting for RNAi. Interestingly, these AGO proteins lack key residues required for mRNA cleavage. Our findings support a two-step model for RNAi, in which functionally and structurally distinct AGOs act sequentially to direct gene silencing.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Gulbenkian PHD Programme Biomed, P-2780156 Oeiras, Portugal; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; Japan Sci & Technol Agcy, CREST, Tokyo 1628666, Japan	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Cold Spring Harbor Laboratory; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Simard, MJ (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	martin.simard@crhdq.ulaval.ca; craig.mello@umassmed.edu	pang, ka ming/H-4082-2011; pang, Ka Ming Ming/AAW-4059-2021; Batista, Pedro J/K-5303-2012; Tolia, Niraj H/D-2332-2014	pang, ka ming/0000-0001-7262-3918; Tolia, Niraj H/0000-0002-2689-1337; Simard, Martin/0000-0002-3189-9309; Joshua-Tor, Leemor/0000-0001-8185-8049	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58800] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; BRENNER S, 1974, GENETICS, V77, P71; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Duchaine TF, 2006, CELL, V124, P343, DOI 10.1016/j.cel.2005.11.036; Evans TC., 2006, TRANSFORMATION MICRO, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1]; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SIMARD MJ, 2005, SCIENCE, V309, P1517; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; SPROAT BS, 1989, NUCLEIC ACIDS RES, V17, P3373, DOI 10.1093/nar/17.9.3373; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Yochem J, 1998, GENETICS, V149, P1323; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	48	444	488	2	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					747	757		10.1016/j.cell.2006.09.033	http://dx.doi.org/10.1016/j.cell.2006.09.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110334	Bronze			2022-12-01	WOS:000242330600021
J	Sommer, MA; Wurtz, RH				Sommer, Marc A.; Wurtz, Robert H.			Influence of the thalamus on spatial visual processing in frontal cortex	NATURE			English	Article							BRAIN-STEM TELLS; EYE FIELD; COROLLARY DISCHARGE; SUPERIOR COLLICULUS; SIGNALS SENT; REPRESENTATION; PATHWAY	Each of our movements activates our own sensory receptors, and therefore keeping track of self- movement is a necessary part of analysing sensory input. One way in which the brain keeps track of self- movement is by monitoring an internal copy, or corollary discharge, of motor commands(1 - 13). This concept could explain why we perceive a stable visual world despite our frequent quick, or saccadic, eye movements: corollary discharge about each saccade would permit the visual system to ignore saccade- induced visual changes(6 - 9). The critical missing link has been the connection between corollary discharge and visual processing. Here we show that such a link is formed by a corollary discharge from the thalamus that targets the frontal cortex. In the thalamus, neurons in the mediodorsal nucleus relay a corollary discharge of saccades from the midbrain superior colliculus to the cortical frontal eye field(10 - 12). In the frontal eye field, neurons use corollary discharge to shift their visual receptive fields spatially before saccades(14,15). We tested the hypothesis that these two components - a pathway for corollary discharge and neurons with shifting receptive fields - form a circuit in which the corollary discharge drives the shift. First we showed that the known spatial and temporal properties of the corollary discharge predict the dynamic changes in spatial visual processing of cortical neurons when saccades are made. Then we moved from this correlation to causation by isolating single cortical neurons and showing that their spatial visual processing is impaired when corollary discharge from the thalamus is interrupted. Thus the visual processing of frontal neurons is spatiotemporally matched with, and functionally dependent on, corollary discharge input from the thalamus. These experiments establish the first link between corollary discharge and visual processing, delineate a brain circuit that is well suited for mediating visual stability, and provide a framework for studying corollary discharge in other sensory systems.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sommer, MA (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	sommer@bns.pitt.edu		Sommer, Marc/0000-0001-5061-763X	Intramural NIH HHS Funding Source: Medline; NATIONAL EYE INSTITUTE [Z01EY000109, ZIAEY000109] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BELL CC, 1984, COMP PHYSL SENSORY S, P637; DELCOMYN F, 1977, NATURE, V269, P160, DOI 10.1038/269160a0; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HANES DP, 1995, VISUAL NEUROSCI, V12, P929, DOI 10.1017/S0952523800009482; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; Sparks D L, 1989, Rev Oculomot Res, V3, P213; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Teuber H.L., 1964, FRONTAL GRANULAR COR, P410; Thier P, 2001, NEUROIMAGE, V14, pS33, DOI 10.1006/nimg.2001.0840; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; VONHELMHOLTZ H, 2000, HELMHOLTZS TREATISE; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3	23	347	348	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					374	377		10.1038/nature05279	http://dx.doi.org/10.1038/nature05279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17093408	Green Published			2022-12-01	WOS:000242018300050
J	Cho, YH; Yoo, SD; Sheen, J				Cho, Young-Hee; Yoo, Sang-Dong; Sheen, Jen			Regulatory functions of nuclear hexokinase1 complex in glucose signaling	CELL			English	Article							CARBON CATABOLITE REPRESSION; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; PROTEIN; GLUCOKINASE; PROTEASOME; ATPASE; LOCALIZATION; COACTIVATOR; RECRUITMENT	Arabidopsis hexokinase1 (HXK1) is a glucose sensor that integrates nutrient and hormone signals to govern gene expression and plant growth in response to environmental cues. How the metabolic enzyme mediates glucose signaling remains a mystery. By coupling proteomic and binary-interaction screens, we discover two nuclear-specific HXK1 unconventional partners: the vacuolar H+-ATPase B1 (VHA-B1) and the 19S regulatory particle of proteasome subunit (RPT5B). Remarkably, vha-B1 and rpt5b mutants uniquely share a broad spectrum of glucose response defects with the HXK1 mutant gin2 (glucose-insensitive2). Genetic and chromatin immunoprecipitation analyses suggest that the nuclear HXK1 forms a glucose signaling complex core with VHA-B1 and RPT5B that directly modulates specific target gene transcription independent of glucose metabolism. The findings support a model in which conserved metabolic enzymes and proteins of well-established activities may perform previously unrecognized nuclear functions.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Genet,Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Genet,Dept Mol Biol, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu			NIGMS NIH HHS [R01 GM060493] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dettmer J, 2005, PLANT J, V41, P117, DOI 10.1111/j.1365-313X.2004.02282.x; ENTIAN KD, 1980, MOL GEN GENET, V178, P633, DOI 10.1007/BF00337871; Fu HY, 1999, PLANT J, V18, P529, DOI 10.1046/j.1365-313X.1999.00479.x; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Harrington GN, 2003, PLANT CELL, V15, P2493, DOI 10.1105/tpc.151130; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Johnson C, 2003, PLANT CELL, V15, P1846, DOI 10.1105/tpc.012211; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Maxwell BB, 2003, PLANT PHYSIOL, V133, P1565, DOI 10.1104/pp.103.025114; Mayordomo I, 2001, YEAST, V18, P1309, DOI 10.1002/yea.780; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; SHEEN J, 1993, EMBO J, V12, P3497, DOI 10.1002/j.1460-2075.1993.tb06024.x; SHEEN J, 1990, PLANT CELL, V2, P1027, DOI 10.1105/tpc.2.10.1027; Shimaoka T, 2004, PLANT CELL PHYSIOL, V45, P672, DOI 10.1093/pcp/pch099; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Strompen G, 2005, PLANT J, V41, P125, DOI 10.1111/j.1365-313X.2004.02283.x; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; WARD JM, 1992, PLANT PHYSIOL, V99, P161, DOI 10.1104/pp.99.1.161; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yang PZ, 2004, J BIOL CHEM, V279, P6401, DOI 10.1074/jbc.M311977200; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	49	319	341	6	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					579	589		10.1016/j.cell.2006.09.028	http://dx.doi.org/10.1016/j.cell.2006.09.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081979	Bronze			2022-12-01	WOS:000241937000021
J	Joukov, V; Groen, AC; Prokhorova, T; Gerson, R; White, E; Rodriguez, A; Walter, JC; Livingston, DM				Joukov, Vladimir; Groen, Aaron C.; Prokhorova, Tatyana; Gerson, Ruth; White, Erinn; Rodriguez, Alison; Walter, Johannes C.; Livingston, David M.			The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly	CELL			English	Article							BRCA1 TUMOR-SUPPRESSOR; CANCER SUSCEPTIBILITY; RING FINGER; CELL; BREAST; CENTROSOME; PROTEIN; GTPASE; PHOSPHORYLATION; UBIQUITINATION	The heterodimeric tumor-suppressor complex BRCA1/BARD1 exhibits E3 ubiquitin ligase activity and participates in cell proliferation and chromosome stability control by incompletely defined mechanisms. Here we show that, in both mammalian cells and Xenopus egg extracts, BRCA1/BARD1 is required for mitotic spindle-pole assembly and for accumulation of TPX2, a major spindle organizer and Ran target, on spindle poles. This function is centrosome independent, operates downstream of Ran GTPase, and depends upon BRCA1/BARD1 E3 ubiquitin ligase activity. Xenopus BRCA1/BARD1 forms endogenous complexes with three spindle-pole proteins, TPX2, NuMA, and XRHAMM-a known TPX2 partner-and specifically attenuates XRHAMM function. These observations reveal a previously unrecognized function of BRCA1/BARD1 in mitotic spindle assembly that likely contributes to its role in chromosome stability control and tumor suppression.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu; david_livingston@dfci.harvard.edu	Joukov, Vladimir/K-3525-2019	Prokhorova, Tatyana/0000-0001-8768-8298; Gerson, Ruth/0000-0002-7987-0206; Walter, Johannes/0000-0002-4186-7570	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62267] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; COMPTON DA, 1993, J CELL BIOL, V120, P947, DOI 10.1083/jcb.120.4.947; Crane R, 2004, BIOL CELL, V96, P215, DOI 10.1016/j.biolcel.2003.09.008; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Deng CX, 2003, HUM MOL GENET, V12, pR113, DOI 10.1093/hmg/ddg082; Desai A, 1999, METHOD CELL BIOL, V61, P385; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; Fant X, 2004, INT REV CYTOL, V238, P1, DOI 10.1016/S0074-7696(04)38001-0; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; McCarthy EE, 2003, MOL CELL BIOL, V23, P5056, DOI 10.1128/MCB.23.14.5056-5063.2003; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Merdes A, 1998, J CELL SCI, V111, P71; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; O'Brien LL, 2006, J CELL BIOL, V173, P685, DOI 10.1083/jcb.200512107; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Sato K, 2004, J BIOL CHEM, V279, P30919, DOI 10.1074/jbc.C400169200; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Smith LT, 2006, GENE CHROMOSOME CANC, V45, P957, DOI 10.1002/gcc.20354; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	46	219	223	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					539	552		10.1016/j.cell.2006.08.053	http://dx.doi.org/10.1016/j.cell.2006.08.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081976	Bronze			2022-12-01	WOS:000241937000018
J	Floto, RA; MacAry, PA; Boname, JM; Mien, TS; Kampmann, B; Hair, JR; Huey, OS; Houben, ENG; Pieters, J; Day, C; Oehlmann, W; Singh, M; Smith, KGC; Lehner, PJ				Floto, R. Andres; MacAry, Paul A.; Boname, Jessica M.; Mien, Tan Suet; Kampmann, Beate; Hair, James R.; Huey, Oh Seen; Houben, Edith N. G.; Pieters, Jean; Day, Cheryl; Oehlmann, Wulf; Singh, Mahavir; Smith, Kenneth G. C.; Lehner, Paul J.			Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5	SCIENCE			English	Article							T-CELLS; CHEMOKINES; CCR5-DELTA-32; TUBERCULOSIS; IMMUNITY	An effective host immune response to mycobacterial infection must control pathogen dissemination without inducing immunopathology. Constitutive overexpression of mycobacterial heat shock protein (myHsp70) is associated with impaired bacterial persistence, but the immune-mediated mechanisms are unknown. We found that myHsp70, in addition to enhancing antigen delivery to human dendritic cells, signaled through the CCR5 chemokine receptor, promoting dendritic cell aggregation, immune synapse formation between dendritic cells and T cells, and the generation of effector immune responses. Thus, CCR5 acts as a pattern-recognition receptor for myHsp70, which may have implications for both the pathophysiology of tuberculosis and the use of myHsps in tumor-directed immunotherapy.	Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 XY, England; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Program Immunol, Singapore 117597, Singapore; Nanyang Technol Univ, Sch Biol Sci, Div Cell & Mol Biol, Singapore, Singapore; Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, London SW7 2AZ, England; Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Nuffield Dept Med, Oxford OX1 3SY, England; Lionex Diagnost & Therapeut GmbH, D-38124 Braunschweig, Germany	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Imperial College London; University of Basel; University of Oxford; Lionex Diagnostics & Therapeutics GmbH	Lehner, PJ (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Hills Rd, Cambridge CB2 XY, England.	pjl30@cam.ac.uk	Tan, Suet/A-2224-2011; Day, Cheryl L/J-9844-2012; Day, Cheryl/GQQ-9720-2022; Houben, Edith N.G./B-2110-2015	Day, Cheryl L/0000-0002-6497-4846; Houben, Edith N.G./0000-0002-8805-2002; Pieters, Jean/0000-0002-5284-9757; Boname, Jessica/0000-0002-5149-5934; Smith, Kenneth/0000-0003-3829-4326; MacAry, Paul/0000-0002-1139-8996; Tan, Suet-Mien/0000-0003-2371-8739; Lehner, Paul Joseph/0000-0001-9383-1054	Medical Research Council [G108/485, G9800943, G0600823] Funding Source: Medline; Wellcome Trust [077273] Funding Source: Medline; MRC [G108/485, G9800943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; de Silva E, 2004, FEMS MICROBIOL LETT, V241, P1, DOI 10.1016/j.femsle.2004.09.040; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Wang YF, 2002, J IMMUNOL, V169, P2422, DOI 10.4049/jimmunol.169.5.2422	20	127	137	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					454	458		10.1126/science.1133515	http://dx.doi.org/10.1126/science.1133515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053144				2022-12-01	WOS:000241382500039
J	Cripe, LD				Cripe, Larry D.			Hope is the thing with feathers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lcripe@iupui.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2006	296	15					1815	1816		10.1001/jama.296.15.1815	http://dx.doi.org/10.1001/jama.296.15.1815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095ST	17047201				2022-12-01	WOS:000241329300001
J	Glenner, H; Thomsen, PF; Hebsgaard, MB; Sorensen, MV; Willerslev, E				Glenner, Henrik; Thomsen, Philip Francis; Hebsgaard, Martin Bay; Sorensen, Martin Vinther; Willerslev, Eske			The origin of insects	SCIENCE			English	Editorial Material							TERRESTRIAL CRUSTACEANS; ARTHROPOD PHYLOGENY; GENES; SEQUENCES; CLASSIFY; HEXAPODS; 28S		Univ Copenhagen, Inst Biol, Dept Evolutionary Biol, Ctr Ancient Genet, DK-2100 Copenhagen, Denmark	University of Copenhagen	Willerslev, E (corresponding author), Univ Copenhagen, Inst Biol, Dept Evolutionary Biol, Ctr Ancient Genet, Univ Pk 15, DK-2100 Copenhagen, Denmark.	ewillerslev@bi.ku.dk	Thomsen, Philip Francis/AAE-9354-2019; Hebsgaard, Martin B/C-8220-2009; Willerslev, Eske/A-9619-2011; Sørensen, Martin V/A-8852-2013; Willerslev, Eske/AAA-5686-2019	Thomsen, Philip Francis/0000-0002-9867-4366; Willerslev, Eske/0000-0002-7081-6748; Sørensen, Martin V/0000-0002-0377-0276; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; Budd G E, 2001, Science, V294, P2047; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Dove H, 2003, DEVELOPMENT, V130, P2161, DOI 10.1242/dev.00442; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Fayers SR, 2003, T ROY SOC EDIN-EARTH, V93, P355; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Haas F, 2003, ORG DIVERS EVOL, V3, P39, DOI 10.1078/1439-6092-00057; Harzsch S, 2006, INTEGR COMP BIOL, V46, P162, DOI 10.1093/icb/icj011; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Luan YX, 2005, MOL BIOL EVOL, V22, P1579, DOI 10.1093/molbev/msi148; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; Regier JC, 2001, MOL PHYLOGENET EVOL, V20, P136, DOI 10.1006/mpev.2001.0956; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; WALOSSEK D, 1993, FOSSILS STRATA, V52, P54; Willmann R, 2005, ORG DIVERS EVOL, V5, P199, DOI 10.1016/j.ode.2004.11.011	24	134	142	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1883	1884		10.1126/science.1129844	http://dx.doi.org/10.1126/science.1129844			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	119EY	17185588				2022-12-01	WOS:000242996800032
J	Munk-Olsen, T; Laursen, TM; Pedersen, CB; Mors, O; Mortensen, PB				Munk-Olsen, Trine; Laursen, Thomas Munk; Pedersen, Carsten Bocker; Mors, Ole; Mortensen, Preben Bo			New parents and mental disorders - A population-based register study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	International Biennial Scientific Meeting of the Marce-Society	SEP 13, 2006	Keele Univ, Keele, ENGLAND		Keele Univ		POSTPARTUM DEPRESSION; POSTNATAL DEPRESSION; RISK; MOTHERS; ADMISSION	Context Studies on postpartum mental disorders among mothers have primarily focused on either depression or psychoses and have generally not included the broader spectrum of mental disorders. A few studies have found that some men have symptoms of depression after becoming fathers, but these studies have not documented whether this exceeds the morbidity among men in general. Objectives To estimate the risk of postpartum mental disorders necessitating hospital admission or outpatient contact for mothers as well as fathers during a 1-year postnatal follow-up period after birth of first live-born child and to investigate whether parents in general differ from nonparents in the risk of admission with a mental disorder and how this difference varies with age. Design, Setting, and Patients Register-based cohort formed by linking information from Danish health and civil service registers. A total of 2 357 942 Danish-born persons were followed up from their 15th birthday or January 1, 1973, whichever came later, until date of onset of the disorder in question, date of death, date of emigration from Denmark, or July 1, 2005, whichever came first. From 1973 to 2005, a total of 630 373 women and 547 431 men became parents for the first time, and during the first year after childbirth, these parents contributed 1 115 639 person-years at risk. Main Outcome Measure First-time psychiatric hospital admission or outpatient contact 0 to 12 months after becoming a parent. Results A total of 1171 mothers and 658 fathers were admitted with a mental disorder to a psychiatric hospital during the first 12 months after parenthood, and the corresponding prevalence of severe mental disorders through the first 3 months after childbirth was 1.03 per 1000 births for mothers and 0.37 per 1000 births for fathers. Compared with women who had given birth 11 to 12 months prior, primiparous women had an increased risk of incident hospital admission with any mental disorder through the first 3 months after childbirth, with the highest risk 10 to 19 days postpartum (relative risk [RR], 7.31; 95% confidence interval [CI], 5.44-9.81). Among mothers, risk was also increased for psychiatric outpatient contacts through the first 3 months after childbirth, also with the highest risk occurring 10 to 19 days postpartum (RR, 2.67; 95% CI, 1.99-3.59). Unlike motherhood, fatherhood was not associated with any increased risk of hospital admission or outpatient contact. Conclusion In Denmark, the risk of postpartum mental disorders among primiparous mothers is increased for several months after childbirth, but among fathers there is no excess of severe mental disorders necessitating admission or outpatient contacts.	Aarhus Univ, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, Psychiat Hosp Aarhus, Ctr Basic Psychiat Res, Risskov, Denmark	Aarhus University; Aarhus University	Munk-Olsen, T (corresponding author), Aarhus Univ, Natl Ctr Register Based Res, Taasingegade 1, DK-8000 Aarhus C, Denmark.	tmo@ncrr.dk	Laursen, Thomas Munk/AFQ-8066-2022; Pedersen, Carsten Bøcker/B-8441-2013; Munk-olsen, Trine/AAS-3546-2021; Mortensen, Preben B/D-2358-2015	Pedersen, Carsten Bøcker/0000-0003-2077-8533; Munk-olsen, Trine/0000-0002-0786-7147; Mortensen, Preben B/0000-0002-5230-9865; Laursen, Thomas Munk/0000-0001-6934-1784; Mors, Ole/0000-0002-5660-0393				American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Andersen PK, 2012, STAT MODELS BASED CO; Areias MEG, 1996, BRIT J PSYCHIAT, V169, P36, DOI 10.1192/bjp.169.1.36; Ballard C, 1996, INT REV PSYCHIATR, V8, P65, DOI 10.3109/09540269609037818; Blackmore ER, 2006, BRIT J PSYCHIAT, V188, P32, DOI 10.1192/bjp.188.1.32; Bloch M, 2000, AM J PSYCHIAT, V157, P924, DOI 10.1176/appi.ajp.157.6.924; Brockington I, 2004, LANCET, V363, P303, DOI 10.1016/S0140-6736(03)15390-1; Brockington IF., 1999, INFANT OBSERV, V2, P116, DOI [10.1080/13698039908400552, DOI 10.1080/13698039908400552]; Clayton D, 2002, STAT MODELS EPIDEMIO; Deater-Deckard K, 1998, AM J PSYCHIAT, V155, P818; Forman DN, 2000, BRIT J OBSTET GYNAEC, V107, P1210; Gale S, 2003, J PSYCHOSOM OBST GYN, V24, P257, DOI 10.3109/01674820309074690; Goodman JH, 2004, J ADV NURS, V45, P26, DOI 10.1046/j.1365-2648.2003.02857.x; Halbreich U, 2005, J AFFECT DISORDERS, V88, P1, DOI 10.1016/j.jad.2005.05.002; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Lane A, 1997, BRIT J PSYCHIAT, V171, P550, DOI 10.1192/bjp.171.6.550; Matthey S, 2003, J AFFECT DISORDERS, V74, P139, DOI 10.1016/S0165-0327(02)00012-5; Miller LJ, 2002, JAMA-J AM MED ASSOC, V287, P762, DOI 10.1001/jama.287.6.762; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; PEDERSEN CB, IN PRESS DANISH MED; Pfuhlmann Bruno, 2002, Curr Psychiatry Rep, V4, P185, DOI 10.1007/s11920-002-0025-6; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Robertson E, 2005, BRIT J PSYCHIAT, V186, P258, DOI 10.1192/bjp.186.3.258; Terp IM, 1998, BRIT J PSYCHIAT, V172, P521, DOI 10.1192/bjp.172.6.521; VIDEBECH P, 1995, ACTA PSYCHIAT SCAND, V91, P167, DOI 10.1111/j.1600-0447.1995.tb09761.x; World Health Organization, 1994, WHO ICD 10 PSYK LID; World Health Organization, 1971, KLASS SYGD UDV DANSK, V8; [No title captured]	30	445	451	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2006	296	21					2582	2589		10.1001/jama.296.21.2582	http://dx.doi.org/10.1001/jama.296.21.2582			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	112ND	17148723	Bronze			2022-12-01	WOS:000242532000020
J	Qiu, AD; Jansen, M; Sakaris, A; Min, SH; Chattopadhyay, S; Tsai, E; Sandoval, C; Zhao, RB; Akabas, MH; Goldman, ID				Qiu, Andong; Jansen, Michaela; Sakaris, Antoinette; Min, Sang Hee; Chattopadhyay, Shrikanta; Tsai, Eugenia; Sandoval, Claudio; Zhao, Rongbao; Akabas, Myles H.; Goldman, I. David			Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption	CELL			English	Article							LOW-PH OPTIMUM; MEMBRANE-TRANSPORT; SOLID TUMORS; HELA-CELLS; IN-VIVO; PRESERVATION; MECHANISM; AFFINITY; HEALTH; ACID	Folates are essential nutrients that are required for one-carbon biosynthetic and epigenetic processes. While folates are absorbed in the acidic milieu of the upper small intestine, the underlying absorption mechanism has not been defined. We now report the identification of a human proton-coupled, high-affinity folate transporter that recapitulates properties of folate transport and absorption in intestine and in various cell types at low pH. We demonstrate that a loss-of-function mutation in this gene is the molecular basis for hereditary folate malabsorption in a family with this disease. This transporter was previously reported to be a lower-affinity, pH-independent heme carrier protein, HCP1. However, the current study establishes that a major function of this gene product is proton-coupled folate transport required for folate homeostasis in man, and we have thus amended the name to PCFT/HCP1.	Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10461 USA; New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York Medical College	Goldman, ID (corresponding author), Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	igoldman@aecom.yu.edu	Qiu, Andong/AAY-1179-2021; kevin, zhang/ABB-3755-2021	Tsai, Eugenia/0000-0002-4619-6067; Akabas, Myles/0000-0001-8781-7846; Jansen, Michaela/0000-0003-1325-9700	NCI NIH HHS [CA82621] Funding Source: Medline; NIGMS NIH HHS [GM77660] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077660] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BENZ R, 1983, BIOPHYS J, V41, P381, DOI 10.1016/S0006-3495(83)84449-X; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6; Geller J, 2002, MEDICINE, V81, P51, DOI 10.1097/00005792-200201000-00004; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; HORNE DW, 1993, P SOC EXP BIOL MED, V202, P385, DOI 10.3181/00379727-202-43550A; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Koepsell H, 2004, PFLUG ARCH EUR J PHY, V447, P666, DOI 10.1007/s00424-003-1089-9; MASON JB, 1990, BIOCHIM BIOPHYS ACTA, V1024, P331, DOI 10.1016/0005-2736(90)90362-R; Mason Joel B., 1994, P1979; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; MCEWAN GTA, 1990, J MED ENG TECHNOL, V14, P16, DOI 10.3109/03091909009028758; MURPHY RF, 1984, J CELL BIOL, V98, P1757, DOI 10.1083/jcb.98.5.1757; Opladen T, 2006, MOL GENET METAB, V87, P61, DOI 10.1016/j.ymgme.2005.08.011; Paulos CM, 2004, MOL PHARMACOL, V66, P1406, DOI 10.1124/mol.104.003723; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Said HM, 2004, ANNU REV PHYSIOL, V66, P419, DOI 10.1146/annurev.physiol.66.032102.144611; SELHUB J, 1981, J BIOL CHEM, V256, P4489; Sharif KA, 2000, BIOTECHNIQUES, V28, P926, DOI 10.2144/00285st06; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Wang YH, 2005, AM J PHYSIOL-CELL PH, V288, pC65, DOI 10.1152/ajpcell.00307.2004; Wang YH, 2004, CLIN CANCER RES, V10, P6256, DOI 10.1158/1078-0432.CCR-04-0645; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Zhao RB, 2005, BBA-BIOMEMBRANES, V1715, P57, DOI 10.1016/j.bbamem.2005.07.003; Zhao RB, 2004, CLIN CANCER RES, V10, P8735, DOI 10.1158/1078-0432.CCR-04-0932; Zhao RB, 2004, CLIN CANCER RES, V10, P718, DOI 10.1158/1078-0432.CCR-1066-03	30	605	625	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					917	928		10.1016/j.cell.2006.09.041	http://dx.doi.org/10.1016/j.cell.2006.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129779	Bronze			2022-12-01	WOS:000242613800010
J	Zhou, GY; Liu, SG; Li, Z; Zhang, DQ; Tang, XL; Zhou, CY; Yan, JH; Mo, JM				Zhou, Guoyi; Liu, Shuguang; Li, Zhian; Zhang, Deqiang; Tang, Xuli; Zhou, Chuanyan; Yan, Junhua; Mo, Jiangming			Old-growth forests can accumulate carbon in soils	SCIENCE			English	Article							ORGANIC-CARBON; CLIMATE-CHANGE		Chinese Acad Sci, S China Bot Garden, Guangzhou 510650, Peoples R China; US Geol Survey, SAIC, Ctr Earth Resources Observat & Sci, Sioux Falls, SD 57198 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Science Applications International Corporation (SAIC); United States Department of the Interior; United States Geological Survey	Zhou, GY (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou 510650, Peoples R China.	gyzhou@scib.ac.cn	Mo, Jiangming/M-2104-2014					Conen F, 2003, GLOBAL CHANGE BIOL, V9, P1515, DOI 10.1046/j.1365-2486.2003.00689.x; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; Johnston CA, 2004, FRONT ECOL ENVIRON, V2, P522, DOI 10.2307/3868382; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Post WM, 2001, CLIMATIC CHANGE, V51, P73, DOI 10.1023/A:1017514802028; Shen CD, 1999, CHINESE SCI BULL, V44, P251, DOI 10.1007/BF02896286	7	336	466	31	417	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2006	314	5804					1417	1417		10.1126/science.1130168	http://dx.doi.org/10.1126/science.1130168			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138894				2022-12-01	WOS:000242406100030
J	Schaffitzel, C; Oswald, M; Berger, I; Ishikawa, T; Abrahams, JP; Koerten, HK; Koning, RI; Ban, N				Schaffitzel, Christiane; Oswald, Miro; Berger, Imre; Ishikawa, Takashi; Abrahams, Jan Pieter; Koerten, Henk K.; Koning, Roman I.; Ban, Nenad			Structure of the E-coli signal recognition particle bound to a translating ribosome	NATURE			English	Article							TRIGGER FACTOR; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; DENSITY MAPS; RESOLUTION; PROTEINS; BINDING; SRP; RNA; MEMBRANE	The prokaryotic signal recognition particle (SRP) targets membrane proteins into the inner membrane(1-4). It binds translating ribosomes and screens the emerging nascent chain for a hydrophobic signal sequence, such as the transmembrane helix of inner membrane proteins. If such a sequence emerges, the SRP binds tightly, allowing the SRP receptor to lock on. This assembly delivers the ribosome-nascent chain complex to the protein translocation machinery in the membrane. Using cryo-electron microscopy and single-particle reconstruction, we obtained a 16 angstrom structure of the Escherichia coli SRP in complex with a translating E. coli ribosome containing a nascent chain with a transmembrane helix anchor. We also obtained structural information on the SRP bound to an empty E. coli ribosome. The latter might share characteristics with a scanning SRP complex, whereas the former represents the next step: the targeting complex ready for receptor binding. High-resolution structures of the bacterial ribosome and of the bacterial SRP components are available, and their fitting explains our electron microscopic density. The structures reveal the regions that are involved in complex formation, provide insight into the conformation of the SRP on the ribosome and indicate the conformational changes that accompany high-affinity SRP binding to ribosome nascent chain complexes upon recognition of the signal sequence.	ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Leiden Univ, Gorlaeus Labs, Leiden Inst Chem, Dept Biophys Struct Chem, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Ctr Electron Microscopy, NL-2300 RC Leiden, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, HPK Bldg,Schafmattstr 20, CH-8093 Zurich, Switzerland.	ban@mol.biol.ethz.ch	Abrahams, Jan Pieter/AAE-4319-2020; Ishikawa, Takashi/E-5023-2017; Abrahams, Jan Pieter/G-7287-2016	Abrahams, Jan Pieter/0000-0001-8216-1868; Ishikawa, Takashi/0000-0002-1976-7477; Abrahams, Jan Pieter/0000-0001-8216-1868; Berger, Imre/0000-0001-7518-9045; Koning, Roman/0000-0001-6736-7147; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760				Bacher G, 1996, NATURE, V381, P248, DOI 10.1038/381248a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Eisner G, 2006, J BIOL CHEM, V281, P7172, DOI 10.1074/jbc.M511388200; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gu SQ, 2003, RNA, V9, P566, DOI 10.1261/rna.2196403; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Padmanabhan S, 2001, STRUCTURE, V9, P859, DOI 10.1016/S0969-2126(01)00641-4; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Raine A, 2004, BIOCHIMIE, V86, P495, DOI 10.1016/j.biochi.2004.05.004; Rinke-Appel J, 2002, RNA, V8, P612, DOI 10.1017/S1355838202020095; Rosenblad MA, 2003, NUCLEIC ACIDS RES, V31, P363, DOI 10.1093/nar/gkg107; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Ullers RS, 2003, J CELL BIOL, V161, P679, DOI 10.1083/jcb.200302130; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	30	108	109	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2006	444	7118					503	506		10.1038/nature05182	http://dx.doi.org/10.1038/nature05182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17086205				2022-12-01	WOS:000242215700050
J	Inaba, K; Murakami, S; Suzuki, M; Nakagawa, A; Yamashita, E; Okada, K; Ito, K				Inaba, Kenji; Murakami, Satoshi; Suzuki, Mamoru; Nakagawa, Atsushi; Yamashita, Eiki; Okada, Kengo; Ito, Koreaki			Crystal structure of the DsbB-DsbA complex reveals a mechanism of disulfide bond generation	CELL			English	Article							MEMBRANE-PROTEIN DSBB; ESCHERICHIA-COLI; RESPIRATORY-CHAIN; FORMATION PATHWAY; REDOX PROPERTIES; BINDING DOMAIN; ISOMERASE DSBC; IDENTIFICATION; CYSTEINES; UBIQUINONE	Oxidation of cysteine pairs to disulfide requires cellular factors present in the bacterial periplasmic space. DsbB is an E coli membrane protein that oxidizes DsbA, a periplasmic dithiol oxidase. To gain insight into disulfide bond formation, we determined the crystal structure of the DsbB-DsbA complex at 3.7 angstrom resolution. The structure of DsbB revealed four transmembrane helices and one short horizontal helix juxtaposed with Cys130 in the mobile periplasmic loop. Whereas DsbB in the resting state contains a Cys104-Cys130 disulfide, Cys104 in the binary complex is engaged in the intermolecular disulfide bond and captured by the hydrophobic groove of DsbA, resulting in separation from Cys130. This cysteine relocation prevents the backward resolution of the complex and allows Cys130 to approach and activate the disulfide-generating reaction center composed of Cys41, Cys44, Arg48, and ubiquinone. We propose that DsbB is converted by its specific substrate, DsbA, to a superoxidizing enzyme, capable of oxidizing this extremely oxidizing oxidase.	Japan Sci & Technol Agcy, CREST, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Nara Inst Sci & Technol, Nara 6300192, Japan; Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan	Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Osaka University; Osaka University; Nara Institute of Science & Technology; Kyoto University	Inaba, K (corresponding author), Kyushu Univ, Div Prot Chem, Post Genome Sci Ctr, Med Inst Bioregulat, Fukuoka 8128582, Japan.	kinaba@virus.kyoto-u.ac.jp; kito@virus.kyoto-u.ac.jp	Nakagawa, Atsushi/D-4329-2009; Suzuki, Mamoru/G-6576-2016; Nakagawa, Atsushi/M-5731-2019; Murakami, Satoshi/E-8155-2015; Yamashita, Eiki/V-6758-2019	Nakagawa, Atsushi/0000-0002-1700-7861; Suzuki, Mamoru/0000-0001-7071-5093; Nakagawa, Atsushi/0000-0002-1700-7861; Murakami, Satoshi/0000-0001-5553-7663; Yamashita, Eiki/0000-0002-4278-0039; Inaba, Kenji/0000-0001-8229-0467				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadokura H, 2000, P NATL ACAD SCI USA, V97, P10884, DOI 10.1073/pnas.97.20.10884; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Kishigami S, 1996, GENES CELLS, V1, P201, DOI 10.1046/j.1365-2443.1996.d01-233.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; Ostermeier C, 1997, CURR OPIN STRUC BIOL, V7, P697, DOI 10.1016/S0959-440X(97)80080-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Sevier CS, 2005, PROTEIN SCI, V14, P1630, DOI 10.1110/ps.051355705; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Takahashi YH, 2004, J BIOL CHEM, V279, P47057, DOI 10.1074/jbc.M407153200; Takahashi YH, 2006, ANTIOXID REDOX SIGN, V8, P743, DOI 10.1089/ars.2006.8.743; Tan J, 2005, J BACTERIOL, V187, P1504, DOI 10.1128/JB.187.4.1504-1510.2005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Xie T, 2002, J BIOL CHEM, V277, P1649, DOI 10.1074/jbc.M108697200; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	50	193	199	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					789	801		10.1016/j.cell.2006.10.034	http://dx.doi.org/10.1016/j.cell.2006.10.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110337	Bronze			2022-12-01	WOS:000242330600024
J	Makadon, HJ; Mayer, KH; Garofalo, R				Makadon, Harvey J.; Mayer, Kenneth H.; Garofalo, Robert			Optimizing primary care for men who have sex with men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; PREVENTION; BEHAVIOR; RATES		Harvard Univ, Sch Med, Harvard Med Int, Boston, MA 02120 USA; Fenway Community Hlth, Fenway Inst, Boston, MA USA; Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA 02215 USA; Brown Univ, Providence, RI 02912 USA; Miriam Hosp, Providence, RI 02906 USA; Northwestern Univ, Childrens Mem Hosp, Chicago, IL 60614 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University	Makadon, HJ (corresponding author), Harvard Univ, Sch Med, Harvard Med Int, 1135 Tremmont St,Suite 900, Boston, MA 02120 USA.	hmaka-don@hms.harvard.edu		Garofalo, Robert/0000-0001-9513-9416				Centers for Disease Control and Prevention, 2004, HIV AIDS SURVEILLANC, V16; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V42, P988; COONEY TG, 1986, MED CLIN N AM, V70, P497, DOI 10.1016/S0025-7125(16)30936-1; Dean L., 2000, J GAY LESBIAN MED AS, V4, P102, DOI DOI 10.1023/A:1009573800168; Elford J, 2003, AIDS EDUC PREV, V15, P294, DOI 10.1521/aeap.15.5.294.23825; ELLINGSON S, 2004, SEXUAL ORG CITY, P93; Fenton KA, 2005, INFECT DIS CLIN N AM, V19, P311, DOI 10.1016/j.idc.2005.04.004; Halkitis PN, 2001, J HOMOSEXUAL, V41, P17, DOI 10.1300/J082v41n02_02; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Khan S, 2001, J HOMOSEXUAL, V40, P99, DOI 10.1300/J082v40n03_06; Laumann E.O., 2000, SOCIAL ORG SEXUALITY; Makadon HJ, 2006, NEW ENGL J MED, V354, P895, DOI 10.1056/NEJMp058259; McClennen JC, 2005, J INTERPERS VIOLENCE, V20, P149, DOI 10.1177/0886260504268762; Miller V, 2001, J ACQ IMMUN DEF SYND, V26, pS34, DOI 10.1097/00126334-200103011-00005; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; MIMIAGA M, 2006, SEX TRANSM DIS; PALEFSKY J, 2006, UPTODATE; Ryan, 1997, Adolesc Med, V8, P207; Sanchez T., 2006, MMWR MORB MORTAL WKL, V55, P752; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Sell RL, 1997, ARCH SEX BEHAV, V26, P643, DOI 10.1023/A:1024528427013; Simmons T., 2003, MARRIED COUPLE UNMAR; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1	23	27	28	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2362	2365		10.1001/jama.296.19.2362	http://dx.doi.org/10.1001/jama.296.19.2362			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	104ZI	17105799				2022-12-01	WOS:000241998700024
J	Walter, LC; Bertenthal, D; Lindquist, K; Konety, BR				Walter, Louise C.; Bertenthal, Daniel; Lindquist, Karla; Konety, Badrinath R.			PSA screening among elderly men with limited life expectancies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOCALIZED PROSTATE-CANCER; UNITED-STATES; COMORBIDITY; GUIDELINES; VIEWPOINT; ACCURACY	Context Most guidelines do not recommend prostate-specific antigen (PSA) screening in elderly men who have limited life expectancies because the known harms of screening outweigh potential benefits. However, there are no large-scale studies of actual PSA screening practices in elderly men, according to life expectancy. Objective To characterize the extent of PSA screening among elderly men, including those with limited life expectancies. Design, Setting, and Participants Cohort study of 597 642 male veterans aged 70 years and older who were seen at 104 US Department of Veterans Affairs facilities during both 2002 and 2003, without a history of prostate cancer, elevated PSA, or prostate cancer symptoms. Charlson comorbidity scores were used to stratify men into 3 groups ranging from best health ( score= 0) to worst health ( score >= 4). Main Outcome Measure Receipt of PSA testing during 2003 was based on US Department of Veterans Affairs data and Medicare claims. Results In 2003, 56% of elderly men had a PSA test performed. Although PSA screening rates decreased with advancing age, within each 5-year age group the percentage of men who underwent a PSA test did not substantially decline with worsening health. For example, among men aged 85 years and older, 34% in best health had a PSA test compared with 36% in worst health. In multivariate analyses, many nonclinical factors, such as marital status and region of the country, had a greater effect on PSA screening than health, and screening rates exceeded 60% for some subgroups of men in worst health. Conclusions Prostate-specific antigen screening rates among elderly veterans with limited life expectancies should be much lower than current practice given the known harms of screening. More attention to prognosis is needed when making screening PSA recommendations to elderly men.	San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA USA; Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, Res Enhancement Award Program Improve Care Older, San Francisco, CA USA; Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Walter, LC (corresponding author), VA Med Ctr, 181G,4150 Clement St, San Francisco, CA 94121 USA.	louise.walter@ucsf.edu		Lindquist, Karla/0000-0002-1971-2273				*AM UR ASS, 2000, ONCOLOGY, V14, P277; [Anonymous], 1976, METHODS MAT DEMOGRAP; Barry MJ, 1998, ANN ONCOL, V9, P1279, DOI 10.1093/oxfordjournals.annonc.a010952; CARTER HB, 1990, J UROLOGY, V143, P742, DOI 10.1016/S0022-5347(17)40078-4; Catalona WJ, 2006, ANN INTERN MED, V144, P441, DOI 10.7326/0003-4819-144-6-200603210-00012; *CDCP, 2003, US LIF TABL, V54; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; Demakis JG, 2000, MED CARE, V38, pS17; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; *DSS PROGR OFF, 2003, DAT VER REP DSS DAT; *EJ HIN JR VA HOSP, 2004, VIREC RES US GUID VH; Fowler JE, 1996, J UROLOGY, V156, P1714, DOI 10.1016/S0022-5347(01)65489-2; Freeman JL, 2002, MED CARE, V40, P36; Gilligan T, 2004, ARCH INTERN MED, V164, P1858, DOI 10.1001/archinte.164.17.1858; Harris R, 2002, ANN INTERN MED, V137, P917, DOI 10.7326/0003-4819-137-11-200212030-00014; Hoffman RM, 2006, ANN INTERN MED, V144, P438, DOI 10.7326/0003-4819-144-6-200603210-00011; Jacobsen SJ, 1996, ARCH INTERN MED, V156, P2462, DOI 10.1001/archinte.156.21.2462; Jerant AF, 2004, ANN FAM MED, V2, P481, DOI 10.1370/afm.118; Krahn MD, 2002, UROLOGY, V60, P258, DOI 10.1016/S0090-4295(02)01712-0; Lu-Yao G, 2003, J NATL CANCER I, V95, P1792, DOI 10.1093/jnci/djg104; McNaughton-Collins M, 2004, AM J MED, V117, P719, DOI 10.1016/j.amjmed.2004.06.036; *NAT VA CTR HLTH P, 2004, PROP NEW CLIN PRACT; Ross LE, 2004, PREV MED, V38, P732, DOI 10.1016/j.ypmed.2004.01.005; *SEER MED PROGR, SAS MACR CHARLS COM; Shen YJ, 2003, MED CARE RES REV, V60, P253, DOI 10.1177/1077558703060002007; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; SMITH MW, 2005, FEE BASIS DATA GUIDE; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Stamey TA, 2004, J UROLOGY, V172, P1297, DOI 10.1097/01.ju.0000139993.51181.5d; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; *US BUR CENS, 2002, CENS 2000 SUMM FIL 3; US Census Bureau, CENS REG DIV US; *US DEP VET AFF, VA INF RES CTR DAT S; *VA INF RES CTR, RS FIND VA MED DAT M; *VA OFF QUAL PERF, 2003, FY 2003 VHA PERF MEA; Veterans Affairs Information Resource Center, 2005, VIREC RES US GUID FY; Volk RJ, 2002, AM J PREV MED, V22, P56, DOI 10.1016/S0749-3797(01)00397-X; Volk Robert J, 2003, Ann Fam Med, V1, P22, DOI 10.1370/afm.7; Voss JD, 2001, J GEN INTERN MED, V16, P831, DOI 10.1046/j.1525-1497.2001.10133.x; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Wolf AMD, 1996, ARCH INTERN MED, V156, P1333, DOI 10.1001/archinte.156.12.1333; Woloshin S, 1999, NEW ENGL J MED, V340, P884, DOI 10.1056/NEJM199903183401112	47	202	204	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2006	296	19					2336	2342		10.1001/jama.296.19.2336	http://dx.doi.org/10.1001/jama.296.19.2336			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	104ZI	17105796	Bronze			2022-12-01	WOS:000241998700021
J	Bursi, F; Weston, SA; Redfield, MM; Jacobsen, SJ; Pakhomov, S; Nkomo, VT; Meverden, RA; Roger, VL				Bursi, Francesca; Weston, Susan A.; Redfield, Margaret M.; Jacobsen, Steven J.; Pakhomov, Serguei; Nkomo, Vuyisile T.; Meverden, Ryan A.; Roger, Veronique L.			Systolic and diastolic heart failure in the community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRESERVED EJECTION FRACTION; VENTRICULAR FILLING PRESSURES; NATRIURETIC PEPTIDE; DOPPLER-ECHOCARDIOGRAPHY; EMERGENCY DIAGNOSIS; PRACTICE GUIDELINES; CLINICAL-FEATURES; OF-CARDIOLOGY; DISEASE; DYSFUNCTION	Context The heart failure (HF) syndrome is heterogeneous. While it can be defined by ejection fraction (EF) and diastolic function, data on the characteristics of HF in the community are scarce, as most studies are retrospective, hospital-based, and rely on clinically indicated tests. Further, diastolic function is seldom systematically assessed based on standardized techniques. Objective To prospectively measure EF, diastolic function, and brain natriuretic peptide (BNP) in community residents with HF. Main Outcome Measures Echocardiographic measures of EF and diastolic function, measurement of blood levels of BNP, and 6-month mortality. Design, Setting, and Participants Olmsted County residents with incident or prevalent HF (inpatients or outpatients) between September 10, 2003, and October 27, 2005, were prospectively recruited to undergo assessment of EF and diastolic function by echocardiography and measurement of BNP. Results A total of 556 study participants underwent echocardiography at HF diagnosis. Preserved EF (>= 50%) was present in 308 (55%) and was associated with older age, female sex, and no history of myocardial infarction (all P < .001). Isolated diastolic dysfunction (diastolic dysfunction with preserved EF) was present in 242 (44%) patients. For patients with reduced EF, moderate or severe diastolic dysfunction was more common than when EF was preserved (odds ratio, 1.67; 95% confidence interval [CI], 1.11-2.51; P = .01). Both low EF and diastolic dysfunction were independently related to higher levels of BNP. At 6 months, mortality was 16% for both preserved and reduced EF (age- and sex-adjusted hazard ratio, 0.85; 95% CI, 0.61-1.19; P = .33 for preserved vs reduced EF). Conclusions In the community, more than half of patients with HF have preserved EF, and isolated diastolic dysfunction is present in more than 40% of cases. Ejection fraction and diastolic dysfunction are independently related to higher levels of BNP. Heart failure with preserved EF is associated with a high mortality rate, comparable to that of patients with reduced EF.	Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Div Biomed Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Roger, VL (corresponding author), Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	roger.veronique@mayo.edu	Roger, Veronique/AAV-5951-2020; Bursi, Francesca/ABB-8483-2020	Bursi, Francesca/0000-0001-6632-3871; Jacobsen, Steven/0000-0002-8174-8533	NHLBI NIH HHS [R01 HL72435] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMICO AF, 1989, AM HEART J, V118, P1259, DOI 10.1016/0002-8703(89)90018-5; [Anonymous], 1997, Diabetes Care, V20 Suppl 1, pS1; Berry C, 2005, HEART, V91, P907, DOI 10.1136/hrt.2004.041996; Bess RL, 2006, ECHOCARDIOGR-J CARD, V23, P332, DOI 10.1111/j.1540-8175.2006.00215.x; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; Bruch C, 2005, AM J CARDIOL, V95, P892, DOI 10.1016/j.amjcard.2004.12.017; Burkhoff D, 2003, CIRCULATION, V107, P656, DOI 10.1161/01.CIR.0000053947.82595.03; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Gonzalez-Vilchez F, 2002, J AM SOC ECHOCARDIOG, V15, P1245, DOI 10.1067/mje.2002.125752; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hunt SA, 2005, J AM COLL CARDIOL, V46, P1116, DOI [DOI 10.1016/j.jacc.2005.08.023, DOI 10.1016/J.JACC.2005.08.023]; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Kass DA, 2005, J CARD FAIL, V11, P188, DOI 10.1016/j.cardfail.2005.01.005; Khan S, 2004, AM J CARDIOL, V94, P1099, DOI 10.1016/j.amjcard.2004.06.080; Kirk V, 2004, EUR J HEART FAIL, V6, P335, DOI 10.1016/j.ejheart.2004.01.002; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4; Maurer MS, 2005, J CARD FAIL, V11, P177, DOI 10.1016/j.cardfail.2004.10.006; McMurray JJV, 2004, J AM COLL CARDIOL, V44, P2398, DOI 10.1016/j.jacc.2004.09.070; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Ommen SR, 2000, CIRCULATION, V102, P1788; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Pakhomov SV, 2005, J BIOMED INFORM, V38, P145, DOI 10.1016/j.jbi.2004.11.016; Philbin EF, 2000, AM J MED, V109, P605, DOI 10.1016/S0002-9343(00)00601-X; Pritchett AM, 2005, J AM COLL CARDIOL, V45, P87, DOI 10.1016/j.jacc.2004.09.054; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Thomas MD, 2004, EUR J HEART FAIL, V6, P125, DOI 10.1016/j.ejheart.2003.11.002; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Yturralde FR, 2005, PROG CARDIOVASC DIS, V47, P314, DOI 10.1016/j.pcad.2005.02.007; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566; Zile MR, 2002, CIRCULATION, V105, P1503, DOI 10.1161/hc1202.105290	42	625	662	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2209	2216		10.1001/jama.296.18.2209	http://dx.doi.org/10.1001/jama.296.18.2209			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090767	Bronze			2022-12-01	WOS:000241827700021
J	Horton, R				Horton, Richard			Reviving reproductive health	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.								0	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1549	1549		10.1016/S0140-6736(06)69484-1	http://dx.doi.org/10.1016/S0140-6736(06)69484-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084738				2022-12-01	WOS:000242180900004
J	Yano, J; Kern, J; Sauer, K; Latimer, MJ; Pushkar, Y; Biesiadka, J; Loll, B; Saenger, W; Messinger, J; Zouni, A; Yachandra, VK				Yano, Junko; Kern, Jan; Sauer, Kenneth; Latimer, Matthew J.; Pushkar, Yulia; Biesiadka, Jacek; Loll, Bernhard; Saenger, Wolfram; Messinger, Johannes; Zouni, Athina; Yachandra, Vittal K.			Where water is oxidized to dioxygen: Structure of the photosynthetic Mn4Ca cluster	SCIENCE			English	Article							OXYGEN-EVOLVING COMPLEX; PHOTOSYSTEM-II; MN-CLUSTER; CRYSTAL-STRUCTURE; S-0 STATE; UNDERGOES OXIDATION; ANGSTROM RESOLUTION; SINGLE-CRYSTALS; D1 POLYPEPTIDE; MANGANESE ION	The oxidation of water to dioxygen is catalyzed within photosystem II ( PSII) by a Mn4Ca cluster, the structure of which remains elusive. Polarized extended x-ray absorption fine structure (EXAFS) measurements on PSII single crystals constrain the Mn4Ca cluster geometry to a set of three similar high-resolution structures. Combining polarized EXAFS and x-ray diffraction data, the cluster was placed within PSII, taking into account the overall trend of the electron density of the metal site and the putative ligands. The structure of the cluster from the present study is unlike either the 3.0 or 3.5 angstrom - resolution x-ray structures or other previously proposed models.	Max Planck Inst Bioorgan Chem, D-45470 Mulheim, Germany; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Melvin Calvin Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Tech Univ Berlin, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany; Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany	Max Planck Society; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Technical University of Berlin; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Free University of Berlin	Messinger, J (corresponding author), Max Planck Inst Bioorgan Chem, Stiftstr 34-36, D-45470 Mulheim, Germany.	messinger@mpi-muelheim.mpg.de; zouni@phosis1.chem.tu-berlin.de; vkyachandra@lbl.gov	Messinger, Johannes/AAC-4221-2019; Loll, Bernhard/J-4815-2019; Kern, Jan/G-2586-2013	Messinger, Johannes/0000-0003-2790-7721; Loll, Bernhard/0000-0001-7928-4488; Kern, Jan/0000-0002-7272-1603	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM055302, R01GM055302] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM055302, R56 GM055302, GM 55302] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahrling KA, 1998, BIOCHEMISTRY-US, V37, P8115, DOI 10.1021/bi980117o; Biesiadka J, 2004, PHYS CHEM CHEM PHYS, V6, P4733, DOI 10.1039/b406989g; Brudvig GW, 1995, ADV CHEM SER, V246, P249; Carrell TG, 2002, J BIOL INORG CHEM, V7, P2, DOI 10.1007/s00775-001-0305-3; Chu HA, 2004, BIOCHEMISTRY-US, V43, P3152, DOI 10.1021/bi035915f; Chu HA, 2001, BBA-BIOENERGETICS, V1503, P69, DOI 10.1016/S0005-2728(00)00216-4; Cinco RM, 2004, BIOCHEMISTRY-US, V43, P13271, DOI 10.1021/bi036308v; Cinco RM, 2002, BIOCHEMISTRY-US, V41, P12928, DOI 10.1021/bi026569p; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FLANK AM, 1986, J AM CHEM SOC, V108, P1049, DOI 10.1021/ja00265a034; Hasegawa K, 1999, CHEM PHYS LETT, V300, P9, DOI 10.1016/S0009-2614(98)01369-4; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kimura Y, 2005, BIOCHEMISTRY-US, V44, P16072, DOI 10.1021/bi051306r; Kimura Y, 2005, J BIOL CHEM, V280, P2078, DOI 10.1074/jbc.M410627200; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kulik LV, 2005, J AM CHEM SOC, V127, P2392, DOI 10.1021/ja043012j; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Messinger J, 1997, BIOCHEMISTRY-US, V36, P11055, DOI 10.1021/bi9711285; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Robblee JH, 2002, J AM CHEM SOC, V124, P7459, DOI 10.1021/ja011621a; SCOTT RA, 1982, J AM CHEM SOC, V104, P5364, DOI 10.1021/ja00384a020; Wydrzynski TJ, 2005, ADV PHOTOSYNTHESIS R, V22; Yachandra VK, 1996, CHEM REV, V96, P2927, DOI 10.1021/cr950052k; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	28	661	671	7	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 3	2006	314	5800					821	825		10.1126/science.1128186	http://dx.doi.org/10.1126/science.1128186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	101GR	17082458	Green Submitted, Green Accepted			2022-12-01	WOS:000241729800048
J	Leventhal, A; Ramlawi, A; Belbiesi, A; D Balicer, R				Leventhal, Alex; Ramlawi, Assad; Belbiesi, Adel; D Balicer, Ran			Regional collaboration in the Middle East to deal with H5N1 avian flu	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Israel Minist Hlth, Publ Hlth Serv, POB 1176, IL-91010 Jerusalem, Israel; Palestinian Author, Minist Hlth, Ramallah, West Bank, Palestine; Jordan Minist Hlth, Amman, Jordan; Steering Comm Pandem Influenza Preparedness, IL-52392 Ramat Gan, Israel		Leventhal, A (corresponding author), Israel Minist Hlth, Publ Hlth Serv, POB 1176, IL-91010 Jerusalem, Israel.	leventhal_a@yahoo.com						Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; *ISR ORN CTR, MIGR BIRDS KNOW NO B; Leventhal A, 2003, LANCET, V361, P1222, DOI 10.1016/S0140-6736(03)12959-5; Levin A, 1998, J NATL CANCER I, V90, P807, DOI 10.1093/jnci/90.11.807; Ress Paul, 2005, BMJ, V331, P1164, DOI 10.1136/bmj.331.7526.1164-b; Skinner H, 2005, LANCET, V365, P1274, DOI 10.1016/S0140-6736(05)74817-0; TULCHINSKY T, 2002, SEPARATE COOPERATE C; *WHO, 2006, AV INFL SIT EG 20 MA; *WHO, H5N1 AV INFL TIM; *WHO, 2005, WHA58 3 REV INT HLTH	10	19	20	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2006	333	7573					856	858		10.1136/bmj.38994.420926.80	http://dx.doi.org/10.1136/bmj.38994.420926.80			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ON	17053248	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000241678500026
J	Niemann, H; Losekann, T; de Beer, D; Elvert, M; Nadalig, T; Knittel, K; Amann, R; Sauter, EJ; Schluter, M; Klages, M; Foucher, JP; Boetius, A				Niemann, Helge; Losekann, Tina; de Beer, Dirk; Elvert, Marcus; Nadalig, Thierry; Knittel, Katrin; Amann, Rudolf; Sauter, Eberhard J.; Schlueter, Michael; Klages, Michael; Foucher, Jean Paul; Boetius, Antje			Novel microbial communities of the Haakon Mosby mud volcano and their role as a methane sink	NATURE			English	Article							SULFATE-REDUCING BACTERIA; ANAEROBIC OXIDATION; CASCADIA MARGIN; HYDRATE RIDGE; WATER COLUMN; SEA; SEDIMENTS; DIVERSITY; ARCHAEA; FLUXES	Mud volcanism is an important natural source of the greenhouse gas methane to the hydrosphere and atmosphere(1,2). Recent investigations show that the number of active submarine mud volcanoes might be much higher than anticipated ( for example, see refs 3 - 5), and that gas emitted from deep-sea seeps might reach the upper mixed ocean(6-8). Unfortunately, global methane emission from active submarine mud volcanoes cannot be quantified because their number and gas release are unknown(9). It is also unclear how efficiently methane-oxidizing microorganisms remove methane. Here we investigate the methane-emitting Haakon Mosby Mud Volcano (HMMV, Barents Sea, 72 degrees N, 14 degrees 44' E; 1,250 m water depth) to provide quantitative estimates of the in situ composition, distribution and activity of methanotrophs in relation to gas emission. The HMMV hosts three key communities: aerobic methanotrophic bacteria (Methylococcales), anaerobic methanotrophic archaea (ANME-2) thriving below siboglinid tubeworms, and a previously undescribed clade of archaea (ANME-3) associated with bacterial mats. We found that the upward flow of sulphate- and oxygen-free mud volcano fluids restricts the availability of these electron acceptors for methane oxidation, and hence the habitat range of methanotrophs. This mechanism limits the capacity of the microbial methane filter at active marine mud volcanoes to <40% of the total flux.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; IFREMER, Ctr Brest, F-29280 Plouzane, France; Int Jacobs Univ Bremen, D-28759 Bremen, Germany	Max Planck Society; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Ifremer	Boetius, A (corresponding author), Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany.	aboetius@mpi-bremen.de	Niemann, Helge/C-6630-2014; Boetius, Antje/D-5459-2013; Lösekann, Tina/J-6358-2014; de Beer, Dirk/L-4840-2013; Amann, Rudolf I/C-6534-2014	Niemann, Helge/0000-0002-3468-8304; Boetius, Antje/0000-0003-2117-4176; de Beer, Dirk/0000-0001-5274-1781; Amann, Rudolf I/0000-0002-0846-7372; Elvert, Marcus/0000-0003-3863-0975; Schlueter, Michael/0000-0002-4997-3802; Loesekann, Tina/0000-0002-7803-9613; Sauter, Eberhard/0000-0001-7954-952X				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bohrmann G, 2003, GEO-MAR LETT, V23, P239, DOI 10.1007/s00367-003-0157-7; Brown KM, 2005, EARTH PLANET SC LETT, V238, P189, DOI 10.1016/j.epsl.2005.06.055; Damm E, 2003, MAR CHEM, V82, P1, DOI 10.1016/S0304-4203(03)00031-8; de Beer D, 2006, LIMNOL OCEANOGR, V51, P1315, DOI 10.4319/lo.2006.51.3.1315; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; Elvert M, 2003, GEOMICROBIOL J, V20, P403, DOI 10.1080/01490450303894; Ginsburg GD, 1999, GEO-MAR LETT, V19, P57, DOI 10.1007/s003670050093; Hinrichs K., 2002, OCEAN MARGIN SYSTEMS, P457, DOI [10.1007/978-3-662-05127-6_28, DOI 10.1007/978-3-662-05127-6_28]; JEROSCH K, UNPUB MAR GEOL; Judd AG, 2002, GEOFLUIDS, V2, P109, DOI 10.1046/j.1468-8123.2002.00027.x; Kaul N, 2006, MAR GEOL, V229, P1, DOI 10.1016/j.margeo.2006.02.004; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Kopf AJ, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000093; Loncke L, 2004, MAR PETROL GEOL, V21, P669, DOI 10.1016/j.marpetgeo.2004.02.004; Luff R, 2003, GEOCHIM COSMOCHIM AC, V67, P3403, DOI 10.1016/S0016-7037(03)00127-3; MacDonald IR, 2002, GEOFLUIDS, V2, P95, DOI 10.1046/j.1468-8123.2002.00023.x; Milkov AV, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016358; Milkov AV, 2004, CHEM GEOL, V205, P347, DOI 10.1016/j.chemgeo.2003.12.030; Niemann H, 2005, BIOGEOSCIENCES, V2, P335, DOI 10.5194/bg-2-335-2005; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Pinheiro LM, 2003, MAR GEOL, V195, P131, DOI 10.1016/S0025-3227(02)00685-0; REEBURGH WS, 2003, TREATISE GEOCHEMISTR, V4, P65, DOI DOI 10.1016/B0-08-043751-6/04036-6; Rehder G, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013966; Sauter EJ, 2006, EARTH PLANET SC LETT, V243, P354, DOI 10.1016/j.epsl.2006.01.041; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Treude T, 2003, MAR ECOL PROG SER, V264, P1, DOI 10.3354/meps264001; Vogt P. R., 1997, EOS T AM GEOPHYS U S, V78, P187; Vogt PR, 1999, GEO-MAR LETT, V19, P2, DOI 10.1007/s003670050088	30	437	483	7	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 19	2006	443	7113					854	858		10.1038/nature05227	http://dx.doi.org/10.1038/nature05227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096FJ	17051217	Green Published			2022-12-01	WOS:000241362700051
J	Schietinger, A; Philip, M; Yoshida, BA; Azadi, P; Liu, H; Meredith, SC; Schreiber, H				Schietinger, Andrea; Philip, Mary; Yoshida, Barbara A.; Azadi, Parastoo; Liu, Hui; Meredith, Stephen C.; Schreiber, Hans			A mutant chaperone converts a wild-type protein into a tumor-specific antigen	SCIENCE			English	Article							AGGREGATION-INDUCING FACTOR; O-GLYCAN; HUMAN CANCER; CELL LINE; EXPRESSION; BETA-1,3-GALACTOSYLTRANSFERASE; IDENTIFICATION; KERATINOCYTES; BIOSYNTHESIS; INDUCTION	Monoclonal antibodies have become important therapeutic agents against certain cancers. Many tumor-specific antigens are mutant proteins that are predominantly intracellular and thus not readily accessible to monoclonal antibodies. We found that a wild-type transmembrane protein could be transformed into a tumor-specific antigen. A somatic mutation in the chaperone gene Cosmc abolished function of a glycosyltransferase, disrupting O-glycan Core 1 synthesis and creating a tumor-specific glycopeptidic neo-epitope consisting of a monosaccharide and a specific wild-type protein sequence. This epitope induced a high-affinity, highly specific, syngeneic monoclonal antibody with antitumor activity. Such tumor-specific glycopeptidic neo-epitopes represent potential targets for monoclonal antibody therapy.	Univ Chicago, Dept Pathol, Comm Immunol, Comm Canc Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Munich, Inst Immunol, D-80336 Munich, Germany; Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University of Chicago; University of Chicago; University of Munich; University System of Georgia; University of Georgia	Schietinger, A (corresponding author), Univ Chicago, Dept Pathol, Comm Immunol, Comm Canc Biol, Chicago, IL 60637 USA.	aschieti@uchicago.edu			NCI NIH HHS [R01-CA37516, R01-CA22677, P01-CA97296] Funding Source: Medline; NCRR NIH HHS [P41RR018502-01] Funding Source: Medline; NICHD NIH HHS [HD 07009] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA097296, R01CA022677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Gandarillas A, 1997, MOL CARCINOGEN, V20, P10, DOI 10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M; Gilboa E, 2001, NAT IMMUNOL, V2, P789, DOI 10.1038/ni0901-789; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; HANISCH FG, 1995, CANCER RES, V55, P4036; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; Iwamoto S, 1999, GLYCOCONJUGATE J, V16, P659, DOI 10.1023/A:1007085202379; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kato Y, 2005, TUMOR BIOL, V26, P195, DOI 10.1159/000086952; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kudo T, 2002, J BIOL CHEM, V277, P47724, DOI 10.1074/jbc.M205839200; Livingston PO, 1995, SEMIN CANCER BIOL, V6, P357, DOI 10.1016/1044-579X(95)90005-5; LLOYD KO, 1987, AM J CLIN PATHOL, V87, P129, DOI 10.1093/ajcp/87.1.129; LLOYD KO, 1990, IMMUNOL ALLERGY CLIN, V10, P765; Lorimer IAJ, 2002, CURR CANCER DRUG TAR, V2, P91, DOI 10.2174/1568009023333926; MATSUURA H, 1988, J BIOL CHEM, V263, P3314; OETTGEN HF, 1990, IMMUNOL ALLERGY CLIN, V10, P607; PILLER V, 1990, J BIOL CHEM, V265, P9264; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Scholl FG, 1999, J CELL SCI, V112, P4601; Schreiber H., 2003, FUNDAMENTAL IMMUNOLO, P1557; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; WARD PL, 1989, J EXP MED, V170, P217, DOI 10.1084/jem.170.1.217; WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0	28	114	128	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					304	308		10.1126/science.1129200	http://dx.doi.org/10.1126/science.1129200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038624				2022-12-01	WOS:000241194100043
J	MacAlister, CA; Ohashi-Ito, K; Bergmann, DC				MacAlister, Cora A.; Ohashi-Ito, Kyoko; Bergmann, Dominique C.			Transcription factor control of asymmetric cell divisions that establish the stomatal lineage	NATURE			English	Article							ARABIDOPSIS; MOUTHS; TOO; MUTANTS; PATTERN	The establishment of new cell lineages during development often requires a symmetry-breaking event. An asymmetric division in the epidermis of plants initiates a lineage that ultimately produces stomatal guard cells. Stomata are pores in the epidermis that serve as the main conduits for gas exchange between plants and the atmosphere; they are critical for photosynthesis and exert a major influence on global carbon and water cycles(1). Recent studies implicated intercellular signalling in preventing the inappropriate production of stomatal complexes(2-4). Genes required to make stomata, however, remained elusive. Here we report the identification of a gene, SPEECHLESS (SPCH), encoding a basic helix - loop helix ( bHLH) transcription factor that is necessary and sufficient for the asymmetric divisions that establish the stomatal lineage in Arabidopsis thaliana. We demonstrate that SPCH and two paralogues are successively required for the initiation, proliferation and terminal differentiation of cells in the stomatal lineage. The stomatal bHLHs define a molecular pathway sufficient to create one of the key cell types in plants. Similar molecules and regulatory mechanisms are used during muscle and neural development(5,6), highlighting a conserved use of closely related bHLHs for cell fate specification and differentiation.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Bergmann, DC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	dbergmann@stanford.edu		Bergmann, Dominique/0000-0003-0873-3543; MacAlister, Cora/0000-0003-1470-0596				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Lucas JR, 2006, J EXP BOT, V57, P71, DOI 10.1093/jxb/erj017; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227	20	358	396	5	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					537	540		10.1038/nature05491	http://dx.doi.org/10.1038/nature05491			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17183265				2022-12-01	WOS:000243867300043
J	Bocquet, N; de Carvalho, LP; Cartaud, J; Neyton, J; Le Poupon, C; Taly, A; Grutter, T; Changeux, JP; Corringer, PJ				Bocquet, Nicolas; de Carvalho, Lia Prado; Cartaud, Jean; Neyton, Jacques; Le Poupon, Chantal; Taly, Antoine; Grutter, Thomas; Changeux, Jean-Pierre; Corringer, Pierre-Jean			A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family	NATURE			English	Article							BINDING-PROTEIN; GATING MECHANISM; DOMAIN; MODULATION; SUBUNIT; DESENSITIZATION; MUTATIONS; REVEALS; FORM; LOOP	Ligand-gated ion channels (LGICs) mediate excitatory and inhibitory transmission in the nervous system. Among them, the pentameric or 'Cys-loop' receptors (pLGICs) compose a family that until recently was found in only eukaryotes. Yet a recent genome search identified putative homologues of these proteins in several bacterial species(1). Here we report the cloning, expression and functional identification of one of these putative homologues from the cyanobacterium Gloeobacter violaceus. It was expressed as a homo-oligomer in HEK 293 cells and Xenopus oocytes, generating a transmembrane cationic channel that is opened by extracellular protons and shows slow kinetics of activation, no desensitization and a single channel conductance of 8 pS. Electron microscopy and cross-linking experiments of the protein fused to the maltose-binding protein and expressed in Escherichia coli are consistent with a homo-pentameric organization. Sequence comparison shows that it possesses a compact structure, with the absence of the amino-terminal helix, the canonical disulphide bridge and the large cytoplasmic domain found in eukaryotic pLGICs. Therefore it embodies a minimal structure required for signal transduction. These data establish the prokaryotic origin of the family. Because Gloeobacter violaceus carries out photosynthesis and proton transport at the cytoplasmic membrane(2), this new proton-gated ion channel might contribute to adaptation to pH change.	Inst Pasteur, CNRS, URA D2182, Unit Receptor & Cognit, F-75015 Paris, France; Univ Paris 06 & 7, Inst Jacques Monod, CNRS, UMR 7590, F-75005 Paris, France; Ecole Normale Super, CNRS, UMR 8544, Neurobiol Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Corringer, PJ (corresponding author), Inst Pasteur, CNRS, URA D2182, Unit Receptor & Cognit, F-75015 Paris, France.	pjcorrin@pasteur.fr	Taly, Antoine/B-3339-2008	Taly, Antoine/0000-0001-5109-0091; Grutter, Thomas/0000-0002-4351-9203				BELKIN S, 1987, PLANT PHYSIOL, V84, P25, DOI 10.1104/pp.84.1.25; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CARTAUD J, 1978, J CELL SCI, V29, P313; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Fischer M, 2001, P NATL ACAD SCI USA, V98, P3567, DOI 10.1073/pnas.041594798; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; HOPFIELD JF, 1988, NATURE, V336, P677, DOI 10.1038/336677a0; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Paoletti P, 1997, J NEUROSCI, V17, P5711; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Schofield CM, 2004, BIOCHEMISTRY-US, V43, P10058, DOI 10.1021/bi036159g; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wilkins ME, 2005, J PHYSIOL-LONDON, V567, P365, DOI 10.1113/jphysiol.2005.088823; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030	30	242	281	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2007	445	7123					116	119		10.1038/nature05371	http://dx.doi.org/10.1038/nature05371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122KG	17167423				2022-12-01	WOS:000243225100047
J	Carandang, R; Seshadri, S; Beiser, A; Kelly-Hayes, M; Kase, CS; Kannel, WB; Wolf, PA				Carandang, Raphael; Seshadri, Sudha; Beiser, Alexa; Kelly-Hayes, Margaret; Kase, Carlos S.; Kannel, William B.; Wolf, Philip A.			Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; ACUTE ISCHEMIC-STROKE; CASE-FATALITY; INCIDENCE RATES; CARDIOVASCULAR-DISEASE; INTERNATIONAL TRENDS; PRIMARY PREVENTION; UNITED-STATES; NEW-ZEALAND; LUND-ORUP	Context Prior estimates of long-term trends in the incidence and severity of stroke have varied; trends in lifetime risk have not been reported. Objective To determine long-term trends in the incidence, lifetime risk, severity, and 30-day mortality of clinical stroke. Design, Setting, and Participants Prospective evaluation of the community-based Framingham Study original and offspring cohorts. Participants were 9152 men and women free of prevalent stroke and undergoing follow-up for up to 50 years over 3 consecutive periods (1950-1977, 1978-1989, and 1990-2004), with biennial ascertainment of stroke risk factor data and active surveillance for incident clinical stroke and cause-specific mortality. Main Outcome Measures Incidence (age-adjusted, sex-specific), severity, 30-day mortality, and mortality-adjusted 10-year and lifetime risk of stroke in each of the specified periods. Results There were 1030 incident clinical strokes ( 450 [44%] in men, 629 atherothrombotic brain infarctions [61%]) in 9152 persons 55 years or older over 174 917 person-years of follow-up. The age-adjusted incidence of first stroke per 1000 person-years in each of the 3 periods was 7.6, 6.2, and 5.3, respectively, in men (P=. 02 for trend) and 6.2, 5.8, and 5.1 in women ( P=. 01 for trend). The lifetime risk at age 65 years decreased from 19.5% to 14.5% in men ( P=. 11) and from 18.0% to 16.1% in women ( P=. 61). Age-adjusted stroke severity did not vary across periods; however, 30-day mortality decreased significantly in men ( from 23% to 14%; P=. 01) but not significantly in women ( from 21% to 20%; P=. 32). Conclusions In this cohort of men and women free of prevalent clinical stroke at initial examination, incidence of stroke has decreased over the past 50 years but the lifetime risk has not declined to the same degree, perhaps due to improved life expectancy. The results of this study suggest that improved control of risk factors has lowered stroke incidence but emphasize the need for continued primary prevention efforts.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; NHLBI, Framingham Heart Study, Framingham, MA USA	Boston University; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wolf, PA (corresponding author), Boston Univ, Sch Med, Dept Neurol, 715 Albany St,B-608, Boston, MA 02118 USA.	pawolf@bu.edu		Wolf, Philip/0000-0002-3628-301X; Kase, Carlos/0000-0002-3047-5010; Seshadri, Sudha/0000-0001-6135-2622; Beiser, Alexa/0000-0001-8551-7778; Kelly-Hayes, Margaret/0000-0001-5938-8052	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-25195] Funding Source: Medline; NINDS NIH HHS [R01 NS017950, 5R01-NS17950] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		American Heart Association, 2006, HEART DIS STROK STAT; Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.42690.bf; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Benatru I, 2006, STROKE, V37, P1674, DOI 10.1161/01.STR.0000226979.56456.a8; BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Broderick J P, 1993, Ann Epidemiol, V3, P476; BRODERICK JP, 1989, STROKE, V20, P577, DOI 10.1161/01.STR.20.5.577; Carolei A, 1997, STROKE, V28, P2500, DOI 10.1161/01.STR.28.12.2500; CHENG XM, 1995, STROKE, V26, P1990, DOI 10.1161/01.STR.26.11.1990; COOPER R, 1990, STROKE, V21, P1274, DOI 10.1161/01.STR.21.9.1274; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Derby CA, 2000, STROKE, V31, P875, DOI 10.1161/01.STR.31.4.875; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; DRURY I, 1984, NEUROLOGY, V34, P653, DOI 10.1212/WNL.34.5.653; EISENBLATTER D, 1995, STROKE, V26, P919, DOI 10.1161/01.STR.26.6.919; Fang J, 2001, STROKE, V32, P2221, DOI 10.1161/hs1001.096193; Fogelholm R, 2003, STROKE, V34, P1840, DOI 10.1161/01.STR.0000085565.91317.4C; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Halliday A, 2004, LANCET, V363, P1491; Hallstrom B, 2002, STROKE, V33, P1624, DOI 10.1161/01.STR.0000017222.48968.6E; HARMSEN P, 1992, STROKE, V23, P1410, DOI 10.1161/01.STR.23.10.1410; Hollander M, 2003, J NEUROL NEUROSUR PS, V74, P317, DOI 10.1136/jnnp.74.3.317; Howard G, 2001, STROKE, V32, P2213, DOI 10.1161/hs1001.096047; Jamrozik K, 1999, STROKE, V30, P2105, DOI 10.1161/01.STR.30.10.2105; Johansson B, 2000, STROKE, V31, P481, DOI 10.1161/01.STR.31.2.481; KAGAN A, 1994, STROKE, V25, P1170, DOI 10.1161/01.STR.25.6.1170; Kapral MK, 2005, STROKE, V36, P809, DOI 10.1161/01.STR.0000157662.09551.e5; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Kubo M, 2006, NEUROLOGY, V66, P1539, DOI 10.1212/01.wnl.0000216132.95207.b4; Kwan J, 2001, CME J GERIATR MED, V3, P94; LAURIA G, 1995, STROKE, V26, P1787, DOI 10.1161/01.STR.26.10.1787; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Morikawa Y, 2000, STROKE, V31, P1583, DOI 10.1161/01.STR.31.7.1583; Muntner P, 2002, STROKE, V33, P1209, DOI 10.1161/01.STR.0000015031.57955.D1; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; Numminen H, 1996, STROKE, V27, P1487, DOI 10.1161/01.STR.27.9.1487; Pessah-Rasmussen H, 2003, STROKE, V34, P913, DOI 10.1161/01.STR.0000063365.10841.43; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Shahar E, 1997, STROKE, V28, P275, DOI 10.1161/01.STR.28.2.275; Sivenius J, 2004, STROKE, V35, P420, DOI 10.1161/01.STR.0000110220.63212.59; Smadja D, 2001, STROKE, V32, P2741, DOI 10.1161/hs1201.099385; Stegmayr B, 1999, STROKE, V30, P709, DOI 10.1161/01.STR.30.4.709; Thorvaldsen P, 1999, STROKE, V30, P2529, DOI 10.1161/01.STR.30.12.2529; THORVALDSEN P, 1995, STROKE; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; WOLF PA, 1992, STROKE, V23, P1551, DOI 10.1161/01.STR.23.11.1551; WOLF PA, 2004, STROKE PATHOPHYSIOLO, P13	56	366	372	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2006	296	24					2939	2946		10.1001/jama.296.24.2939	http://dx.doi.org/10.1001/jama.296.24.2939			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120FD	17190894	Bronze			2022-12-01	WOS:000243069000025
J	Venken, KJT; He, YC; Hoskins, RA; Bellen, HJ				Venken, Koen J. T.; He, Yuchun; Hoskins, Roger A.; Bellen, Hugo J.			P[acman]: A BAC transgenic platform for targeted insertion of large DNA fragments in D-melanogaster	SCIENCE			English	Article							PHYSICAL MAP; GENOME; SYSTEM; TRANSFORMATION; CHROMOSOME; PIGGYBAC; SEQUENCE; VECTORS; CLONING; GENES	We describe a transgenesis platform for Drosophila melanogaster that integrates three recently developed technologies: a conditionally amplifiable bacterial artificial chromosome (BAC), recombineering, and bacteriophage phi C31-mediated transgenesis. The BAC is maintained at low copy number, facilitating plasmid maintenance and recombineering, but is induced to high copy number for plasmid isolation. Recombineering allows gap repair and mutagenesis in bacteria. Gap repair efficiently retrieves DNA fragments up to 133 kilobases long from P1 or BAC clones. phi C31-mediated transgenesis integrates these large DNA fragments at specific sites in the genome, allowing the rescue of lethal mutations in the corresponding genes. This transgenesis platform should greatly facilitate structure/function analyses of most Drosophila genes.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Biol, Berkeley, CA 94720 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hbellen@bcm.edu	Venken, Koen/B-9909-2013	Venken, Koen/0000-0003-0741-4698; Bellen, Hugo/0000-0001-5992-5989	NIGMS NIH HHS [GM067858-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; CELNIKER SE, 2002, GENOME BIOL, V6, pH79; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; Jafar-Nejad H, 2004, MOL CELL BIOL, V24, P8803, DOI 10.1128/MCB.24.20.8803-8812.2004; Kimmerly W, 1996, GENOME RES, V6, P414, DOI 10.1101/gr.6.5.414; Kotzamanis G, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-1; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li X, 2001, MOL GENET GENOMICS, V266, P190, DOI 10.1007/s004380100525; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryder Edward, 2003, Briefings in Functional Genomics & Proteomics, V2, P57, DOI 10.1093/bfgp/2.1.57; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Sorrell DA, 2005, BIOTECHNOL ADV, V23, P431, DOI 10.1016/j.biotechadv.2005.03.003; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Xu HF, 2006, MOL GENET GENOMICS, V276, P31, DOI 10.1007/s00438-006-0124-x	25	550	586	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1747	1751		10.1126/science.1134426	http://dx.doi.org/10.1126/science.1134426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17138868				2022-12-01	WOS:000242833600050
J	Ding, B; Seeman, NC				Ding, Baoquan; Seeman, Nadrian C.			Operation of a DNA robot arm inserted into a 2D DNA crystalline substrate	SCIENCE			English	Article							NANOSCALE; DESIGN	The success of nanorobotics requires the precise placement and subsequent operation of specific nanomechanical devices at particular locations. The structural programmability of DNA makes it a particularly attractive system for nanorobotics. We have developed a cassette that enables the placement of a robust, sequence-dependent DNA robot arm within a two-dimensional (2D) crystalline DNA array. The cassette contains the device, an attachment site, and a reporter of state. We used atomic force microscopy to demonstrate that the rotary device is fully functional after insertion. Thus, a nanomechanical device can operate within a fixed frame of reference.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM029554] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Birac JJ, 2006, J MOL GRAPH MODEL, V25, P470, DOI 10.1016/j.jmgm.2006.03.005; Carbone A, 2002, P NATL ACAD SCI USA, V99, P12577, DOI 10.1073/pnas.202418299; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Liao SP, 2004, SCIENCE, V306, P2072, DOI 10.1126/science.1104299; Qiu HX, 1997, J MOL BIOL, V267, P881, DOI 10.1006/jmbi.1997.0918; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2005, REP PROG PHYS, V68, P237, DOI 10.1088/0034-4885/68/1/R05; Shen ZY, 2004, J AM CHEM SOC, V126, P1666, DOI 10.1021/ja038381e; Sherman WB, 2006, BIOPHYS J, V90, P4546, DOI 10.1529/biophysj.105.080390; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a	12	182	184	7	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1583	1585		10.1126/science.1131372	http://dx.doi.org/10.1126/science.1131372			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158323	Green Accepted			2022-12-01	WOS:000242624600037
J	Malin, MC; Edgett, KS; Posiolova, LV; McColley, SM; Dobrea, EZN				Malin, Michael C.; Edgett, Kenneth S.; Posiolova, Liliya V.; McColley, Shawn M.; Dobrea, Eldar Z. Noe			Present-day impact cratering rate and contemporary gully activity on Mars	SCIENCE			English	Article							MARTIAN GULLIES; ORBITER CAMERA; GLOBAL SURVEYOR; CARBON-DIOXIDE; SURFACE RUNOFF; LIQUID WATER; CONSTRAINTS; METEOROIDS; CHRONOLOGY; ATMOSPHERE	The Mars Global Surveyor Mars Orbiter Camera has acquired data that establish the present-day impact cratering rate and document new deposits formed by downslope movement of material in mid-latitude gullies on Mars. Twenty impacts created craters 2 to 150 meters in diameter within an area of 21.5 x 10(6) square kilometers between May 1999 and March 2006. The values predicted by models that scale the lunar cratering rate to Mars are close to the observed rate, implying that surfaces devoid of craters are truly young and that as yet unrecognized processes of denudation must be operating. The new gully deposits, formed since August 1999, are light toned and exhibit attributes expected from emplacement aided by a fluid with the properties of liquid water: relatively long, extended, digitate distal and marginal branches, diversion around obstacles, and low relief. The observations suggest that liquid water flowed on the surface of Mars during the past decade.	Malin Space Sci Syst, San Diego, CA 92191 USA		Malin, MC (corresponding author), Malin Space Sci Syst, POB 910148, San Diego, CA 92191 USA.			Edgett, Kenneth/0000-0001-7197-5751				Caplinger MA, 2001, J GEOPHYS RES-PLANET, V106, P23595, DOI 10.1029/2000JE001341; CEPLECHA Z, 1993, ASTRON ASTROPHYS, V279, P615; Ceplecha Z, 1995, EARTH MOON PLANETS, V68, P107, DOI 10.1007/BF00671501; Christensen PR, 2003, NATURE, V422, P45, DOI 10.1038/nature01436; Costard F, 2002, SCIENCE, V295, P110, DOI 10.1126/science.1064419; Gaidos EJ, 2001, ICARUS, V153, P218, DOI 10.1006/icar.2001.6649; GAULT DE, 1970, RADIO SCI, V5, P273, DOI 10.1029/RS005i002p00273; Gilmore MS, 2002, GEOLOGY, V30, P1107, DOI 10.1130/0091-7613(2002)030<1107:ROAIFO>2.0.CO;2; Hartmann WK, 1999, METEORIT PLANET SCI, V34, P167, DOI 10.1111/j.1945-5100.1999.tb01743.x; Hartmann WK, 2005, ICARUS, V174, P294, DOI 10.1016/j.icarus.2004.11.023; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; HEIDMANN JL, 2004, ICARUS, V168, P285; HEIDMANN JL, 2005, J GEOPHYS RES, V110, DOI DOI 10.1029/2004JE002261; Hoffman N, 2002, ASTROBIOLOGY, V2, P313, DOI 10.1089/153110702762027899; Horz F, 1999, SCIENCE, V285, P2105, DOI 10.1126/science.285.5436.2105; HORZ F, 2004, LUNAR PLANET SCI, V35, P1116; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; McEwen AS, 2006, ANNU REV EARTH PL SC, V34, P535, DOI 10.1146/annurev.earth.34.031405.125018; McEwen AS, 2005, ICARUS, V176, P351, DOI 10.1016/j.icarus.2005.02.009; Mellon MT, 2001, J GEOPHYS RES-PLANET, V106, P23165, DOI 10.1029/2000JE001424; MELOSH HJ, 1981, MULTIRING BASINS, P29; Musselwhite DS, 2001, GEOPHYS RES LETT, V28, P1283, DOI 10.1029/2000GL012496; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; Popova O, 2003, METEORIT PLANET SCI, V38, P905, DOI 10.1111/j.1945-5100.2003.tb00287.x; Shoemaker E. M., 1965, 32700 JET PROP LAB, P75; Stewart ST, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001465; Sullivan R, 2001, J GEOPHYS RES-PLANET, V106, P23607, DOI 10.1029/2000JE001296; Treiman AH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001900; [No title captured]	32	322	326	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2006	314	5805					1573	1577		10.1126/science.1135156	http://dx.doi.org/10.1126/science.1135156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158321				2022-12-01	WOS:000242624600034
J	Bondy, C; Bakalov, VK; Lange, ED; Ceniceros, I				Bondy, Carolyn; Bakalov, Vladimir K.; Lange, Eileen Dunn; Ceniceros, Irene			Deficient medical care for adults with the Turner syndrome	ANNALS OF INTERNAL MEDICINE			English	Letter									NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bondy, C (corresponding author), NICHHD, NIH, Bethesda, MD 20892 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000628] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bakalov VK, 2003, AM J MED, V115, P259, DOI 10.1016/S0002-9343(03)00364-4; Lin AE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e12; Nielsen J, 1990, Birth Defects Orig Artic Ser, V26, P209; Ostberg JE, 2004, J CLIN ENDOCR METAB, V89, P5966, DOI 10.1210/jc.2004-1090; Saenger P, 2001, J CLIN ENDOCR METAB, V86, P3061, DOI 10.1210/jc.86.7.3061	5	27	27	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2006	145	11					866	867		10.7326/0003-4819-145-11-200612050-00020	http://dx.doi.org/10.7326/0003-4819-145-11-200612050-00020			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	114PE	17146077				2022-12-01	WOS:000242677300016
J	Bell, P; Binagwaho, A				Bell, Peter; Binagwaho, Agnes			The Joint Learning Initiative on Children and HIV/AIDS	LANCET			English	Editorial Material									Emory Univ, Carter Ctr, Atlanta, GA 30307 USA; Commiss Natl Lutte SIDA, Kigali, Rwanda	Emory University	Bell, P (corresponding author), Emory Univ, Carter Ctr, Atlanta, GA 30307 USA.	peter.bell@emory.edu						Horton R, 2006, LANCET, V368, P716, DOI 10.1016/S0140-6736(06)69266-0; *UNICEF, 2005, CHILDR MISS FAC AIDS; UNICEF, 2004, FRAM PROT CAR SUPP O; UNICEF, 2006, AFR ORPH VULN GEN CH; 2006, LANCET, V368, P424; JOINT LEARNING INITI	6	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1850	1851		10.1016/S0140-6736(06)69753-5	http://dx.doi.org/10.1016/S0140-6736(06)69753-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126701				2022-12-01	WOS:000242345900007
J	Feng, ZY; Li, W; Ward, A; Piggott, BJ; Larkspur, ER; Sternberg, PW; Xu, XZS				Feng, Zhaoyang; Li, Wei; Ward, Alex; Piggott, Beverly J.; Larkspur, Erin R.; Sternberg, Paul W.; Xu, X. Z. Shawn			A C-elegans model of nicotline-dependent behavior: Regulation by TRP-family channels	CELL			English	Article							CAENORHABDITIS-ELEGANS; ACETYLCHOLINE-RECEPTORS; SYNAPTIC-TRANSMISSION; NEMATODE; TOLERANCE; G(Q)ALPHA; NEUROBIOLOGY; ADAPTATION; ENCODES; PATHWAY	Nicotine, the primary addictive substance in tobacco, induces profound behavioral responses in mammals, but the underlying genetic mechanisms are riot well understood. Here we develop a C. elegans model of nicotine-dependent behavior. We show that worms exhibit behavioral responses to nicotine that parallel those observed in mammals, including acute response, tolerance, withdrawal, and sensitization. These Nicotine responses require nicotinic acetylcholine receptor (nAChR) family genes that are known to mediate nicotine dependence in mammals, suggesting functional conservation of nAChRs in nicotine responses. Importantly, we find that mutant worms lacking TRPC (transient receptor potential canonical) channels are defective in their response to nicotine and that such a defect can be rescued by a human TRPC channel, revealing an unexpected role or TRPC channels in regulating nicotine-dependent behavior. Thus, C. elegans can be used to characterize known genes as well as to identify new genes regulating nicotine responses.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu	Piggott, Beverly/GQH-4796-2022	Sternberg, Paul/0000-0002-7699-0173	NEI NIH HHS [T32EY017878, T32 EY017878] Funding Source: Medline; NIDA NIH HHS [7R01DA018341-02, R01 DA018341] Funding Source: Medline; NIGMS NIH HHS [R01 GM078276, T32 GM008322, T32GM008322, R01 GM078276-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY017878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322, R01GM078276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018341] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Ballivet M, 1996, J MOL BIOL, V258, P261, DOI 10.1006/jmbi.1996.0248; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Champtiaux N, 2004, PROG BRAIN RES, V145, P235, DOI 10.1016/S0079-6123(03)45016-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Dwoskin LP, 1999, PSYCHOPHARMACOLOGY, V145, P442, DOI 10.1007/s002130051079; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Kenny PJ, 2001, PHARMACOL BIOCHEM BE, V70, P531, DOI 10.1016/S0091-3057(01)00651-7; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MARKS MJ, 1986, J PHARMACOL EXP THER, V237, P809; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Scholz H, 2005, NATURE, V436, P845, DOI 10.1038/nature03864; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Waggoner LE, 2000, J NEUROSCI, V20, P8802; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8; Zhao BB, 2003, J NEUROSCI, V23, P5319; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	42	116	140	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					621	633		10.1016/j.cell.2006.09.035	http://dx.doi.org/10.1016/j.cell.2006.09.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081982	Green Accepted, Bronze			2022-12-01	WOS:000241937000024
J	Whitfield, CW; Behura, SK; Berlocher, SH; Clark, AG; Johnston, JS; Sheppard, WS; Smith, DR; Suarez, AV; Weaver, D; Tsutsui, ND				Whitfield, Charles W.; Behura, Susanta K.; Berlocher, Stewart H.; Clark, Andrew G.; Johnston, J. Spencer; Sheppard, Walter S.; Smith, Deborah R.; Suarez, Andrew V.; Weaver, Daniel; Tsutsui, Neil D.			Thrice out of Africa: Ancient and recent expansions of the honey bee, Apis mellifera	SCIENCE			English	Article							TROPICAL YUCATAN; 4TH LINEAGE; HYBRIDIZATION; IDENTIFICATION; VARIABILITY; POPULATIONS; COLONIES; AMERICA; MEXICO; EAST	We characterized Apis mellifera in both native and introduced ranges using 1136 single-nucleotide polymorphisms genotyped in 341 individuals. Our results indicate that A. mellifera originated in Africa and expanded into Eurasia at least twice, resulting in populations in eastern and western Europe that are geographically close but genetically distant. A third expansion in the New World has involved the near-replacement of previously introduced "European" honey bees by descendants of more recently introduced A. m. scutellata ("African" or "killer" bees). Our analyses of spatial transects and temporal series in the New World revealed differential replacement of alleles derived from eastern versus western Europe, with admixture evident in all individuals.	Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Program Ecol & Evolutionary Biol, Urbana, IL 61801 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Entomol Program, Lawrence, KS 66045 USA; Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; LP & Bee Weaver Apiaries Inc, Bee Power, Navasota, TX 77868 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Cornell University; Texas A&M University System; Texas A&M University College Station; Washington State University; Washington State University; University of Kansas; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Irvine; University of California System; University of California Irvine	Whitfield, CW (corresponding author), Univ Illinois, Dept Entomol, 505 S Goodwin Ave, Urbana, IL 61801 USA.	charlie@life.uiuc.edu	Smith, Deborah/V-1676-2019	Smith, Deborah/0000-0002-2581-5009; behura, Susanta/0000-0003-1057-2435; Clark, Andrew/0000-0001-7159-8511				[Anonymous], 2000, CROP POLLINATION BEE; Arias MC, 2005, MOL PHYLOGENET EVOL, V37, P25, DOI 10.1016/j.ympev.2005.02.017; Clarke KE, 2002, EVOLUTION, V56, P1462; COMUET JM, 1991, APIDOLOGIE CELLE, V22, P627; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI [10.4324/9780203819937, DOI 10.4324/9780203819937]; Franck P, 2000, APIDOLOGIE, V31, P167, DOI 10.1051/apido:2000114; *HON BEE GEN SEQ C, IN PRESS NATURE; Kerr W., 1967, S AFR BEE J, V39, P33; KERR WE, 1982, AM BEE J, V122, P196; Page RE, 2002, GENETICS, V160, P375; Palmer MR, 2000, J HERED, V91, P42, DOI 10.1093/jhered/91.1.42; Quezada-Euan JJG, 1998, APIDOLOGIE, V29, P555, DOI 10.1051/apido:19980608; Quezada-Euan JJG, 2000, APIDOLOGIE, V31, P443, DOI 10.1051/apido:2000135; Rinderer T. E., 1993, Scientific American, V269, P52; RINDERER TE, 1993, APIDOLOGIE, V24, P569, DOI 10.1051/apido:19930605; RINDERER TE, 1991, SCIENCE, V253, P309, DOI 10.1126/science.253.5017.309; RUTTNER F, 1978, APIDOLOGIE, V9, P363, DOI 10.1051/apido:19780408; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; SHEPPARD WS, 1991, NATURE, V349, P782, DOI 10.1038/349782a0; SHEPPARD WS, 1989, AM BEE J, V129, P617; SHEPPARD WS, 1989, APIDOLOGIE, V20, P419, DOI 10.1051/apido:19890507; Sheppard WS, 2000, ANN ENTOMOL SOC AM, V93, P159, DOI 10.1603/0013-8746(2000)093[0159:IOADBI]2.0.CO;2; Sheppard WS, 2003, APIDOLOGIE, V34, P367, DOI 10.1051/apido:2003037; Shriver Mark D., 2005, Human Genomics, V2, P81; Smith DR, 1997, APIDOLOGIE, V28, P269, DOI 10.1051/apido:19970503; SUGDEN EA, 1990, GLEANINGS BEE CULT, V119, P18; WILSON EO, 1971, INSECT SOC, P94	29	286	304	3	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					642	645		10.1126/science.1132772	http://dx.doi.org/10.1126/science.1132772			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068261				2022-12-01	WOS:000241557800045
J	Ambati, BK; Nozaki, M; Singh, N; Takeda, A; Jani, PD; Suthar, T; Albuquerque, RJC; Richter, E; Sakurai, E; Newcomb, MT; Kleinman, ME; Caldwell, RB; Lin, Q; Ogura, Y; Orecchia, A; Samuelson, DA; Agnew, DW; St Leger, J; Green, WR; Mahasreshti, PJ; Curiel, DT; Kwan, D; Marsh, H; Ikeda, S; Leiper, LJ; Collinson, JM; Bogdanovich, S; Khurana, TS; Shibuya, M; Baldwin, ME; Ferrara, N; Gerber, HP; De Falco, S; Witta, J; Baffi, JZ; Raisler, BJ; Ambati, J				Ambati, Balamurali K.; Nozaki, Miho; Singh, Nirbhai; Takeda, Atsunobu; Jani, Pooja D.; Suthar, Tushar; Albuquerque, Romulo J. C.; Richter, Elizabeth; Sakurai, Eiji; Newcomb, Michael T.; Kleinman, Mark E.; Caldwell, Ruth B.; Lin, Qing; Ogura, Yuichiro; Orecchia, Angela; Samuelson, Don A.; Agnew, Dalen W.; St. Leger, Judy; Green, W. Richard; Mahasreshti, Parameshwar J.; Curiel, David T.; Kwan, Donna; Marsh, Helene; Ikeda, Sakae; Leiper, Lucy J.; Collinson, J. Martin; Bogdanovich, Sasha; Khurana, Tejvir S.; Shibuya, Masabumi; Baldwin, Megan E.; Ferrara, Napoleone; Gerber, Hans-Peter; De Falco, Sandro; Witta, Jassir; Baffi, Judit Z.; Raisler, Brian J.; Ambati, Jayakrishna			Corneal avascularity is due to soluble VEGF receptor-1	NATURE			English	Article							GENETIC ABLATION; TYROSINE KINASE; NEOVASCULARIZATION; GROWTH; MICE; FLT-1; ANGIOGENESIS; INHIBITION; ABNORMALITIES; ANIRIDIA	Corneal avascularity - the absence of blood vessels in the cornea is required for optical clarity and optimal vision, and has led to the cornea being widely used for validating pro- and anti-angiogenic therapeutic strategies for many disorders(1-4). But the molecular underpinnings of the avascular phenotype have until now remained obscure(5-10) and are all the more remarkable given the presence in the cornea of vascular endothelial growth factor (VEGF)-A, a potent stimulator of angiogenesis, and the proximity of the cornea to vascularized tissues. Here we show that the cornea expresses soluble VEGF receptor-1 (sVEGFR-1; also known as sflt-1) and that suppression of this endogenous VEGF-A trap(11) by neutralizing antibodies, RNA interference or Cre-lox-mediated gene disruption abolishes corneal avascularity in mice. The spontaneously vascularized corneas of corn1 and Pax6(+/-) mice(12,13) and Pax6(+/-) patients with aniridia(14) are deficient in sflt-1, and recombinant sflt-1 administration restores corneal avascularity in corn1 and Pax6(+/-) mice. Manatees, the only known creatures uniformly to have vascularized corneas(15), do not express sflt-1, whereas the avascular corneas of dugongs, also members of the order Sirenia, elephants, the closest extant terrestrial phylogenetic relatives of manatees, and other marine mammals ( dolphins and whales) contain sflt-1, indicating that it has a crucial, evolutionarily conserved role. The recognition that sflt-1 is essential for preserving the avascular ambit of the cornea can rationally guide its use as a platform for angiogenic modulators, supports its use in treating neovascular diseases, and might provide insight into the immunological privilege of the cornea.	Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30907 USA; Med Coll Georgia, Dept Cell Biol, Augusta, GA 30907 USA; Augusta Vet Affairs Med Ctr, Augusta, GA 30907 USA; Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; Nagoya City Univ, Sch Med, Dept Ophthalmol, Nagoya, Aichi 4678601, Japan; Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; IRCCS, IDI, Mol & Cell Biol Lab, I-00167 Rome, Italy; Univ Florida, Coll Vet Med, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA; Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; Sea World, Dept Pathol, San Diego, CA 92109 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Wilmer Inst, Eye Pathol Lab, Baltimore, MD 21205 USA; Univ Alabama, Gene Therapy Ctr, Div Human Gene Therapy, Birmingham, AL 35294 USA; James Cook Univ N Queensland, Sch Trop Environm Studies & Geog, Townsville, Qld 4811, Australia; Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; Dept Mol Oncol, San Francisco, CA 94080 USA; CNR, Inst Genet & Biophys, I-80131 Naples, Italy	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Kentucky; University of Kentucky; University of Kentucky; Nagoya City University; Vanderbilt University; IRCCS Istituto Dermopatico dell'Immacolata (IDI); State University System of Florida; University of Florida; University of California System; University of California Davis; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Alabama System; University of Alabama Birmingham; James Cook University; University of Wisconsin System; University of Wisconsin Madison; University of Aberdeen; University of Pennsylvania; University of Pennsylvania; University of Tokyo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Ambati, BK (corresponding author), Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30907 USA.	bambati@mail.mcg.edu; jamba2@uky.edu	Samuelson, Don/GXA-0970-2022; De Falco, Sandro/P-6724-2015; Collinson, Jon Martin/I-9997-2019; St. Leger, Judy/AAD-3565-2019	St. Leger, Judy/0000-0002-6213-3429; Caldwell, Ruth/0000-0003-0168-0354; De Falco, Sandro/0000-0002-6501-1697; Kleinman, Mark/0000-0001-8557-7949; Marsh, Helene/0000-0003-3492-4992	Wellcome Trust [074127] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ambati BK, 2003, CORNEA, V22, P465, DOI 10.1097/00003226-200307000-00013; Ambati BK, 2003, INVEST OPHTH VIS SCI, V44, P590, DOI 10.1167/iovs.02-0685; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Cursiefen C, 2004, INVEST OPHTH VIS SCI, V45, P1117, DOI 10.1167/iovs.03-0940; Dana MR, 1996, INVEST OPHTH VIS SCI, V37, P2485; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; GIMBRONE MA, 1974, J NATL CANCER I, V52, P413, DOI 10.1093/jnci/52.2.413; Graubert MD, 2001, AM J PATHOL, V158, P1399, DOI 10.1016/S0002-9440(10)64091-6; Harper JY, 2005, VET OPHTHALMOL, V8, P89, DOI 10.1111/j.1463-5224.2005.00351.x; Hiratsuka S, 2005, MOL CELL BIOL, V25, P346, DOI 10.1128/MCB.25.1.346-354.2005; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; Ikeda S, 2003, HUM MOL GENET, V12, P1029, DOI 10.1093/hmg/ddg112; Jo DW, 2001, NAT BIOTECHNOL, V19, P929, DOI 10.1038/nbt1001-929; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lin Q, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-25; MAGNUS H, 1999, OPHTHALMOLOGY ANCIEN; MEYER K., 1940, AMER JOUR OPHTHALMOL, V23, P1320; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; SHARMA PV, 2001, SUSRUTA SAMHITA; Smith RS, 1996, INVEST OPHTH VIS SCI, V37, P397; Stechschulte SU, 2001, INVEST OPHTH VIS SCI, V42, P1975; Wiegand S. J., 1884, INVEST OPHTHALMOL VI, V45	30	507	541	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					993	997		10.1038/nature05249	http://dx.doi.org/10.1038/nature05249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17051153	Green Accepted			2022-12-01	WOS:000241523400055
J	Binder, V; Albert, MH; Kabus, M; Bertone, M; Meindl, A; Belohradsky, BH				Binder, Vera; Albert, Michael H.; Kabus, Maria; Bertone, Marko; Meindl, Alfons; Belohradsky, Bernd H.			The genotype of the original Wiskott phenotype	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WASP GENE-MUTATIONS; ALDRICH-SYNDROME; TRANSLATION	The Wiskott-Aldrich syndrome is an X-linked hereditary disorder associated with combined immunodeficiency, thrombocytopenia, small platelets, eczema, and increased susceptibility to autoimmune disorders and cancers. It is caused by mutations in the gene (WAS) for the Wiskott-Aldrich syndrome protein (WASP). We investigated family members of the patients originally described by Wiskott in 1937 and identified a new frame shift mutation in exon 1 of WAS. This mutation is likely to be the hypothesized genotype that caused the severe form of the Wiskott-Aldrich syndrome in the three brothers described by Wiskott.	Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynecol, D-81675 Munich, Germany; Univ Munich, Dr von Haunersches Childrens Hosp, Dept Hematol & Oncol, Munich, Germany; Univ Munich, Dr von Haunersches Childrens Hosp, Dept Immunol & Infect Dis, Munich, Germany; Tech Univ Dresden, Acad Sect, Municipal Hosp Dresden Neustadt, Dept Pediat, D-8027 Dresden, Germany	Technical University of Munich; University of Munich; University of Munich; Technische Universitat Dresden; Municipal Hospital Dresden	Meindl, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynecol, Ismaninger Str 22, D-81675 Munich, Germany.	alfons.meindl@lrz.tu-muenchen.de	Binder, Vera/N-2078-2015					ALDRICH RA, 1954, PEDIATRICS, V13, P133; ANCLIFF PJ, 2001, BLOOD, V98, P439; Belohradsky B H, 1978, Ergeb Inn Med Kinderheilkd, V41, P85; Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; den Dunnen JT, 2000, HUM MUTAT, V15, P7; DERRY JMJ, 1995, HUM MOL GENET, V4, P1127, DOI 10.1093/hmg/4.7.1127; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; Devriendt K, 2001, NAT GENET, V27, P313, DOI 10.1038/85886; Filipovich AH, 2001, BLOOD, V97, P1598, DOI 10.1182/blood.V97.6.1598; *HUM GEN VAR SOC, REC DESCR SEQ VAR; Imai K, 2004, BLOOD, V103, P456, DOI 10.1182/blood-2003-05-1480; IMAI K, 2004, WASPBASE DATABASE PU; Imai K, 2003, CURR OPIN ALLERGY CL, V3, P427, DOI 10.1097/01.all.0000104452.09202.9c; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Notarangelo LD, 2003, CURR OPIN IMMUNOL, V15, P585, DOI 10.1016/S0952-7915(03)00112-2; Ochs Hans D, 2005, Curr Opin Hematol, V12, P284, DOI 10.1097/01.moh.0000168520.98990.19; Ochs HD, 1999, PRIMARY IMMUNODEFICIENCY DISEASES, P292; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Schindelhauer D, 1996, HUM GENET, V98, P68, DOI 10.1007/s004390050162; SULLIVAN KE, 1994, J PEDIATR-US, V125, P876, DOI 10.1016/S0022-3476(05)82002-5; Thrasher AJ, 2000, CLIN EXP IMMUNOL, V120, P2, DOI 10.1046/j.1365-2249.2000.01193.x; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; WISKOTT A, 1937, MONATSSCHR KINDERH, V68, P212	25	17	17	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 26	2006	355	17					1790	1793		10.1056/NEJMoa062520	http://dx.doi.org/10.1056/NEJMoa062520			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098HV	17065640				2022-12-01	WOS:000241512500007
J	Libuda, DE; Winston, F				Libuda, Diana E.; Winston, Fred			Amplification of histone genes by circular chromosome formation in Saccharomyces cerevisiae	NATURE			English	Article							CHROMATIN-STRUCTURE; TRANSPOSABLE ELEMENTS; MEIOTIC RECOMBINATION; CELL-CYCLE; YEAST; TRANSCRIPTION; H2A; REPLICATION; SEQUENCE; SUBTYPES	Proper histone levels are critical for transcription, chromosome segregation, and other chromatin-mediated processes(1-7). In Saccharomyces cerevisiae, the histones H2A and H2B are encoded by two gene pairs, named HTA1-HTB1 and HTA2-HTB2 (ref. 8). Previous studies have demonstrated that when HTA2-HTB2 is deleted, HTA1-HTB1 dosage compensates at the transcriptional level(4,9). Here we show that a different mechanism of dosage compensation, at the level of gene copy number, can occur when HTA1-HTB1 is deleted. In this case, HTA2-HTB2 amplifies via creation of a new, small, circular chromosome. This duplication, which contains 39 kb of chromosome II, includes HTA2-HTB2, the histone H3-H4 locus HHT1-HHF1, a centromere and origins of replication. Formation of the new chromosome occurs by recombination between two Ty1 retrotransposon elements that flank this region. Following meiosis, recombination between these two particular Ty1 elements occurs at a greatly elevated level in hta1-htb1 Delta mutants, suggesting that a decreased level of histones H2A and H2B specifically stimulates this amplification of histone genes. Our results demonstrate another mechanism by which histone gene dosage is controlled to maintain genomic integrity.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Winston, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	winston@genetics.med.harvard.edu		Libuda, Diana/0000-0002-4944-1814	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032967] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM032967] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Aroya S, 2004, MOL CELL, V15, P221, DOI 10.1016/j.molcel.2004.06.002; CLARKADAMS CD, 1988, GENE DEV, V2, P150, DOI 10.1101/gad.2.2.150; Ercan S, 2005, MOL CELL BIOL, V25, P7976, DOI 10.1128/MCB.25.18.7976-7987.2005; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; HEREFORD L, 1979, CELL, V18, P1261, DOI 10.1016/0092-8674(79)90237-X; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; KOLODRUBETZ D, 1982, P NATL ACAD SCI-BIOL, V79, P7814, DOI 10.1073/pnas.79.24.7814; KUPIEC M, 1988, GENETICS, V119, P549; KUPIEC M, 1988, MOL CELL BIOL, V8, P2942, DOI 10.1128/MCB.8.7.2942; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; MORAN L, 1990, GENE DEV, V4, P752, DOI 10.1101/gad.4.5.752; NORRIS D, 1988, SCIENCE, V242, P759, DOI 10.1126/science.2847314; NORRIS D, 1987, MOL CELL BIOL, V7, P3473, DOI 10.1128/MCB.7.10.3473; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; ROEDER GS, 1983, MOL GEN GENET, V190, P117; RYKOWSKI MC, 1981, CELL, V25, P477, DOI 10.1016/0092-8674(81)90066-0; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wu XH, 1996, CELL, V87, P277, DOI 10.1016/S0092-8674(00)81345-8; Zeyl C, 2004, RES MICROBIOL, V155, P217, DOI 10.1016/j.resmic.2003.12.006	26	63	63	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					1003	1007		10.1038/nature05205	http://dx.doi.org/10.1038/nature05205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17066037	Green Accepted			2022-12-01	WOS:000241523400057
J	Downward, J				Downward, Julian			Signal transduction: Prelude to an anniversary for the RAS oncogene	SCIENCE			English	Editorial Material							GERMLINE MUTATIONS; ACTIVATION; KRAS		Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3PX, England	Cancer Research UK	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	julian.downward@cancer.org.uk	Downward, Julian/A-3251-2012	Downward, Julian/0000-0002-2331-4729				Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Augsten M, 2006, EMBO REP, V7, P46, DOI 10.1038/sj.embor.7400560; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; 2006, BEATS INT CANC C 24	11	34	37	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2006	314	5798					433	434		10.1126/science.1134727	http://dx.doi.org/10.1126/science.1134727			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053139				2022-12-01	WOS:000241382500031
J	Roux, I; Safieddine, S; Nouvian, R; Grati, M; Simmler, MC; Bahloul, I; Perfettini, I; Le Gall, M; Rostaing, P; Hamard, G; Triller, A; Avan, P; Moser, T; Petit, C				Roux, Isabelle; Safieddine, Saaid; Nouvian, Regis; Grati, M'hamed; Simmler, Marie-Christine; Bahloul, Isabelle; Perfettini, Isabelle; Le Gall, Morgane; Rostaing, Philippe; Hamard, Ghislaine; Triller, Antoine; Avan, Paul; Moser, Tobias; Petit, Christine			Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse	CELL			English	Article							INNER HAIR-CELLS; AFFERENT SYNAPSE; SYNAPTOTAGMIN-I; MEMBRANE REPAIR; TRANSMITTER RELEASE; MUSCULAR-DYSTROPHY; CALCIUM-DEPENDENCE; FUSION-COMPETENCE; CA(V)1.3 CHANNELS; CA2+ SENSOR	The auditory inner hair cell (IHC) ribbon synapse operates with an exceptional temporal precision and maintains a high level of neurotransmitter release. However, the molecular mechanisms underlying IHC synaptic exocytosis are largely unknown. We studied otoferlin, a predicted C2-domain transmembrane protein, which is defective in a recessive form of human deafness. We show that otoferlin expression in the hair cells correlates with afferent synapto-genesis and find that otoferlin localizes to ribbon-associated synaptic vesicles. Otoferlin binds Ca2+ and displays Ca2+,-dependent interactions with the SNARE proteins syntaxin1 and SNAP25. Otoferlin deficient mice (Otof(-/-)) are profoundly deaf. Exocytosis in Otof(-/-) IHCs is almost completely abolished, despite normal ribbon synapse morphogenesis and Ca2+ current. Thus, otoferlin is essential for a late step of synaptic vesicle exocytosis and may act as the major Ca2+ sensor triggering membrane fusion at the IHC ribbon synapse.	Inst Pasteur, Coll France, INSERM, UMRS587,Unite Genet Deficits Sensoriels, F-75015 Paris, France; Univ Gottingen, Dept Otolaryngol, D-37075 Gottingen, Germany; Univ Gottingen, Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; CNRS, UMR 7592, Inst Jacques Monod, F-75005 Paris, France; Inst Cochin, Plate Forme Recombinaison Homol, F-75014 Paris, France; Ecole Normale Super, INSERM, U497, F-75005 Paris, France; Fac Med, Lab Biophys Sensorielle, F-63001 Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; University of Gottingen; University of Gottingen; Wellcome Trust Sanger Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite de Franche-Comte	Petit, C (corresponding author), Inst Pasteur, Coll France, INSERM, UMRS587,Unite Genet Deficits Sensoriels, 25 Rue Dr Roux, F-75015 Paris, France.	cpetit@pasteur.fr	Roux, Isabelle/AAC-8120-2020; Nouvian, Regis/AAW-4207-2021; Nouvian, Regis/AFQ-8065-2022; Grati, M'hamed/C-9563-2011; Moser, Tobias/L-5068-2014; AVAN, Paul/J-6878-2015	Nouvian, Regis/0000-0002-0901-4666; Nouvian, Regis/0000-0002-0901-4666; Moser, Tobias/0000-0001-7145-0533; AVAN, Paul/0000-0003-1054-1479; Le Gall, Morgane/0000-0002-4935-7065; BAHLOUL, Amel/0000-0001-7042-4616; Grati, M'hamed/0000-0002-4490-1682; Grati, Mhamed/0000-0001-5149-3245; TRILLER, Antoine/0000-0002-7530-1233; Petit, Christine/0000-0002-9069-002X; Roux, Isabelle/0000-0001-7527-7520; Safieddine, Saaid/0000-0002-6159-0572				Achanzar WE, 1997, J CELL SCI, V110, P1073; Agulhon C, 2003, J COMP NEUROL, V462, P71, DOI 10.1002/cne.10712; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Brandt A, 2003, J NEUROSCI, V23, P10832; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Dallos P, 1991, Curr Opin Neurobiol, V1, P215, DOI 10.1016/0959-4388(91)90081-H; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; de Caprona MDC, 2004, BRAIN RES BULL, V64, P289, DOI 10.1016/j.brainresbull.2004.08.004; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; Eybalin M, 2002, EUR J NEUROSCI, V15, P1409, DOI 10.1046/j.1460-9568.2002.01978.x; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Johnson SL, 2005, J PHYSIOL-LONDON, V563, P177, DOI 10.1113/jphysiol.2004.074740; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Kee Y, 1996, J NEUROSCI, V16, P1975; Keen EC, 2006, P NATL ACAD SCI USA, V103, P5537, DOI 10.1073/pnas.0601103103; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; KIM DO, 1986, HEARING RES, V22, P105, DOI 10.1016/0378-5955(86)90088-2; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Le Calvez S, 1998, HEARING RES, V120, P51, DOI 10.1016/S0378-5955(98)00051-3; Lenzi D, 2001, BIOESSAYS, V23, P831, DOI 10.1002/bies.1118; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; Margittai M, 2003, BIOCHEMISTRY-US, V42, P4009, DOI 10.1021/bi027437z; Matsubara A, 1996, J NEUROSCI, V16, P4457; MerchanPerez A, 1996, J COMP NEUROL, V371, P208, DOI 10.1002/(SICI)1096-9861(19960722)371:2<208::AID-CNE2>3.0.CO;2-6; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; PUJOL R, 1998, DEV SENSORY NEURAL S; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROBERTSON D, 1992, J MICROSC-OXFORD, V168, P85, DOI 10.1111/j.1365-2818.1992.tb03253.x; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; Rodriguez-Ballesteros M, 2003, HUM MUTAT, V22, P451, DOI 10.1002/humu.10274; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Safieddine S, 2002, MOL CELL NEUROSCI, V20, P343, DOI 10.1006/mcne.2002.1120; Safieddine S, 1997, J NEUROSCI, V17, P7523; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shin OH, 2005, J BIOL CHEM, V280, P1641, DOI 10.1074/jbc.M407305200; SOBKOWICZ HM, 1986, J NEUROCYTOL, V15, P693, DOI 10.1007/BF01625188; STEEL KPH, 1992, DEV AUDITORY VESTIBU, P221; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Varga R, 2003, J MED GENET, V40, P45, DOI 10.1136/jmg.40.1.45; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	74	412	456	1	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					277	289		10.1016/j.cell.2006.08.040	http://dx.doi.org/10.1016/j.cell.2006.08.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055430	Bronze			2022-12-01	WOS:000241827100016
J	Lein, ES; Hawrylycz, MJ; Ao, N; Ayres, M; Bensinger, A; Bernard, A; Boe, AF; Boguski, MS; Brockway, KS; Byrnes, EJ; Chen, L; Chen, L; Chen, TM; Chin, MC; Chong, J; Crook, BE; Czaplinska, A; Dang, CN; Datta, S; Dee, NR; Desaki, AL; Desta, T; Diep, E; Dolbeare, TA; Donelan, MJ; Dong, HW; Dougherty, JG; Duncan, BJ; Ebbert, AJ; Eichele, G; Estin, LK; Faber, C; Facer, BA; Fields, R; Fischer, SR; Fliss, TP; Frensley, C; Gates, SN; Glattfelder, KJ; Halverson, KR; Hart, MR; Hohmann, JG; Howell, MP; Jeung, DP; Johnson, RA; Karr, PT; Kawal, R; Kidney, JM; Knapik, RH; Kuan, CL; Lake, JH; Laramee, AR; Larsen, KD; Lau, C; Lemon, TA; Liang, AJ; Liu, Y; Luong, LT; Michaels, J; Morgan, JJ; Morgan, RJ; Mortrud, MT; Mosqueda, NF; Ng, LL; Ng, R; Orta, GJ; Overly, CC; Pak, TH; Parry, SE; Pathak, SD; Pearson, OC; Puchalski, RB; Riley, ZL; Rockett, HR; Rowland, SA; Royall, JJ; Ruiz, MJ; Sarno, NR; Schaffnit, K; Shapovalova, NV; Sivisay, T; Slaughterbeck, CR; Smith, SC; Smith, KA; Smith, BI; Sodt, AJ; Stewart, NN; Stumpf, KR; Sunkin, SM; Sutram, M; Tam, A; Teemer, CD; Thaller, C; Thompson, CL; Varnam, LR; Visel, A; Whitlock, RM; Wohnoutka, PE; Wolkey, CK; Wong, VY; Wood, M; Yaylaoglu, MB; Young, RC; Youngstrom, BL; Yuan, XF; Zhang, B; Zwingman, TA; Jones, AR				Lein, Ed S.; Hawrylycz, Michael J.; Ao, Nancy; Ayres, Mikael; Bensinger, Amy; Bernard, Amy; Boe, Andrew F.; Boguski, Mark S.; Brockway, Kevin S.; Byrnes, Emi J.; Chen, Lin; Chen, Li; Chen, Tsuey-Ming; Chin, Mei Chi; Chong, Jimmy; Crook, Brian E.; Czaplinska, Aneta; Dang, Chinh N.; Datta, Suvro; Dee, Nick R.; Desaki, Aimee L.; Desta, Tsega; Diep, Ellen; Dolbeare, Tim A.; Donelan, Matthew J.; Dong, Hong-Wei; Dougherty, Jennifer G.; Duncan, Ben J.; Ebbert, Amanda J.; Eichele, Gregor; Estin, Lili K.; Faber, Casey; Facer, Benjamin A.; Fields, Rick; Fischer, Shanna R.; Fliss, Tim P.; Frensley, Cliff; Gates, Sabrina N.; Glattfelder, Katie J.; Halverson, Kevin R.; Hart, Matthew R.; Hohmann, John G.; Howell, Maureen P.; Jeung, Darren P.; Johnson, Rebecca A.; Karr, Patrick T.; Kawal, Reena; Kidney, Jolene M.; Knapik, Rachel H.; Kuan, Chihchau L.; Lake, James H.; Laramee, Annabel R.; Larsen, Kirk D.; Lau, Christopher; Lemon, Tracy A.; Liang, Agnes J.; Liu, Ying; Luong, Lon T.; Michaels, Jesse; Morgan, Judith J.; Morgan, Rebecca J.; Mortrud, Marty T.; Mosqueda, Nerick F.; Ng, Lydia L.; Ng, Randy; Orta, Geralyn J.; Overly, Caroline C.; Pak, Tu H.; Parry, Sheana E.; Pathak, Sayan D.; Pearson, Owen C.; Puchalski, Ralph B.; Riley, Zackery L.; Rockett, Hannah R.; Rowland, Stephen A.; Royall, Joshua J.; Ruiz, Marcos J.; Sarno, Nadia R.; Schaffnit, Katherine; Shapovalova, Nadiya V.; Sivisay, Taz; Slaughterbeck, Clifford R.; Smith, Simon C.; Smith, Kimberly A.; Smith, Bryan I.; Sodt, Andy J.; Stewart, Nick N.; Stumpf, Kenda-Ruth; Sunkin, Susan M.; Sutram, Madhavi; Tam, Angelene; Teemer, Carey D.; Thaller, Christina; Thompson, Carol L.; Varnam, Lee R.; Visel, Axel; Whitlock, Ray M.; Wohnoutka, Paul E.; Wolkey, Crissa K.; Wong, Victoria Y.; Wood, Matthew; Yaylaoglu, Murat B.; Young, Rob C.; Youngstrom, Brian L.; Yuan, Xu Feng; Zhang, Bin; Zwingman, Theresa A.; Jones, Allan R.			Genome-wide atlas of gene expression in the adult mouse brain	NATURE			English	Article							IN-SITU HYBRIDIZATION; HIPPOCAMPAL-FORMATION; PROTEIN-SYNTHESIS; RAT; ORGANIZATION; NEURONS; PATTERNS; MEMORY; PROFILES; DATABASE	Molecular approaches to understanding the functional circuitry of the nervous system promise new insights into the relationship between genes, brain and behaviour. The cellular diversity of the brain necessitates a cellular resolution approach towards understanding the functional genomics of the nervous system. We describe here an anatomically comprehensive digital atlas containing the expression patterns of,20,000 genes in the adult mouse brain. Data were generated using automated high-throughput procedures for in situ hybridization and data acquisition, and are publicly accessible online. Newly developed image-based informatics tools allow global genome-scale structural analysis and cross-correlation, as well as identification of regionally enriched genes. Unbiased fine-resolution analysis has identified highly specific cellular markers as well as extensive evidence of cellular heterogeneity not evident in classical neuroanatomical atlases. This highly standardized atlas provides an open, primary data resource for a wide variety of further studies concerning brain organization and function.	Allen Inst Brain Sci, Seattle, WA 98103 USA; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Max Planck Inst Biophys Chem, Dept Genes & Behav, D-37077 Gottingen, Germany	Allen Institute for Brain Science; Baylor College of Medicine; Max Planck Society	Lein, ES (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	edl@alleninstitute.org; allanj@alleninstitute.org	Visel, Axel/A-9398-2009; Morgan, James/GRO-2905-2022; Martinez, Octavio/B-7375-2009; Morgan, James/N-8104-2018; Wood, Matthew/HDN-1469-2022	Visel, Axel/0000-0002-4130-7784; Morgan, James/0000-0002-8920-1065; Dee, Nick/0000-0002-2831-9254; Wood, Matthew/0000-0002-5436-6011; Karr, Paul/0000-0003-3560-2178; Larsen, Kirk/0000-0002-7809-2916; Bernard, Amy/0000-0003-2540-1153; Pathak, Shankar D/0000-0001-9689-7577; Thompson, Carol/0000-0003-1528-3237				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Boguski MS, 2004, NAT NEUROSCI, V7, P429, DOI 10.1038/nn1232; Brecht M, 2004, J NEUROSCI, V24, P9223, DOI 10.1523/JNEUROSCI.3344-04.2004; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chan TF, 2005, IMAGE PROCESSING AND ANALYSIS, P1, DOI 10.1137/1.9780898717877; Christiansen JH, 2006, NUCLEIC ACIDS RES, V34, pD637, DOI 10.1093/nar/gkj006; Datson NA, 2001, HIPPOCAMPUS, V11, P430, DOI 10.1002/hipo.1058; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GRAVEL C, 1990, J COMP NEUROL, V291, P79, DOI 10.1002/cne.902910107; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Heuer H, 2003, NEUROSCIENCE, V119, P43, DOI 10.1016/S0306-4522(03)00100-3; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Kamme F, 2003, J NEUROSCI, V23, P3607; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; NG L, IN PRESS IEEE T COMP; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Siddiqui AS, 2005, P NATL ACAD SCI USA, V102, P18485, DOI 10.1073/pnas.0509455102; Small SA, 2002, REV NEUROSCIENCE, V13, P183; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Swanson L. W, 2004, BRAIN MAPS STRUCTURE; THOMPSON PM, 2000, HDB MED IMAGING PROC; Tole S, 1997, DEVELOPMENT, V124, P4959; Toledo-Rodriguez M, 2005, J PHYSIOL-LONDON, V567, P401, DOI 10.1113/jphysiol.2005.089250; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; Vavouri T, 2005, CURR OPIN GENET DEV, V15, P395, DOI 10.1016/j.gde.2005.05.002; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; VOOGD J, 1987, PARASAGITTAL ZONATIO; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	55	3451	3489	11	248	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					168	176		10.1038/nature05453	http://dx.doi.org/10.1038/nature05453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17151600				2022-12-01	WOS:000243384300043
J	Mitro, N; Mak, PA; Vargas, L; Godio, C; Hampton, E; Molteni, V; Kreusch, A; Saez, E				Mitro, Nico; Mak, Puiying A.; Vargas, Leo; Godio, Cristina; Hampton, Eric; Molteni, Valentina; Kreusch, Andreas; Saez, Enrique			The nuclear receptor LXR is a glucose sensor	NATURE			English	Article							ELEMENT-BINDING PROTEIN-1C; X-RECEPTOR; LIVER; METABOLISM; ALPHA; TRANSCRIPTION; MICE; HOMEOSTASIS; LIPOGENESIS; DEFICIENCY	The liver has a central role in glucose homeostasis, as it has the distinctive ability to produce and consume glucose(1). On feeding, glucose influx triggers gene expression changes in hepatocytes to suppress endogenous glucose production and convert excess glucose into glycogen or fatty acids to be stored in adipose tissue(2). This process is controlled by insulin, although debate exists as to whether insulin acts directly or indirectly on the liver(3). In addition to stimulating pancreatic insulin release, glucose also regulates the activity of ChREBP, a transcription factor that modulates lipogenesis(4). Here we describe another mechanism whereby glucose determines its own fate: we show that glucose binds and stimulates the transcriptional activity of the liver X receptor (LXR), a nuclear receptor that coordinates hepatic lipid metabolism. D-Glucose and D-glucose-6-phosphate are direct agonists of both LXR-alpha and LXR-beta. Glucose activates LXR at physiological concentrations expected in the liver and induces expression of LXR target genes with efficacy similar to that of oxysterols, the known LXR ligands. Cholesterol homeostasis genes that require LXR for expression are upregulated in liver and intestine of fasted mice re-fed with a glucose diet, indicating that glucose is an endogenous LXR ligand. Our results identify LXR as a transcriptional switch that integrates hepatic glucose metabolism and fatty acid synthesis.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute	Saez, E (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Hopkins Dr, San Diego, CA 92121 USA.	esaez@scripps.edu		Godio, Cristina/0000-0003-2639-6368; Mitro, Nico/0000-0002-5000-3619				Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Cherrington AD, 2005, J CLIN INVEST, V115, P1136, DOI 10.1172/JCI200525152; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Fehr M, 2004, J FLUORESC, V14, P603, DOI 10.1023/B:JOFL.0000039347.94943.99; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Moore MC, 2003, BEST PRACT RES CL EN, V17, P343, DOI 10.1016/S1521-690X(03)00036-8; Parks EJ, 2002, P NUTR SOC, V61, P281, DOI 10.1079/PNS2002148; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; STEHNOBITTEL L, 1995, SCIENCE, V270, P1835, DOI 10.1126/science.270.5243.1835; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409	24	406	434	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					219	223		10.1038/nature05449	http://dx.doi.org/10.1038/nature05449			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17187055				2022-12-01	WOS:000243384300054
J	Canfield, DE; Poulton, SW; Narbonne, GM				Canfield, Don E.; Poulton, Simon W.; Narbonne, Guy M.			Late-Neoproterozoic deep-ocean oxygenation and the rise of animal life	SCIENCE			English	Article							MISTAKEN POINT; SNOWBALL; IRON; PRESERVATION; ORIGIN	Because animals require oxygen, an increase in late-Neoproterozoic oxygen concentrations has been suggested as a stimulus for their evolution. The iron content of deep-sea sediments shows that the deep ocean was anoxic and ferruginous before and during the Gaskiers glaciation 580 million years ago and that it became oxic afterward. The first known members of the Ediacara biota arose shortly after the Gaskiers glaciation, suggesting a causal link between their evolution and this oxygenation event. A prolonged stable oxic environment may have permitted the emergence of bilateral motile animals some 25 million years later.	Univ So Denmark, Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark; Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Queens Univ, Dept Geol Sci & Geol Engn, Kingston, ON K7L 3N6, Canada	University of Southern Denmark; University of Southern Denmark; Newcastle University - UK; Queens University - Canada	Canfield, DE (corresponding author), Univ So Denmark, Nord Ctr Earth Evolut, Campusvej 55, DK-5230 Odense M, Denmark.	dec@biology.sdu.dk	Narbonne, Guy M/I-7518-2012; Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366; Poulton, Simon/0000-0001-7621-189X	Natural Environment Research Council [NE/C518465/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Benus AP., 1988, GEOLOGICAL SURVEY B, P8; BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BOWRING SA, 2003, ASTROBIOLOGY, V2, P112; Broecker W., 1982, TRACERS SEA; CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; CANFIELD DE, 1994, CHEM GEOL, V114, P315, DOI 10.1016/0009-2541(94)90061-2; Clapham ME, 2003, PALEOBIOLOGY, V29, P527, DOI 10.1666/0094-8373(2003)029<0527:POTOKA>2.0.CO;2; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GARDINER S, 1988, CAN J EARTH SCI, V25, P1579, DOI 10.1139/e88-151; Gorjan P, 2000, PRECAMBRIAN RES, V100, P151, DOI 10.1016/S0301-9268(99)00073-X; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Halverson Galen P., 2006, V27, P231; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Hurtgen MT, 2006, EARTH PLANET SC LETT, V245, P551, DOI 10.1016/j.epsl.2006.03.026; Knoll AH, 2006, LETHAIA, V39, P13, DOI 10.1080/00241160500409223; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Knoll AH, 2003, LIFE YOUNG PLANET 1; Marshall CR, 2006, ANNU REV EARTH PL SC, V34, P355, DOI 10.1146/annurev.earth.33.031504.103001; MISRA SB, 1971, GEOL SOC AM BULL, V82, P979, DOI 10.1130/0016-7606(1971)82[979:SADHOL]2.0.CO;2; NARBONNE G. M., 2005, LIFE SNOWBALL MISTAK; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; NARBONNE GM, 2001, B5 GEOL ASS CAN; Olcott AN, 2006, GEOCHIM COSMOCHIM AC, V70, pA456, DOI 10.1016/j.gca.2006.06.918; Olcott AN, 2005, SCIENCE, V310, P471, DOI 10.1126/science.1115769; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Poulton SW, 2002, AM J SCI, V302, P774, DOI 10.2475/ajs.302.9.774; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; RUNNEGAR B, 1991, GLOBAL PLANET CHANGE, V97, P97; SCOTESE CR, 2001, PALEOMAP PROJECT, V51; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; WILLIAMS H, 1979, GEOL SURV CAN MEM, V389; Wood DA, 2003, CAN J EARTH SCI, V40, P1375, DOI 10.1139/E03-048; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318	37	659	732	10	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2007	315	5808					92	95		10.1126/science.1135013	http://dx.doi.org/10.1126/science.1135013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	122WU	17158290				2022-12-01	WOS:000243259100042
J	Greenaway, C; Dongier, P; Boivin, JF; Tapiero, B; Miller, M; Schwartzman, K				Greenaway, Christina; Dongier, Pierre; Boivin, Jean-Francois; Tapiero, Bruce; Miller, Mark; Schwartzman, Kevin			Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees	ANNALS OF INTERNAL MEDICINE			English	Article							VISITING FRIENDS; UNITED-STATES; EPIDEMIOLOGY; ELIMINATION	Background: Despite effective vaccination programs for measles, mumps, and rubella in the United States and Canada, outbreaks continue to occur in susceptible subgroups, such as foreign-born persons. Objective: To determine the susceptibility of newly arrived immigrants and refugees to measles, mumps, and rubella. Design: Seroprevalence study. etting: Two hospitals and three community clinics in Montreal, Quebec, Canada. Patients: 1480 adult immigrants and refugees who were recruited from October 2002 to December 2004. Measurements: Sociodemographic and clinical data and serology for measles, mumps, and rubella. Results: Thirty-six percent (range, 22% to 54%) of the study population was nonimmune to at least 1 of the 3 diseases. This proportion varied by age, sex, and region of origin. In multivariate analysis and after adjustment for region of origin, age, and socioeconomic factors, immigrant women had higher odds (odds ratio, 2.1) of being immune to measles (95% CI, 1.2 to 3.8) and an odds ratio of 1.7 of being nonimmune to rubella (CI, 1.2 to 2.6) compared with immigrant men. Limitations: The results from the community-based convenience sample of immigrants may not be generalizable to all immigrant populations. Conclusions: Many new immigrants and refugees, particularly women, are susceptible to measles, mumps, or rubella and may benefit from targeted vaccination programs.	McGill Univ, Sir Mortimer B Davis Jewish Hosp, Cote des Neiges Local Community Hlth Ctr, Div Infect Dis, Montreal, PQ H3T 1E2, Canada; Hop St Justine, Montreal, PQ H3T 1C5, Canada	McGill University; Universite de Montreal	Greenaway, C (corresponding author), McGill Univ, Sir Mortimer B Davis Jewish Hosp, Cote des Neiges Local Community Hlth Ctr, Div Infect Dis, 3755 Cote St Catherine Rd,Room G-143, Montreal, PQ H3T 1E2, Canada.	ca.greenaway@mcgill.ca						Angell SY, 2005, ANN INTERN MED, V142, P67, DOI 10.7326/0003-4819-142-1-200501040-00013; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856; Barnett ED, 2002, CLIN INFECT DIS, V35, P403, DOI 10.1086/341772; *CAN NAT REP IMM, 1999, PEADIAT CHILD HL SC, V4, pC5; *CDC, TECHN INSTR PAN PHYS; Gershman K., 2006, Morbidity and Mortality Weekly Report, V55, P559; *IMM QUEB GOV QUEB, 2001, PORTR IMM POP 2001 C; King A, 2004, J INFECT DIS, V189, pS236, DOI 10.1086/378499; Oster NV, 2004, J INFECT DIS, V189, pS48, DOI 10.1086/374854; Papania MJ, 2004, J INFECT DIS, V189, pS61, DOI 10.1086/381557; Reef SE, 2002, JAMA-J AM MED ASSOC, V287, P464, DOI 10.1001/jama.287.4.464; *STAT CAN, 2001, IMM CIT 2001 CENS OT; U.S. Census Bureau, 2000 CENS POP HOUS; United Nations, 2002, INT MIGR REP 2002; *WHO, 2004, WHO VACC PREV DIS MO; Willis Bayo C., 2005, Morbidity and Mortality Weekly Report, V54, P1; 1994, MMWR MORB MORTAL WKL, V43, P391; 1994, MMWR MORB MORTAL WKL, V43, P397	19	33	33	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2007	146	1					20	W4		10.7326/0003-4819-146-1-200701020-00005	http://dx.doi.org/10.7326/0003-4819-146-1-200701020-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188BK	17200218				2022-12-01	WOS:000247893300003
J	Sandblad, L; Busch, KE; Tittmann, P; Gross, H; Brunner, D; Hoenger, A				Sandblad, Linda; Busch, Karl Emanuel; Tittmann, Peter; Gross, Heinz; Brunner, Damian; Hoenger, Andreas			The Schizosaccharomyces pombe EB1 homolog Mal3p binds and stabilizes the microtubule lattice seam	CELL			English	Article							END-TRACKING PROTEINS; 3-DIMENSIONAL STRUCTURE; STRUCTURAL INSIGHTS; BETA-TUBULIN; IN-VITRO; KINESIN; TIP1P; DECORATION; COOPERATE; DYNAMICS	End binding 1 (EB1) proteins are highly conserved regulators of microtubule dynamics. Using electron microscopy (EM) and high-resolution surface shadowing we have studied the microtubule-binding properties of the fission yeast EB1 homolog Mal3p. This allowed for a direct visualization of Mal3p bound on the surface of microtubules. Mal3p particles usually formed a single line on each microtubule along just one of the multiple grooves that are formed by adjacent protofilaments. We provide structural data showing that the alignment of Mal3p molecules coincides with the microtubule lattice seam as well as data suggesting that Mal3p not only binds but also stabilizes this seam. Accordingly, Mal3p stabilizes microtubules through a specific interaction with what is potentially the weakest part of the microtubule in a way not previously demonstrated. Our findings further suggest that microtubules exhibit two distinct reaction platforms on their surface that can independently interact with target structures such as microtubule-associated proteins, motors, kinetochores, or membranes.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; ETH, Swiss Fed Inst Technol, Electron Microscopy Ctr, CH-8093 Zurich, Switzerland; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Colorado System; University of Colorado Boulder	Brunner, D (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	brunner@embl.de; andreas.hoenger@colorado.edu	Brunner, Damian/F-2024-2011	Hoenger, Andreas/0000-0001-9176-6658; Busch, Karl Emanuel/0000-0001-7886-3226; Brunner, Damian/0000-0001-5250-492X				AFZELIUS BA, 1990, J CELL SCI, V95, P207; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; AMOS LA, 1979, NATURE, V279, P607, DOI 10.1038/279607a0; AMOS LA, 1974, J CELL SCI, V14, P523; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Austin JR, 2005, J CELL SCI, V118, P3895, DOI 10.1242/jcs.02512; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; BEURON F, 2001, STRUCTURAL ANAL MICR, V164; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; CHRETIEN D, 1991, BIOL CELL, V71, P161, DOI 10.1016/0248-4900(91)90062-R; Chretien D, 1996, STRUCTURE, V4, P1031, DOI 10.1016/S0969-2126(96)00110-4; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Dias DP, 1999, J MOL BIOL, V287, P287, DOI 10.1006/jmbi.1999.2597; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; GROSS H, 1990, 12TH P INT C MICR, V1, P510; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; Hoenger A, 2000, BIOL CHEM, V381, P1001, DOI 10.1515/BC.2000.123; HOENGER A, 1995, NATURE, V376, P271, DOI 10.1038/376271a0; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; KIKKAWA M, 1994, J CELL BIOL, V127, P1965, DOI 10.1083/jcb.127.6.1965; Ligon LA, 2006, FEBS LETT, V580, P1327, DOI 10.1016/j.febslet.2006.01.050; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; MANDELKOW EM, 1985, J MOL BIOL, V181, P123, DOI 10.1016/0022-2836(85)90330-4; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Santarella RA, 2004, J MOL BIOL, V339, P539, DOI 10.1016/j.jmb.2004.04.008; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; SMITH PR, 1977, J ULTRA MOL STRUCT R, V61, P124, DOI 10.1016/S0022-5320(77)90011-9; SONG YH, 1995, J CELL BIOL, V128, P81, DOI 10.1083/jcb.128.1.81; SONG YH, 1993, P NATL ACAD SCI USA, V90, P1671, DOI 10.1073/pnas.90.5.1671; Song YH, 2001, EMBO J, V20, P6213, DOI 10.1093/emboj/20.22.6213; Sosa H, 1996, J MOL BIOL, V260, P743, DOI 10.1006/jmbi.1996.0434; SU LK, 1995, CANCER RES, V55, P2972; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042	47	123	125	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1415	1424		10.1016/j.cell.2006.11.025	http://dx.doi.org/10.1016/j.cell.2006.11.025			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190604	Bronze			2022-12-01	WOS:000243690000020
J	Aylwin, CJ; Konig, TC; Brennan, NW; Shirley, PJ; Davies, G; Walsh, MS; Brohi, K				Aylwin, Christopher J.; Koenig, Thomas C.; Brennan, Nora W.; Shirley, Peter J.; Davies, Gareth; Walsh, Michael S.; Brohi, Karim			Reduction in critical mortality in urban mass casualty incidents: analysis of triage, surge, and resource use after the London bombings on July 7, 2005	LANCET			English	Article							TERRORIST BOMBINGS; TRAUMA CARE; INJURIES; MANAGEMENT; CITY	Background The terrorist bombings in London on July 7, 2005, produced the largest mass casualty event in the UK since World War 2. The aim of this study was to analyse the prehospital and in-hospital response to the incident and identify system processes that optimise resource use and reduce critical mortality. Methods This study was a retrospective analysis of the London-wide prehospital response and the in-hospital response of one academic trauma Centre. Data for injuries, outcome, triage, patient flow, and resource use were obtained by the review of emergency services and hospital records. Findings There were 775 casualties and 56 deaths, 53 at scene. 55 patients were triaged to priority dispatch and 20 patients were critically injured. Critical mortality was low at 15% and not due to poor availability of resources. Over-triage rates were reduced where advanced prehospital teams did initial scene triage. The Royal London Hospital received 194 casualties, 27 arrived as seriously injured. Maximum surge rate was 18 seriously injured patients per hour and resuscitation room capacity was reached within 15 min. 17 patients needed surgery and 264 units of blood products were used in the first 15 h, close to the hospital's routine daily blood use. Interpretation Critical mortality was reduced by rapid advanced major incident management and seems unrelated to over-triage. Hospital surge capacity can be maintained by repeated effective triage and implementing a hospital-wide damage control philosophy, keeping investigations to a minimum, and transferring patients rapidly to definitive care.	Royal London Hosp, Dept Trauma Surg, London E1 1BB, England; Royal London Hosp, Dept Intens Care Med, London E1 1BB, England; Royal London Hosp, Dept Emergency Med & Prehosp Care, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital	Brohi, K (corresponding author), Royal London Hosp, Dept Trauma Surg, London E1 1BB, England.	karim@trauma.org						[Anonymous], EMERGO TRAIN SYSTEM; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Biancolini CA, 1999, J TRAUMA, V47, P728, DOI 10.1097/00005373-199910000-00019; Christie P M, 1998, J Med Syst, V22, P289; Cushman JG, 2003, J TRAUMA, V54, P147, DOI 10.1097/00005373-200301000-00018; de Ceballos JPG, 2005, CRIT CARE, V9, P104, DOI 10.1186/cc2995; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Frykberg ER, 2002, J TRAUMA, V53, P201, DOI 10.1097/00005373-200208000-00001; FRYKBERG ER, 1987, MIL MED, V152, P563; Hirshberg A, 1999, J TRAUMA, V47, P545, DOI 10.1097/00005373-199909000-00020; Hirshberg A, 2001, ANN EMERG MED, V37, P647, DOI 10.1067/mem.2001.115650; Hirshberg A, 2005, J TRAUMA, V58, P686, DOI 10.1097/01.TA.0000159243.70507.86; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Lockey DJ, 2005, RESUSCITATION, V66, pIX, DOI 10.1016/j.resuscitation.2005.07.005; *LOND EM SERV LIAI, MAJ INC PROC MAN; Mackway-Jones K, 2019, MAJOR INCIDENT MEDIC, V2; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; Moore FA, 2004, LANCET, V363, P1988, DOI 10.1016/S0140-6736(04)16415-5; Schmidt PJ, 2002, NEW ENGL J MED, V346, P617, DOI 10.1056/NEJM200202213460813; *WHO, 2005, WHO ANN REP HLTH ACT	20	270	279	2	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 23	2006	368	9554					2219	2225		10.1016/S0140-6736(06)69896-6	http://dx.doi.org/10.1016/S0140-6736(06)69896-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189033				2022-12-01	WOS:000243076800029
J	Abu-Raddad, LJ; Patnaik, P; Kublin, JG				Abu-Raddad, Laith J.; Patnaik, Padmaja; Kublin, James G.			Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CLINICAL EPISODES; ADULTS; TRANSMISSION; REPLICATION; UGANDA; TUBERCULOSIS; ACTIVATION; INDUCTION; COHORT	Mounting evidence has revealed pathological interactions between HIV and malaria in dually infected patients, but the public health implications of the interplay have remained unclear. A transient almost one-log elevation in HIV viral load occurs during febrile malaria episodes; in addition, susceptibility to malaria is enhanced in HIV-infected patients. A mathematical model applied to a setting in Kenya with an adult population of roughly 200,000 estimated that, since 1980, the disease interaction may have been responsible for 8,500 excess HIV infections and 980,000 excess malaria episodes. Co-infection might also have facilitated the geographic expansion of malaria in areas where HIV prevalence is high. Hence, transient and repeated increases in HIV viral load resulting from recurrent co-infection with malaria may be an important factor in promoting the spread of HIV in sub-Saharan Africa.	Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA; Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27599 USA; Univ Washington, Int Hlth Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Abu-Raddad, LJ (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA.	laith@scharp.org; jkublin@fhcrc.org	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Kublin, James/0000-0003-1279-3741	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI 27757] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2004, MAL HIV INT THEIR IM; BRUCE-CHWATT L. J., 1963, W AFRICAN MED JOUR, V12, P199; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Froebel K, 2004, PARASITE IMMUNOL, V26, P213, DOI 10.1111/j.0141-9838.2004.00701.x; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; *JOINT UN PROGR HI, AIDS EP UP 2005; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Kirungi WL, 2006, SEX TRANSM INFECT, V82, pI36, DOI 10.1136/sti.2005.017111; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Maher D, 2005, TROP MED INT HEALTH, V10, P734, DOI 10.1111/j.1365-3156.2005.01456.x; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Patnaik P, 2005, J INFECT DIS, V192, P984, DOI 10.1086/432730; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pisell TL, 2002, AIDS, V16, P1503, DOI 10.1097/00002030-200207260-00007; Quigley MA, 2005, TROP MED INT HEALTH, V10, P894, DOI 10.1111/j.1365-3156.2005.01461.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Whitworth JAG, 2005, LANCET, V365, P196; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212	28	309	321	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2006	314	5805					1603	1606		10.1126/science.1132338	http://dx.doi.org/10.1126/science.1132338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113UX	17158329				2022-12-01	WOS:000242624600044
J	Anderson, ARA; Weaver, AM; Cummings, PT; Quaranta, V				Anderson, Alexander R. A.; Weaver, Alissa M.; Cummings, Peter T.; Quaranta, Vito			Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment	CELL			English	Article							GROWTH; MODEL; METASTASIS; PROGRESSION	Emergence of invasive behavior in cancer is life-threatening, yet ill-defined due to its multifactorial nature. We present a multiscale mathematical model of cancer invasion, which considers cellular and microenvironmental factors simultaneously and interactively. Unexpectedly, the model simulations predict that harsh tumor microenvironment conditions (e.g., hypoxia, heterogenous extracellular matrix) exert a dramatic selective force on the tumor, which grows as an invasive mass with fingering margins, dominated by a few clones with aggressive traits. In contrast, mild microenvironment conditions (e.g., normoxia, homogeneous matrix) allow clones with similar aggressive traits to coexist with less aggressive phenotypes in a heterogeneous tumor mass with smooth, noninvasive margins. Thus, the genetic make-up of a cancer cell may realize its invasive potential through a clonal evolution process driven by definable microenvironmental selective forces. Our mathematical model provides a theoretical/ experimental framework to quantitatively characterize this selective pressure for invasion and test ways to eliminate it.	Univ Dundee, Div Math, Dundee DD1 4HN, Scotland; Vanderbilt Univ, Dept Chem Engn, Nashville, TN 37235 USA; Oak Ridge Natl Lab, Nanomat Theory Inst, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA	University of Dundee; Vanderbilt University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; Vanderbilt University	Anderson, ARA (corresponding author), Univ Dundee, Div Math, Dundee DD1 4HN, Scotland.	anderson@maths.dundee.ac.uk; vito.quaranta@vanderbilt.edu	Cummings, Peter T/B-8762-2013; Quaranta, Vito/G-6512-2016; Anderson, Alexander R.A./A-2713-2011	Cummings, Peter T/0000-0002-9766-2216; Quaranta, Vito/0000-0001-7491-8672; Anderson, Alexander R.A./0000-0002-2536-4383	NATIONAL CANCER INSTITUTE [U54CA113007, K22CA109590] Funding Source: NIH RePORTER; NCI NIH HHS [K22 CA109590, U54 CA113007] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Anderson ARA, 1997, FUND APPL NEMATOL, V20, P165; AndersonAR ChaplainMA, 2000, J THEORETICAL MED, V2, P129, DOI DOI 10.1080/10273660008833042; Araujo RP, 2004, B MATH BIOL, V66, P1039, DOI 10.1016/j.bulm.2003.11.002; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chaplain MAJ, 1996, MATH COMPUT MODEL, V23, P47, DOI 10.1016/0895-7177(96)00019-2; EIGEN M, 1993, GENE, V135, P37, DOI 10.1016/0378-1119(93)90047-7; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Kerbel R S, 1990, Adv Cancer Res, V55, P87, DOI 10.1016/S0065-230X(08)60469-8; KORCZAK B, 1988, MOL CELL BIOL, V8, P3143, DOI 10.1128/MCB.8.8.3143; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liotta LA, 2003, NAT GENET, V33, P10, DOI 10.1038/ng0103-10; Maley CC, 2005, SEMIN CANCER BIOL, V15, P474, DOI 10.1016/j.semcancer.2005.06.004; Matrisian LM, 2001, CANCER RES, V61, P3844; Michor F, 2005, SEMIN CANCER BIOL, V15, P484, DOI 10.1016/j.semcancer.2005.06.005; Michor F, 2004, CELL CYCLE, V3, P358; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; RAK JW, 1993, IN VITRO CELL DEV-AN, V29A, P742; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rubin H, 2003, ADV CANCER RES, V90, P1, DOI 10.1016/S0065-230X(03)90001-7; Weiss L, 1990, Adv Cancer Res, V54, P159, DOI 10.1016/S0065-230X(08)60811-8; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327	33	513	525	1	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					905	915		10.1016/j.cell.2006.09.042	http://dx.doi.org/10.1016/j.cell.2006.09.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129778	Bronze			2022-12-01	WOS:000242613800009
J	Cheeseman, IM; Chappie, JS; Wilson-Kubalek, EM; Desai, A				Cheeseman, Iain M.; Chappie, Joshua S.; Wilson-Kubalek, Elizabeth M.; Desai, Arshad			The conserved KMN network constitutes the core microtubule-binding site of the kinetochore	CELL			English	Article							OUTER KINETOCHORE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; SPINDLE CHECKPOINT; NDC80 COMPLEX; ATTACHMENT; ARCHITECTURE; COMPONENTS; INTERFACE; DYNAMICS	The microtubule-binding interface of the kinetochore is of central importance in chromosome segregation. Although kinetochore components that stabilize, translocate on, and affect the polymerization state of microtubules have been identified, none have proven essential for kinetochore-microtubule interactions. Here, we examined the conserved KNL-1 /Mis12 complex/Ndc80 complex (KMN) network, which is essential for kinetochore-microtubule interactions in vivo. We identified two distinct microtubule-binding activities within the KMN network: one associated with the Ndc80/Nuf2 subunits of the Ndc80 complex, and a second in KNL-1. Formation of the complete KMN network, which additionally requires the Mis12 complex and the Spc24/Spc25 subunits of the Ndc80 complex, synergistically enhances microtubule-binding activity. Phosphorylation by Aurora B, which corrects improper kinetochore-microtubule connections in vivo, reduces the affinity of the Ndc80 complex for microtubules in vitro. Based on these findings, we propose that the conserved KMN network constitutes the core microtubule-binding site of the kinetochore.	Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, Ctr Integrat Mol Biosci, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute	Cheeseman, IM (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, CMM E,Room 3052, La Jolla, CA 92093 USA.	icheeseman@ucsd.edu; abdesai@ucsd.edu	Chappie, Joshua S./AAV-6076-2021	Chappie, Joshua S./0000-0002-5733-7275; Cheeseman, Iain/0000-0002-3829-5612	NIGMS NIH HHS [R01 GM074215, GM61938, GM52468] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052468, R01GM074215, R01GM061938] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Schrader, 1953, MITOSIS MOVEMENT CHR; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349	32	711	726	2	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					983	997		10.1016/j.cell.2006.09.039	http://dx.doi.org/10.1016/j.cell.2006.09.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129783	Bronze			2022-12-01	WOS:000242613800015
J	Sidibe, M; Ramiah, I; Buse, K				Sidibe, Michel; Ramiah, Ilavenil; Buse, Kent			Alignment, harmonisation, and accountability in HIV/AIDS	LANCET			English	Editorial Material									UNAIDS, Country & Reg Support, Geneva, Switzerland; Overseas Dev Inst, London SE1 7JD, England	UNAIDS	Buse, K (corresponding author), UNAIDS, Country & Reg Support, Geneva, Switzerland.	k.buse@odi.org.uk	Buse, Kent/AAK-6688-2020	Buse, Kent/0000-0002-5485-0110				Sidibe M, 2006, J ROY SOC MED, V99, P497, DOI 10.1258/jrsm.99.10.497; *UNAIDS, UN ACC UNAIDS ASS SC; *UNAIDS, 2006, EFF MULT ACT AIDS HA; UNAIDS, 2005, GLOB TASK TEAM IMPR; 2005, JOINT PROGR ENHANCED	5	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1853	1854		10.1016/S0140-6736(06)69755-9	http://dx.doi.org/10.1016/S0140-6736(06)69755-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126703				2022-12-01	WOS:000242345900009
J	Cleland, J; Ali, MM				Cleland, John; Ali, Mohamed M.			Sexual abstinence, contraception, and condom use by young African women: a secondary analysis of survey data	LANCET			English	Article							BALANCED ABC APPROACH; PARTNER REDUCTION; AIDS-PREVENTION; HIV-INFECTION; BEHAVIOR; RISK; COUNTRIES; VIOLENCE	Background Drug therapy for people with AIDS is a humanitarian priority but prevention of HIV infection remains essential. Focusing on young single African women, we aimed to assess trends in a set of behaviours-sexual abstinence, Contraceptive use, and condom use-that are known to affect the rates of HIV transmission. Methods We did a secondary analysis of public-access data sets in 18 African countries (132 800 women), and calculated changes in a set of behavioural. indicators over time. We standardised these trends from nationally representative surveys to adjust for within-country changes in age, education, and type of residential location. Findings Between about 1993 and 2001, the percentage of women reporting no sexual experience changed little. During the same period, the percentage of sexually experienced women who reported no sexual intercourse in the previous 3 months (secondary abstinence) rose significantly in seven of 18 countries and the median for all 18 countries increased from 43.8% to 49.2%. Use of condoms for pregnancy prevention rose significantly in 13 of 18 countries and the median proportion increased from 5.3% to 18.8%. The median rate of annual increase of condom use was 1.41 percentage points (95% CI 1.12-2.25). In the 13 countries with available data, condom use at most recent coitus rose from a median of 19.3% to 28.4%. Over half (58.5%) of condom users were motivated, at least in part, by a wish to avoid pregnancy. Interpretation Condom promotion campaigns in sub-Saharan Africa have affected the behaviour of young single women; the pace of change has matched the rise in contraceptive use by married couples in developing countries over recent decades. Thus continuing efforts to promote condom use with emphasis on pregnancy prevention are justified.	London Sch Hyg & Trop Med, Ctr Populat Studies, London WC1B 3DP, England; WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Cleland, J (corresponding author), London Sch Hyg & Trop Med, Ctr Populat Studies, 49-51 Bedford Sq, London WC1B 3DP, England.	John.Cleland@lshtm.ac.uk	Cleland, John G./AAZ-4185-2020	Cleland, John G./0000-0002-1471-7016				AHMAN E, 2004, UNSAFE ABORTION GLOB; Ali MM, 2005, SOC SCI MED, V60, P1175, DOI 10.1016/j.socscimed.2004.07.002; Bass E, 2005, LANCET, V365, P2077, DOI 10.1016/S0140-6736(05)66717-7; Blum RW, 2004, J ADOLESCENT HEALTH, V34, P428, DOI [10.1016/j.jadohealth.2003.09.022, 10.1016/S1054-139X(03)00543-3]; Castle S, 2003, STUD FAMILY PLANN, V34, P186, DOI 10.1111/j.1728-4465.2003.00186.x; Che Y, 2004, CONTRACEPTION, V69, P15, DOI 10.1016/j.contraception.2003.08.006; Cleland J, 2006, AIDS, V20, P1, DOI 10.1097/01.aids.0000194135.35758.cd; Cleland J, 2004, SEX TRANSM INFECT, V80, P1, DOI 10.1136/sti.2004.013151; Das P, 2005, LANCET INFECT DIS, V5, P263, DOI 10.1016/S1473-3099(05)70097-9; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Genuis SJ, 2004, BMJ-BRIT MED J, V328, P894, DOI 10.1136/bmj.328.7444.894; Global HIV Prevention Working Group, 2004, HIV PREV ER EXP TREA; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Jemmott JB, 2000, AIDS, V14, pS40; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Kim JC, 2005, BMJ-BRIT MED J, V331, P769, DOI 10.1136/bmj.331.7519.769; Lagarde E, 2001, AIDS, V15, pS71, DOI 10.1097/00002030-200108004-00008; Lesthaeghe RonJ., 1994, NUPTIALITY SUBSAHARA, P25; Mayhew SH, 2004, HEALTH POLICY PLANN, V19, pI50, DOI 10.1093/heapol/czh045; Meekers D, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-5; Myer L, 2002, INT J STD AIDS, V13, P62; OAKLEY A, 1995, AIDS, V9, P479, DOI 10.1097/00002030-199509050-00010; *ORC MACR, MEASURE DHS STATCOMP; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; SHAH I, 2004, REPROD HEALTH MATTER, V24, P9; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; Slaymaker E, 2004, SEX TRANSM INFECT, V80, P13, DOI 10.1136/sti.2004.011635; Stephenson JM, 2000, AIDS, V14, pS115; *UN POP DIV, 1999, LEV TRENDS CONTR US; UNAIDS, 2005, INT HIV PREV; *US AID, MEASURE EV PROJ; White R, 2000, AIDS, V14, P2323, DOI 10.1097/00002030-200010200-00013; *WHO JOINT UN PROG, 2005, AIDS EP UPD	35	94	95	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2006	368	9549					1788	1793		10.1016/S0140-6736(06)69738-9	http://dx.doi.org/10.1016/S0140-6736(06)69738-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	108FJ	17113428				2022-12-01	WOS:000242225400032
J	Kazantseva, A; Goltsov, A; Zinchenko, R; Grigorenko, AP; Abrukova, AV; Moliaka, YK; Kirillov, AG; Guo, ZR; Lyle, S; Ginter, EK				Kazantseva, Anastasiya; Goltsov, Andrey; Zinchenko, Rena; Grigorenko, Anastasia P.; Abrukova, Anna V.; Moliaka, Yuri K.; Kirillov, Alexander G.; Guo, Zhiru; Lyle, Stephen; Ginter, Evgeny K.			Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH	SCIENCE			English	Article							LYSOPHOSPHATIDIC ACID; STEM-CELLS; CATALYTIC TRIAD; HYPOTRICHOSIS; DIFFERENTIATION; ALOPECIA; A(1); SKIN	The molecular mechanisms controlling human hair growth and scalp hair loss are poorly understood. By screening about 350,000 individuals in two populations from the Volga-Ural region of Russia, we identified a gene mutation in families who show an inherited form of hair loss and a hair growth defect. Affected individuals were homozygous for a deletion in the LIPH gene on chromosome 3q27, caused by short interspersed nuclear element - retrotransposon - mediated recombination. The LIPH gene is expressed in hair follicles and encodes a phospholipase called lipase H ( alternatively known as membrane-associated phosphatidic acid - selective phospholipase A1 alpha), an enzyme that regulates the production of bioactive lipids. These results suggest that lipase H participates in hair growth and development.	Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA; Russian Acad Med Sci, Mental Hlth Res Ctr, Lab Mol Brain Genet, Moscow 113152, Russia; Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119992, Russia; Russian Acad Med Sci, Natl Res Ctr Med Genet, Moscow 109801, Russia; GUZ Presidents Prenatal Ctr Chuvash Republ, Cheboksary, Russia; Minist Hlth & Social Dev Chuvash Republ, Cheboksary, Russia; Univ Massachusetts, Sch Med, Dept Canc Biol & Pathol, Worcester, MA 01605 USA; Russian Acad Sci, NI Vavilov Gen Genet Res Inst, Moscow, Russia	University of Massachusetts System; University of Massachusetts Worcester; Russian Academy of Medical Sciences; Lomonosov Moscow State University; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Ministry of Health of the Russian Federation; University of Massachusetts System; University of Massachusetts Worcester; Russian Academy of Sciences; Vavilov Institute of General Genetics	Kazantseva, A (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, 303 Belmont St, Worcester, MA 01604 USA.	Evgeny.Rogaev@umassmed.edu	Grigorenko, Anastasia/AAN-8226-2020; Zinchenko, Rena A/A-9554-2016; Rogaev, Evgeny/AAN-7662-2020; Kazantseva, Anastasiya/E-7351-2014	Zinchenko, Rena A/0000-0003-3586-3458; 	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002179] Funding Source: NIH RePORTER; NIAMS NIH HHS [K08-AR02179] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Aoki J, 2002, BBA-MOL CELL BIOL L, V1582, P26, DOI 10.1016/S1388-1981(02)00134-8; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Carriere F, 1998, BBA-REV BIOMEMBRANES, V1376, P417, DOI 10.1016/S0304-4157(98)00016-1; CHOI S, 2004, AM J PHYSL GAST 0802; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Hiramatsu T, 2003, J BIOL CHEM, V278, P49438, DOI 10.1074/jbc.M213018200; Hiraoka M, 2005, J LIPID RES, V46, P2441, DOI 10.1194/jlr.M500248-JLR200; Jin WJ, 2002, GENOMICS, V80, P268, DOI 10.1006/geno.2002.6837; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kubiak RJ, 2001, BIOCHEMISTRY-US, V40, P5422, DOI 10.1021/bi002371y; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Lyle S, 1998, J CELL SCI, V111, P3179; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; PIAZZA GA, 1995, EXP CELL RES, V216, P51, DOI 10.1006/excr.1995.1007; Rogaev EI, 1999, LANCET, V354, P1097, DOI 10.1016/S0140-6736(99)02816-0; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; van Leeuwen FN, 2003, BIOCHEM SOC T, V31, P1209	22	152	162	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					982	985		10.1126/science.1133276	http://dx.doi.org/10.1126/science.1133276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095700				2022-12-01	WOS:000241896000050
J	Skordalakes, E; Berger, JM				Skordalakes, Emmanuel; Berger, James M.			Structural insights into RNA-dependent ring closure and ATPase activation by the Rho termination factor	CELL			English	Article							HELICASE DNAB PROTEIN; TRANSCRIPTION-TERMINATION; CRYSTAL-STRUCTURE; BINDING DOMAIN; CONFORMATIONAL-CHANGES; SEQUENTIAL HYDROLYSIS; PHYSICAL-PROPERTIES; MECHANISM; CRYSTALLOGRAPHY; RECOGNITION	Hexameric helicases and translocases are required for numerous essential nucleic-acid transactions. To better understand the mechanisms by which these enzymes recognize target substrates and use nucleotide hydrolysis to power molecular movement, we have determined the structure of the Rho transcription termination factor, a hexameric RNA/DNA helicase, with single-stranded RNA bound to the motor domains of the protein. The structure reveals a closed-ring "trimer of dimers" conformation for the hexamer that contains an unanticipated arrangement of conserved loops required for nucleic-acid translocation. RNA extends across a shallow intersubunit channel formed by conserved amino acids required for RNA-stimulated ATP hydrolysis and translocation and directly contacts a conserved lysine, just upstream of the catalytic GKT triad, in the phosphate-binding (P loop) motif of the ATP-binding pocket. The structure explains the molecular effects of numerous mutations and provides new insights into the links between substrate recognition, ATP turnover, and coordinated strand movement.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 327B Hildebrand Hall 3206, Berkeley, CA 94720 USA.	jmberger@berkeley.edu	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALIFANO P, 1991, CELL, V64, P553; Allison TJ, 1998, NAT STRUCT BIOL, V5, P352, DOI 10.1038/nsb0598-352; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Bogden CE, 1999, MOL CELL, V3, P487, DOI 10.1016/S1097-2765(00)80476-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bujalowski W, 2000, BIOCHEMISTRY-US, V39, P2106, DOI 10.1021/bi992413m; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; DOMBROSKI AJ, 1988, J BIOL CHEM, V263, P18802; ENGEL D, 1984, NUCLEIC ACIDS RES, V12, P7389, DOI 10.1093/nar/12.19.7389; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P121, DOI 10.1021/bi00116a018; GEISELMANN J, 1992, PROTEIN SCI, V1, P850, DOI 10.1002/pro.5560010703; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P111, DOI 10.1021/bi00116a017; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Horiguchi T, 1997, J MOL BIOL, V269, P514, DOI 10.1006/jmbi.1997.1059; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jeong YJ, 2004, J BIOL CHEM, V279, P18370, DOI 10.1074/jbc.M309162200; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DE, 1999, J BIOL CHEM, V274, P32667, DOI 10.1074/jbc.274.46.32667; Kim DE, 2001, J BIOL CHEM, V276, P13902, DOI 10.1074/jbc.M011043200; Lisal J, 2005, J BIOL CHEM, V280, P23157, DOI 10.1074/jbc.M502658200; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCSWIGGEN JA, 1988, J MOL BIOL, V199, P609, DOI 10.1016/0022-2836(88)90305-1; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MODRAK D, 1994, BIOCHEMISTRY-US, V33, P8292, DOI 10.1021/bi00193a016; MORGAN WD, 1985, NUCLEIC ACIDS RES, V13, P3739, DOI 10.1093/nar/13.10.3739; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; RICHARDSON JP, 1986, J MOL BIOL, V189, P413, DOI 10.1016/0022-2836(86)90313-X; RICHARDSON JP, 1982, J BIOL CHEM, V257, P5760; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Richardson JP, 1996, J BIOL CHEM, V271, P1251, DOI 10.1074/jbc.271.3.1251; RICHARDSON JP, 1980, BIOCHEMISTRY-US, V19, P4293, DOI 10.1021/bi00559a022; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; SEIFRIED SE, 1991, J MOL BIOL, V221, P1139; SEIFRIED SE, 1992, P NATL ACAD SCI USA, V89, P10454, DOI 10.1073/pnas.89.21.10454; SHIGESADA K, 1980, NUCLEIC ACIDS RES, V8, P3355, DOI 10.1093/nar/8.15.3355; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; Stitt BL, 2001, BIOCHEMISTRY-US, V40, P2276, DOI 10.1021/bi002253a; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; Xu Y, 2002, J BIOL CHEM, V277, P30023, DOI 10.1074/jbc.M111009200; XU Y, 2000, J BIOL CHEM, V278, P1279; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740	63	95	96	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					553	564		10.1016/j.cell.2006.08.051	http://dx.doi.org/10.1016/j.cell.2006.08.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081977	Bronze			2022-12-01	WOS:000241937000019
J	Hummon, AB; Richmond, TA; Verleyen, P; Baggerman, G; Huybrechts, J; Ewing, MA; Vierstraete, E; Rodriguez-Zas, SL; Schoofs, L; Robinson, GE; Sweedler, JV				Hummon, Amanda B.; Richmond, Timothy A.; Verleyen, Peter; Baggerman, Geert; Huybrechts, Jurgen; Ewing, Michael A.; Vierstraete, Evy; Rodriguez-Zas, Sandra L.; Schoofs, Liliane; Robinson, Gene E.; Sweedler, Jonathan V.			From the genome to the proteome: Uncovering peptides in the Apis brain	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; HONEY-BEE; NEUROPEPTIDE; IDENTIFICATION; FAMILY	Neuropeptides, critical brain peptides that modulate animal behavior by affecting the activity of almost every neuronal circuit, are inherently difficult to predict directly from a nascent genome sequence because of extensive posttranslational processing. The combination of bioinformatics and proteomics allows unprecedented neuropeptide discovery from an unannotated genome. Within the Apis mellifera genome, we have inferred more than 200 neuropeptides and have confirmed the sequences of 100 peptides. This study lays the groundwork for future molecular studies of Apis neuropeptides with the identification of 36 genes, 33 of which were previously unreported.	Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Katholieke Univ Leuven, Lab Dev Physiol Genom & Proteom, B-3000 Louvain, Belgium; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; KU Leuven; University of Illinois System; University of Illinois Urbana-Champaign	Rodriguez-Zas, SL (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.	jsweedle@uiuc.edu	schoofs, liliane/ABD-2943-2020; Sweedler, Jonathan V/A-9405-2009; Schoofs, Liliane/F-2815-2010	Sweedler, Jonathan V/0000-0003-3107-9922; Ewing, Michael/0000-0001-5271-5655; Schoofs, Liliane/0000-0002-1673-432X; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Baggerman, Geert/0000-0002-0661-931X	NIDA NIH HHS [P30 DA018310, P30 DA01830] Funding Source: Medline; NIDCD NIH HHS [DC006395] Funding Source: Medline; NIGMS NIH HHS [GM068946, R01 GM068946] Funding Source: Medline; NINDS NIH HHS [NS31609, R01 NS031609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS031609, R01NS031609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Audsley N, 2006, PEPTIDES, V27, P512, DOI 10.1016/j.peptides.2005.08.022; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Bonnard E, 2001, PEPTIDES, V22, P1085, DOI 10.1016/S0196-9781(01)00425-9; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Chartrel N, 2003, P NATL ACAD SCI USA, V100, P15247, DOI 10.1073/pnas.2434676100; Dockray GJ, 2004, EXP PHYSIOL, V89, P229, DOI 10.1113/expphysiol.2004.027169; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hummon AB, 2003, J PROTEOME RES, V2, P650, DOI 10.1021/pr034046d; Husson SJ, 2005, BIOCHEM BIOPH RES CO, V335, P76, DOI 10.1016/j.bbrc.2005.07.044; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nichols R, 1999, ANN NY ACAD SCI, V897, P264, DOI 10.1111/j.1749-6632.1999.tb07897.x; RIEHEL MA, 2002, SCIENCE, V2898, P172; SCHAEFER M, 1985, CELL, V41, P457, DOI 10.1016/S0092-8674(85)80019-2; Takeuchi H, 2003, INSECT MOL BIOL, V12, P291, DOI 10.1046/j.1365-2583.2003.00414.x; Verleyen P, 2006, PEPTIDES, V27, P493, DOI 10.1016/j.peptides.2005.03.065; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V320, P334, DOI 10.1016/j.bbrc.2004.05.173; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807	18	241	260	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					647	649		10.1126/science.1124128	http://dx.doi.org/10.1126/science.1124128			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068263				2022-12-01	WOS:000241557800047
J	Gostin, LO				Gostin, Lawrence O.			HIV screening in health care settings - Public health and civil liberties in conflict?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; PERSONS AWARE; TRANSMISSION; PREVENTION; STRATEGIES; UNAWARE; VIRUS; WOMEN		Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC USA; Johns Hopkins Univ, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1149; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; [Anonymous], NO TIM LOS GETT MOR; Bayer R, 2006, NEW ENGL J MED, V355, P647, DOI 10.1056/NEJMp068153; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Gindler J. S., 1995, Morbidity and Mortality Weekly Report, V44, P1; Gostin LO, 1997, NEW ENGL J MED, V337, P1162, DOI 10.1056/NEJM199710163371611; GOSTIN LO, 1989, JAMA-J AM MED ASSOC, V261, P1621; *HLTH RES ED TRUST, 2006, MAP HIV TEST LAWS US; HODGE JG, 2004, ADV HIV PREVENTION I; *I MED, 1999, RED ODDS PREV PER TR; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; PECKHAM C, 1995, NEW ENGL J MED, V333, P298, DOI 10.1056/NEJM199508033330507; Rotheram-Borus MJ, 2000, ARCH PEDIAT ADOL MED, V154, P435, DOI 10.1001/archpedi.154.5.435; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P597; Watensky RP, 2005, AM J MED, V118, P292, DOI 10.1016/j.amjmed.2004.07.055	22	53	53	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2006	296	16					2023	2025		10.1001/jama.296.16.2023	http://dx.doi.org/10.1001/jama.296.16.2023			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098BL	17062866				2022-12-01	WOS:000241495300025
J	Call, ME; Schnell, JR; Xu, CQ; Lutz, RA; Chou, JJ; Wucherpfennig, KW				Call, Matthew E.; Schnell, Jason R.; Xu, Chenqi; Lutz, Regina A.; Chou, James J.; Wucherpfennig, Kai W.			The structure of the zeta zeta transmembrane dimer reveals features essential for its assembly with the T cell receptor	CELL			English	Article							ISOTOPICALLY ENRICHED PROTEINS; ANTIGEN RECEPTOR; J-COUPLINGS; CHAIN DIMERIZATION; CHEMICAL-SHIFTS; CD3-ZETA CHAIN; ALPHA-HELICES; CD3 COMPLEX; ASSOCIATION; EXPRESSION	The T cell receptor (TCR) alpha beta heterodimer communicates ligand binding to the cell interior via noncovalently associated CD3 gamma epsilon, CD3 delta epsilon, and xi xi dimers. While structures of extracellular components of the TCR-CD3 complex are known, the transmembrane (TM) domains that mediate assembly have eluded structural characterization. Incorporation of the xi xi signaling module is known to require one basic TCR alpha and two xi xi aspartic acid TM residues. We report the NMR structure of the xi xi(TM) dinner, a left-handed coiled coil with substantial polar contacts. Mutagenesis experiments demonstrate that three polar positions are critical for xi xi dimerization and assembly with TCR. The two aspartic acids create a single structural unit at the a interface stabilized by extensive hydrogen bonding, and there is evidence for a structural water molecule (or molecules) within close proximity. This structural unit, representing only the second transmembrane dinner interface solved to date, serves as a paradigm for the assembly of all modules involved in TCR signaling.	Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chou, JJ (corresponding author), Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA.	james_chou@hms.harvard.edu; kai_wucherpfennig@dfci.harvard.edu	Chou, James J/N-9840-2013; Chou, James/AAD-6230-2022	Chou, James J/0000-0002-4442-0344; Chou, James/0000-0002-4442-0344; Call, Matthew/0000-0001-5846-6469; Xu, Chenqi/0000-0002-4968-6782	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI054520] Funding Source: Medline; NIBIB NIH HHS [EB002026, P41 EB002026] Funding Source: Medline; PHS HHS [F32] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALCOVER A, 1990, J BIOL CHEM, V265, P4131; BAX A, 1994, METHOD ENZYMOL, V239, P79; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; Bolliger L, 1999, J IMMUNOL, V163, P3867; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Diethrich EB, 1996, J ENDOVASC SURG, V3, P132, DOI 10.1583/1074-6218(1996)003<0132:IFCASA>2.0.CO;2; Exley M, 1991, Semin Immunol, V3, P283; Feng JW, 2005, IMMUNITY, V22, P427, DOI 10.1016/j.immuni.2005.02.005; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; GEISLER C, 1989, J IMMUNOL, V143, P4069; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; GRZESIEK S, 1993, J BIOMOL NMR, V3, P487; Hu JS, 1996, J AM CHEM SOC, V118, P8170, DOI 10.1021/ja9616239; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; Hu JS, 1997, J BIOMOL NMR, V9, P323, DOI 10.1023/A:1018691228238; Ishikawa S, 2004, INT IMMUNOL, V16, P1019, DOI 10.1093/intimm/dxh103; KEARSE KP, 1995, IMMUNITY, V2, P391; KUSTER H, 1990, J BIOL CHEM, V265, P6448; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MacKenzie KR, 1996, J BIOMOL NMR, V7, P256; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Pillai B, 2001, PROTEINS, V43, P57, DOI 10.1002/1097-0134(20010401)43:1<57::AID-PROT1017>3.0.CO;2-D; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; STALEY JP, 1994, PROTEIN SCI, V3, P1822, DOI 10.1002/pro.5560031021; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Tomasello E, 1998, J BIOL CHEM, V273, P34115, DOI 10.1074/jbc.273.51.34115; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; VUISTER GW, 1993, J AM CHEM SOC, V115, P5334, DOI 10.1021/ja00065a071; Walters KJ, 1997, J AM CHEM SOC, V119, P5958, DOI 10.1021/ja963309k; WEISSMAN AM, 1988, SCIENCE, V239, P1018, DOI 10.1126/science.3278377; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	49	182	188	2	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					355	368		10.1016/j.cell.2006.08.044	http://dx.doi.org/10.1016/j.cell.2006.08.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055436	Bronze, Green Accepted			2022-12-01	WOS:000241827100022
J	Schroder, L; Lowery, TJ; Hilty, C; Wemmer, DE; Pines, A				Schroeder, Leif; Lowery, Thomas J.; Hilty, Christian; Wemmer, David E.; Pines, Alexander			Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor	SCIENCE			English	Article							LASER-POLARIZED XE-129; XENON BIOSENSOR; IN-VIVO; FUNCTIONALIZED XENON; SATURATION-TRANSFER; NMR; DELIVERY; SPECTROSCOPY; EXCHANGE; AGENTS	A magnetic resonance approach is presented that enables high-sensitivity, high-contrast molecular imaging by exploiting xenon biosensors. These sensors link xenon atoms to specific biomolecular targets, coupling the high sensitivity of hyperpolarized nuclei with the specificity of biochemical interactions. We demonstrated spatial resolution of a specific target protein in vitro at micromolar concentration, with a readout scheme that reduces the required acquisition time by >3300-fold relative to direct detection. This technique uses the signal of free hyperpolarized xenon to dramatically amplify the sensor signal via chemical exchange saturation transfer (CEST). Because it is similar to 10,000 times more sensitive than previous CEST methods and other molecular magnetic resonance imaging techniques, it marks a critical step toward the application of xenon biosensors as selective contrast agents in biomedical applications.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wemmer, DE (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	dewemmer@lbl.gov; pines@berkeley.edu	Schröder, Leif/H-6036-2011; Hilty, Christian/C-1892-2015	Schröder, Leif/0000-0003-4901-0325; Hilty, Christian/0000-0003-2539-2568				Aime S, 2005, ANGEW CHEM INT EDIT, V44, P1813, DOI 10.1002/anie.200462566; ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0; Bartik K, 1998, J AM CHEM SOC, V120, P784, DOI 10.1021/ja972377j; Bifone A, 1996, P NATL ACAD SCI USA, V93, P12932, DOI 10.1073/pnas.93.23.12932; Goffeney N, 2001, J AM CHEM SOC, V123, P8628, DOI 10.1021/ja0158455; Goodson BM, 1997, P NATL ACAD SCI USA, V94, P14725, DOI 10.1073/pnas.94.26.14725; Han SI, 2005, ANAL CHEM, V77, P4008, DOI 10.1021/ac0500479; Hilty C, 2006, ANGEW CHEM INT EDIT, V45, P70, DOI 10.1002/anie.200502693; Huber G, 2006, J AM CHEM SOC, V128, P6239, DOI 10.1021/ja060266r; Knagge K, 2004, CHEM PHYS LETT, V397, P11, DOI 10.1016/j.cplett.2004.08.050; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Lowery TJ, 2003, MAGN RESON IMAGING, V21, P1235, DOI 10.1016/j.mri.2003.08.025; MAUDSLEY AA, 1983, J MAGN RESON, V51, P147, DOI 10.1016/0022-2364(83)90113-0; Mugler JP, 1997, MAGN RESON MED, V37, P809, DOI 10.1002/mrm.1910370602; Mynar JL, 2006, J AM CHEM SOC, V128, P6334, DOI 10.1021/ja061735s; Spence MM, 2004, J AM CHEM SOC, V126, P15287, DOI 10.1021/ja0483037; Spence MM, 2001, P NATL ACAD SCI USA, V98, P10654, DOI 10.1073/pnas.191368398; Swanson SD, 1999, MAGNET RESON MED, V42, P1137, DOI 10.1002/(SICI)1522-2594(199912)42:6<1137::AID-MRM19>3.0.CO;2-4; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956	20	359	368	5	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2006	314	5798					446	449		10.1126/science.1131847	http://dx.doi.org/10.1126/science.1131847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	096MW	17053143	Green Submitted			2022-12-01	WOS:000241382500036
J	Beulens, JWJ; Rimm, EB; Ascherio, A; Spiegelman, D; Hendriks, HFJ; Mukamal, KJ				Beulens, Joline W. J.; Rimm, Eric B.; Ascherio, Alberto; Spiegelman, Donna; Hendriks, Henk F. J.; Mukamal, Kenneth J.			Alcohol consumption and risk for coronary heart disease among men with hypertension	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CONFIDENCE-INTERVALS; MEASUREMENT ERROR; MORTALITY; REPRODUCIBILITY; FREQUENCY; VALIDITY; WOMEN; WINE	Background: Heavy alcohol consumption increases risk for hypertension, which is in itself a strong risk factor for cardiovascular disease (CVD). However, data on the association between alcohol consumption and CVD among individuals with hypertension are scarce. Objective: To assess whether alcohol consumption is inversely associated with CVD among men with hypertension. Design: Prospective cohort study. Setting: United States. Participants: 11 711 men with hypertension from the Health Professionals Follow-Up Study. Measurements: Alcohol consumption was assessed every 4 years by using a food-frequency questionnaire. Incident cases of nonfatal myocardial infarction (MI), fatal coronary heart disease, and stroke were documented from 1986 to 2002. Results: During follow-up, 653 patients with MI were documented. Compared with patients abstaining from alcohol, the hazard ratio for participants with MI consuming 0.1 to 4.9 grams of alcohol per day was 1.09 (95% CI, 0.86 to 1.37); consuming 5 to 9.9 grams of alcohol per day was 0.81 (CI, 0.60 to 1.08 g/d); consuming 10 to 14.9 grams of alcohol per day was 0.68 (CI, 0.51 to 0.91 g/d); consuming 15 to 29.9 grams of alcohol per day was 0.72 (CI, 0.54 to 0.97 g/d); consuming 30 to 49.9 grams of alcohol per day was 0.67 (CI, 0.48 to 0.94 g/d); and consuming 50 or more grams of alcohol per day was 0.41 (CI, 0.22 to 0.77 g/d) (P < 0.001 for trend). Associations were similar for fatal and nonfatal MI. Alcohol consumption was not associated with total death or death due to CVD. Risks for total and ischemic stroke for patients consuming 10 to 29.9 g of alcohol per day were 1.40 (CI, 0.93 to 2.12) and 1.55 (CI, 0.90 to 2.68) compared with that of abstainers. When corrected for measurement error in alcohol consumption, dietary variables, and body mass index, the hazard ratio for participants with MI per 12.5 grams per day increment of alcohol intake was 0.68 (CI, 0.46 to 1.00). Limitations: Hypertension, alcohol consumption, and CVD risk factors were assessed by self-report. Available data used to correct for measurement error were primarily restricted to dietary variables. Conclusions: In this population of men with hypertension, moderate alcohol consumption was associated with a decreased risk for MI but not with risks for total death or death due to CVD. As in the general population, men with hypertension who drink moderately and safely may not need to change their drinking habits.	Harvard Univ, Sch Med, Sch Publ Hlth, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Wageningen & Res Ctr, NL-6700 HB Wageningen, Netherlands; TNO Qual Life, Zeist, Netherlands	Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Wageningen University & Research; Netherlands Organization Applied Science Research	Beulens, JWJ (corresponding author), Univ Utrecht, Med Ctr, Utrecht Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	J.Beulens@umcutrecht.nl	Hendriks, Henk/AAU-5987-2021; Mukamal, Kenneth/GVR-7978-2022	Beulens, Joline/0000-0002-4181-0937	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLDITZ GA, 1991, AM J CLIN NUTR, V54, P49, DOI 10.1093/ajcn/54.1.49; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Cushman WC, 1998, ARCH INTERN MED, V158, P1197, DOI 10.1001/archinte.158.11.1197; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Day NE, 2004, INT J EPIDEMIOL, V33, P1373, DOI 10.1093/ije/dyh138; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Fox MP, 2005, INT J EPIDEMIOL, V34, P1370, DOI 10.1093/ije/dyi184; FOX MP, 2006, EPIDEMIOLOGIC METHOD; Fuchs FD, 2001, HYPERTENSION, V37, P1242, DOI 10.1161/01.HYP.37.5.1242; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goldberg IJ, 2001, CIRCULATION, V103, P472; HENDRIKS HFJ, 1994, BRIT MED J, V308, P1003, DOI 10.1136/bmj.308.6935.1003; KIYOHARA Y, 1995, STROKE, V26, P368, DOI 10.1161/01.STR.26.3.368; LOGAN R, 1997, SAS BLINPLUS MACRO; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; Malinski MK, 2004, ARCH INTERN MED, V164, P623, DOI 10.1001/archinte.164.6.623; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; MARMOT M, 1991, BMJ-BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565; Mukamal KJ, 2005, CIRCULATION, V112, P1406, DOI 10.1161/CIRCULATIONAHA.105.537704; Mukamal KJ, 2005, ANN INTERN MED, V142, P11, DOI 10.7326/0003-4819-142-1-200501040-00007; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Ngandu NH, 1997, STAT MED, V16, P611, DOI 10.1002/(SICI)1097-0258(19970330)16:6<611::AID-SIM437>3.0.CO;2-T; PALMER AJ, 1995, J HYPERTENS, V13, P957, DOI 10.1097/00004872-199509000-00004; Rehm JT, 1997, AM J EPIDEMIOL, V146, P495, DOI 10.1093/oxfordjournals.aje.a009303; Reims HM, 2004, J HUM HYPERTENS, V18, P381, DOI 10.1038/sj.jhh.1001731; Renaud SC, 2004, AM J CLIN NUTR, V80, P621; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rimm EB, 1996, AM J EPIDEMIOL, V143, P1094; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Rose G.A., 1982, CARDIOVASCULAR SURVE; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; SHAPER AG, 1988, LANCET, V2, P1267; Sierksma A, 2002, EUR J CLIN NUTR, V56, P1130, DOI 10.1038/sj.ejcn.1601459; Tanasescu M, 2001, J AM COLL CARDIOL, V38, P1836, DOI 10.1016/S0735-1097(01)01655-2; Thadhani R, 2002, ARCH INTERN MED, V162, P569, DOI 10.1001/archinte.162.5.569; Therneau TM, 1997, P 1 SEATTL S BIOST S, P51; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; WANNAMETHEE G, 1995, BRIT HEART J, V74, P324; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	49	91	99	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 2	2007	146	1					10	W3		10.7326/0003-4819-146-1-200701020-00004	http://dx.doi.org/10.7326/0003-4819-146-1-200701020-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188BK	17200217				2022-12-01	WOS:000247893300002
J	Heathcote, E				Heathcote, Edwin			Maggie's Centres	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Heathcote, E (corresponding author), Financial Times, London, England.	edwinheathcote@hotmail.com							0	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1304	1305		10.1136/bmj.39062.614132.55	http://dx.doi.org/10.1136/bmj.39062.614132.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185717	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000243160700015
J	Baker, BJ; Tyson, GW; Webb, RI; Flanagan, J; Hugenholtz, P; Allen, EE; Banfield, JF				Baker, Brett J.; Tyson, Gene W.; Webb, Richard I.; Flanagan, Judith; Hugenholtz, Philip; Allen, Eric E.; Banfield, Jillian F.			Lineages of acidophilic archaea revealed by community genomic analysis	SCIENCE			English	Article							MICROORGANISMS; ASSEMBLAGES; DIVERSITY; BACTERIA; PHYLUM	Novel, low-abundance microbial species can be easily overlooked in standard polymerase chain reaction (PCR)-based surveys. We used community genomic data obtained without PCR or cultivation to reconstruct DNA fragments bearing unusual 16S ribosomal RNA ( rRNA) and protein-coding genes from organisms belonging to novel archaeal lineages. The organisms are minor components of all biofilms growing in pH 0.5 to 1.5 solutions within the Richmond Mine, California. Probes specific for 16S rRNA showed that the fraction less than 0.45 micrometers in diameter is dominated by these organisms. Transmission electron microscope images revealed that the cells are pleomorphic with unusual folded membrane protrusions and have apparent volumes of < 0.006 cubic micrometer.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; Univ Queensland, Dept Microbiol & Parasitol, Brisbane, Qld 4072, Australia	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Queensland; University of Queensland	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jill@eps.berkeley.edu	Hugenholtz, Philip/AAD-9138-2019; Hugenholtz, Philip/G-9608-2011; Tyson, Gene W/C-6558-2013; Baker, Brett/P-1783-2014	Hugenholtz, Philip/0000-0001-5386-7925; Hugenholtz, Philip/0000-0001-5386-7925; Tyson, Gene W/0000-0001-8559-9427; Baker, Brett/0000-0002-5971-1021; Banfield, Jill/0000-0001-8203-8771; Flanagan, Judith/0000-0002-4053-3288				Baker BJ, 2003, ENVIRON MICROBIOL, V5, P267, DOI 10.1046/j.1462-2920.2003.00408.x; Baker BJ, 2003, APPL ENVIRON MICROB, V69, P5512, DOI 10.1128/AEM.69.9.5512-5518.2003; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Druschel GK, 2004, GEOCHEM T, V5, P13, DOI 10.1186/1467-4866-5-13; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Huber H, 2003, RES MICROBIOL, V154, P165, DOI 10.1016/S0923-2508(03)00035-4; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Miteva VI, 2005, APPL ENVIRON MICROB, V71, P7806, DOI 10.1128/AEM.71.12.7806-7818.2005; Nomura N, 1998, J BACTERIOL, V180, P3635, DOI 10.1128/JB.180.14.3635-3643.1998; RIEGER G, 1995, J STRUCT BIOL, V115, P78, DOI 10.1006/jsbi.1995.1032; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; *STEER GROUP WORKS, 1999, SIZ LIM VER SMALL MI; Sunna A, 2003, EXTREMOPHILES, V7, P63, DOI 10.1007/s00792-002-0296-1; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100	24	153	162	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1933	1935		10.1126/science.1132690	http://dx.doi.org/10.1126/science.1132690			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185602				2022-12-01	WOS:000242996800051
J	Ibrahim, F; Rohr, J; Jeong, WJ; Hesson, J; Cerutti, H				Ibrahim, Fadia; Rohr, Jennifer; Jeong, Won-Joong; Hesson, Jennifer; Cerutti, Heriberto			Untemplated oligoadenylation promotes degradation of RISC-cleaved transcripts	SCIENCE			English	Article							RNAS; EXOSOME; COMPLEX		Univ Nebraska, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Cerutti, H (corresponding author), Univ Nebraska, Lincoln, NE 68588 USA.	hcerutti@unl.edu		Ibrahim, Fadia/0000-0002-4344-765X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062915] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062915-06, GM62915] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	7	72	79	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2006	314	5807					1893	1893		10.1126/science.1135268	http://dx.doi.org/10.1126/science.1135268			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185594	Green Submitted			2022-12-01	WOS:000242996800038
J	Zaiss, DM; Yang, L; Shah, PR; Kobie, JJ; Urban, JF; Mosmann, TR				Zaiss, Dietmar M.; Yang, Li; Shah, Pranav R.; Kobie, James J.; Urban, Joseph F.; Mosmann, Tim R.			Amphiregulin, a T(H)2 cytokine enhancing resistance to nematodes	SCIENCE			English	Article							PARASITE; MOUSE		Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA; ARS, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD 20705 USA	University of Rochester; University of Rochester; United States Department of Agriculture (USDA)	Mosmann, TR (corresponding author), Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Tim_Mosmann@urmc.rochester.edu		Urban, Joseph/0000-0002-1590-8869; Zaiss, Dietmar M.W./0000-0003-3596-7062	NIAID NIH HHS [AI48604] Funding Source: Medline; PHS HHS [DFG/ZA280] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048604] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045; POTTEN CS, 1995, GUT, V36, P864, DOI 10.1136/gut.36.6.864; Shea-Donohue T, 2004, CURR OPIN GASTROEN, V20, P3, DOI 10.1097/00001574-200401000-00003; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939	7	133	138	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1746	1746		10.1126/science.1133715	http://dx.doi.org/10.1126/science.1133715			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170297				2022-12-01	WOS:000242833600049
J	Fuss, B; Becker, T; Zinke, I; Hoch, M				Fuss, Bernhard; Becker, Thomas; Zinke, Ingo; Hoch, Michael			The cytohesin Steppke is essential for insulin signalling in Drosophila	NATURE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHOINOSITIDE 3-KINASE; CELL-GROWTH; RECEPTOR; ARF; NUMBER; MECHANISMS; AKT/PKB; PATHWAY; BINDING	In metazoans, the insulin signalling pathway has a key function in regulating energy metabolism and organismal growth(1). Its activation stimulates a highly conserved downstream kinase cascade that includes phosphatidylinositol-3-OH kinase ( PI( 3) K) and the serine - threonine protein kinase Akt. This study identifies a new component of insulin signalling in Drosophila, the steppke gene ( step). step encodes a member of the cytohesin family of guanine nucleotide exchange factors ( GEFs), which have been characterized as activators for ADP-ribosylation factor (ARF) GTPases(2-4). In step mutant animals both cell size and cell number are reduced, resulting in decreased body size and body weight in larvae, pupae and adults. step acts upstream of PI( 3) K and is required for the proper regulation of Akt and the transcription factor FOXO. Temporally controlled interference with the GEF activity of the Step protein by feeding the chemical inhibitor SecinH3 causes a block of insulin signalling and a phenocopy of the step mutant growth defect. Step represses its own expression and the synthesis of growth inhibitors such as the translational repressor 4E-BP. Our findings indicate a crucial role of an ARF - GEF in insulin signalling that has implications for understanding insulin-related disorders, such as diabetes and obesity.	Univ Bonn, Lab Mol Dev Biol, LIMES Inst, Program Unit Dev & Genet, D-53115 Bonn, Germany	University of Bonn	Hoch, M (corresponding author), Univ Bonn, Lab Mol Dev Biol, LIMES Inst, Program Unit Dev & Genet, Meckenheimer Allee 169, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de	Gimenez, Luis E Diaz/D-9291-2011					Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Hafen E, 2004, SWISS MED WKLY, V134, P711; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Randazzo PA, 2001, TRENDS BIOCHEM SCI, V26, P220, DOI 10.1016/S0968-0004(01)01806-0; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science.1068094; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Xuan ZY, 2005, MECH AGEING DEV, V126, P209, DOI 10.1016/j.mad.2004.09.021; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	27	108	109	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					945	948		10.1038/nature05412	http://dx.doi.org/10.1038/nature05412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167488				2022-12-01	WOS:000242805400060
J	Ledford, H				Ledford, Heidi			Making it up as you go along	NATURE			English	News Item																		WILLIAMS RH, 2006, 8 INT C GREENH GAS C	1	9	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					677	678		10.1038/444677a	http://dx.doi.org/10.1038/444677a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151629				2022-12-01	WOS:000242581100017
J	Sampaolesi, M; Blot, S; D'Antona, G; Granger, N; Tonlorenzi, R; Innocenzi, A; Mognol, P; Thibaud, JL; Galvez, BG; Barthelemy, I; Perani, L; Mantero, S; Guttinger, M; Pansarasa, O; Rinaldi, C; De Angelis, MGC; Torrente, Y; Bordignon, C; Bottinelli, R; Cossu, G				Sampaolesi, Maurilio; Blot, Stephane; D'Antona, Giuseppe; Granger, Nicolas; Tonlorenzi, Rossana; Innocenzi, Anna; Mognol, Paolo; Thibaud, Jean-Laurent; Galvez, Beatriz G.; Barthelemy, Ines; Perani, Laura; Mantero, Sara; Guttinger, Maria; Pansarasa, Orietta; Rinaldi, Chiara; De Angelis, M. Gabriella Cusella; Torrente, Yvan; Bordignon, Claudio; Bottinelli, Roberto; Cossu, Giulio			Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs	NATURE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; T-CELLS; EXPRESSION; MULTIPOTENT; THERAPY; REPAIR; TRANSPLANTATION; POPULATION; DELIVERY	Duchenne muscular dystrophy remains an untreatable genetic disease that severely limits motility and life expectancy in affected children. The only animal model specifically reproducing the alterations in the dystrophin gene and the full spectrum of human pathology is the golden retriever dog model. Affected animals present a single mutation in intron 6, resulting in complete absence of the dystrophin protein, and early and severe muscle degeneration with nearly complete loss of motility and walking ability. Death usually occurs at about 1 year of age as a result of failure of respiratory muscles. Here we report that intra-arterial delivery of wild-type canine mesoangioblasts (vessel-associated stem cells) results in an extensive recovery of dystrophin expression, normal muscle morphology and function ( confirmed by measurement of contraction force on single fibres). The outcome is a remarkable clinical amelioration and preservation of active motility. These data qualify mesoangioblasts as candidates for future stem cell therapy for Duchenne patients.	Univ Vita & Salute, San Raffaele Sci Inst, Stem Cell Res Inst, I-20132 Milan, Italy; Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy; Univ Pavia, Interuniv Inst Myol, I-27100 Pavia, Italy; Ecole Vet Alfort, Neurobiol Lab, F-94704 Maisons Alfort, France; Politecn Milan, Dept Bioengn, I-20130 Milan, Italy; Inst Cell Biol & Tissue Engn, I-00128 Rome, Italy; Univ Milan, Dept Neurol Sci, IRCCS, Fdn Policlin Milano, I-20122 Milan, Italy; Univ Milan, Dept Biol, I-20130 Milan, Italy; Univ Milan, Ctr Stem Cell Res, I-20130 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pavia; University of Pavia; Ecole Nationale Veterinaire d'Alfort (ENVA); Polytechnic University of Milan; University of Milan; University of Milan; University of Milan	Cossu, G (corresponding author), Univ Vita & Salute, San Raffaele Sci Inst, Stem Cell Res Inst, Via Olgettina 58, I-20132 Milan, Italy.	roberto.bottinelli@unipv.it; cossu.giulio@hsr.it	Gálvez, Beatriz G./H-1644-2015; Bottinelli, Roberto/AAC-1904-2020; Tonlorenzi, Rossana/AAN-2241-2020; Sampaolesi, Maurilio/H-6509-2013; Mantero, Sara/F-6587-2013; Blot, Stephane/K-7573-2019; Perani, Laura/AAN-2838-2020; Pansarasa, Orietta/A-2012-2019; TORRENTE, YVAN/A-2964-2015; Blot, Stephane/F-7420-2011	Gálvez, Beatriz G./0000-0002-8082-9323; Bottinelli, Roberto/0000-0002-4960-7490; Sampaolesi, Maurilio/0000-0002-2422-3757; Perani, Laura/0000-0001-8616-3377; D'Antona, Giuseppe/0000-0002-0683-5565; Granger, Nicolas/0000-0002-3036-3908; TORRENTE, YVAN/0000-0002-2705-3984; MANTERO, SARA/0000-0002-1264-0465; Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346; Barthelemy, Ines/0000-0002-4747-5893; Tonlorenzi, Rossana/0000-0002-6060-8208; Blot, Stephane/0000-0002-8982-0317	Telethon [GSP030543] Funding Source: Medline	Telethon(Fondazione Telethon)		Bachrach E, 2004, P NATL ACAD SCI USA, V101, P3581, DOI 10.1073/pnas.0400373101; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Childers MK, 2005, MUSCLE NERVE, V31, P768, DOI 10.1002/mus.20298; Cossu G, 2004, TRENDS MOL MED, V10, P516, DOI 10.1016/j.molmed.2004.08.007; Dell'Agnola C, 2004, BLOOD, V104, P4311, DOI 10.1182/blood-2004-06-2247; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Emery A E, 1989, Prog Clin Biol Res, V306, P15; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Galli D, 2005, ARTERIOSCL THROM VAS, V25, P692, DOI 10.1161/01.ATV.0000156402.52029.ce; Galvez BG, 2006, J CELL BIOL, V174, P231, DOI 10.1083/jcb.200512085; HARPER SQ, 2004, NAT MED, V8, P253; Howell JM, 1997, NEUROMUSCULAR DISORD, V7, P325; Karpati G, 1997, CURR OPIN NEUROL, V10, P430, DOI 10.1097/00019052-199710000-00013; Kornegay JN, 2003, NEUROMUSCULAR DISORD, V13, P493, DOI 10.1016/S0960-8966(03)00025-7; KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Pavlath GK, 2002, J NEUROIMMUNOL, V125, P42, DOI 10.1016/S0165-5728(02)00026-7; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325	25	552	572	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					574	579		10.1038/nature05282	http://dx.doi.org/10.1038/nature05282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17108972	Green Published			2022-12-01	WOS:000242377600039
J	Green, RE; Krause, J; Ptak, SE; Briggs, AW; Ronan, MT; Simons, JF; Du, L; Egholm, M; Rothberg, JM; Paunovic, M; Paabo, S				Green, Richard E.; Krause, Johannes; Ptak, Susan E.; Briggs, Adrian W.; Ronan, Michael T.; Simons, Jan F.; Du, Lei; Egholm, Michael; Rothberg, Jonathan M.; Paunovic, Maja; Paeaebo, Svante			Analysis of one million base pairs of Neanderthal DNA	NATURE			English	Article							ANCESTRAL POPULATION SIZES; MODERN HUMAN ORIGINS; ANCIENT DNA; ENZYMATIC AMPLIFICATION; MITOCHONDRIAL GENOME; DIVERGENCE TIMES; MTDNA SEQUENCE; MODERN HUMANS; DIVERSITY; ARTIFACTS	Neanderthals are the extinct hominid group most closely related to contemporary humans, so their genome offers a unique opportunity to identify genetic changes specific to anatomically fully modern humans. We have identified a 38,000- year- old Neanderthal fossil that is exceptionally free of contamination from modern human DNA. Direct high- throughput sequencing of a DNA extract from this fossil has thus far yielded over one million base pairs of hominoid nuclear DNA sequences. Comparison with the human and chimpanzee genomes reveals that modern human and Neanderthal DNA sequences diverged on average about 500,000 years ago. Existing technology and fossil resources are now sufficient to initiate a Neanderthal genome- sequencing effort.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; 454 Life Sci, Branford, CT 06405 USA; Croatian Acad Sci & Arts, Inst Quaternary Paleontol & Geol, HR-10000 Zagreb, Croatia	Max Planck Society; Croatian Academy of Sciences & Arts	Green, RE (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	green@eva.mpg.de	Krause, Johannes/AFP-2642-2022; Krause, Johannes/E-6640-2015	Krause, Johannes/0000-0001-9144-3920; Krause, Johannes/0000-0001-5475-4690; Green, Richard/0000-0003-0516-5827				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bischoff JL, 2003, J ARCHAEOL SCI, V30, P275, DOI 10.1006/jasc.2002.0834; Caramelli D, 2006, CURR BIOL, V16, pR630, DOI 10.1016/j.cub.2006.07.043; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; FRANCISCUS RG, 2002, NEANDERTHALS; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; HUBLIN JJ, 1998, CLIMATIC CHANGES PAL; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Innan H, 2006, MOL BIOL EVOL, V23, P1040, DOI 10.1093/molbev/msj109; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paabo S, 1999, TRENDS CELL BIOL, V9, pM13, DOI 10.1016/S0968-0004(99)01497-8; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Rannala B, 2003, GENETICS, V164, P1645; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Schmitz RW, 2002, P NATL ACAD SCI USA, V99, P13342, DOI 10.1073/pnas.192464099; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Takahata N, 2001, MOL BIOL EVOL, V18, P172, DOI 10.1093/oxfordjournals.molbev.a003791; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wall JD, 2003, GENETICS, V163, P395; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375	50	465	506	9	221	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					330	336		10.1038/nature05336	http://dx.doi.org/10.1038/nature05336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108958	Bronze			2022-12-01	WOS:000242018300040
J	Yamada, S; Suzuki, Y; Suzuki, T; Le, MQ; Nidom, CA; Sakai-Tagawa, Y; Muramoto, Y; Ito, M; Kiso, M; Horimoto, T; Shinya, K; Sawada, T; Kiso, M; Usui, T; Murata, T; Lin, YP; Hay, A; Haire, LF; Stevens, DJ; Russell, RJ; Gamblin, SJ; Skehel, JJ; Kawaoka, Y				Yamada, Shinya; Suzuki, Yasuo; Suzuki, Takashi; Le, Mai Q.; Nidom, Chairul A.; Sakai-Tagawa, Yuko; Muramoto, Yukiko; Ito, Mutsumi; Kiso, Maki; Horimoto, Taisuke; Shinya, Kyoko; Sawada, Toshihiko; Kiso, Makoto; Usui, Taiichi; Murata, Takeomi; Lin, Yipu; Hay, Alan; Haire, Lesley F.; Stevens, David J.; Russell, Rupert J.; Gamblin, Steven J.; Skehel, John J.; Kawaoka, Yoshihiro			Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors	NATURE			English	Article							AVIAN INFLUENZA; AMINO-ACID; SPECIFICITY; INFECTION; H2	H5N1 influenza A viruses have spread to numerous countries in Asia, Europe and Africa, infecting not only large numbers of poultry, but also an increasing number of humans, often with lethal effects(1,2). Human and avian influenza A viruses differ in their recognition of host cell receptors: the former preferentially recognize receptors with saccharides terminating in sialic acid-alpha 2,6-galactose ( SA alpha 2,6Gal), whereas the latter prefer those ending in SA alpha 2,3Gal ( refs 3 - 6). A conversion from SA alpha 2,3Gal to SA alpha 2,6Gal recognition is thought to be one of the changes that must occur before avian influenza viruses can replicate efficiently in humans and acquire the potential to cause a pandemic. By identifying mutations in the receptor- binding haemagglutinin ( HA) molecule that would enable avian H5N1 viruses to recognize human- type host cell receptors, it may be possible to predict ( and thus to increase preparedness for) the emergence of pandemic viruses. Here we show that some H5N1 viruses isolated from humans can bind to both human and avian receptors, in contrast to those isolated from chickens and ducks, which recognize the avian receptors exclusively. Mutations at positions 182 and 192 independently convert the HAs of H5N1 viruses known to recognize the avian receptor to ones that recognize the human receptor. Analysis of the crystal structure of the HA from an H5N1 virus used in our genetic experiments shows that the locations of these amino acids in the HA molecule are compatible with an effect on receptor binding. The amino acid changes that we identify might serve as molecular markers for assessing the pandemic potential of H5N1 field isolates.	Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Chubu Univ, Coll Life & Hlth Sci, Aichi 4878501, Japan; Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; COE Program 21st Century, Shizuoka 4228526, Japan; Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; Airlangga Univ, Trop Dis Ctr, Avian Influenza Lab, Surabaya, Indonesia; Tottori Univ, Avian Zoonosis Res Ctr, Tottori 6808553, Japan; Gifu Univ, United Grad Sch Agr Sci, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; Univ Shizuoka, Dept Appl Biol Chem, Shizuoka 4228529, Japan; MRC, Natl Inst Med Res, London NW7 1AA, England; Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Chubu University; University of Shizuoka; National Institute of Hygiene & Epidemiology (NIHE); Airlangga University; Tottori University; Gifu University; University of Shizuoka; MRC National Institute for Medical Research; University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan.	kawaoka@ims.u-tokyo.ac.jp		Gamblin, Steve/0000-0001-5331-639X; Yasuo, Suzuki/0000-0003-3518-5642	Medical Research Council [MC_U117512711, G0600522, MC_U117512708] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U117512711, G0600522, MC_U117512708] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CLEMENTS ML, 1992, J CLIN MICROBIOL, V30, P655, DOI 10.1128/JCM.30.3.655-662.1992; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Enserink M, 2006, SCIENCE, V311, P932; GUBAREVA LV, 1994, VIROLOGY, V199, P89, DOI 10.1006/viro.1994.1100; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; HARDY CT, 1995, VIROLOGY, V211, P302, DOI 10.1006/viro.1995.1405; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1983, VIROLOGY, V131, P394, DOI 10.1016/0042-6822(83)90507-X; Shinya K, 2005, J VIROL, V79, P9926, DOI 10.1128/JVI.79.15.9926-9932.2005; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Totani K, 2003, GLYCOBIOLOGY, V13, P315, DOI 10.1093/glycob/cwg032; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; Zambon MC, 2001, REV MED VIROL, V11, P227, DOI 10.1002/rmv.319	26	474	524	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2006	444	7117					378	382		10.1038/nature05264	http://dx.doi.org/10.1038/nature05264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105GL	17108965				2022-12-01	WOS:000242018300051
J	Poinar, GO; Danforth, BN				Poinar, G. O., Jr.; Danforth, B. N.			A fossil bee from Early Cretaceous Burmese amber	SCIENCE			English	Article									Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Cornell University; Oregon State University	Danforth, BN (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	bnd1@cornell.edu		Danforth, Bryan/0000-0002-6495-428X				[Anonymous], 2000, BEES WORLD; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Cruickshank RD, 2003, J ASIAN EARTH SCI, V21, P441, DOI 10.1016/S1367-9120(02)00044-5; Melo Gabriel A.R., 1999, Scientific Papers Natural History Museum the University of Kansas, V14, P1; Soltis D, 2005, PHYLOGENY EVOLUTION; THORP RW, 1979, ANN MO BOT GARD, V66, P788, DOI 10.2307/2398919	6	75	87	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 27	2006	314	5799					614	614		10.1126/science.1134103	http://dx.doi.org/10.1126/science.1134103			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098XT	17068254				2022-12-01	WOS:000241557800036
J	Weinstock, GM; Robinson, GE; Gibbs, RA; Worley, KC; Evans, JD; Maleszka, R; Robertson, HM; Weaver, DB; Beye, M; Bork, P; Elsik, CG; Hartfelder, K; Hunt, GJ; Zdobnov, EM; Amdam, GV; Bitondi, MMG; Collins, AM; Cristino, AS; Lattorff, HMG; Lobo, CH; Moritz, RFA; Nunes, FMF; Page, RE; Simoes, ZLP; Wheeler, D; Carninci, P; Fukuda, S; Hayashizaki, Y; Kai, C; Kawai, J; Sakazume, N; Sasaki, D; Tagami, M; Albert, S; Baggerman, G; Beggs, KT; Bloch, G; Cazzamali, G; Cohen, M; Drapeau, MD; Eisenhardt, D; Emore, C; Ewing, MA; Fahrbach, SE; Foret, S; Grimmelikhuijzen, CJP; Hauser, F; Hummon, AB; Huybrechts, J; Jones, AK; Kadowaki, T; Kaplan, N; Kucharski, R; Leboulle, G; Linial, M; Littleton, JT; Mercer, AR; Richmond, TA; Rodriguez-Zas, SL; Rubin, EB; Sattelle, DB; Schlipalius, D; Schoofs, L; Shemesh, Y; Sweedler, JV; Velarde, R; Verleyen, P; Vierstraete, E; Williamson, MR; Ament, SA; Brown, SJ; Corona, M; Dearden, PK; Dunn, WA; Elekonich, MM; Fujiyuki, T; Gattermeier, I; Gempe, T; Hasselmann, M; Kadowaki, T; Kage, E; Kamikouchi, A; Kubo, T; Kucharski, R; Kunieda, T; Lorenzen, MD; Milshina, NV; Morioka, M; Ohashi, K; Overbeek, R; Ross, CA; Schioett, M; Shippy, T; Takeuchi, H; Toth, AL; Willis, JH; Wilson, MJ; Gordon, KHJ; Letunic, I; Hackett, K; Peterson, J; Felsenfeld, A; Guyer, M; Solignac, M; Agarwala, R; Cornuet, JM; Monnerot, M; Mougel, F; Reese, JT; Vautrin, D; Gillespie, JJ; Cannone, JJ; Gutell, RR; Johnston, JS; Eisen, MB; Iyer, VN; Iyer, V; Kosarev, P; Mackey, AJ; Solovyev, V; Souvorov, A; Aronstein, KA; Bilikova, K; Chen, YP; Clark, AG; Decanini, LI; Gelbart, WM; Hetru, C; Hultmark, D; Imler, JL; Jiang, HB; Kanost, M; Kimura, K; Lazzaro, BP; Lopez, DL; Simuth, J; Thompson, GJ; Zou, Z; De Jong, P; Sodergren, E; Csuros, M; Milosavljevic, A; Osoegawa, K; Richards, S; Shu, CL; Duret, L; Elhaik, E; Graur, D; Anzola, JM; Campbell, KS; Childs, KL; Collinge, D; Crosby, MA; Dickens, CM; Grametes, LS; Grozinger, CM; Jones, PL; Jorda, M; Ling, X; Matthews, BB; Miller, J; Mizzen, C; Peinado, MA; Reid, JG; Russo, SM; Schroeder, AJ; St Pierre, SE; Wang, Y; Zhou, PL; Jiang, HY; Kitts, P; Ruef, B; Venkatraman, A; Zhang, L; Aquino-Perez, G; Whitfield, CW; Behura, SK; Berlocher, SH; Sheppard, WS; Smith, DR; Suarez, AV; Tsutsui, ND; Wei, XH; Wheeler, D; Havlak, P; Li, BS; Liu, Y; Sodergren, E; Jolivet, A; Lee, S; Nazareth, LV; Pu, LL; Thorn, R; Stolc, V; Newman, T; Samanta, M; Tongprasit, WA; Claudianos, C; Berenbaum, MR; Biswas, S; de Graaf, DC; Feyereisen, R; Johnson, RM; Oakeshott, JG; Ranson, H; Schuler, MA; Muzny, D; Chacko, J; Davis, C; Dinh, H; Gill, R; Hernandez, J; Hines, S; Hume, J; Jackson, L; Kovar, C; Lewis, L; Miner, G; Morgan, M; Nguyen, N; Okwuonu, G; Paul, H; Santibanez, J; Savery, G; Svatek, A; Villasana, D; Wright, R				Weinstock, George M.; Robinson, Gene E.; Gibbs, Richard A.; Worley, Kim C.; Evans, Jay D.; Maleszka, Ryszard; Robertson, Hugh M.; Weaver, Daniel B.; Beye, Martin; Bork, Peer; Elsik, Christine G.; Hartfelder, Klaus; Hunt, Greg J.; Zdobnov, Evgeny M.; Amdam, Gro V.; Bitondi, Marcia M. G.; Collins, Anita M.; Cristino, Alexandre S.; Lattorff, H. Michael G.; Lobo, Carlos H.; Moritz, Robin F. A.; Nunes, Francis M. F.; Page, Robert E., Jr.; Simoes, Zila L. P.; Wheeler, Diana; Carninci, Piero; Fukuda, Shiro; Hayashizaki, Yoshihide; Kai, Chikatoshi; Kawai, Jun; Sakazume, Naoko; Sasaki, Daisuke; Tagami, Michihira; Albert, Stefan; Baggerman, Geert; Beggs, Kyle T.; Bloch, Guy; Cazzamali, Giuseppe; Cohen, Mira; Drapeau, Mark David; Eisenhardt, Dorothea; Emore, Christine; Ewing, Michael A.; Fahrbach, Susan E.; Foret, Sylvain; Grimmelikhuijzen, Cornelis J. P.; Hauser, Frank; Hummon, Amanda B.; Huybrechts, Jurgen; Jones, Andrew K.; Kadowaki, Tatsuhiko; Kaplan, Noam; Kucharski, Robert; Leboulle, Gerard; Linial, Michal; Littleton, J. Troy; Mercer, Alison R.; Richmond, Timothy A.; Rodriguez-Zas, Sandra L.; Rubin, Elad B.; Sattelle, David B.; Schlipalius, David; Schoofs, Liliane; Shemesh, Yair; Sweedler, Jonathan V.; Velarde, Rodrigo; Verleyen, Peter; Vierstraete, Evy; Williamson, Michael R.; Ament, Seth A.; Brown, Susan J.; Corona, Miguel; Dearden, Peter K.; Dunn, W. Augustine; Elekonich, Michelle M.; Fujiyuki, Tomoko; Gattermeier, Irene; Gempe, Tanja; Hasselmann, Martin; Kadowaki, Tatsuhiko; Kage, Eriko; Kamikouchi, Azusa; Kubo, Takeo; Kucharski, Robert; Kunieda, Takekazu; Lorenzen, Marce D.; Milshina, Natalia V.; Morioka, Mizue; Ohashi, Kazuaki; Overbeek, Ross; Ross, Christian A.; Schioett, Morten; Shippy, Teresa; Takeuchi, Hideaki; Toth, Amy L.; Willis, Judith H.; Wilson, Megan J.; Gordon, Karl H. J.; Letunic, Ivica; Hackett, Kevin; Peterson, Jane; Felsenfeld, Adam; Guyer, Mark; Solignac, Michel; Agarwala, Richa; Cornuet, Jean Marie; Monnerot, Monique; Mougel, Florence; Reese, Justin T.; Vautrin, Dominique; Gillespie, Joseph J.; Cannone, Jamie J.; Gutell, Robin R.; Johnston, J. Spencer; Eisen, Michael B.; Iyer, Venky N.; Iyer, Vivek; Kosarev, Peter; Mackey, Aaron J.; Solovyev, Victor; Souvorov, Alexandre; Aronstein, Katherine A.; Bilikova, Katarina; Chen, Yan Ping; Clark, Andrew G.; Decanini, Laura I.; Gelbart, William M.; Hetru, Charles; Hultmark, Dan; Imler, Jean-Luc; Jiang, Haobo; Kanost, Michael; Kimura, Kiyoshi; Lazzaro, Brian P.; Lopez, Dawn L.; Simuth, Jozef; Thompson, Graham J.; Zou, Zhen; De Jong, Pieter; Sodergren, Erica; Csuroes, Miklos; Milosavljevic, Aleksandar; Osoegawa, Kazutoyo; Richards, Stephen; Shu, Chung-Li; Duret, Laurent; Elhaik, Eran; Graur, Dan; Anzola, Juan M.; Campbell, Kathryn S.; Childs, Kevin L.; Collinge, Derek; Crosby, Madeline A.; Dickens, C. Michael; Grametes, L. Sian; Grozinger, Christina M.; Jones, Peter L.; Jorda, Mireia; Ling, Xu; Matthews, Beverly B.; Miller, Jonathan; Mizzen, Craig; Peinado, Miguel A.; Reid, Jeffrey G.; Russo, Susan M.; Schroeder, Andrew J.; St Pierre, Susan E.; Wang, Ying; Zhou, Pinglei; Jiang, Huaiyang; Kitts, Paul; Ruef, Barbara; Venkatraman, Anand; Zhang, Lan; Aquino-Perez, Gildardo; Whitfield, Charles W.; Behura, Susanta K.; Berlocher, Stewart H.; Sheppard, Walter S.; Smith, Deborah R.; Suarez, Andrew V.; Tsutsui, Neil D.; Wei, Xuehong; Wheeler, David; Havlak, Paul; Li, Bingshan; Liu, Yue; Sodergren, Erica; Jolivet, Angela; Lee, Sandra; Nazareth, Lynne V.; Pu, Ling-Ling; Thorn, Rachel; Stolc, Viktor; Newman, Thomas; Samanta, Manoj; Tongprasit, Waraporn A.; Claudianos, Charles; Berenbaum, May R.; Biswas, Sunita; de Graaf, Dirk C.; Feyereisen, Rene; Johnson, Reed M.; Oakeshott, John G.; Ranson, Hilary; Schuler, Mary A.; Muzny, Donna; Chacko, Joseph; Davis, Clay; Dinh, Huyen; Gill, Rachel; Hernandez, Judith; Hines, Sandra; Hume, Jennifer; Jackson, LaRonda; Kovar, Christie; Lewis, Lora; Miner, George; Morgan, Margaret; Nguyen, Ngoc; Okwuonu, Geoffrey; Paul, Heidi; Santibanez, Jireh; Savery, Glenford; Svatek, Amanda; Villasana, Donna; Wright, Rita		Honeybee Genome Sequencing Consort	Insights into social insects from the genome of the honeybee Apis mellifera	NATURE			English	Review							DROSOPHILA-NINAG OXIDOREDUCTASE; TRANSPOSABLE ELEMENTS; MITOCHONDRIAL-DNA; ANOPHELES-GAMBIAE; GENE-EXPRESSION; FRUIT-FLY; STATISTICAL-ANALYSIS; MOLECULAR EVOLUTION; MARINER TRANSPOSONS; MALARIA MOSQUITO	Here we report the genome sequence of the honeybee Apis mellifera, a key model for social behaviour and essential to global ecology through pollination. Compared with other sequenced insect genomes, the A. mellifera genome has high A+T and CpG contents, lacks major transposon families, evolves more slowly, and is more similar to vertebrates for circadian rhythm, RNA interference and DNA methylation genes, among others. Furthermore, A. mellifera has fewer genes for innate immunity, detoxification enzymes, cuticle-forming proteins and gustatory receptors, more genes for odorant receptors, and novel genes for nectar and pollen utilization, consistent with its ecology and social organization. Compared to Drosophila, genes in early developmental pathways differ in Apis, whereas similarities exist for functions that differ markedly, such as sex determination, brain function and behaviour. Population genetics suggests a novel African origin for the species A. mellifera and insights into whether Africanized bees spread throughout the New World via hybridization or displacement.	Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Hum Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; USDA ARS, Bee Res Lab, BARC E, Beltsville, MD 20705 USA; USDA ARS, Natl Program Staff, Beltsville, MD 20705 USA; Australian Natl Univ, ARC, Special Ctr Mol Genet Dev, Res Sch Biol Sci, Canberra, ACT 0200, Australia; Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Program Ecol & Evolutionary Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Bee Power LP, Navasota, TX 77868 USA; Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; Univ Houston, Dept Chem, Houston, TX 77204 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, Brazil; Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogenicos, Ribeirao Preto, Brazil; Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Pret, Dept Biol, BR-14049900 Ribeirao Preto, Brazil; Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; Univ Geneva, Sch Med, CMU, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Univ Sao Paulo, Inst Matemat & Estatist, Sao Paulo, Brazil; Univ Halle Wittenberg, Inst Zool Mol Okol, D-06099 Halle, Saale, Germany; Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; RIKEN, Genom Sci Ctr, Lab Genome Explorat Res Grp, Yokohama, Kanagawa 2300045, Japan; Inst Med Strahlenkunde & Zellforsch, D-97078 Wurzburg, Germany; Katholieke Univ Leuven, Lab Dev Physiol Genom & Prote, B-3000 Louvain, Belgium; Univ Otago, Dept Biochem, Lab Evolut & Dev, Dunedin, New Zealand; Univ Otago, Dept Zool, Dunedin, New Zealand; Hebrew Univ Jerusalem, Dept Evolut Systemat & Ecol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Sudarsky Ctr Computat Biol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; Univ Copenhagen, Inst Biol, Dept Cell Biol & Comparat Zool, Ctr Funct & Comparat Insect Genom, DK-2100 Copenhagen, Denmark; NYU, Dept Biol, New York, NY 10003 USA; Free Univ Berlin, FB Biol Chem Pharm, D-14195 Berlin, Germany; Univ Oxford, MRC, Funct Genet Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; CSIRO Entomol, Canberra, ACT 2601, Australia; MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Ghent, Lab Zoophysiol, B-9000 Ghent, Belgium; Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; USDA ARS, GMPRC, Manhattan, KS 66502 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; CNRS, Lab Evolut Genomes & Speciat, F-91198 Gif Sur Yvette, France; Fellowship Interpretat Genomes, Burr Ridge, IL 60527 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, US Dept HHS, Bethesda, MD 20894 USA; INRA, Ctr Biol & Gest Populat, F-34988 St Gely Du Fesc, France; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA; Virginia Tech, Bioinformat Facil, Virginia Bioinformat Inst 0477, Blacksburg, VA 24061 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Softberry Inc, Mt Kisco, NY 10549 USA; Univ Penn, Penn Genom Inst, Philadelphia, PA 19104 USA; Univ London Royal Holloway & Bedford New Coll, Egham TW20 0EX, Surrey, England; USDA ARS, Honey Bee Unit, Weslaco, TX 78596 USA; Slovak Acad Sci, Bratislava 84551, Slovakia; Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden; Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3058517, Japan; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Childrens Hosp Oakland, BACPAC Resources, Oakland, CA 94609 USA; Univ Lyon 1, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; N Carolina State Univ, Dept Entomol, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; Univ Kansas, Dept Ecol & Evolutionary Biol Entomol, Lawrence, KS 66045 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; NASA, Ames Genome Res Facil, Moffett Field, CA 94035 USA; Systemix Inst, Cupertino, CA 95014 USA; Univ Montreal, Dept Informat & Rech Operat, Montreal, PQ H3C 3J7, Canada; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Oncol Res Inst, Lhospitalet De Llobregat 08907, Catalonia, Spain; INRA, F-06903 Sophia Antipolis, France; Univ Nice Sophia Antipolis, Ctr Rech Sophia Antipolis, UMR 1112, F-06903 Sophia Antipolis, France	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Australian National University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Heinrich Heine University Dusseldorf; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Texas A&M University System; Texas A&M University College Station; University of Houston System; University of Houston; University of Houston System; University of Houston; Universidade de Sao Paulo; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Geneva; Arizona State University; Arizona State University-Tempe; Universidade de Sao Paulo; Martin Luther University Halle Wittenberg; University of Arizona; RIKEN; KU Leuven; University of Otago; University of Otago; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Copenhagen; New York University; Free University of Berlin; University of Oxford; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Ghent University; Wake Forest University; United States Department of Agriculture (USDA); Kansas State University; Kansas State University; University System of Georgia; University of Georgia; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Tokyo; Nagoya University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); INRAE; Institut de Recherche pour le Developpement (IRD); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Virginia Polytechnic Institute & State University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Wellcome Trust Sanger Institute; University of Pennsylvania; University of London; Royal Holloway University London; United States Department of Agriculture (USDA); Slovak Academy of Sciences; Cornell University; Cornell University; Harvard University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Umea University; Oklahoma State University System; Oklahoma State University - Stillwater; National Agriculture & Food Research Organization - Japan; University of Sydney; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of North Carolina; North Carolina State University; Washington State University; University of Kansas; University of California System; University of California Irvine; National Aeronautics & Space Administration (NASA); Universite de Montreal; Liverpool School of Tropical Medicine; University of Liverpool; INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Weinstock, GM (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	gwstock@bcm.edu	Schiøtt, Morten/AAJ-8945-2021; Beggs, Kyle/A-5843-2009; Gordon, Karl H J/A-1976-2008; Hauser, Frank/M-2952-2014; Hultmark, Dan/C-5058-2013; Johnson, Reed M./H-3742-2011; Nunes, Francis M. F./F-5871-2010; Simoes, Zila Luz Paulino/H-7314-2014; Schiøtt, Morten/H-4118-2012; Maleszka, Ryszard/A-6078-2008; Schlipalius, David/B-8155-2011; Linial, Michal/B-9143-2011; Moritz, Robin FA/K-6053-2012; Weinstock, George M/C-6314-2013; Bloch, Guy/I-5861-2019; Jiang, Haobo/A-6519-2008; Foret, Sylvain/C-7661-2011; Hasselmann, Martin/ABB-6485-2021; Hasselmann, Martin/E-7681-2014; Blow, joe/C-8616-2009; Takeuchi, Hideaki/W-6739-2018; Dearden, Peter/B-7607-2008; Linial, Michal/AAQ-9259-2020; Elhaik, Eran/H-6838-2019; Sweedler, Jonathan V/A-9405-2009; Imler, Jean-Luc/GXH-4323-2022; schoofs, liliane/ABD-2943-2020; Fujiyuki, Tomoko Kaito/GYD-6398-2022; Letunic, Ivica/A-6032-2009; Jordà, Mireia/Z-4519-2019; Kaplan, Noam/A-3544-2011; Peinado, Miguel A./A-5591-2008; Smith, Deborah/V-1676-2019; Evans, Jay D/C-8408-2012; Li, Bingshan/H-1944-2011; Kawai, Jun/A-6451-2016; Elsik, Christine G/C-4120-2017; Carninci, Piero/K-1568-2014; Cristino, Alexandre S/A-5834-2012; Solovyev, Victor/C-4614-2013; Hartfelder, Klaus/L-2300-2019; Bitondi, Marcia MG/E-8014-2012; TAKEUCHI, HIDEAKI/G-4969-2014; Bork, Peer/F-1813-2013; Kaplan, Noam/K-4383-2019; Kunieda, Takekazu/G-4946-2014; Zdobnov, Evgeny/AAB-2745-2022; Wheeler, David A/M-9740-2018; Miller, Jonathan/M-4389-2014; Wilson, Matthew H/K-3193-2013; KUBO, TAKEO/G-4951-2014; Feyereisen, René/Y-7514-2019; Feyereisen, René/I-3140-2012; Hartfelder, Klaus/A-4293-2009; Letunic, Ivica/K-1102-2019; Lattorff, Michael/F-6287-2010; Oakeshott, John G/B-5365-2009; Zdobnov, Evgeny M/K-1133-2012; Thompson, Graham J/B-6508-2008; zou, zhen/C-6134-2016; FORET, Sylvain/B-9207-2012; Schoofs, Liliane/F-2815-2010; Childs, Kevin/C-9513-2014	Schiøtt, Morten/0000-0002-4309-8090; Gordon, Karl H J/0000-0002-4371-0454; Hauser, Frank/0000-0001-5563-2345; Hultmark, Dan/0000-0002-6506-5855; Johnson, Reed M./0000-0002-2431-0180; Nunes, Francis M. F./0000-0002-7769-3058; Schiøtt, Morten/0000-0002-4309-8090; Maleszka, Ryszard/0000-0003-1855-555X; Schlipalius, David/0000-0002-8102-7031; Moritz, Robin FA/0000-0003-0791-887X; Weinstock, George M/0000-0002-2997-4592; Bloch, Guy/0000-0003-1624-4926; Hasselmann, Martin/0000-0003-3305-4024; Takeuchi, Hideaki/0000-0001-6610-3895; Dearden, Peter/0000-0001-7790-9675; Linial, Michal/0000-0002-9357-4526; Elhaik, Eran/0000-0003-4795-1084; Sweedler, Jonathan V/0000-0003-3107-9922; Fujiyuki, Tomoko Kaito/0000-0001-5533-4129; Kaplan, Noam/0000-0001-9940-1987; Peinado, Miguel A./0000-0002-4090-793X; Smith, Deborah/0000-0002-2581-5009; Evans, Jay D/0000-0002-0036-4651; Elsik, Christine G/0000-0002-4248-7713; Carninci, Piero/0000-0001-7202-7243; Cristino, Alexandre S/0000-0002-3468-0919; Solovyev, Victor/0000-0001-8885-493X; Hartfelder, Klaus/0000-0001-7981-8427; Bitondi, Marcia MG/0000-0002-5619-6378; Bork, Peer/0000-0002-2627-833X; Kaplan, Noam/0000-0001-9940-1987; Zdobnov, Evgeny/0000-0002-5178-1498; Wheeler, David A/0000-0002-9056-6299; Miller, Jonathan/0000-0003-2190-6824; Feyereisen, René/0000-0002-9560-571X; Feyereisen, René/0000-0002-9560-571X; Hartfelder, Klaus/0000-0001-7981-8427; Letunic, Ivica/0000-0003-3560-4288; Lattorff, Michael/0000-0002-8603-6332; Oakeshott, John G/0000-0001-8324-7874; zou, zhen/0000-0003-3550-7656; Brown, Susan/0000-0002-7984-0445; Kunieda, Takekazu/0000-0002-6256-1335; Schoofs, Liliane/0000-0002-1673-432X; Jiang, Haobo/0000-0003-1357-1315; Baggerman, Geert/0000-0002-0661-931X; Ranson, Hilary/0000-0003-2332-8247; Littleton, J. Troy/0000-0001-5576-2887; Gillespie, Joseph/0000-0002-5447-7264; Shippy, Teresa/0000-0003-2305-7432; Claudianos, Charles/0000-0002-9799-9572; Wilson, Megan/0000-0003-3425-5071; Childs, Kevin/0000-0002-3680-062X; Anzola, Juan/0000-0003-2677-6731; Duret, Laurent/0000-0003-2836-3463; Ruef, Barbara/0000-0001-8690-979X; Lorenzen, Marce/0000-0003-2318-1388; , Derek/0000-0002-3940-3777; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046; Kanost, Michael/0000-0002-6827-0061; Schroeder, Andrew/0000-0002-5824-7917; Mercer, Alison/0000-0001-8110-4247; Kubo, Takeo/0000-0002-5914-5269; Eisen, Michael/0000-0002-7528-738X; Kucharski, Robert/0000-0002-1708-1877; Fukuda, Shiro/0000-0002-0065-662X; behura, Susanta/0000-0003-1057-2435; Jones, Andrew/0000-0002-7835-0890; Corona, Miguel/0000-0002-2582-5397; Simoes, Zila Luz Paulino/0000-0003-2363-6178; Ewing, Michael/0000-0001-5271-5655; Jorda, Mireia/0000-0003-3709-1850; Rodriguez-Zas, Sandra/0000-0003-1122-4758; Worley, Kim/0000-0002-0282-1000	Medical Research Council [MC_U137761447] Funding Source: Medline; NIGMS NIH HHS [R01 GM067317-03, R37 GM041247, R01 GM067317, R01 GM058634-08] Funding Source: Medline; NINDS NIH HHS [R01 NS043244, R01 NS040296, R01 NS040296-06] Funding Source: Medline; Wellcome Trust [062023] Funding Source: Medline; MRC [MC_U137761447] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067317, R01GM058634, R37GM041247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296, R01NS043244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ahmad ST, 2006, J BIOL CHEM, V281, P9205, DOI 10.1074/jbc.M510293200; Albert S, 1999, J MOL EVOL, V49, P290, DOI 10.1007/PL00006551; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Aronstein K, 2005, APIDOLOGIE, V36, P3, DOI 10.1051/apido:2004062; Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Baudry E, 2004, GENETICS, V167, P243, DOI 10.1534/genetics.167.1.243; BERENBAUM MR, 1999, MOL BIOL TOXIC RESPO, P553; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BEYE M, 1993, BIOTECHNIQUES, V14, P372; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; BEYE M, 1995, J HERED, V86, P145, DOI 10.1093/oxfordjournals.jhered.a111545; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; BEYE M, IN PRESS GENOME RES; Biessmann H, 2005, GENETICS, V171, P1767, DOI 10.1534/genetics.105.048827; Biessmann H, 1998, INSECT MOL BIOL, V7, P83, DOI 10.1046/j.1365-2583.1998.71054.x; BIGOT Y, 1992, GENE, V121, P347, DOI 10.1016/0378-1119(92)90142-C; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogdanov S, 1998, J APICULT RES, V37, P57, DOI 10.1080/00218839.1998.11100956; Bolshakov VN, 2002, GENOME RES, V12, P57, DOI 10.1101/gr.196101; Casacuberta E, 2005, CYTOGENET GENOME RES, V110, P152, DOI 10.1159/000084947; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; CLAUDIANOS C, IN PRESS INSECT MOL; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cohen N, 2005, MOL BIOL EVOL, V22, P1260, DOI 10.1093/molbev/msi115; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Corona M, 1999, J EXP BIOL, V202, P929; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Cowan CR, 2001, PLANT PHYSIOL, V125, P532, DOI 10.1104/pp.125.2.532; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Danforth BN, 2006, MOL PHYLOGENET EVOL, V39, P358, DOI 10.1016/j.ympev.2005.09.022; Danforth BN, 2006, P NATL ACAD SCI USA, V103, P15118, DOI 10.1073/pnas.0604033103; DAVIDSON EH, 2001, GENOME REGULATORY SY; Dearden PK, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-6; DEARDEN PK, IN PRESS GENOME RES; DRAPEAU MD, IN PRESS GENOME RES; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; EBERT PR, 1995, INSECT MOL BIOL, V4, P69, DOI 10.1111/j.1365-2583.1995.tb00010.x; Eiglmeier K, 2005, INSECT BIOCHEM MOLEC, V35, P799, DOI 10.1016/j.ibmb.2005.02.020; EISENHARDT D, IN PRESS INSECT MOL; ELSIK CG, IN PRESS GENOME BIOL; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Evans JD, 2001, BIOESSAYS, V23, P62, DOI 10.1002/1521-1878(200101)23:1&lt;62::AID-BIES1008&gt;3.0.CO;2-7; EVANS JD, IN PRESS INSECT MOL; Evans JSO, 2000, INT J INORG MATER, V2, P1; Feyereisen R., 2005, P1; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FORET S, IN PRESS GENOME RES; Foster KR, 2006, TRENDS ECOL EVOL, V21, P57, DOI 10.1016/j.tree.2005.11.020; Franck P, 2000, APIDOLOGIE, V31, P167, DOI 10.1051/apido:2000114; Fujiwara H, 2005, CHROMOSOME RES, V13, P455, DOI 10.1007/s10577-005-0990-9; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gerber S, 2000, HUM GENET, V107, P276, DOI 10.1007/s004390000350; GILLESPIE JJ, IN PRESS INSECT MOL; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Goodwin TJD, 2004, MOL GENET GENOMICS, V272, P47, DOI 10.1007/s00438-004-1028-2; Gregorc A, 1998, CELL BIOL INT, V22, P137, DOI 10.1006/cbir.1998.0232; Grimaldi David, 2005, pi; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hamilton W.D., 1972, Annual Rev Ecol Syst, V3, P193, DOI 10.1146/annurev.es.03.110172.001205; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Hepperle C, 2001, NATURWISSENSCHAFTEN, V88, P113, DOI 10.1007/s001140000196; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; *HON BEE GEN SEQ C, 2002, PROP SEQ NEW TARG GE; *HUM GEN SEQ CTR B, 2006, HON BEE GEN PROJ; HUMMON AB, IN PRESS SCIENCE; HUNT G, IN PRESS NATURWISSEN; HUNT GJ, 1995, GENETICS, V139, P1371; ILTIS H, 1923, LIFE MENDEL; JONES AK, IN PRESS GENOME RES; JORDAN RA, 1974, J INSECT PHYSIOL, V20, P2513, DOI 10.1016/0022-1910(74)90035-3; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Krieger MJB, 2003, INSECT MOL BIOL, V12, P155, DOI 10.1046/j.1365-2583.2003.00397.x; Kucharski R, 2000, GENE, V242, P399, DOI 10.1016/S0378-1119(99)00503-X; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; McAllister BF, 1997, MOL BIOL EVOL, V14, P69, DOI 10.1093/oxfordjournals.molbev.a025704; Melnikova L, 2005, CHROMOSOME RES, V13, P431, DOI 10.1007/s10577-005-0992-7; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mongin E, 2004, TRENDS PARASITOL, V20, P49, DOI 10.1016/j.pt.2003.11.003; Morse R.A., 1997, HONEY BEE PESTS PRED; Morse R.A., 2000, BEE CULTURE, V128, P2, DOI DOI 10.3896/IBRA.1.49.1.01; Nakao H, 1999, DEV GENES EVOL, V209, P312, DOI 10.1007/s004270050257; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Oakeshott JG., 2005, COMPREHENSIVE MOL IN, V5, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Ranson H., 2005, P383; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Robertson H.M., 1993, Insect Molecular Biology, V2, P125, DOI 10.1111/j.1365-2583.1993.tb00132.x; ROBERTSON HM, 1993, NATURE, V362, P241, DOI 10.1038/362241a0; ROBERTSON HM, 1995, ANNU REV ENTOMOL, V40, P333, DOI 10.1146/annurev.en.40.010195.002001; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; ROBERTSON HM, 2002, MOBILE DNA, V2; ROBERTSON HM, IN PRESS GENOME RES; Robertson Hugh M., 2005, American Entomologist, V51, P166; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; Rosellini D, 2000, P FORAG GR, V9, P314; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; RUTTNER F, 1978, APIDOLOGIE, V9, P363, DOI 10.1051/apido:19780408; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI DOI 10.1007/978-3-642-72649-1; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; SAVARD J, IN PRESS GENOME RES; Schmid-Hempel P., 1998, Parasites in social insects.; Schroder R, 2006, DEV GENES EVOL, V216, P277, DOI 10.1007/s00427-005-0054-3; SHEPPARD WS, 1991, NATURE, V349, P782, DOI 10.1038/349782a0; Sheppard WS, 1999, GENET MOL BIOL, V22, P73, DOI 10.1590/S1415-47571999000100015; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; Si A, 2004, PHARMACOL BIOCHEM BE, V77, P191, DOI 10.1016/j.pbb.2003.09.023; SINHA S, IN PRESS P NATL ACAD; SKRZIPEK KH, 1974, Z ZELLFORSCH MIK ANA, V147, P589, DOI 10.1007/BF00307257; SMITH DR, 1988, EXPERIENTIA, V44, P257, DOI 10.1007/BF01941730; SMITH WC, 1990, J MOL EVOL, V30, P72, DOI 10.1007/BF02102454; Solignac M, 2004, GENETICS, V167, P253, DOI 10.1534/genetics.167.1.253; SOLIGNAC M, UNPUB GENOME BIOL; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Tomlinson A, 2001, MOL CELL, V7, P487, DOI 10.1016/S1097-2765(01)00196-4; Townson SM, 1998, J NEUROSCI, V18, P2412; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Tremolada P, 2004, ECOTOXICOLOGY, V13, P589, DOI 10.1023/B:ECTX.0000037193.28684.05; *TRIB GEN SEQ PROJ, 2006, TRIB CAST V 2 0 ASS; Tsuchimoto M, 2005, DEV GENES EVOL, V215, P564, DOI 10.1007/s00427-005-0021-z; VARRICCHIO P, 1995, MOL BIOL, V25, P603; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; VELARDE RA, IN PRESS INSECT MOL; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WALLNER K, 1995, AM BEE J, V135, P817; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; WANG Y, IN PRESS SCIENCE; West-Eberhard Mary Jane, 2003, pi; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; WHITFIELD CW, IN PRESS SCIENCE; WHITFIELD CW, IN PRESS P NATL ACAD; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; WILLIS JH, 2005, COMPREHENSIVE MOL IN, V4, P79; Wilson E.O., 1971, INSECT SOC; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Winston M. L., 1987, BIOL HONEY BEE; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; WITTHOFT W., 1967, Z MORPHOL TIERE, V61, P160, DOI 10.1007/BF00298776; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; XIONG Y, 1988, NUCLEIC ACIDS RES, V16, P10561, DOI 10.1093/nar/16.22.10561; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; ZDOBNOV E, IN PRESS TRENDS GENE; Zdobnov EM, 2005, FEBS LETT, V579, P3355, DOI 10.1016/j.febslet.2005.04.006; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	180	1339	1442	12	572	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 26	2006	443	7114					931	949		10.1038/nature05260	http://dx.doi.org/10.1038/nature05260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098LZ	17073008	Green Accepted, Bronze			2022-12-01	WOS:000241523400044
J	Eisenstein, EL; Anstrom, KJ; Kong, DF; Shaw, LK; Tuttle, RH; Mark, DB; Kramer, JM; Harrington, RA; Matchar, DB; Kandzari, DE; Peterson, ED; Schulman, KA; Califf, RM				Eisenstein, Eric L.; Anstrom, Kevin J.; Kong, David F.; Shaw, Linda K.; Tuttle, Robert H.; Mark, Daniel B.; Kramer, Judith M.; Harrington, Robert A.; Matchar, David B.; Kandzari, David E.; Peterson, Eric D.; Schulman, Kevin A.; Califf, Robert M.			Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY; ANTIPLATELET THERAPY; SIROLIMUS; TRIAL; THROMBOSIS; SURVIVAL; PREDICTORS; OCCLUSION; DISEASE	Context Recent studies of drug-eluting intracoronary stents suggest that current antiplatelet regimens may not be sufficient to prevent late stent thrombosis. Objective To assess the association between clopidogrel use and long-term clinical outcomes of patients receiving drug-eluting stents (DES) and bare-metal stents (BMS) for treatment of coronary artery disease. Design, Setting, and Patients An observational study examining consecutive patients receiving intracoronary stents at Duke Heart Center, a tertiary care medical center in Durham, NC, between January 1, 2000, and July 31, 2005, with follow-up contact at 6, 12, and 24 months through September 7, 2006. Study population included 4666 patients undergoing initial percutaneous coronary intervention with BMS (n = 3165) or DES (n = 1501). Landmark analyses were performed among patients who were event-free (no death, myocardial infarction [MI], or revascularization) at 6- and 12-month follow-up. At these points, patients were divided into 4 groups based on stent type and self-reported clopidogrel use: DES with clopidogrel, DES without clopidogrel, BMS with clopidogrel, and BMS without clopidogrel. Main Outcome Measures Death, nonfatal MI, and the composite of death or MI at 24-month follow-up. Results Among patients with DES who were event-free at 6 months (637 with and 579 without clopidogrel), clopidogrel use was a significant predictor of lower adjusted rates of death (2.0% with vs 5.3% without; difference, -3.3%; 95% CI, -6.3% to -0.3%; P = .03) and death or MI (3.1% vs 7.2%; difference, -4.1%; 95% CI, -7.6% to -0.6%; P = .02) at 24 months. However, among patients with BMS (417 with and 1976 without clopidogrel), there were no differences in death (3.7% vs 4.5%; difference, -0.7%; 95% CI, -2.9% to 1.4%; P = .50) and death or MI (5.5% vs 6.0%; difference, -0.5%; 95% CI, -3.2% to 2.2%; P = .70). Among patients with DES who were event-free at 12 months (252 with and 276 without clopidogrel), clopidogrel use continued to predict lower rates of death (0% vs 3.5%; difference, -3.5%; 95% CI, -5.9% to -1.1%; P = .004) and death or MI (0% vs 4.5%; difference, -4.5%; 95% CI, -7.1% to -1.9%; P < .001) at 24 months. However, among patients with BMS (346 with and 1644 without clopidogrel), there continued to be no differences in death (3.3% vs 2.7%; difference, 0.6%; 95% CI, -1.5% to 2.8%; P = .57) and death or MI (4.7% vs 3.6%; difference, 1.0%; 95% CI, -1.6% to 3.6%; P = .44). Conclusions The extended use of clopidogrel in patients with DES may be associated with a reduced risk for death and death or MI. However, the appropriate duration for clopidogrel administration can only be determined within the context of a large-scale randomized clinical trial.	Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Biostat & Bioinformat, Durham, NC 27710 USA; Duke Translat Med Inst, Durham, NC 27710 USA; Duke Ctr Clin Hlth Policy Res, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Eisenstein, EL (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Dept Med, Box 3865,2400 Pratt St,Room 0311, Durham, NC 27710 USA.	eric.eisenstein@duke.edu	Matchar, David/M-3951-2019; Peterson, Eric David/ABF-5033-2021	Matchar, David/0000-0003-3020-2108; Mark, Daniel/0000-0001-6340-8087	PHS HHS [290-05-0032] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; Anstrom KJ, 2001, BIOMETRICS, V57, P1207, DOI 10.1111/j.0006-341X.2001.01207.x; Bang H, 2000, BIOMETRIKA, V87, P329, DOI 10.1093/biomet/87.2.329; Berger PB, 2002, AM HEART J, V143, P841, DOI 10.1067/mhj.2002.121929; CALIFF RM, 1989, JAMA-J AM MED ASSOC, V261, P2077, DOI 10.1001/jama.261.14.2077; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; *CORD CORP, COMMUNICATION   0707; Cutlip DE, 2001, CIRCULATION, V103, P1967; FORTIN DF, 1995, AM J CARDIOL, V76, P1177, DOI 10.1016/S0002-9149(99)80331-2; GOOLEY TA, 2006, HDB STAT CLIN ONCOLO, P557; Harrington RA, 2006, J AM COLL CARDIOL, V48, P2592, DOI 10.1016/j.jacc.2006.10.025; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; MOSES JW, 2006, AM COLL CARD ANN SCI; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Regar E, 2004, AM J CARDIOL, V93, P1271, DOI 10.1016/j.amjcard.2004.02.013; ROSATI RA, 1975, ARCH INTERN MED, V135, P1017, DOI 10.1001/archinte.135.8.1017; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; *US FDA, CYPHER SIR EL COR ST; *US FDA, TAXUS EXPR 2 PACL EL	28	711	770	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2007	297	2					159	168		10.1001/jama.297.2.joc60179	http://dx.doi.org/10.1001/jama.297.2.joc60179			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	124GI	17148711	Bronze			2022-12-01	WOS:000243355900025
J	Gottar, M; Gobert, V; Matskevich, AA; Reichhart, JM; Wang, CS; Butt, TM; BeIvin, M; Hoffmann, JA; Ferrandon, D				Gottar, Marie; Gobert, Vanessa; Matskevich, Alexey A.; Reichhart, Jean-Marc; Wang, Chengshu; Butt, Tariq M.; BeIvin, Marcia; Hoffmann, Jules A.; Ferrandon, Dominique			Dual detection of fungal infections in Drosophila via recognition of glucans and sensing of virulence factors	CELL			English	Article							POSITIVE BACTERIAL-INFECTIONS; GRAM-NEGATIVE BACTERIA; IMMUNE-RESPONSE; METARHIZIUM-ANISOPLIAE; ANTIMICROBIAL PEPTIDE; DEFICIENT DROSOPHILA; MANDUCA-SEXTA; TOLL PATHWAY; HOST-DEFENSE; PROTEIN	The Drosophila immune system discriminates between various types of infections and activates appropriate signal transduction pathways to combat the invading microorganisms. The Toll pathway is required for the host response against fungal and most Gram-positive bacterial infections. The sensing of Gram-positive bacteria is mediated by the pattern recognition receptors PGRP-SA and GNBP1 that cooperate to detect the presence of infections in the host. Here, we report that GNBP3 is a pattern recognition receptor that is required for the detection of fungal cell wall components. Strikingly, we find that there is a second, parallel pathway acting jointly with GNBP3. The Drosophila Persephone protease activates the Toll pathway when proteolytically matured by the secreted fungal virulence factor PR1. Thus, the detection of fungal infections in Drosophila relies both on the recognition of invariant microbial patterns and on monitoring the effects of virulence factors on the host.	CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France; Exelixis Inc, San Francisco, CA 94083 USA; Univ Wales Swansea, Dept Biol Sci, Swansea SA2 8PP, W Glam, Wales	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Exelixis, Inc.; Swansea University	Ferrandon, D (corresponding author), CNRS, Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France.	d.ferrandon@ibmc.u-strasbg.fr	Wang, Chengshu/A-1656-2011	Wang, Chengshu/0000-0003-1477-1466; FERRANDON, Dominique/0000-0001-7680-7773; Butt, Tariq/0000-0002-8789-9543	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI044220, P01 AI044220-08, P01 AI44220] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alarco AM, 2004, J IMMUNOL, V172, P5622, DOI 10.4049/jimmunol.172.9.5622; Bagga S, 2004, GENE, V324, P159, DOI 10.1016/j.gene.2003.09.031; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chung WO, 2004, J IMMUNOL, V173, P5165, DOI 10.4049/jimmunol.173.8.5165; Clarkson JM, 1996, TRENDS MICROBIOL, V4, P197, DOI 10.1016/0966-842X(96)10022-6; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Ferrandon D, 2004, SEMIN IMMUNOL, V16, P43, DOI 10.1016/j.smim.2003.10.008; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hansen KK, 2005, P NATL ACAD SCI USA, V102, P8363, DOI 10.1073/pnas.0409535102; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jung AC, 2001, BIOTECHNIQUES, V30, P594, DOI 10.2144/01303rr04; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kaneko T, 2005, CELL MICROBIOL, V7, P461, DOI 10.1111/j.1462-5822.2005.00504.x; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lee MH, 2004, J BIOL CHEM, V279, P3218, DOI 10.1074/jbc.M309821200; Lee SH, 2006, PROTEIN SCI, V15, P304, DOI 10.1110/ps.051813506; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Roberts D.W., 1981, BIOL CONIDIAL FUNGI, P201; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; STLEGER RJ, 1992, EUR J BIOCHEM, V204, P991, DOI 10.1111/j.1432-1033.1992.tb16721.x; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wang CS, 2005, FUNGAL GENET BIOL, V42, P704, DOI 10.1016/j.fgb.2005.04.006; Wang CS, 2002, FEMS MICROBIOL LETT, V213, P251, DOI 10.1111/j.1574-6968.2002.tb11314.x	47	300	311	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 29	2006	127	7					1425	1437		10.1016/j.cell.2006.10.046	http://dx.doi.org/10.1016/j.cell.2006.10.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190605	Bronze, Green Accepted			2022-12-01	WOS:000243690000021
J	Phillips, JA				Phillips, John A.			Is Burkitt's lymphoma sexy enough?	LANCET			English	Editorial Material											Phillips, JA (corresponding author), 60 Old Rossorry Rd, Enniskillen BT74 7LF, Fermanagh, North Ireland.	jnsphillips@tiscali.co.uk							0	5	5	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 23	2006	368	9554					2251	2252		10.1016/S0140-6736(06)69898-X	http://dx.doi.org/10.1016/S0140-6736(06)69898-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120HY	17189037				2022-12-01	WOS:000243076800033
J	Boutin, S; Wauters, LA; McAdam, AG; Humphries, MM; Tosi, G; Dhondt, AA				Boutin, Stan; Wauters, Lucas A.; McAdam, Andrew G.; Humphries, Murray M.; Tosi, Guido; Dhondt, Andre A.			Anticipatory reproduction and population growth in seed predators	SCIENCE			English	Article							SCIURUS-VULGARIS; LIFE-HISTORY; RED; DYNAMICS	Mast seeding, the intermittent, synchronous production of large seed crops by a population of plants, is a well-known example of resource pulses that create lagged responses in successive trophic levels of ecological communities. These lags arise because seed predators are thought capable of increasing reproduction and population size only after the resource pulse is available for consumption. The resulting satiation of predators is a widely cited explanation for the evolution of masting. Our study shows that both American and Eurasian tree squirrels anticipate resource pulses and increase reproductive output before a masting event, thereby increasing population size in synchrony with the resource pulse and eliminating the population lag thought to be universal in resource pulse systems.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Insubria, Dept Environm Hlth & Safety, I-21100 Varese, Italy; Michigan State Univ, Dept Zool, Dept Fisheries & Wildlife, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA; McGill Univ, Ste Anne De Bellevue, PQ H9X 3V9, Canada; Cornell Univ, Ornithol Lab, Ithaca, NY 14850 USA; Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium	University of Alberta; University of Insubria; Michigan State University; McGill University; Cornell University; University of Antwerp	Boutin, S (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	stan.boutin@ualberta.ca	McAdam, Andrew G/G-1802-2010; Boutin, Stan A/A-2619-2014; Dhondt, André/A-8292-2008	McAdam, Andrew G/0000-0001-7323-2572; Boutin, Stan A/0000-0001-6317-038X; Wauters, Lucas Armand/0000-0002-7012-9200; Wauters, Lucas/0000-0002-4871-5035; Dhondt, Andre/0000-0002-4946-1401				Bayliss P, 2002, PHILOS T ROY SOC B, V357, P1233, DOI 10.1098/rstb.2002.1124; BECKER CD, 1993, CAN J ZOOL, V71, P1326, DOI 10.1139/z93-183; BERGER PJ, 1981, SCIENCE, V214, P69, DOI 10.1126/science.7025210; BRONSON FH, 1989, REPROD BIOL; CAUGHLEY G, 1981, THEORETICAL ECOLOGY, pCH6; Clutton-Brock T. H., 1988, REPROD SUCCESS; CLUTTONBROCK TH, 1999, EVOLUTION PARENTAL C; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; EIS S, 1972, Canadian Journal of Forest Research, V2, P460, DOI 10.1139/x72-070; Fitzgerald BM, 2004, NEW ZEAL J ZOOL, V31, P167, DOI 10.1080/03014223.2004.9518370; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; HEDLIN A. F., 1964, FOREST SCI, V10, P124; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Koenig WD, 2005, AM SCI, V93, P340, DOI 10.1511/2005.54.970; Larsen KW, 1997, J MAMMAL, V78, P192, DOI 10.2307/1382652; LIGON JD, 1974, NATURE, V250, P80, DOI 10.1038/250080a0; McAdam AG, 2003, EVOLUTION, V57, P1689; McKone MJ, 2001, NEW ZEAL J ZOOL, V28, P89, DOI 10.1080/03014223.2001.9518259; McNeilly AS, 2001, REPROD FERT DEVELOP, V13, P583, DOI 10.1071/RD01056; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Ruf T, 2006, ECOLOGY, V87, P372, DOI 10.1890/05-0672; RUSCH DA, 1978, ECOLOGY, V59, P400, DOI 10.2307/1936382; SMITH MC, 1968, J WILDLIFE MANAGE, V32, P305, DOI 10.2307/3798975; WAUTERS L, 1992, J ZOOL, V227, P71, DOI 10.1111/j.1469-7998.1992.tb04345.x; Wauters LA, 2004, J ANIM ECOL, V73, P11, DOI 10.1111/j.1365-2656.2004.00792.x; WAUTERS LA, 1989, J ZOOL, V217, P93, DOI 10.1111/j.1469-7998.1989.tb02477.x; Wilson PR, 1998, BIOL CONSERV, V83, P175, DOI 10.1016/S0006-3207(97)00055-4; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690	31	195	199	5	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1928	1930		10.1126/science.1135520	http://dx.doi.org/10.1126/science.1135520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185600				2022-12-01	WOS:000242996800049
J	Clutton-Brock, TH; Hodge, SJ; Spong, G; Russell, AF; Jordan, NR; Bennett, NC; Sharpe, LL; Manser, MB				Clutton-Brock, T. H.; Hodge, S. J.; Spong, G.; Russell, A. F.; Jordan, N. R.; Bennett, N. C.; Sharpe, L. L.; Manser, M. B.			Intrasexual competition and sexual selection in cooperative mammals	NATURE			English	Article							FEMALE; DOMINANCE; EVOLUTION; BEHAVIOR; RANK	In most animals, the sex that invests least in its offspring competes more intensely for access to the opposite sex and shows greater development of secondary sexual characters than the sex that invests most(1,2). However, in some mammals where females are the primary care-givers, females compete more frequently or intensely with each other than males(3-5). A possible explanation is that, in these species, the resources necessary for successful female reproduction are heavily concentrated and intrasexual competition for breeding opportunities is more intense among females than among males. Intrasexual competition between females is likely to be particularly intense in cooperative breeders where a single female monopolizes reproduction in each group(6). Here, we use data from a twelve-year study of wild meerkats (Suricata suricatta), where females show high levels of reproductive skew, to show that females gain greater benefits from acquiring dominant status than males and traits that increase competitive ability exert a stronger influence on their breeding success. Females that acquire dominant status also develop a suite of morphological, physiological and behavioural characteristics that help them to control other group members. Our results show that sex differences in parental investment are not the only mechanism capable of generating sex differences in reproductive competition and emphasize the extent to which competition for breeding opportunities between females can affect the evolution of sex differences and the operation of sexual selection.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; Uppsala Univ, Dept Anim Ecol, SE-75236 Uppsala, Sweden; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Univ Stellenbosch, Dept Zool, ZA-7602 Matieland, South Africa; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland	University of Cambridge; University of Pretoria; Uppsala University; University of Sheffield; Stellenbosch University; University of Zurich	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	thcb@cam.ac.uk	Bennett, Nigel Charles/E-4238-2010	Bennett, Nigel Charles/0000-0001-9748-2947; Jordan, Neil/0000-0002-0712-8301; Spong, Goran/0000-0002-1246-5046	Natural Environment Research Council [NE/C511348/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andersson Malte, 1994; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BRETT RA, 1991, REPROD NAKED MOLE RA, P67; Buston P, 2003, BEHAV ECOL, V14, P576, DOI 10.1093/beheco/arg036; Carlson AA, 2004, HORM BEHAV, V46, P141, DOI 10.1016/j.yhbeh.2004.01.009; Clutton-Brock T.H., 1983, P457; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P2291, DOI 10.1098/rspb.1998.0573; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 2002, SCIENCE, V297, P253, DOI 10.1126/science.1071412; Clutton-Brock TH, 2004, ANIM BEHAV, V68, P1029, DOI 10.1016/j.anbehav.2003.10.024; CLUTTONBROCK TH, 2004, SEXUAL SELECTION PRI; Darwin C., 1871, P423; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ENGH A, 2002, SOCIAL COMPLEXITY; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; Faulkes Christopher G., 1997, P302; Forsgren E, 2004, NATURE, V429, P551, DOI 10.1038/nature02562; FRICKE H, 1977, NATURE, V266, P830, DOI 10.1038/266830a0; Griffin AS, 2003, BEHAV ECOL, V14, P472, DOI 10.1093/beheco/arg040; Hauber ME, 2005, INTEGR COMP BIOL, V45, P903, DOI 10.1093/icb/45.5.903; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; O'Riain MJ, 2000, P NATL ACAD SCI USA, V97, P13194, DOI 10.1073/pnas.97.24.13194; Scantlebury M, 2002, P ROY SOC B-BIOL SCI, V269, P2147, DOI 10.1098/rspb.2002.2108; Shellman-Reeve Janet S., 1997, P52; Sherman PW, 2002, J ZOOL, V258, P307, DOI 10.1017/S0952836902001437; Trivers R.L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215	30	225	227	2	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1065	1068		10.1038/nature05386	http://dx.doi.org/10.1038/nature05386			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183322				2022-12-01	WOS:000242971100055
J	Rome, LC; Flynn, L; Yoo, TD				Rome, Lawrence C.; Flynn, Louis; Yoo, Taeseung D.			Biomechanics - Rubber bands reduce the cost of carrying loads	NATURE			English	Article							BACK-PAIN; WALKING; CHILDREN; MASS		Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Rome, LC (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.	lrome@sas.upenn.edu		Flynn, Louis/0000-0003-2966-0355				BALOGUN JA, 1986, ERGONOMICS, V29, P1623, DOI 10.1080/00140138608967274; Chatterjee A, 2002, INT J ROBOT RES, V21, P621, DOI 10.1177/027836402322023213; Donelan JM, 2002, J EXP BIOL, V205, P3717; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; KRAM R, 1991, J APPL PHYSIOL, V71, P1119, DOI 10.1152/jappl.1991.71.3.1119; Negrini S, 2002, SPINE, V27, P187, DOI 10.1097/00007632-200201150-00014; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Taimela S, 1997, SPINE, V22, P1132, DOI 10.1097/00007632-199705150-00013; TROUSSIER B, 1994, SCAND J REHABIL MED, V26, P143	10	103	104	11	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1023	1024		10.1038/4441023a	http://dx.doi.org/10.1038/4441023a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183310				2022-12-01	WOS:000242971100043
J	Gross, CP; Andersen, MS; Krumholz, HM; McAvay, GJ; Proctor, D; Tinetti, ME				Gross, Cary P.; Andersen, Martin S.; Krumholz, Harlan M.; McAvay, Gail J.; Proctor, Deborah; Tinetti, Mary E.			Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; BREAST-CANCER; UNITED-STATES; COVERAGE; US; COLONOSCOPY; POPULATION; PREDICTORS; INSURANCE; CARCINOMA	Context Medicare's reimbursement policy was changed in 1998 to provide coverage for screening colonoscopies for patients with increased colon cancer risk, and expanded further in 2001 to cover screening colonoscopies for all individuals. Objective To determine whether the Medicare reimbursement policy changes were associated with an increase in either colonoscopy use or early stage colon cancer diagnosis. Design, Setting, and Participants Patients in the Surveillance, Epidemiology, and End Results Medicare linked database who were 67 years of age and older and had a primary diagnosis of colon cancer during 1992-2002, as well as a group of Medicare beneficiaries who resided in Surveillance, Epidemiology, and End Results areas but who were not diagnosed with cancer. Main Outcome Measures Trends in colonoscopy and sigmoidoscopy use among Medicare beneficiaries without cancer were assessed using multivariate Poisson regression. Among the patients with cancer, stage was classified as early ( stage I) vs all other ( stages II-IV). Time was categorized as period 1 ( no screening coverage, 19921997), period 2 ( limited coverage, January 1998-June 2001), and period 3 ( universal coverage, July 2001-December 2002). A multivariate logistic regression (outcome = early stage) was used to assess temporal trends in stage at diagnosis; an interaction term between tumor site and time was included. Results Colonoscopy use increased from an average rate of 285/ 100 000 per quarter in period 1 to 889 and 1919/100 000 per quarter in periods 2 ( P <. 001) and 3 ( P vs 2 <. 001), respectively. During the study period, 44 924 eligible patients were diagnosed with colorectal cancer. The proportion of patients diagnosed at an early stage increased from 22.5% in period 1 to 25.5% in period 2 and 26.3% in period 3 ( P <. 001 for each pair-wise comparison). The changes in Medicare coverage were strongly associated with early stage at diagnosis for patients with proximal colon lesions ( adjusted relative risk period 2 vs 1, 1.19; 95% confidence interval, 1.13-1.26; adjusted relative risk period 3 vs 2, 1.10; 95% confidence interval, 1.02-1.17) but weakly associated, if at all, for patients with distal colon lesions ( adjusted relative risk period 2 vs 1, 1.07; 95% confidence interval, 1.01-1.13; adjusted relative risk period 3 vs 2, 0.97; 95% confidence interval, 0.90-1.05). Conclusions Expansion of Medicare reimbursement to cover colon cancer screening was associated with an increased use of colonoscopy for Medicare beneficiaries, and for those who were diagnosed with colon cancer, an increased probability of being diagnosed at an early stage. The selective effect of the coverage change on proximal colon lesions suggests that increased use of whole-colon screening modalities such as colonoscopy may have played a pivotal role.	Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Geriatr, New Haven, CT 06520 USA; Yale Univ, Sch Med, Gastroenterol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Scholars Program, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, Gen Internal Med Sect, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu	Andersen, Martin/J-7018-2019; , Harlan/AAI-2875-2020	Andersen, Martin/0000-0001-5982-2541; 	NATIONAL INSTITUTE ON AGING [K08AG024842, P30AG021342] Funding Source: NIH RePORTER; NIA NIH HHS [1 K08 AG24842, P30AG21342] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams EK, 2004, PREV MED, V38, P551, DOI 10.1016/j.ypmed.2003.12.014; *AM CANC SOC, EST NEW CANC CAS DEA; American Cancer Society, 2005, CANC FACTS FIG; [Anonymous], 2001, FED REGISTER, V66, P55246; Berg AO, 2002, AM J NURS, V102, P107; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; Brenes GA, 2000, PREV MED, V31, P410, DOI 10.1006/pmed.2000.0729; Chao A, 2004, AM J PUBLIC HEALTH, V94, P1775, DOI 10.2105/AJPH.94.10.1775; Cooper GS, 2005, CANCER, V103, P696, DOI 10.1002/cncr.20839; Cooper GS, 2004, AM J GASTROENTEROL, V99, P1544, DOI 10.1111/j.1572-0241.2004.30902.x; Cress RD, 2000, PREV MED, V31, P447, DOI 10.1006/pmed.2000.0730; Dans PE, 1996, RADIOLOGY, V198, P657, DOI 10.1148/radiology.198.3.8628850; Etzioni DA, 2004, CANCER-AM CANCER SOC, V101, P2523, DOI 10.1002/cncr.20692; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Greene J, 2001, HEALTH CARE FINANC R, V22, P141; Gross CP, 2006, ANN INTERN MED, V145, P646, DOI 10.7326/0003-4819-145-9-200611070-00006; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; Ioannou GN, 2003, AM J GASTROENTEROL, V98, P2082, DOI 10.1016/S0002-9270(03)00423-4; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Keating NL, 2005, J GEN INTERN MED, V20, P38, DOI 10.1111/j.1525-1497.2004.40079.x; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Ko CW, 2002, ARCH INTERN MED, V162, P2581, DOI 10.1001/archinte.162.22.2581; MILLER BA, 1992, NIH PUBLICATION, V92, P2789; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; POTOSKY AL, 1993, MED CARE, V31, P732; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Ries LA, 1999, SEER CANC STAT REV; Ries LAG, 2004, SEER CANC STAT REV 1; Ries LAG, 2005, SEER CANC STAT REV 1; Riley GF, 1999, JAMA-J AM MED ASSOC, V281, P720, DOI 10.1001/jama.281.8.720; RILEY GF, 1994, AM J PUBLIC HEALTH, V84, P1598, DOI 10.2105/AJPH.84.10.1598; SAS Institute Inc, 2004, SAS STAT 9 1 US GUID; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Shih YCT, 2006, HEALTH AFFAIR, V25, P1153, DOI 10.1377/hlthaff.25.4.1153; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Smith S, 2003, HIST TODAY, V53, P43; Tomoda H, 1998, ONCOL REP, V5, P481; Troisi RJ, 1999, CANCER, V85, P1670, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1670::AID-CNCR5>3.0.CO;2-M; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	43	163	164	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2006	296	23					2815	2822		10.1001/jama.296.23.2815	http://dx.doi.org/10.1001/jama.296.23.2815			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	116TR	17179458	Bronze			2022-12-01	WOS:000242826400023
J	Razavi, R; Chan, Y; Afifiyan, FN; Liu, XJ; Wan, X; Yantha, J; Tsui, H; Tang, L; Tsai, S; Santamaria, P; Drivers, JP; Serreze, D; Salter, MW; Dosch, HM				Razavi, Rozita; Chan, Yin; Afifiyan, F. Nikoo; Liu, Xue Jun; Wan, Xiang; Yantha, Jason; Tsui, Hubert; Tang, Lan; Tsai, Sue; Santamaria, Pere; Drivers, John P.; Serreze, David; Salter, Michael W.; Dosch, H. -Michael			TRPV1(+) sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes	CELL			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; GENE-RELATED PEPTIDE; DELAYED-TYPE HYPERSENSITIVITY; REGULATORY T-CELLS; SUBSTANCE-P; INSULIN-SECRETION; NOD MICE; RECEPTOR; MOUSE; SUSCEPTIBILITY	In type 1 diabetes, T cell-mediated death of pancreatic beta cells produces insulin deficiency. However, what attracts or restricts broadly autoreactive lymphocyte pools to the pancreas remains unclear. We report that TRPV1(+) pancreatic sensory neurons control islet inflammation and insulin resistance. Eliminating these neurons in diabetes-prone NOD mice prevents insulitis and diabetes, despite systemic persistence of pathogenic T cell pools. Insulin resistance and beta cell stress of prediabetic NOD mice are prevented when TRPV1(+) neurons are eliminated. TRPV1(NOD), localized to the Idd4.1 diabetes-risk locus, is a hypofunctional mutant, mediating depressed neurogenic inflammation. Delivering the neuropeptide substance P by intra-arterial injection into the NOD pancreas reverses abnormal insulin resistance, insulitis, and diabetes for weeks. Concordantly, insulin sensitivity is enhanced in trpv1(-/-) mice, whereas insulitis/diabetes-resistant NODxB6Idd4-congenic mice, carrying wild-type TRPV1, show restored TRPV1 function and insulin sensitivity. Our data uncover a fundamental role for insulin-responsive TRPV1(+) sensory neurons in beta cell function and diabetes pathoetiology.	Univ Toronto, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Immunol, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Univ Calgary, Fac Med, Julia McFarlane Diabet Res Ctr, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; Jackson Lab, Bar Harbor, ME 04609 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Calgary; University of Calgary; Jackson Laboratory	Dosch, HM (corresponding author), Univ Toronto, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada.	hmdosch@sickkids.ca	Santamaria, Pere/ABF-6823-2021	Tsai, Sue/0000-0002-6261-5233; Chan, Yin/0000-0003-2741-8258				Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2001, J IMMUNOL, V167, P655, DOI 10.4049/jimmunol.167.2.655; Amrani A, 1998, ENDOCRINOLOGY, V139, P1115, DOI 10.1210/en.139.3.1115; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Babaya N, 2005, BIOCHEM BIOPH RES CO, V328, P158, DOI 10.1016/j.bbrc.2004.12.149; BARAKAT A, 1994, BIOSCIENCE REP, V14, P1, DOI 10.1007/BF01901633; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Boulard O, 2002, J IMMUNOL, V168, P4192, DOI 10.4049/jimmunol.168.8.4192; BRETHERTONWATT D, 1992, ANN NY ACAD SCI, V657, P299, DOI 10.1111/j.1749-6632.1992.tb22777.x; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Butterfield RJ, 1999, J IMMUNOL, V162, P3096; Carrillo J, 2005, DIABETES, V54, P69, DOI 10.2337/diabetes.54.1.69; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; ChancellorFreeland C, 1995, ANN NY ACAD SCI, V771, P472, DOI 10.1111/j.1749-6632.1995.tb44703.x; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; CUA DJ, 1995, EUR J IMMUNOL, V25, P2318, DOI 10.1002/eji.1830250830; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Grattan M, 2002, DIABETES, V51, P215, DOI 10.2337/diabetes.51.1.215; Hadaya K, 2005, J AUTOIMMUN, V24, P125, DOI 10.1016/j.jaut.2005.01.001; HELME RD, 1987, J IMMUNOL, V139, P3470; HERMANSEN K, 1990, REGUL PEPTIDES, V27, P149, DOI 10.1016/0167-0115(90)90213-G; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Ivakine EA, 2005, J IMMUNOL, V174, P7129, DOI 10.4049/jimmunol.174.11.7129; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Ji H, 1999, IMMUNOL REV, V169, P139, DOI 10.1111/j.1600-065X.1999.tb01312.x; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Khachatryan A, 1997, J IMMUNOL, V158, P1409; LeRoith D, 2006, INT J BIOCHEM CELL B, V38, P904, DOI 10.1016/j.biocel.2005.01.019; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Moesgaard SG, 2005, AM J PHYSIOL-ENDOC M, V288, pE1137, DOI 10.1152/ajpendo.00356.2004; MORIKAWA Y, 1993, CELL IMMUNOL, V152, P200, DOI 10.1006/cimm.1993.1279; Nielsen K, 2004, DIABETOLOGIA, V47, P2185, DOI 10.1007/s00125-004-1578-1; NILSSON G, 1991, INT J IMMUNOPHARMACO, V13, P21, DOI 10.1016/0192-0561(91)90021-X; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; Persson-Sjogren S, 2005, J AUTOIMMUN, V24, P269, DOI 10.1016/j.jaut.2005.02.003; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rosmalen JGM, 2002, TRENDS ENDOCRIN MET, V13, P209, DOI 10.1016/S1043-2760(02)00600-8; Rosmalen JGM, 2000, LAB INVEST, V80, P769, DOI 10.1038/labinvest.3780080; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Santoni G, 1996, J NEUROIMMUNOL, V68, P131, DOI 10.1016/0165-5728(96)00081-1; Sathianathan V, 2003, EUR J NEUROSCI, V18, P2477, DOI 10.1046/j.1460-9568.2003.03004.x; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Van Buren JJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-17; van de Wall EHEM, 2005, LIFE SCI, V77, P1283, DOI 10.1016/j.lfs.2005.03.011; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Winer S, 2001, J IMMUNOL, V166, P2831, DOI 10.4049/jimmunol.166.4.2831; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466	60	239	287	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1123	1135		10.1016/j.cell.2006.10.038	http://dx.doi.org/10.1016/j.cell.2006.10.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174891	Bronze			2022-12-01	WOS:000242991000012
J	Tyzio, R; Cossart, R; Khalilov, I; Minlebaev, M; Hubner, CA; Represa, A; Ben-Ari, Y; Khazipov, R				Tyzio, Roman; Cossart, Rosa; Khalilov, Ilgam; Minlebaev, Marat; Huebner, Christian A.; Represa, Alfonso; Ben-Ari, Yehezkel; Khazipov, Rustem			Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery	SCIENCE			English	Article							EXCITATORY ACTIONS; NEONATAL HIPPOCAMPUS; NEURONS; CELLS; OSCILLATIONS; VASOPRESSIN; SYNAPSES; CHANNELS; SEIZURES; SLICES	We report a signaling mechanism in rats between mother and fetus aimed at preparing fetal neurons for delivery. In immature neurons, gamma-aminobutyric acid (GABA) is the primary excitatory neurotransmitter. We found that, shortly before delivery, there is a transient reduction in the intracellular chloride concentration and an excitatory-to-inhibitory switch of GABA actions. These events were triggered by oxytocin, an essential maternal hormone for labor. In vivo administration of an oxytocin receptor antagonist before delivery prevented the switch of GABA actions in fetal neurons and aggravated the severity of anoxic episodes. Thus, maternal oxytocin inhibits fetal neurons and increases their resistance to insults during delivery.	Univ Mediterranee, Inst Neurobiol Mediterranee, INSERM, U29, F-13273 Marseille 09, France; Univ Hamburg, Klinikum Eppendorf, Inst Human Genet, D-20251 Hamburg, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Hamburg	Ben-Ari, Y (corresponding author), Univ Mediterranee, Inst Neurobiol Mediterranee, INSERM, U29, Campus Sci Luminy,Boite Postale 13, F-13273 Marseille 09, France.	ben-ari@inmed.univ-mrs.fr	Khazipov, Roustem/M-1834-2016; MINLEBAEV, Marat/R-4794-2019; Hübner, Christian/A-2950-2017; Khalilov, Ilgam/B-5267-2015; Cossart, Rosa/E-7674-2014; MINLEBAEV, Marat/B-4927-2015; Cossart, Rosa/AAT-7934-2020; Represa, Alfonso/M-7383-2016	Khazipov, Roustem/0000-0002-6763-2841; MINLEBAEV, Marat/0000-0002-0722-7027; Hübner, Christian/0000-0002-1030-4943; Khalilov, Ilgam/0000-0002-9468-4778; Cossart, Rosa/0000-0003-2111-6638; MINLEBAEV, Marat/0000-0002-0722-7027; Cossart, Rosa/0000-0003-2111-6638; Represa, Alfonso/0000-0002-5096-8939; Ben-Ari, Yehezkel/0000-0001-6208-8480				ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CONNOR JA, 1987, J NEUROSCI, V7, P1384; Dzhala V, 2000, ANN NEUROL, V48, P632, DOI 10.1002/1531-8249(200010)48:4<632::AID-ANA10>3.3.CO;2-V; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Malek A, 1996, J Matern Fetal Med, V5, P245, DOI 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.3.CO;2-L; Marandi N, 2002, PFLUG ARCH EUR J PHY, V445, P357, DOI 10.1007/s00424-002-0933-7; Maric D, 1998, EUR J NEUROSCI, V10, P2532, DOI 10.1046/j.1460-9568.1998.00284.x; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Raggenbass M, 2001, PROG NEUROBIOL, V64, P307, DOI 10.1016/S0301-0082(00)00064-2; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SERAFINI R, 1995, J PHYSIOL-LONDON, V488, P371, DOI 10.1113/jphysiol.1995.sp020973; Serradeil-Le Gal C, 2004, J PHARMACOL EXP THER, V309, P414, DOI 10.1124/jpet.103.061200; Theodosis DT, 2006, MOL CELL NEUROSCI, V31, P785, DOI 10.1016/j.mcn.2006.01.006; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Tyzio R, 1999, J NEUROSCI, V19, P10372; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Volpe J., 2017, VOLPES NEUROLOGY NEW, V6th edn; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	32	327	339	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1788	1792		10.1126/science.1133212	http://dx.doi.org/10.1126/science.1133212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170309	Green Published			2022-12-01	WOS:000242833600063
J	de Oliveira, T; Pybus, OG; Rambaut, A; Salemi, M; Cassol, S; Ciccozzi, M; Rezza, G; Gattinara, GC; D'Arrigo, R; Amicosante, M; Perrin, L; Colizzi, V; Perno, CF				de Oliveira, Tulio; Pybus, Oliver G.; Rambaut, Andrew; Salemi, Marco; Cassol, Sharon; Ciccozzi, Massimo; Rezza, Giovanni; Gattinara, Guido Castelli; D'Arrigo, Roberta; Amicosante, Massimo; Perrin, Luc; Colizzi, Vittorio; Perno, Carlo Federico		Benghazi Study Grp	Molecular epidemiology - HIV-1 and HCV sequences from Libyan outbreak	NATURE			English	Article							HEPATITIS-C VIRUS; NOSOCOMIAL OUTBREAK		Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Florida, Coll Med, Gainesville, FL 32610 USA; Univ Pretoria, Fac Hlth Sci, ZA-0001 Pretoria, South Africa; Ist Super Sanita, Dept Infect Dis, I-00161 Rome, Italy; Bambino Gesu Pediat Hosp, Dept Immunol & Infect Dis, I-00165 Rome, Italy; Spallanzani Inst Infect Dis, I-00149 Rome, Italy; Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy; Univ Hosp Geneva, CH-1211 Geneva, Switzerland; Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy	University of Oxford; University of Edinburgh; State University System of Florida; University of Florida; University of Pretoria; Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; University of Rome Tor Vergata; University of Geneva; University of Rome Tor Vergata; University of Rome Tor Vergata	de Oliveira, T (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	tulio.deoliveira@zoo.ox.ac.uk	CICCOZZI, MASSIMO/C-6484-2016; castelli, guido/AAA-1507-2020; Ciccozzi, Massimo/AAC-3271-2022; perno, carlo federico/O-1544-2016; rezza, giovanni/D-4393-2016; Pybus, Oliver G/B-2640-2012; Rambaut, Andrew/B-2481-2009	CICCOZZI, MASSIMO/0000-0003-3866-9239; castelli, guido/0000-0002-3282-7462; Ciccozzi, Massimo/0000-0003-3866-9239; rezza, giovanni/0000-0003-0268-6790; Pybus, Oliver G/0000-0002-8797-2667; Rambaut, Andrew/0000-0003-4337-3707; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Amicosante, Massimo/0000-0002-2372-3311				Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; *EUR COMM, 2006, TECHN MISS LIB ILL I; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Goldmann DA, 2002, J ALLERGY CLIN IMMUN, V110, pS21, DOI 10.1067/mai.2002.125337; *HUMAN RIGHTS WATC, 2006, STEMM FLOW, V18; MONTAGNIER L, 2006, REPORT BENGHAZI OUTB; Ndjomou J, 2003, J GEN VIROL, V84, P2333, DOI 10.1099/vir.0.19240-0; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Visco-Comandini U, 2002, AIDS RES HUM RETROV, V18, P727, DOI 10.1089/088922202760072366; Yerly S, 2001, J INFECT DIS, V184, P369, DOI 10.1086/322036	12	99	100	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					836	837		10.1038/444836a	http://dx.doi.org/10.1038/444836a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17171825	Bronze			2022-12-01	WOS:000242805400034
J	Kouros-Mehr, H; Slorach, EM; Sternlicht, MD; Werb, Z				Kouros-Mehr, Hosein; Slorach, Euan M.; Sternlicht, Mark D.; Werb, Zena			GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland	CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; REGULATORY NETWORKS; STEM-CELLS; GENE; EXPRESSION; PROLIFERATION; MORPHOGENESIS; REVEALS; IDENTIFICATION	The GATA family of transcription factors plays fundamental roles in cell-fate specification. However, it is unclear if these genes are necessary for the maintenance of cellular differentiation after development. We identified GATA-3 as the most highly enriched transcription factor in the mammary epithelium of pubertal mice. GATA-3 was found in the luminal cells of mammary ducts and the body cells of terminal end buds (TEBs). Upon conditional deletion of GATA-3, mice exhibited severe defects in mammary development due to failure in TEB formation during puberty. After acute GATA-3 loss, adult mice exhibited undifferentiated luminal cell expansion with basement-membrane detachment, which led to caspase-mediated cell death in the long term. Further, FOXA1 was identified as a downstream target of GATA-3 in the mammary gland. This suggests that GATA-3 actively maintains luminal epithelial differentiation in the adult mammary gland, which raises important implications for the pathogenesis of breast cancer.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, 513 Parnassus Ave, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu			NCI NIH HHS [R01 CA057621-15, CA057621, R01 CA057621-16A1, R01 CA057621] Funding Source: Medline; NIEHS NIH HHS [ES012801, U01 ES012801-04S3, U01 ES012801] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES012801] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barczak A, 2003, GENOME RES, V13, P1775, DOI 10.1101/gr.1048803; Bertucci F, 2000, HUM MOL GENET, V9, P2981, DOI 10.1093/hmg/9.20.2981; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cheng GJ, 2004, P NATL ACAD SCI USA, V101, P3739, DOI 10.1073/pnas.0307864100; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Grogan JL, 2002, CURR OPIN IMMUNOL, V14, P366, DOI 10.1016/S0952-7915(02)00340-0; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Gruvberger S, 2001, CANCER RES, V61, P5979; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hoch RV, 1999, INT J CANCER, V84, P122; Jacobsen CM, 2002, DEV BIOL, V241, P34, DOI 10.1006/dbio.2001.0424; Jenssen TK, 2002, HUM GENET, V111, P411, DOI 10.1007/s00439-002-0804-5; Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Utomo ARH, 1999, NAT BIOTECHNOL, V17, P1091, DOI 10.1038/15073; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yang HH, 2002, DEVELOPMENT, V129, P2233	45	490	508	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					1041	1055		10.1016/j.cell.2006.09.048	http://dx.doi.org/10.1016/j.cell.2006.09.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129787	Bronze, Green Accepted			2022-12-01	WOS:000242613800019
J	Hampson, LA; Agrawal, M; Joffe, S; Gross, CP; Verter, J; Emanuel, EJ				Hampson, Lindsay A.; Agrawal, Manish; Joffe, Steven; Gross, Cary P.; Verter, Joel; Emanuel, Ezekiel J.			Patients' views on financial conflicts of interest in cancer research trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POTENTIAL RESEARCH PARTICIPANTS; ACADEMIC MEDICAL-CENTERS; INFORMED CONSENT; TRUST; PHYSICIANS; DISCLOSURE; PROFESSION	BACKGROUND: Financial ties between researchers or medical centers and companies whose drugs are being tested have come under increasing scrutiny. METHODS: We conducted in-person interviews with 253 patients in cancer-research trials (a 93% response rate) at five U.S. medical centers to determine their attitudes regarding potential financial conflicts of interest among researchers and medical centers. RESULTS: More than 90% of patients expressed little or no worry about financial ties that researchers or institutions might have with drug companies. Most patients said they would have enrolled in the trial even if the drug company had paid the researcher for speaking (82% of those interviewed) or consulting (75%) or if the researcher had received royalty payments (70%) or owned stock in the company (76%). Similarly, most patients would have enrolled in the trial if their cancer center had owned stock in the drug company (77%) or received royalty payments from the company (79%). Most patients believed it was ethical for researchers to receive speaking fees (81%) or consulting fees (82%) from the company. However, a substantial minority of patients wanted disclosure of the oversight system for researchers (40%) and of researchers' financial interests (31%); 17% thought no disclosure to patients was necessary. CONCLUSIONS: Most patients in cancer-research trials were not worried about financial ties between researchers or medical centers and drug companies and would still have enrolled in the trial if they had known about such financial ties. A substantial minority wanted to be informed about the oversight system to protect against financial conflicts of interest and about researchers' financial interests.	NIH, Dept Clin Bioeth, Ctr Clin, Bethesda, MD 20892 USA; Univ Michigan, Sch Med, Ann Arbor, MI USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT USA; Stat Collaborat, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Yale University; Yale University	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Ctr Clin, Bldg 10,Rm 1C118, Bethesda, MD 20892 USA.	eemanuel@nih.gov	Hampson, Lindsay A./GZL-8235-2022; Joffe, Steven/H-3941-2019	Hampson, Lindsay A./0000-0002-0740-7984; Joffe, Steven/0000-0002-0667-7384				ANGELL M, 2000, HHS C HUM SUBJ PROT; Balkrishnan R, 2003, MED CARE, V41, P1058, DOI 10.1097/01.MLR.0000083743.15238.9F; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Brennan TA, 2006, JAMA-J AM MED ASSOC, V295, P429, DOI 10.1001/jama.295.4.429; *COUNC ETH JUD AFF, 2000, MAN CONFL INT COND C; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; *DEP HHS, 2003, FED REGISTER, V68, P15456; Forster HP, 2001, LANCET, V358, P1449, DOI 10.1016/S0140-6736(01)06534-5; Foster RS, 2003, J AM COLL SURGEONS, V196, P505, DOI 10.1016/S1072-7515(03)00110-8; Hall MA, 2002, MED CARE RES REV, V59, P293, DOI 10.1177/1077558702059003004; Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223; Hall MA, 2002, HEALTH SERV RES, V37, P1419, DOI 10.1111/1475-6773.01070; Hall MA, 2003, MED CARE RES REV, V60, P118; HORSTMANN E, 2004, 2004 ASCO ANN M P S, V22, P6059; Jellinek Michael S, 1982, IRB, V4, P9, DOI 10.2307/3564273; Kim SYH, 2004, J MED ETHICS, V30, P73, DOI 10.1136/jme.2002.001461; LAPUMA J, 1995, BRIT MED J, V310, P1660, DOI 10.1136/bmj.310.6995.1660; LAPUMA J, 1995, BRIT MED J, V311, P373; *NAT I MENT HLTH, 2004, SUMM ALL RES PROGR M; RODWIN MA, 1989, NEW ENGL J MED, V321, P1405, DOI 10.1056/NEJM198911163212010; Roizen Ron, 1988, IRB, V10, P9, DOI 10.2307/3564103; ROTHMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P2782, DOI 10.1001/jama.269.21.2782; SPIRO HM, 1986, JAMA-J AM MED ASSOC, V255, P1174; *TASK FORC FIN CON, 2001, PROT SUBJ PRES TRUST; Task Force on Research Accountability, 2001, REP IND I FIN CONFL; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; Ubel PA, 1997, SOC SCI MED, V44, P647, DOI 10.1016/S0277-9536(96)00217-1; Weinfurt KP, 2006, J GEN INTERN MED, V21, P901, DOI 10.1111/j.1525-1497.2006.00502.x; Weinfurt KP, 2006, ACAD MED, V81, P113, DOI 10.1097/00001888-200602000-00003; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; *WORLD MED ASS, 2006, DECL HELS; Zubrod CG, 1960, J CHRON DIS, V11, P7	33	100	103	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 30	2006	355	22					2330	2337		10.1056/NEJMsa064160	http://dx.doi.org/10.1056/NEJMsa064160			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	110CG	17135586	Bronze			2022-12-01	WOS:000242355300008
J	Nyanzi, S				Nyanzi, Stella			From minuscule biomedical models to sexuality's depths	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Publ Hlth & Policy Dept, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Nyanzi, S (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Publ Hlth & Policy Dept, Keppel St, London WC1E 7HT, England.	snyanzi@yahoo.com		Nyanzi, Stella/0000-0002-6400-4014				Aggleton, 2000, FRAMING SEXUAL SUBJE, P241; BOYCE P, 2006, 16 INT AIDS C TOR CA; Caceres C, 1996, BISEXUALITIES AIDS I, P136; DIXONMUELLER R, 1993, STUD FAMILY PLANN, V24, P269, DOI 10.2307/2939221; Jackson S, 1997, SOCIOL REV, V45, P551, DOI 10.1111/1467-954X.00077; Miller A., 2000, HLTH HUMAN RIGHTS, V4, P69; Nyanzi S, 2004, CULT HEALTH SEX, V6, P239, DOI 10.1080/13691050310001658208; Parker Richard, 2000, FRAMING SEXUAL SUBJE; VANCE CS, 1991, SOC SCI MED, V33, P875, DOI 10.1016/0277-9536(91)90259-F; VANCE CS, 1992, PLEASURE DANGER EXPL; Weeks J., 1985, SEXUALITY ITS DISCON	11	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2006	368	9550					1851	1852		10.1016/S0140-6736(06)69754-7	http://dx.doi.org/10.1016/S0140-6736(06)69754-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	109YQ	17126702				2022-12-01	WOS:000242345900008
J	Rigby, N; Baillie, K				Rigby, Neville; Baillie, Kate			Challenging the future: the Global Prevention Alliance	LANCET			English	Editorial Material									Int Assoc Study Obes, Int Obes Taskforce, London NW1 2NR, England		Rigby, N (corresponding author), Int Assoc Study Obes, Int Obes Taskforce, London NW1 2NR, England.	nrigby@iaso.org						Hastings G., 2003, REV RES EFFECTS FOOD; *MCGILL HLTH CHALL, 2006, ACC PREV CHILDH OB W; *UN U, 2000, FOOD NUTR B S, V21, P1; *WHO, 2006, NCD GLOB INF; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization/Europe, 2006, WHO EUR MIN C COUNT	7	8	8	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2006	368	9548					1629	1631		10.1016/S0140-6736(06)69674-8	http://dx.doi.org/10.1016/S0140-6736(06)69674-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	106KI	17098064				2022-12-01	WOS:000242099000007
J	Valiyaveetil, FI; Leonetti, M; Muir, TW; MacKinnon, R				Valiyaveetil, Francis I.; Leonetti, Manuel; Muir, Tom W.; MacKinnon, Roderick			Ion selectivity in a semisynthetic K+ channel locked in the conductive conformation	SCIENCE			English	Article							POTASSIUM CHANNEL; FILTER	Potassium channels are K+-selective protein pores in cell membrane. The selectivity filter is the functional unit that allows K+ channels to distinguish potassium (K+) and sodium (Na+) ions. The filter's structure depends on whether K+ or Na+ ions are bound inside it. We synthesized a K+ channel containing the D-enantiomer of alanine in place of a conserved glycine and found by x-ray crystallography that its filter maintains the K+ (conductive) structure in the presence of Na+ and very low concentrations of K+. This channel conducts Na+ in the absence of K+ but not in the presence of K+. These findings demonstrate that the ability of the channel to adapt its structure differently to K+ and Na+ is a fundamental aspect of ion selectivity, as is the ability of multiple K+ ions to compete effectively with Na+ for the conductive filter.	Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; Ecole Normale Super, Dept Biol, F-75005 Paris, France	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Muir, TW (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	muirt@rockefeller.edu; mackinn@rockefeller.edu	Muir, Tom/AHD-0860-2022	Muir, Tom/0000-0001-9635-0344; Leonetti, Manuel/0000-0002-4881-405X	NIBIB NIH HHS [EB001991] Funding Source: Medline; NIGMS NIH HHS [GM55843, GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949, R29GM055843, R01GM055843] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Hille B., 2001, IONIC CHANNELS EXCIT, P814; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Rivas JCM, 2001, P NATL ACAD SCI USA, V98, P9478, DOI 10.1073/pnas.161257798; Valiyaveetil FI, 2004, P NATL ACAD SCI USA, V101, P17045, DOI 10.1073/pnas.0407820101; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	9	108	110	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2006	314	5801					1004	1007		10.1126/science.1133415	http://dx.doi.org/10.1126/science.1133415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17095703				2022-12-01	WOS:000241896000057
J	MacLaren, RE; Pearson, RA; MacNeil, A; Douglas, RH; Salt, TE; Akimoto, M; Swaroop, A; Sowden, JC; Ali, RR				MacLaren, R. E.; Pearson, R. A.; MacNeil, A.; Douglas, R. H.; Salt, T. E.; Akimoto, M.; Swaroop, A.; Sowden, J. C.; Ali, R. R.			Retinal repair by transplantation of photoreceptor precursors	NATURE			English	Article							RDS MUTANT MICE; PROGENITOR CELLS; RETINITIS-PIGMENTOSA; MAMMALIAN RETINA; RHODOPSIN GENE; MOUSE RETINA; IN-VIVO; DIFFERENTIATION; DEGENERATION; RODS	Photoreceptor loss causes irreversible blindness in many retinal diseases. Repair of such damage by cell transplantation is one of the most feasible types of central nervous system repair; photoreceptor degeneration initially leaves the inner retinal circuitry intact and new photoreceptors need only make single, short synaptic connections to contribute to the retinotopic map. So far, brain- and retina-derived stem cells transplanted into adult retina have shown little evidence of being able to integrate into the outer nuclear layer and differentiate into new photoreceptors(1-4). Furthermore, there has been no demonstration that transplanted cells form functional synaptic connections with other neurons in the recipient retina or restore visual function. This might be because the mature mammalian retina lacks the ability to accept and incorporate stem cells or to promote photoreceptor differentiation. We hypothesized that committed progenitor or precursor cells at later ontogenetic stages might have a higher probability of success upon transplantation. Here we show that donor cells can integrate into the adult or degenerating retina if they are taken from the developing retina at a time coincident with the peak of rod genesis(5). These transplanted cells integrate, differentiate into rod photoreceptors, form synaptic connections and improve visual function. Furthermore, we use genetically tagged postmitotic rod precursors expressing the transcription factor Nrl (ref. 6) ( neural retina leucine zipper) to show that successfully integrated rod photoreceptors are derived only from immature post-mitotic rod precursors and not from proliferating progenitor or stem cells. These findings define the ontogenetic stage of donor cells for successful rod photoreceptor transplantation.	UCL, Dev Biol Unit, Inst Child Hlth, London WC1N 1EH, England; UCL, Inst Ophthalmol, Div Mol Therapy, London EC1V 9EL, England; Moorfields Eye Hosp, Vitreretinal Serv, London EC1V 2PD, England; City Univ London, Henry Wellcome Lab Vis Sci, Dept Optometry & Visual Sci, London EC1V 0HB, England; Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; UCL, Mol Immunol Unit, Inst Child Hlth, London WC1N 1EH, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; City University London; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of London; University College London	Swaroop, A (corresponding author), UCL, Dev Biol Unit, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	swaroop@umich.edu; r.ali@ucl.ac.uk	Pearson, Rachael/Y-3339-2018; Akimoto, Masayuki/AAP-3676-2020; Salt, Thomas E/A-6405-2009	Pearson, Rachael/0000-0002-1107-1969; Ali, Robin/0000-0003-3126-6517; Sowden, Jane/0000-0003-0937-2479; MacLaren, Robert/0000-0002-3096-4682; Swaroop, Anand/0000-0002-1975-1141; Akimoto, Masayuki/0000-0002-5899-2925	Medical Research Council [G0300341, G0601588] Funding Source: Medline; MRC [G0300341] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; Chacko DM, 2000, BIOCHEM BIOPH RES CO, V268, P842, DOI 10.1006/bbrc.2000.2153; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Kashofer K, 2005, GENE THER, V12, P1229, DOI 10.1038/sj.gt.3302571; Koulen P, 2002, INVEST OPHTH VIS SCI, V43, P1933; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Sakaguchi DS, 2004, DEV NEUROSCI-BASEL, V26, P336, DOI 10.1159/000082275; SANYAL S, 1988, CURR EYE RES, V7, P1183, DOI 10.3109/02713688809033222; Swain PK, 2001, J BIOL CHEM, V276, P36824, DOI 10.1074/jbc.M105855200; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toda K, 1999, VISUAL NEUROSCI, V16, P391, DOI 10.1017/S0952523899162187; Van Hoffelen SJ, 2003, INVEST OPHTH VIS SCI, V44, P426, DOI 10.1167/iovs.02-0269; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; Yang P, 2002, J NEUROSCI RES, V69, P466, DOI 10.1002/jnr.10320; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	29	797	843	2	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					203	207		10.1038/nature05161	http://dx.doi.org/10.1038/nature05161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17093405	Green Published			2022-12-01	WOS:000241867200040
J	Ben-Chaim, Y; Chanda, B; Dascal, N; Bezanilla, F; Parnas, I; Parnas, H				Ben-Chaim, Yair; Chanda, Baron; Dascal, Nathan; Bezanilla, Francisco; Parnas, Itzchak; Parnas, Hanna			Movement of 'gating charge' is coupled to ligand binding in a G-protein-coupled receptor	NATURE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; VOLTAGE CONTROL; ACTIVATION; CHANNEL; SELECTIVITY; RELEASE	Activation by agonist binding of G-protein-coupled receptors (GPCRs) controls most signal transduction processes(1). Although these receptors span the cell membrane, they are not considered to be voltage sensitive. Recently it was shown that both the activity of GPCRs(2-5) and their affinity towards agonists(6) are regulated by membrane potential. However, it remains unclear whether GPCRs intrinsically respond to changes in membrane potential. Here we show that two prototypical GPCRs, the m2 and m1 muscarinic receptors (m2R and m1R), display charge-movement-associated currents analogous to 'gating currents' of voltage-gated channels. The gating charge - voltage relationship of m2R correlates well with the voltage dependence of the affinity of the receptor for acetylcholine. The loop that couples m2R and m1R to their G protein has a crucial function in coupling voltage sensing to agonist-binding affinity. Our data strongly indicate that GPCRs serve as sensors for both transmembrane potential and external chemical signals.	Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; Univ Chicago, Inst Mol Pediat Sci, Chicago, IL 60637 USA	Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison; Tel Aviv University; University of Chicago	Parnas, H (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel.	hannap@huji.ac.il	Dascal, Nathan/O-3915-2015	Dascal, Nathan/0000-0002-5397-4146; Chanda, Baron/0000-0003-4954-7034				ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bradley SR, 2000, J NEUROSCI, V20, P3085, DOI 10.1523/JNEUROSCI.20-09-03085.2000; COHEN-ARMON M, 1993, J BIOL CHEM, V268, P9824; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; HAGA K, 1986, J BIOL CHEM, V261, P133; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HULME EC, 1995, LIFE SCI, V56, P891, DOI 10.1016/0024-3205(95)00025-2; Ilouz N, 1999, J BIOL CHEM, V274, P29519, DOI 10.1074/jbc.274.41.29519; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; Martinez-Pinna J, 2004, J PHYSIOL-LONDON, V555, P61, DOI 10.1113/jphysiol.2003.056846; MARTY A, 1989, J PHYSIOL-LONDON, V419, P665, DOI 10.1113/jphysiol.1989.sp017892; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Ohana L, 2006, J BIOL CHEM, V281, P24204, DOI 10.1074/jbc.M513447200; Ong BH, 2001, PFLUG ARCH EUR J PHY, V441, P604, DOI 10.1007/s004240000459; Parnas H, 2000, TRENDS NEUROSCI, V23, P60, DOI 10.1016/S0166-2236(99)01498-8; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rakowski RF, 1997, ANN NY ACAD SCI, V834, P231, DOI 10.1111/j.1749-6632.1997.tb52254.x; Stefani E, 1998, METHOD ENZYMOL, V293, P300; WESS J, 1990, MOL PHARMACOL, V38, P517; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	30	129	131	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 2	2006	444	7115					106	109		10.1038/nature05259	http://dx.doi.org/10.1038/nature05259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17065983				2022-12-01	WOS:000241701500055
J	Fisher, DO; Double, MC; Blomberg, SP; Jennions, MD; Cockburn, A				Fisher, Diana O.; Double, Michael C.; Blomberg, Simon P.; Jennions, Michael D.; Cockburn, Andrew			Post-mating sexual selection increases lifetime fitness of polyandrous females in the wild	NATURE			English	Article							SPERM SELECTION; GOOD GENES; PATERNITY; SUCCESS; EVOLUTION; BENEFITS; POPULATION; CRICKET; MATES; SIZE	Females often mate with several males before producing offspring(1). Field studies of vertebrates suggest, and laboratory experiments on invertebrates confirm, that even when males provide no material benefits, polyandry can enhance offspring survival(2,3). This enhancement is widely attributed to genetic benefits that arise whenever paternity is biased towards males that sire more viable offspring(1,4,5). Field studies suggest that post-mating sexual selection biases fertilization towards genetically more compatible males(6,7) and one controlled experiment has shown that, when females mate with close kin, polyandry reduces the relative number of inbred offspring(8). Another potential genetic benefit of polyandry is that it increases offspring survival because males with more competitive ejaculates sire more viable offspring(9). Surprisingly, however, there is no unequivocal evidence for this process(10). Here, by experimentally assigning mates to females, we show that polyandry greatly increases offspring survival in the Australian marsupial Antechinus stuartii. DNA profiling shows that males that gain high paternity under sperm competition sire offspring that are more viable. This beneficial effect occurs in both the laboratory and the wild. Crucially, there are no confounding non-genetic maternal effects that could arise if polyandry increases female investment in a particular reproductive event(10) because A. stuartii is effectively semelparous. Our results therefore show that polyandry improves female lifetime fitness in nature. The threefold increase in offspring survival is not negated by a decline in maternal lifespan and is too large to be offset by an equivalent decline in the reproductive performance of surviving offspring.	Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia	Australian National University; Australian National University	Fisher, DO (corresponding author), Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia.	diana.fisher@anu.edu.au	Blomberg, Simone P/B-7613-2008; Jennions, Michael D/C-7560-2009; Fisher, Diana O/C-1324-2010	Blomberg, Simone P/0000-0003-1062-0839; Jennions, Michael D/0000-0001-9221-2788; Fisher, Diana O/0000-0002-4017-3710				BATES D, 2006, MATRIX MATRIX PACKAG; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2005, EVOLUTION, V59, P106; Fisher DO, 2006, ANIM BEHAV, V71, P289, DOI 10.1016/j.anbehav.2005.03.041; Fisher DO, 2006, BEHAV ECOL, V17, P164, DOI 10.1093/beheco/arj012; Fisher DO, 2005, AUST J ZOOL, V53, P103, DOI 10.1071/ZO04068; *GENST COMM, 2005, GENST MAN VERS 8; Holleley CE, 2006, MOL ECOL, V15, P3439, DOI 10.1111/j.1365-294X.2006.03001.x; Hosken DJ, 2003, P ROY SOC B-BIOL SCI, V270, P1933, DOI 10.1098/rspb.2003.2443; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kozielska M, 2004, P ROY SOC B-BIOL SCI, V271, P165, DOI 10.1098/rspb.2003.2585; Kraaijeveld-Smit FJL, 2003, MOL ECOL, V12, P475, DOI 10.1046/j.1365-294X.2003.01745.x; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; R Core Development Team, 2006, R LANG ENV STAT COMP; SELWOOD L, 1980, AUST J ZOOL, V28, P649; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Thuman KA, 2005, ANIM BEHAV, V69, P765, DOI 10.1016/j.anbehav.2004.10.003; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI 10.1111/j.1558-5646.1998.tb02252.x; Tregenza T, 2003, EVOLUTION, V57, P297, DOI 10.1111/j.0014-3820.2003.tb00264.x; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Weigensberg I, 1998, J EVOLUTION BIOL, V11, P135, DOI 10.1007/s000360050071; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zeh JA, 2006, NATURE, V439, P201, DOI 10.1038/nature04260; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	30	153	154	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					89	92		10.1038/nature05206	http://dx.doi.org/10.1038/nature05206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080089				2022-12-01	WOS:000241701500051
J	Chavez, AE; Singer, JH; Diamond, JS				Chavez, Andres E.; Singer, Joshua H.; Diamond, Jeffrey S.			Fast neurotransmitter release triggered by Ca influx through AMPA-type glutamate receptors	NATURE			English	Article							MAMMALIAN RIBBON SYNAPSE; ROD BIPOLAR CELLS; AMACRINE CELLS; RAT RETINA; ACCUMULATING NEURONS; RABBIT RETINA; CALCIUM; A17; INHIBITION; TERMINALS	Feedback inhibition at reciprocal synapses between A17 amacrine cells and rod bipolar cells (RBCs) shapes light-evoked responses in the retina(1-3). Glutamate-mediated excitation of A17 cells elicits GABA (gamma-aminobutyric acid)-mediated inhibitory feedback onto RBCs4-6, but the mechanisms that underlie GABA release from the dendrites of A17 cells are unknown. If, as observed at all other synapses studied, voltage-gated calcium channels (VGCCs) couple membrane depolarization to neurotransmitter release(7), feedforward excitatory postsynaptic potentials could spread through A17 dendrites to elicit 'surround' feedback inhibitory transmission at neighbouring synapses. Here we show, however, that GABA release from A17 cells in the rat retina does not depend on VGCCs or membrane depolarization. Instead, calcium-permeable AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors (AMPARs), activated by glutamate released from RBCs, provide the calcium influx necessary to trigger GABA release from A17 cells. The AMPAR-mediated calcium signal is amplified by calcium-induced calcium release (CICR) from intracellular calcium stores. These results describe a fast synapse that operates independently of VGCCs and membrane depolarization and reveal a previously unknown form of feedback inhibition within a neural circuit.	NINDS, Synapt Physiol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Diamond, JS (corresponding author), NINDS, Synapt Physiol Unit, NIH, Bethesda, MD 20892 USA.	diamondj@ninds.nih.gov	Diamond, Jeffrey/C-1835-2015	Diamond, Jeffrey/0000-0002-1770-2629	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K22NS043365, Z01NS003039] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NINDS NIH HHS [K22 NS043365] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baumgarten H G, 1978, Ann N Y Acad Sci, V305, P3, DOI 10.1111/j.1749-6632.1978.tb31507.x; Bloomfield SA, 2000, J PHYSIOL-LONDON, V523, P771, DOI 10.1111/j.1469-7793.2000.t01-1-00771.x; Brandstatter JH, 1997, J NEUROSCI, V17, P9298; Dong CJ, 2003, J NEUROPHYSIOL, V89, P2159, DOI 10.1152/jn.01008.2002; Drose S, 1997, J EXP BIOL, V200, P1; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hartveit E, 1996, J NEUROPHYSIOL, V76, P401, DOI 10.1152/jn.1996.76.1.401; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; KOLB H, 1981, VISION RES, V21, P1625, DOI 10.1016/0042-6989(81)90046-8; Menger N, 2000, VISUAL NEUROSCI, V17, P769, DOI 10.1017/S0952523800175108; NAKATSUKA K, 1985, INVEST OPHTH VIS SCI, V26, P1109; Nawy S, 2004, J PHYSIOL-LONDON, V558, P137, DOI 10.1113/jphysiol.2004.064980; NELSON R, 1985, J NEUROPHYSIOL, V54, P592, DOI 10.1152/jn.1985.54.3.592; SANDELL JH, 1986, J NEUROSCI, V6, P3331; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; Sidach SS, 2002, J NEUROSCI, V22, P2023, DOI 10.1523/JNEUROSCI.22-06-02023.2002; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2003, J NEUROSCI, V23, P10923; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; STERLING P, 1986, J NEUROSCI, V6, P1314; VANEY DI, 1986, SCIENCE, V233, P444, DOI 10.1126/science.3726538; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P141, DOI 10.1016/S0014-2999(02)01838-1; Vigh J, 2005, J NEUROSCI, V25, P11412, DOI 10.1523/JNEUROSCI.2203-05.2005; Warrier A, 2005, J NEUROPHYSIOL, V94, P4196, DOI 10.1152/jn.00604.2005; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Zhang J, 2002, J NEUROSCI, V22, P10871	30	131	134	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 12	2006	443	7112					705	708		10.1038/nature05123	http://dx.doi.org/10.1038/nature05123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093HX	17036006				2022-12-01	WOS:000241160500049
J	Kim, K; Lerou, P; Yabuuchi, A; Lengerke, C; Ng, K; West, J; Kirby, A; Daly, MJ; Daley, GQ				Kim, Kitai; Lerou, Paul; Yabuuchi, Akiko; Lengerke, Claudia; Ng, Kitwa; West, Jason; Kirby, Andrew; Daly, Mark J.; Daley, George Q.			Histocompatible embryonic stem cells by parthenogenesis	SCIENCE			English	Article							MOUSE; GENOME; INSTABILITY; MICE	Genetically matched pluripotent embryonic stem (ES) cells generated via nuclear transfer or parthenogenesis (pES cells) are a potential source of histocompatible cells and tissues for transplantation. After parthenogenetic activation of murine oocytes and interruption of meiosis I or II, we isolated and genotyped pES cells and characterized those that carried the full complement of major histocompatibility complex (MHC) antigens of the oocyte donor. Differentiated tissues from these pES cells engrafted in immunocompetent MHC-matched mouse recipients, demonstrating that selected pES cells can serve as a source of histocompatible tissues for transplantation.	Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Newborn Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Daley, GQ (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Lengerke, Claudia/AAV-8745-2021; Daly, Mark J/B-2453-2017; West, Jason/I-4445-2014	Lengerke, Claudia/0000-0001-5442-2805; Daly, Mark J/0000-0002-0949-8752; West, Jason/0000-0002-7252-8651	NICHD NIH HHS [T32: HD07466] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN ND, 1994, DEVELOPMENT, V120, P1473; BALAKIER H, 1976, J EMBRYOL EXP MORPH, V35, P25; Cibelli JB, 2002, SCIENCE, V295, P819, DOI 10.1126/science.1065637; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Hernandez L, 2003, P NATL ACAD SCI USA, V100, P13344, DOI 10.1073/pnas.2234026100; Hoglund P, 1997, IMMUNOL REV, V155, P11, DOI 10.1111/j.1600-065X.1997.tb00936.x; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Klebs SHG, 2003, J IMMUNOL METHODS, V276, P197, DOI 10.1016/S0022-1759(03)00063-2; KUBIAK J, 1991, DEVELOPMENT, V111, P763; Lin H, 2003, STEM CELLS, V21, P152, DOI 10.1634/stemcells.21-2-152; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Opelz G, 1999, Rev Immunogenet, V1, P334; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; ROBERTSON EJ, 1983, J EMBRYOL EXP MORPH, V74, P297; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; VANDEWATER J, 1989, NEW ENGL J MED, V320, P1377, DOI 10.1056/NEJM198905253202104; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	21	166	186	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					482	486		10.1126/science.1133542	http://dx.doi.org/10.1126/science.1133542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17170255				2022-12-01	WOS:000243726600037
J	Van Dyke, T				Van Dyke, Terry			p53 and tumor suppression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DNA-DAMAGE		Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Van Dyke, T (corresponding author), Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA.							Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595	4	22	24	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	2007	356	1					79	81		10.1056/NEJMcibr066301	http://dx.doi.org/10.1056/NEJMcibr066301			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	122EX	17202460				2022-12-01	WOS:000243209600014
J	Vanhollebeke, B; Truc, P; Poelvoorde, P; Pays, A; Joshi, PP; Katti, R; Jannin, JG; Pays, E				Vanhollebeke, Benoit; Truc, Philippe; Poelvoorde, Philippe; Pays, Annette; Joshi, Prashant P.; Katti, Ravindra; Jannin, Jean G.; Pays, Etienne			Brief report: Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN SERUM; RHODESIENSE; RESISTANCE; PROTEIN; INDIA; GENE	Humans have innate immunity against Trypanosoma brucei brucei that is known to involve apolipoprotein L-I (APOL1). Recently, a case of T. evansi infection in a human was identified in India. We investigated whether the APOL1 pathway was involved in this occurrence. The serum of the infected patient was found to have no trypanolytic activity, and the finding was linked to the lack of APOL1, which was due to frameshift mutations in both APOL1 alleles. Trypanolytic activity was restored by the addition of recombinant APOL1. The lack of APOL1 explained the patient's infection with T. evansi.	Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, B-6041 Gosselies, Belgium; Inst Rech Dev, Unite Rech Trypanosomoses Africaines 117, Montpellier, France; Govt Med Coll, Dept Med, Nagpur, Maharashtra, India; Directorate Hlth Serv, Bombay, Maharashtra, India; WHO, Communicable Dis Control Prevent & Eradicat, CH-1211 Geneva, Switzerland	Universite Libre de Bruxelles; Institut de Recherche pour le Developpement (IRD); World Health Organization	Pays, E (corresponding author), Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, 12 Rue Professeurs Jeener & Brachet, B-6041 Gosselies, Belgium.	epays@ulb.ac.be		Vanhollebeke, Benoit/0000-0002-0353-365X				Gibson WC, 2005, PARASITOLOGY, V131, P143, DOI 10.1017/S0031182005007560; HAWKING F, 1978, T ROY SOC TROP MED H, V72, P405, DOI 10.1016/0035-9203(78)90136-0; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Joshi PP, 2006, T ROY SOC TROP MED H, V100, P989, DOI 10.1016/j.trstmh.2005.11.003; Joshi PP, 2005, AM J TROP MED HYG, V73, P491, DOI 10.4269/ajtmh.2005.73.491; Juyal P. D., 1998, Journal of Parasitic Diseases, V22, P67; LAVERAN A, 1912, TRYPANOSOMES TRPANOS, P379; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; TRUC P, IN PRESS INFECT GENE; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	13	130	140	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2006	355	26					2752	2756		10.1056/NEJMoa063265	http://dx.doi.org/10.1056/NEJMoa063265			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	120UA	17192540				2022-12-01	WOS:000243110500007
J	Johnson, C; Goodman, NW				Johnson, Chris; Goodman, Neville W.			Time to stop sniffing the air: snapshot survey	BRITISH MEDICAL JOURNAL			English	Editorial Material									Southmead Gen Hosp, Bristol BS10 5NB, Avon, England	Southmead Hospital	Goodman, NW (corresponding author), Southmead Gen Hosp, Bristol BS10 5NB, Avon, England.	nev.w.goodman@bris.ac.uk						Cattermole GN, 2002, ANAESTHESIA, V57, P411; GOLDSACK N, 1999, STUDENT BMJ, V7; LIM SL, 1994, ANAESTHESIA, V49, P255; Pinnock C, 1999, FUNDAMENTALS ANAESTH, P49	4	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2006	333	7582					1295	1296		10.1136/bmj.39015.726690.47	http://dx.doi.org/10.1136/bmj.39015.726690.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	121MC	17185713	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000243160700011
J	Cookson, MR; Hardy, J				Cookson, Mark R.; Hardy, John			Clinical implications of basic research: The persistence of memory	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UBIQUITIN		NIA, Neurogenet Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cookson, MR (corresponding author), NIA, Neurogenet Lab, Bethesda, MD 20892 USA.		Cookson, Mark/AAW-2516-2021; Hardy, John/C-2451-2009	Cookson, Mark/0000-0002-1058-3831; Hardy, John/0000-0002-3122-0423	Medical Research Council [G0701075] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000953, ZIAAG000953] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Selkoe DJ, 2002, SCIENCE, V298, P963; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008	4	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2006	355	25					2697	2698		10.1056/NEJMcibr065999	http://dx.doi.org/10.1056/NEJMcibr065999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	118QG	17182998				2022-12-01	WOS:000242956200015
J	Chen, Y; Corriden, R; Inoue, Y; Yip, L; Hashiguchi, N; Zinkernagel, A; Nizet, V; Insel, PA; Junger, WG				Chen, Yu; Corriden, Ross; Inoue, Yoshiaki; Yip, Linda; Hashiguchi, Naoyuki; Zinkernagel, Annelies; Nizet, Victor; Insel, Paul A.; Junger, Wolfgang G.			ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors	SCIENCE			English	Article							ADENOSINE; MIGRATION; CHEMOATTRACTANT; NUCLEOTIDES; STIMULATION; EOSINOPHILS; LEUKOCYTES; SYSTEM; CELLS	Cells must amplify external signals to orient and migrate in chemotactic gradient fields. We find that human neutrophils release adenosine triphosphate (ATP) from the leading edge of the cell surface to amplify chemotactic signals and direct cell orientation by feedback through P2Y2 nucleotide receptors. Neutrophils rapidly hydrolyze released ATP to adenosine that then acts via A3-type adenosine receptors, which are recruited to the leading edge, to promote cell migration. Thus, ATP release and autocrine feedback through P2Y2 and A3 receptors provide signal amplification, controlling gradient sensing and migration of neutrophils.	Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Junger, WG (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	wjunger@ucsd.edu	Junger, Wolfgang G/I-1932-2013; Nizet, Victor/AAF-3190-2019; Zinkernagel, Annelies S/F-1780-2017	Junger, Wolfgang G/0000-0003-3350-8452; Zinkernagel, Annelies S/0000-0003-4700-1118; Nizet, Victor/0000-0003-3847-0422	NIDDK NIH HHS [T32 DK007202] Funding Source: Medline; NIGMS NIH HHS [GM-60475, GM-66232, R01 GM-51477] Funding Source: Medline; OCPHP CDC HHS [PR043034] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051477, R01GM066232, R01GM060475] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OCPHP CDC HHS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Fredholm BB, 1997, GEN PHARMACOL-VASC S, V28, P345, DOI 10.1016/S0306-3623(96)00169-3; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Kimmel AR, 2004, CURR OPIN GENET DEV, V14, P540, DOI 10.1016/j.gde.2004.08.001; Knight D, 1997, J LEUKOCYTE BIOL, V62, P465, DOI 10.1002/jlb.62.4.465; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Seo JK, 1997, J IMMUNOL, V158, P1895; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Walker BAM, 1997, AM J RESP CELL MOL, V16, P531, DOI 10.1165/ajrcmb.16.5.9160835; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Yegutkin G, 2000, BRIT J PHARMACOL, V129, P921, DOI 10.1038/sj.bjp.0703136; Zhang Y, 1996, BIOCHEM PHARMACOL, V51, P957, DOI 10.1016/0006-2952(95)02403-4; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	21	635	652	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2006	314	5806					1792	1795		10.1126/science.1132559	http://dx.doi.org/10.1126/science.1132559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170310				2022-12-01	WOS:000242833600064
J	Mandel, CR; Kaneko, S; Zhang, HL; Gebauer, D; Vethantham, V; Manley, JL; Tong, L				Mandel, Corey R.; Kaneko, Syuzo; Zhang, Hailong; Gebauer, Damara; Vethantham, Vasupradha; Manley, James L.; Tong, Liang			Polyadenylation factor CPSF-73 is the pre-mRNA 3 '-end-processing endonuclease	NATURE			English	Article							METALLO-BETA-LACTAMASE; CRYSTAL-STRUCTURE; PROTEIN; CLEAVAGE; FOLD; RECOMBINATION; TRANSCRIPTION; EUKARYOTES; POLYMERASE; MECHANISM	Most eukaryotic messenger RNA precursors (pre-mRNAs) undergo extensive maturational processing, including cleavage and polyadenylation at the 3'-end(1-8). Despite the characterization of many proteins that are required for the cleavage reaction, the identity of the endonuclease is not known(4,9,10). Recent analyses indicated that the 73-kDa subunit of cleavage and polyadenylation specificity factor (CPSF-73) might be the endonuclease for this and related reactions(10-15), although no direct data confirmed this. Here we report the crystal structures of human CPSF-73 at 2.1 angstrom resolution, complexed with zinc ions and a sulphate that might mimic the phosphate group of the substrate, and the related yeast protein CPSF-100 (Ydh1) at 2.5 angstrom resolution. Both CPSF-73 and CPSF-100 contain two domains, a metallo-beta-lactamase domain and a novel beta-CASP ( named for metallo-beta-lactamase, CPSF, Artemis, Snm1, Pso2) domain(12). The active site of CPSF-73, with two zinc ions, is located at the interface of the two domains. Purified recombinant CPSF-73 possesses RNA endonuclease activity, and mutations that disrupt zinc binding in the active site abolish this activity. Our studies provide the first direct experimental evidence that CPSF-73 is the pre-mRNA 3'-end-processing endonuclease.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Kaneko, Syuzo/GPP-3257-2022	Kaneko, Syuzo/0000-0003-4558-9800; Tong, Liang/0000-0002-0563-6468; Manley, James/0000-0002-8341-1459	NIGMS NIH HHS [R01 GM077175-01A2, R01 GM077175] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077175] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; Garrity JD, 2005, BIOCHEMISTRY-US, V44, P1078, DOI 10.1021/bi048385b; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hirose Y, 1997, J BIOL CHEM, V272, P29636, DOI 10.1074/jbc.272.47.29636; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; Kolev NG, 2005, GENE DEV, V19, P2583, DOI 10.1101/gad.1371105; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mandel CR, 2006, ACTA CRYSTALLOGR F, V62, P1041, DOI 10.1107/S1744309106038152; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	30	309	317	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2006	444	7121					953	956		10.1038/nature05363	http://dx.doi.org/10.1038/nature05363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17128255	Green Accepted			2022-12-01	WOS:000242805400062
J	Hogenauer, C; Langner, C; Beubler, E; Lippe, IT; Schicho, R; Gorkiewicz, G; Krause, R; Gerstgrasser, N; Krejs, GJ; Hinterleitner, TA				Hoegenauer, Christoph; Langner, Cord; Beubler, Eckhard; Lippe, Irmgard T.; Schicho, Rudolf; Gorkiewicz, Gregor; Krause, Robert; Gerstgrasser, Nikolas; Krejs, Guenter J.; Hinterleitner, Thomas A.			Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DIARRHEA; TOXIN; CYTOTOXIN; CELLS	BACKGROUND: Antibiotic-associated hemorrhagic colitis is a distinct form of antibiotic-associated colitis in which Clostridium difficile is absent. Although the cause is not known, previous reports have suggested a role of Klebsiella oxytoca. METHODS: We studied 22 consecutive patients who had suspected antibiotic-associated colitis and who were negative for C. difficile. Patients underwent diagnostic colonoscopy, and among those who received a diagnosis of antibiotic-associated hemorrhagic colitis, stool samples were cultured for K. oxytoca. We isolated K. oxytoca strains and tested them for cytotoxin production using a tissue-culture assay. In addition, we also cultured stool samples obtained from 385 healthy subjects for K. oxytoca. An in vivo animal model for antibiotic-associated hemorrhagic colitis was established with the use of Sprague-Dawley rats. RESULTS: Of the 22 patients, 6 had findings on colonoscopy that were consistent with the diagnosis of antibiotic-associated hemorrhagic colitis, and 5 of these 6 patients had positive cultures for K. oxytoca. No other common enteric pathogens were found in the five patients. Before the onset of colitis, all five were receiving penicillins, and two were also taking nonsteroidal antiinflammatory drugs (NSAIDs). All isolated K. oxytoca strains produced cytotoxin. K. oxytoca was found in 1.6% of the healthy subjects. In the animal model, K. oxytoca was found only in the colon of rats that received amoxicillin-clavulanate in addition to being inoculated with K. oxytoca. In these rats, infection with K. oxytoca induced a right-sided hemorrhagic colitis that was not observed in uninfected animals that received amoxicillin-clavulanate, indomethacin (an NSAID), or both. CONCLUSIONS: Our fulfillment of Koch's postulates for cytotoxin-producing K. oxytoca suggests that it is the causative organism in at least some cases of antibiotic-associated hemorrhagic colitis. Infection with K. oxytoca should be considered in patients with antibiotic-associated colitis who are negative for C. difficile.	Med Univ Graz, Dept Internal Med, A-8036 Graz, Austria; Med Univ Graz, Inst Pathol, A-8036 Graz, Austria; Med Univ Graz, Inst Expt & Clin Pharmacol, A-8036 Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Hogenauer, C (corresponding author), Med Univ Graz, Dept Internal Med, Auenbruggerpl 15, A-8036 Graz, Austria.	christoph.hoegenauer@meduni-graz.at	Gorkiewicz, Gregor/ABF-1602-2021	Gorkiewicz, Gregor/0000-0003-1149-4782; Schicho, Rudolf/0000-0002-5726-4731; Hogenauer, Christoph/0000-0003-4566-0806				BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Beaugerie L, 2003, CLIN GASTROENTEROL H, V1, P370, DOI 10.1053/S1542-3565(03)00183-6; Bellaiche G, 1997, GASTROEN CLIN BIOL, V21, P764; BENOIT R, 1992, GASTROEN CLIN BIOL, V16, P860; BRUMFITT W, 1986, ANTIMICROB AGENTS CH, V30, P335, DOI 10.1128/AAC.30.2.335; Chen J, 2004, GASTROINTEST ENDOSC, V60, P142, DOI 10.1016/S0016-5107(04)01537-8; Etienney I, 2003, GUT, V52, P260, DOI 10.1136/gut.52.2.260; Evans JMM, 1997, GUT, V40, P619, DOI 10.1136/gut.40.5.619; Gleeson MH, 2003, ALIMENT PHARM THER, V17, P817, DOI 10.1046/j.1365-2036.2003.01519.x; GRIFFIN PM, 1990, GASTROENTEROLOGY, V99, P142, DOI 10.1016/0016-5085(90)91241-W; HEER M, 1989, SCHWEIZ MED WSCHR, V119, P733; HIGAKI M, 1990, MICROBIOL IMMUNOL, V34, P147, DOI 10.1111/j.1348-0421.1990.tb00999.x; Koga H, 1999, DIS COLON RECTUM, V42, P1502, DOI 10.1007/BF02235056; Lode H, 2001, SCAND J INFECT DIS, V33, P899, DOI 10.1080/00365540110076714; MINAMI J, 1992, J GEN MICROBIOL, V138, P1921, DOI 10.1099/00221287-138-9-1921; MINAMI J, 1994, INFECT IMMUN, V62, P172, DOI 10.1128/IAI.62.1.172-177.1994; MINAMI J, 1989, MICROB PATHOGENESIS, V7, P203, DOI 10.1016/0882-4010(89)90056-9; O'Loughlin EV, 2001, MICROBES INFECT, V3, P493, DOI 10.1016/S1286-4579(01)01405-8; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; SAKURAI Y, 1979, DIGEST DIS SCI, V24, P910, DOI 10.1007/BF01311944; Soussi F, 2001, GASTROEN CLIN BIOL, V25, P814; TOFFLER RB, 1978, LANCET, V2, P707; Yonei Y, 1996, J GASTROEN HEPATOL, V11, P681, DOI 10.1111/j.1440-1746.1996.tb00314.x	24	169	187	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2418	2426		10.1056/NEJMoa054765	http://dx.doi.org/10.1056/NEJMoa054765			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151365				2022-12-01	WOS:000242581400006
J	Cang, Y; Zhang, JX; Nicholas, SA; Bastien, J; Li, BJ; Zhou, PB; Goff, SP				Cang, Yong; Zhang, Jianxuan; Nicholas, Sally A.; Bastien, Jayson; Li, Baojie; Zhou, Pengbo; Goff, Stephen P.			Deletion of DDB1 in mouse brain and lens leads to p53-dependent elimination of proliferating cells	CELL			English	Article							UBIQUITIN LIGASE; DNA-DAMAGE; XERODERMA-PIGMENTOSUM; GENOME STABILITY; COP9 SIGNALOSOME; V PROTEIN; PROTEOLYSIS; CDT1; REPLICATION; MICE	DDB1, a component of the Cul4 ubiquitin ligase complex, promotes protein ubiquitination in diverse cellular functions, including nuclear excision repair, regulation of the cell cycle, and DNA replication. To investigate its physiological significance, we generated mice with null and floxed alleles of the DDB1 gene. Here we report that null mutation of DDB1 caused early embryonic lethality, while conditional inactivation of the gene in brain and lens led to neuronal and lens degeneration, brain hemorrhages, and neonatal death. These defects stemmed from a selective elimination of nearly all proliferating neuronal progenitor cells and lens epithelial cells by apoptosis. The cell death was preceded by aberrant accumulation of cell cycle regulators and increased genomic instability and could be partially rescued by removal of the tumor suppressor protein p53. Our results indicate that DDB1 plays an essential role in maintaining viability and genomic integrity of dividing cells.	Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 138673, Singapore	Columbia University; Howard Hughes Medical Institute; Cornell University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Goff, SP (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	goff@cancercenter.columbia.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547; Cang, Yong/0000-0002-1148-7008	NATIONAL CANCER INSTITUTE [R01CA118085, P01CA023767, R01CA098210, R37CA030488, R56CA098210] Funding Source: NIH RePORTER; NCI NIH HHS [CA 23767, CA098210, CA118085, R37 CA 30488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Bhat SP, 2001, BIOSCIENCE REP, V21, P537, DOI 10.1023/A:1017952128502; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bondar T, 2004, J BIOL CHEM, V279, P9937, DOI 10.1074/jbc.M312570200; Bootsma D., 2002, GENETIC BASIS HUMAN, P211; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Groisman R, 2006, GENE DEV, V20, P1429, DOI 10.1101/gad.378206; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Holmberg C, 2005, GENE DEV, V19, P853, DOI 10.1101/gad.329905; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Takata K, 2004, GENETICS, V168, P855, DOI 10.1534/genetics.103.025965; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Watanabe T, 1999, J NEUROCHEM, V72, P549, DOI 10.1046/j.1471-4159.1999.0720549.x; Wen PH, 2005, DEVELOPMENT, V132, P3873, DOI 10.1242/dev.01946; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yang J, 2000, MECH DEVELOP, V94, P287, DOI 10.1016/S0925-4773(00)00301-4; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	36	112	115	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					929	940		10.1016/j.cell.2006.09.045	http://dx.doi.org/10.1016/j.cell.2006.09.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129780	Bronze			2022-12-01	WOS:000242613800011
J	DeLuca, JG; Gall, WE; Ciferri, C; Cimini, D; Musacchio, A; Salmon, ED				DeLuca, Jennifer G.; Gall, Walter E.; Ciferri, Claudio; Cimini, Daniela; Musacchio, Andrea; Salmon, E. D.			Kinetochore microtubule dynamics and attachment stability are regulated by Hec1	CELL			English	Article							SMALL-MOLECULE INHIBITOR; MITOTIC SPINDLE; AURORA-B; CENTROMERIC MCAK; NDC80 COMPLEX; XENOPUS EGGS; PROTEIN; METAPHASE; SEGREGATION; ORIENTATION	Mitotic cells face the challenging tasks of linking kinetochores to growing and, shortening microtubules and actively regulating these dynamic attachments to produce accurate chromosome segregation. We report here that Ndc80/Hec1 functions in regulating kinetochore microtubule plus-end dynamics and attachment stability. Microinjection of an antibody to the N terminus of Hec1 suppresses both microtubule detachment and microtubule plus-end polymerization and depolymerization at kinetochores of PtK1 cells. Centromeres become hyperstretched, kinetochore fibers shorten from spindle poles, kinetochore microtubule attachment errors increase, and chromosomes severely mis-segregate. The N terminus of Hec1 is phosphorylated by Aurora B kinase in vitro, and cells expressing N-terminal nonphosphorylatable mutants of Hec1 exhibit an increase in merotelic attachments, hyperstretching of centromeres, and errors in chromosome segregation. These findings reveal a key role for the Hec1 N terminus in controlling dynamic behavior of kinetochore microtubules.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy	University of North Carolina; University of North Carolina Chapel Hill; Virginia Polytechnic Institute & State University; IRCCS European Institute of Oncology (IEO)	DeLuca, JG (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	jgdeluca@email.unc.edu	Cimini, Daniela/A-3039-2016; , Proteomics Core UNC/AFQ-7201-2022	Cimini, Daniela/0000-0002-4082-4894; Musacchio, Andrea/0000-0003-2362-8784	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024364, F32GM066588, R01GM024364, F32GM067370] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM67370, GM66588, R37 GM024364, GM24364] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Cameron LA, 2006, J CELL BIOL, V173, P173, DOI 10.1083/jcb.200601075; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; CASSIMERIS L, 1990, J CELL SCI, V96, P9; Charrasse S, 1998, J CELL SCI, V111, P1371; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2001, J CELL BIOL, V155, P1137, DOI 10.1083/jcb.200109063; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Chen YM, 1997, MOL CELL BIOL, V17, P6049, DOI 10.1128/MCB.17.10.6049; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Le Blanc JCY, 2003, PROTEOMICS, V3, P859, DOI 10.1002/pmic.200300415; Maiato H, 2003, CELL, V113, P891, DOI 10.1016/S0092-8674(03)00465-3; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; MITCHISON TJ, 1992, J CELL BIOL, V119, P569, DOI 10.1083/jcb.119.3.569; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Moore A, 2004, TRENDS CELL BIOL, V14, P537, DOI 10.1016/j.tcb.2004.09.001; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tien AC, 2004, MOL CELL PROTEOMICS, V3, P93, DOI 10.1074/mcp.M300072-MCP200; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.E02-04-0236; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; WEISENBERG RC, 1981, BIOCHEM BIOPH RES CO, V102, P924, DOI 10.1016/0006-291X(81)91626-0; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	54	526	536	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					969	982		10.1016/j.cell.2006.09.047	http://dx.doi.org/10.1016/j.cell.2006.09.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129782	Bronze, Green Submitted			2022-12-01	WOS:000242613800014
J	Serizawa, S; Miyamichi, K; Takeuchi, H; Yamagishi, Y; Suzuki, M; Sakano, H				Serizawa, Shou; Miyamichi, Kazunari; Takeuchi, Haruki; Yamagishi, Yuya; Suzuki, Misao; Sakano, Hitoshi			A neuronal identity code for the odorant receptor-specific and activity-dependent axon sorting	CELL			English	Article							OLFACTORY SENSORY NEURONS; GENE-EXPRESSION; MOLECULAR-BASIS; EPH RECEPTORS; BULB; MAP; PROJECTIONS; SYSTEM; MOUSE; GLOMERULI	In the mouse, olfactory sensory neurons (OSNs) expressing the same odorant receptor (OR) converge their axons to a specific set of glomeruli in the olfactory bulb. To study how OR-instructed axonal fasciculation is controlled, we searched for genes whose expression profiles are correlated with the expressed ORs. Using the transgenic mouse in which the majority of OSNs express a particular OR, we identified such genes coding for the homophilic adhesive molecules Kirrel2/Kirrel3 and repulsive molecules ephrin-A5/EphA5. In the CNGA2 knockout mouse, where the odor-evoked cation influx is disrupted, Kirrel2 and EphA5 were downregulated, while Kirrel3 and ephrin-A5 were upregulated, indicating that these genes are transcribed in an activity-dependent manner. Mosaic analysis demonstrated that gain of function of these genes generates duplicated glomeruli. We propose that a specific set of adhesive/repulsive molecules, whose expression levels are determined by OR molecules, regulate the axonal fasciculation of OSNs during the process of glomerular map formation.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; Japan Sci & Technol Agcy, CREST Program, Kawaguchi, Saitama 3320012, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kumamoto University	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Miyamichi, Kazunari/AAO-3705-2021	Takeuchi, Haruki/0000-0003-4911-4060				Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Cramer Karina S., 1995, Current Opinion in Neurobiology, V5, P106, DOI 10.1016/0959-4388(95)80094-8; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Minaki Y, 2005, NEUROSCI RES, V52, P250, DOI 10.1016/j.neures.2005.03.014; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; SAUCIER D, 1986, BRAIN RES BULL, V16, P455, DOI 10.1016/0361-9230(86)90173-5; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; St John JA, 2002, DEV BRAIN RES, V138, P1, DOI 10.1016/S0165-3806(02)00454-6; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Yu TT, 2005, J COMP NEUROL, V483, P251, DOI 10.1002/cne.20429; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	46	244	248	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 1	2006	127	5					1057	1069		10.1016/j.cell.2006.10.031	http://dx.doi.org/10.1016/j.cell.2006.10.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129788	Bronze			2022-12-01	WOS:000242613800020
J	Slessareva, JE; Dohlman, HG				Slessareva, Janna E.; Dohlman, Henrik G.			G protein signaling in yeast: New components, new connections, new compartments	SCIENCE			English	Editorial Material							ALPHA-SUBUNIT; ACTIVATION		Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu		Dohlman, Henrik/0000-0003-2443-0729	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM065533] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01-GM065533] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Elion EA, 2001, J CELL SCI, V114, P3967; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Guo M, 2003, MOL CELL, V12, P517, DOI 10.1016/S1097-2765(03)00307-1; HELMS JB, 1995, FEBS LETT, V369, P84, DOI 10.1016/0014-5793(95)00620-O; Lyons DM, 1996, MOL CELL BIOL, V16, P4095; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Roman DL, 2007, MOL PHARMACOL, V71, P169, DOI 10.1124/mol.106.028670; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6	19	37	39	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2006	314	5804					1412	1413		10.1126/science.1134041	http://dx.doi.org/10.1126/science.1134041			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110UF	17138892				2022-12-01	WOS:000242406100028
J	Le Cam, L; Linares, LK; Paul, C; Julien, E; Lacroix, M; Hatchi, E; Triboulet, R; Bossis, G; Shmueli, A; Rodriguez, MS; Coux, O; Sardet, C				Le Cam, Laurent; Linares, Laetitia K.; Paul, Conception; Julien, Eric; Lacroix, Matthieu; Hatchi, Elodie; Triboulet, Robinson; Bossis, Guillaume; Shmueli, Ayelet; Rodriguez, Manuel S.; Coux, Olivier; Sardet, Claude			E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation	CELL			English	Article							CELL-CYCLE ARREST; TRANSCRIPTION FACTOR P120(E4F); C-TERMINAL DOMAIN; GROWTH ARREST; DNA-DAMAGE; IN-VITRO; POSTTRANSLATIONAL MODIFICATIONS; ACTIVATES TRANSCRIPTION; NEGATIVE REGULATOR; TUMOR-SUPPRESSOR	p53 is regulated by multiple posttranslational modifications, including Hdm2-mediated ubiquitylation that drives its proteasomal degradation. Here, we identify the p53-associated factor E4F1, a ubiquitously expressed zinc-finger protein first identified as a cellular target of the viral oncoprotein E1A, as an atypical ubiquitin E3 ligase for p53 that modulates its effector functions without promoting proteolysis. E4F1 stimulates oligo-ubiquitylation in the hinge region of p53 on lysine residues distinct from those targeted by Hdm2 and previously described to be acetylated by the acetyltransferase PCAF. E4F1 and PCAF mediate mutually exclusive posttranslational modifications of p53. E4F1-dependent Ub-p53 conjugates are associated with chromatin, and their stimulation coincides with the induction of a p53-dependent transcriptional program specifically involved in cell cycle arrest, and not apoptosis. Collectively, our data reveal that E4F1 is a key posttranslational regulator of p53, which modulates its effector functions involved in alternative cell fates: growth arrest or apoptosis.	UMII, Inst Genet Mol, CNRS, UMR5535, F-34293 Montpellier, France; CNRS, FRE 2593, CRBM, F-34293 Montpellier, France; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; CIC BIOGUNE, Proteom Unit, Derio 48160, Spain; Univ Gottingen, Dept Biochem, D-37073 Gottingen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Weizmann Institute of Science; CIC bioGUNE; University of Gottingen	Le Cam, L (corresponding author), UMII, Inst Genet Mol, CNRS, UMR5535, IFR122, F-34293 Montpellier, France.	llecam@igmm.cnrs.fr; claude.sardet@igmm.cnrs.fr	Bossis, Guillaume/C-7172-2012; Lacroix, Matthieu/O-1928-2018; Coux, Olivier/B-3406-2010; Coux, Olivier/P-6847-2019; Le Cam, Laurent/O-1408-2016; Linares, Laetitia LKL/F-9901-2018; JULIEN, ERIC/Y-5873-2019	Lacroix, Matthieu/0000-0002-1268-9058; Coux, Olivier/0000-0001-8455-3849; Coux, Olivier/0000-0001-8455-3849; Linares, Laetitia LKL/0000-0003-1661-2119; JULIEN, ERIC/0000-0003-2976-666X; LE CAM, Laurent/0000-0003-0325-878X; bossis, guillaume/0000-0002-3349-8250				Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Ahmed-Choudhury J, 2005, CANCER RES, V65, P2690, DOI 10.1158/0008-5472.CAN-04-3593; Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Aurelio ON, 1998, CANCER RES, V58, P2190; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chagraoui J, 2006, GENE DEV, V20, P2110, DOI 10.1101/gad.1453406; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Colombo R, 2003, ONCOGENE, V22, P2541, DOI 10.1038/sj.onc.1206379; Di Stefano V, 2005, ONCOGENE, V24, P5431, DOI 10.1038/sj.onc.1208717; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Fajas L, 2001, MOL CELL BIOL, V21, P2956, DOI 10.1128/MCB.21.8.2956-2966.2001; Fajas L, 2000, P NATL ACAD SCI USA, V97, P7738, DOI 10.1073/pnas.130198397; Fenton SL, 2004, CANCER RES, V64, P102, DOI 10.1158/0008-5472.CAN-03-2622; Fernandes ER, 1999, MOL CELL BIOL, V19, P4739; Fernandes ER, 1997, MOL CELL BIOL, V17, P1890, DOI 10.1128/MCB.17.4.1890; Fernandes ER, 1998, MOL CELL BIOL, V18, P459, DOI 10.1128/MCB.18.1.459; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Kong XT, 2001, J BIOL CHEM, V276, P32990, DOI 10.1074/jbc.M103681200; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Le Cam L, 2004, MOL CELL BIOL, V24, P6467, DOI 10.1128/MCB.24.14.6467-6475.2004; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; LEE KAW, 1987, EMBO J, V6, P1345, DOI 10.1002/j.1460-2075.1987.tb02374.x; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; RAYCHAUDHURI P, 1987, EMBO J, V6, P4073, DOI 10.1002/j.1460-2075.1987.tb02753.x; Rizos H, 2003, J BIOL CHEM, V278, P4981, DOI 10.1074/jbc.M210978200; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Rooney RJ, 2001, CELL GROWTH DIFFER, V12, P505; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sandy P, 2000, ONCOGENE, V19, P188, DOI 10.1038/sj.onc.1203250; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Terui T, 2003, CANCER RES, V63, P8948; Tessari MA, 2003, MOL CELL BIOL, V23, P9104, DOI 10.1128/MCB.23.24.9104-9116.2003; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173	78	158	165	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					775	788		10.1016/j.cell.2006.09.031	http://dx.doi.org/10.1016/j.cell.2006.09.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110336	Bronze			2022-12-01	WOS:000242330600023
J	Gross, CP; McAvay, GJ; Krumholz, HM; Paltiel, AD; Bhasin, D; Tinetti, ME				Gross, Cary P.; McAvay, Gail J.; Krumholz, Harlan M.; Paltiel, A. David; Bhasin, Devina; Tinetti, Mary E.			The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: Implications for screening	ANNALS OF INTERNAL MEDICINE			English	Article							FECAL-OCCULT-BLOOD; UNITED-STATES; ELDERLY-PATIENTS; COLONOSCOPY; GUIDELINES; MEDICARE; ADULTS; POPULATION; PREDICTORS; RATIONALE	Background: Older adults with shorter life expectancies may receive less benefit from colorectal cancer screening than younger, healthier patients. Objective: To determine the degree to which life expectancy after diagnosis of an early-stage cancer varies according to age or coexisting chronic illness. Design: Retrospective cohort study. Setting: Population-based cancer registry with linked administrative claims data. Patients: Patients 67 years of age or older who received a diagnosis of colorectal cancer from 1993 through 1999. Measurements: Chronic conditions were identified by searching Medicare claims. Using a life-table approach, the authors quantified the degree to which life expectancy associated with each cancer stage at diagnosis varied with patient age, sex, and burden of chronic conditions. Results: The final study sample consisted of 35 755 patients. After accounting for cancer stage at diagnosis, the authors found that life expectancy was strongly related to both age and the burden of chronic illness. Among men who received a diagnosis of stage I cancer at 67 years of age, life expectancy decreased from 19.1 years (95% Cl, 17.8 to 20.5 years) for patients with no chronic conditions to 12.4 years (Cl, 11.4 to 13.5 years) for those with 1 or 2 conditions and 7.6 years (Cl, 6.1 to 9.4 years) for those with 3 or more conditions. A similar trend was noted among female counterparts with life expectancy decreasing from approximately 23 years to 16 years and 7 years for the 3 chronic condition groups, respectively. For men and women 81 years of age with no chronic illnesses, life expectancy after stage I cancer diagnosis was 10.3 years (Cl, 9.2 to 11.9 years) and 13.8 years (Cl, 12.3 to 15.3 years), respectively. Limitations: Administrative claims may not identify all chronic conditions. Life expectancy estimates at the population level are averages and, therefore, may not accurately predict the life expectancy of individual patients. Conclusions: Coexisting chronic illness is associated with a substantial reduction in life expectancy after diagnosis of early-stage colorectal cancer. Physicians should consider this when deciding whether to screen older persons.	Yale Univ, Sch Med, Primary Care Ctr, New Haven, CT 06520 USA; Robert Wood Johnson Clin Scholars Program, New Haven, CT USA	Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu	, Harlan/AAI-2875-2020	Paltiel, A. David/0000-0002-4861-3290	NIA NIH HHS [P30AG21342, 1 K08 AG24842] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG024842, P30AG021342] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM CANC SOC, 2005, CANC FACT FIG 2005; Berg AO, 2002, AM J NURS, V102, P107; Chao A, 2004, AM J PUBLIC HEALTH, V94, P1775, DOI 10.2105/AJPH.94.10.1775; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Ioannou GN, 2003, AM J GASTROENTEROL, V98, P2082, DOI 10.1016/S0002-9270(03)00423-4; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lamont EB, 2002, MED CARE, V40, P201, DOI 10.1097/00005650-200203000-00004; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; POTOSKY AL, 1993, MED CARE, V31, P732; Ries LAG, 2004, SEER CANC STAT REV 1; Ries LAG, 2005, SEER CANC STAT REV 1; Schrag D, 2001, J CLIN ONCOL, V19, P3712, DOI 10.1200/JCO.2001.19.17.3712; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1661, DOI 10.1053/j.gastro.2004.09.052; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Smith RA, 2003, CA-CANCER J CLIN, V53, P27, DOI 10.3322/canjclin.53.1.27; Stevens T, 2003, AM J GASTROENTEROL, V98, P1881, DOI 10.1016/S0002-9270(03)00425-8; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594	26	131	133	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 7	2006	145	9					646	653		10.7326/0003-4819-145-9-200611070-00006	http://dx.doi.org/10.7326/0003-4819-145-9-200611070-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	100ZD	17088577				2022-12-01	WOS:000241707800002
J	Glasier, A; Gulmezoglu, AM				Glasier, Anna; Guelmezoglu, A. Metin			Putting sexual and reproductive health on the agenda	LANCET			English	Editorial Material									NHS Lothian, Edinburgh EH4 1NL, Midlothian, Scotland; Univ Edinburgh, Edinburgh EH4 1NL, Midlothian, Scotland; WHO, Special Programme Res Dev & Res Training Huma, UNDP UNFPA, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Edinburgh; United Nations Population Fund; World Health Organization	Glasier, A (corresponding author), NHS Lothian, Edinburgh EH4 1NL, Midlothian, Scotland.	Anna.Glasier@lpct.scot.nhs.uk						CLELAND J, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69480-4; FATHALLA MF, 2006, LANCET          1101; GATES B, 2006, 16 INT AIDS C KEYN S; GLASIER A, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69478-6; GRIMES DA, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69481-6; LOW N, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69482-8; WELLINGS K, 2006, LANCET          1101, DOI DOI 10.1016/S0140-6736(06)69479-8; WHO, 2006, GLOB STRAT PREV CONT	8	19	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 4	2006	368	9547					1550	1551		10.1016/S0140-6736(06)69485-3	http://dx.doi.org/10.1016/S0140-6736(06)69485-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	107OM	17084739				2022-12-01	WOS:000242180900005
J	Jackson, A; Mavoori, J; Fetz, EE				Jackson, Andrew; Mavoori, Jaideep; Fetz, Eberhard E.			Long-term motor cortex plasticity induced by an electronic neural implant	NATURE			English	Article							CORTICAL PLASTICITY; MOVEMENT REPRESENTATIONS; DEPENDENT PLASTICITY; POTENTIATION; STIMULATION; ACTIVATION; INDUCTION; RECOVERY	It has been proposed that the efficacy of neuronal connections is strengthened when there is a persistent causal relationship between presynaptic and postsynaptic activity. Such activity-dependent plasticity may underlie the reorganization of cortical representations during learning, although direct in vivo evidence is lacking. Here we show that stable reorganization of motor output can be induced by an artificial connection between two sites in the motor cortex of freely behaving primates. An autonomously operating electronic implant used action potentials recorded on one electrode to trigger electrical stimuli delivered at another location. Over one or more days of continuous operation, the output evoked from the recording site shifted to resemble the output from the corresponding stimulation site, in a manner consistent with the potentiation of synaptic connections between the artificially synchronized populations of neurons. Changes persisted in some cases for more than one week, whereas the output from sites not incorporated in the connection was unaffected. This method for inducing functional reorganization in vivo by using physiologically derived stimulus trains may have practical application in neurorehabilitation after injury.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fetz, EE (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	fetz@u.washington.edu		Jackson, Andrew/0000-0001-8701-6387				AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; BARANYI A, 1981, NATURE, V290, P413, DOI 10.1038/290413a0; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; FETZ E, 1991, CEREB CORTEX, V9, P1; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Huang YY, 2004, P NATL ACAD SCI USA, V101, P859, DOI 10.1073/pnas.2237201100; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Jackson A, 2003, NEURON, V38, P115, DOI 10.1016/S0896-6273(03)00162-4; JACKSON A, IN PRESS J NEUROPHYS; Jackson A, 2006, IEEE T NEUR SYS REH, V14, P187, DOI 10.1109/TNSRE.2006.875547; JANKOWSKA E, 1975, J PHYSIOL-LONDON, V249, P617, DOI 10.1113/jphysiol.1975.sp011034; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321, DOI 10.1152/jn.1998.80.6.3321; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mavoori J, 2005, J NEUROSCI METH, V148, P71, DOI 10.1016/j.jneumeth.2005.04.017; Maynard EM, 1999, J NEUROSCI, V19, P8083; Monfils MH, 2005, NEUROSCIENTIST, V11, P471, DOI 10.1177/1073858405278015; Monfils MH, 2004, CEREB CORTEX, V14, P586, DOI 10.1093/cercor/bhh020; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463, DOI 10.3109/08990229009144720; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Prochazka A, 2001, J PHYSIOL-LONDON, V533, P99, DOI 10.1111/j.1469-7793.2001.0099b.x; RACINE RJ, 1995, BRAIN RES, V702, P87, DOI 10.1016/0006-8993(95)01025-0; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; Stickgold R, 2005, SLEEP, V28, P1225, DOI 10.1093/sleep/28.10.1225	34	309	323	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					56	60		10.1038/nature05226	http://dx.doi.org/10.1038/nature05226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17057705				2022-12-01	WOS:000241701500043
J	Hagadorn, JW; Xiao, SH; Donoghue, PCJ; Bengtson, S; Gostling, NJ; Pawlowska, M; Raff, EC; Raff, RA; Turner, FR; Chongyu, Y; Zhou, C; Yuan, X; McFeely, MB; Stampanoni, M; Nealson, KH				Hagadorn, James W.; Xiao, Shuhai; Donoghue, Philip C. J.; Bengtson, Stefan; Gostling, Neil J.; Pawlowska, Maria; Raff, Elizabeth C.; Raff, Rudolf A.; Turner, F. Rudolf; Chongyu, Yin; Zhou, Chuanming; Yuan, Xunlai; McFeely, Matthew B.; Stampanoni, Marco; Nealson, Kenneth H.			Cellular and subcellular structure of neoproterozoic animal embryos	SCIENCE			English	Article							DOUSHANTUO FORMATION; TAPHONOMY; ALGAE	Stereoblastic embryos from the Doushantuo Formation of China exhibit occasional asynchronous cell division, with diminishing blastomere volume as cleavage proceeded. Asynchronous cell division is common in modern embryos, implying that sophisticated mechanisms for differential cell division timing and embryonic cell lineage differentiation evolved before 551 million years ago. Subcellular structures akin to organelles, coated yolk granules, or lipid vesicles occur in these embryos. Paired reniform structures within embryo cells may represent fossil evidence of cells about to undergo division. Embryos exhibit no evidence of epithelial organization, even in embryos composed of similar to 1000 cells. Many of these features are compatible with metazoans, but the absence of epithelialization is consistent only with a stem-metazoan affinity for Doushantuo embryos.	Amherst Coll, Dept Geol, Amherst, MA 01002 USA; Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Swedish Museum Nat Hist, Dept Palaeozool, SE-10405 Stockholm, Sweden; Indiana Univ, Dept Biol, Bloomington, IN 47401 USA; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; Chinese Acad Sci, Nanjing Inst Geol & Paleontol, State Key Lab Paleobiol & Strat, Nanjing 210008, Peoples R China; Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	Amherst College; Virginia Polytechnic Institute & State University; University of Bristol; Swedish Museum of Natural History; Indiana University System; Indiana University Bloomington; University of Sydney; Chinese Academy of Geological Sciences; Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Southern California	Hagadorn, JW (corresponding author), Amherst Coll, Dept Geol, Amherst, MA 01002 USA.	jwhagadorn@amherst.edu	Stampanoni, Marco/GRR-9695-2022; Stampanoni, Marco/J-4099-2013; Donoghue, Philip/A-3873-2008; Zhou, Chuanming/E-5313-2010; Xiao, Shuhai/A-2190-2009; Stampanoni, Marco/AAZ-3033-2021	Stampanoni, Marco/0000-0001-7486-6681; Stampanoni, Marco/0000-0001-7486-6681; Donoghue, Philip/0000-0003-3116-7463; Xiao, Shuhai/0000-0003-4655-2663; Stampanoni, Marco/0000-0001-7486-6681; Bengtson, Stefan/0000-0003-0206-5791; Gostling, Neil J./0000-0002-5960-7769	Natural Environment Research Council [NE/C511256/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baer v., 1828, ENTWICKLUNGSGESCHICH; Bartley JK, 1996, PALAIOS, V11, P571, DOI 10.2307/3515192; Bengston S., 2003, P289; Bengtson S, 2004, SCIENCE, V306; Campbell R.D., 1974, P133; Chen J, 2005, DAWN ANIMAL WORLD; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JY, 2006, SCIENCE, V312, P1644, DOI 10.1126/science.1125964; Chen JY, 2004, SCIENCE, V306; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; CHIEN P, 2001, PALEOBIOS S, V21, P41; Donoghue PCJ, 2006, NATURE, V442, P680, DOI 10.1038/nature04890; Dornbos SQ, 2006, PALAIOS, V21, P3, DOI 10.2110/palo.2004.p04-37; Fell P.E., 1974, pUnpaginated; Fell Paul E., 1997, P39; HAGADORN JW, 2001, PALEOBIOS, V21, P60; HAGADORN JW, 2002, GEOLOGICAL SOC AM AB, V34, P169; KNOLL AH, 1975, SCIENCE, V190, P52, DOI 10.1126/science.190.4209.52; KUME K, 1988, INVERTEBRATE EMBRYOL; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; MARTILL DM, 1990, NATURE, V346, P171, DOI 10.1038/346171a0; Morris SC, 1998, CURR OPIN GENET DEV, V8, P662, DOI 10.1016/S0959-437X(98)80034-8; Raff EC, 2006, P NATL ACAD SCI USA, V103, P5846, DOI 10.1073/pnas.0601536103; SCHOPF J W, 1968, Journal of Paleontology, V42, P651; SPERLING EA, IN PRESS J GEOL SOC; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2002, PALEOBIOLOGY, V28, P244, DOI 10.1666/0094-8373(2002)028<0244:MTAMON>2.0.CO;2	30	135	157	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2006	314	5797					291	294		10.1126/science.1133129	http://dx.doi.org/10.1126/science.1133129			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093TV	17038620				2022-12-01	WOS:000241194100039
J	Gale, CR; Deary, IJ; Batty, GD; Schoon, I				Gale, Catharine R.; Deary, Ian J.; Batty, G. David; Schoon, Ingrid			IQ in childhood and vegetarianism in adulthood: 1970 British cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MENTAL SURVEY 1932; MORTALITY; INTELLIGENCE; MIDSPAN; ABILITY; LINKING; HEALTH; DIETS; RISK; LIFE	Objective To examine the relation between IQ in childhood and vegetarianism in adulthood. Design Prospective cohort study in which IQ was assessed by tests of mental ability at age 10 years and vegetarianism by self-report at age 30 years. Setting Great Britain. Participants 8170 men and women aged 30 years participating in the 1970 British cohort study, a national birth cohort. Main outcome measures Self-reported vegetarianism and type of diet followed. Results 366 (4.5%) participants said they were vegetarian, although 123 (33.6%) admitted eating fish or chicken. Vegetarians were more likely to be female, to be of higher social class (both in childhood and currently), and to have attained higher academic or vocational qualifications, although these socioeconomic advantages were not reflected in their income. Higher IQ at age 10 years was associated with an increased likelihood of being vegetarian at age 30 (odds ratio for one standard deviation increase in childhood IQ score 1.38, 95% confidence interval 1.24 to 1.53). IQ remained a statistically significant predictor of being vegetarian as an adult after adjustment for social class (both in childhood and currently), academic or vocational qualifications, and sex (1.20, 1.06 to 1.36). Exclusion of those who said they were vegetarian but ate fish or chicken had little effect on the strength of this association. Conclusion Higher scores for IQ in childhood are associated with an increased likelihood of being a vegetarian as an adult.	Univ Southampton, Med Res Council, Epidemiol Resource Ctr, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; Univ Glasgow, Med Res Council, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; City Univ London, Dept Psychol, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Edinburgh; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Glasgow; City University London	Gale, CR (corresponding author), Univ Southampton, Med Res Council, Epidemiol Resource Ctr, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England.	crg@mrc.soton.ac.uk	Schoon, Ingrid/E-7430-2010; Batty, GD/Y-4401-2018; Schoon, Ingrid/AAC-5715-2019; Deary, Ian J/C-6297-2009; Gale, Catharine R/B-1653-2012	Batty, GD/0000-0003-1822-5753; Schoon, Ingrid/0000-0002-4262-3711; Deary, Ian J/0000-0002-1733-263X; Gale, Catharine/0000-0002-3361-8638	MRC [MC_U130059821] Funding Source: UKRI; Economic and Social Research Council [RES-225-25-2001] Funding Source: researchfish; Medical Research Council [U1475000002] Funding Source: researchfish; Medical Research Council [MC_U130059821] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x; Batty GD, 2004, BMJ-BRIT MED J, V329, P585, DOI 10.1136/bmj.329.7466.585; BATTY GD, 2006, IN PRESS J EPIDEMIOL; CARROLL J, 2006, HUMAN COGNITIVE ABIL; DEARY I, 2006, IN PRESS INTELLIGENC; Elliott C., 1978, BRIT ABILITY SCALES; FRANKLIN B, 1962, AUTOBIOGRAPHY B FRAN; Fu CH, 2006, AM J CARDIOL, V97, P380, DOI 10.1016/j.amjcard.2005.08.057; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Martin LT, 2004, J EPIDEMIOL COMMUN H, V58, P674, DOI 10.1136/jech.2003.016444; Schoon I., 2003, CHANGING BRITAIN CHA; Taylor MD, 2003, J EPIDEMIOL COMMUN H, V57, P464, DOI 10.1136/jech.57.6.464	15	52	52	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2007	334	7587					245	248B		10.1136/bmj.39030.675069.55	http://dx.doi.org/10.1136/bmj.39030.675069.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135SD	17175567	Green Published, Bronze			2022-12-01	WOS:000244172400030
J	Tanaka, S; Umemori, T; Hirai, K; Muramatsu, S; Kamimura, Y; Araki, H				Tanaka, Seiji; Umemori, Toshiko; Hirai, Kazuyuki; Muramatsu, Sachiko; Kamimura, Yoichiro; Araki, Hiroyuki			CDK-dependent phosphorylation of Sld2 and Sld3 initiates DNA replication in budding yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL DNA; RE-REPLICATION; PROTEIN-KINASE; CELL-CYCLE; COMPLEX; GINS; PROGRESSION; INTERACTS; DPB11	In eukaryotic cells, cyclin-dependent kinases (CDKs) have an important involvement at various points in the cell cycle. At the onset of S phase, active CDK is essential for chromosomal DNA replication(1), although its precise role is unknown. In budding yeast ( Saccharomyces cerevisiae), the replication protein Sld2 (ref. 2) is an essential CDK substrate(3), but its phospho-mimetic form (Sld2-11D) alone neither affects cell growth(4) nor promotes DNA replication in the absence of CDK activity(4), suggesting that other essential CDK substrates promote DNA replication. Here we show that both an allele of CDC45 (JET1) and high-copy DPB11, in combination with Sld2-11D, separately confer CDK-independent DNA replication. Although Cdc45 is not an essential CDK substrate, CDK-dependent phosphorylation of Sld3, which associates with Cdc45 ( ref. 5), is essential and generates a binding site for Dpb11. Both the JET1 mutation and high-copy DPB11 by-pass the requirement for Sld3 phosphorylation in DNA replication. Because phosphorylated Sld2 binds to the carboxy-terminal pair of BRCT domains in Dpb11 ( ref. 4), we propose that Dpb11 connects phosphorylated Sld2 and Sld3 to facilitate interactions between replication proteins, such as Cdc45 and GINS. Our results demonstrate that CDKs regulate interactions between BRCT-domain-containing replication proteins and other phosphorylated proteins for the initiation of chromosomal DNA replication; similar regulation may take place in higher eukaryotes.	Res Org Informat & Syst, Natl Inst Genet, Div Microbial Genet, Shizuoka 4118540, Japan; SOKENDAI, Dept Genet, Shizuoka 4118540, Japan; CREST, Kawaguchi, Saitama 3320012, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST)	Araki, H (corresponding author), Res Org Informat & Syst, Natl Inst Genet, Div Microbial Genet, Yata 1111 Mishima, Shizuoka 4118540, Japan.	hiaraki@lab.nig.ac.jp	Tanaka, Seiji/Q-8601-2019; Kamimura, Yoichiro/M-2585-2017	Tanaka, Seiji/0000-0003-3882-3494; Hirai, Kazuyuki/0000-0003-1640-3667				ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Schwob Etienne, 2006, V47, P295; Sivaprasad Umasundari, 2006, V47, P63; Tak YS, 2006, EMBO J, V25, P1987, DOI 10.1038/sj.emboj.7601075; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Walter Johannes C., 2006, V47, P89; ZEGERMAN P, 2006, NATURE          1213, DOI DOI 10.1038/NATURE05432	29	335	337	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2007	445	7125					328	332		10.1038/nature05465	http://dx.doi.org/10.1038/nature05465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	126HT	17167415				2022-12-01	WOS:000243504700048
J	Wetzel, C; Hu, J; Riethmacher, D; Benckendorff, A; Harder, L; Eilers, A; Moshourab, R; Kozlenkov, A; Labuz, D; Caspani, O; Erdmann, B; Machelska, H; Heppenstall, PA; Lewin, GR				Wetzel, Christiane; Hu, Jing; Riethmacher, Dieter; Benckendorff, Anne; Harder, Lena; Eilers, Andreas; Moshourab, Rabih; Kozlenkov, Alexey; Labuz, Dominika; Caspani, Ombretta; Erdmann, Bettina; Machelska, Halina; Heppenstall, Paul A.; Lewin, Gary R.			A stomatin-domain protein essential for touch sensation in the mouse	NATURE			English	Article							SENSING ION CHANNELS; SENSORY NEURONS; C-ELEGANS; MEMBRANE-PROTEIN; RECEPTOR NEURONS; MECHANOSENSATION; PAIN; RAT; MECHANORECEPTOR; LOCALIZATION	Touch and mechanical pain are first detected at our largest sensory surface, the skin. The cell bodies of sensory neurons that detect such stimuli are located in the dorsal root ganglia, and subtypes of these neurons are specialized to detect specific modalities of mechanical stimuli. Molecules have been identified that are necessary for mechanosensation in invertebrates but so far not in mammals. In Caenorhabditis elegans, mec-2 is one of several genes identified in a screen for touch insensitivity and encodes an integral membrane protein with a stomatin homology domain(1). Here we show that about 35% of skin mechanoreceptors do not respond to mechanical stimuli in mice with a mutation in stomatin-like protein 3 (SLP3, also called Stoml3), a mammalian mec-2 homologue that is expressed in sensory neurons. In addition, mechanosensitive ion channels found in many sensory neurons do not function without SLP3. Tactile-driven behaviours are also impaired in SLP3 mutant mice, including touch-evoked pain caused by neuropathic injury. SLP3 is therefore indispensable for the function of a subset of cutaneous mechanoreceptors, and our data support the idea that this protein is an essential subunit of a mammalian mechanotransducer.	Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany; Charite Univ Med Berlin, D-13125 Berlin, Germany; Univ Hamburg, Zentrum Mol Neurobiol, D-20251 Hamburg, Germany; Charite Univ Med Berlin, Klin Anaesthesiol & Operat Med, D-12200 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lewin, GR (corresponding author), Max Delbruck Ctr Mol Med, Dept Neurosci, Robert Rossle Str 10, D-13125 Berlin, Germany.	glewin@mdc-berlin.de	Riethmacher, Dieter/AAB-8690-2022; Riethmacher, Dieter/A-6242-2010; Lewin, Gary R/B-8028-2011; Riethmacher, Dieter/AAP-2227-2021; Hu, Jing/G-2092-2011	Riethmacher, Dieter/0000-0002-4206-5529; moshourab, rabih/0000-0002-9180-8472; Machelska, Halina/0000-0001-6315-2958; Caspani, Ombretta/0000-0002-9700-3149; Wetzel, Christiane/0000-0003-0587-8018; Lewin, Gary/0000-0002-2890-6352				Brockschnieder D, 2004, MOL CELL BIOL, V24, P7636, DOI 10.1128/MCB.24.17.7636-7642.2004; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Fricke B, 2003, ANAT EMBRYOL, V207, P1, DOI 10.1007/s00429-003-0324-7; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; LEWIN GR, 1991, J NEUROPHYSIOL, V66, P1205, DOI 10.1152/jn.1991.66.4.1205; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Manni A, 2004, SOIL SEDIMENT CONTAM, V13, P391, DOI 10.1080/10588330490466003; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Shin JB, 2003, NAT NEUROSCI, V6, P724, DOI 10.1038/nn1076; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2	29	175	184	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2007	445	7124					206	209		10.1038/nature05394	http://dx.doi.org/10.1038/nature05394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17167420				2022-12-01	WOS:000243384300051
J	Sandall, S; Severin, F; McLeod, IX; Yates, JR; Oegema, K; Hyman, A; Desai, A				Sandall, Sharsti; Severin, Fedor; McLeod, Ian X.; Yates, John R., III; Oegema, Karen; Hyman, Anthony; Desai, Arshad			A Bir1-Sli15 complex connects centromeres to microtubules and is required to sense kinetochore tension	CELL			English	Article							CHROMOSOME SEGREGATION; BUDDING YEAST; AURORA-B; PROTEIN-KINASE; SPINDLE CHECKPOINT; CELL-DIVISION; SACCHAROMYCES-CEREVISIAE; APOPTOSIS FAMILY; CLEAVAGE FURROW; INCENP BINDS	Proper connections between centromeres and spindle microtubules are of critical importance in ensuring accurate segregation of the genome during cell division. Using an in vitro approach based on the sequence-specific budding yeast centromere, we identified a complex of the chromosomal passenger proteins Bir1 and Sli15 (Survivin and INCENP) that links centromeres to microtubules. This linkage does not require Ipl1/Aurora B kinase, whose targeting and activation are controlled by Bir1 and Sli15. Ipl1 is the tension-dependent regulator of centromere-microtubule interactions that ensures chromosome biorientation on the spindle. Elimination of the linkage between centromeres and microtubules mediated by Bir1-Sli15 phenocopies mutations that selectively cripple Ipl1 kinase activation. These findings lead us to propose that the Bir1-Sli15-mediated linkage, which bridges centromeres and microtubules and includes the Aurora kinase-activating domain of INCENP family proteins, is the tension sensor that relays the mechanical state of centromere-microtubule attachments into local control of Ipl1 kinase activity.	Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; Scripps Research Institute	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, CMM E Room 3052,9500 Gilman Dr, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Severin, Fedor/AAD-5444-2019; Hyman, Tony/F-1923-2011	Severin, Fedor/0000-0001-6703-1256	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR11823, P41 RR011823] Funding Source: Medline; NIGMS NIH HHS [R01 GM074215, R01 GM074215-02, R01 GM074215-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Biggins S, 2003, CURR BIOL, V13, pR449, DOI 10.1016/S0960-9822(03)00369-5; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Clarke L, 1998, CURR OPIN GENET DEV, V8, P212, DOI 10.1016/S0959-437X(98)80143-3; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gillis AN, 2005, J CELL BIOL, V171, P773, DOI 10.1083/jcb.200507017; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HYMAN AA, 1992, NATURE, V359, P533, DOI 10.1038/359533a0; Indjeian VB, 2005, SCIENCE, V307, P130, DOI 10.1126/science.1101366; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; KINGSBURY J, 1991, CELL, V66, P483, DOI 10.1016/0092-8674(81)90012-X; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; NICKLAS RB, 1969, J CELL BIOL, V43, P40, DOI 10.1083/jcb.43.1.40; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Severin F, 1999, METHOD CELL BIOL, V61, P145; Severin FF, 1997, NATURE, V388, P888, DOI 10.1038/42270; SORGER PK, 1994, J CELL BIOL, V127, P995, DOI 10.1083/jcb.127.4.995; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Stoepel J, 2005, MOL BIOL CELL, V16, P5465, DOI 10.1091/mbc.E05-04-0337; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wheatley SP, 2001, EXP CELL RES, V262, P122, DOI 10.1006/excr.2000.5088; Widlund PO, 2006, MOL BIOL CELL, V17, P1065, DOI 10.1091/mbc.E05-07-0640; Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208	56	100	108	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1179	1191		10.1016/j.cell.2006.09.049	http://dx.doi.org/10.1016/j.cell.2006.09.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17174893	Green Accepted, Bronze			2022-12-01	WOS:000242991000016
J	Sandford, SA; Aleon, J; Alexander, CMO; Araki, T; Bajt, S; Baratta, GA; Borg, J; Bradley, JP; Brownlee, DE; Brucato, JR; Burchell, MJ; Busemann, H; Butterworth, A; Clemett, SJ; Cody, G; Colangeli, L; Cooper, G; D'Hendecourt, L; Djouadi, Z; Dworkin, JP; Ferrini, G; Fleckenstein, H; Flynn, GJ; Franchi, IA; Fries, M; Gilles, MK; Glavin, DP; Gounelle, M; Grossemy, F; Jacobsen, C; Keller, LP; Kilcoyne, ALD; Leitner, J; Matrajt, G; Meibom, A; Mennella, V; Mostefaoui, S; Nittler, LR; Palumbo, ME; Papanastassiou, DA; Robert, F; Rotundi, A; Snead, CJ; Spencer, MK; Stadermann, FJ; Steele, A; Stephan, T; Tsou, P; Tyliszczak, T; Westphal, AJ; Wirick, S; Wopenka, B; Yabuta, H; Zare, RN; Zolensky, ME				Sandford, Scott A.; Aleon, Jerome; Alexander, Conel M. O'D.; Araki, Tohru; Bajt, Sasa; Baratta, Giuseppe A.; Borg, Janet; Bradley, John P.; Brownlee, Donald E.; Brucato, John R.; Burchell, Mark J.; Busemann, Henner; Butterworth, Anna; Clemett, Simon J.; Cody, George; Colangeli, Luigi; Cooper, George; D'Hendecourt, Louis; Djouadi, Zahia; Dworkin, Jason P.; Ferrini, Gianluca; Fleckenstein, Holger; Flynn, George J.; Franchi, Ian A.; Fries, Marc; Gilles, Mary K.; Glavin, Daniel P.; Gounelle, Matthieu; Grossemy, Faustine; Jacobsen, Chris; Keller, Lindsay P.; Kilcoyne, A. L. David; Leitner, Jan; Matrajt, Graciela; Meibom, Anders; Mennella, Vito; Mostefaoui, Smail; Nittler, Larry R.; Palumbo, Maria E.; Papanastassiou, Dimitri A.; Robert, Francois; Rotundi, Alessandra; Snead, Christopher J.; Spencer, Maegan K.; Stadermann, Frank J.; Steele, Andrew; Stephan, Thomas; Tsou, Peter; Tyliszczak, Tolek; Westphal, Andrew J.; Wirick, Sue; Wopenka, Brigitte; Yabuta, Hikaru; Zare, Richard N.; Zolensky, Michael E.			Organics captured from comet 81P/Wild 2 by the Stardust spacecraft	SCIENCE			English	Article							RAMAN-SPECTROSCOPY; INTERSTELLAR; DUST; IDENTIFICATION; MOLECULES; MATTER; IDPS	Organics found in comet 81P/ Wild 2 samples show a heterogeneous and unequilibrated distribution in abundance and composition. Some organics are similar, but not identical, to those in interplanetary dust particles and carbonaceous meteorites. A class of aromatic-poor organic material is also present. The organics are rich in oxygen and nitrogen compared with meteoritic organics. Aromatic compounds are present, but the samples tend to be relatively poorer in aromatics than are meteorites and interplanetary dust particles. The presence of deuterium and nitrogen-15 excesses suggest that some organics have an interstellar/ protostellar heritage. Although the variable extent of modification of these materials by impact capture is not yet fully constrained, a diverse suite of organic compounds is present and identifiable within the returned samples.	NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA; Lawrence Livermore Natl Lab, Glenn I Seaborg Inst, Livermore, CA 94550 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Ctr Rech Petrog & Geochim, F-54501 Vandoeuvre Les Nancy, France; N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; Lawrence Livermore Natl Lab, Inst Geophys & Planetary Phys, Livermore, CA 94550 USA; Inst Astrophys Spatiale, F-91405 Orsay, France; Osserv Astrofis Catania, Ist Nazl Astrofis, I-95123 Catania, Italy; Univ Washington, Dept Astron, Seattle, WA 98195 USA; Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; Univ Kent, Sch Phys Sci, Canterbury CT2 7NH, Kent, England; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; NASA, Lyndon B Johnson Space Ctr, Expense Reduct Consulting Inc, Houston, TX 77058 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA; NASA, Goddard Space Flight Ctr, Goddard Ctr Astrobiol, Greenbelt, MD 20771 USA; SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Calif Berkeley, Div Chem Sci, Berkeley, CA 94720 USA; Museum Natl Hist Nat, Lab Etud Mat Extraterr, Paris, France; Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; Univ Munster, Inst Planetol, D-48149 Munster, Germany; CALTECH, Jet Prop Lab, Div Sci, Pasadena, CA 91109 USA; Univ Naples Parthenope, Dipartimento Sci Applicate, I-80133 Naples, Italy; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Washington Univ, Dept Phys, St Louis, MO 63130 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Carnegie Institution for Science; Universite de Lorraine; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Istituto Nazionale Astrofisica (INAF); University of Washington; University of Washington Seattle; Istituto Nazionale Astrofisica (INAF); University of Kent; University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Plattsburgh; Open University - UK; University of California System; University of California Berkeley; Museum National d'Histoire Naturelle (MNHN); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Munster; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Parthenope University Naples; Stanford University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sandford, SA (corresponding author), NASA, Ames Res Ctr, Astrophys Branch, Moffett Field, CA 94035 USA.	ssandford@mail.arc.nasa.gov	Bajt, Sasa/O-4695-2019; Stephan, Thomas/C-1023-2008; Glavin, Daniel P/D-6194-2012; Yabuta, Hikaru/M-9041-2014; Matrajt, Graciela/A-4812-2017; 1.4, ALS Beamline/I-1886-2014; Bajt, Sasa/G-2228-2010; Steele, Andrew/A-3573-2013; Jacobsen, Chris Johnson/E-2827-2015; Zare, Richard N./A-8410-2009; Yabuta, Hikaru/S-2662-2018; Baratta, Giuseppe/AAY-6188-2021; Alexander, Conel M. O'D./N-7533-2013; Appourchaux, Thierry/F-4692-2010; Dworkin, Jason P./C-9417-2012; Kilcoyne, Arthur A L/I-1465-2013; Leitner, Jan/A-7391-2015; Araki, Tohru/K-9301-2015	Bajt, Sasa/0000-0002-7163-7602; Stephan, Thomas/0000-0001-6377-8731; Glavin, Daniel P/0000-0001-7779-7765; Yabuta, Hikaru/0000-0002-4625-5362; Steele, Andrew/0000-0001-9643-2841; Jacobsen, Chris Johnson/0000-0001-8562-0353; Alexander, Conel M. O'D./0000-0002-8558-1427; Dworkin, Jason P./0000-0002-3961-8997; Kilcoyne, Arthur A L/0000-0002-8805-8690; Leitner, Jan/0000-0003-3655-6273; Araki, Tohru/0000-0002-2689-4642; Zare, Richard/0000-0001-5266-4253; Rotundi, Alessandra/0000-0001-5467-157X; Colangeli, Luigi/0000-0001-6801-9152; Zolensky, Michael/0000-0002-3181-1303; Busemann, Henner/0000-0002-0867-6908; Palumbo, MariaElisabetta/0000-0002-9122-491X; Butterworth, Anna/0000-0002-6439-1472; Burchell, Mark/0000-0002-2680-8943; Brucato, John Robert/0000-0002-4738-5521; Meibom, Anders/0000-0002-4542-2819; Baratta, Giuseppe/0000-0002-3688-160X; Mennella, Vito/0000-0001-9525-895X				Aleon J, 2004, ICARUS, V167, P424, DOI 10.1016/j.icarus.2003.10.012; Baratta GA, 2004, J RAMAN SPECTROSC, V35, P487, DOI 10.1002/jrs.1169; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Bonal L, 2006, GEOCHIM COSMOCHIM AC, V70, P1849, DOI 10.1016/j.gca.2005.12.004; Brownlee DE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002087; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CLEMETT SJ, 1993, SCIENCE, V262, P721, DOI 10.1126/science.262.5134.721; DELSEMME AH, 1992, ADV SPACE RES-SERIES, V12, P5, DOI 10.1016/0273-1177(92)90147-P; Festou C.M., 2004, COMETS 2; FLYNN GJ, 2006, IPAP C SERIES, V7, P315; Glavin DP, 2006, METEORIT PLANET SCI, V41, P889, DOI 10.1111/j.1945-5100.2006.tb00493.x; Keller LP, 2006, SCIENCE, V314, P1728, DOI 10.1126/science.1135796; KISSEL J, 1987, NATURE, V326, P755, DOI 10.1038/326755a0; Kissel J, 2004, SCIENCE, V304, P1774, DOI 10.1126/science.1098836; Matrajt G, 2005, ASTRON ASTROPHYS, V433, P979, DOI 10.1051/0004-6361:20041605; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; MUMMA MJ, 1993, PROTOSTARS PLANETS, V3, P1171; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Quirico E, 2005, PLANET SPACE SCI, V53, P1443, DOI 10.1016/j.pss.2005.07.009; SANDFORD SA, 1991, ASTROPHYS J, V371, P607, DOI 10.1086/169925; SCHUTTE WA, 1993, ICARUS, V104, P118, DOI 10.1006/icar.1993.1087; Strazzulla G, 2001, SPECTROCHIM ACTA A, V57, P825, DOI 10.1016/S1386-1425(00)00447-9; Strazzulla G, 1999, SPACE SCI REV, V90, P269, DOI 10.1023/A:1005270703284; WOPENKA B, 1993, AM MINERAL, V78, P533; WOPENKA B, 1988, EARTH PLANET SC LETT, V88, P221, DOI 10.1016/0012-821X(88)90079-9; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	29	458	465	0	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2006	314	5806					1720	1724		10.1126/science.1135841	http://dx.doi.org/10.1126/science.1135841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116WD	17170291				2022-12-01	WOS:000242833600043
J	Wu, SM; Fujiwara, Y; Cibulsky, SM; Clapham, DE; Lien, CL; Schultheiss, TM; Orkin, SH				Wu, Sean M.; Fujiwara, Yuko; Cibulsky, Susan M.; Clapham, David E.; Lien, Ching-ling; Schultheiss, Thomas M.; Orkin, Stuart H.			Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart	CELL			English	Article							CARDIAC NEURAL CREST; CARDIOVASCULAR-SYSTEM; PROGENITOR CELLS; OUTFLOW TRACT; STEM-CELLS; NKX2-5; DIFFERENTIATION; TRANSCRIPTION; EXPRESSION; EMBRYOS	Despite recent advances in delineating the mechanisms involved in cardiogenesis, cellular lineage specification remains incompletely understood. To explore the relationship between developmental fate and potential, we isolated a cardiac-specific Nkx2.5(+) cell population from the developing mouse embryo. The majority of these cells differentiated into cardiomyocytes and conduction system cells. Some, surprisingly, adopted a smooth muscle fate. To address the clonal origin of these lineages, we isolated Nkx2.5+ cells from in vitro differentiated murine embryonic stem cells and found similar to 28% of these cells expressed c-kit. These c-kit(+) cells possessed the capacity for long-term in vitro expansion and differentiation into both cardiomyocytes and smooth muscle cells from a single cell. We confirmed these findings by isolating c-kit(+)Nkx2.5(+) cells from mouse embryos and demonstrated their capacity for bipotential differentiation in vivo. Taken together, these results support the existence of a common precursor for cardiovascular lineages in the mammalian heart.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Childrens Hosp Los Angeles, Saban Res Inst, Dept Cardiothorac Surg, Los Angeles, CA 90027 USA; Univ So Calif, Keck Sch Med, Los Angeles, CA 90027 USA; Beth Israel Deaconess Med Ctr, Dept Mol & Vasc Med, Boston, MA 02114 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Children's Hospital Los Angeles; University of Southern California; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	orkin@bloodgroup.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428; Wu, Sean/0000-0002-0000-3821	NHLBI NIH HHS [K08 HL081086, T32 HL007572, T32 HL002807] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL081086] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; COFFIN JD, 1988, DEVELOPMENT, V102, P735; CohenGould L, 1996, DEV BIOL, V177, P265, DOI 10.1006/dbio.1996.0161; EISENBERG CA, 1995, DEV BIOL, V167, P469, DOI 10.1006/dbio.1995.1042; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; GARCIAMARTINEZ V, 1993, DEV BIOL, V159, P706, DOI 10.1006/dbio.1993.1276; GOURDIE RG, 1995, DEVELOPMENT, V121, P1423; HATADA Y, 1994, DEVELOPMENT, V120, P2879; Hungerford JE, 1996, DEV BIOL, V178, P375, DOI 10.1006/dbio.1996.0225; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jain MK, 1998, CIRC RES, V83, P980, DOI 10.1161/01.RES.83.10.980; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Le Lievre C S, 1975, J Embryol Exp Morphol, V34, P125; Li L, 1996, CIRC RES, V78, P188, DOI 10.1161/01.RES.78.2.188; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Lien CL, 1999, DEVELOPMENT, V126, P75; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; ROSENQUIST GLENN C., 1966, CARNEGIE INST WASH PUBL, V38, P111; Samaha FF, 1996, J BIOL CHEM, V271, P395, DOI 10.1074/jbc.271.1.395; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stanley EG, 2002, INT J DEV BIOL, V46, P431; STAVROS T, 1996, DEV BIOL, V178, P430; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Tirosh-Finkel L, 2006, DEVELOPMENT, V133, P1943, DOI 10.1242/dev.02365; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; WALDO KL, 1993, ANAT RECORD, V237, P385, DOI 10.1002/ar.1092370312; WOBUS AM, 1991, DIFFERENTIATION, V48, P173, DOI 10.1111/j.1432-0436.1991.tb00255.x	39	400	422	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 15	2006	127	6					1137	1150		10.1016/j.cell.2006.10.028	http://dx.doi.org/10.1016/j.cell.2006.10.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	119CY	17123591	Bronze			2022-12-01	WOS:000242991000013
J	Biondi, EG; Reisinger, SJ; Skerker, JM; Arif, M; Perchuk, BS; Ryan, KR; Laub, MT				Biondi, Emanuele G.; Reisinger, Sarah J.; Skerker, Jeffrey M.; Arif, Muhammad; Perchuk, Barrett S.; Ryan, Kathleen R.; Laub, Michael T.			Regulation of the bacterial cell cycle by an integrated genetic circuit	NATURE			English	Article							DNA-REPLICATION; HISTIDINE KINASE; POLAR LOCALIZATION; PROTEIN; PROGRESSION; DIVISION; CTRA	How bacteria regulate cell cycle progression at a molecular level is a fundamental but poorly understood problem. In Caulobacter crescentus, two-component signal transduction proteins are crucial for cell cycle regulation, but the connectivity of regulators involved has remained elusive and key factors are unidentified. Here we identify ChpT, an essential histidine phosphotransferase that controls the activity of CtrA, the master cell cycle regulator. We show that the essential histidine kinase CckA initiates two phosphorelays, each requiring ChpT, which lead to the phosphorylation and stabilization of CtrA. Downregulation of CckA activity therefore results in the dephosphorylation and degradation of CtrA, which in turn allow the initiation of DNA replication. Furthermore, we show that CtrA triggers its own destruction by promoting cell division and inducing synthesis of the essential regulator DivK, which feeds back to downregulate CckA immediately before S phase. Our results define a single integrated circuit whose components and connectivity can account for the cell cycle oscillations of CtrA in Caulobacter.	Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Harvard University; University of California System; University of California Berkeley	Laub, MT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	laub@mit.edu		Laub, Michael/0000-0002-8288-7607				Biondi EG, 2006, MOL MICROBIOL, V59, P386, DOI 10.1111/j.1365-2958.2005.04970.x; Collier J, 2006, EMBO J, V25, P346, DOI 10.1038/sj.emboj.7600927; Cross FR, 2003, DEV CELL, V4, P741, DOI 10.1016/S1534-5807(03)00119-9; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Holtzendorff J, 2006, BIOESSAYS, V28, P355, DOI 10.1002/bies.20384; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103; Jacobs C, 2003, MOL MICROBIOL, V47, P1279, DOI 10.1046/j.1365-2958.2003.03379.x; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; Ohta N, 2000, PROKARYOTIC DEVELOPMENT, P341; Pierce DL, 2006, J BACTERIOL, V188, P2473, DOI 10.1128/JB.188.7.2473-2482.2006; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Sciochetti SA, 2002, J BACTERIOL, V184, P6037, DOI 10.1128/JB.184.21.6037-6049.2002; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Wang Y, 2001, MOL MICROBIOL, V40, P347, DOI 10.1046/j.1365-2958.2001.02395.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wortinger M, 2000, EMBO J, V19, P4503, DOI 10.1093/emboj/19.17.4503; Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443	34	197	199	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					899	904		10.1038/nature05321	http://dx.doi.org/10.1038/nature05321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17136100				2022-12-01	WOS:000242805400049
J	Colgrove, J				Colgrove, James			The ethics and politics of compulsory HPV vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10012 USA	Columbia University	Colgrove, J (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, Ctr Hist & Eth Publ Hlth, New York, NY 10012 USA.							COLGROVE JK, 2006, STATE IMMUNITY PLITI; Lo B, 2006, BMJ-BRIT MED J, V332, P1106, DOI 10.1136/bmj.332.7550.1106; Salmon DA, 2006, LANCET, V367, P436, DOI 10.1016/S0140-6736(06)68144-0; Temte JL, 2006, BMJ-BRIT MED J, V332, P715, DOI 10.1136/bmj.332.7543.715; Zimmerman RK, 2006, VACCINE, V24, P4812, DOI 10.1016/j.vaccine.2006.03.019	5	116	122	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2006	355	23					2389	2391		10.1056/NEJMp068248	http://dx.doi.org/10.1056/NEJMp068248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	113EO	17151362	Green Submitted			2022-12-01	WOS:000242581400001
J	Amazigo, U; Boatin, B				Amazigo, Uche; Boatin, Boakye			The future of onchocerciasis control in Africa	LANCET			English	Editorial Material									WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland; WHO African Programme Onchocerciasis Control, Ouagadougou, Burkina Faso	World Health Organization	Amazigo, U (corresponding author), WHO African Programme Onchocerciasis Control, Ouagadougou, Burkina Faso.	amazigouv@oncho.oms.bf						Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; *WHO, 2002, SUCC AFR ONCH CONTR; *WHO AFR PROGR ONC, 2006, STRAT OV FUT ONCH CO; *WHO AFR PROGR ONC, 2006, PARTN M FUT ONCH CON; *WHO AFR PROGR ONC, 2001, PROGR DOC PHAS 2 200	5	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2006	368	9551					1946	1947		10.1016/S0140-6736(06)69786-9	http://dx.doi.org/10.1016/S0140-6736(06)69786-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	113JD	17141687				2022-12-01	WOS:000242593300008
J	von Bubnoff, A				von Bubnoff, Andreas			Seeking new antibiotics in nature's backyard	CELL			English	Editorial Material																			0	12	12	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 1	2006	127	5					867	869		10.1016/j.cell.2006.11.021	http://dx.doi.org/10.1016/j.cell.2006.11.021			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	113RA	17129770	Bronze			2022-12-01	WOS:000242613800001
J	Sigal, A; Milo, R; Cohen, A; Geva-Zatorsky, N; Klein, Y; Liron, Y; Rosenfeld, N; Danon, T; Perzov, N; Alon, U				Sigal, Alex; Milo, Ron; Cohen, Ariel; Geva-Zatorsky, Naama; Klein, Yael; Liron, Yuvalal; Rosenfeld, Nitzan; Danon, Tamar; Perzov, Natalie; Alon, Uri			Variability and memory of protein levels in human cells	NATURE			English	Article							NOISE-PROPAGATION; GENE-EXPRESSION; STOCHASTICITY; PROTEOMICS; LOCI	Protein expression is a stochastic process that leads to phenotypic variation among cells(1-6). The cell - cell distribution of protein levels in microorganisms has been well characterized(7-23) but little is known about such variability in human cells. Here, we studied the variability of protein levels in human cells, as well as the temporal dynamics of this variability, and addressed whether cells with higher than average protein levels eventually have lower than average levels, and if so, over what timescale does this mixing occur. We measured fluctuations over time in the levels of 20 endogenous proteins in living human cells, tagged by the gene for yellow fluorescent protein at their chromosomal loci(24). We found variability with a standard deviation that ranged, for different proteins, from about 15% to 30% of the mean. Mixing between high and low levels occurred for all proteins, but the mixing time was longer than two cell generations ( more than 40 h) for many proteins. We also tagged pairs of proteins with two colours, and found that the levels of proteins in the same biological pathway were far more correlated than those of proteins in different pathways. The persistent memory for protein levels that we found might underlie individuality in cell behaviour and could set a timescale needed for signals to affect fully every member of a cell population.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	Sigal, Alex/GWC-7488-2022; Geva-Zatorsky, Naama/AAP-9176-2021; Milo, Hilla/C-8767-2016	Sigal, Alex/0000-0001-8571-2004; Geva-Zatorsky, Naama/0000-0002-7303-854X; Milo, Ron/0000-0003-1641-2299				Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Alon U, 2006, INTRO SYSTEMS BIOL D; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Clyne PJ, 2003, GENETICS, V165, P1433; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Jarvik JW, 2002, BIOTECHNIQUES, V33, P852, DOI 10.2144/02334rr02; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281	29	396	404	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					643	646		10.1038/nature05316	http://dx.doi.org/10.1038/nature05316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17122776				2022-12-01	WOS:000242377600053
J	Kim, YG; Raunser, S; Munger, C; Wagner, J; Song, YL; Cygler, M; Walz, T; Oh, BH; Sacher, M				Kim, Yeon-Gil; Raunser, Stefan; Munger, Christine; Wagner, John; Song, Young-Lan; Cygler, Miroslaw; Walz, Thomas; Oh, Byung-Ha; Sacher, Michael			The architecture of the multisubunit TRAPP I complex suggests a model for vesicle tethering	CELL			English	Article							CRYSTAL-STRUCTURE; CIS-GOLGI; MEMBRANE; IDENTIFICATION; RECEPTOR; BET3; MECHANISM; TRANSPORT; SUBUNITS; REVEALS	Transport protein particle (TRAPP) 1 is a multi-subunit vesicle tethering factor composed of seven subunits involved in ER-to-Golgi trafficking. The functional mechanism of the complex and how the subunits interact to form a functional unit are unknown. Here, we have used a multidisciplinary approach that includes X-ray crystallography, electron microscopy, biochemistry, and yeast genetics to elucidate the architecture of TRAPP 1. The complex is organized through lateral juxtaposition of the subunits into a flat and elongated particle. We have also localized the site of guanine nucleotide exchange activity to a highly conserved surface encompassing several subunits. We propose that TRAPP 1 attaches to Golgi membranes with its large flat surface containing many highly conserved residues and forms a platform for protein-protein interactions. This study provides the most comprehensive view of a multisubunit vesicle tethering complex to date, based on which a model for the function of this complex, involving Rab1-GTP and long, coiled-coil tethers, is presented.	Pohang Univ Sci & Technol, Ctr Biomol Recognit, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea; Pohang Univ Sci & Technol, Div Mol & Life Sci, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Harvard University; Harvard Medical School; McGill University; National Research Council Canada; Concordia University - Canada	Oh, BH (corresponding author), Pohang Univ Sci & Technol, Ctr Biomol Recognit, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea.	bhoh@postech.ac.kr; msacher@alcor.concordia.ca	Raunser, Stefan/AHE-1573-2022; Oh, Byung-Ha/C-2061-2011	Raunser, Stefan/0000-0001-9373-3016; Walz, Thomas/0000-0003-2606-2835	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62580] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cheng YF, 2006, J MOL BIOL, V355, P1048, DOI 10.1016/j.jmb.2005.11.021; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; Jiang Y, 1998, GENETICS, V149, P833; Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403; Kim MS, 2005, TRAFFIC, V6, P1183, DOI 10.1111/j.1600-0854.2005.00352.x; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; Lowe M, 2000, CURR BIOL, V10, pR407, DOI 10.1016/S0960-9822(00)00505-4; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pfeffer SR, 1996, ANNU REV CELL DEV BI, V12, P441, DOI 10.1146/annurev.cellbio.12.1.441; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Valsdottir R, 2001, FEBS LETT, V508, P201, DOI 10.1016/S0014-5793(01)02993-3; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Waters MG, 2000, TRAFFIC, V1, P588, DOI 10.1034/j.1600-0854.2000.010802.x; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Whyte JRC, 2002, J CELL SCI, V115, P2627	37	141	148	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 17	2006	127	4					817	830		10.1016/j.cell.2006.09.029	http://dx.doi.org/10.1016/j.cell.2006.09.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	109TB	17110339	Bronze			2022-12-01	WOS:000242330600026
J	Gale, EAM				Gale, Edwin A. M.			Dying of diabetes	LANCET			English	Editorial Material									Univ Bristol, Southmead Hosp, Dept Clin Sci, Bristol BS10 5NB, Avon, England	Southmead Hospital; University of Bristol	Gale, EAM (corresponding author), Univ Bristol, Southmead Hosp, Dept Clin Sci, Bristol BS10 5NB, Avon, England.	Edwin.Gale@bristol.ac.uk						[Anonymous], 2006, BRIT NATL FORMULARY; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Hauber A, 2006, DIABETOLOGIA, V49, P247, DOI 10.1007/s00125-005-0108-0; McKee RL, 2001, PEOPLE EYE STORIES D, V1st; *NOV NORD, 2005, NOV NORD ANN REP FIN; Pendsey S., 1998, DIABETES VOICE, V11, P4; Piette JD, 2004, DIABETES CARE, V27, P384, DOI 10.2337/diacare.27.2.384; 2006, STATES PETITION FDA	8	26	28	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 11	2006	368	9548					1626	1628		10.1016/S0140-6736(06)69672-4	http://dx.doi.org/10.1016/S0140-6736(06)69672-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	106KI	17098062				2022-12-01	WOS:000242099000005
J	Hornung, V; Ellegast, J; Kim, S; Brzozka, K; Jung, A; Kato, H; Poeck, H; Akira, S; Conzelmann, KK; Schlee, M; Endres, S; Hartmann, G				Hornung, Veit; Ellegast, Jana; Kim, Sarah; Brzozka, Krzysztof; Jung, Andreas; Kato, Hiroki; Poeck, Hendrik; Akira, Shizuo; Conzelmann, Karl-Klaus; Schlee, Martin; Endres, Stefan; Hartmann, Gunther			5 '-triphosphate RNA is the ligand for RIG-I	SCIENCE			English	Article							PLASMACYTOID DENDRITIC CELLS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; ACTIVATION; INDUCTION; ACID; POLYADENYLATION; REPLICATION; RECOGNITION; RESPONSES	The structural basis for the distinction of viral RNA from abundant self RNA in the cytoplasm of virally infected cells is largely unknown. We demonstrated that the 5'-triphosphate end of RNA generated by viral polymerases is responsible for retinoic acid - inducible protein I (RIG-I) mediated detection of RNA molecules. Detection of 5'-triphosphate RNA is abrogated by capping of the 5'-triphosphate end or by nucleoside modification of RNA, both occurring during posttranscriptional RNA processing in eukaryotes. Genomic RNA prepared from a negative-strand RNA virus and RNA prepared from virus-infected cells ( but not from noninfected cells) triggered a potent interferon-alpha response in a phosphatase-sensitive manner. 5'-triphosphate RNA directly binds to RIG-I. Thus, uncapped 5'-triphosphate RNA ( now termed 3pRNA) present in viruses known to be recognized by RIG-I, but absent in viruses known to be detected by MDA-5 such as the picornaviruses, serves as the molecular signature for the detection of viral infection by RIG-I.	Univ Bonn, Univ Hosp, Div Clin Pharmacol, D-53105 Bonn, Germany; Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80336 Munich, Germany; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; Univ Munich, Max von Pettenkofer Inst, Dept Virol, D-81377 Munich, Germany; Univ Munich, Gene Ctr, D-81377 Munich, Germany	University of Bonn; University of Munich; Osaka University; University of Munich; University of Munich	Hartmann, G (corresponding author), Univ Bonn, Univ Hosp, Div Clin Pharmacol, D-53105 Bonn, Germany.	gunther.hartmann@ukb.uni-bonn.de	Hornung, Veit/C-3565-2012; Conzelmann, Karl-Klaus/L-7239-2013; Schlee, Martin/AAL-1238-2021; Hartmann, Gunther/P-7492-2017; Akira, Shizuo/C-3134-2009; Kim-Hellmuth, Sarah/AAF-4911-2021	Hornung, Veit/0000-0002-4150-194X; Hartmann, Gunther/0000-0003-1021-2018; Kim-Hellmuth, Sarah/0000-0001-8791-5729; Brzozka, Krzysztof/0000-0001-7563-6482; Schlee, Martin/0000-0003-3671-7639; Conzelmann, Karl-Klaus/0000-0002-8614-3656; Ellegast, Jana/0000-0003-4201-4227				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Brzozka K, 2006, J VIROL, V80, P2675, DOI 10.1128/JVI.80.6.2675-2683.2006; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; LEE YF, 1977, P NATL ACAD SCI USA, V74, P59, DOI 10.1073/pnas.74.1.59; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; SINGH R, 1989, P NATL ACAD SCI USA, V86, P8280, DOI 10.1073/pnas.86.21.8280; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	19	1773	1908	5	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 10	2006	314	5801					994	997		10.1126/science.1132505	http://dx.doi.org/10.1126/science.1132505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103OG	17038590				2022-12-01	WOS:000241896000054
J	Gheorghiade, M; Abraham, WT; Albert, NM; Greenberg, BH; O'Connor, CM; She, LL; Stough, WG; Yancy, CW; Young, JB; Fonarow, GC				Gheorghiade, Mihai; Abraham, William T.; Albert, Nancy M.; Greenberg, Barry H.; O'Connor, Christopher M.; She, Lilin; Gattis Stough, Wendy; Yancy, Clyde W.; Young, James B.; Fonarow, Gregg C.		OPTIMIZE-HF Investigators Coordina	Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK STRATIFICATION; UNITED-STATES; MORTALITY; HYPERTENSION; RATIONALE; DESIGN	Context The association between systolic blood pressure (SBP) at admission, clinical characteristics, and outcomes in patients hospitalized for heart failure who have reduced or relatively preserved systolic function has not been well studied. Objective To evaluate the relationship between SBP at admission, clinical profile, and outcomes in patients hospitalized for acute heart failure. Design, Setting, and Patients Cohort study using data from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) registry and performance-improvement program for patients hospitalized with heart failure at 259 US hospitals between March 2003 and December 2004. Patients were divided into quartiles by SBP at hospital admission (< 120, 120-139, 140-161, and > 161 mm Hg). In-hospital outcomes were based on 48 612 patients aged 18 years or older with heart failure. Of the 41 267 patients with left ventricular function assessed, 21 149 (51%) had preserved left ventricular function. Postdischarge outcomes were based on a prespecified subgroup (n = 5791, 10% of patients) with follow-up data assessed between 60 and 90 days. Main Outcome Measures In-hospital and postdischarge mortality. Results Patients with higher SBP were more likely to be female and black and to have preserved systolic function. Fifty percent of the patients had SBP higher than 140 mm Hg at admission. Patients with lower SBP at admission had higher in-hospital and postdischarge mortality rates. Higher SBP at admission was associated with lower in-hospital mortality rates: 7.2% (< 120 mm Hg), 3.6% (120-139 mm Hg), 2.5% (140-161 mm Hg), and 1.7% (> 161 mm Hg) (P < .001 for overall difference). Postdischarge mortality rates in the follow-up cohort by SBP at admission were 14.0%, 8.4%, 6.0%, and 5.4%, respectively (P < .001 for overall difference). Conclusions Systolic hypertension is common in patients hospitalized for heart failure. Systolic blood pressure is an independent predictor of morbidity and mortality in patients with heart failure with either reduced or relatively preserved systolic function. Low SBP (< 120 mm Hg) at hospital admission identifies patients who have a poor prognosis despite medical therapy. These findings may have important therapeutic implications because characteristics and outcomes differ greatly among patients with heart failure with varying SBP.	Univ Calif Los Angeles, Med Ctr, Dept Med, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA 90095 USA; Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; Ohio State Univ, Div Cardiol, Columbus, OH 43210 USA; Cleveland Clin Fdn, George M & Linda H Kaufman Ctr Heart Failure, Cleveland, OH 44195 USA; Univ Calif San Diego, Med Ctr, Dept Med, San Diego, CA 92103 USA; Duke Clin Res Inst, Durham, NC USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Campbell Univ, Sch Pharm, Res Triangle Pk, NC USA; Univ Texas, SW Med Ctr, Dept Med, Dallas, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Northwestern University; Feinberg School of Medicine; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; University of California System; University of California San Diego; Duke University; Duke University; Campbell University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Fonarow, GC (corresponding author), Univ Calif Los Angeles, Med Ctr, Dept Med, Ahmanson UCLA Cardiomyopathy Ctr, 10833 LeConte Ave,Room 47-123 CHS, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Stough, Wendy G/R-4287-2016; Fonarow, Gregg C/D-5988-2014	Stough, Wendy G/0000-0001-8290-1205; Fonarow, Gregg C/0000-0002-3192-8093				Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Aronson D, 2004, AM J MED, V116, P466, DOI 10.1016/j.amjmed.2003.11.014; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Chen HH, 2002, J CARD FAIL, V8, P279, DOI 10.1054/jcaf.2002.128871; Cotter G, 2005, CIRCULATION, V112, pU661; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Felker GM, 2004, J CARD FAIL, V10, P460, DOI 10.1016/j.cardfail.2004.02.011; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Mebazaa A, 2005, AM HEART ASS SCI SES; PACKER M, 2005, AM HEART ASS SCI SES; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Teerlink JR, 2005, AM HEART J, V150, P46, DOI 10.1016/j.ahj.2005.04.035; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	20	679	709	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2006	296	18					2217	2226		10.1001/jama.296.18.2217	http://dx.doi.org/10.1001/jama.296.18.2217			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	102QM	17090768	Bronze			2022-12-01	WOS:000241827700022
J	Grenyer, R; Orme, CDL; Jackson, SF; Thomas, GH; Davies, RG; Davies, TJ; Jones, KE; Olson, VA; Ridgely, RS; Rasmussen, PC; Ding, TS; Bennett, PM; Blackburn, TM; Gaston, KJ; Gittleman, JL; Owens, IPF				Grenyer, Richard; Orme, C. David L.; Jackson, Sarah F.; Thomas, Gavin H.; Davies, Richard G.; Davies, T. Jonathan; Jones, Kate E.; Olson, Valerie A.; Ridgely, Robert S.; Rasmussen, Pamela C.; Ding, Tzung-Su; Bennett, Peter M.; Blackburn, Tim M.; Gaston, Kevin J.; Gittleman, John L.; Owens, Ian P. F.			Global distribution and conservation of rare and threatened vertebrates	NATURE			English	Article							RESERVE SELECTION; INDICATOR GROUPS; HOTSPOTS; ECOREGIONS; PATTERNS	Global conservation strategies commonly assume that different taxonomic groups show congruent geographical patterns of diversity, and that the distribution of extinction-prone species in one group can therefore act as a surrogate for vulnerable species in other groups when conservation decisions are being made(1-4). The validity of these assumptions remains unclear, however, because previous tests have been limited in both geographical and taxonomic extent(5-12). Here we use a database on the global distribution of 19,349 living bird, mammal and amphibian species to show that, although the distribution of overall species richness is very similar among these groups, congruence in the distribution of rare and threatened species is markedly lower. Congruence is especially low among the very rarest species. Cross-taxon congruence is also highly scale dependent, being particularly low at the finer spatial resolutions relevant to real protected areas. 'Hotspots' of rarity and threat are therefore largely non-overlapping across groups, as are areas chosen to maximize species complementarity. Overall, our results indicate that 'silver-bullet' conservation strategies alone will not deliver efficient conservation solutions. Instead, priority areas for biodiversity conservation must be based on high-resolution data from multiple taxa.	Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Zool Soc London, Inst Zool, London NW1 4RY, England; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; Michigan State Univ Museum, E Lansing, MI 48824 USA; Dept Zool, E Lansing, MI 48824 USA; Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 106, Taiwan; NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England	University of Virginia; Imperial College London; University of Sheffield; University of Birmingham; Zoological Society of London; Drexel University; Michigan State University; National Taiwan University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Grenyer, R (corresponding author), Royal Bot Gardens, Jodrell Lab, Richmond TW9 3AB, Surrey, England.	r.grenyer@kew.org; jlg@uga.edu; i.owens@imperial.ac.uk	Jones, Kate/Y-3317-2019; Davies, Richard/H-7447-2019; Owens, Ian PF/F-1392-2010; Thomas, Gavin/AAE-8959-2019; Blackburn, Tim/AAC-3144-2019; Blackburn, Tim M/A-7685-2011; DING, Tzung-Su/AAG-7712-2019; Jones, Kate E/G-4768-2010	Jones, Kate/0000-0001-5231-3293; Blackburn, Tim/0000-0003-0152-2663; Jones, Kate E/0000-0001-5231-3293; Owens, Ian/0000-0001-6080-3321; DING, Tzung-Su/0000-0002-1102-3879; Thomas, Gavin/0000-0002-1982-6051	Natural Environment Research Council [NE/B503492/1, NER/O/S/2001/01230] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baillie JE, 2004, IUCN RED LIST THREAT; *BIRDL INT, 2006, WORLD BIRD DAT; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; CLIFFORD P, 1989, BIOMETRICS, V45, P123, DOI 10.2307/2532039; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Gaston K.J., 1994, RARITY, P1, DOI [DOI 10.1007/978-94-011-0701-3_1, 10.1007/978-94-011-0701-3]; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; *IUCN, 2006, GLOB MAMM ASS; IUCN, 2006, IUCN RED LIST THREAT; IUCN Conservation International and Nature Serve, 2004, GLOB AMPH ASS; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1046/J.1461-0248.2002.00376.X; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pearson DL, 1999, J BIOGEOGR, V26, P1079, DOI 10.1046/j.1365-2699.1999.00337.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Rodrigues AS, 2000, ECOGRAPHY, V23, P565, DOI 10.1034/j.1600-0587.2000.230507.x; SECHREST WW, 2003, THESIS U VIRGINIA; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; *WDPA CONS, 2005, WORLD DAT PROT AR; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366	30	390	412	5	240	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 2	2006	444	7115					93	96		10.1038/nature05237	http://dx.doi.org/10.1038/nature05237			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100WS	17080090				2022-12-01	WOS:000241701500052
J	Shiau, AK; Harris, SF; Southworth, DR; Agard, DA				Shiau, Andrew K.; Harris, Seth F.; Southworth, Daniel R.; Agard, David A.			Structural analysis of E-coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements	CELL			English	Article							CRYSTAL-STRUCTURE; MOLECULAR CHAPERONE; SUBSTRATE-BINDING; ATPASE ACTIVITY; PROTEIN; COMPLEX; IDENTIFICATION; INHIBITION; HYDROLYSIS; DISSECTION	In eukaryotes, the ubiquitous and abundant members of the 90 kilodalton heat-shock protein (hsp90) chaperone family facilitate the folding and conformational changes of a broad array of proteins important in cell signaling, proliferation, and survival. Here we describe the effects of nucleotides on the structure of full-length HtpG, the Escherichia coli hsp90 ortho-log. By electron microscopy, the nucleotide-free, AMPPNP bound, and ADP bound states of HtpG adopt completely distinct conformations. Structural characterization of nucleotide-free and ADP bound HtpG was extended to higher resolution by X-ray crystallography. In the absence of nucleotide, HtpG exhibits an "open" conformation in which the three domains of each monomer present hydrophobic elements into the large cleft formed by the dimer. By contrast, AIDP binding drives dramatic conformational changes that allow these hydrophobic elements to converge and shield each other from solvent, suggesting a mechanism by which nucleotides could control client protein binding and release.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Kalypsys Inc, Dept Biol, San Diego, CA 92121 USA; Roche Palo Alto, Palo Alto, CA 94304 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058390] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK58390] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Chiosis G, 2003, CURR CANCER DRUG TAR, V3, P371, DOI 10.2174/1568009033481778; Chu FX, 2006, PROTEIN SCI, V15, P1260, DOI 10.1110/ps.052065106; Corbett KD, 2005, STRUCTURE, V13, P873, DOI 10.1016/j.str.2005.03.013; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Dymock BW, 2005, J MED CHEM, V48, P4212, DOI 10.1021/jm050355z; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Grantcharova V, 2001, CURR OPIN STRUC BIOL, V11, P70, DOI 10.1016/S0959-440X(00)00176-7; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; Huai Q, 2005, STRUCTURE, V13, P579, DOI 10.1016/j.str.2004.12.018; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maruya M, 1999, J MOL BIOL, V285, P903, DOI 10.1006/jmbi.1998.2349; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Workman P, 2004, TRENDS MOL MED, V10, P47, DOI 10.1016/j.molmed.2003.12.005; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	37	341	349	1	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 20	2006	127	2					329	340		10.1016/j.cell.2006.09.027	http://dx.doi.org/10.1016/j.cell.2006.09.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055434	Bronze			2022-12-01	WOS:000241827100020
J	Haland, G; Carlsen, KCL; Sandvik, L; Devulapalli, CS; Munthe-Kaas, MC; Pettersen, M; Carlsen, KH				Haland, Geir; Carlsen, Karin C. Lodrup; Sandvik, Leiv; Devulapalli, Chandra Sekhar; Munthe-Kaas, Monica Cheng; Pettersen, Morten; Carlsen, Kai-Hakon		ORAACLE	Reduced lung function at birth and the risk of asthma at 10 years of age	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPIRATORY FLOW PATTERNS; BRONCHIAL OBSTRUCTION; AIRWAY FUNCTION; EARLY-LIFE; INFANTS; CHILDREN; MECHANICS; EXPOSURE; WHEEZE	BACKGROUND Reduced lung function in early infancy has been associated with later obstructive airway diseases. We assessed whether reduced lung function shortly after birth predicts asthma 10 years later. METHODS We conducted a prospective birth cohort study of healthy infants in which we measured lung function shortly after birth with the use of tidal breathing flow-volume loops (the fraction of expiratory time to peak tidal expiratory flow to total expiratory time [t(sub PTEF)/t(sub E)]) in 802 infants and passive respiratory mechanics, including respiratory-system compliance, in 664 infants. At 10 years of age, 616 children (77%) were reassessed by measuring lung function, exercise-induced bronchoconstriction, and bronchial hyperresponsiveness (by means of a methacholine challenge) and by conducting a structured interview to determine whether there was a history of asthma or current asthma. RESULTS As compared with children whose t(sub PTEF)/t(sub E) shortly after birth was above the median, children whose t(sub PTEF)/t(sub E) was at or below the median were more likely at 10 years of age to have a history of asthma (24.3% vs. 16.2%, P=0.01), to have current asthma (14.6% vs. 7.5%, P=0.005), and to have severe bronchial hyperresponsiveness, defined as a methacholine dose of less than 1.0 micromol causing a 20% fall in the forced expiratory volume in 1 second (FEV(sub 1)) (9.1% vs. 4.9%, P=0.05). As compared with children whose respiratory-system compliance was above the median, children with respiratory compliance at or below the median more often had a history of asthma (27.4% vs. 14.8%; P=0.001) and current asthma (15.0% vs. 7.7%, P=0.009), although this measure was not associated with later measurements of lung function. At 10 years of age, t(sub PTEF)/t(sub E) at birth correlated weakly with the maximal midexpiratory flow rate (r=0.10, P=0.01) but not with FEV(sub 1) or forced vital capacity. CONCLUSIONS Reduced lung function at birth is associated with an increased risk of asthma by 10 years of age.	Rigshosp Radiumhosp Med Ctr, Dept Pediat, Voksentoppen, N-0491 Oslo, Norway; Ullevaal Univ Hosp, Dept Pediat, Div Woman & Child, Oslo, Norway; Ullevaal Univ Hosp, Clin Res Ctr, Oslo, Norway; Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Haland, G (corresponding author), Rigshosp Radiumhosp Med Ctr, Dept Pediat, Voksentoppen, Ullveien 14, N-0491 Oslo, Norway.	haland@medisin.uio.no	Devulapalli, Chandra Sekhar/B-6170-2008	Devulapalli, Chandra Sekhar/0000-0001-5473-9642				BANOVCIN P, 1995, PEDIATR RES, V38, P218, DOI 10.1203/00006450-199508000-00014; Carlsen KCL, 1997, EUR RESPIR J, V10, P1774, DOI 10.1183/09031936.97.10081774; Carlsen KCL, 2006, ALLERGY, V61, P454, DOI 10.1111/j.1398-9995.2005.00938.x; CARLSEN KCL, 1994, EUR RESPIR J, V7, P1660, DOI 10.1183/09031936.94.07091660; CARLSEN KCL, 1997, EUR RESP MON, V5, P27; Carlsen KH, 2000, RESP MED, V94, P750, DOI 10.1053/rmed.2000.0809; Carlsen L, 1999, PEDIATR ALLERGY IMMU, V10, P89, DOI 10.1034/j.1399-3038.1999.00028.x; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; CUTRERA R, 1991, PEDIATR PULM, V10, P6, DOI 10.1002/ppul.1950100103; LESOUEF PN, 1984, AM REV RESPIR DIS, V129, P552; LODRUP KC, 1992, PEDIATR PULM, V12, P99, DOI 10.1002/ppul.1950120208; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MARTINEZ FD, 1991, AM REV RESPIR DIS, V143, P312, DOI 10.1164/ajrccm/143.2.312; MARTINEZ FD, 1988, NEW ENGL J MED, V319, P1112, DOI 10.1056/NEJM198810273191702; MORRIS MJ, 1981, THORAX, V36, P135, DOI 10.1136/thx.36.2.135; Murray CS, 2002, THORAX, V57, P388, DOI 10.1136/thorax.57.5.388; Nystad W, 2001, EUR J EPIDEMIOL, V17, P209, DOI 10.1023/A:1017926403763; Ronmark E, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e37; Seddon PC, 1996, AM J RESP CRIT CARE, V153, P1248, DOI 10.1164/ajrccm.153.4.8616549; TAGER IB, 1993, AM REV RESPIR DIS, V147, P811, DOI 10.1164/ajrccm/147.4.811; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC; vanderEnt CK, 1996, AM J RESP CRIT CARE, V153, P1253, DOI 10.1164/ajrccm.153.4.8616550; YOUNG S, 1994, J PEDIATR-US, V124, P681, DOI 10.1016/S0022-3476(05)81355-1; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x; Yuksel B, 1996, THORAX, V51, P815, DOI 10.1136/thx.51.8.815	25	273	282	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2006	355	16					1682	1689		10.1056/NEJMoa052885	http://dx.doi.org/10.1056/NEJMoa052885			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	096DN	17050892				2022-12-01	WOS:000241357300009
J	Lam, YC; Bowman, AB; Jafar-Neiad, P; Lim, J; Richman, R; Fryer, JD; Hyun, ED; Duvick, LA; Brr, HT; Botas, J; Zoghbi, HY				Lam, Yung C.; Bowman, Aaron B.; Jafar-Neiad, Paymaan; Lim, Janghoo; Richman, Ronald; Fryer, John D.; Hyun, Eric D.; Duvick, Lisa A.; Brr, Harry T.; Botas, Juan; Zoghbi, Huda Y.			ATAXIN-1 interacts with the repressor capicua in its native complex to cause SCA1 neuropathology	CELL			English	Article							BULBAR MUSCULAR-ATROPHY; HISTONE ACETYLTRANSFERASE ACTIVITY; TRANSGENIC MOUSE MODEL; DISEASE GENE HOMOLOG; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; MEDIATES NEURODEGENERATION; EMBRYONIC LETHALITY; EXPANDED ATAXIN-7; AXH DOMAIN	Spinocerebellar ataxia type 1 (SCA1) is one of several neurodegenerative diseases caused by expansion of a polyglutamine tract in the disease protein, in this case, ATAXIN-1 (ATXN1). A key question in the field is whether neurotoxicity is mediated by aberrant, novel interactions with the expanded protein or whether its wild-type functions are augmented to a deleterious degree. We examined soluble protein complexes from mouse cerebellum and found that the majority of wild-type and expanded ATXN1 assembles into large stable complexes containing the transcriptional repressor Capicua. ATXN1 directly binds Capicua and modulates Capicua repressor activity in Drosophila and mammalian cells, and its loss decreases the steady-state level of Capicua. Interestingly, the S776A mutation, which abrogates the neurotoxicity of expanded ATXN1, substantially reduces the association of mutant ATXN1 with Capicua in vivo. These data provide insight into the function of ATXN1 and suggest that SCA1 neuropathology depends on native, not novel, protein interactions.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu		Zoghbi, Huda/0000-0002-0700-3349; Orr, Harry/0000-0001-6118-741X; Bowman, Aaron/0000-0001-8728-3346	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R37NS022920, R01NS027699, R01NS045667] Funding Source: NIH RePORTER; NICHD NIH HHS [HD024064] Funding Source: Medline; NINDS NIH HHS [NS22920, NS27699, NS45667] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atkey MR, 2006, DEVELOPMENT, V133, P2115, DOI 10.1242/dev.02369; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Chen SM, 2004, HUM MOL GENET, V13, P53, DOI 10.1093/hmg/ddh005; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Eriksen JL, 2005, TRENDS MOL MED, V11, P91, DOI 10.1016/j.molmed.2005.01.001; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Jimenez G, 2000, GENE DEV, V14, P224; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MACDONALD ME, 2003, SCI STKE, V207, pPE48; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matsumoto T, 2005, J BIOCHEM, V138, P105, DOI 10.1093/jb/mvi118; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; Okazawa H, 2002, NEURON, V34, P701, DOI 10.1016/S0896-6273(02)00697-9; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roch F, 2002, DEVELOPMENT, V129, P993; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Strom AL, 2005, NEUROBIOL DIS, V20, P646, DOI 10.1016/j.nbd.2005.04.018; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	55	226	232	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 29	2006	127	7					1335	1347		10.1016/j.cell.2006.11.038	http://dx.doi.org/10.1016/j.cell.2006.11.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	128WI	17190598	Bronze			2022-12-01	WOS:000243690000014
J	Royo-Torres, R; Cobos, A; Alcala, L				Royo-Torres, Rafael; Cobos, Alberto; Alcala, Luis			A giant European dinosaur and a new sauropod clade	SCIENCE			English	Article								Fossils of a giant sauropod dinosaur, Turiasaurus riodevensis, have been recovered from terrestrial deposits of the Villar del Arzobispo Formation (Jurassic-Cretaceous boundary) of Riodeva (Teruel Province, Spain). Its humerus length ( 1790 millimeters) and estimated mass ( 40 to 48 metric tons) indicate that it may have been the most massive terrestrial animal in Europe and one of the largest in the world. Phylogenetic analysis indicates that the fossil represents a member of a hitherto unrecognized group of primitive European eusauropods that evolved in the Jurassic.	Fdn Conjurito Paleontol Tereul Dinopolis, E-44002 Teruel, Spain		Royo-Torres, R (corresponding author), Fdn Conjurito Paleontol Tereul Dinopolis, Ave Sagunto, E-44002 Teruel, Spain.	royo@dinopolis.com	Alcalá, Luis/P-5793-2014; Alcalá, Luis/A-7413-2009; Torres, Rafael Royo/AAE-3183-2019	Alcalá, Luis/0000-0002-6369-6186; Torres, Rafael Royo/0000-0001-5116-3000; Cobos, Alberto/0000-0001-9162-334X				[Anonymous], 1999, REV MUSEO ARGENTINE, V5, P13; Barco Jose Luis, 2005, Naturaleza Aragonesa, V15, P4; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; Buffetaut Eric, 1994, Revue de Paleobiologie Volume Special, V7, P17; Casanovas Maria Lourdes, 2001, Paleontologia i Evolucio, V32-33, P99; Fezer R., 1988, Arbeiten aus dem Institut fuer Geologie und Palaeontologie an der Universitaet Stuttgart Neue Folge, V84, P1; Gillette D.D., 1991, Journal of Vertebrate Paleontology, V11, P417; Lapparent A. F., 1957, Memorias Servicos Geologicos Portugal NS, V2, P1; Luquetti AO, 2005, REV SOC BRAS MED TRO, V38, P27; Mazzetta Gerardo V., 2004, Historical Biology, V16, P71, DOI 10.1080/08912960410001715132; Naish D, 2004, CRETACEOUS RES, V25, P787, DOI 10.1016/j.cretres.2004.07.002; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P167; Paul G.S., 1988, HUNTERIA, V2, P1; Royo-Torres R., 2005, Geogaceta, V38, P23; ROYOTORRES R, 2004, GEOTEMAS, V6, P59; Sanchez-Hernandez B, 2005, ZOOTAXA, P1; Sanchez-Hernandez B, 2006, ZOOTAXA, P63, DOI 10.11646/zootaxa.1201.1.3; SANZ J L, 1987, Estudios Geologicos (Madrid), P45; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel MJ, 2000, J VERTEBR PALEONTOL, V20, P109, DOI 10.1671/0272-4634(2000)020[0109:SPANSF]2.0.CO;2; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wiman C, 1929, PALAEONTOLOGIA SINIC, V6, P1; You HL, 2004, ACTA GEOL SIN-ENGL, V78, P907; YOUNG CC, 1972, VERT PALEONTOL PALEO, V8, P1	27	98	104	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2006	314	5807					1925	1927		10.1126/science.1132885	http://dx.doi.org/10.1126/science.1132885			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	119EY	17185599				2022-12-01	WOS:000242996800048
J	Jin, RS; Rummel, A; Binz, T; Brunger, AT				Jin, Rongsheng; Rummel, Andreas; Binz, Thomas; Brunger, Axel T.			Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity	NATURE			English	Article							H-CC-DOMAIN; SYNAPTOTAGMIN-I; BINDING-SITES; TETANUS; THERMODYNAMICS; TRANSLOCATION; MEMBRANES; TOXINS	Botulinum neurotoxins (BoNTs) are produced by Clostridium botulinum and cause the neuroparalytic syndrome of botulism. With a lethal dose of 1 ng kg(-1), they pose a biological hazard to humans and a serious potential bioweapon threat(1). BoNTs bind with high specificity at neuromuscular junctions and they impair exocytosis of synaptic vesicles containing acetylcholine through specific proteolysis of SNAREs (soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors), which constitute part of the synaptic vesicle fusion machinery(2,3). The molecular details of the toxin-cell recognition have been elusive. Here we report the structure of a BoNT in complex with its protein receptor: the receptor-binding domain of botulinum neurotoxin serotype B (BoNT/B) bound to the luminal domain of synaptotagmin II, determined at 2.15 angstrom resolution. On binding, a helix is induced in the luminal domain which binds to a saddle-shaped crevice on a distal tip of BoNT/B. This crevice is adjacent to the non-overlapping ganglioside-binding site of BoNT/B. Synaptotagmin II interacts with BoNT/B with nanomolar affinity, at both neutral and acidic endosomal pH. Biochemical and neuronal ex vivo studies of structure-based mutations indicate high specificity and affinity of the interaction, and high selectivity of BoNT/B among synaptotagmin I and II isoforms. Synergistic binding of both synaptotagmin and ganglioside imposes geometric restrictions on the initiation of BoNT/B translocation after endocytosis. Our results provide the basis for the rational development of preventive vaccines or inhibitors against these neurotoxins.	Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Hannover Medical School; Hannover Medical School	Brunger, AT (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	brunger@stanford.edu	Jin, Rongsheng/M-7797-2013; Rummel, Andreas/I-7449-2013	Jin, Rongsheng/0000-0003-0348-7363; Rummel, Andreas/0000-0002-0645-1641; Brunger, Axel/0000-0001-5121-2036				Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2001, ACTA CRYSTALLOGR D, V57, P1743, DOI 10.1107/S0907444901013531; HABERMANN E, 1980, N-S ARCH PHARMACOL, V311, P33, DOI 10.1007/BF00500299; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Jayaraman S, 2005, BIOCHEM BIOPH RES CO, V330, P97, DOI 10.1016/j.bbrc.2005.02.123; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kozaki S, 1998, MICROB PATHOGENESIS, V25, P91, DOI 10.1006/mpat.1998.0214; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; PANG ZP, IN PRESS J NEUROSCI; Perozzo R, 2004, J RECEPT SIG TRANSD, V24, P1, DOI 10.1081/RRS-120037896; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2003, J MOL BIOL, V326, P835, DOI 10.1016/S0022-2836(02)01403-1; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; RUMMEL A, IN PRESS P NATL ACAD; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005	30	188	199	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2006	444	7122					1092	1095		10.1038/nature05387	http://dx.doi.org/10.1038/nature05387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17167421				2022-12-01	WOS:000242971100061
J	Watts, PC; Buley, KR; Boardman, W; Ciofi, C; GibsonO, R				Watts, Phillip C.; Buley, Kevin R.; Boardman, Wayne; Ciofi, Claudio; GibsonO, Richard			Parthenogenesis in komodo dragons	NATURE			English	Article							EXTINCTION		Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; N England Zool Soc, Chester Zoo, Upton By Chester CH2 1LH, England; Zool Soc London, London NW1 4RY, England; Univ Florence, Dept Anim Biol & Genet, I-50125 Florence, Italy	University of Liverpool; Zoological Society of London; University of Florence	Watts, PC (corresponding author), Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.	p.c.watts@liv.ac.uk	Boardman, Wayne/ABE-7528-2020; Boardman, Wayne S.J/J-6479-2013; Ciofi, Claudio/AAH-9461-2019; Watts, Phill/G-7257-2011	Boardman, Wayne/0000-0002-1746-0682; Watts, Phillip/0000-0001-7755-187X; CIOFI, CLAUDIO/0000-0001-8537-8659				AVISE JC, 1992, EVOL BIOL, V26, P225; Ciofi C, 2004, HERPETOL J, V14, P99; Ciofi C, 1998, MOL ECOL, V7, P134; Groot TVM, 2003, HEREDITY, V90, P130, DOI 10.1038/sj.hdy.6800210; HALVERSON J, 2002, BIOL CONSERVATION KO, P165; Lenk P, 2005, AMPHIBIA-REPTILIA, V26, P507, DOI 10.1163/156853805774806296; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Sherratt TN, 2005, NATURE, V435, P1039, DOI 10.1038/4351039a; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL	10	100	105	1	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2006	444	7122					1021	1022		10.1038/4441021a	http://dx.doi.org/10.1038/4441021a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	118VH	17183308				2022-12-01	WOS:000242971100041
J	Schussler, A; Martin, H; Cohen, D; Fitz, M; Wipf, D				Schuessler, Arthur; Martin, Holger; Cohen, David; Fitz, Michael; Wipf, Daniel			Characterization of a carbohydrate transporter from symbiotic glomeromycotan fungi	NATURE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGUS; GLOMUS-INTRARADICES; CARBON; PHYLOGENY; HYPHAE; GENOME; ROOTS; GENES	The symbiotic relationships between mycorrhizal fungi and plants have an enormous impact on terrestrial ecosystems(1). Most common are the arbuscular mycorrhizas, formed by fungi belonging to the phylum Glomeromycota(2). Arbuscular mycorrhizal fungi facilitate the uptake of soil nutrients by plants(3) and in exchange obtain carbohydrates, thus representing a large sink(4) for atmospheric plant-fixed CO2. However, how carbohydrates are transported through the symbiotic interface is still unknown. Here we report the characterization of the first known glomeromycotan monosaccharide transporter, GpMST1, by exploiting the unique symbiosis of a glomeromycotan fungus (Geosiphon pyriformis) with cyanobacteria(5). The GpMST1 gene has a very low GC content and contains six introns with unusual boundaries. GpMST1 possesses twelve predicted transmembrane domains and functions as a proton cotransporter with highest affinity for glucose, then mannose, galactose and fructose. It belongs to an as yet uncharacterized phylogenetic monosaccharide transporter clade. This initial characterization of a new transporter family involved in fungal symbiosis will lead to a better understanding of carbon flows in terrestrial environments.	Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany; Univ Bonn, IZMB, NWG Transport Mycorrhiza, D-53115 Bonn, Germany	Technical University of Darmstadt; University of Bonn	Schussler, A (corresponding author), Dept Biol 1, Bereich Genet, Maria Ward Str 1A, D-80638 Munich, Germany.	arthur.schuessler@lrz.uni-muenchen.de	Schüßler, Arthur/F-1681-2011	Cohen, David/0000-0002-0320-8865; Fitz, Michael/0000-0001-9192-0280; Wipf, Daniel/0000-0001-7197-5612				Bago B, 2003, PLANT PHYSIOL, V131, P1496, DOI 10.1104/pp.102.007765; BONFANTE P, 2001, MYCOTA, V9, P45; GARCIA M, 2006, 5 INT C MYC 23 27 JU, P200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gould G.W., 1997, FACILITATIVE GLUCOSE, P1; Hamacher T, 2002, MICROBIOL-SGM, V148, P2783, DOI 10.1099/00221287-148-9-2783; Hildebrandt U, 2006, FEMS MICROBIOL LETT, V254, P258, DOI 10.1111/j.1574-6968.2005.00027.x; KLUGE M, 1991, PLANTA, V185, P311, DOI 10.1007/BF00201049; KNOBLAUCH M, 1995, THESIS, P1; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Marx J, 2004, SCIENCE, V304, P234, DOI 10.1126/science.304.5668.234; Meeks JC, 2001, PHOTOSYNTH RES, V70, P85, DOI 10.1023/A:1013840025518; Sawaki H, 2001, FEMS MICROBIOL LETT, V195, P109, DOI 10.1111/j.1574-6968.2001.tb10506.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schussler A, 2002, PLANT SOIL, V244, P75, DOI 10.1023/A:1020238728910; Schussler A, 2005, SOIL BIOL, V4, P271; Schussler A, 1996, PROTOPLASMA, V190, P53, DOI 10.1007/BF01281194; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI; Solaiman MDZ, 1997, NEW PHYTOL, V136, P533, DOI 10.1046/j.1469-8137.1997.00757.x; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; vanKuyk PA, 2004, BIOCHEM J, V379, P375, DOI 10.1042/BJ20030624; VELA GM, 2006, 5 INT C MYC 23 27 JU, P40; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Wipf D, 2003, GENOME, V46, P177, DOI [10.1139/g02-121, 10.1139/G02-121]	25	95	108	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2006	444	7121					933	936		10.1038/nature05364	http://dx.doi.org/10.1038/nature05364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	116LW	17167486				2022-12-01	WOS:000242805400057
J	Sanderson, K				Sanderson, Katharine			A field in ferment	NATURE			English	News Item																			0	76	86	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2006	444	7120					673	676		10.1038/444673a	http://dx.doi.org/10.1038/444673a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113EL	17151628				2022-12-01	WOS:000242581100015
J	Di Micco, R; Fumagalli, M; Cicalese, A; Piccinin, S; Gasparini, P; Luise, C; Schurra, C; Garre, M; Nuciforo, PG; Bensimon, A; Maestro, R; Pelicci, PG; di Fagagna, FD				Di Micco, Raffaella; Fumagalli, Marzia; Cicalese, Angelo; Piccinin, Sara; Gasparini, Patrizia; Luise, Chiara; Schurra, Catherine; Garre, Massimiliano; Nuciforo, Paolo Giovanni; Bensimon, Aaron; Maestro, Roberta; Pelicci, Pier Giuseppe; di Fagagna, Fabrizio d'Adda			Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication	NATURE			English	Article							HUMAN-CELLS; GENOMIC INSTABILITY; GENETIC INSTABILITY; CELLULAR SENESCENCE; HA-RAS; P53; CYCLE; CDC6; REREPLICATION; TUMORIGENESIS	Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response(DDR)(1,2). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence(3-6). It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.	IFOM Fdn, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Ctr Riferimento Oncol, IRCCS, I-33081 Aviano, Italy; Inst Pasteur, Genome Stabil Unit, F-75724 Paris, France; Genom Vis, F-75724 Paris, France	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); IRCCS Aviano (CRO); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	di Fagagna, FD (corresponding author), IFOM Fdn, FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy.	fabrizio.dadda@ifom-ieo-campus.it	Maestro, Roberta/M-1846-2015; Pelicci, Pier Giuseppe/AAL-6572-2020; Di MICCO, RAFFAELLA/ABH-7906-2020; Gasparini, Patrizia/Q-7626-2016; Maestro, Roberta/P-9748-2019; d'Adda di Fagagna, Fabrizio/AAC-4683-2022; PICCININ, SARA/AAZ-2679-2020; Nuciforo, Paolo/Q-2885-2019	Maestro, Roberta/0000-0002-6642-5592; Gasparini, Patrizia/0000-0002-9548-3724; Maestro, Roberta/0000-0002-6642-5592; d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; PICCININ, SARA/0000-0002-7987-4020; Nuciforo, Paolo/0000-0003-1380-0990; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; Fumagalli, Marzia/0000-0002-2036-4544; Di Micco, Raffaella/0000-0002-0639-8238; Garre', Massimiliano/0000-0001-9332-0270				Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; DENKO NC, 1994, P NATL ACAD SCI USA, V91, P5124, DOI 10.1073/pnas.91.11.5124; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lebofsky Ronald, 2003, Briefings in Functional Genomics & Proteomics, V1, P385, DOI 10.1093/bfgp/1.4.385; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Williams GH, 1998, P NATL ACAD SCI USA, V95, P14932, DOI 10.1073/pnas.95.25.14932	29	1305	1331	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2006	444	7119					638	642		10.1038/nature05327	http://dx.doi.org/10.1038/nature05327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	110KK	17136094				2022-12-01	WOS:000242377600052
J	Kolano, C; Helbing, J; Kozinski, M; Sander, W; Hamm, P				Kolano, Christoph; Helbing, Jan; Kozinski, Mariusz; Sander, Wolfram; Hamm, Peter			Watching hydrogen-bond dynamics in a beta-turn by transient two-dimensional infrared spectroscopy	NATURE			English	Article							PICOSECOND CONFORMATIONAL TRANSITION; PHOTOSWITCHABLE PEPTIDE; PROTEIN; ISOTOPOMERS; DISULFIDE; IR	X-ray crystallography and nuclear magnetic resonance measurements provide us with atomically resolved structures of an ever-growing number of biomolecules. These static structural snapshots are important to our understanding of biomolecular function, but real biomolecules are dynamic entities that often exploit conformational changes and transient molecular interactions to perform their tasks. Nuclear magnetic resonance methods can follow such structural changes, but only on millisecond timescales under non-equilibrium conditions. Time-resolved X-ray crystallography has recently been used to monitor the photodissociation of CO from myoglobin on a subnanosecond timescale(1), yet remains challenging to apply more widely. In contrast, two-dimensional infrared spectroscopy, which maps vibrational coupling between molecular groups and hence their relative positions and orientations(2-11), is now routinely used to study equilibrium processes on picosecond timescales. Here we show that the extension of this method into the non-equilibrium regime(12,13) allows us to observe in real time in a short peptide the weakening of an intramolecular hydrogen bond and concomitant opening of a beta-turn. We find that the rate of this process is two orders of magnitude faster than the 'folding speed limit' established for contact formation between protein side chains(14).	Univ Zurich, Inst Phys Chem, CH-8057 Zurich, Switzerland; Ruhr Univ Bochum, Lehrstuhl Organ Chem 2, D-44801 Bochum, Germany	University of Zurich; Ruhr University Bochum	Kolano, C (corresponding author), Univ Zurich, Inst Phys Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	c.kolano@pci.unizh.ch; p.hamm@pci.unizh.ch	Hamm, Peter/O-1247-2013; Helbing, Jan/A-5609-2013	Hamm, Peter/0000-0003-1106-6032; Sander, Wolfram/0000-0002-1640-7505				Asbury JB, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.237402; Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597; Bredenbeck J, 2005, P NATL ACAD SCI USA, V102, P2379, DOI 10.1073/pnas.0406948102; Bredenbeck J, 2004, J CHEM PHYS, V121, P5943, DOI 10.1063/1.1779575; Bredenbeck J, 2003, J PHYS CHEM B, V107, P8654, DOI 10.1021/jp034552q; Bredenbeck J, 2003, P NATL ACAD SCI USA, V100, P6452, DOI 10.1073/pnas.1036583100; Cowan ML, 2005, NATURE, V434, P199, DOI 10.1038/nature03383; Fang C, 2005, J PHYS CHEM B, V109, P18652, DOI 10.1021/jp052525p; Golonzka O, 2001, PHYS REV LETT, V86, P2154, DOI 10.1103/PhysRevLett.86.2154; Hamm P, 1998, J PHYS CHEM B, V102, P6123, DOI 10.1021/jp9813286; Hamm P, 1997, J CHEM PHYS, V106, P519, DOI 10.1063/1.473392; Kolano C, 2004, EUR J ORG CHEM, V2004, P4167, DOI 10.1002/ejoc.200400174; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Lu HSM, 1997, J AM CHEM SOC, V119, P7173, DOI 10.1021/ja970567o; Mohanty D, 1997, J MOL BIOL, V272, P423, DOI 10.1006/jmbi.1997.1246; Mohanty D, 2000, INT J QUANTUM CHEM, V80, P1125, DOI 10.1002/1097-461X(2000)80:4/5<1125::AID-QUA62>3.0.CO;2-J; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Mukherjee P, 2006, P NATL ACAD SCI USA, V103, P3528, DOI 10.1073/pnas.0508833103; Nguyen PH, 2006, BIOPHYS J, V91, P1224, DOI 10.1529/biophysj.106.084996; Pimentel GC, 1960, HYDROGEN BOND, P67; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Satzger H, 2004, CHEM PHYS LETT, V396, P191, DOI 10.1016/j.cplett.2004.08.024; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Volk M, 1997, J PHYS CHEM B, V101, P8607, DOI 10.1021/jp971951a; Wang JP, 2006, J PHYS CHEM B, V110, P7545, DOI 10.1021/jp057564f; Woutersen S, 2002, J PHYS-CONDENS MAT, V14, pR1035, DOI 10.1088/0953-8984/14/39/202; Woutersen S, 2000, J PHYS CHEM B, V104, P11316, DOI 10.1021/jp001546a; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609	28	286	289	1	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2006	444	7118					469	472		10.1038/nature05352	http://dx.doi.org/10.1038/nature05352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	108BQ	17122853				2022-12-01	WOS:000242215700042
J	Mora, JR; Iwata, M; Eksteen, B; Song, SY; Junt, T; Senman, B; Otipoby, KL; Yokota, A; Takeuchi, H; Ricciardi-Castagnoli, P; Rajewsky, K; Adams, DH; von Andrian, UH				Mora, J. Rodrigo; Iwata, Makoto; Eksteen, Bertus; Song, Si-Young; Junt, Tobias; Senman, Balimkiz; Otipoby, Kevin L.; Yokota, Aya; Takeuchi, Hajime; Ricciardi-Castagnoli, Paola; Rajewsky, Klaus; Adams, David H.; von Andrian, Ulrich H.			Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells	SCIENCE			English	Article							A-DEFICIENT RATS; T-CELLS; IMMUNOGLOBULIN-A; IMMUNE-SYSTEM; RECEPTOR; INTERLEUKIN-6; RESPONSES; LYMPHOCYTES; SPECIFICITY; EXPRESSION	Normal intestinal mucosa contains abundant immunoglobulin A (IgA) - secreting cells, which are generated from B cells in gut-associated lymphoid tissues (GALT). We show that dendritic cells ( DC) from GALT induce T cell - independent expression of IgA and gut-homing receptors on B cells. GALT-DC-derived retinoic acid (RA) alone conferred gut tropism but could not promote IgA secretion. However, RA potently synergized with GALT-DC-derived interleukin-6 (IL-6) or IL-5 to induce IgA secretion. Consequently, mice deficient in the RA precursor vitamin A lacked IgA-secreting cells in the small intestine. Thus, GALT-DC shape mucosal immunity by modulating B cell migration and effector activity through synergistically acting mediators.	Ctr Blood Res, Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan; Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Tokushima Bunri University; University of Birmingham; University of Milano-Bicocca	Mora, JR (corresponding author), Ctr Blood Res, Inst Biomed Res, 800 Huntington Ave, Boston, MA 02115 USA.	mora@cbr.med.harvard.edu; uva@cbr.med.harvard.edu	von Andrian, Ulrich H/A-5775-2008; Junt, Tobias/AAE-4389-2021; Castagnoli, Paola/E-8288-2010; Adams, David H/C-9092-2009; Eckhardt, Erik/G-1567-2010	Adams, David H/0000-0001-6776-0336; Rajewsky, Klaus/0000-0002-6633-6370	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054936, R01HL062524, P01HL056949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054636, R01AI061663] Funding Source: NIH RePORTER; Medical Research Council [G9818340B] Funding Source: researchfish; Medical Research Council [G0601816] Funding Source: Medline; NHLBI NIH HHS [HL54936, HL62524, HL56949] Funding Source: Medline; NIAID NIH HHS [AI-061663, R37 AI054636] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Bjersing JL, 2002, CLIN EXP IMMUNOL, V130, P404, DOI 10.1046/j.1365-2249.2002.02009.x; Borsutzky S, 2004, J IMMUNOL, V173, P3305, DOI 10.4049/jimmunol.173.5.3305; CHENG L, 1993, EUR J CLIN NUTR, V47, P88; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; Dudda JC, 2005, EUR J IMMUNOL, V35, P1056, DOI 10.1002/eji.200425817; Gadina M, 2001, CURR OPIN IMMUNOL, V13, P363, DOI 10.1016/S0952-7915(00)00228-4; Hiroi T, 1999, J IMMUNOL, V162, P821; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Johansson-Lindbom B, 2003, J EXP MED, V198, P963, DOI 10.1084/jem.20031244; Kantele A, 2005, J INFECT DIS, V191, P312, DOI 10.1086/426943; Kunkel EJ, 2003, J CLIN INVEST, V111, P1001, DOI 10.1172/JCI200317244; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Mora JR, 2006, CURR TOP MICROBIOL, V308, P83; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Nikawa T, 1999, J NUTR, V129, P934, DOI 10.1093/jn/129.5.934; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; SIRISINHA S, 1980, CLIN EXP IMMUNOL, V40, P127; SOMMER A, 1986, LANCET, V1, P1169; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; TOKUYAMA H, 1993, CELL IMMUNOL, V150, P353, DOI 10.1006/cimm.1993.1203; VanCott JL, 2000, J VIROL, V74, P5250, DOI 10.1128/JVI.74.11.5250-5256.2000; Williams MB, 1998, J IMMUNOL, V161, P4227	28	734	774	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2006	314	5802					1157	1160		10.1126/science.1132742	http://dx.doi.org/10.1126/science.1132742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	105PW	17110582				2022-12-01	WOS:000242045800048
J	Wiesmann, C; Katschke, KJ; Yin, JP; Helmy, KY; Steffek, M; Fairbrother, WJ; McCallum, SA; Embuscado, L; DeForge, L; Hass, PE; Campagne, MV				Wiesmann, Christian; Katschke, Kenneth J., Jr.; Yin, JianPing; Helmy, Karim Y.; Steffek, Micah; Fairbrother, Wayne J.; McCallum, Scott A.; Embuscado, Lizette; DeForge, Laura; Hass, Philip E.; van Lookeren Campagne, Menno			Structure of C3b in complex with CRIg gives insights into regulation of complement activation	NATURE			English	Article							ALTERNATIVE PATHWAY; COMPONENT C3; PUTATIVE THIOESTER; C5 CONVERTASE; FACTOR-H; BINDING; BIOLOGY; CD35; CR-1; C3-CONVERTASE	The complement system is a key part of the innate immune system, and is required for clearance of pathogens from the bloodstream(1). After exposure to pathogens, the third component of the complement system, C3, is cleaved to C3b which, after recruitment of factor B, initiates formation of the alternative pathway convertases(2-4). CRIg, a complement receptor expressed on macrophages, binds to C3b and iC3b mediating phagocytosis of the particles 5, but it is unknown how CRIg selectively recognizes proteolytic C3-fragments and whether binding of CRIg to C3b inhibits convertase activation. Here we present the crystal structure of C3b in complex with CRIg and, using CRIg mutants, provide evidence that CRIg acts as an inhibitor of the alternative pathway of complement. The structure shows that activation of C3 induces major structural rearrangements, including a dramatic movement (>80 angstrom) of the thioester-bond-containing domain through which C3b attaches to pathogen surfaces. We show that CRIg is not only a phagocytic receptor, but also a potent inhibitor of the alternative pathway convertases. The structure provides insights into the complex macromolecular structural rearrangements that occur during complement activation and inhibition. Moreover, our structure - function studies relating the structural basis of complement activation and the means by which CRIg inhibits the convertases provide important clues to the development of therapeutics that target complement.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Assay Technol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Wiesmann, C (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way S, San Francisco, CA 94080 USA.	wiesmann.christian@gene.com; menno@gene.com	McCallum, Scott A./K-3769-2018	Wiesmann, Christian/0000-0002-4092-9880				FISHELSON Z, 1983, J BIOL CHEM, V258, P7411; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Gadjeva M, 1998, J IMMUNOL, V161, P985; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; JANSSEN BJ, IN PRESS MOL IMMUNOL; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kostavasil I, 1997, J IMMUNOL, V158, P1763; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Lambris JD, 1996, J IMMUNOL, V156, P4821; Langnaese K, 2000, BBA-GENE STRUCT EXPR, V1492, P522, DOI 10.1016/S0167-4781(00)00131-7; Liddington R, 2005, NATURE, V437, P484, DOI 10.1038/437484a; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Rawal N, 1998, J BIOL CHEM, V273, P16828, DOI 10.1074/jbc.273.27.16828; Rawal N, 2000, J IMMUNOL, V164, P1379, DOI 10.4049/jimmunol.164.3.1379; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; TANIGUCHISIDLE A, 1994, J IMMUNOL, V153, P5285; VOGT W, 1978, IMMUNOLOGY, V34, P29; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	23	169	188	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2006	444	7116					217	220		10.1038/nature05263	http://dx.doi.org/10.1038/nature05263			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	103DZ	17051150				2022-12-01	WOS:000241867200043
J	Olsen, JV; Blagoev, B; Gnad, F; Macek, B; Kumar, C; Mortensen, P; Mann, M				Olsen, Jesper V.; Blagoev, Blagoy; Gnad, Florian; Macek, Boris; Kumar, Chanchal; Mortensen, Peter; Mann, Matthias			Global, in vivo, and site-specific phosphorylation dynamics in signaling networks	CELL			English	Article							GROWTH-FACTOR RECEPTOR; MASS-SPECTROMETRY; TYROSINE PHOSPHORYLATION; PROTEIN-PHOSPHORYLATION; PHOSPHOPROTEOME ANALYSIS; QUANTITATIVE PROTEOMICS; TRANSCRIPTIONAL CONTROL; CELL-CULTURE; AMINO-ACIDS; KINASE	Cell signaling mechanisms often transmit information via posttranslational protein modifications, most importantly reversible protein phosphorylation. Here we develop and apply a general mass spectrometric technology for identification and quantitation of phosphorylation sites as a function of stimulus, time, and subcellular location. We have detected 6,600 phosphorylation sites on 2,244 proteins and have determined their temporal dynamics after stimulating HeLa cells with epidermal growth factor (EGF) and recorded them in the Phosida database. Fourteen percent of phosphorylation sites are modulated at least 2-fold by EGF, and these were classified by their temporal profiles. Surprisingly, a majority of proteins contain multiple phosphorylation sites showing different kinetics, suggesting that they serve as platforms for integrating signals. In addition to protein kinase cascades, the targets of reversible phosphorylation include ubiquitin ligases, guanine nucleotide exchange factors, and at least 46 different transcriptional regulators. The dynamic phosphoproteorne provides a missing link in a global, integrative view of cellular regulation.	Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany	University of Southern Denmark; Max Planck Society	Blagoev, B (corresponding author), Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark.	bab@bmb.sdu.dk; mmann@biochem.mpg.de	Macek, Boris/N-1442-2015; Kumar, Chanchal/C-2901-2008; Mann, Matthias/A-3454-2013; Olsen, Jesper/C-4738-2008; Olsen, Jesper/ABH-4638-2020	Macek, Boris/0000-0002-1206-2458; Mann, Matthias/0000-0003-1292-4799; Olsen, Jesper/0000-0002-4747-4938; Blagoev, Blagoy/0000-0002-3596-0066; Gnad, Florian/0000-0002-2287-2251				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Amanchy R, 2005, J PROTEOME RES, V4, P1661, DOI 10.1021/pr050134h; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Chen WG, 2004, EXPERT REV PROTEOMIC, V1, P343, DOI 10.1586/14789450.1.3.343; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P10828; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; Devoy A, 2005, ESSAYS BIOCHEM, V41, P187, DOI 10.1042/EB0410187; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Mumby M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-230; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; *RDC TEAM R DEV CO, 2006, R LANG ENV STAT COMP; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Soderling SH, 2006, BIOCHEM SOC T, V34, P73, DOI 10.1042/BST0340073; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; STOVER DR, 2004, CLIN PROTEOM, V1, P69; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Ventura JJ, 2003, MOL CELL BIOL, V23, P2871, DOI 10.1128/MCB.23.8.2871-2882.2003; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	61	2684	4079	5	476	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2006	127	3					635	648		10.1016/j.cell.2006.09.026	http://dx.doi.org/10.1016/j.cell.2006.09.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	104DS	17081983	Bronze			2022-12-01	WOS:000241937000025
J	Zhu, SJ; Lin, SW; Kao, CF; Awasaki, T; Chiang, AS; Lee, T				Zhu, Sijun; Lin, Suewei; Kao, Chih-Fei; Awasaki, Takeshi; Chiang, Ann-Shyn; Lee, Tzumin			Gradients of the Drosophila Chinmo BTB-zinc finger protein govern neuronal temporal identity	CELL			English	Article							DEVELOPING NERVOUS-SYSTEM; MUSHROOM BODIES; OLFACTORY MAP; CELL-TYPES; PROGENITORS; NEUROBLAST; FATE; NEUROGENESIS; MELANOGASTER; RESTRICTION	Many neural progenitors, including Drosophila mushroom body (MB) and projection neuron (PN) neuroblasts, sequentially give rise to different subtypes of neurons throughout development. We identified a novel BTB-zinc finger protein, named Chinmo (Chronologically inappropriate morphogenesis), that governs neuronal temporal identity during postembryonic development of the Drosophila brain. In both MB and PN lineages, loss of Chinmo autonomously causes early-born neurons to adopt the fates of late-born neurons from the same lineages. Interestingly, primarily due to a posttranscriptional control, MB neurons born at early developmental stages contain more abundant Chinmo than their later-born siblings. Further, the temporal identity of MB progeny can be transformed toward earlier or later fates by reducing or increasing Chinmo levels, respectively. Taken together, we suggest that a temporal gradient of Chinmo (Chinmo(high) -> Chinmo(low)) helps specify distinct birth order-dependent cell fates in an extended neuronal lineage.	Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Massachusetts, Dept Neurol, Sch Med, Worcester, MA 01605 USA; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Massachusetts System; University of Massachusetts Worcester; National Tsing Hua University	Lee, T (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	tzumin.lee@umassmed.edu	Lin, Suewei/AAA-3962-2021; AWASAKI, Takeshi/AAO-7579-2021	Lin, Suewei/0000-0001-7079-7818; AWASAKI, Takeshi/0000-0003-2662-6389; Chiang, Ann-Shyn/0000-0001-9668-7115	NINDS NIH HHS [NS42049] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042049] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Belliveau MJ, 2000, J NEUROSCI, V20, P2247; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Brody T, 2002, DEVELOPMENT, V129, P3763; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Desai AR, 2000, DEVELOPMENT, V127, P2863; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JARMAN AP, 1993, DEVELOPMENT, V119, P19; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Rapaport DH, 2001, J NEUROBIOL, V49, P129, DOI 10.1002/neu.1070; Schmid A, 1999, DEVELOPMENT, V126, P4653; Soula C, 2001, DEVELOPMENT, V128, P1369; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; YANG MY, 1995, NEURON, V15, P45; Zhu SJ, 2005, J NEUROSCI, V25, P4189, DOI 10.1523/JNEUROSCI.0149-05.2005; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	29	162	163	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 20	2006	127	2					409	422		10.1016/j.cell.2006.08.045	http://dx.doi.org/10.1016/j.cell.2006.08.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	102QH	17055440	Bronze			2022-12-01	WOS:000241827100026
